data_2kep_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kep _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.234 0.274 0 N-CA-C 108.549 -0.908 . . . . 72.3 108.549 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -107.14 82.3 1.66 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.297 0.57 . . . . 63.24 111.669 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -154.55 159.06 32.28 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.177 -1.786 . . . . 75.52 106.177 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.99 138.48 52.53 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.673 2.249 . . . . 72.12 111.305 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 72.99 -35.94 0.34 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.073 1.349 . . . . 72.15 113.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -74.19 -25.54 59.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.5 64.64 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.878 -1.055 . . . . 72.53 109.847 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -85.32 -25.62 27.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.093 -1.077 . . . . 71.13 108.093 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 86.4 t -74.63 -44.36 46.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.239 -0.891 . . . . 75.42 109.545 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -65.7 -25.45 67.32 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 115.145 -0.934 . . . . 75.32 111.659 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.5 -49.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.747 -0.835 . . . . 74.33 108.747 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 54' ' ' ILE . . . -64.44 -24.74 67.73 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.987 -1.006 . . . . 72.04 112.064 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.1 mmmt -65.74 -26.41 67.72 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.604 0.716 . . . . 75.14 110.762 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.2 -26.94 29.48 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 110.005 -1.238 . . . . 73.22 110.005 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.615 ' O ' HG13 ' A' ' 57' ' ' ILE . 65.7 m-20 -78.26 -38.13 43.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.432 -0.384 . . . . 75.02 110.687 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 50' ' ' ALA . 19.8 pt -66.61 -38.19 81.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.355 -0.216 . . . . 74.1 111.082 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -69.0 -26.72 65.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.002 0.43 . . . . 70.31 110.121 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -66.93 -45.16 78.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 75.41 110.242 174.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 53' ' ' ASP . 34.1 mt -64.73 -42.27 94.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.729 -0.669 . . . . 71.21 109.507 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.15 -28.4 66.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.865 -0.607 . . . . 53.33 111.235 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.62 -30.1 29.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 72.21 110.02 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.67 -28.1 30.87 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.712 -0.677 . . . . 73.14 110.366 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.48 -30.7 71.09 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.822 -1.177 . . . . 75.12 107.822 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.615 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.8 t70 -71.22 -23.25 61.98 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 122.183 0.992 . . . . 71.11 109.273 173.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 mtt -83.59 -28.43 28.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.726 -0.67 . . . . 64.43 110.724 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.531 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 70.8 t80 -71.55 -36.06 70.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.553 -1.277 . . . . 74.4 107.553 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.637 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 74.8 tttt -53.95 -36.09 62.46 Favored 'General case' 0 C--O 1.208 -1.114 0 CA-C-N 114.917 -1.038 . . . . 72.12 109.108 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.8 tp -76.48 -36.73 57.69 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.011 -0.541 . . . . 74.34 111.333 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.538 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 19.0 t70 -71.95 -23.77 61.5 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 112.035 0.383 . . . . 75.1 112.035 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.2 20.03 5.84 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 109.13 -0.693 . . . . 71.34 109.13 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 p90 42.95 32.96 0.46 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.999 1.437 . . . . 73.44 113.602 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 159.1 0.99 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.762 -0.829 . . . . 73.34 108.762 -172.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.637 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 23.7 m-85 -78.55 151.48 77.41 Favored Pre-proline 0 N--CA 1.425 -1.717 0 O-C-N 123.486 0.491 . . . . 75.41 111.23 173.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 30.8 Cg_endo -66.28 162.26 36.89 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.349 2.7 . . . . 74.52 111.055 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.433 ' HG ' ' HB2' ' A' ' 76' ' ' GLN . 69.5 p -98.62 156.33 16.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.27 -1.752 . . . . 65.24 106.27 174.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -12.58 60.9 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 119.656 1.116 . . . . 73.1 111.765 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -102.09 -64.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.979 -0.45 . . . . 75.22 110.742 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.433 ' HB2' ' HG ' ' A' ' 73' ' ' SER . 14.9 mm100 -74.12 -40.87 62.37 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 110.253 -0.277 . . . . 70.11 110.253 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -74.49 -20.94 79.43 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.088 -1.529 . . . . 74.25 113.458 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.0 -47.37 62.47 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.567 -1.642 . . . . 72.33 106.567 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 30.4 mt-10 -60.98 -33.48 73.29 Favored 'General case' 0 C--O 1.169 -3.175 0 CA-C-N 114.994 -1.003 . . . . 75.02 110.347 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.35 -7.05 55.44 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.629 . . . . 52.23 111.811 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -95.92 -18.5 20.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.932 -0.576 . . . . 73.45 110.322 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.86 -34.32 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 116.2 -0.454 . . . . 74.44 111.863 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 42.7 pttt -125.97 152.29 45.89 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.564 -2.013 . . . . 74.14 105.564 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -54.74 135.08 64.97 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 118.956 0.798 . . . . 73.13 111.813 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.531 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 18.3 Cg_endo -60.87 125.05 16.19 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.944 3.096 . . . . 74.41 113.352 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.0 t -84.1 139.92 32.14 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.429 -1.323 . . . . 73.53 107.429 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.13 -131.84 8.35 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.682 -1.767 . . . . 75.3 108.682 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.15 97.4 32.0 Favored Pre-proline 0 C--N 1.299 -1.591 0 CA-C-N 118.088 0.944 . . . . 74.31 111.966 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -92.46 150.25 2.94 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.335 1.356 . . . . 73.54 109.568 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -79.66 160.33 69.8 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.044 -1.095 . . . . 73.3 108.044 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.6 97.63 0.27 Allowed 'Trans proline' 0 C--O 1.249 1.056 0 CA-C-N 120.602 1.251 . . . . 74.44 109.64 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.538 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . 8.2 tmtm? -152.74 147.29 25.91 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.924 -2.25 . . . . 73.54 104.924 -175.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -81.76 92.7 6.68 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.278 -0.969 . . . . 73.44 111.051 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.478 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.9 t90 -54.9 143.69 25.25 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.288 1.035 . . . . 73.31 111.584 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.37 137.2 53.43 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.855 0.862 . . . . 74.41 109.003 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -84.71 -169.06 2.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.011 -0.737 . . . . 72.21 109.011 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t0 71.1 12.47 6.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.304 1.442 . . . . 71.0 110.535 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.52 14.98 30.93 Favored Glycine 0 N--CA 1.425 -2.061 0 CA-C-N 114.341 -1.3 . . . . 74.34 112.946 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.478 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.43 91.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 122.633 1.206 . . . . 74.2 109.533 -174.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -123.92 171.26 9.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 113.91 -1.495 . . . . 73.21 109.282 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -94.12 -168.57 1.89 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.396 -1.335 . . . . 73.32 107.396 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.73 70.85 3.26 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.716 1.246 . . . . 75.51 110.535 175.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.1 mt -130.34 147.63 66.59 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 115.064 -0.971 . . . . 73.14 110.715 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.7 -168.52 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.395 2.063 . . . . 75.13 110.526 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.592 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -86.13 173.8 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.556 -0.905 . . . . 75.42 108.556 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' A' ' 107' ' ' PRO . 4.1 p-10 -72.77 157.58 88.59 Favored Pre-proline 0 C--O 1.249 1.068 0 CA-C-N 118.654 0.661 . . . . 74.32 111.786 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 24.3 Cg_endo -59.8 171.47 2.79 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.615 2.21 . . . . 65.24 113.197 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 68.45 15.09 9.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.503 1.521 . . . . 73.43 110.482 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.2 69.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.135 -0.939 . . . . 64.43 114.132 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.18 142.29 40.96 Favored Pre-proline 0 C--O 1.253 1.249 0 CA-C-N 117.76 0.78 . . . . 74.44 111.26 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.592 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 84.0 Cg_endo -85.04 147.74 10.45 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.491 2.127 . . . . 71.42 111.681 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.33 141.94 56.97 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.564 0.697 . . . . 74.33 110.627 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -104.63 112.84 26.07 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.772 -1.195 . . . . 74.32 107.772 176.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -117.4 118.9 33.48 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.955 -1.02 . . . . 75.3 109.585 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 70.2 mt -127.55 154.56 45.03 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.347 -1.353 . . . . 71.41 107.347 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.436 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . . . -104.13 -178.39 0.62 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 116.592 -1.671 . . . . 64.05 108.669 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 16.8 Cg_endo . . . . . 0 C--N 1.389 2.71 0 C-N-CA 123.269 2.646 . . . . 74.14 115.113 -165.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.474 -2.528 0 CA-C-O 119.095 -0.836 . . . . 72.12 114.334 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.555 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 2.7 Cg_exo -39.78 -20.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.217 1 C-N-CA 126.941 5.094 . . . . 73.25 116.967 176.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 48.6 p90 -164.85 168.41 17.74 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.739 0.7 . . . . 73.14 112.134 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.5 m-20 -139.93 107.02 5.45 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.642 1.177 . . . . 74.11 109.662 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.85 140.95 44.56 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 117.363 -1.735 . . . . 72.52 111.998 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 24.4 p90 -166.52 170.08 13.15 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 72.04 111.727 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 m -124.33 151.22 44.57 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 107.596 -1.261 . . . . 75.44 107.596 174.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.0 mt -74.96 157.89 34.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.854 0.359 . . . . 74.2 110.989 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.85 179.21 49.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.506 -0.854 . . . . 62.22 112.209 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.44 63.11 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.812 0.845 . . . . 74.33 112.882 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -94.79 3.38 55.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.397 0.617 . . . . 73.32 110.844 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.81 34.74 55.77 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 116.246 -0.434 . . . . 75.4 112.585 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -139.96 147.92 41.18 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.827 -0.186 . . . . 75.45 110.526 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.47 105.8 17.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.189 0.995 . . . . 75.42 110.649 173.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.11 -173.25 20.24 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 115.162 -0.926 . . . . 75.41 111.075 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.38 127.02 8.14 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 108.479 -1.848 . . . . 71.54 108.479 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 57.9 m 179.18 -176.76 0.27 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.264 -1.754 . . . . 75.32 106.264 -171.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.19 -71.86 0.45 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.763 0.711 . . . . 71.2 110.186 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -99.04 -6.12 29.09 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.134 0.492 . . . . 74.43 111.231 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 10.3 m-20 -100.58 7.85 43.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.384 0.611 . . . . 75.12 110.197 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . -89.48 156.62 18.53 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.482 -0.781 . . . . 60.52 110.874 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.17 129.05 34.05 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.706 -2.331 . . . . 73.52 104.706 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 22.8 pt -114.19 113.79 44.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 CA-C-O 121.663 0.744 . . . . 74.22 110.88 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.05 -179.68 40.72 Favored Glycine 0 N--CA 1.408 -3.184 0 N-CA-C 110.949 -0.86 . . . . 62.04 110.949 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.51 156.19 40.04 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 109.888 -0.412 . . . . 72.35 109.888 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 7.1 p90 -155.69 177.25 11.6 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 115.3 -0.864 . . . . 74.23 109.226 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -129.93 136.39 49.42 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 123.894 0.746 . . . . 75.21 110.079 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.526 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 30.6 t30 . . . . . 0 C--O 1.255 1.347 0 O-C-N 125.833 1.958 . . . . 75.43 107.299 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 112.224 0.453 . . . . 73.42 112.224 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -100.36 80.63 2.26 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.901 -1.148 . . . . 70.15 107.901 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -145.53 158.08 51.01 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.311 -1.366 . . . . 64.12 107.311 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.53 123.24 10.98 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.113 2.542 . . . . 74.12 111.873 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t70 75.62 -32.47 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 126.824 2.05 . . . . 40.23 111.772 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -69.87 -13.9 62.48 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.833 -0.542 . . . . 75.22 110.804 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.42 -27.83 69.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.451 -0.795 . . . . 74.21 109.254 171.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -82.08 -25.72 34.28 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 108.183 -1.043 . . . . 75.55 108.183 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.9 t -75.11 -43.99 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.656 0.741 . . . . 73.11 110.015 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 t -66.63 -38.26 86.55 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.91 -1.041 . . . . 75.33 110.993 -174.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.09 -30.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 119.819 -0.752 . . . . 74.44 110.064 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.41 81.39 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 115.789 -0.641 . . . . 62.13 111.51 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.649 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 67.8 mttm -66.05 -25.43 67.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.211 0.529 . . . . 64.55 111.435 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.73 -34.36 25.08 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.037 -1.225 . . . . 72.12 110.037 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.551 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 m-20 -77.1 -32.95 56.98 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.083 0.771 . . . . 73.02 113.083 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.77 -34.79 62.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.162 -0.336 . . . . 71.12 111.414 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.649 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.2 mptp? -69.92 -30.19 67.54 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.531 0.682 . . . . 75.43 109.782 176.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.19 -44.5 91.81 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.175 -0.921 . . . . 64.43 110.21 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 53' ' ' ASP . 76.1 mt -60.9 -39.22 81.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.074 -0.967 . . . . 74.52 110.152 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HB3' ' ND2' ' A' ' 145' ' ' ASN . . . -57.73 -35.47 70.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.249 0.343 . . . . 73.44 111.529 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.14 -34.28 70.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.999 0.428 . . . . 73.44 110.112 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.26 -29.35 48.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.476 . . . . 71.34 110.26 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.19 -29.73 67.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.349 -1.352 . . . . 70.25 107.349 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.569 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 38.9 m-20 -69.79 -24.46 63.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.509 -0.769 . . . . 72.51 110.961 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.7 mtm -79.25 -34.35 42.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.426 -0.91 . . . . 72.12 109.954 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.434 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 90.5 t80 -65.43 -36.79 84.98 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 107.648 -1.242 . . . . 74.14 107.648 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 37.8 ttpt -54.32 -37.74 65.2 Favored 'General case' 0 C--O 1.203 -1.381 0 CA-C-N 115.419 -0.81 . . . . 73.55 110.103 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.04 -27.68 23.04 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.819 -0.752 . . . . 73.14 112.576 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.578 ' HA ' ' O ' ' A' ' 90' ' ' GLN . 12.7 t70 -76.41 -25.48 54.55 Favored 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 120.034 -0.666 . . . . 71.22 111.289 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -121.2 22.37 10.91 Favored 'General case' 0 CA--C 1.458 -2.573 0 O-C-N 120.92 -1.112 . . . . 72.42 110.257 174.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 p90 43.29 32.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 125.111 1.507 . . . . 74.12 113.366 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.5 157.35 0.47 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.797 -1.186 . . . . 65.03 107.797 -173.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 17.0 m-85 -76.07 156.03 84.23 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 109.067 -0.716 . . . . 73.1 109.067 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 36.3 Cg_endo -64.05 156.78 56.85 Favored 'Trans proline' 0 C--O 1.217 -0.557 0 C-N-CA 122.606 2.204 . . . . 73.43 112.2 -177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.406 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 62.8 p -93.49 155.38 17.37 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.992 -2.225 . . . . 65.25 104.992 171.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -8.48 55.19 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 119.716 1.144 . . . . 75.14 111.097 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -102.58 -66.01 0.96 Allowed 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.903 -0.589 . . . . 75.43 110.741 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -81.13 -35.53 31.44 Favored 'General case' 0 CA--C 1.467 -2.227 0 O-C-N 121.287 -0.883 . . . . 65.31 112.589 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -72.56 -21.58 79.45 Favored Glycine 0 N--CA 1.417 -2.631 0 C-N-CA 118.014 -2.041 . . . . 73.12 111.562 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.78 -43.62 62.58 Favored 'General case' 0 C--O 1.246 0.912 0 N-CA-C 105.995 -1.854 . . . . 73.11 105.995 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -61.44 -36.53 80.63 Favored 'General case' 0 C--O 1.192 -1.94 0 CA-C-N 114.473 -1.24 . . . . 74.01 110.349 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -84.54 -3.01 58.2 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.697 0.799 . . . . 74.3 112.598 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 58.0 mt -93.99 -27.31 16.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.498 -0.556 . . . . 73.24 109.498 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.07 -37.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.762 -0.654 . . . . 74.12 111.382 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.443 ' HB2' ' HZ2' ' A' ' 83' ' ' LYS . 4.9 ttmp? -118.65 149.22 41.77 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.48 -1.674 . . . . 73.23 106.48 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -54.69 132.98 65.05 Favored Pre-proline 0 C--O 1.245 0.83 0 CA-C-O 120.767 0.318 . . . . 71.55 111.246 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -58.41 153.26 48.74 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 124.792 3.661 . . . . 54.45 113.9 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.7 p -90.94 137.82 32.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.38 -0.827 . . . . 72.5 110.174 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.39 -161.33 18.99 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.997 -1.241 . . . . 72.52 109.997 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -111.75 105.08 56.59 Favored Pre-proline 0 N--CA 1.391 -3.378 0 N-CA-C 108.864 -0.791 . . . . 71.14 108.864 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 3.0 Cg_endo -86.31 162.56 9.82 Favored 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 122.954 2.436 . . . . 74.13 110.242 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' A' ' 67' ' ' ASP . 81.2 mm-40 -91.3 111.41 48.66 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 109.608 -0.515 . . . . 74.33 109.608 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -51.1 101.51 0.05 OUTLIER 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 124.336 3.357 . . . . 74.41 117.936 -166.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -135.84 83.52 2.02 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.254 -1.017 . . . . 74.32 108.254 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 16.01 84.16 0.01 OUTLIER 'General case' 0 C--O 1.247 0.929 0 C-N-CA 127.676 2.391 . . . . 73.5 114.058 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.674 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -55.68 137.56 49.13 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.085 0.469 . . . . 71.05 110.917 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.08 129.21 35.67 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.258 -0.883 . . . . 74.41 109.719 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.38 174.27 8.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.876 0.846 . . . . 74.33 110.929 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 66.02 28.55 10.41 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.924 -1.489 . . . . 72.1 110.407 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 99.41 16.38 29.71 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.054 -1.43 . . . . 62.54 115.313 165.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.674 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 2.5 m-85 63.04 90.15 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 122.492 1.139 . . . . 74.13 111.608 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 mt -117.64 171.8 7.78 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.82 -1.082 . . . . 72.45 112.224 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -93.47 -163.4 1.04 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 112.955 -1.93 . . . . 74.3 107.454 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.47 28.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.717 1.207 . . . . 73.15 112.944 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -107.36 148.14 36.57 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.766 -0.584 . . . . 74.22 111.342 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.15 -167.74 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.111 2.54 . . . . 71.25 110.041 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.97 167.89 2.12 Favored 'Isoleucine or valine' 0 C--O 1.258 1.527 0 N-CA-C 108.287 -1.005 . . . . 74.3 108.287 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.412 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 t70 -79.87 151.81 73.95 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 119.761 -0.776 . . . . 50.41 109.554 -171.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 59.7 Cg_exo -44.85 171.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 124.082 3.188 . . . . 54.43 113.953 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.466 ' CD1' ' HA ' ' A' ' 130' ' ' ALA . 2.3 m-90 69.91 14.28 7.93 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 126.127 1.771 . . . . 74.35 109.287 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.78 21.19 58.03 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 114.765 -1.107 . . . . 54.1 112.773 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -92.96 120.86 66.81 Favored Pre-proline 0 C--O 1.254 1.341 0 N-CA-C 112.881 0.697 . . . . 71.51 112.881 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.631 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.1 Cg_exo -59.6 143.91 99.55 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.592 2.195 . . . . 71.52 111.138 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 43.2 m-85 -69.39 143.1 53.76 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.605 -1.258 . . . . 73.23 107.605 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.507 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -103.07 119.65 39.25 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.196 -1.409 . . . . 75.24 107.196 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.26 117.93 34.97 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.289 0.566 . . . . 75.32 111.118 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.9 mt -128.8 153.7 47.15 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.525 -0.761 . . . . 65.35 109.044 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.449 ' HB2' ' HD2' ' A' ' 117' ' ' PRO . . . -113.91 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.408 -2.571 0 CA-C-O 117.89 -1.052 . . . . 71.43 109.597 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 32.2 Cg_endo . . . . . 0 C--N 1.377 2.075 0 C-N-CA 122.493 2.129 . . . . 75.1 114.699 -171.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.483 -1.937 0 CA-C-O 118.136 -1.369 . . . . 64.43 113.431 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 23.2 Cg_exo -41.37 -23.66 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.473 1 C-N-CA 126.905 5.07 . . . . 74.1 117.467 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 146' ' ' TRP . 54.8 p90 -179.51 170.14 1.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.364 0.529 . . . . 73.31 110.114 173.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -137.41 109.0 6.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.997 -0.742 . . . . 73.44 108.997 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.24 126.29 51.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.54 -0.911 . . . . 72.34 108.54 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 113' ' ' GLN . 29.8 p90 -166.92 162.77 15.96 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 122.851 0.094 . . . . 74.4 110.771 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.418 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 23.0 t -126.07 143.13 51.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.9 -1.518 . . . . 73.23 106.9 171.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.507 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 87.8 mt -60.07 136.27 57.97 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.351 0.407 . . . . 73.51 110.067 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 141' ' ' ALA . . . -75.32 -164.49 13.84 Favored Glycine 0 C--O 1.229 -0.195 0 C-N-CA 121.111 -0.566 . . . . 44.32 114.058 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 108' ' ' TRP . . . -55.37 -34.47 64.34 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.5 0.926 . . . . 73.04 113.5 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.13 -2.23 53.04 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.707 0.765 . . . . 70.03 109.348 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.73 17.22 80.08 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.8 -0.92 . . . . 74.34 110.8 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -100.46 144.85 28.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 112.072 0.397 . . . . 75.43 112.072 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.11 101.14 11.45 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 103.005 -2.961 . . . . 72.43 103.005 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.24 -173.02 22.76 Favored Glycine 0 CA--C 1.497 -1.093 0 CA-C-N 114.387 -1.278 . . . . 74.13 110.984 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.63 126.54 8.22 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 108.377 -1.889 . . . . 74.34 108.377 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.478 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 39.6 m 178.07 -178.7 0.26 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 126.746 2.019 . . . . 73.43 106.224 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.76 -58.29 2.14 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.683 -0.858 . . . . 73.11 108.683 171.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -89.09 -38.58 14.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.272 -0.876 . . . . 75.34 111.846 -175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -90.45 8.68 32.55 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.177 0.513 . . . . 73.52 111.313 -174.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.478 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -104.87 157.54 17.14 Favored 'General case' 0 CA--C 1.477 -1.835 0 CA-C-N 115.585 -0.734 . . . . 74.31 109.828 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.73 136.47 38.17 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 107.149 -1.426 . . . . 73.31 107.149 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.432 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -94.73 118.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 121.622 0.725 . . . . 65.4 109.274 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.19 157.0 25.9 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.595 -1.288 . . . . 74.12 114.421 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.513 ' ND2' ' HB3' ' A' ' 58' ' ' ALA . 4.4 t30 -148.92 129.53 14.03 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 125.208 1.403 . . . . 75.05 107.571 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.465 ' HA ' ' CE1' ' A' ' 123' ' ' PHE . 5.1 p90 -160.63 177.18 10.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.212 0.529 . . . . 72.14 111.439 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -115.63 134.27 55.21 Favored 'General case' 0 CA--C 1.472 -2.031 0 N-CA-C 107.725 -1.213 . . . . 64.44 107.725 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 24.9 t-20 . . . . . 0 C--N 1.292 -1.927 0 N-CA-C 107.713 -1.217 . . . . 74.21 107.713 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.431 ' H1 ' ' CB ' ' A' ' 48' ' ' THR . 1.4 mpt? . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.226 -0.657 . . . . 74.4 109.226 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 m -97.58 74.11 2.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.401 0.619 . . . . 53.25 110.339 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -148.49 158.5 40.42 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.054 -0.975 . . . . 75.14 108.472 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 44' ' ' GLN . 76.1 Cg_exo -50.63 121.25 7.63 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.633 2.889 . . . . 74.13 112.771 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t0 76.88 -26.4 0.19 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.023 1.729 . . . . 72.43 110.778 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.449 ' H ' ' C ' ' A' ' 42' ' ' PRO . 73.2 mm-40 -70.96 -17.0 62.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.204 -0.907 . . . . 73.15 108.702 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.37 68.91 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.231 -0.895 . . . . 74.32 109.75 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 55.3 mttp -83.75 -25.68 30.31 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 108.549 -0.908 . . . . 71.54 108.549 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 52.0 t -74.79 -43.03 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.615 0.722 . . . . 74.01 109.494 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.431 ' CB ' ' H1 ' ' A' ' 39' ' ' MET . 7.4 t -63.99 -31.85 73.18 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.034 -0.984 . . . . 72.25 111.718 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -79.8 -39.63 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 119.533 -0.867 . . . . 73.02 109.565 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.22 80.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.254 1.022 . . . . 71.23 112.356 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -65.72 -24.92 67.08 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.256 0.551 . . . . 73.45 111.141 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.21 -27.88 21.86 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.093 -0.803 . . . . 64.53 111.093 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.75 -38.98 57.94 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.168 0.509 . . . . 73.1 110.624 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 pt -66.31 -35.12 74.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.011 -0.541 . . . . 75.52 109.897 174.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 9.6 tptp -68.89 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 74.33 109.74 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.54 -40.73 97.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.31 -0.859 . . . . 70.44 109.614 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 99' ' ' TYR . 74.3 mt -66.14 -35.12 74.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 115.014 -0.994 . . . . 72.41 110.665 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -27.49 69.29 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.279 0.562 . . . . 75.54 111.018 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.19 -33.44 29.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.695 0.759 . . . . 71.34 109.413 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.12 53.71 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.562 -0.745 . . . . 61.31 110.886 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -68.27 -30.18 69.14 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 72.44 108.571 178.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.516 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 3.2 t70 -66.49 -30.43 70.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 71.43 109.64 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 88.8 mtp -74.66 -33.92 62.61 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.962 -0.563 . . . . 75.3 110.212 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -71.55 -36.18 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.219 -0.66 . . . . 74.25 109.219 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.602 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 15.5 pttp -67.74 -16.39 64.11 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 119.123 -1.031 . . . . 72.42 109.269 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.1 tp -88.65 -36.12 16.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.838 -1.074 . . . . 75.53 109.808 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 23.9 t70 -75.17 -24.55 57.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.026 0.38 . . . . 73.24 112.026 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.77 24.48 5.71 Favored 'General case' 0 CA--C 1.464 -2.361 0 C-N-CA 119.747 -0.781 . . . . 75.5 109.637 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.34 32.48 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.418 1.487 . . . . 74.43 113.925 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.03 161.23 0.57 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.701 -1.222 . . . . 73.33 107.701 -174.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.602 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 16.4 m-85 -77.14 155.07 82.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 123.475 0.485 . . . . 73.24 110.816 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.457 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.0 Cg_endo -63.59 162.12 29.11 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.142 2.561 . . . . 73.14 112.457 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.0 p -98.32 155.24 17.3 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 105.507 -2.034 . . . . 73.35 105.507 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.43 ' CA ' ' HB1' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.79 -11.55 60.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 119.56 1.073 . . . . 74.34 111.549 -173.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -102.02 -65.42 0.99 Allowed 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.855 -0.612 . . . . 72.31 110.295 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -77.14 -39.52 48.95 Favored 'General case' 0 CA--C 1.493 -1.222 0 O-C-N 122.079 -0.388 . . . . 74.32 111.044 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.587 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -77.18 -21.17 74.09 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 118.529 -1.796 . . . . 62.45 112.961 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 82' ' ' VAL . 6.3 tt -70.27 -49.99 44.16 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.644 -1.243 . . . . 74.13 107.644 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.3 -23.92 64.8 Favored 'General case' 0 C--O 1.188 -2.139 0 CA-C-N 115.289 -0.868 . . . . 75.5 110.104 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.21 -7.11 58.82 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.164 -0.471 . . . . 73.12 111.945 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 96.4 mt -91.56 -24.82 19.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.646 -0.872 . . . . 72.3 108.646 171.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 78' ' ' LEU . 21.8 t -90.84 -47.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.964 -1.016 . . . . 72.25 110.942 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -117.75 151.25 37.66 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 125.904 1.681 . . . . 73.13 108.411 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.435 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -53.34 129.49 51.66 Favored Pre-proline 0 C--O 1.249 1.059 0 N-CA-C 108.955 -0.757 . . . . 71.42 108.955 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -58.5 127.36 24.37 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 124.067 3.178 . . . . 62.32 113.05 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -93.16 107.94 19.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.503 -0.771 . . . . 74.42 110.155 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.49 -133.06 3.94 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 109.065 -1.614 . . . . 43.42 109.065 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -125.02 87.79 54.97 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 117.781 0.791 . . . . 63.44 112.733 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.85 163.0 6.13 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 122.818 2.345 . . . . 65.01 108.455 171.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -108.37 148.03 36.82 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 108.952 -0.759 . . . . 75.43 108.952 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.458 ' C ' ' HD2' ' A' ' 92' ' ' LYS . 74.5 Cg_exo -50.82 98.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.63 2.886 . . . . 62.45 116.089 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.458 ' HD2' ' C ' ' A' ' 91' ' ' PRO . 2.6 mptp? -147.27 148.75 31.76 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 127.641 2.377 . . . . 75.14 106.618 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -73.69 89.27 1.76 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 111.632 0.234 . . . . 73.03 111.632 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.614 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.2 t90 -54.96 143.76 25.29 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.59 1.156 . . . . 74.31 112.224 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.548 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 15.5 t-20 -126.39 137.02 53.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.158 -0.928 . . . . 73.03 111.137 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -86.23 173.79 9.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.659 0.742 . . . . 74.14 111.502 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.9 t70 69.08 15.32 8.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.497 -1.229 . . . . 64.05 112.435 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 119.6 8.81 8.84 Favored Glycine 0 CA--C 1.494 -1.276 0 C-N-CA 119.529 -1.319 . . . . 63.1 114.437 168.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.614 ' OH ' ' HA ' ' A' ' 94' ' ' TRP 0.268 0.3 OUTLIER 65.67 78.56 0.27 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 123.231 1.491 . . . . 75.12 110.787 -174.458 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -121.42 169.09 10.97 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 112.715 -2.038 . . . . 73.11 107.769 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.01 -164.5 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.26 -1.015 . . . . 73.33 108.26 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.45 68.34 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 122.655 1.217 . . . . 74.22 109.275 173.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 148.63 70.84 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 114.564 -1.198 . . . . 74.42 111.0 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -168.2 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.058 2.505 . . . . 72.11 110.795 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.636 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 9.6 p -79.59 166.47 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 108.95 -0.759 . . . . 72.52 108.95 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.37 153.88 76.63 Favored Pre-proline 0 C--O 1.252 1.194 0 N-CA-C 108.805 -0.813 . . . . 65.03 108.805 -172.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.0 172.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.432 2.755 . . . . 74.22 114.549 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.457 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 2.2 m-90 69.92 15.16 7.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.64 1.976 . . . . 73.32 109.66 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 13.67 52.77 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.83 -1.077 . . . . 72.43 114.152 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.15 132.96 43.81 Favored Pre-proline 0 N--CA 1.424 -1.769 0 CA-C-O 121.832 0.825 . . . . 74.53 111.595 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.636 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 71.8 Cg_endo -75.13 154.94 42.23 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 122.716 2.278 . . . . 70.53 111.142 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.68 136.37 48.99 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 106.898 -1.519 . . . . 74.44 106.898 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -102.66 114.06 27.97 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 105.225 -2.139 . . . . 73.42 105.225 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -104.4 118.35 36.4 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.303 -0.862 . . . . 65.02 109.996 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 93.5 mt -129.35 153.18 48.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.758 -0.83 . . . . 71.3 108.758 176.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -108.78 -177.31 0.46 Allowed Pre-proline 0 N--CA 1.412 -2.35 0 CA-C-O 116.588 -1.672 . . . . 74.35 107.633 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.735 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 18.2 Cg_endo . . . . . 0 C--N 1.386 2.54 0 C-N-CA 122.653 2.235 . . . . 74.04 115.35 -165.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.735 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.489 -1.561 0 CA-C-O 118.986 -0.897 . . . . 72.05 114.597 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.582 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -39.2 -20.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.062 1 C-N-CA 127.201 5.267 . . . . 64.32 118.025 177.415 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -170.98 165.65 7.57 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.605 0.639 . . . . 74.33 110.059 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 19.6 m-20 -135.08 110.37 8.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.487 -0.931 . . . . 75.03 108.487 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.404 HD11 ' C ' ' A' ' 125' ' ' LEU . 3.4 tm? -118.81 129.54 55.28 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.116 -0.698 . . . . 74.53 109.116 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -166.97 168.72 13.65 Favored 'General case' 0 C--O 1.204 -1.322 0 O-C-N 123.492 0.495 . . . . 72.44 109.9 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 15.6 m -124.13 142.28 51.35 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.354 -2.091 . . . . 74.03 105.354 171.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.44 143.09 50.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.932 -0.707 . . . . 71.52 111.748 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.68 174.48 11.09 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 116.026 -0.534 . . . . 75.12 113.826 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.96 5.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.593 1.331 . . . . 65.33 114.593 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.12 -10.18 34.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.365 -0.976 . . . . 71.03 108.365 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.74 88.16 Favored Glycine 0 CA--C 1.507 -0.434 0 CA-C-N 115.502 -0.772 . . . . 33.13 111.534 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -140.62 151.31 44.53 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 106.486 -1.672 . . . . 75.02 106.486 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.649 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -66.75 113.02 4.54 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.86 -0.422 . . . . 74.22 109.86 -173.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -140.52 -173.34 13.36 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 116.29 -0.414 . . . . 73.03 112.696 -174.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -139.8 127.84 3.72 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.333 -0.937 . . . . 42.11 111.782 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.519 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 74.2 m 178.81 -177.98 0.29 Allowed 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 128.38 2.672 . . . . 70.41 105.07 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.14 -54.0 47.31 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.862 1.21 . . . . 71.34 111.454 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.12 -14.63 15.33 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.629 -0.829 . . . . 74.33 112.468 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 16.7 m-20 -95.31 9.37 40.08 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.774 -0.77 . . . . 73.33 111.21 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . -87.41 155.08 20.18 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 109.059 -0.719 . . . . 61.23 109.059 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.649 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 42.1 m-20 -79.26 124.09 28.05 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.09 -1.818 . . . . 74.23 106.09 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.19 120.82 46.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 CA-C-N 115.956 -0.565 . . . . 73.24 109.95 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.28 177.54 40.61 Favored Glycine 0 N--CA 1.412 -2.964 0 C-N-CA 119.348 -1.406 . . . . 63.43 112.878 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.436 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -162.02 158.67 25.35 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.112 -1.81 . . . . 73.13 106.112 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -168.94 177.57 4.9 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.429 0.633 . . . . 65.44 112.623 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -109.88 121.61 45.62 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.611 -1.626 . . . . 74.04 106.611 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.342 0 O-C-N 124.24 0.962 . . . . 71.41 110.557 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 N-CA-C 106.135 -1.802 . . . . 74.23 106.135 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -113.47 83.38 1.83 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.828 0.677 . . . . 73.54 112.828 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -153.22 165.83 16.82 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.088 -1.449 . . . . 75.05 107.088 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -49.24 139.35 27.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.55 2.167 . . . . 74.12 111.043 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.15 -49.0 0.53 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.258 1.423 . . . . 63.25 110.0 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.439 ' OE1' ' HB3' ' A' ' 138' ' ' ASP . 74.8 mm-40 -68.52 -23.36 64.53 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.419 -1.264 . . . . 75.21 110.166 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.09 -26.37 68.19 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.504 0.722 . . . . 71.23 110.579 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -85.46 -24.19 27.51 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.39 -0.596 . . . . 72.03 109.39 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.18 -42.18 51.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.955 -0.757 . . . . 75.35 108.955 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.7 t -67.84 -25.88 65.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.471 -0.786 . . . . 74.33 112.387 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.8 -37.79 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 119.609 -0.836 . . . . 74.41 109.462 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 143' ' ' ILE . . . -58.73 -33.93 70.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.252 1.021 . . . . 72.33 111.505 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.503 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 73.7 mmtt -65.44 -26.15 67.83 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.801 0.81 . . . . 73.04 110.217 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.56 -33.31 10.34 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.378 -1.089 . . . . 71.2 110.378 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -71.95 -33.7 68.4 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.999 0.428 . . . . 63.51 111.718 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.474 HD12 ' C ' ' A' ' 144' ' ' GLY . 11.5 pt -68.04 -34.09 64.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.8 -0.36 . . . . 75.34 110.28 172.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 14.0 mptt -65.76 -29.79 70.34 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.997 0.427 . . . . 75.44 110.787 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.42 93.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 71.32 110.011 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.3 mt -67.15 -34.31 68.67 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-N 115.191 -0.913 . . . . 73.41 110.627 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.511 ' HB1' ' OD1' ' A' ' 145' ' ' ASN . . . -59.68 -35.63 74.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.944 0.402 . . . . 63.45 110.448 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.86 -31.9 63.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.298 0.571 . . . . 63.04 109.903 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.02 -28.3 43.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.801 -0.636 . . . . 74.12 110.601 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.79 -31.15 69.95 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.361 -1.348 . . . . 75.43 107.361 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.7 m-20 -72.79 -18.26 61.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.72 -0.673 . . . . 70.11 110.353 171.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.7 mtm -84.26 -31.16 25.1 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 121.995 -0.441 . . . . 74.11 111.632 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.64 -37.11 70.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.07 -1.456 . . . . 74.2 107.07 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HD2' ' CE1' ' A' ' 71' ' ' TYR . 86.0 tttt -54.94 -31.28 60.29 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.733 -1.121 . . . . 75.25 109.605 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.5 tp -83.5 -35.41 24.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.479 -0.782 . . . . 74.11 110.531 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.407 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 23.6 t70 -78.49 -25.55 45.74 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.209 0.448 . . . . 65.4 112.209 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.566 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.9 OUTLIER -125.94 22.35 7.39 Favored 'General case' 0 CA--C 1.461 -2.457 0 O-C-N 121.398 -0.814 . . . . 70.24 110.881 175.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 p90 43.18 34.16 0.65 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.858 1.263 . . . . 63.31 113.703 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.7 161.3 0.67 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.664 -1.236 . . . . 75.01 107.664 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 65' ' ' LYS . 12.3 m-85 -75.9 161.47 75.58 Favored Pre-proline 0 C--N 1.309 -1.172 0 O-C-N 123.367 0.417 . . . . 73.54 111.717 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.519 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 1.7 Cg_endo -78.44 164.11 26.58 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.226 1.951 . . . . 74.55 109.363 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 p -97.78 156.43 16.57 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.931 -1.877 . . . . 60.41 105.931 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -4.12 31.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.13 -1.428 . . . . 62.23 111.051 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -102.8 -67.65 0.87 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.772 -0.649 . . . . 75.11 109.648 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -80.58 -34.99 34.88 Favored 'General case' 0 CA--C 1.487 -1.481 0 CA-C-N 115.973 -0.558 . . . . 71.24 111.468 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.554 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.34 -20.51 78.78 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 118.225 -1.941 . . . . 71.35 112.696 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.97 -50.86 37.63 Favored 'General case' 0 C--O 1.26 1.606 0 N-CA-C 107.53 -1.285 . . . . 70.2 107.53 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 8.5 pt-20 -65.19 -28.25 69.26 Favored 'General case' 0 C--O 1.17 -3.09 0 CA-C-N 114.866 -1.061 . . . . 73.41 109.824 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -77.44 -6.16 52.44 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.629 0.603 . . . . 60.13 112.629 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 95.5 mt -95.38 -19.43 19.93 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.161 0.505 . . . . 65.34 110.014 172.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.5 t -98.53 -39.43 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.565 1.174 . . . . 73.2 110.715 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 25.1 tttm -121.29 148.3 44.49 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 127.521 2.328 . . . . 71.23 107.659 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -56.76 132.84 78.66 Favored Pre-proline 0 N--CA 1.475 0.775 0 O-C-N 123.141 0.275 . . . . 74.05 111.542 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 37.6 Cg_endo -63.44 128.74 23.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 123.327 2.684 . . . . 74.31 112.096 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -90.99 105.5 17.87 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.5 -0.773 . . . . 75.33 110.238 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.27 7.69 Favored Glycine 0 N--CA 1.418 -2.528 0 N-CA-C 109.906 -1.278 . . . . 73.12 109.906 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -118.62 88.2 33.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.936 0.368 . . . . 74.15 110.902 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.566 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 13.8 Cg_endo -92.69 159.4 2.86 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.707 1.605 . . . . 63.12 109.438 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -88.21 159.12 48.47 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.047 -0.723 . . . . 74.42 109.047 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.39 99.21 0.2 Allowed 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 121.692 1.595 . . . . 75.43 111.427 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.55 148.25 28.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.899 -1.889 . . . . 75.1 105.899 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.585 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 51.3 m-80 -65.48 91.36 0.12 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 122.373 -0.204 . . . . 74.44 111.503 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.509 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.2 t90 -66.6 140.27 57.93 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.483 -0.562 . . . . 74.32 109.483 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -127.95 134.47 49.31 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.811 -0.811 . . . . 72.15 108.811 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -75.58 -169.36 1.02 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.319 -0.993 . . . . 74.0 108.319 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.7 t70 67.64 15.3 9.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.973 0.892 . . . . 71.32 110.819 169.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 102.95 9.79 38.86 Favored Glycine 0 CA--C 1.495 -1.214 0 CA-C-N 114.995 -1.002 . . . . 73.33 113.855 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.509 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.2 OUTLIER 61.88 92.37 0.06 Allowed 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 122.085 0.945 . . . . 74.34 109.601 -173.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.422 HD22 ' H ' ' A' ' 101' ' ' LYS . 2.7 tt -128.91 155.63 44.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.014 -1.847 . . . . 74.44 106.014 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.422 ' H ' HD22 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.97 -171.93 0.35 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.053 -0.351 . . . . 64.25 110.053 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 28.81 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.797 1.036 . . . . 63.13 113.797 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 101' ' ' LYS . 3.5 mm? -105.41 147.99 35.55 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 109.296 -0.631 . . . . 75.4 109.296 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.98 -167.96 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.975 2.45 . . . . 71.34 111.897 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.582 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.0 175.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.417 -0.957 . . . . 73.35 108.417 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.584 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.7 t70 -78.73 159.92 73.04 Favored Pre-proline 0 C--O 1.256 1.44 0 CA-C-N 119.081 0.855 . . . . 72.12 109.173 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 4.0 Cg_endo -49.05 170.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 123.551 2.834 . . . . 53.42 113.242 173.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 66.71 14.56 9.83 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.437 1.895 . . . . 73.3 110.931 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 -0.65 34.86 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.804 -0.635 . . . . 74.31 114.002 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.9 135.45 87.6 Favored Pre-proline 0 C--O 1.263 1.791 0 CA-C-O 121.451 0.643 . . . . 74.34 112.077 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.582 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 92.2 Cg_endo -80.22 154.12 21.82 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 C-N-CA 122.118 1.879 . . . . 73.43 110.035 174.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -74.4 143.17 44.9 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.651 -1.24 . . . . 73.45 107.651 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -102.18 113.89 27.56 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 104.656 -2.35 . . . . 74.34 104.656 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.56 118.21 36.49 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.988 -1.006 . . . . 74.33 111.882 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 87.8 mt -129.11 144.19 51.12 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.107 -0.951 . . . . 74.02 109.242 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -101.59 -177.0 0.5 Allowed Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 104.404 -2.443 . . . . 75.21 104.404 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 10.2 Cg_endo . . . . . 0 C--N 1.385 2.491 0 CA-C-N 123.179 2.171 . . . . 73.34 113.015 -168.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.491 -1.415 0 CA-C-O 118.887 -0.951 . . . . 74.22 114.112 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.484 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 33.5 Cg_exo -38.61 -27.08 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.131 1 C-N-CA 127.163 5.242 . . . . 75.23 117.992 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -173.2 146.71 1.47 Allowed 'General case' 0 C--O 1.249 1.039 0 CA-C-N 119.071 0.85 . . . . 74.3 111.859 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 1.2 m-20 -118.48 106.61 12.86 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.142 -1.429 . . . . 71.43 107.142 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.3 129.52 46.45 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 120.886 -1.134 . . . . 74.04 110.76 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -165.21 166.46 18.88 Favored 'General case' 0 C--O 1.194 -1.832 0 CA-C-N 116.845 -0.161 . . . . 73.24 111.251 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.0 t -125.28 139.94 53.27 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 63.11 105.649 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.13 155.29 20.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.914 1.079 . . . . 74.12 113.914 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.75 165.15 37.76 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 110.774 -0.931 . . . . 71.41 110.774 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.46 -24.01 4.56 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 115.924 1.824 . . . . 75.33 115.924 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.27 -1.72 28.34 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.575 -0.703 . . . . 74.02 111.603 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.49 38.49 5.0 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.466 -0.873 . . . . 72.22 113.813 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -130.34 147.84 52.1 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.305 -0.628 . . . . 73.03 109.305 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 9.4 pt-20 -101.89 105.46 16.28 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.077 -1.453 . . . . 74.23 107.077 167.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.18 -173.73 21.39 Favored Glycine 0 C--N 1.29 -1.991 0 N-CA-C 110.395 -1.082 . . . . 55.2 110.395 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.91 129.78 10.01 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.687 -1.365 . . . . 65.45 109.687 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.558 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 39.9 t 179.59 -178.39 0.38 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.735 -1.58 . . . . 70.22 106.735 -172.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.439 ' HB3' ' OE1' ' A' ' 44' ' ' GLN . 4.3 m-20 -87.26 -66.8 0.87 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.345 -0.613 . . . . 74.35 109.345 173.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.83 -30.73 14.67 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.928 -1.033 . . . . 74.44 111.908 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.76 17.88 16.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.649 0.738 . . . . 70.04 110.907 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.558 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -100.67 155.75 17.71 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-N 114.943 -1.026 . . . . 71.11 109.554 176.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.8 p-10 -79.13 135.06 36.72 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.397 -1.334 . . . . 74.43 107.397 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.555 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -104.18 123.64 58.11 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-N 115.728 -0.669 . . . . 75.34 109.623 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -159.29 179.81 34.63 Favored Glycine 0 N--CA 1.412 -2.911 0 C-N-CA 118.878 -1.63 . . . . 74.41 112.702 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.511 ' OD1' ' HB1' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -137.5 150.4 47.52 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 105.774 -1.935 . . . . 63.41 105.774 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -143.87 144.54 31.79 Favored 'General case' 0 C--N 1.267 -3.013 0 C-N-CA 119.269 -0.972 . . . . 72.21 110.003 -165.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -127.38 95.68 4.34 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.87 -1.53 . . . . 65.45 106.87 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.6 t30 . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 113.816 -1.538 . . . . 72.22 107.676 -176.725 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.8 ttt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.55 -1.278 . . . . 71.14 107.55 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.9 m -104.94 86.66 2.49 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.902 0.704 . . . . 71.43 112.902 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -153.77 159.75 31.72 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.184 -1.413 . . . . 73.42 107.184 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.09 125.55 16.55 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.681 2.254 . . . . 74.34 111.787 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 75.95 -33.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.779 2.032 . . . . 64.1 111.55 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -70.0 -20.7 63.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.784 0.802 . . . . 73.2 109.217 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.85 64.29 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.715 -1.13 . . . . 72.02 110.13 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.432 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 91.6 mttt -89.25 -25.08 21.9 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.766 -0.827 . . . . 75.02 108.766 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.39 -43.89 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 108.34 -0.985 . . . . 75.21 108.34 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.0 t -66.26 -29.59 69.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.403 -1.271 . . . . 73.25 111.831 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -83.87 -33.75 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.039 -0.665 . . . . 73.41 110.248 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.95 -34.27 68.86 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.752 -0.658 . . . . 73.14 111.587 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.612 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 57.2 mtpt -70.39 -25.45 63.25 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.769 -0.772 . . . . 74.1 111.97 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.06 -26.21 45.6 Favored Glycine 0 C--O 1.246 0.88 0 N-CA-C 109.495 -1.442 . . . . 53.34 109.495 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.589 ' O ' HG13 ' A' ' 57' ' ' ILE . 20.7 t70 -77.32 -38.38 50.57 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.265 -0.967 . . . . 62.35 109.391 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 pt -65.92 -30.39 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 122.202 -0.311 . . . . 73.52 110.823 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.612 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.2 mptm? -71.08 -27.3 63.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.571 -0.452 . . . . 75.2 110.277 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -69.92 -48.87 56.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.568 -0.742 . . . . 60.42 110.243 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 53' ' ' ASP . 30.6 mt -61.06 -42.6 93.77 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 115.192 -0.913 . . . . 74.11 108.985 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -28.91 68.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.502 . . . . 61.12 111.876 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.04 -24.21 35.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.512 0.672 . . . . 73.14 109.606 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.05 29.76 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.754 -0.832 . . . . 51.55 108.754 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -68.77 -31.14 69.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.211 -1.403 . . . . 74.11 107.211 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.3 m-20 -68.92 -24.25 64.27 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.911 -0.586 . . . . 73.13 110.007 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 mmt -78.35 -34.98 48.06 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 120.889 -0.324 . . . . 71.21 111.305 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.541 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 58.7 t80 -69.8 -36.66 75.87 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.55 -1.278 . . . . 72.01 107.55 174.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.568 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 80.9 tttt -54.34 -35.36 62.64 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 114.876 -1.056 . . . . 72.41 110.485 173.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 62' ' ' ASP . 95.6 mt -87.0 -29.09 22.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 116.199 -0.455 . . . . 73.33 111.317 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t70 -78.2 -24.37 47.16 Favored 'General case' 0 C--O 1.201 -1.451 0 CA-C-O 120.632 0.253 . . . . 74.34 111.383 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -128.99 24.38 5.64 Favored 'General case' 0 CA--C 1.469 -2.14 0 N-CA-C 109.175 -0.676 . . . . 75.44 109.175 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.6 p90 42.97 31.44 0.33 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 126.131 1.772 . . . . 70.42 114.736 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.41 162.33 0.51 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.66 -1.237 . . . . 74.21 107.66 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.568 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.4 m-85 -76.6 153.57 83.54 Favored Pre-proline 0 C--N 1.296 -1.739 0 C-N-CA 120.252 -0.579 . . . . 70.42 110.274 173.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 20.8 Cg_endo -61.98 164.37 16.94 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 123.28 2.653 . . . . 65.14 110.904 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.422 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 37.8 p -95.05 155.36 16.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.354 -1.721 . . . . 74.13 106.354 173.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.05 -12.8 62.01 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 119.837 1.199 . . . . 61.31 110.503 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -102.48 -65.24 1.0 Allowed 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.938 -1.028 . . . . 75.15 110.746 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -84.79 -29.23 25.58 Favored 'General case' 0 CA--C 1.478 -1.797 0 O-C-N 121.885 -0.509 . . . . 74.45 111.387 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 72' ' ' PRO . . . -74.53 -20.79 79.46 Favored Glycine 0 N--CA 1.411 -3.022 0 C-N-CA 119.202 -1.475 . . . . 74.45 111.818 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.46 -46.14 70.58 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.226 -1.768 . . . . 74.42 106.226 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.96 -21.66 66.43 Favored 'General case' 0 C--O 1.17 -3.103 0 CA-C-N 114.762 -1.108 . . . . 74.14 110.814 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -89.89 -4.22 57.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.656 0.741 . . . . 73.15 111.351 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.409 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 4.7 mp -99.51 -21.21 16.03 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.521 -0.763 . . . . 73.22 110.086 174.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.412 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 35.9 t -108.01 -30.97 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 115.985 -0.552 . . . . 73.45 110.737 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.7 mptp? -122.57 150.5 42.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.018 1.327 . . . . 72.44 107.978 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.427 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 9.2 mtpm? -54.9 135.71 66.23 Favored Pre-proline 0 N--CA 1.48 1.05 0 CA-C-N 118.405 0.548 . . . . 73.22 111.351 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 13.5 Cg_endo -53.04 153.09 16.51 Favored 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 124.633 3.556 . . . . 75.44 114.1 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 p -98.96 132.49 44.24 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.788 -0.642 . . . . 63.43 109.844 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.79 -137.38 14.26 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.903 -1.279 . . . . 75.21 109.903 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -129.7 105.85 17.09 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 117.362 0.581 . . . . 73.02 110.364 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -85.54 162.94 10.94 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.072 1.848 . . . . 74.35 108.979 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.14 156.69 46.22 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.446 -0.946 . . . . 72.23 108.446 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -58.45 98.76 0.1 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.583 2.189 . . . . 75.44 116.08 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 67.5 mttm -151.32 148.52 28.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.545 1.938 . . . . 73.24 107.757 172.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -82.13 97.35 8.15 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.815 -0.354 . . . . 64.44 110.304 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.524 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.2 t90 -54.68 142.74 27.32 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.554 1.142 . . . . 73.11 112.696 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -123.85 136.96 54.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.956 -1.02 . . . . 74.03 109.212 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -81.09 -163.9 0.67 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 75.32 108.208 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 61.96 23.61 13.93 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.297 0.639 . . . . 74.41 110.915 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.409 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 78.54 24.41 62.94 Favored Glycine 0 CA--C 1.48 -2.12 0 CA-C-N 114.981 -1.009 . . . . 73.35 112.819 171.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.524 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 63.39 78.1 0.3 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 123.136 1.446 . . . . 70.0 109.138 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.0 tp -117.67 166.9 11.86 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.041 -1.89 . . . . 72.52 107.861 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.64 -174.72 5.43 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 75.13 109.299 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 35.35 1.03 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.516 1.151 . . . . 74.52 110.395 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.04 149.07 40.34 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 113.804 -1.543 . . . . 75.24 108.842 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.29 177.08 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.483 2.789 . . . . 75.12 113.835 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 5.1 p -79.39 175.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.41 -0.814 . . . . 75.51 109.066 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.3 p-10 -69.89 158.68 86.64 Favored Pre-proline 0 C--O 1.258 1.527 0 N-CA-C 113.496 0.924 . . . . 73.43 113.496 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.432 ' CB ' ' HB3' ' A' ' 46' ' ' LYS . 50.5 Cg_exo -58.0 171.73 1.51 Allowed 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.815 2.343 . . . . 74.51 111.47 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.498 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 3.2 m-90 65.94 14.49 9.62 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 125.033 1.333 . . . . 73.35 108.845 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.66 57.98 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.189 -1.369 . . . . 64.25 115.033 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.553 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 7.5 m-80 -92.91 152.62 41.69 Favored Pre-proline 0 C--O 1.264 1.824 0 CA-C-N 118.947 1.374 . . . . 75.45 108.573 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.469 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 58.8 Cg_endo -82.33 141.06 11.22 Favored 'Trans proline' 0 N--CA 1.425 -2.522 0 C-N-CA 121.32 1.347 . . . . 75.05 110.579 165.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 31.7 m-85 -68.07 144.76 54.94 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 109.743 -0.466 . . . . 74.41 109.743 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -102.36 119.3 38.58 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.212 -1.403 . . . . 74.14 107.212 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -107.77 118.1 35.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.249 -1.389 . . . . 74.33 107.249 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 95.7 mt -129.23 153.17 48.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.254 -0.647 . . . . 71.31 109.254 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 74' ' ' THR . . . -117.81 -178.37 0.53 Allowed Pre-proline 0 N--CA 1.414 -2.26 0 CA-C-O 117.319 -1.324 . . . . 72.24 108.273 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 36.5 Cg_endo . . . . . 0 CA--C 1.492 -1.601 0 CA-C-N 122.041 1.765 . . . . 73.24 114.651 -170.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.465 -3.045 0 CA-C-O 118.447 -1.196 . . . . 41.23 115.587 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 39.8 Cg_exo -43.93 -23.71 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.168 1 C-N-CA 126.455 4.77 . . . . 73.03 115.711 176.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.0 p90 -176.12 169.35 2.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 118.023 0.374 . . . . 73.23 110.095 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 24.3 m-20 -136.79 112.24 9.27 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.4 -1.333 . . . . 74.02 107.4 174.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.511 HD23 ' HB ' ' A' ' 57' ' ' ILE . 47.5 tp -124.53 126.29 45.59 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.465 -0.494 . . . . 74.33 109.952 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 31.2 p90 -167.38 168.49 13.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.738 -0.385 . . . . 74.14 111.261 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.542 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 50.9 p -125.63 146.55 49.66 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.088 -1.078 . . . . 74.22 108.088 171.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.452 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 90.3 mt -66.69 145.38 55.62 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 110.341 -0.244 . . . . 74.5 110.341 175.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -81.1 -171.03 44.33 Favored Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.163 -1.017 . . . . 73.34 112.412 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.22 -8.21 5.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.896 1.073 . . . . 61.15 113.896 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -94.74 -9.71 33.85 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.133 0.492 . . . . 75.32 109.941 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.9 12.09 84.2 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 111.772 -0.531 . . . . 63.32 111.772 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -140.12 147.74 40.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.446 0.699 . . . . 74.24 109.17 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -81.72 114.3 20.28 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.29 0.567 . . . . 74.44 111.021 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.04 -174.23 21.1 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.216 -1.154 . . . . 55.4 110.216 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.18 126.63 8.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.639 -1.267 . . . . 74.31 110.078 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.466 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.3 m 177.92 -177.27 0.21 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.808 2.043 . . . . 73.25 106.134 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.45 -69.55 0.68 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.771 -1.172 . . . . 75.24 112.388 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -91.17 -21.99 20.88 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.126 0.489 . . . . 74.52 111.504 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.81 -6.72 59.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.125 0.488 . . . . 73.54 110.673 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.466 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -92.92 156.68 16.78 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.376 -0.829 . . . . 63.11 111.505 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.85 118.4 20.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.635 -1.246 . . . . 75.12 107.635 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.417 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.7 132.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.583 0 N-CA-C 108.525 -0.917 . . . . 72.23 108.525 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.0 176.79 42.47 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.248 -1.453 . . . . 73.34 112.072 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.66 145.98 24.78 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.477 -1.305 . . . . 71.2 107.477 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.486 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 7.4 p90 -161.35 175.47 12.2 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 116.072 -0.513 . . . . 75.42 110.477 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -113.61 122.62 47.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.921 -1.881 . . . . 72.23 105.921 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.305 -1.335 0 C-N-CA 124.587 1.155 . . . . 73.02 108.346 -178.501 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.501 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 20.1 mmt . . . . . 0 CA--C 1.505 -0.782 0 N-CA-C 110.467 -0.198 . . . . 72.35 110.467 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 m -107.29 73.79 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.054 0.454 . . . . 74.12 109.892 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -155.16 151.77 23.58 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 124.018 0.927 . . . . 74.23 109.42 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.87 131.42 38.2 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.534 2.823 . . . . 75.54 112.632 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 77.02 -36.14 0.24 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.321 2.249 . . . . 74.11 110.898 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.5 mm100 -68.92 -24.11 64.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.47 0.652 . . . . 71.01 109.569 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' O ' HG11 ' A' ' 49' ' ' VAL . . . -66.77 -27.1 67.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.472 -0.786 . . . . 74.11 109.543 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -79.19 -26.13 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.228 -0.656 . . . . 75.12 109.228 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.8 -43.15 46.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.292 -0.867 . . . . 73.22 109.139 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -69.87 -33.03 71.7 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.1 -0.954 . . . . 63.32 111.592 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 45' ' ' ALA . 11.2 m -73.92 -31.93 32.22 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 C-N-CA 119.361 -0.936 . . . . 74.02 109.694 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.28 82.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.793 -0.639 . . . . 74.34 110.408 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.557 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 96.2 mttt -69.95 -25.29 63.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.408 0.623 . . . . 74.33 111.561 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.6 -27.74 46.0 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 109.944 -1.262 . . . . 63.11 109.944 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.596 ' O ' HG13 ' A' ' 57' ' ' ILE . 5.2 t70 -73.99 -42.63 60.13 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.397 -0.902 . . . . 74.32 109.014 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.2 pt -63.93 -28.86 45.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 73.45 110.782 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.5 mptp? -70.74 -30.6 67.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.027 0.441 . . . . 74.43 110.346 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.73 -44.13 70.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 54.31 109.741 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 53' ' ' ASP . 36.8 mt -65.17 -39.77 86.6 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 CA-C-N 115.126 -0.943 . . . . 74.44 109.983 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.76 -31.56 66.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.345 -0.389 . . . . 73.24 111.007 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.24 46.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.222 0.534 . . . . 52.24 109.798 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.45 -26.64 38.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.019 -0.537 . . . . 70.43 109.917 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -30.44 69.98 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.132 -1.433 . . . . 74.24 107.132 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 68.9 m-20 -72.66 -18.54 61.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.484 -0.78 . . . . 75.43 109.817 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 mmt -82.11 -35.23 28.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.772 -0.649 . . . . 73.11 109.559 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 82.7 t80 -68.58 -34.71 76.27 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.386 -1.338 . . . . 71.04 107.386 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 85.9 tttt -55.87 -30.39 61.43 Favored 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 114.597 -1.183 . . . . 75.45 110.026 173.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.18 -34.41 20.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.804 0.298 . . . . 75.41 111.804 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.14 -23.74 61.35 Favored 'General case' 0 C--O 1.196 -1.763 0 CA-C-O 120.677 0.275 . . . . 61.35 111.273 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -129.51 20.56 5.64 Favored 'General case' 0 CA--C 1.452 -2.794 0 O-C-N 121.927 -0.483 . . . . 74.12 111.839 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 p90 42.69 32.68 0.4 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.87 1.356 . . . . 72.34 113.693 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 161.41 1.18 Allowed 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.898 -1.149 . . . . 72.44 107.898 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.3 m-85 -79.33 159.48 72.45 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 123.287 0.367 . . . . 63.42 111.557 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.437 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 58.3 Cg_endo -71.56 160.41 48.42 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.531 2.154 . . . . 75.3 112.377 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.6 p -96.28 155.33 16.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.232 -2.136 . . . . 74.43 105.232 171.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.437 ' CA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.48 -9.54 54.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 119.156 0.889 . . . . 64.51 110.777 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -102.7 -67.04 0.89 Allowed 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.737 -0.665 . . . . 71.41 110.629 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -81.56 -38.37 26.25 Favored 'General case' 0 CA--C 1.477 -1.837 0 C-N-CA 120.32 -0.552 . . . . 74.01 111.298 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 81' ' ' LEU . . . -71.95 -20.6 78.96 Favored Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 118.395 -1.86 . . . . 72.41 112.141 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.33 -47.0 53.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.539 -1.282 . . . . 63.51 107.539 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -65.02 -31.06 72.11 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-N 115.643 -0.708 . . . . 72.34 110.606 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -82.63 -5.12 58.64 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.186 0.517 . . . . 74.34 111.992 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 13.7 tp -96.33 -24.56 16.12 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.203 -1.036 . . . . 73.33 108.203 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.95 -38.14 5.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.135 -0.939 . . . . 73.41 110.751 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 61.9 mtpt -124.2 151.98 43.44 Favored 'General case' 0 C--O 1.204 -1.342 0 C-N-CA 125.552 1.541 . . . . 74.3 108.126 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -54.57 127.67 59.55 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 113.324 0.861 . . . . 74.11 113.324 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.7 123.07 12.91 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.97 3.78 . . . . 71.42 115.797 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -99.57 115.12 28.66 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.13 -1.395 . . . . 71.12 108.35 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 150.8 -116.76 0.79 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.091 -1.604 . . . . 41.3 109.091 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -137.65 90.97 14.19 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 117.558 0.679 . . . . 75.21 110.64 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.53 162.88 0.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.637 2.225 . . . . 73.42 112.448 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.251 0.6 OUTLIER -110.16 132.22 21.58 Favored Pre-proline 0 C--N 1.261 -3.261 0 CA-C-N 112.89 -1.959 . . . . 74.12 106.502 -171.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.91 99.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.688 2.925 . . . . 64.45 114.271 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -152.15 149.36 28.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.41 -1.7 . . . . 74.5 106.41 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.83 99.28 2.61 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 118.697 0.68 . . . . 73.44 111.201 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.502 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.5 t90 -61.97 144.11 55.55 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 125.028 1.331 . . . . 74.4 111.652 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.29 134.06 54.1 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.722 -0.672 . . . . 72.33 109.291 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.85 176.06 8.17 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.935 0.874 . . . . 74.01 111.354 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 57.78 28.97 16.71 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.436 -1.711 . . . . 74.34 112.858 168.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 120.65 -4.81 11.8 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.277 -1.439 . . . . 64.41 115.36 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.502 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.93 93.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.368 1.08 . . . . 74.4 109.411 -169.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.459 HD21 ' H ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -131.76 170.1 15.29 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.224 -2.139 . . . . 65.51 105.224 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.459 ' H ' HD21 ' A' ' 100' ' ' LEU . 96.4 mttt -88.93 -165.02 1.23 Allowed 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.725 -1.213 . . . . 71.04 107.725 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.23 32.54 0.45 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.893 0.854 . . . . 73.21 112.231 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.3 mp -94.77 149.61 36.67 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 125.028 1.331 . . . . 74.52 109.463 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.84 -167.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.643 2.895 . . . . 71.41 113.735 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 111' ' ' PRO . 4.5 p -101.28 176.12 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.813 -1.18 . . . . 71.42 107.813 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.43 144.87 95.0 Favored Pre-proline 0 C--O 1.255 1.384 0 CA-C-N 118.705 0.684 . . . . 73.34 111.29 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.39 171.78 0.13 Allowed 'Trans proline' 0 C--O 1.195 -1.633 0 C-N-CA 123.79 2.993 . . . . 73.02 112.597 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.433 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.2 m-90 62.54 14.97 7.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.921 1.289 . . . . 75.34 109.471 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.37 12.97 77.13 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 116.401 1.32 . . . . 73.13 116.401 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.433 ' ND2' ' HE3' ' A' ' 108' ' ' TRP . 14.9 m-80 -78.64 125.03 85.04 Favored Pre-proline 0 C--O 1.256 1.433 0 CA-C-N 120.15 1.975 . . . . 73.45 111.482 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.423 ' HA ' HG23 ' A' ' 105' ' ' VAL . 39.4 Cg_exo -67.53 146.71 74.97 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.093 1.862 . . . . 75.42 108.734 167.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.58 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 54.2 m-85 -68.93 145.33 53.74 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.381 0.61 . . . . 74.14 112.122 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.4 ' HG2' ' HA ' ' A' ' 127' ' ' SER . 2.5 mm100 -101.85 118.23 36.48 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.555 -2.017 . . . . 71.52 105.555 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.53 118.64 35.67 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.708 -0.678 . . . . 75.21 111.958 -177.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -129.81 154.0 47.69 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.294 -0.866 . . . . 73.14 109.838 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.496 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -101.76 -177.26 0.53 Allowed Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-O 116.572 -1.68 . . . . 64.41 107.817 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 10.1 Cg_endo . . . . . 0 C--N 1.393 2.896 0 C-N-CA 123.585 2.857 . . . . 74.52 115.48 -164.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.423 -2.23 0 CA-C-O 118.749 -1.028 . . . . 34.01 113.336 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.59 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -35.07 -23.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.48 1 C-N-CA 127.339 5.36 . . . . 74.02 118.778 179.97 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.485 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 54.4 p90 -166.21 171.59 12.09 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 119.593 1.088 . . . . 72.13 112.042 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.86 106.57 6.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.009 0.924 . . . . 72.14 108.889 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.39 128.3 52.07 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.686 -0.857 . . . . 74.01 108.686 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.401 ' CB ' ' HA3' ' A' ' 144' ' ' GLY . 42.0 p90 -166.91 168.1 14.26 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 110.298 -0.26 . . . . 73.12 110.298 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.58 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 13.1 t -125.64 154.35 42.45 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.893 -1.521 . . . . 63.1 106.893 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.17 157.45 37.72 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.839 -0.344 . . . . 74.34 111.534 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.17 -169.94 29.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.235 -0.983 . . . . 61.21 112.999 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.03 -21.84 66.44 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.134 0.79 . . . . 73.04 113.134 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -94.43 -2.47 51.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.65 0.738 . . . . 75.44 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.72 45.68 73.92 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.042 -1.623 . . . . 75.44 109.042 -174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -135.28 144.34 46.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.849 -1.167 . . . . 73.45 107.849 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . 0.253 0.5 OUTLIER -102.86 106.7 17.33 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 121.982 0.896 . . . . 74.21 111.014 173.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.01 -173.34 20.26 Favored Glycine 0 C--N 1.294 -1.793 0 N-CA-C 111.066 -0.813 . . . . 64.03 111.066 -177.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -111.77 125.61 7.31 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 107.727 -2.149 . . . . 73.31 107.727 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.526 ' CB ' ' HB3' ' A' ' 140' ' ' ASP . 74.6 m 179.24 -176.34 0.26 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.897 1.279 . . . . 72.14 107.898 -167.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.21 -73.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.943 0.401 . . . . 73.32 110.412 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -107.22 -8.98 16.23 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.554 0.692 . . . . 74.24 110.12 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.526 ' HB3' ' CB ' ' A' ' 137' ' ' SER . 22.2 t70 -89.65 2.32 54.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 123.073 1.416 . . . . 73.3 108.871 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -92.36 155.8 17.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.73 -1.577 . . . . 73.31 110.595 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.73 122.46 29.13 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.775 -1.935 . . . . 63.45 105.775 171.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.509 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.29 113.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-O 121.982 0.896 . . . . 75.34 111.142 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' A' ' 126' ' ' TYR . . . -163.56 -179.8 38.16 Favored Glycine 0 N--CA 1.41 -3.087 0 C-N-CA 119.271 -1.442 . . . . 60.54 112.917 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.11 158.83 19.73 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.437 -1.32 . . . . 64.34 107.437 -177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.485 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 9.8 p90 -163.2 177.58 8.93 Favored 'General case' 0 C--N 1.279 -2.467 0 O-C-N 123.657 0.598 . . . . 75.1 110.629 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -105.33 120.58 41.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.229 -1.396 . . . . 73.21 107.229 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.298 -1.647 0 O-C-N 125.167 1.542 . . . . 72.34 106.87 178.842 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 25.7 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.134 0.492 . . . . 65.53 111.04 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -113.86 62.55 0.65 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.104 -0.702 . . . . 73.21 109.104 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -155.58 160.25 30.99 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.347 -0.983 . . . . 75.33 108.347 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -28.63 119.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 126.053 4.502 . . . . 70.13 116.341 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t70 65.33 -37.24 0.23 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 127.605 2.362 . . . . 74.23 113.912 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.76 -19.96 64.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.305 0.574 . . . . 74.35 110.123 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 39' ' ' MET . . . -64.1 -24.48 67.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.303 -0.862 . . . . 74.44 109.988 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.417 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 89.2 mttt -86.1 -25.0 26.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.019 -0.734 . . . . 74.41 109.019 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.431 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 58.0 t -74.25 -44.26 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-N 115.493 -0.776 . . . . 74.45 109.814 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.3 t -65.7 -36.04 82.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.063 -0.971 . . . . 75.4 111.512 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 m -74.21 -35.79 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 C-N-CA 119.917 -0.713 . . . . 73.42 109.74 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.9 74.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.932 -0.576 . . . . 73.04 110.378 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 73.7 mmtt -65.63 -25.9 67.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.431 0.634 . . . . 73.34 110.293 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.59 -31.52 18.44 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 110.595 -1.002 . . . . 61.13 110.595 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 57' ' ' ILE . 77.2 m-20 -76.53 -33.8 58.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.915 0.388 . . . . 74.43 110.323 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -67.11 -35.81 75.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.954 -0.387 . . . . 72.14 109.954 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -66.78 -30.7 70.97 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 120.878 0.371 . . . . 75.3 110.665 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.35 -45.39 88.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.338 -0.846 . . . . 72.55 110.046 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 53' ' ' ASP . 64.2 mt -64.81 -38.66 83.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 CA-C-N 115.267 -0.879 . . . . 73.34 110.161 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.48 68.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.999 0.428 . . . . 62.52 111.498 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.83 -33.21 27.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.566 0.698 . . . . 74.25 109.727 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.07 35.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.668 -0.697 . . . . 73.43 111.108 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.12 -30.35 71.28 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.778 -1.193 . . . . 75.35 107.778 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 18.9 t70 -73.71 -24.62 59.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.527 -0.76 . . . . 74.23 110.084 174.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.9 mtm -78.56 -25.77 45.45 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.789 -0.569 . . . . 74.15 110.465 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 31.1 t80 -72.04 -40.31 68.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.545 -1.65 . . . . 73.13 106.545 170.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 31.7 tttm -54.25 -37.29 64.5 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.307 -0.86 . . . . 74.4 110.354 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -73.01 -36.49 67.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.612 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.545 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.1 t70 -71.65 -23.46 61.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.327 0.651 . . . . 71.21 112.192 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.402 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.7 OUTLIER -128.48 20.29 6.18 Favored 'General case' 0 CA--C 1.457 -2.625 0 O-C-N 121.941 -0.474 . . . . 75.13 110.089 178.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.3 p90 42.9 31.65 0.34 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.118 1.511 . . . . 73.41 112.63 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.12 161.99 0.46 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.378 -1.341 . . . . 71.45 107.378 -171.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -74.67 158.96 84.31 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 112.746 0.647 . . . . 75.43 112.746 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.507 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 49.1 Cg_endo -72.69 159.27 49.01 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 123.164 2.576 . . . . 71.52 109.776 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.49 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 70.5 p -90.43 156.26 18.34 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.442 -1.318 . . . . 73.12 107.442 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 t -65.86 -17.78 64.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 119.767 1.167 . . . . 75.43 111.232 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.65 -65.9 0.94 Allowed 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.082 -0.387 . . . . 72.4 111.706 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.3 mm-40 -81.3 -32.63 33.04 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 120.959 -0.296 . . . . 74.23 111.573 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 72' ' ' PRO . . . -74.68 -20.85 79.37 Favored Glycine 0 N--CA 1.408 -3.188 0 C-N-CA 118.958 -1.591 . . . . 71.44 112.712 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.81 -46.41 68.71 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.484 -1.672 . . . . 73.41 106.484 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.16 -14.74 62.37 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 114.718 -1.128 . . . . 74.05 111.044 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.454 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . -89.84 -8.68 51.44 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.332 0.587 . . . . 72.45 110.16 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 88.9 mt -93.08 -22.68 18.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.841 -0.618 . . . . 74.42 109.634 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.31 -34.96 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 115.885 -0.598 . . . . 64.04 111.545 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -122.84 151.23 41.89 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.314 -1.736 . . . . 75.22 106.314 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -53.67 137.04 53.65 Favored Pre-proline 0 N--CA 1.49 1.542 0 CA-C-N 119.058 0.844 . . . . 74.25 111.636 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.553 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 17.9 Cg_endo -55.41 137.67 78.06 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 124.558 3.505 . . . . 73.35 117.071 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 p -89.74 -179.66 5.81 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 112.927 -1.942 . . . . 70.45 107.558 173.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 -131.15 13.22 Favored Glycine 0 C--O 1.249 1.042 0 C-N-CA 119.72 -1.229 . . . . 71.4 110.423 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -135.93 89.98 19.81 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 112.372 0.508 . . . . 74.24 112.372 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 96.7 Cg_endo -91.95 163.25 3.28 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.784 2.323 . . . . 75.24 109.523 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -99.86 158.63 31.75 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 108.477 -0.934 . . . . 75.24 108.477 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.83 99.28 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.038 1.826 . . . . 73.41 110.622 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.553 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 12.7 tmtt? -151.49 147.39 26.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.025 -1.472 . . . . 75.04 107.025 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.553 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 38.1 m-80 -63.34 89.52 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.025 0.75 . . . . 74.11 113.025 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.553 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 84.1 t90 -66.08 144.6 56.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.763 1.625 . . . . 73.33 111.326 175.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.53 130.39 52.36 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.359 -0.608 . . . . 71.02 109.359 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.457 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 62.5 pttt -83.3 -171.55 3.64 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.465 -0.894 . . . . 65.45 108.723 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.1 t0 66.27 28.72 9.86 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.243 1.021 . . . . 75.41 108.829 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 91.57 9.13 63.28 Favored Glycine 0 CA--C 1.473 -2.535 0 CA-C-N 114.021 -1.445 . . . . 73.5 114.114 167.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.7 OUTLIER 61.61 79.46 0.25 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.667 -1.234 . . . . 72.51 107.667 -172.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.426 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.5 tt -124.55 152.3 43.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.678 -1.601 . . . . 75.54 106.678 -171.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.72 179.71 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.675 -0.861 . . . . 74.24 108.675 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -80.66 67.08 6.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.386 1.088 . . . . 74.14 113.738 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.66 147.6 61.41 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 105.548 -2.019 . . . . 65.24 105.548 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.81 -168.84 0.25 Allowed 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.24 1.96 . . . . 75.12 112.139 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.37 173.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.687 -1.597 . . . . 75.35 106.687 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.9 p-10 -79.59 157.45 74.7 Favored Pre-proline 0 C--O 1.252 1.228 0 CA-C-N 119.155 0.889 . . . . 72.42 112.723 -170.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.417 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 10.3 Cg_endo -54.12 171.2 0.39 Allowed 'Trans proline' 0 C--O 1.201 -1.352 0 C-N-CA 123.571 2.848 . . . . 75.44 111.939 173.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 65.09 15.02 9.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.997 1.319 . . . . 65.23 109.559 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.73 27.87 64.7 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.234 -1.348 . . . . 75.22 114.804 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.506 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 4.5 m-80 -89.64 151.16 45.47 Favored Pre-proline 0 C--O 1.257 1.455 0 CA-C-N 119.24 1.52 . . . . 74.43 108.459 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 62.9 Cg_endo -82.14 144.91 13.54 Favored 'Trans proline' 0 N--CA 1.411 -3.379 0 N-CA-C 108.28 -1.469 . . . . 72.44 108.28 165.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 68.9 m-85 -67.28 143.01 56.68 Favored 'General case' 0 C--O 1.253 1.286 0 N-CA-C 106.535 -1.654 . . . . 73.54 106.535 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -101.2 114.47 28.46 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.167 -1.79 . . . . 72.21 106.167 -175.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -98.69 119.04 36.75 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.972 -1.122 . . . . 75.43 107.972 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.0 mt -128.46 153.14 47.44 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.463 -1.31 . . . . 71.01 107.463 175.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.455 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . . . -124.89 -179.05 0.77 Allowed Pre-proline 0 N--CA 1.395 -3.178 0 N-CA-C 107.605 -1.257 . . . . 73.32 107.605 -175.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 43.6 Cg_endo . . . . . 0 N--CA 1.44 -1.668 0 C-N-CA 121.512 1.474 . . . . 73.33 114.092 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.466 -3.005 0 CA-C-O 118.871 -0.961 . . . . 72.44 113.528 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 147' ' ' ASP . 44.0 Cg_exo -64.26 -28.14 63.99 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.522 3.481 . . . . 74.14 111.99 165.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.5 p90 176.0 164.9 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.409 0.684 . . . . 75.1 110.024 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 32.6 m-20 -139.64 123.07 17.17 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.537 -0.542 . . . . 72.21 109.537 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -130.66 124.66 32.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.423 -0.954 . . . . 72.33 108.423 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.569 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 44.3 p90 -167.4 168.11 13.34 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-O 119.505 -0.284 . . . . 72.24 110.914 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -126.25 156.57 40.09 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.77 0.828 . . . . 74.44 109.636 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.16 151.59 46.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.418 -0.355 . . . . 72.2 111.363 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.28 -178.86 45.79 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.443 -0.884 . . . . 75.24 112.21 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.96 25.96 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.2 1.185 . . . . 61.11 114.2 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -94.48 -9.99 33.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.986 -0.685 . . . . 74.25 111.241 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.47 4.87 72.96 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.827 -0.909 . . . . 63.51 110.827 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -99.69 144.03 29.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.654 -0.869 . . . . 64.5 108.654 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.7 105.07 16.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.949 -1.13 . . . . 75.4 107.949 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.27 -173.55 20.63 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.079 -0.808 . . . . 63.2 111.079 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.77 127.63 9.27 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 108.312 -1.915 . . . . 62.23 108.312 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.4 m 179.53 -177.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 125.904 1.682 . . . . 75.32 107.53 -170.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.43 -72.96 0.45 Allowed 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.644 -0.822 . . . . 73.51 111.043 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -95.84 -14.65 23.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.01 0.433 . . . . 74.02 111.543 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -97.49 5.47 49.59 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.383 0.611 . . . . 71.33 110.353 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.23 156.96 18.93 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.329 -0.85 . . . . 74.01 112.597 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -78.76 112.94 16.41 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.45 -1.685 . . . . 74.13 106.45 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.505 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 119.06 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.083 0 CA-C-N 114.939 -1.028 . . . . 71.13 111.451 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -169.96 -179.2 41.45 Favored Glycine 0 N--CA 1.41 -3.043 0 C-N-CA 119.612 -1.28 . . . . 72.23 112.859 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.0 149.46 28.9 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.9 -1.518 . . . . 73.32 106.9 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.46 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 4.1 p90 -170.19 178.38 3.86 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.334 0.588 . . . . 73.31 110.19 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.551 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 36.1 t70 -118.3 137.02 53.35 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.511 -1.663 . . . . 64.33 106.511 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 3.7 p-10 . . . . . 0 C--O 1.253 1.24 0 O-C-N 124.586 1.179 . . . . 65.22 109.013 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 107.566 -1.272 . . . . 72.23 107.566 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -119.78 88.97 3.04 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.026 0.75 . . . . 72.14 113.026 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -156.29 170.73 8.36 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.191 -1.781 . . . . 74.14 106.191 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -43.1 125.57 4.28 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 123.434 2.756 . . . . 71.34 113.838 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.1 -33.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.61 1.564 . . . . 42.11 113.346 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -73.23 -28.93 62.44 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.709 -0.478 . . . . 75.22 109.709 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.01 72.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.008 -0.738 . . . . 75.23 109.008 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -74.7 -25.28 59.04 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.161 -0.927 . . . . 74.34 109.889 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.588 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 56.5 t -75.29 -44.57 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 71.15 109.09 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -73.62 -31.94 63.81 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.446 -0.797 . . . . 73.31 112.102 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -71.74 -36.17 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 119.404 -0.918 . . . . 72.43 109.034 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HB3' HD13 ' A' ' 143' ' ' ILE . . . -65.16 -31.67 72.97 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.344 -0.844 . . . . 71.31 111.251 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 31.5 mmmt -64.86 -25.75 68.03 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.239 0.542 . . . . 73.44 110.549 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.79 -33.5 15.58 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.953 -0.859 . . . . 73.5 110.953 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.263 19.8 m-20 -81.13 -26.35 36.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.377 0.88 . . . . 74.05 113.377 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.96 -31.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.867 -0.79 . . . . 72.14 108.867 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -70.41 -25.91 63.44 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.212 -0.662 . . . . 73.13 109.212 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.05 -47.3 71.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.087 -0.961 . . . . 73.42 109.868 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.84 -45.75 97.49 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.085 -0.961 . . . . 70.24 109.621 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.81 57.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.009 -0.541 . . . . 73.34 112.379 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.36 -39.6 16.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.879 0.371 . . . . 65.41 110.609 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 99' ' ' TYR . . . -77.42 -28.31 52.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.477 -0.489 . . . . 74.23 110.907 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.86 -26.66 66.14 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.6 -1.259 . . . . 75.12 107.6 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 t70 -76.12 -21.09 57.03 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.149 -0.932 . . . . 72.35 108.698 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.9 mtt -77.37 -37.44 52.19 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.616 -0.678 . . . . 75.51 109.465 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.433 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 73.4 t80 -61.98 -37.34 84.42 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.994 -1.113 . . . . 71.15 107.994 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.631 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.6 tttt -54.47 -39.47 67.52 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 114.638 -1.165 . . . . 70.44 109.796 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.64 -30.45 36.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.358 0.873 . . . . 74.11 113.358 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -71.14 -24.95 62.37 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.388 0.614 . . . . 73.41 110.873 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.4 23.15 5.96 Favored 'General case' 0 CA--C 1.454 -2.736 0 O-C-N 121.372 -0.83 . . . . 74.14 111.669 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 42.58 32.82 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.448 1.499 . . . . 74.25 113.67 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.34 151.41 0.27 Allowed 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.608 -0.886 . . . . 71.43 108.608 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.631 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 21.2 m-85 -74.79 152.55 87.0 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 123.266 0.354 . . . . 72.41 110.271 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 32.7 Cg_endo -62.01 164.9 15.56 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.562 2.841 . . . . 74.33 112.557 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.428 ' C ' ' HB2' ' A' ' 116' ' ' ALA . 58.2 p -102.46 154.98 18.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.614 -1.995 . . . . 64.44 105.614 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.494 ' N ' ' HB2' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.07 -8.21 43.1 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 119.312 0.96 . . . . 74.43 110.614 -175.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.37 -67.02 0.89 Allowed 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 116.046 -0.524 . . . . 73.54 109.996 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -77.95 -39.56 42.24 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 121.958 -0.464 . . . . 75.24 110.652 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.61 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.73 -21.03 77.59 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 118.675 -1.726 . . . . 65.33 113.157 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 tt -68.0 -49.06 63.83 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.257 -1.386 . . . . 74.31 107.257 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 17.9 mt-10 -68.03 -26.69 66.01 Favored 'General case' 0 C--O 1.166 -3.302 0 CA-C-N 114.767 -1.106 . . . . 70.23 111.386 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.18 -7.69 58.41 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.31 0.576 . . . . 73.25 111.35 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 81.7 mt -93.28 -22.72 18.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.788 -0.642 . . . . 74.14 109.604 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.45 -38.3 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 116.134 -0.485 . . . . 74.51 112.056 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 57.0 pttt -119.01 151.25 38.54 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.673 -1.603 . . . . 72.35 106.673 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -55.19 130.82 68.79 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 122.754 0.422 . . . . 74.13 110.373 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.436 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 30.6 Cg_endo -58.88 124.22 15.23 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.554 2.836 . . . . 65.43 112.493 -173.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.2 p -83.27 116.08 22.26 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.652 -0.704 . . . . 73.13 110.487 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.43 -136.46 6.73 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.889 -1.684 . . . . 74.21 108.889 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -133.91 94.12 19.2 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 117.296 0.548 . . . . 72.12 111.481 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.27 162.65 17.5 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 123.007 2.471 . . . . 75.23 108.868 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.4 108.59 34.66 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 108.823 -0.806 . . . . 73.41 108.823 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -29.08 98.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.254 1 C-N-CA 125.857 4.372 . . . . 73.11 117.643 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -138.77 149.48 45.05 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 125.971 1.708 . . . . 74.02 107.562 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.59 92.12 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.336 -0.393 . . . . 71.2 110.628 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.59 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 86.2 t90 -65.65 143.02 57.84 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 115.608 -0.724 . . . . 74.21 110.102 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -135.38 133.14 38.39 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.534 -0.757 . . . . 70.12 109.038 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -78.28 -171.53 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.327 -0.99 . . . . 74.53 108.327 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t0 66.89 25.25 9.52 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 122.189 0.995 . . . . 71.2 109.266 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 90.56 12.85 60.52 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 114.311 -1.313 . . . . 74.41 113.643 170.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.59 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.1 m-85 62.26 81.26 0.2 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.701 1.238 . . . . 74.43 107.811 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.0 tp -128.72 172.24 11.44 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.807 -1.542 . . . . 74.32 108.926 -171.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -77.29 -172.67 2.54 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.743 -1.206 . . . . 70.13 107.743 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -87.1 63.94 8.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.877 1.322 . . . . 73.52 108.966 177.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 tp -115.6 142.45 28.91 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.159 -1.837 . . . . 73.11 110.711 -172.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -68.37 -167.17 0.17 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.393 2.728 . . . . 75.02 110.826 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.693 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.83 173.17 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 109.114 -0.698 . . . . 71.21 109.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.521 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.6 t70 -80.73 161.57 63.38 Favored Pre-proline 0 C--O 1.255 1.35 0 N-CA-C 108.553 -0.906 . . . . 72.11 108.553 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 72.1 Cg_exo -47.24 170.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.067 2.511 . . . . 74.3 114.258 172.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.495 ' CG ' ' HA ' ' A' ' 130' ' ' ALA . 1.7 m-90 65.79 14.27 9.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.928 2.091 . . . . 74.51 111.034 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.52 -6.71 15.54 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.86 -0.609 . . . . 63.32 114.043 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.89 133.94 88.04 Favored Pre-proline 0 C--O 1.258 1.534 0 N-CA-C 113.019 0.748 . . . . 54.51 113.019 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.693 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 72.0 Cg_endo -75.58 145.86 29.99 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.659 2.239 . . . . 73.01 112.098 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -69.7 134.01 48.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.258 -1.386 . . . . 64.11 107.258 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -104.2 113.98 27.9 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.328 -0.851 . . . . 72.01 109.315 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.92 118.24 36.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.663 -1.606 . . . . 74.25 106.663 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.1 mt -128.82 153.59 47.28 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.687 -1.227 . . . . 72.24 107.687 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.494 ' HB2' ' N ' ' A' ' 74' ' ' THR . . . -109.77 -178.58 0.57 Allowed Pre-proline 0 N--CA 1.404 -2.745 0 CA-C-O 116.589 -1.672 . . . . 60.44 107.672 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 12.4 Cg_endo . . . . . 0 C--N 1.389 2.681 0 C-N-CA 123.005 2.47 . . . . 75.15 115.488 -162.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.428 -1.898 0 CA-C-O 118.374 -1.237 . . . . 72.1 113.0 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.534 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 13.4 Cg_exo -37.85 -26.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 127.299 5.332 . . . . 73.14 118.559 -178.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.261 40.3 p90 -169.32 147.08 3.63 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.353 0.979 . . . . 75.11 113.12 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.6 m-20 -112.47 109.83 19.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.281 -1.327 . . . . 74.42 107.441 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.493 ' O ' ' HA3' ' A' ' 144' ' ' GLY . 3.2 tm? -124.7 129.93 51.44 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.957 -0.697 . . . . 74.54 109.655 -176.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 55.7 p90 -167.81 164.59 14.17 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 112.442 0.534 . . . . 72.42 112.442 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -125.8 136.67 53.38 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.386 -2.449 . . . . 73.14 104.386 166.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.88 154.27 12.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.483 0.659 . . . . 75.44 112.392 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.43 173.31 40.38 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.894 -1.048 . . . . 75.52 113.902 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.495 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -48.36 -28.81 3.41 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 116.732 2.123 . . . . 75.21 116.732 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.26 -7.37 42.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.447 0.567 . . . . 72.42 111.397 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.43 28.31 25.09 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.495 -0.86 . . . . 75.32 112.439 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -127.65 138.63 52.88 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.634 -0.876 . . . . 73.54 108.634 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.39 105.38 7.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.617 0.722 . . . . 72.13 109.741 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.41 -174.4 22.2 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.812 -0.709 . . . . 71.54 113.873 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -116.79 128.66 8.01 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.363 -1.495 . . . . 75.54 109.363 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 38.8 m -178.26 -177.36 0.58 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 125.758 1.623 . . . . 75.55 108.196 -170.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.38 -73.25 0.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.877 -0.515 . . . . 73.03 110.53 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.44 -6.96 29.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.188 0.518 . . . . 72.45 111.718 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -100.54 9.34 42.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.335 0.588 . . . . 71.5 110.917 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . -86.11 157.78 19.95 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.813 -0.631 . . . . 60.4 111.162 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.73 112.33 13.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.931 -1.877 . . . . 73.24 105.931 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.535 HD11 ' O ' ' A' ' 143' ' ' ILE . 2.6 pp -96.32 123.45 48.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.472 0.653 . . . . 73.13 111.067 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -175.11 177.24 47.17 Favored Glycine 0 N--CA 1.413 -2.869 0 N-CA-C 110.155 -1.178 . . . . 72.34 110.155 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -103.36 162.92 12.6 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.136 -1.802 . . . . 70.35 106.136 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -143.64 124.7 14.43 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.119 -1.067 . . . . 75.24 108.119 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -111.58 112.38 24.05 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.899 -1.519 . . . . 75.43 106.899 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--N 1.293 -1.88 0 N-CA-C 109.413 -0.588 . . . . 71.14 109.413 -177.424 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.458 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.8 mpt? . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.358 -0.608 . . . . 73.13 109.358 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -118.12 84.62 2.2 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.82 0.819 . . . . 74.52 110.501 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.407 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 99.1 mtt180 -153.07 165.78 16.88 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 106.292 -1.744 . . . . 70.11 106.292 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 44' ' ' GLN . 72.2 Cg_exo -53.94 130.25 38.32 Favored 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 122.515 2.143 . . . . 64.44 111.422 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 47' ' ' VAL . 33.5 m-20 72.85 -31.67 0.23 Allowed 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 125.393 1.477 . . . . 70.21 113.597 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 13.9 mm100 -68.93 -32.59 72.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.955 -0.757 . . . . 73.5 108.955 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.63 -17.89 64.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 74.44 110.747 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 57.0 mttp -89.44 -24.66 21.82 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.156 -0.683 . . . . 73.41 109.156 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 43' ' ' ASP . 59.5 t -75.0 -43.93 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.913 0.863 . . . . 73.54 108.698 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -64.65 -28.11 69.39 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.227 -1.351 . . . . 75.11 111.762 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.16 -37.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 119.597 -0.841 . . . . 74.22 110.146 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.677 -0.692 . . . . 71.44 110.667 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 55.0 mtpt -68.53 -22.47 64.51 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 121.379 0.609 . . . . 65.42 111.749 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.56 -31.1 46.63 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.618 -1.393 . . . . 73.11 109.618 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.6 m-20 -76.08 -31.15 58.6 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.223 -0.489 . . . . 72.41 111.359 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 pt -66.89 -30.82 50.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 C-N-CA 120.373 -0.531 . . . . 73.31 109.879 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 14.2 mptt -67.17 -31.83 72.51 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 120.075 -0.65 . . . . 75.5 109.984 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.4 71.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 73.14 110.83 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.453 HG12 HD13 ' A' ' 100' ' ' LEU . 44.1 mt -62.75 -43.15 98.49 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 116.013 -0.539 . . . . 74.24 109.715 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -22.72 66.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.02 0.438 . . . . 72.44 111.681 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 -33.96 20.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.397 0.618 . . . . 65.13 109.951 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 99' ' ' TYR . . . -81.9 -27.48 33.38 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.155 -0.475 . . . . 73.35 110.552 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.28 -30.33 71.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 106.927 -1.508 . . . . 74.32 106.927 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 20.0 t70 -73.92 -17.21 61.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.705 -1.134 . . . . 65.12 109.21 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.8 mtm -84.01 -32.17 25.08 Favored 'General case' 0 C--O 1.204 -1.307 0 O-C-N 121.638 -0.664 . . . . 73.24 109.428 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -63.61 -35.47 80.61 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.17 -1.789 . . . . 64.54 106.17 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.638 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 60.5 tttp -58.12 -38.01 75.69 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 115.594 -0.73 . . . . 74.23 110.569 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 tp -74.73 -36.22 62.66 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.492 0.663 . . . . 74.35 109.667 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 92' ' ' LYS . 13.8 t70 -74.37 -24.55 59.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.188 -0.914 . . . . 74.24 111.772 -174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.572 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -128.54 22.84 5.92 Favored 'General case' 0 CA--C 1.455 -2.699 0 O-C-N 121.549 -0.719 . . . . 73.13 110.62 177.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 42.44 31.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.501 1.52 . . . . 75.31 112.822 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.64 161.43 0.52 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.873 -1.158 . . . . 73.13 107.873 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.638 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 19.7 m-85 -75.74 155.07 85.27 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 123.301 0.376 . . . . 73.14 111.872 174.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.433 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 37.0 Cg_endo -66.7 157.8 59.22 Favored 'Trans proline' 0 C--O 1.211 -0.849 0 C-N-CA 122.693 2.262 . . . . 72.3 110.391 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 p -94.37 155.55 16.93 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 107.119 -1.437 . . . . 74.44 107.119 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -72.79 -4.54 32.2 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.013 1.279 . . . . 72.53 111.257 -176.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -102.75 -66.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 120.113 -0.635 . . . . 64.53 110.241 169.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -74.94 -45.99 38.68 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.531 -0.544 . . . . 71.31 109.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -72.16 -19.97 78.83 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 120.322 -0.942 . . . . 73.52 113.775 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tt -73.17 -48.66 33.4 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 107.841 -1.17 . . . . 75.13 107.841 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.53 -37.13 82.61 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 108.323 -0.991 . . . . 74.33 108.323 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -77.89 -5.61 51.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.041 0.756 . . . . 63.31 113.041 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.481 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 15.3 tp -94.43 -23.47 17.73 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.38 -0.97 . . . . 73.41 108.38 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.28 -38.78 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.924 -1.034 . . . . 63.52 110.562 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 43.8 tttm -124.06 150.69 44.68 Favored 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 126.598 1.959 . . . . 74.11 107.17 -174.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -54.11 141.66 49.5 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 113.242 0.83 . . . . 74.44 113.242 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 7.7 Cg_endo -45.15 136.47 10.67 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 125.104 3.87 . . . . 72.44 115.992 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -101.41 -11.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.63 -1.168 . . . . 73.25 108.989 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.84 -148.62 24.07 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.949 -0.861 . . . . 52.43 110.949 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -117.12 101.16 53.34 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-O 121.555 0.693 . . . . 75.13 111.345 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.572 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 95.6 Cg_endo -99.71 162.82 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.772 2.981 . . . . 74.41 112.447 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -87.54 159.04 50.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.822 -1.177 . . . . 74.21 107.822 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.75 98.42 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.612 1.541 . . . . 74.22 112.904 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HB2' ' OD2' ' A' ' 67' ' ' ASP . 2.3 mptp? -150.05 148.12 28.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.008 1.723 . . . . 74.33 106.46 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.57 98.01 5.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.004 0.431 . . . . 61.32 111.034 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.606 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 85.5 t90 -54.73 144.18 23.01 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.349 1.86 . . . . 73.14 113.042 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -116.65 135.33 53.88 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.526 1.13 . . . . 75.14 109.221 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -82.39 178.7 8.1 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 122.09 0.947 . . . . 74.4 110.909 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 55.63 45.92 23.76 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.894 -1.957 . . . . 70.1 111.905 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 105.7 -10.19 45.09 Favored Glycine 0 CA--C 1.477 -2.336 0 CA-C-N 114.427 -1.26 . . . . 62.05 114.856 163.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.606 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 64.55 96.15 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 122.182 0.991 . . . . 72.55 109.63 -171.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.453 HD13 HG12 ' A' ' 57' ' ' ILE . 59.3 tp -138.79 170.04 16.71 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.697 -1.138 . . . . 73.25 107.937 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.82 -170.32 2.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.747 -1.575 . . . . 74.43 106.747 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.71 75.91 10.27 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.606 -0.837 . . . . 74.44 109.996 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -130.85 147.85 67.86 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.379 -1.282 . . . . 74.04 108.753 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.59 178.01 7.26 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.538 2.159 . . . . 74.54 112.806 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 111' ' ' PRO . 3.9 p -85.5 175.75 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.716 -0.846 . . . . 73.41 108.716 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.8 p-10 -78.65 158.2 76.1 Favored Pre-proline 0 C--O 1.251 1.184 0 CA-C-N 119.381 0.991 . . . . 74.34 113.132 -170.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.435 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 7.8 Cg_endo -54.52 171.07 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.266 2.644 . . . . 74.55 112.654 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.508 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 3.1 m-90 64.01 14.69 8.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.559 1.544 . . . . 74.34 108.856 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.46 38.33 79.5 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 114.026 -1.443 . . . . 73.02 115.167 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.527 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 13.2 m-80 -91.68 146.32 32.88 Favored Pre-proline 0 C--O 1.266 1.924 0 CA-C-N 119.954 1.877 . . . . 73.35 108.898 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' HG23 ' A' ' 105' ' ' VAL . 36.6 Cg_endo -89.35 137.83 3.12 Favored 'Trans proline' 0 N--CA 1.428 -2.377 0 C-N-CA 122.053 1.835 . . . . 72.44 109.565 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.646 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 59.2 m-85 -68.04 143.41 55.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.883 0.373 . . . . 74.35 110.601 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.511 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -102.67 117.34 34.46 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.112 -1.44 . . . . 75.41 107.112 -176.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -104.14 120.65 41.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.876 -0.416 . . . . 74.13 109.876 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 92.6 mt -127.98 153.56 46.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.452 -0.573 . . . . 73.43 109.452 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.442 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -109.63 -176.61 0.41 Allowed Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 116.567 -1.683 . . . . 74.42 107.306 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.712 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 18.5 Cg_endo . . . . . 0 C--N 1.384 2.405 0 C-N-CA 122.383 2.055 . . . . 71.12 114.707 -169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.712 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 C--O 1.202 -1.894 0 CA-C-O 118.462 -1.188 . . . . 65.34 113.632 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.569 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 32.4 Cg_exo -40.3 -23.98 0.13 Allowed 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 126.782 4.988 . . . . 71.12 117.731 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 51.3 p90 -176.64 163.8 2.4 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 118.351 0.523 . . . . 73.32 109.682 176.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 146' ' ' TRP . 23.9 m-20 -139.86 118.45 12.28 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 124.279 0.987 . . . . 71.32 108.792 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . 0.26 4.4 pp -143.27 138.24 29.45 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.283 -1.367 . . . . 73.41 112.649 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.502 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 39.5 p90 -165.46 167.06 17.93 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.871 -1.059 . . . . 75.41 108.332 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.646 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 8.7 t -125.79 157.35 37.73 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.849 -1.167 . . . . 74.45 107.849 172.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.511 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 91.3 mt -67.33 154.13 42.05 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.835 0.709 . . . . 75.23 111.185 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.22 -164.58 21.89 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.342 -0.932 . . . . 71.22 114.16 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.9 -16.85 32.72 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.758 1.022 . . . . 75.2 113.758 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -106.29 1.55 26.01 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.625 0.726 . . . . 74.22 110.026 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 43.16 99.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.1 -0.8 . . . . 73.12 111.1 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 134' ' ' GLU . 8.8 tmtt? -141.15 147.16 37.99 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.231 -1.396 . . . . 75.03 107.231 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.538 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.72 106.55 18.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.795 0.807 . . . . 75.45 111.426 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.64 -178.85 24.97 Favored Glycine 0 C--N 1.291 -1.963 0 N-CA-C 110.722 -0.951 . . . . 70.0 110.722 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.89 127.09 8.81 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.468 -1.853 . . . . 70.45 108.468 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.46 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 53.3 m 179.28 -177.48 0.31 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.775 1.63 . . . . 74.02 107.507 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.96 -74.68 0.35 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.874 0.368 . . . . 63.34 110.638 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -94.0 -16.67 23.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.024 0.44 . . . . 65.25 111.086 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.99 3.95 53.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.56 0.695 . . . . 71.24 109.9 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.46 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -97.98 157.05 16.34 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 115.211 -0.904 . . . . 71.54 111.175 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.34 134.74 37.43 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.735 -1.209 . . . . 72.15 107.735 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -107.21 121.33 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 115.335 -0.848 . . . . 73.14 111.633 -175.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 126' ' ' TYR . . . -167.05 177.32 41.75 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 118.727 -1.702 . . . . 54.31 114.279 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.517 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -156.56 157.08 34.71 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.627 -0.786 . . . . 72.02 109.357 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.519 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 4.9 p90 -163.08 177.1 9.41 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.529 0.518 . . . . 75.2 111.204 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 122' ' ' PRO . 35.3 t70 -120.02 130.79 54.89 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.186 -1.783 . . . . 74.23 106.186 175.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 C--N 1.296 -1.728 0 O-C-N 124.387 1.054 . . . . 73.22 110.316 -174.861 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.45 ' H1 ' ' CB ' ' A' ' 48' ' ' THR . 2.0 mpt? . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 110.611 -0.144 . . . . 74.51 110.611 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -103.07 77.91 1.6 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.293 0.568 . . . . 74.25 112.342 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -155.43 158.93 32.03 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 107.203 -1.406 . . . . 72.12 107.203 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.92 143.93 69.8 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.277 1.985 . . . . 74.42 110.716 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 75.06 -52.25 0.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.85 1.26 . . . . 64.43 110.96 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 39' ' ' MET . 86.6 mt-30 -68.48 -17.96 64.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 75.24 110.601 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.42 -27.11 68.86 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.529 -0.759 . . . . 74.1 110.018 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.74 -25.04 24.9 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.523 -0.547 . . . . 72.21 109.523 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 92.3 t -74.09 -43.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.587 -0.733 . . . . 73.1 109.112 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.45 ' CB ' ' H1 ' ' A' ' 39' ' ' MET . 5.8 t -68.18 -29.84 68.81 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.056 -0.975 . . . . 75.33 111.504 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.0 t -76.36 -47.69 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.935 -0.395 . . . . 74.42 109.935 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.398 -0.819 . . . . 64.25 111.498 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 47.6 mtpt -67.4 -23.57 65.57 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.239 -0.584 . . . . 73.15 112.316 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.78 -37.68 38.74 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.896 -1.145 . . . . 73.11 110.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.54 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 m-20 -77.34 -24.16 50.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.426 -0.51 . . . . 75.45 111.813 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 51' ' ' LYS . 15.5 pt -72.69 -27.26 25.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.084 -0.646 . . . . 74.21 110.842 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 2.0 mptm? -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.49 -0.884 . . . . 73.45 109.58 173.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -65.53 -42.38 92.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.327 -0.851 . . . . 63.31 109.86 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 53' ' ' ASP . 73.7 mt -62.99 -34.29 65.57 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.655 -0.702 . . . . 64.23 110.111 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.03 -31.3 70.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.846 0.355 . . . . 75.11 110.766 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.51 42.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.261 0.553 . . . . 63.04 109.849 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.99 35.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.009 -0.541 . . . . 74.34 110.155 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -30.01 68.67 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.982 -1.488 . . . . 74.3 106.982 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 17.3 t70 -68.67 -29.01 67.38 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.111 -0.949 . . . . 72.44 109.963 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -71.99 -36.21 69.71 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.46 -0.496 . . . . 74.34 109.668 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -70.28 -38.03 74.96 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 107.794 -1.188 . . . . 75.34 107.794 174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 29.2 tttm -54.21 -35.89 62.9 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.646 -0.706 . . . . 71.33 110.661 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.37 -33.91 32.06 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.596 -0.274 . . . . 72.23 111.62 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.71 -24.25 62.61 Favored 'General case' 0 C--O 1.177 -2.76 0 CA-C-O 120.545 0.212 . . . . 74.11 111.1 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.521 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.9 OUTLIER -127.01 18.66 7.14 Favored 'General case' 0 CA--C 1.463 -2.401 0 O-C-N 120.778 -1.202 . . . . 71.53 111.428 177.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.19 32.44 0.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.066 1.346 . . . . 74.25 112.663 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.82 162.11 0.57 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.072 -1.455 . . . . 54.11 107.072 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -80.48 155.87 73.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 111.858 0.318 . . . . 75.44 111.858 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.451 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 31.8 Cg_endo -66.03 161.87 37.92 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.048 2.499 . . . . 74.33 110.64 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -97.85 156.61 16.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.301 -1.37 . . . . 71.33 107.301 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 t -66.61 -13.79 61.57 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 119.138 0.881 . . . . 74.44 110.94 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 -65.14 1.01 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.448 -0.342 . . . . 75.42 111.33 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -77.41 -33.88 54.88 Favored 'General case' 0 CA--C 1.481 -1.707 0 O-C-N 121.95 -0.468 . . . . 73.1 111.197 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.507 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -76.73 -20.9 75.75 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 118.881 -1.628 . . . . 73.13 112.554 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.78 -49.53 61.91 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 106.069 -1.826 . . . . 75.04 106.069 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.0 -33.59 73.49 Favored 'General case' 0 C--O 1.169 -3.174 0 CA-C-N 114.646 -1.161 . . . . 71.44 110.272 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -80.07 -5.37 55.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.802 0.668 . . . . 64.41 112.802 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 84.6 mt -96.42 -17.8 20.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.192 0.52 . . . . 75.01 109.858 173.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.53 -33.93 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.373 0.606 . . . . 74.23 111.441 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 83.8 tttt -122.67 148.79 44.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 126.357 1.863 . . . . 64.12 106.861 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -56.51 135.56 76.98 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 118.152 0.433 . . . . 74.45 111.157 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.47 150.75 87.71 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.825 3.017 . . . . 74.42 112.685 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -98.45 146.81 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.618 -0.433 . . . . 74.44 110.557 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.71 -146.39 18.55 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.932 -1.267 . . . . 64.54 109.932 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -126.72 86.43 58.61 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-O 121.663 0.744 . . . . 71.32 111.697 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 1.6 Cg_endo -82.17 154.76 16.84 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.975 2.45 . . . . 74.41 111.126 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.2 143.5 65.23 Favored Pre-proline 0 C--O 1.211 -0.927 0 C-N-CA 123.615 0.766 . . . . 63.11 110.087 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.65 100.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.178 3.252 . . . . 74.51 115.017 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -147.31 148.02 30.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.203 -1.777 . . . . 75.22 106.203 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.33 91.58 3.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.484 -0.562 . . . . 74.5 109.484 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.636 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.7 t90 -54.58 138.83 40.07 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 123.969 0.793 . . . . 74.41 111.514 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -126.72 134.4 50.67 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 114.966 -1.016 . . . . 72.13 109.965 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 24.1 pttm -90.95 -176.43 4.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.321 -0.552 . . . . 72.54 109.883 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 72.43 15.59 5.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.137 1.375 . . . . 74.1 109.958 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.39 5.17 28.4 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 114.709 -1.132 . . . . 72.54 114.769 170.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.636 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 67.84 93.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.276 1.036 . . . . 74.02 110.644 -175.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.7 tp -132.6 158.33 42.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.899 -1.046 . . . . 74.41 108.651 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -84.85 -171.76 3.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.419 -0.956 . . . . 72.43 108.419 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 70.62 4.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.599 1.19 . . . . 74.24 110.504 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.9 mt -126.83 147.65 62.04 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 114.694 -1.139 . . . . 73.13 109.442 -174.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.63 158.36 53.73 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.634 1.556 . . . . 74.32 109.663 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 111' ' ' PRO . 6.0 p -79.6 175.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.43 -0.581 . . . . 75.54 109.43 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 5.8 p-10 -71.38 158.19 88.48 Favored Pre-proline 0 C--O 1.249 1.062 0 N-CA-C 113.375 0.88 . . . . 74.32 113.375 -168.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.36 169.1 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.679 2.919 . . . . 71.01 112.06 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 64.13 15.27 9.18 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.842 1.257 . . . . 74.42 109.142 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.0 68.43 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 114.266 -1.334 . . . . 52.11 115.152 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.486 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 3.8 m-80 -91.78 154.18 43.8 Favored Pre-proline 0 C--O 1.262 1.733 0 CA-C-N 119.927 1.863 . . . . 74.22 109.04 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HA ' HG21 ' A' ' 105' ' ' VAL . 1.5 Cg_endo -85.73 152.08 10.08 Favored 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 121.801 1.667 . . . . 75.11 108.365 165.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 70.0 m-85 -69.16 143.96 53.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.907 0.384 . . . . 74.43 110.252 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 1.6 mm100 -101.47 120.86 40.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.48 -1.674 . . . . 72.22 106.48 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.38 118.93 37.95 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 73.15 112.693 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 89.2 mt -130.34 153.71 48.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.669 -0.863 . . . . 72.4 108.669 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.425 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -113.5 -177.8 0.47 Allowed Pre-proline 0 C--N 1.297 -1.71 0 CA-C-O 117.055 -1.45 . . . . 71.3 109.284 -176.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 19.0 Cg_endo . . . . . 0 C--N 1.382 2.33 0 C-N-CA 122.956 2.437 . . . . 74.52 115.882 -166.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.683 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.488 -1.628 0 CA-C-O 118.704 -1.053 . . . . 64.41 113.548 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 11.1 Cg_exo -37.85 -29.52 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.574 1 C-N-CA 126.857 5.038 . . . . 73.34 118.343 -179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -170.43 151.76 3.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.915 1.234 . . . . 71.3 113.856 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -113.65 106.66 14.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.703 1.601 . . . . 74.43 107.518 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.81 125.03 32.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.747 -0.781 . . . . 71.01 109.416 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.401 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 27.0 p90 -167.1 165.35 15.64 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 110.41 -0.218 . . . . 72.12 110.41 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.1 p -125.7 148.0 49.18 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.805 -0.813 . . . . 63.14 108.805 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.26 133.5 50.72 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.776 0.658 . . . . 74.13 112.776 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.95 173.18 31.8 Favored Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 111.202 -0.759 . . . . 74.54 111.202 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.21 -20.32 26.24 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 115.583 1.697 . . . . 74.42 115.583 -173.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.534 ' OD2' ' HE2' ' A' ' 133' ' ' LYS . 5.0 t70 -94.88 -0.99 53.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.722 0.773 . . . . 72.34 109.757 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.76 24.48 60.15 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 111.319 -0.713 . . . . 74.03 111.319 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.534 ' HE2' ' OD2' ' A' ' 131' ' ' ASP . 68.5 mttm -112.13 147.31 36.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.151 0.5 . . . . 74.22 111.771 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -100.71 102.33 13.41 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 102.751 -3.055 . . . . 75.25 102.751 165.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 -173.29 23.14 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.196 -1.366 . . . . 51.35 111.446 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.15 128.16 8.11 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 107.311 -2.316 . . . . 61.22 107.311 172.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.543 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 62.8 m -177.78 -179.04 0.75 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.022 1.329 . . . . 73.24 107.463 -171.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.62 -68.6 0.55 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.323 0.583 . . . . 62.43 110.156 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.48 -16.42 11.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.223 -0.899 . . . . 73.53 110.857 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -82.72 -9.92 59.14 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.244 -0.434 . . . . 70.01 110.762 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.543 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -86.96 155.13 20.31 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.211 -0.904 . . . . 74.22 110.849 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.88 136.16 36.61 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.869 -1.53 . . . . 75.1 106.869 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 143' ' ' ILE . 2.9 pp -97.84 130.86 45.96 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.66 -1.237 . . . . 60.35 107.66 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -143.26 153.25 24.68 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 118.712 -1.709 . . . . 64.42 114.294 -173.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -120.08 129.55 54.26 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.264 -2.125 . . . . 71.53 105.264 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -142.43 144.1 32.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.806 -0.813 . . . . 74.35 108.806 -168.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -130.47 115.13 16.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.97 -1.122 . . . . 75.2 107.97 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 107.34 -1.356 . . . . 55.4 107.34 179.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 109.378 -0.601 . . . . 64.34 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -92.4 62.02 3.91 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.906 0.706 . . . . 73.41 112.906 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -148.38 147.79 26.75 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 107.497 -1.297 . . . . 74.54 107.497 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.06 151.69 26.83 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.469 2.113 . . . . 73.43 109.835 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 76.76 -57.28 0.54 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.224 1.009 . . . . 72.23 109.389 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.79 -16.39 63.78 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.888 -0.508 . . . . 64.41 111.344 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 -25.89 67.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.872 -0.604 . . . . 61.3 109.386 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -83.49 -24.58 31.68 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 108.825 -0.806 . . . . 74.54 108.825 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.37 -43.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.82 -0.627 . . . . 75.24 110.233 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -66.43 -39.59 89.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.095 -0.502 . . . . 74.31 111.901 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.02 -34.79 51.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.786 0.327 . . . . 64.02 110.289 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.36 87.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.055 -0.521 . . . . 60.01 110.671 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 66.1 mttm -65.68 -25.6 67.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.357 0.598 . . . . 72.43 111.225 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 -32.31 35.5 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.762 -1.209 . . . . 74.33 110.538 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' ALA 0.354 70.4 m-20 -87.33 -20.62 26.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.268 1.21 . . . . 74.54 114.268 -175.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.416 HD13 ' C ' ' A' ' 144' ' ' GLY . 15.4 pt -71.64 -28.43 31.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.714 -0.847 . . . . 74.53 108.714 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.544 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -73.82 -27.03 60.9 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.844 -0.616 . . . . 75.42 110.565 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -62.5 -43.27 99.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.444 -0.798 . . . . 64.12 109.958 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 53' ' ' ASP . 27.3 mt -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.735 0 CA-C-N 115.232 -0.895 . . . . 73.11 109.681 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.69 -25.28 62.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.835 -0.62 . . . . 71.31 111.995 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.78 -35.12 20.92 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.196 0.522 . . . . 44.43 110.11 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 99' ' ' TYR . . . -80.58 -28.3 37.19 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.779 -0.368 . . . . 64.33 111.242 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.89 -26.85 64.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.883 -1.155 . . . . 72.32 107.883 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.3 t70 -69.09 -23.97 64.08 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.287 1.041 . . . . 65.04 109.232 173.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.417 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 51.1 ttm -78.76 -37.94 39.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.534 -0.757 . . . . 73.32 109.674 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.457 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 81.9 t80 -66.01 -38.12 87.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.063 -1.088 . . . . 75.54 108.063 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.54 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 75.9 tttt -54.54 -33.14 59.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.357 -1.292 . . . . 75.11 109.945 173.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 tp -83.13 -34.93 25.94 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.683 -0.407 . . . . 75.25 110.593 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.98 -25.61 62.78 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 120.901 0.381 . . . . 75.42 111.909 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.56 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -125.65 19.84 7.92 Favored 'General case' 0 CA--C 1.462 -2.427 0 O-C-N 121.068 -1.02 . . . . 65.51 110.949 175.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 p90 43.85 33.65 0.77 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 124.621 1.201 . . . . 73.23 113.549 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.85 160.36 1.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.739 -0.837 . . . . 75.54 108.739 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.54 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 27.6 m-85 -82.98 152.66 66.03 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.932 -0.396 . . . . 72.23 109.932 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.498 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.9 Cg_endo -63.82 164.73 20.67 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.972 3.114 . . . . 71.22 112.96 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.1 p -97.67 156.25 16.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 106.049 -1.834 . . . . 74.34 106.049 172.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.408 ' N ' ' HB1' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -66.15 -14.47 61.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.43 0.633 . . . . 75.14 110.566 -176.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.42 -66.19 0.94 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.385 -0.598 . . . . 71.35 109.385 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -79.66 -35.98 38.42 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 116.186 -0.461 . . . . 72.53 111.087 -173.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.574 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -76.77 -21.4 74.56 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 118.021 -2.037 . . . . 62.11 112.453 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.23 -46.85 66.37 Favored 'General case' 0 C--O 1.259 1.591 0 N-CA-C 106.491 -1.67 . . . . 73.31 106.491 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.8 mt-10 -60.37 -37.69 81.54 Favored 'General case' 0 C--O 1.171 -3.067 0 CA-C-N 114.603 -1.18 . . . . 72.11 109.401 174.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 85' ' ' PRO . . . -77.37 -3.26 39.22 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.862 0.689 . . . . 64.21 112.862 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 76.8 mt -95.18 -22.79 17.61 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.099 0.476 . . . . 72.34 110.168 173.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -107.78 -25.88 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.547 0.689 . . . . 74.14 111.222 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 85.0 tttt -127.03 147.39 50.14 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 126.432 1.893 . . . . 74.12 107.001 -175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -54.86 128.53 63.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.606 0.762 . . . . 75.12 111.78 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 37.1 Cg_endo -66.8 131.03 24.62 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.405 2.737 . . . . 74.23 111.701 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -94.68 -179.15 4.78 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.11 -0.7 . . . . 61.53 109.11 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.88 -125.12 8.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 108.207 -1.957 . . . . 74.41 108.207 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.8 80.21 14.2 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 118.093 0.946 . . . . 72.53 112.697 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.56 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 14.4 Cg_endo -82.94 142.54 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.205 1.936 . . . . 70.32 110.479 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -83.06 115.98 61.79 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 107.149 -1.426 . . . . 72.14 107.149 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.508 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 51.4 Cg_exo -51.18 98.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 123.409 2.74 . . . . 71.42 117.678 -168.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -111.19 148.93 31.71 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 101.995 -3.335 . . . . 72.45 101.995 163.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.54 99.6 0.11 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 120.108 -0.637 . . . . 71.04 109.736 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.595 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.2 t90 -62.16 141.88 57.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 124.42 1.088 . . . . 74.25 110.693 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.99 133.4 50.57 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.719 -0.673 . . . . 74.31 109.284 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -82.46 -176.92 6.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.15 0.5 . . . . 71.31 110.359 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.4 t70 71.36 15.71 6.22 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.498 1.119 . . . . 71.2 110.292 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 109.21 7.97 27.89 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.057 -0.974 . . . . 73.5 114.115 171.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.595 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 63.78 92.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.136 0.97 . . . . 71.05 109.139 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.514 HD21 ' N ' ' A' ' 101' ' ' LYS . 6.8 tt -138.21 168.01 20.64 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.978 -1.489 . . . . 72.21 106.978 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.514 ' N ' HD21 ' A' ' 100' ' ' LEU . 71.5 mmtt -72.44 179.8 3.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.216 -1.031 . . . . 72.22 108.216 176.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -80.41 77.21 7.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.172 0.987 . . . . 74.54 110.376 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.9 mt -131.41 149.89 74.86 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.806 -1.543 . . . . 75.24 108.394 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.49 -170.17 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.861 1.707 . . . . 73.45 111.035 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.598 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.5 p -83.93 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.705 -0.85 . . . . 65.03 108.705 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.547 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 t0 -75.38 156.79 85.24 Favored Pre-proline 0 C--O 1.251 1.175 0 N-CA-C 108.898 -0.778 . . . . 75.31 108.898 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.547 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 6.0 Cg_endo -49.15 170.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 123.689 2.926 . . . . 74.31 113.408 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.479 ' HB2' HD21 ' A' ' 110' ' ' ASN . 1.7 m-90 67.21 14.39 9.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.959 1.704 . . . . 74.42 110.467 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.87 22.8 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 115.467 -0.788 . . . . 71.11 114.25 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.479 HD21 ' HB2' ' A' ' 108' ' ' TRP . 56.7 m-80 -69.95 134.53 87.72 Favored Pre-proline 0 C--O 1.255 1.378 0 N-CA-C 113.319 0.859 . . . . 65.11 113.319 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.598 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.5 Cg_endo -71.51 154.12 60.36 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.429 2.086 . . . . 74.41 110.404 173.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -73.29 141.2 47.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.882 -1.525 . . . . 75.43 106.882 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.3 mm100 -102.89 113.83 27.6 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.417 -1.697 . . . . 63.51 106.417 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.57 120.02 40.05 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.72 -0.673 . . . . 71.21 112.518 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 97.5 mt -129.29 153.61 47.65 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.385 0.674 . . . . 74.35 109.246 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.418 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . . . -109.14 -179.1 0.63 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 117.104 -1.426 . . . . 74.01 108.364 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.723 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 25.0 Cg_endo . . . . . 0 C--N 1.384 2.416 0 C-N-CA 123.042 2.495 . . . . 72.43 116.785 -162.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.479 -2.218 0 CA-C-O 118.65 -1.083 . . . . 65.13 113.248 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.512 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 11.8 Cg_exo -43.34 -24.67 0.61 Allowed 'Trans proline' 0 C--N 1.371 1.754 1 C-N-CA 126.052 4.502 . . . . 71.23 117.179 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -168.89 143.91 3.24 Favored 'General case' 0 C--O 1.254 1.308 0 CA-C-N 118.861 0.755 . . . . 74.12 112.18 173.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.3 m-20 -122.99 117.68 26.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.518 -1.29 . . . . 73.33 107.518 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 pp -145.42 140.03 27.32 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.742 -0.783 . . . . 63.44 111.671 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.462 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 45.8 p90 -166.23 167.88 15.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.295 -1.002 . . . . 74.54 108.295 -175.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.9 p -124.18 136.85 54.49 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.593 -0.891 . . . . 74.24 108.593 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.65 135.3 57.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.846 -0.742 . . . . 73.43 111.541 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.87 -172.2 9.74 Favored Glycine 0 CA--C 1.495 -1.173 0 CA-C-N 115.817 -0.629 . . . . 65.32 112.848 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.33 -7.81 10.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 114.101 1.148 . . . . 73.23 114.101 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.66 -7.05 41.91 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.091 -0.644 . . . . 74.2 110.149 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 22.16 76.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 121.124 -0.56 . . . . 73.24 111.764 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -140.53 143.51 35.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.625 -1.25 . . . . 74.35 107.625 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -81.66 108.93 15.62 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.712 0.767 . . . . 74.12 109.997 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.4 -173.94 20.41 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.265 -0.88 . . . . 70.15 111.526 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.62 128.11 8.31 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.735 -0.946 . . . . 71.03 110.735 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.512 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 19.4 m 178.17 -176.87 0.21 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 127.143 2.177 . . . . 72.44 105.962 -172.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -87.49 -58.36 2.61 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.931 -1.107 . . . . 75.4 110.827 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.71 -28.81 13.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.638 0.732 . . . . 75.14 111.408 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.95 9.17 23.11 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.761 -0.587 . . . . 73.51 111.753 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.512 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -99.29 155.75 17.35 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 115.845 -0.616 . . . . 62.34 110.782 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -80.47 125.6 30.15 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.174 -1.417 . . . . 73.15 107.174 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 2.6 pp -106.71 141.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.508 -0.923 . . . . 73.23 108.508 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.416 ' C ' HD13 ' A' ' 54' ' ' ILE . . . -173.78 170.85 44.01 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 118.212 -1.946 . . . . 71.24 114.41 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -113.72 137.26 51.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.847 -1.538 . . . . 74.2 106.847 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -141.79 124.53 15.99 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.562 . . . . 64.33 106.781 -170.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -102.73 114.2 28.24 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.053 -1.091 . . . . 71.23 108.053 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.3 p30 . . . . . 0 C--N 1.294 -1.814 0 N-CA-C 107.759 -1.2 . . . . 73.53 107.759 -178.881 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.459 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 1.2 mpt? . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.257 -0.645 . . . . 74.33 109.257 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.7 m -100.03 86.09 3.18 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.597 0.713 . . . . 74.33 112.077 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -148.14 163.6 26.06 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 106.35 -1.722 . . . . 73.15 106.35 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 44' ' ' GLN . 71.0 Cg_exo -52.88 130.14 36.18 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.681 2.254 . . . . 70.52 111.374 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.55 -34.21 0.28 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 126.004 1.721 . . . . 63.23 111.008 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 42' ' ' PRO . 15.8 mm100 -68.29 -20.49 64.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 75.1 109.37 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.53 -29.46 70.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.315 -0.857 . . . . 62.35 110.073 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -80.62 -26.55 37.68 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 108.108 -1.071 . . . . 75.54 108.108 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.3 t -75.35 -43.6 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.572 -0.74 . . . . 74.44 110.299 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 39' ' ' MET . 7.1 t -67.93 -37.05 81.18 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.584 -0.735 . . . . 73.34 111.309 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.87 -34.26 32.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 110.127 -0.323 . . . . 74.43 110.127 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.755 -0.657 . . . . 71.43 110.616 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 70.9 mmtt -65.28 -26.31 68.02 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.421 0.629 . . . . 74.25 111.05 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.29 -32.48 19.81 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.536 -1.025 . . . . 73.1 110.536 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.642 ' O ' HG13 ' A' ' 57' ' ' ILE . 70.1 m-20 -77.11 -33.58 56.88 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 120.917 -0.313 . . . . 72.43 111.465 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 pt -67.73 -29.74 46.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.701 -0.4 . . . . 72.32 110.313 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -73.23 -30.17 63.3 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.212 -0.662 . . . . 73.41 109.212 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 53' ' ' ASP . . . -64.43 -40.58 96.01 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.052 -0.976 . . . . 74.01 109.991 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 53' ' ' ASP . 28.8 mt -66.28 -40.18 86.16 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.628 0 CA-C-N 115.103 -0.953 . . . . 74.22 109.71 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.03 66.8 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.29 -0.413 . . . . 74.23 111.447 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.03 -29.69 26.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.154 0.502 . . . . 74.51 110.319 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.31 -28.13 23.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.078 0.466 . . . . 72.4 110.975 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.99 -28.29 65.4 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.812 -1.551 . . . . 72.44 106.812 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.9 t70 -70.06 -24.16 63.2 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.598 -1.183 . . . . 74.22 108.75 172.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.7 mmt -79.93 -34.73 38.64 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.468 -0.787 . . . . 73.31 110.216 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 49.0 t80 -67.69 -31.7 71.84 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 107.103 -1.443 . . . . 75.14 107.103 171.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 56.9 tttp -57.92 -32.5 67.82 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.654 -0.703 . . . . 75.54 110.326 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -77.01 -36.11 56.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.148 0.499 . . . . 72.41 110.206 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -71.06 -25.44 62.63 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-N 115.7 -0.682 . . . . 74.33 110.856 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.5 18.41 5.29 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.924 -0.56 . . . . 72.23 110.27 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 p90 42.89 31.35 0.31 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.014 1.326 . . . . 53.21 113.253 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.44 162.5 0.52 Allowed 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.516 -1.29 . . . . 71.12 107.516 -172.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 21.2 m-85 -78.63 151.63 77.32 Favored Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 120.305 -0.558 . . . . 74.55 111.31 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.466 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 14.1 Cg_endo -59.76 170.55 3.45 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 124.307 3.338 . . . . 74.32 112.725 177.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.43 ' C ' ' HB1' ' A' ' 116' ' ' ALA . 77.7 p -101.82 155.66 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.492 -1.67 . . . . 74.15 106.492 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.55 -15.07 62.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 119.796 1.18 . . . . 65.24 111.814 -173.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.48 -63.74 1.1 Allowed 'General case' 0 C--O 1.241 0.619 0 CA-C-N 116.311 -0.404 . . . . 72.31 110.886 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 48.8 mt-30 -76.08 -38.53 56.92 Favored 'General case' 0 CA--C 1.484 -1.584 0 C-N-CA 120.889 -0.325 . . . . 75.32 110.646 -174.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 72' ' ' PRO . . . -71.31 -21.23 78.56 Favored Glycine 0 N--CA 1.418 -2.512 0 C-N-CA 119.101 -1.523 . . . . 72.54 112.83 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.54 -45.5 75.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.728 -1.582 . . . . 75.05 106.728 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.6 mt-10 -79.88 -2.83 45.37 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.842 -1.072 . . . . 72.31 111.077 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.452 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -99.8 -8.16 24.53 Favored 'General case' 0 C--O 1.204 -1.33 0 CA-C-O 121.677 0.751 . . . . 74.04 109.326 174.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 77' ' ' GLY . 5.4 mp -98.52 -24.25 15.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.481 -0.781 . . . . 72.21 110.026 174.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.92 -27.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.913 -0.585 . . . . 63.01 111.129 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 87.8 tttt -130.04 151.49 50.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.558 -1.645 . . . . 63.34 106.558 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -53.55 135.08 53.77 Favored Pre-proline 0 N--CA 1.485 1.308 0 CA-C-N 118.7 0.682 . . . . 75.02 110.94 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 7.2 Cg_endo -47.99 130.05 19.18 Favored 'Trans proline' 0 C--O 1.246 0.885 1 C-N-CA 125.357 4.038 . . . . 75.35 116.355 -170.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -82.19 148.97 28.16 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.183 -1.414 . . . . 72.24 107.183 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.66 -157.28 22.29 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 109.634 -1.386 . . . . 41.12 109.634 -176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.43 99.69 29.69 Favored Pre-proline 1 N--CA 1.369 -4.521 0 CA-C-N 117.68 0.74 . . . . 74.43 110.195 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -95.41 162.64 1.54 Allowed 'Trans proline' 0 N--CA 1.443 -1.493 0 C-N-CA 122.126 1.884 . . . . 75.24 109.756 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -82.8 159.18 63.92 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.432 . . . . 75.5 109.835 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.35 99.9 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.904 1.736 . . . . 75.21 111.315 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -150.51 146.07 26.38 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.485 -1.302 . . . . 73.45 107.485 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.64 89.52 1.32 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 120.733 0.301 . . . . 73.32 111.088 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.455 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 88.7 t90 -54.91 139.48 40.27 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.954 -1.021 . . . . 74.31 111.733 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.43 130.01 56.69 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.788 -1.096 . . . . 75.54 108.961 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -74.38 177.62 5.79 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.933 0.873 . . . . 73.01 110.801 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 62.24 36.11 14.98 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.345 -1.752 . . . . 74.24 109.398 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.55 7.73 63.03 Favored Glycine 0 CA--C 1.488 -1.611 0 CA-C-N 113.749 -1.569 . . . . 63.41 115.224 165.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 63.12 85.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.253 1.025 . . . . 72.4 108.649 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.1 tt -138.8 155.63 48.01 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.517 -1.66 . . . . 74.32 106.517 -173.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -63.53 141.5 58.74 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.799 -1.186 . . . . 74.3 107.799 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -74.0 79.09 1.69 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.039 0.923 . . . . 74.21 112.323 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -130.35 149.21 72.71 Favored Pre-proline 0 C--N 1.288 -2.094 0 CA-C-N 113.773 -1.558 . . . . 74.2 108.061 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 171.82 1.21 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.792 2.328 . . . . 73.23 111.873 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.6 p -79.21 171.78 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.547 0 CA-C-N 116.342 -0.39 . . . . 71.42 110.082 -173.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.486 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.2 t70 -82.76 153.89 67.76 Favored Pre-proline 0 C--O 1.256 1.423 0 C-N-CA 119.579 -0.848 . . . . 71.32 109.67 -169.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 10.3 Cg_exo -42.81 171.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.867 3.044 . . . . 73.35 115.051 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.424 ' CG ' ' HA ' ' A' ' 130' ' ' ALA . 2.7 m-90 70.15 14.17 7.7 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.484 2.313 . . . . 74.04 109.175 -175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.15 19.09 56.63 Favored Glycine 0 N--CA 1.466 0.635 0 CA-C-N 114.967 -1.015 . . . . 65.03 113.176 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.05 128.26 65.97 Favored Pre-proline 0 C--O 1.27 2.139 0 CA-C-O 121.526 0.679 . . . . 73.25 111.84 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.546 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 73.7 Cg_endo -80.46 154.2 21.1 Favored 'Trans proline' 0 N--CA 1.419 -2.888 0 C-N-CA 122.264 1.976 . . . . 75.15 110.302 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 46.7 m-85 -80.75 139.49 36.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.823 -1.177 . . . . 72.43 107.823 172.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.51 ' OE1' HD12 ' A' ' 128' ' ' LEU . 1.2 mm100 -103.98 118.45 36.7 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.327 -1.36 . . . . 72.55 107.327 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -103.82 117.66 34.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.893 -1.151 . . . . 71.43 107.893 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.0 mt -129.57 153.42 48.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.413 -0.958 . . . . 72.31 108.413 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.488 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -109.56 179.63 0.81 Allowed Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-O 117.001 -1.475 . . . . 74.21 108.351 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 116' ' ' ALA . 9.1 Cg_endo . . . . . 0 C--N 1.38 2.2 0 C-N-CA 123.565 2.844 . . . . 71.52 114.796 -168.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.731 0 N-CA-C 117.952 1.941 . . . . 74.13 117.952 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 7.2 Cg_exo -31.25 -26.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.502 1 C-N-CA 129.208 6.605 . . . . 74.31 119.505 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.285 47.6 p90 -169.9 149.03 3.61 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 119.717 1.144 . . . . 72.43 112.912 170.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.0 OUTLIER -112.66 106.29 14.65 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.483 -1.303 . . . . 73.12 107.483 -176.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.4 tm? -128.46 128.08 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.202 -0.936 . . . . 73.51 110.254 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -166.57 164.33 17.0 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 120.855 -0.338 . . . . 74.33 111.862 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.455 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 23.0 t -125.07 141.71 51.95 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.882 -2.266 . . . . 74.25 104.882 171.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 113' ' ' GLN . 5.3 mp -59.56 155.0 16.2 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.789 1.033 . . . . 72.41 113.789 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.7 172.85 53.79 Favored Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 115.561 -0.745 . . . . 70.02 112.292 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.424 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -47.52 -28.47 2.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 116.79 2.144 . . . . 62.32 116.79 -173.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.33 -2.06 52.8 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.837 0.744 . . . . 72.21 111.27 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.42 24.75 27.82 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.986 -0.626 . . . . 71.35 112.082 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -140.89 146.32 37.31 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.412 -0.588 . . . . 75.21 109.412 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -81.88 117.85 22.47 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 120.825 0.345 . . . . 64.32 110.777 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -149.47 -174.23 20.71 Favored Glycine 0 C--N 1.317 -0.497 0 N-CA-C 110.441 -1.064 . . . . 43.41 110.441 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.91 128.14 8.6 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 109.791 -1.324 . . . . 73.14 109.791 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 140' ' ' ASP . 23.2 t 178.02 -176.65 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.384 -0.969 . . . . 73.24 108.384 -171.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.41 -71.11 0.36 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.116 -0.698 . . . . 74.11 109.116 172.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -98.76 -17.06 18.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.303 0.573 . . . . 71.02 111.525 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 15.1 m-20 -91.67 9.24 33.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.683 0.754 . . . . 73.11 110.763 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -92.54 152.87 19.4 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.591 -0.731 . . . . 70.31 110.31 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.79 119.39 21.93 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.931 -1.877 . . . . 70.41 105.931 171.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.35 128.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 115.754 -0.657 . . . . 73.11 109.936 -174.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.13 -179.8 38.56 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 118.463 -1.827 . . . . 75.5 113.31 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 7.2 t30 -123.73 147.88 47.09 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 105.725 -1.954 . . . . 73.33 105.725 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -142.88 135.92 28.15 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.75 -1.204 . . . . 75.44 107.75 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.9 106.58 13.97 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.176 -1.009 . . . . 73.15 108.484 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.465 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 2.6 t-20 . . . . . 0 N--CA 1.419 -1.988 0 N-CA-C 107.087 -1.449 . . . . 73.32 107.087 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.7 ttt . . . . . 0 C--O 1.217 -0.65 0 N-CA-C 107.724 -1.213 . . . . 73.14 107.724 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -110.22 89.41 3.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.024 0.916 . . . . 64.45 110.426 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -155.89 161.29 29.79 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.191 -1.781 . . . . 72.03 106.191 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.02 120.53 0.54 Allowed 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 124.057 3.171 . . . . 74.34 114.68 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t0 74.36 -35.79 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 126.81 2.044 . . . . 64.14 112.186 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HA ' HG21 ' A' ' 47' ' ' VAL . 84.6 mm-40 -68.76 -24.39 64.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.504 0.668 . . . . 72.45 109.528 176.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.502 ' O ' HG11 ' A' ' 49' ' ' VAL . . . -62.11 -29.17 70.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.035 -0.984 . . . . 70.02 109.329 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.8 -23.73 39.05 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.118 -0.492 . . . . 74.33 110.249 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 44' ' ' GLN . 40.2 t -74.59 -44.01 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.189 -1.041 . . . . 74.44 108.189 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.6 t -67.96 -34.2 76.11 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.52 -0.763 . . . . 73.34 111.525 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 45' ' ' ALA . 19.8 m -69.22 -43.3 81.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 C-N-CA 119.434 -0.906 . . . . 74.13 109.566 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.74 91.01 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.128 0.971 . . . . 75.44 110.958 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 58.7 mtpt -66.6 -21.89 66.13 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.635 -0.711 . . . . 74.43 111.925 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.27 -31.71 18.86 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 110.105 -1.198 . . . . 73.53 110.105 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -70.42 -39.33 74.49 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.331 0.586 . . . . 75.53 110.622 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.6 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 17.6 pt -70.23 -25.5 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.942 -0.572 . . . . 71.45 110.673 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -68.41 -31.87 71.51 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.735 -0.839 . . . . 72.41 108.735 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -29.3 64.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.272 -0.876 . . . . 63.24 109.78 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 18.1 mm -59.88 -48.3 88.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 CA-C-N 115.03 -0.987 . . . . 74.32 108.731 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.421 ' HB1' HD22 ' A' ' 145' ' ' ASN . . . -58.22 -34.01 69.95 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.854 0.359 . . . . 63.21 111.314 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.53 -42.54 67.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.736 -0.665 . . . . 75.41 111.037 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.41 24.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.464 0.542 . . . . 64.43 112.464 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.31 -30.11 69.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.166 -1.42 . . . . 74.42 107.166 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.5 t70 -69.88 -27.61 64.96 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.289 1.042 . . . . 73.33 109.601 173.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 63.3 mtt -78.34 -30.21 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.707 -0.679 . . . . 74.53 110.331 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -71.3 -36.22 71.56 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.017 -1.105 . . . . 72.21 108.017 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 51.9 tttp -55.17 -31.59 61.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.316 -0.856 . . . . 73.44 109.93 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.93 -31.05 23.84 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.291 -0.868 . . . . 75.32 110.806 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.46 -27.12 56.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.925 0.393 . . . . 74.23 111.333 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.47 24.16 5.13 Favored 'General case' 0 CA--C 1.46 -2.513 0 N-CA-C 109.479 -0.563 . . . . 74.4 109.479 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.3 p90 43.26 33.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.417 1.087 . . . . 72.45 113.824 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 179.87 160.09 0.82 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.125 -0.694 . . . . 72.3 109.125 -173.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.509 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 24.4 m-85 -81.23 150.91 68.86 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 123.451 0.469 . . . . 75.1 110.131 171.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.546 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.8 Cg_endo -65.01 170.09 10.91 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.607 2.871 . . . . 74.42 113.255 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.3 p -110.01 153.98 23.82 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.196 -1.779 . . . . 74.45 106.196 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.412 ' N ' ' HB2' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -59.59 -20.98 59.62 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.433 0.635 . . . . 72.21 111.933 -178.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -98.38 -65.95 0.93 Allowed 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 122.055 -0.403 . . . . 73.14 111.313 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -75.99 -37.32 58.64 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 116.604 -0.271 . . . . 75.22 111.287 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.546 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -78.53 -21.41 69.5 Favored Glycine 0 N--CA 1.413 -2.865 0 C-N-CA 118.372 -1.871 . . . . 75.52 112.83 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.92 -44.64 65.74 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 106.324 -1.732 . . . . 72.11 106.324 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 10.1 mm-40 -60.47 -41.34 93.97 Favored 'General case' 0 C--O 1.162 -3.526 0 CA-C-N 114.7 -1.136 . . . . 65.53 109.828 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.55 1.37 19.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.942 0.719 . . . . 64.51 112.942 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 63.5 mt -101.64 -20.97 14.8 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.229 -0.295 . . . . 73.05 111.008 172.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.3 t -111.04 -26.42 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-O 121.822 0.82 . . . . 74.41 111.026 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 38.3 ttmt -122.87 146.65 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 126.972 2.109 . . . . 72.32 105.83 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.419 ' HG3' ' CE3' ' A' ' 94' ' ' TRP . 3.8 mppt? -55.95 141.86 66.27 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 118.517 0.599 . . . . 72.2 111.501 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.77 122.35 10.87 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 123.063 2.508 . . . . 74.31 112.397 -172.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.3 p -71.26 140.66 50.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.335 -1.302 . . . . 71.15 111.132 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.12 -116.55 5.61 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.54 -1.024 . . . . 75.11 110.54 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.24 92.53 7.48 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 112.872 0.693 . . . . 73.34 112.872 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.73 162.38 14.27 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.739 1.626 . . . . 73.33 107.954 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -74.87 158.97 84.03 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-O 118.608 -0.71 . . . . 75.24 109.392 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.42 98.3 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 121.56 1.507 . . . . 70.53 110.625 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 10.1 tmtt? -152.77 144.18 23.31 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.183 -1.784 . . . . 75.43 106.183 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.503 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 33.5 m-80 -78.7 94.76 5.14 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 118.239 0.472 . . . . 71.43 111.315 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.432 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.5 t90 -57.65 144.17 38.69 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.037 1.335 . . . . 75.21 112.519 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 2.5 t-20 -120.93 135.16 55.27 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.806 -1.088 . . . . 73.22 108.984 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -84.06 -174.3 5.2 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.435 -0.58 . . . . 75.41 109.435 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 58.91 34.64 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 114.241 1.2 . . . . 74.24 114.241 176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 89.87 6.55 69.59 Favored Glycine 0 CA--C 1.487 -1.717 0 CA-C-N 115.344 -0.844 . . . . 72.21 114.358 168.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.432 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.5 OUTLIER 66.18 91.9 0.08 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.311 1.053 . . . . 71.53 111.301 -176.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.3 tp -138.28 170.97 15.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.618 -1.173 . . . . 74.0 108.174 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.87 -165.54 1.22 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.729 -0.607 . . . . 74.24 109.617 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 39.83 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.893 0.854 . . . . 75.33 112.272 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.8 mt -102.13 148.59 35.59 Favored Pre-proline 0 C--N 1.294 -1.844 0 C-N-CA 124.328 1.051 . . . . 73.1 110.2 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.85 -166.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.908 3.072 . . . . 72.02 112.229 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.464 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 3.6 p -85.01 172.04 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 107.353 -1.351 . . . . 71.13 107.353 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.591 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -80.21 155.98 74.3 Favored Pre-proline 0 C--O 1.256 1.415 0 C-N-CA 119.723 -0.791 . . . . 74.32 109.847 -172.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 11.2 Cg_endo -54.3 171.54 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.562 2.842 . . . . 74.03 113.298 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.57 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 65.57 15.76 10.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.909 1.684 . . . . 71.13 109.738 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.63 29.76 75.86 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.921 -1.036 . . . . 74.34 113.926 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.57 ' ND2' ' HB2' ' A' ' 108' ' ' TRP . 58.1 m-80 -93.11 119.82 67.36 Favored Pre-proline 0 C--O 1.249 1.056 0 CA-C-N 117.672 0.736 . . . . 75.33 110.802 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.464 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 46.3 Cg_exo -62.91 143.12 90.77 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 121.955 1.77 . . . . 74.42 108.824 168.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -69.18 144.4 53.79 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.149 0.5 . . . . 75.02 110.332 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.644 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -102.62 114.77 29.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.403 -1.703 . . . . 74.13 106.403 -178.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.13 117.3 34.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.395 -1.335 . . . . 74.41 107.395 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.1 mt -129.67 154.02 47.56 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.239 0.542 . . . . 74.4 109.808 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -112.78 -178.63 0.54 Allowed Pre-proline 0 N--CA 1.401 -2.884 0 CA-C-O 116.109 -1.9 . . . . 54.44 106.959 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 9.5 Cg_endo . . . . . 0 C--N 1.395 3.023 0 C-N-CA 123.146 2.564 . . . . 72.32 115.191 -164.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.486 -1.723 0 CA-C-O 118.553 -1.137 . . . . 73.24 113.058 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 34.9 Cg_exo -36.61 -29.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 1 C-N-CA 126.637 4.892 . . . . 74.32 118.352 -178.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.515 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 46.4 p90 -172.17 168.27 5.76 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.102 0.865 . . . . 73.52 111.247 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.6 106.33 5.63 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.835 0.854 . . . . 75.33 109.145 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.427 ' HG ' ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -125.48 127.31 46.28 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.579 -0.896 . . . . 73.13 108.579 -178.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.545 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 30.0 p90 -166.61 169.42 13.65 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.252 -0.579 . . . . 71.14 112.301 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.2 t -125.02 149.27 47.93 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.681 -1.229 . . . . 72.4 107.681 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.644 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 82.1 mt -69.16 154.6 41.78 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 110.355 -0.239 . . . . 73.12 110.355 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.36 -174.76 24.8 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 121.449 -0.405 . . . . 62.23 113.87 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -55.15 -24.37 26.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.906 1.446 . . . . 72.14 114.906 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -93.85 -6.04 46.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.21 -0.596 . . . . 74.51 110.946 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.4 ' O ' HD11 ' A' ' 128' ' ' LEU . . . 91.17 19.18 43.39 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.608 -0.806 . . . . 64.12 113.086 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -140.79 148.62 40.92 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.326 -0.62 . . . . 74.1 109.326 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.36 122.57 23.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.111 0.481 . . . . 74.45 110.55 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.62 -175.06 22.27 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 110.369 -1.092 . . . . 72.31 110.369 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -115.19 127.34 7.59 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 108.102 -1.999 . . . . 64.41 108.102 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 69.3 m 179.66 -177.15 0.33 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.617 1.167 . . . . 72.44 108.22 -169.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.94 -67.65 0.74 Allowed 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.95 0.156 . . . . 75.25 110.692 170.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.19 -21.34 17.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.137 0.494 . . . . 75.4 111.609 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -93.21 15.07 16.26 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.153 0.501 . . . . 75.01 111.077 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . -91.68 155.86 18.0 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 115.995 -0.548 . . . . 64.11 111.164 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.44 127.86 32.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.235 -1.765 . . . . 73.51 106.235 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.498 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -96.96 121.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 108.333 -0.988 . . . . 63.54 108.333 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -142.26 152.54 23.77 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.188 -1.482 . . . . 71.4 114.796 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 54' ' ' ILE . 3.6 t30 -130.25 120.08 23.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.536 -1.283 . . . . 63.11 107.536 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.515 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 2.5 p90 -160.24 177.57 10.51 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.722 0.772 . . . . 75.03 111.945 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.34 117.44 26.96 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 106.377 -1.712 . . . . 74.53 106.377 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 C--N 1.298 -1.641 0 N-CA-C 106.966 -1.494 . . . . 71.23 106.966 -176.908 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 108.444 -0.947 . . . . 72.1 108.444 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 m -121.64 80.12 1.64 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.361 0.6 . . . . 75.0 111.749 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -149.82 161.17 32.18 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.937 -1.875 . . . . 72.14 105.937 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -45.71 128.78 11.17 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.032 2.488 . . . . 71.23 112.088 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.266 20.6 m-20 75.99 -41.33 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.281 1.432 . . . . 64.2 113.705 -176.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.55 -23.03 64.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.265 0.555 . . . . 74.23 110.113 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.51 65.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.084 -0.962 . . . . 65.21 110.512 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -88.35 -26.56 22.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.212 -1.033 . . . . 73.41 108.212 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 39.1 t -75.71 -40.76 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.076 -0.966 . . . . 65.11 109.948 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -63.48 -29.55 70.81 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.487 -0.779 . . . . 74.22 110.861 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -73.63 -44.85 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 108.357 -0.979 . . . . 74.11 108.357 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB1' HD11 ' A' ' 143' ' ' ILE . . . -58.47 -42.33 87.25 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.937 -1.029 . . . . 74.45 111.532 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -66.7 -25.07 66.35 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 121.331 0.586 . . . . 74.41 111.944 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.81 -22.86 34.82 Favored Glycine 0 C--N 1.31 -0.889 0 N-CA-C 110.447 -1.061 . . . . 55.24 110.447 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 15.4 t70 -82.25 -38.33 24.62 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.296 -0.631 . . . . 74.45 109.296 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 pt -65.53 -34.56 71.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.231 -0.655 . . . . 74.33 109.231 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -66.98 -28.04 67.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.783 -0.451 . . . . 73.23 109.783 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 53' ' ' ASP . . . -65.82 -44.04 86.81 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.334 -0.617 . . . . 74.41 109.334 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.83 -38.94 84.01 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.238 -0.892 . . . . 74.22 109.863 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.4 ' HB1' ' OD1' ' A' ' 145' ' ' ASN . . . -59.62 -26.38 65.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.073 0.463 . . . . 72.15 111.573 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.7 -33.2 18.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.091 0.472 . . . . 75.41 110.204 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.501 ' HA ' ' SD ' ' A' ' 63' ' ' MET . . . -84.36 -26.83 28.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.033 -0.531 . . . . 74.21 111.898 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.1 -25.39 62.58 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.003 -1.48 . . . . 75.54 107.003 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 28.7 t70 -75.4 -20.1 59.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.827 -1.079 . . . . 72.51 109.193 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.501 ' SD ' ' HA ' ' A' ' 60' ' ' ALA . 72.3 mtp -81.29 -29.72 34.21 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.378 -0.828 . . . . 74.41 109.538 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.18 -39.36 71.89 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 106.246 -1.761 . . . . 73.11 106.246 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 32.8 tttm -56.26 -26.55 52.05 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.178 -0.919 . . . . 64.32 110.175 173.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.22 -36.58 19.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.853 -0.612 . . . . 70.45 110.418 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.473 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.8 t70 -74.23 -25.94 59.95 Favored 'General case' 0 C--O 1.209 -1.054 0 O-C-N 122.281 -0.262 . . . . 73.34 111.318 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.598 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -127.02 20.39 6.95 Favored 'General case' 0 CA--C 1.456 -2.668 0 CA-C-O 118.75 -0.643 . . . . 74.11 111.209 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 43.07 32.15 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.733 1.271 . . . . 75.11 113.191 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.95 161.44 0.56 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.776 -1.194 . . . . 73.12 107.776 -172.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 12.6 m-85 -76.93 157.15 81.97 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 123.361 0.413 . . . . 74.33 111.923 174.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 6.9 Cg_exo -72.86 170.41 19.73 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.838 2.358 . . . . 61.31 111.334 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 p -104.28 156.27 18.05 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.05 -1.463 . . . . 75.22 107.05 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -12.3 61.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 119.711 1.141 . . . . 62.53 110.492 -175.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -100.85 -65.09 0.99 Allowed 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.865 -0.607 . . . . 64.43 110.581 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -75.79 -39.55 56.73 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 120.548 -0.461 . . . . 74.34 110.133 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -73.83 -21.38 79.33 Favored Glycine 0 N--CA 1.415 -2.765 0 C-N-CA 119.091 -1.528 . . . . 74.03 113.785 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.65 -46.86 44.05 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 107.625 -1.25 . . . . 64.13 107.625 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.09 -29.99 70.7 Favored 'General case' 0 C--O 1.183 -2.41 0 CA-C-N 114.955 -1.021 . . . . 74.13 110.119 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -86.03 -0.27 55.12 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.488 0.493 . . . . 74.51 112.252 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 65.9 mt -97.01 -21.47 17.39 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.404 0.621 . . . . 74.4 110.058 172.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.79 -30.67 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 121.575 0.702 . . . . 74.42 110.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 99.2 mttt -125.35 151.49 46.02 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 125.942 1.697 . . . . 71.03 107.436 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -54.27 142.16 49.64 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 112.755 0.65 . . . . 63.53 112.755 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HA ' ' HB1' ' A' ' 80' ' ' ALA . 6.7 Cg_endo -45.42 131.64 12.13 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.961 3.774 . . . . 71.33 114.96 -175.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -95.07 -1.49 52.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.939 -1.028 . . . . 74.25 110.032 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.99 11.74 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.258 -0.883 . . . . 73.11 111.586 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -126.7 86.08 59.3 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-O 121.555 0.693 . . . . 74.2 110.642 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.598 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 88.4 Cg_endo -91.35 161.82 3.68 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.585 2.19 . . . . 73.33 112.911 -176.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.06 134.96 20.52 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.471 -0.937 . . . . 74.45 108.471 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -35.78 100.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 125.219 3.946 . . . . 74.14 115.014 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.85 147.3 27.08 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.018 -1.845 . . . . 74.13 106.018 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.523 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 3.7 m-20 -70.28 101.4 1.9 Allowed 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.501 0.667 . . . . 70.31 111.726 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.46 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 85.2 t90 -67.46 145.05 55.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.783 -1.099 . . . . 63.15 110.892 175.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -131.18 134.56 46.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.923 -0.769 . . . . 71.45 108.923 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -82.25 -165.84 1.11 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.486 -1.302 . . . . 75.24 107.486 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 66.15 19.05 11.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.533 1.158 . . . . 75.22 109.139 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 85.08 17.25 63.31 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.43 -1.259 . . . . 74.44 113.214 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.3 m-85 64.37 90.06 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.325 1.06 . . . . 75.4 110.602 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.3 tp -138.49 169.28 18.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.963 -1.125 . . . . 73.1 107.963 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -86.69 -171.94 3.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.948 -1.131 . . . . 71.22 107.948 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 70.05 2.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.661 1.22 . . . . 74.4 110.849 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -130.41 147.83 67.45 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.197 -1.365 . . . . 74.0 108.314 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.84 -168.98 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.835 2.357 . . . . 75.14 112.001 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 111' ' ' PRO . 4.7 p -88.45 174.64 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 107.847 -1.168 . . . . 73.33 107.847 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.448 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 9.4 t70 -78.7 152.67 77.95 Favored Pre-proline 0 C--O 1.256 1.444 0 CA-C-N 119.255 0.934 . . . . 62.3 110.359 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 90.0 Cg_exo -49.76 172.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.573 2.849 . . . . 73.34 114.162 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 68.88 14.43 8.9 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.746 2.018 . . . . 74.34 109.026 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.9 33.33 78.12 Favored Glycine 0 C--N 1.32 -0.325 0 CA-C-N 114.83 -1.077 . . . . 63.12 112.628 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -93.72 131.99 30.9 Favored Pre-proline 0 C--O 1.258 1.506 0 N-CA-C 111.934 0.346 . . . . 71.45 111.934 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.436 ' HA ' HG23 ' A' ' 105' ' ' VAL . 66.6 Cg_endo -78.32 151.09 26.05 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 122.264 1.976 . . . . 74.24 110.362 174.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 8.6 m-85 -78.51 142.39 37.47 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.789 0.328 . . . . 72.1 110.309 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.566 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -104.52 113.82 27.63 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 106.45 -1.685 . . . . 75.41 106.45 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.5 118.0 35.14 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.113 -1.81 . . . . 74.23 106.113 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 91.2 mt -129.35 145.4 51.39 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.188 -0.671 . . . . 73.54 109.188 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -106.81 -178.32 0.58 Allowed Pre-proline 0 N--CA 1.402 -2.838 0 CA-C-O 115.907 -1.996 . . . . 52.25 106.641 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 2.9 Cg_endo . . . . . 0 C--N 1.394 2.927 0 C-N-CA 123.049 2.499 . . . . 73.51 114.556 -162.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.424 -2.107 0 N-CA-C 117.331 1.692 . . . . 74.33 117.331 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.532 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 44.6 Cg_exo -36.93 -37.24 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 127.629 5.553 . . . . 71.31 118.209 -175.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.289 29.3 p90 -161.28 144.73 12.84 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 117.829 -1.548 . . . . 74.15 114.776 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -113.79 105.87 13.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.586 -1.635 . . . . 54.02 106.586 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.42 126.9 41.51 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.863 -1.148 . . . . 74.15 109.865 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -167.39 166.13 14.62 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.218 0.324 . . . . 73.3 111.837 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.5 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 29.8 t -125.37 149.74 47.86 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.607 -1.998 . . . . 72.41 105.607 170.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.566 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 95.0 mt -63.68 145.09 56.39 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.719 0.295 . . . . 75.24 110.851 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.17 -169.67 45.98 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.416 -0.897 . . . . 74.32 111.404 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.5 -6.29 14.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 123.818 0.847 . . . . 71.45 113.101 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -96.0 -9.07 31.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.559 0.695 . . . . 74.41 110.101 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.53 7.88 70.01 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-N 115.815 -0.629 . . . . 73.22 113.301 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -140.05 147.55 40.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.827 -1.546 . . . . 74.03 106.827 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 119.81 21.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.668 -0.813 . . . . 62.44 111.643 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.75 -173.94 21.3 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.492 -1.043 . . . . 74.3 110.492 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.07 127.55 7.84 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.164 -1.574 . . . . 75.31 109.164 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.496 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 58.1 m 178.79 -177.54 0.27 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 126.421 1.888 . . . . 65.01 106.68 -171.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.85 -76.77 0.17 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.065 -0.654 . . . . 70.12 110.738 171.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -96.44 -14.7 22.22 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.731 -0.388 . . . . 74.32 111.708 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -90.13 3.28 53.86 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.334 0.587 . . . . 74.24 110.689 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.496 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -94.68 157.74 15.83 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 115.149 -0.932 . . . . 74.21 110.297 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.19 126.85 31.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.68 -1.6 . . . . 72.53 106.68 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -96.86 119.05 44.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.657 0.742 . . . . 74.43 111.287 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -174.44 162.35 32.57 Favored Glycine 0 N--CA 1.41 -3.096 0 C-N-CA 119.515 -1.326 . . . . 53.42 112.202 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.4 ' OD1' ' HB1' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -106.2 160.79 15.07 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.476 -0.935 . . . . 64.53 108.476 177.176 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -143.01 137.4 29.27 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.138 -1.06 . . . . 75.31 108.138 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -106.46 91.66 3.79 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.66 -1.216 . . . . 74.54 109.111 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.505 ' HB2' ' HA3' ' A' ' 121' ' ' GLY . 10.1 t30 . . . . . 0 CA--C 1.506 -0.732 0 O-C-N 126.282 2.239 . . . . 75.23 107.45 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 107.042 -1.466 . . . . 75.33 107.042 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -118.44 98.21 6.15 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.809 0.67 . . . . 75.45 112.809 -173.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -155.58 165.49 18.29 Favored Pre-proline 0 C--O 1.252 1.23 0 N-CA-C 104.9 -2.259 . . . . 74.51 104.9 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.7 124.57 12.53 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.747 2.298 . . . . 74.31 111.913 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 75.08 -26.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.969 2.108 . . . . 75.23 111.777 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -68.69 -19.23 64.37 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 121.659 -0.651 . . . . 74.55 109.47 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.17 65.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.159 -0.928 . . . . 75.33 110.188 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' O ' HG22 ' A' ' 49' ' ' VAL . 66.1 mttm -90.35 -25.58 20.38 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.041 -0.726 . . . . 73.43 109.041 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.6 t -73.93 -40.92 53.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.75 0.785 . . . . 74.21 109.018 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 t -65.43 -25.84 67.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.795 -1.093 . . . . 74.22 111.668 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 46' ' ' LYS . 6.0 m -82.69 -34.35 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 108.746 -0.835 . . . . 73.53 108.746 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' O ' HG12 ' A' ' 54' ' ' ILE . . . -61.84 -32.24 72.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.112 -0.949 . . . . 73.54 110.815 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.3 mmmt -65.14 -25.2 67.65 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.954 -0.567 . . . . 72.31 110.372 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.47 -27.29 18.11 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 111.164 -0.774 . . . . 52.02 111.164 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -79.19 -36.25 40.55 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.802 -0.444 . . . . 64.24 109.802 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 50' ' ' ALA . 26.6 pt -69.17 -31.02 48.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.595 -0.52 . . . . 73.22 109.595 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.5 tptt -65.79 -33.03 74.91 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.096 -0.705 . . . . 73.25 109.096 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.54 80.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.337 -0.847 . . . . 74.0 110.038 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.415 ' CG2' ' HG ' ' A' ' 125' ' ' LEU . 53.2 mt -68.27 -36.94 77.11 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 CA-C-N 115.829 -0.623 . . . . 73.22 110.238 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.39 66.81 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.032 0.444 . . . . 62.14 110.766 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -88.63 -36.03 16.5 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 115.482 -0.781 . . . . 61.3 110.202 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.1 -28.12 60.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.004 0.43 . . . . 72.12 111.186 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -29.45 68.56 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.598 -1.26 . . . . 75.44 107.598 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.4 t70 -72.84 -23.15 60.72 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.873 -1.058 . . . . 54.33 109.475 174.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 62.5 mtt -81.26 -39.65 24.97 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.943 -0.762 . . . . 75.25 108.943 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 87.7 t80 -64.39 -35.75 81.92 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.076 -1.083 . . . . 74.52 108.076 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.593 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 82.3 tttt -54.95 -31.78 60.86 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.052 -0.977 . . . . 75.23 111.215 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.9 -29.05 16.9 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.632 0.604 . . . . 73.42 112.632 172.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.499 ' OD1' ' HB2' ' A' ' 92' ' ' LYS . 19.4 t70 -72.15 -24.3 61.43 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.98 0.512 . . . . 73.03 111.311 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -128.48 18.84 6.32 Favored 'General case' 0 CA--C 1.455 -2.686 0 N-CA-C 108.071 -1.085 . . . . 75.11 108.071 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.0 p90 43.61 32.88 0.59 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.436 1.495 . . . . 72.55 114.134 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.15 161.09 1.09 Allowed 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.595 -0.891 . . . . 73.13 108.595 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.593 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 15.6 m-85 -78.12 154.02 79.88 Favored Pre-proline 0 N--CA 1.427 -1.62 0 O-C-N 123.713 0.633 . . . . 65.53 111.466 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.504 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 31.2 Cg_endo -66.87 165.76 24.87 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.108 2.539 . . . . 74.44 111.736 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.429 ' C ' ' HB1' ' A' ' 116' ' ' ALA . 41.4 p -100.27 155.45 17.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.75 -1.944 . . . . 70.23 105.75 170.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.438 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 1.3 t -67.23 -12.13 59.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 119.736 1.153 . . . . 74.04 111.664 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -102.63 -64.9 1.03 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.268 -0.423 . . . . 74.04 111.062 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.33 -34.54 48.52 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 122.113 -0.367 . . . . 74.42 110.455 -174.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -78.4 -20.71 71.41 Favored Glycine 0 N--CA 1.412 -2.901 0 C-N-CA 119.112 -1.518 . . . . 63.14 112.757 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.78 -44.57 66.39 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 105.361 -2.088 . . . . 74.55 105.361 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 13.5 mm-40 -65.51 -16.69 63.92 Favored 'General case' 0 C--O 1.189 -2.09 0 CA-C-N 114.141 -1.39 . . . . 73.51 111.454 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -98.37 -3.39 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.374 0.607 . . . . 74.41 111.391 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 mp -98.56 -15.56 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 73.53 108.773 173.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.04 -39.93 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.602 -0.726 . . . . 75.15 110.859 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 5.6 ttpm? -116.35 150.29 37.96 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.047 -1.464 . . . . 74.45 107.047 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -54.37 137.02 60.48 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 118.341 0.518 . . . . 72.53 111.474 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.79 140.59 81.03 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.49 2.793 . . . . 74.34 111.994 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.7 p -83.04 178.1 8.3 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.004 -0.544 . . . . 75.34 110.346 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.12 -114.58 4.58 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.12 -0.792 . . . . 73.35 111.12 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -148.56 116.41 3.93 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 120.611 -0.435 . . . . 74.53 110.931 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -103.5 162.94 0.24 Allowed 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 123.846 3.031 . . . . 73.54 111.088 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -76.65 159.29 79.59 Favored Pre-proline 0 C--O 1.207 -1.167 0 O-C-N 121.682 -0.636 . . . . 73.23 109.557 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -70.77 99.06 0.82 Allowed 'Trans proline' 0 C--O 1.248 1.015 0 C-N-CA 121.335 1.356 . . . . 75.15 112.586 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.499 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 67.6 mttm -146.66 148.56 32.17 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.818 -1.919 . . . . 75.41 105.818 174.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -76.41 92.99 3.43 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.628 -0.829 . . . . 72.53 110.372 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.6 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 79.4 t90 -53.69 143.53 20.24 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.237 1.415 . . . . 71.45 111.578 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -124.11 136.72 54.43 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.816 -1.083 . . . . 75.24 109.806 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 64.0 pttt -88.04 -168.75 2.31 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.631 -0.878 . . . . 75.34 108.631 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.66 16.3 6.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.708 1.242 . . . . 71.22 110.212 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.56 11.67 50.29 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.246 -1.343 . . . . 73.15 113.979 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.6 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.88 91.37 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.272 1.034 . . . . 70.43 111.181 -176.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 46.2 tp -138.94 156.09 47.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.551 -1.204 . . . . 74.11 108.414 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.488 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.5 mmmt -77.53 -177.63 4.84 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.45 -0.944 . . . . 75.22 108.45 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -82.29 74.22 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.5 -0.88 . . . . 64.53 110.86 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.88 147.83 67.8 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 125.133 1.373 . . . . 63.41 107.32 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.98 166.46 12.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.834 2.356 . . . . 73.42 113.704 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.428 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 6.2 p -79.36 176.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.408 -0.815 . . . . 75.43 109.138 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.29 146.09 96.4 Favored Pre-proline 0 C--O 1.257 1.466 0 N-CA-C 112.508 0.558 . . . . 75.32 112.508 -175.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.57 171.46 0.1 Allowed 'Trans proline' 0 C--O 1.197 -1.535 0 C-N-CA 124.118 3.212 . . . . 74.22 112.916 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.496 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.1 m-90 62.27 14.96 7.18 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.971 1.308 . . . . 75.05 109.298 -177.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.47 30.05 76.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.811 1.084 . . . . 73.41 115.811 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.496 ' ND2' ' HE3' ' A' ' 108' ' ' TRP . 15.4 m-80 -93.17 130.66 35.17 Favored Pre-proline 0 C--O 1.256 1.398 0 CA-C-N 119.085 1.443 . . . . 74.22 110.981 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 27.0 Cg_endo -70.98 148.57 57.45 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 121.434 1.423 . . . . 74.41 109.18 168.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.448 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 32.9 m-85 -69.45 143.86 53.45 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.07 0.462 . . . . 71.54 111.963 -177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.408 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -102.61 114.22 28.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.802 -1.925 . . . . 54.22 105.802 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.25 120.09 41.18 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.258 -0.883 . . . . 70.52 111.311 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.1 mt -127.72 153.57 46.36 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.629 -0.878 . . . . 75.11 108.629 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -114.85 -178.69 0.53 Allowed Pre-proline 0 N--CA 1.406 -2.666 0 CA-C-O 117.035 -1.46 . . . . 73.2 107.73 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 18.7 Cg_endo . . . . . 0 CA--C 1.482 -2.083 0 C-N-CA 122.522 2.148 . . . . 71.41 115.116 -170.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.432 -1.577 0 CA-C-O 118.337 -1.257 . . . . 72.42 112.53 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.546 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 20.2 Cg_exo -41.21 -25.04 0.22 Allowed 'Trans proline' 0 N--CA 1.504 2.112 1 C-N-CA 126.954 5.103 . . . . 74.32 118.852 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.0 p90 178.19 165.95 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.997 0.817 . . . . 71.52 109.766 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.437 ' HA ' ' CB ' ' A' ' 146' ' ' TRP . 2.6 m-20 -139.32 113.17 8.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.371 0.668 . . . . 73.11 109.424 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.431 ' H ' ' HB3' ' A' ' 146' ' ' TRP . 0.3 OUTLIER -125.29 124.58 41.93 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.786 -0.766 . . . . 74.51 110.371 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -164.43 166.43 20.58 Favored 'General case' 0 C--O 1.208 -1.109 0 O-C-N 123.087 0.242 . . . . 64.04 110.352 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.448 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 18.8 t -125.51 153.21 43.93 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.381 -1.34 . . . . 73.44 107.381 171.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.408 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 88.8 mt -66.26 128.6 36.77 Favored 'General case' 0 C--O 1.204 -1.316 0 O-C-N 123.227 0.329 . . . . 73.45 111.557 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.53 15.89 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.918 -0.658 . . . . 63.53 112.235 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.24 -16.74 9.02 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.82 1.415 . . . . 74.33 114.82 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.4 -9.38 35.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.15 0.976 . . . . 72.33 109.802 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.85 10.28 86.33 Favored Glycine 0 CA--C 1.505 -0.585 0 CA-C-N 115.334 -0.848 . . . . 74.14 112.281 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 5.2 mmpt? -124.77 147.89 48.43 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.58 0.352 . . . . 74.42 110.348 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.59 104.91 17.29 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 122.081 0.944 . . . . 74.22 108.733 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.85 -173.64 21.08 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.24 -0.891 . . . . 63.22 111.169 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.28 127.59 9.08 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.646 -1.782 . . . . 73.43 108.646 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.457 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 37.6 m 179.63 -177.91 0.36 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.207 -1.775 . . . . 73.2 106.207 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.54 -75.37 0.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 118.294 0.497 . . . . 62.41 110.32 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -99.76 -17.95 17.46 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.87 -0.604 . . . . 73.42 110.831 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.47 -8.21 59.02 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.466 0.65 . . . . 70.23 109.989 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.457 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -87.14 156.97 19.48 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 114.806 -1.088 . . . . 72.25 109.136 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -77.39 134.51 38.41 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.543 -1.28 . . . . 75.23 107.543 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.509 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.5 pp -96.82 119.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.893 -0.594 . . . . 73.31 110.719 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -174.33 167.2 39.49 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 118.818 -1.658 . . . . 75.5 113.116 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.59 150.1 36.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.977 -0.749 . . . . 75.43 108.977 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.587 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 13.7 p90 -165.11 179.23 6.47 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.768 -0.651 . . . . 75.41 109.831 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -119.43 122.23 41.26 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.55 -1.278 . . . . 64.31 107.55 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.06 -1.089 . . . . 71.33 108.06 177.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.471 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.4 mpt? . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.426 -0.953 . . . . 72.03 108.426 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.5 t -108.88 77.77 1.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.074 -0.65 . . . . 74.25 110.724 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -155.16 155.26 29.87 Favored Pre-proline 0 C--N 1.316 -0.871 0 C-N-CA 124.814 1.246 . . . . 75.11 107.986 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.59 138.56 75.23 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.684 2.256 . . . . 65.53 110.894 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t70 76.56 -37.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.716 2.007 . . . . 74.44 110.49 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 77.8 mt-30 -68.68 -21.07 64.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.66 0.743 . . . . 75.2 109.504 173.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.22 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 55.4 109.943 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 67.3 mttm -93.23 -24.47 18.18 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.954 -0.758 . . . . 73.43 108.954 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.65 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 97.7 t -71.48 -44.66 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 108.248 -1.019 . . . . 73.43 108.248 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -65.96 -15.9 63.4 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.069 -0.969 . . . . 72.14 111.248 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -84.08 -52.66 12.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.585 -0.894 . . . . 72.45 108.585 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.81 71.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.792 -1.094 . . . . 64.53 112.979 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 30.8 mmmt -65.36 -25.74 67.72 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.739 0.78 . . . . 72.32 109.982 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -27.97 24.92 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.836 -0.906 . . . . 75.22 110.836 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.409 ' OD1' HD12 ' A' ' 103' ' ' LEU . 77.5 m-20 -77.23 -34.67 55.95 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.137 0.494 . . . . 63.55 110.607 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.0 pt -68.1 -34.22 65.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 116.021 -0.536 . . . . 74.13 109.558 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -67.24 -29.36 68.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 74.21 109.811 178.133 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.52 75.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.337 -0.847 . . . . 74.31 109.5 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.479 HG12 ' HG ' ' A' ' 100' ' ' LEU . 66.8 mt -66.64 -34.81 72.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.568 0 CA-C-N 115.355 -0.838 . . . . 75.15 110.02 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.68 -26.61 68.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.117 0.485 . . . . 71.24 111.22 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -87.23 -34.36 18.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.119 0.485 . . . . 74.35 109.752 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.63 -28.55 33.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.632 0.604 . . . . 61.11 112.632 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.53 -29.84 68.51 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.216 -1.401 . . . . 74.41 107.216 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 32.4 t70 -71.89 -21.66 61.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.193 -1.367 . . . . 64.23 109.1 174.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.0 mtt -83.0 -30.29 28.28 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.754 -0.591 . . . . 75.13 109.607 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CD1' ' HD3' ' A' ' 72' ' ' PRO . 55.1 t80 -68.47 -35.62 77.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.955 -1.498 . . . . 73.33 106.955 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 83.9 tttt -55.02 -35.77 64.78 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.206 -0.906 . . . . 74.23 110.044 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.93 -36.43 56.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 73.12 111.813 172.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' HB2' ' HD3' ' A' ' 92' ' ' LYS . 13.4 t70 -71.02 -26.69 63.22 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.81 -0.632 . . . . 75.04 111.178 -172.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -130.47 22.42 5.13 Favored 'General case' 0 CA--C 1.449 -2.929 0 CA-C-O 118.975 -0.536 . . . . 71.42 112.009 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.7 p90 42.99 31.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.063 1.477 . . . . 74.31 113.495 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.18 161.44 0.6 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.683 -1.228 . . . . 74.31 107.683 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 26.0 m-85 -80.08 154.14 74.92 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 123.289 0.368 . . . . 73.34 111.062 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.517 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 22.9 Cg_endo -64.43 167.62 14.54 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 123.471 2.781 . . . . 73.15 111.803 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.404 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 53.2 p -98.21 155.71 17.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.635 -1.617 . . . . 75.11 106.635 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -66.13 -15.45 63.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 118.967 0.803 . . . . 64.43 111.283 -175.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -102.23 -64.49 1.06 Allowed 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 122.156 -0.34 . . . . 73.12 111.465 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -75.89 -39.65 56.01 Favored 'General case' 0 CA--C 1.486 -1.519 0 O-C-N 122.171 -0.33 . . . . 73.43 110.795 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.534 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -73.61 -20.85 79.86 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 118.614 -1.755 . . . . 72.14 113.169 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.5 -48.12 73.68 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 106.94 -1.504 . . . . 74.34 106.94 177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 48.4 mt-10 -71.22 -23.09 61.95 Favored 'General case' 0 C--O 1.18 -2.597 0 CA-C-N 114.553 -1.203 . . . . 74.15 111.019 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.414 ' HB1' ' HA2' ' A' ' 77' ' ' GLY . . . -82.76 -2.79 55.4 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.266 0.555 . . . . 73.21 111.125 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 70.8 mt -96.23 -28.24 14.63 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.479 -0.782 . . . . 70.41 110.217 173.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.77 -32.5 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.438 0.637 . . . . 70.34 111.183 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 35.8 ttpt -120.59 150.48 40.82 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.188 -1.782 . . . . 75.41 106.188 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -54.54 141.32 54.99 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 118.489 0.586 . . . . 74.4 111.118 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.64 136.32 64.39 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.539 2.826 . . . . 71.21 111.878 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -81.47 -21.67 38.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.694 -0.685 . . . . 70.3 111.138 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.03 -146.39 9.26 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.894 -1.282 . . . . 72.44 109.894 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -117.69 95.87 48.52 Favored Pre-proline 0 C--N 1.288 -2.104 0 O-C-N 122.397 -0.472 . . . . 74.43 110.795 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.93 162.08 32.49 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.727 1.618 . . . . 75.53 108.751 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -82.69 159.21 64.16 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-O 118.205 -0.902 . . . . 73.53 108.958 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.48 97.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.707 1.605 . . . . 74.2 111.41 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 55.5 tttm -152.09 147.33 26.34 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.894 -1.891 . . . . 74.41 105.894 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.88 91.55 3.56 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.936 -0.306 . . . . 73.34 111.153 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -54.53 144.03 22.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.003 1.321 . . . . 74.02 111.498 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 3.1 t-20 -123.43 135.19 53.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.516 -0.766 . . . . 74.44 109.99 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -84.88 176.34 8.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.47 0.652 . . . . 75.22 111.398 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 71.4 20.28 4.97 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.608 1.563 . . . . 62.02 111.388 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.527 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 103.16 12.13 32.29 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.904 -1.141 . . . . 63.43 112.718 171.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.434 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 0.5 OUTLIER 62.75 85.33 0.13 Allowed 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.552 1.168 . . . . 73.11 108.89 -173.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.479 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -133.32 150.4 51.87 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.485 -2.043 . . . . 71.44 105.485 -174.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' N ' HD22 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.03 -178.14 0.96 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.908 0.322 . . . . 73.32 110.738 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -77.62 53.02 1.04 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.882 1.325 . . . . 74.32 112.718 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.409 HD12 ' OD1' ' A' ' 53' ' ' ASP . 70.8 mt -118.55 148.57 44.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 113.578 -1.647 . . . . 73.3 107.858 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.01 -175.46 1.46 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.604 2.202 . . . . 74.14 113.188 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.1 p -79.71 173.44 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.261 1.68 0 N-CA-C 108.271 -1.011 . . . . 75.33 108.271 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.551 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 5.8 p-10 -79.8 160.34 69.41 Favored Pre-proline 0 C--O 1.252 1.198 0 N-CA-C 113.635 0.976 . . . . 74.21 113.635 -168.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.4 ' CB ' ' HB3' ' A' ' 46' ' ' LYS . 10.8 Cg_endo -56.11 169.53 1.43 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.358 2.705 . . . . 73.14 111.681 173.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 64.81 14.58 9.27 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.853 1.261 . . . . 64.34 109.127 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.19 25.33 62.2 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 114.014 -1.448 . . . . 74.42 115.381 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.551 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 8.2 m-80 -82.73 148.74 58.56 Favored Pre-proline 0 C--O 1.271 2.215 0 CA-C-N 119.497 1.649 . . . . 63.2 108.634 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.475 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 3.6 Cg_endo -88.89 148.47 5.8 Favored 'Trans proline' 0 N--CA 1.424 -2.57 0 C-N-CA 121.988 1.792 . . . . 64.23 109.087 168.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -68.2 142.49 55.66 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 120.48 -0.488 . . . . 71.21 110.136 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.0 mm100 -101.7 119.52 38.91 Favored 'General case' 0 C--O 1.266 1.928 0 N-CA-C 105.027 -2.212 . . . . 74.5 105.027 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 118.3 33.84 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.405 -1.332 . . . . 74.41 107.405 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 75.9 mt -129.98 150.36 51.29 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.01 -0.737 . . . . 75.1 109.01 169.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.461 ' HB2' ' HD2' ' A' ' 117' ' ' PRO . . . -122.24 -178.47 0.63 Allowed Pre-proline 0 N--CA 1.402 -2.836 0 N-CA-C 105.124 -2.176 . . . . 72.5 105.124 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.727 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 17.9 Cg_endo . . . . . 0 CA--C 1.492 -1.589 0 CA-C-N 122.327 1.867 . . . . 74.42 114.094 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.484 -1.893 0 CA-C-O 118.023 -1.432 . . . . 72.0 112.424 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.501 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 16.6 Cg_exo -41.51 -23.88 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.914 1 C-N-CA 126.667 4.911 . . . . 74.45 118.525 -177.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.604 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.6 p90 177.59 156.51 0.35 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.656 0.662 . . . . 74.43 110.285 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 2.7 m-20 -134.29 106.83 7.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.025 0.828 . . . . 75.13 108.789 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.8 126.55 53.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.856 -0.794 . . . . 65.04 108.856 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.549 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 23.9 p90 -168.2 168.61 11.52 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 120.571 -0.451 . . . . 74.24 111.554 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 67.6 m -125.78 152.25 45.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.524 -1.287 . . . . 73.42 107.524 166.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.424 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 96.5 mt -60.17 148.64 35.49 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.742 0.651 . . . . 72.42 111.562 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.02 -172.27 5.27 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.768 0.667 . . . . 71.12 114.768 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.47 -28.15 63.12 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 114.021 1.119 . . . . 73.35 114.021 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -94.23 -5.66 46.41 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.264 -0.574 . . . . 74.23 110.493 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.82 27.43 56.7 Favored Glycine 0 C--N 1.319 -0.386 0 N-CA-C 110.531 -1.028 . . . . 52.23 110.531 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -125.89 141.48 51.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.78 -1.193 . . . . 75.34 107.78 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.602 ' HA ' ' OD1' ' A' ' 142' ' ' ASP 0.271 0.0 OUTLIER -81.15 106.72 13.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.833 0.825 . . . . 73.33 112.767 178.556 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.09 173.27 29.82 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.347 -0.842 . . . . 73.54 113.315 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.4 129.61 9.88 Favored Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.586 -1.806 . . . . 73.13 108.586 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.633 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 23.8 m -178.76 -177.24 0.5 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.223 1.409 . . . . 74.31 107.513 -171.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -97.46 -49.9 4.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.045 -1.062 . . . . 71.45 108.887 171.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.448 ' HA ' HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -88.28 -41.65 12.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.679 -0.691 . . . . 74.2 110.673 -177.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.28 18.3 14.05 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.606 0.717 . . . . 73.11 110.8 -175.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . -81.2 156.88 25.44 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.259 -0.882 . . . . 72.21 109.922 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.602 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 36.4 m-20 -76.87 129.85 36.78 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 104.508 -2.404 . . . . 74.32 104.508 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.539 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -94.98 111.97 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 C-N-CA 118.59 -1.244 . . . . 73.01 108.37 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -175.09 176.69 47.2 Favored Glycine 1 N--CA 1.396 -4.027 0 CA-C-N 114.413 -1.267 . . . . 55.54 110.852 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.29 149.23 24.09 Favored 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 107.872 -1.158 . . . . 73.05 107.872 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.604 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 2.1 p90 -156.77 177.83 11.04 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 123.707 0.629 . . . . 72.12 112.082 -173.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -125.05 115.3 20.3 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.5 -0.926 . . . . 71.04 108.5 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 117.227 -1.368 . . . . 75.2 108.376 178.509 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.9 ttt . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 106.633 -1.618 . . . . 73.55 106.633 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.3 m -104.11 87.11 2.69 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.189 0.811 . . . . 72.32 113.189 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -154.54 154.16 28.96 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 104.835 -2.283 . . . . 74.11 104.835 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 44' ' ' GLN . 9.6 Cg_endo -54.1 141.07 70.04 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 122.167 1.911 . . . . 74.1 110.45 176.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 75.73 -36.13 0.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.299 1.44 . . . . 75.23 110.785 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 42' ' ' PRO . 78.2 mt-30 -77.16 -15.16 59.63 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.689 -0.632 . . . . 74.52 109.961 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.7 75.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.134 -0.939 . . . . 72.32 110.545 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -86.94 -22.11 25.83 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.816 -0.629 . . . . 74.35 110.871 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 49.1 t -73.09 -43.21 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 121.421 0.629 . . . . 74.12 109.599 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 t -64.52 -38.42 90.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.09 -0.505 . . . . 74.43 111.747 -177.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.2 t -70.35 -37.31 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 108.917 -0.772 . . . . 75.51 108.917 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -58.56 -40.67 83.7 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.908 -1.042 . . . . 65.35 111.151 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 13.8 mmmm -65.57 -25.66 67.51 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.163 -0.472 . . . . 72.52 111.182 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.22 -28.15 23.58 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.606 -0.807 . . . . 73.3 111.088 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -82.11 -30.1 31.38 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.008 0.433 . . . . 72.43 111.469 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 50' ' ' ALA . 17.2 pt -73.0 -27.21 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.305 -0.558 . . . . 74.12 109.943 172.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 28.5 tptt -72.58 -26.83 61.85 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.391 -0.596 . . . . 74.34 109.391 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.86 -44.34 81.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 73.24 109.16 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.9 mt -63.44 -34.62 68.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.684 0 CA-C-N 115.124 -0.944 . . . . 74.24 110.178 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.462 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . . . -60.71 -34.42 74.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.898 0.38 . . . . 73.54 111.135 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -80.81 -26.85 36.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.837 -0.62 . . . . 74.53 110.051 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.13 -29.25 24.97 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 120.926 0.393 . . . . 74.14 110.733 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -27.48 62.4 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.218 -1.401 . . . . 75.42 107.218 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 10.7 t70 -66.45 -32.26 73.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.613 -1.176 . . . . 73.52 108.71 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 67.1 mtt -76.2 -31.1 58.26 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 115.18 -0.918 . . . . 73.43 109.518 177.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -69.95 -37.97 76.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.52 -0.548 . . . . 73.33 109.52 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 19.4 pttp -66.36 -19.23 65.75 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 118.867 -1.133 . . . . 75.22 109.453 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.33 -38.21 17.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.545 -0.752 . . . . 74.05 110.471 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 15.9 t70 -73.3 -26.82 61.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.12 0.415 . . . . 73.14 112.12 -174.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.36 24.48 5.87 Favored 'General case' 0 CA--C 1.455 -2.676 0 N-CA-C 108.108 -1.071 . . . . 64.12 108.108 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 44.09 32.82 0.7 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.84 1.256 . . . . 73.42 113.731 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.35 155.98 0.41 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.755 -0.831 . . . . 61.03 108.755 -174.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.653 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 10.2 m-85 -77.14 157.73 80.7 Favored Pre-proline 0 N--CA 1.423 -1.779 0 O-C-N 123.572 0.545 . . . . 74.02 110.932 171.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.476 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 60.8 Cg_endo -70.78 163.25 39.74 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.756 2.304 . . . . 63.34 113.244 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.6 p -104.93 155.14 19.21 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.464 -2.05 . . . . 73.15 105.464 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.497 ' N ' ' HB3' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -67.44 -11.9 58.95 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.105 0.955 . . . . 74.32 111.504 -173.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -102.31 -65.58 0.98 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 121.795 -0.566 . . . . 71.23 110.377 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -77.72 -34.69 52.55 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 116.375 -0.375 . . . . 75.42 111.011 -170.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -84.26 -20.94 58.0 Favored Glycine 0 N--CA 1.417 -2.605 0 C-N-CA 118.664 -1.732 . . . . 75.15 112.658 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -73.7 -42.72 60.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.582 -1.636 . . . . 71.45 106.582 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.98 -27.4 67.42 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-N 115.435 -0.802 . . . . 73.25 110.826 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -84.79 -4.08 58.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.092 0.472 . . . . 75.13 111.515 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tp -95.79 -25.38 16.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.524 0.678 . . . . 75.52 109.297 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.05 -41.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.608 -0.724 . . . . 75.21 110.366 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -111.41 148.51 32.9 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.41 -0.959 . . . . 74.3 108.41 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.63 128.08 60.92 Favored Pre-proline 0 C--O 1.25 1.125 0 C-N-CA 124.067 0.947 . . . . 74.2 109.797 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.461 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 19.7 Cg_endo -53.62 126.39 21.67 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 124.503 3.469 . . . . 74.13 113.613 -171.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -74.44 117.91 16.79 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.667 -1.151 . . . . 73.35 110.566 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.67 -146.14 16.06 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 108.761 -1.736 . . . . 74.43 108.761 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -125.83 92.83 45.45 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 112.901 0.704 . . . . 70.14 112.901 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.461 ' HG3' ' HG2' ' A' ' 85' ' ' PRO . 85.8 Cg_endo -76.0 163.12 33.63 Favored 'Trans proline' 0 C--O 1.262 1.693 0 C-N-CA 122.649 2.233 . . . . 73.03 107.562 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.35 159.57 83.35 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 108.584 -0.895 . . . . 74.44 108.584 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.69 98.01 0.18 Allowed 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 121.11 1.207 . . . . 71.15 110.332 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.1 tmtm? -151.79 148.31 27.7 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.474 -2.046 . . . . 70.53 105.474 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.535 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 90.0 m-20 -72.85 93.76 1.74 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.909 0.707 . . . . 62.34 112.909 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.537 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.4 t90 -64.18 144.37 57.17 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.851 0.86 . . . . 73.4 110.472 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -131.81 135.5 46.79 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.162 -0.681 . . . . 65.14 109.162 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 63.5 pttt -85.09 -174.88 5.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.075 0.464 . . . . 74.13 109.777 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 70.2 15.04 7.6 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.473 1.109 . . . . 63.31 110.4 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.3 14.93 21.0 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.498 -1.228 . . . . 72.11 114.078 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 61.17 89.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.449 1.118 . . . . 75.25 110.975 -176.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 57.2 tp -128.01 170.82 12.46 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 124.756 1.222 . . . . 74.23 108.092 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.2 mmmt -88.04 179.47 6.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.549 -1.278 . . . . 73.22 107.549 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.26 0.0 OUTLIER -77.33 72.37 3.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.851 1.31 . . . . 72.55 110.959 175.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -130.73 148.21 69.2 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 113.643 -1.617 . . . . 72.4 107.808 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.18 170.41 13.28 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.871 1.714 . . . . 74.01 110.887 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 111' ' ' PRO . 5.3 p -79.73 171.7 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.774 -0.824 . . . . 74.12 108.774 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.503 ' OD2' ' HD2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -75.55 149.03 83.51 Favored Pre-proline 0 C--O 1.253 1.269 0 C-N-CA 119.884 -0.726 . . . . 74.41 112.364 -171.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.503 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 36.0 Cg_exo -47.09 171.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.373 3.382 . . . . 72.3 113.93 172.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 70.14 14.81 7.67 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 126.677 1.991 . . . . 75.23 108.596 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.91 32.29 59.12 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 114.174 -1.375 . . . . 73.24 113.057 -175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -92.27 125.67 55.54 Favored Pre-proline 0 C--O 1.263 1.796 0 CA-C-N 116.752 0.276 . . . . 73.13 111.212 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.469 ' HA ' HG21 ' A' ' 105' ' ' VAL . 7.9 Cg_exo -71.1 154.09 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.034 1.822 . . . . 60.12 108.522 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -71.75 142.75 49.74 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.969 -1.093 . . . . 74.12 108.806 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.569 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 2.1 mm100 -102.14 113.76 27.31 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 105.066 -2.198 . . . . 73.12 105.066 -178.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.62 118.46 36.64 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.823 -1.081 . . . . 74.43 111.318 -177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.2 mt -129.31 154.02 47.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.345 -0.843 . . . . 61.01 109.343 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 74' ' ' THR . . . -108.93 -177.38 0.47 Allowed Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-O 116.971 -1.49 . . . . 75.42 108.711 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.717 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 20.1 Cg_endo . . . . . 0 C--N 1.389 2.696 0 C-N-CA 123.19 2.593 . . . . 72.33 116.359 -162.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.717 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.426 -1.981 0 CA-C-O 118.027 -1.43 . . . . 64.23 111.303 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.566 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -34.81 -27.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.033 1 C-N-CA 127.052 5.168 . . . . 73.45 118.027 -178.937 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 50.8 p90 -165.45 170.42 14.5 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 118.749 0.704 . . . . 74.43 111.156 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.7 m-20 -132.4 107.13 8.31 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.534 -1.284 . . . . 72.33 107.534 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.09 128.97 54.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.557 -0.905 . . . . 71.51 108.557 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -166.28 166.01 17.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.004 -0.369 . . . . 73.43 110.004 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.5 t -124.95 146.76 49.22 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.96 -1.867 . . . . 72.4 105.96 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.569 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 98.3 mt -64.23 155.97 30.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.788 0.328 . . . . 72.44 111.429 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -83.76 -166.19 39.89 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.577 -0.821 . . . . 73.2 112.368 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.69 -22.05 64.99 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.553 0.946 . . . . 62.0 113.553 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.86 -2.75 52.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.755 0.788 . . . . 75.31 110.527 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.421 ' O ' HD11 ' A' ' 128' ' ' LEU . . . 72.29 27.44 69.91 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.797 -0.716 . . . . 51.02 111.74 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -140.07 148.45 41.77 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 123.159 0.583 . . . . 65.22 110.553 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -84.87 109.18 17.94 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.433 0.635 . . . . 73.53 110.596 176.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -147.6 -173.22 18.48 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.851 -1.068 . . . . 61.21 110.67 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.27 128.21 8.12 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.849 -1.7 . . . . 74.44 108.849 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.2 m 179.95 -177.48 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.879 1.672 . . . . 72.0 106.698 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -78.66 -62.56 1.65 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.929 0.331 . . . . 61.22 110.229 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.52 -11.82 14.03 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.513 0.56 . . . . 72.53 112.513 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.69 11.71 28.09 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.757 0.789 . . . . 70.02 110.595 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.0 155.8 17.86 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.805 -1.089 . . . . 62.51 110.275 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.1 p-10 -79.67 135.66 36.6 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.31 -1.737 . . . . 74.15 106.31 173.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.524 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.34 113.11 29.92 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 108.041 -1.096 . . . . 74.03 108.041 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.65 151.5 18.98 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 119.368 -1.396 . . . . 73.3 114.582 -170.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 5.2 t30 -153.13 127.0 8.91 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 113.555 -1.323 . . . . 74.43 107.704 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.428 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 5.7 p90 -150.73 157.67 43.23 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 120.119 -0.632 . . . . 73.31 112.398 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -94.14 108.19 20.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.525 -1.657 . . . . 73.43 106.525 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.3 t30 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 114.534 -1.212 . . . . 65.32 108.696 -176.748 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.413 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 108.387 -0.968 . . . . 74.35 108.387 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -115.62 89.03 3.01 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.832 -0.747 . . . . 65.11 110.225 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -155.65 161.56 29.2 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 125.983 1.713 . . . . 73.42 106.426 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 44' ' ' GLN . 85.2 Cg_exo -51.49 133.17 42.72 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.463 2.109 . . . . 62.53 110.908 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 74.63 -37.25 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.98 1.312 . . . . 70.2 111.624 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.1 mm100 -68.69 -24.97 64.56 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.266 0.555 . . . . 70.15 109.931 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.77 -16.92 64.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.342 -0.845 . . . . 73.02 110.242 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.51 -25.89 22.32 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 108.369 -0.975 . . . . 74.32 108.369 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 47.4 t -75.82 -43.38 39.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.631 -0.713 . . . . 75.34 110.216 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -65.23 -29.02 69.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.27 -0.877 . . . . 74.1 111.585 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.7 m -84.03 -34.49 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.158 -0.617 . . . . 73.13 109.941 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.413 ' HB3' ' CD1' ' A' ' 143' ' ' ILE . . . -60.2 -37.84 81.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.465 -0.789 . . . . 55.12 110.451 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 70.2 mmtt -65.3 -26.23 67.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.704 -0.68 . . . . 75.11 110.423 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.99 -28.39 18.29 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.225 -0.988 . . . . 75.1 111.324 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.45 -27.26 32.01 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.04 0.385 . . . . 72.32 112.04 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 pt -72.06 -30.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.303 -0.559 . . . . 73.21 109.617 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 73.0 mmtt -71.52 -24.27 61.93 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 116.414 -0.357 . . . . 72.34 110.704 175.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.03 75.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.621 -0.718 . . . . 74.23 109.554 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.7 mt -68.99 -34.07 62.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.385 -0.825 . . . . 75.31 109.673 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.409 ' HB1' ' ND2' ' A' ' 145' ' ' ASN . . . -58.97 -33.98 71.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 62.05 110.783 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.494 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -82.36 -36.27 26.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.485 -0.779 . . . . 73.04 110.166 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.59 -28.92 41.06 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.042 0.386 . . . . 74.53 112.042 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -70.38 -30.14 66.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.964 -1.495 . . . . 73.14 106.964 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.7 t70 -71.08 -19.54 62.46 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.453 -1.249 . . . . 74.04 109.543 174.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.8 mtt -81.54 -41.04 22.22 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.921 -0.77 . . . . 61.03 108.921 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.58 -35.97 82.7 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 107.612 -1.255 . . . . 72.03 107.612 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.589 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.1 tttt -54.37 -40.07 67.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.908 -1.042 . . . . 72.0 110.631 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.22 -32.25 38.52 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.527 -0.469 . . . . 74.01 111.363 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.515 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 36.1 t70 -69.81 -24.03 63.41 Favored 'General case' 0 C--O 1.184 -2.37 0 C-N-CA 121.02 -0.272 . . . . 74.44 111.413 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -128.03 19.16 6.54 Favored 'General case' 0 CA--C 1.459 -2.527 0 O-C-N 121.137 -0.977 . . . . 65.11 110.909 176.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 43.58 34.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.893 1.371 . . . . 73.22 113.107 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.92 152.9 0.37 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.532 -1.213 . . . . 74.41 108.096 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.589 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.6 m-85 -76.38 148.65 80.76 Favored Pre-proline 0 N--CA 1.431 -1.401 0 O-C-N 123.496 0.498 . . . . 74.05 110.76 172.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 28.4 Cg_endo -61.41 162.27 21.13 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.811 3.007 . . . . 65.21 111.883 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -96.77 156.06 16.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.632 -1.618 . . . . 75.23 106.632 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 t -69.12 -11.58 60.92 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.287 0.948 . . . . 73.13 110.934 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -102.45 -65.84 0.97 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.096 -0.502 . . . . 75.43 110.99 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.33 -40.42 51.39 Favored 'General case' 0 CA--C 1.486 -1.505 0 O-C-N 122.141 -0.349 . . . . 72.4 110.393 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -74.7 -20.54 79.48 Favored Glycine 0 N--CA 1.41 -3.066 0 C-N-CA 119.25 -1.453 . . . . 43.13 113.076 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.38 -45.64 68.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.742 -1.577 . . . . 74.54 106.742 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.45 -8.68 57.09 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.18 -0.918 . . . . 64.44 111.733 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -96.88 -6.01 36.81 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.478 0.656 . . . . 71.13 110.209 175.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 86.4 mt -95.06 -19.81 19.84 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.791 -0.818 . . . . 74.43 108.791 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 t -106.11 -44.56 7.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.633 -0.712 . . . . 64.0 110.931 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.2 mppt? -108.82 148.69 30.19 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.216 -1.031 . . . . 73.23 108.216 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.54 133.05 63.71 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 123.82 0.848 . . . . 74.24 109.833 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 18.4 Cg_endo -55.3 121.05 9.23 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.688 2.925 . . . . 74.31 113.291 -172.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 t -87.12 -2.48 58.66 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.479 -1.237 . . . . 75.33 109.175 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.29 -147.75 12.61 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.768 -0.933 . . . . 74.01 110.768 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -115.63 99.13 52.16 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 117.7 0.75 . . . . 73.03 110.462 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.483 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 85.7 Cg_endo -102.85 162.2 0.28 Allowed 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 122.904 2.403 . . . . 71.53 112.887 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.44 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 45.5 mt-30 -105.54 98.55 17.56 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 106.0 -1.852 . . . . 74.41 106.0 174.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -36.69 99.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 125.186 3.924 . . . . 64.23 119.675 -167.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.515 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 4.1 mptp? -109.53 149.17 30.01 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 102.103 -3.295 . . . . 74.25 102.103 160.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.35 92.34 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 123.268 0.355 . . . . 73.22 110.277 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.567 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -54.95 140.85 35.89 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 124.969 1.308 . . . . 75.31 112.678 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.59 137.89 54.55 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.929 -1.032 . . . . 73.24 110.14 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -93.12 -178.1 4.68 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.736 0.779 . . . . 73.24 111.023 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t0 65.73 24.29 11.5 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.649 1.58 . . . . 74.1 110.846 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.91 27.58 Favored Glycine 0 CA--C 1.496 -1.132 0 CA-C-N 114.643 -1.162 . . . . 71.41 115.051 168.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.567 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.5 90.28 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.384 1.087 . . . . 74.25 110.775 -175.114 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.502 HD21 ' N ' ' A' ' 101' ' ' LYS . 5.7 tt -138.18 151.04 47.33 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.356 -2.461 . . . . 74.41 104.356 -179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.502 ' N ' HD21 ' A' ' 100' ' ' LEU . 55.8 mtmt -67.39 -172.47 0.23 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.357 -0.537 . . . . 74.51 111.597 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 67.94 6.42 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.094 0.95 . . . . 74.31 111.384 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.52 148.28 69.44 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 126.263 1.825 . . . . 62.43 107.488 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.19 -171.56 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.126 2.551 . . . . 74.04 113.289 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.2 p -85.66 175.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 N-CA-C 108.611 -0.885 . . . . 74.3 108.611 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.457 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.3 t70 -77.58 158.35 78.76 Favored Pre-proline 0 C--O 1.251 1.182 0 CA-C-N 118.89 0.768 . . . . 70.0 109.692 -170.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 68.4 Cg_exo -47.55 170.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.39 2.726 . . . . 74.33 113.855 173.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.685 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 1.2 m-90 65.13 15.46 10.01 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.018 1.727 . . . . 75.21 110.565 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.15 1.67 50.35 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.135 -0.939 . . . . 54.42 114.993 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.685 ' ND2' ' HB2' ' A' ' 108' ' ' TRP . 47.5 m-80 -70.51 128.08 91.46 Favored Pre-proline 0 C--O 1.258 1.544 0 N-CA-C 113.78 1.03 . . . . 70.32 113.78 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 21.1 Cg_exo -67.76 146.64 73.32 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.194 1.929 . . . . 74.42 108.706 166.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -69.64 144.42 52.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.869 -0.789 . . . . 74.03 108.869 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -100.63 113.65 26.68 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.058 -2.201 . . . . 75.31 105.058 -177.269 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.07 119.03 38.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.115 -0.948 . . . . 73.13 111.983 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 88.4 mt -129.33 153.23 48.05 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.251 -1.018 . . . . 71.44 108.251 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.499 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -104.25 -178.62 0.65 Allowed Pre-proline 0 N--CA 1.419 -2.017 0 CA-C-O 116.55 -1.691 . . . . 71.03 108.486 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 122' ' ' PRO . 6.9 Cg_endo . . . . . 0 C--N 1.384 2.437 0 C-N-CA 123.704 2.936 . . . . 72.04 115.623 -165.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.956 0 N-CA-C 116.552 1.381 . . . . 72.13 116.552 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.564 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -34.3 -19.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.576 1 C-N-CA 128.608 6.205 . . . . 73.34 120.367 -178.789 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 147' ' ' ASP . 19.3 p90 -171.53 151.9 3.09 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.112 1.324 . . . . 72.43 113.698 171.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.51 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.1 m-20 -112.27 106.8 15.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.02 -1.474 . . . . 73.13 107.02 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.51 128.37 45.55 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.979 -0.688 . . . . 72.2 109.879 -177.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.511 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 33.9 p90 -165.94 165.34 18.17 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 111.927 0.343 . . . . 72.41 111.927 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 t -125.6 138.19 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.296 -1.372 . . . . 73.32 107.296 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.26 128.13 34.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 111.642 0.238 . . . . 75.4 111.642 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.86 171.32 22.51 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.389 -0.684 . . . . 64.33 111.389 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.31 -3.34 1.88 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 115.489 1.662 . . . . 75.43 115.489 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -100.33 -2.11 34.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.796 0.808 . . . . 73.35 109.739 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.95 38.86 64.4 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.037 -0.825 . . . . 73.33 111.037 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -138.84 147.87 43.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.056 -0.72 . . . . 74.2 109.056 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -97.99 103.33 15.26 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 105.976 -1.861 . . . . 74.44 105.976 165.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.53 -172.34 20.29 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.03 -1.441 . . . . 75.42 111.209 -171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.57 8.76 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.472 -1.051 . . . . 74.13 110.472 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.554 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 13.4 m 177.82 -177.67 0.21 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 127.663 2.385 . . . . 70.12 105.895 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -66.49 0.92 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 119.03 0.832 . . . . 75.24 110.341 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.23 -27.71 22.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.108 0.956 . . . . 74.21 111.707 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 9.55 42.86 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.572 0.701 . . . . 63.22 111.448 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.554 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -103.36 157.41 17.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 115.129 -0.942 . . . . 71.32 109.466 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.45 127.23 31.88 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.991 -1.485 . . . . 74.45 106.991 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.448 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 133.45 37.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.811 -1.181 . . . . 73.23 107.811 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.03 169.59 34.74 Favored Glycine 0 N--CA 1.414 -2.814 0 C-N-CA 117.685 -2.198 . . . . 65.42 114.276 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.409 ' ND2' ' HB1' ' A' ' 58' ' ' ALA . 8.0 t30 -131.36 148.35 52.66 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.141 -1.8 . . . . 71.23 106.141 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -143.61 135.12 26.14 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.637 -0.825 . . . . 74.54 110.346 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.464 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 16.1 t0 -104.66 105.25 15.26 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 105.675 -1.972 . . . . 74.51 105.675 174.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 C--N 1.274 -2.696 0 N-CA-C 105.94 -1.874 . . . . 75.13 105.94 178.1 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.8 ttt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 73.24 109.449 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 m -96.18 91.3 5.85 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.676 0.75 . . . . 72.44 112.66 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 12.6 ptp180 -156.79 165.0 19.72 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 106.859 -1.534 . . . . 75.24 106.859 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -42.79 120.33 1.8 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.864 3.043 . . . . 74.14 114.608 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.65 -31.86 0.23 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 127.575 2.35 . . . . 65.22 113.048 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 10.7 mm100 -68.92 -22.78 64.14 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.967 -1.123 . . . . 75.1 107.967 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.74 -26.1 68.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.659 -1.155 . . . . 72.44 109.912 173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 63.3 mttp -80.6 -26.08 38.06 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.928 -0.768 . . . . 72.13 108.928 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 43.9 t -74.29 -44.57 48.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 122.054 0.931 . . . . 75.03 108.637 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 t -71.11 -30.99 67.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.474 -1.239 . . . . 75.34 112.071 -173.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.63 -40.21 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 120.321 -0.552 . . . . 73.44 110.124 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.53 -31.68 70.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.275 0.56 . . . . 61.41 111.122 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 29.6 mtpp -66.26 -25.43 66.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.989 0.899 . . . . 75.35 111.281 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.96 -30.49 31.55 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.737 -1.345 . . . . 63.45 109.737 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.669 ' O ' HG13 ' A' ' 57' ' ' ILE . 72.9 m-20 -73.33 -38.54 65.76 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.314 -0.443 . . . . 73.1 110.739 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.451 HD12 ' C ' ' A' ' 144' ' ' GLY . 19.0 pt -62.49 -36.2 73.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 121.209 -0.196 . . . . 64.34 111.052 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.87 -30.15 70.24 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.942 -0.703 . . . . 72.33 110.8 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -69.13 -44.35 72.54 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.677 -0.692 . . . . 72.44 111.048 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 53' ' ' ASP . 23.3 mt -63.52 -42.49 96.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-N 115.349 -0.841 . . . . 65.33 109.223 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.54 -27.71 67.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.863 -0.608 . . . . 73.05 111.618 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -76.91 -30.63 56.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.618 0.723 . . . . 73.23 109.416 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.88 -24.45 38.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.172 -0.467 . . . . 73.23 110.115 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.91 -31.25 71.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.37 -1.344 . . . . 74.13 107.37 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 4.5 t70 -66.08 -28.82 69.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.174 -0.921 . . . . 71.42 109.66 170.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.8 ttm -82.82 -28.24 30.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.914 -0.585 . . . . 73.14 110.166 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -72.46 -34.35 67.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.318 -1.364 . . . . 74.14 107.318 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 28.5 ttpp -57.5 -25.76 60.28 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.215 -0.902 . . . . 74.43 109.561 171.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.9 tp -87.3 -36.0 18.12 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 123.386 0.674 . . . . 75.24 111.365 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.51 -27.0 58.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.942 0.401 . . . . 75.11 110.398 -173.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -130.61 24.39 5.08 Favored 'General case' 0 CA--C 1.457 -2.621 0 N-CA-C 112.418 0.525 . . . . 73.31 112.418 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.1 p90 42.65 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 125.015 1.447 . . . . 75.35 113.948 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.24 161.74 1.13 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.747 -0.835 . . . . 63.15 108.747 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.505 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 13.4 m-85 -78.89 155.52 77.75 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 123.617 0.573 . . . . 75.42 110.501 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 51.0 Cg_endo -73.81 160.74 43.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.341 2.028 . . . . 75.52 110.917 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -92.58 155.74 17.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.096 -1.816 . . . . 73.24 106.096 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 t -70.1 -7.32 40.49 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.61 1.095 . . . . 74.11 111.421 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -103.02 -66.89 0.91 Allowed 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 121.934 -0.479 . . . . 71.44 110.877 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -84.17 -31.65 25.03 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.905 -0.589 . . . . 75.32 112.469 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -78.35 -21.32 70.25 Favored Glycine 0 N--CA 1.409 -3.126 0 C-N-CA 117.54 -2.267 . . . . 74.02 111.316 176.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.89 -46.67 70.99 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 106.602 -1.629 . . . . 75.42 106.602 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.0 -31.62 72.94 Favored 'General case' 0 N--CA 1.396 -3.174 0 CA-C-N 114.918 -1.037 . . . . 73.1 109.358 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.8 -2.21 42.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 73.51 111.917 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.542 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 63.3 mt -98.26 -24.56 15.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.915 -0.584 . . . . 75.21 110.28 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.42 -32.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.367 0.603 . . . . 64.11 110.687 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -117.66 146.43 43.7 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 125.266 1.426 . . . . 74.0 107.158 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -54.59 129.19 62.69 Favored Pre-proline 0 N--CA 1.433 -1.3 0 C-N-CA 123.506 0.722 . . . . 74.3 109.641 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -58.96 126.17 20.32 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 124.214 3.276 . . . . 75.12 113.163 -172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -96.62 91.49 5.77 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-O 122.051 0.929 . . . . 73.3 109.876 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.6 -126.33 1.18 Allowed Glycine 0 N--CA 1.422 -2.284 0 CA-C-N 114.365 -1.289 . . . . 74.13 110.03 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -126.56 91.93 46.29 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 117.208 0.504 . . . . 71.41 109.704 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -97.21 162.91 0.98 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.65 1.567 . . . . 71.31 110.632 172.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -90.33 159.08 42.56 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.41 -1.33 . . . . 74.45 107.41 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.05 98.18 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.441 1.427 . . . . 63.11 111.965 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -151.53 147.43 26.81 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.921 -2.251 . . . . 74.22 104.921 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.26 94.4 8.42 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.831 -0.748 . . . . 74.54 110.128 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -54.05 140.23 32.24 Favored 'General case' 0 C--O 1.251 1.156 0 C-N-CA 124.235 1.014 . . . . 75.1 112.665 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -115.6 132.25 56.69 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.052 -1.431 . . . . 74.12 109.56 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -79.15 -176.88 5.36 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 119.759 -0.776 . . . . 72.13 109.522 175.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' CG ' ' HH ' ' A' ' 114' ' ' TYR . 7.2 t70 69.34 31.06 3.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.437 -1.256 . . . . 73.13 109.477 170.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 92.02 7.15 64.46 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-N 114.469 -1.241 . . . . 75.12 113.534 167.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 62.91 87.57 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.817 -1.179 . . . . 75.1 107.817 -169.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.457 ' HG ' HG12 ' A' ' 57' ' ' ILE . 2.7 tt -129.96 149.88 51.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.902 -1.888 . . . . 74.54 105.902 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -73.8 -178.74 3.32 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.011 -0.366 . . . . 75.43 110.011 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -82.21 73.61 9.23 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.582 1.182 . . . . 74.1 109.504 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -130.64 148.59 70.65 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.859 -1.973 . . . . 72.43 107.256 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.57 177.28 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.05 1.833 . . . . 74.14 111.117 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 3.3 p -82.41 174.67 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.521 -0.918 . . . . 73.31 108.521 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.0 t70 -69.45 139.1 89.12 Favored Pre-proline 0 C--O 1.258 1.503 0 N-CA-C 110.579 -0.156 . . . . 64.22 110.579 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.437 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 6.3 Cg_endo -50.5 172.19 0.09 OUTLIER 'Trans proline' 0 C--O 1.193 -1.744 0 C-N-CA 124.13 3.22 . . . . 74.21 113.301 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.405 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 66.64 14.67 9.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.118 1.367 . . . . 74.33 109.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.21 32.17 81.38 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 55.21 114.671 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.472 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 90.8 m-20 -92.9 119.97 67.44 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 117.629 0.714 . . . . 73.13 110.698 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.465 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 36.8 Cg_exo -68.41 139.58 45.7 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.291 1.327 . . . . 75.23 108.669 167.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.63 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 56.0 m-85 -68.36 144.74 54.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.051 0.453 . . . . 74.01 110.317 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.558 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -102.3 114.06 27.9 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.839 -1.541 . . . . 72.44 106.839 -176.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.422 ' HH ' ' CG ' ' A' ' 97' ' ' ASP . 10.2 m-85 -99.41 118.47 36.11 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.656 -1.239 . . . . 71.42 107.656 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.77 153.64 47.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.763 0.664 . . . . 73.41 109.223 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.492 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . . . -121.85 -179.77 0.82 Allowed Pre-proline 0 N--CA 1.393 -3.302 0 N-CA-C 107.852 -1.166 . . . . 72.42 107.852 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 26.6 Cg_endo . . . . . 0 N--CA 1.449 -1.144 0 C-N-CA 122.066 1.844 . . . . 75.14 114.272 -174.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.792 0 CA-C-O 118.481 -1.177 . . . . 63.1 112.542 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 147' ' ' ASP . 54.4 Cg_exo -60.63 -26.43 82.89 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.109 3.206 . . . . 73.03 110.84 165.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.1 p90 -173.81 168.08 4.33 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.61 0.764 . . . . 72.31 110.019 166.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.61 112.56 8.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.904 -1.147 . . . . 62.54 107.904 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.417 HD22 ' HB ' ' A' ' 57' ' ' ILE . 52.9 tp -128.14 123.97 35.72 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.213 -0.929 . . . . 73.4 110.505 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -168.06 169.06 11.45 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 120.889 -0.324 . . . . 72.24 111.474 -174.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.63 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 22.2 t -125.14 160.69 28.53 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.844 -1.539 . . . . 75.22 106.844 170.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.558 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 89.5 mt -68.83 167.1 16.26 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.307 0.38 . . . . 74.11 110.636 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.65 -170.81 43.51 Favored Glycine 0 CA--C 1.496 -1.143 0 C-N-CA 119.419 -1.372 . . . . 73.3 111.77 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.65 -15.1 36.77 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.391 0.676 . . . . 72.31 112.731 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -94.45 -9.38 35.71 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.205 0.526 . . . . 74.15 110.714 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.8 23.73 66.29 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 121.109 -0.567 . . . . 73.54 112.167 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.01 148.62 42.12 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.47 -0.937 . . . . 70.31 108.47 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.44 105.98 18.06 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.693 0.759 . . . . 53.34 110.835 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.02 -174.32 21.16 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.148 -0.933 . . . . 73.12 111.234 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.74 129.58 9.94 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.577 -1.409 . . . . 61.25 109.577 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.3 m -177.74 -178.49 0.72 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 124.604 1.162 . . . . 63.41 108.275 -171.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -99.67 -25.99 14.21 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.754 -0.378 . . . . 72.21 111.933 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.88 -33.45 2.93 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.608 0.718 . . . . 53.14 110.038 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -95.38 15.21 20.1 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.909 -0.587 . . . . 70.11 110.897 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -87.27 155.32 20.12 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-N 115.994 -0.548 . . . . 63.41 110.043 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.73 129.11 34.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.901 -1.518 . . . . 74.01 106.901 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 143' ' ' ILE . 2.9 pp -96.48 115.92 37.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-O 121.472 0.653 . . . . 75.2 109.301 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.451 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -163.97 177.81 39.61 Favored Glycine 0 N--CA 1.417 -2.57 0 C-N-CA 118.756 -1.688 . . . . 72.3 113.719 -176.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.48 146.05 16.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.26 -1.385 . . . . 75.33 107.26 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 16.2 p90 -157.41 168.76 26.4 Favored 'General case' 0 C--N 1.267 -2.999 0 CA-C-O 120.972 0.415 . . . . 74.23 110.798 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 17.3 t70 -105.87 125.19 50.7 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.069 -1.456 . . . . 71.52 107.069 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.423 ' HA ' ' CD ' ' A' ' 122' ' ' PRO . 4.0 p-10 . . . . . 0 N--CA 1.421 -1.882 0 O-C-N 125.01 1.444 . . . . 71.05 108.553 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.5 tpp . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.692 0.282 . . . . 74.15 110.764 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -105.87 91.79 3.89 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.91 -0.494 . . . . 65.54 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -148.69 164.95 19.28 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 106.547 -1.649 . . . . 75.14 106.547 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 44' ' ' GLN . 51.7 Cg_exo -46.98 120.5 4.22 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.204 2.602 . . . . 70.43 112.939 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t70 73.34 -30.07 0.21 Allowed 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 127.135 2.174 . . . . 64.41 110.928 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 42' ' ' PRO . 14.0 mm100 -68.02 -25.17 65.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.224 -0.898 . . . . 74.3 109.516 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.48 65.37 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.314 -0.857 . . . . 71.12 110.328 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -87.65 -26.69 22.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.457 -0.942 . . . . 75.14 108.457 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 37.6 t -74.71 -44.6 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.71 0.767 . . . . 74.22 109.261 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.2 t -59.85 -38.18 81.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.326 -1.306 . . . . 73.33 112.889 -172.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -84.37 -34.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 119.88 -0.728 . . . . 74.45 110.442 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.2 -32.99 71.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.136 -0.484 . . . . 75.13 111.813 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 12.2 mmmm -65.73 -25.33 67.24 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.993 0.902 . . . . 75.43 110.048 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.6 -22.54 39.58 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.632 -0.987 . . . . 60.44 110.632 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 57' ' ' ILE . 75.5 m-20 -82.76 -38.48 23.15 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.671 0.272 . . . . 75.54 110.27 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.7 pt -64.02 -32.53 57.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.432 -0.581 . . . . 75.13 109.432 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -33.03 73.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.907 -0.588 . . . . 70.32 110.621 176.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.64 74.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.023 -0.535 . . . . 63.22 110.334 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 53' ' ' ASP . 55.3 mt -65.09 -37.83 81.21 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 CA-C-N 115.755 -0.657 . . . . 74.14 110.268 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.57 67.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.219 0.533 . . . . 74.04 111.06 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.27 -19.99 24.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.194 0.521 . . . . 34.22 110.251 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -29.02 21.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.226 0.536 . . . . 73.2 110.115 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.92 -30.27 67.64 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.688 -1.597 . . . . 74.55 106.688 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.592 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 31.8 t70 -73.15 -20.51 60.89 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.351 -1.295 . . . . 72.1 109.428 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.2 ttt -79.18 -34.32 43.14 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 115.747 -0.661 . . . . 75.42 109.367 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.429 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 1.3 t80 -64.05 -39.66 94.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.695 -1.595 . . . . 74.23 106.695 172.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.612 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 76.7 tttt -54.61 -33.02 59.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.813 -1.085 . . . . 75.02 110.304 175.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 99.3 mt -82.83 -36.2 25.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.137 -0.483 . . . . 74.53 111.522 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.16 -25.26 63.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.255 0.465 . . . . 70.11 112.255 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 12.0 m-80 -128.67 18.94 6.21 Favored 'General case' 0 CA--C 1.442 -3.209 0 O-C-N 121.962 -0.461 . . . . 74.44 111.062 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 p90 43.37 33.51 0.62 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 125.13 1.519 . . . . 74.11 112.558 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -177.52 156.3 1.16 Allowed 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.709 -1.219 . . . . 71.01 107.709 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.612 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.3 m-85 -78.83 148.6 72.72 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 123.254 0.347 . . . . 74.14 111.257 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 33.6 Cg_endo -66.4 158.41 55.4 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.892 2.394 . . . . 63.01 109.752 174.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.478 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 47.4 p -94.01 156.71 16.46 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.841 -1.17 . . . . 74.43 107.841 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t -66.38 -13.09 60.14 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 119.9 1.227 . . . . 74.11 111.165 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -102.21 -64.75 1.04 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 121.982 -0.449 . . . . 71.2 111.162 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -40.26 60.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 109.096 -0.705 . . . . 72.51 109.096 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.486 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -72.52 -20.75 79.61 Favored Glycine 0 N--CA 1.407 -3.27 0 C-N-CA 119.717 -1.23 . . . . 73.25 113.665 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.06 -47.31 62.49 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.349 -1.352 . . . . 74.24 107.349 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.56 -32.11 70.05 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 115.571 -0.74 . . . . 71.33 110.177 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -83.64 -5.54 59.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.786 0.661 . . . . 51.31 112.786 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 42.1 mt -93.14 -24.21 18.33 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.506 0.669 . . . . 65.31 109.822 174.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 t -102.72 -35.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.403 -0.817 . . . . 75.3 110.533 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 95.4 mttt -126.51 150.9 48.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.732 -1.581 . . . . 75.23 106.732 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -54.22 141.15 52.25 Favored Pre-proline 0 N--CA 1.48 1.063 0 N-CA-C 113.244 0.831 . . . . 74.14 113.244 -172.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.429 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 30.2 Cg_endo -61.15 152.66 70.23 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.974 3.116 . . . . 74.34 114.551 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -110.78 111.19 22.19 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 114.14 -1.391 . . . . 74.33 110.219 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.53 -121.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.769 -0.729 . . . . 70.44 111.583 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -136.96 91.91 14.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 C-N-CA 121.136 -0.226 . . . . 73.32 110.527 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.519 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 18.3 Cg_endo -95.27 161.54 1.6 Allowed 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 121.925 1.75 . . . . 74.21 110.596 172.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -87.63 159.26 49.92 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 106.76 -1.57 . . . . 73.21 106.76 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.55 99.31 0.31 Allowed 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 120.906 1.07 . . . . 73.54 110.684 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -150.84 149.33 29.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.571 -1.64 . . . . 74.11 106.571 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -66.01 97.58 0.38 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.007 0.743 . . . . 75.2 113.007 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.551 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.1 t90 -71.94 143.5 49.26 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.752 -0.658 . . . . 74.45 109.573 171.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -134.95 137.4 43.06 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.604 -0.517 . . . . 75.45 109.604 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -76.46 -166.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.142 -0.688 . . . . 75.14 109.142 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 66.32 8.65 5.8 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.437 1.095 . . . . 73.3 112.509 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 96.0 21.02 24.31 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 115.212 -0.904 . . . . 60.55 111.771 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.6 93.51 0.08 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.322 1.058 . . . . 74.31 111.101 -177.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.43 152.67 48.73 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.122 -0.944 . . . . 74.54 108.98 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.83 -169.05 2.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.976 -1.12 . . . . 74.23 107.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 70.69 0.98 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 122.747 1.261 . . . . 72.25 110.492 174.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.43 148.54 70.52 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 125.765 1.626 . . . . 72.31 108.331 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.63 -168.76 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.425 2.083 . . . . 73.14 110.754 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.622 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.7 p -86.41 174.25 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 106.576 -1.638 . . . . 64.41 106.576 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.433 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 4.3 t70 -97.37 151.59 37.75 Favored Pre-proline 0 C--O 1.252 1.193 0 C-N-CA 117.255 -1.778 . . . . 71.15 110.818 -173.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -38.79 171.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.824 3.683 . . . . 54.22 115.383 166.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.467 ' HB2' HD21 ' A' ' 110' ' ' ASN . 3.5 m-90 67.9 14.5 9.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.386 -1.733 . . . . 71.33 107.064 -171.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.31 29.22 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 114.052 -1.431 . . . . 72.44 114.497 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.467 HD21 ' HB2' ' A' ' 108' ' ' TRP . 54.1 m-80 -92.14 131.57 34.6 Favored Pre-proline 0 C--O 1.261 1.661 0 CA-C-N 117.941 0.871 . . . . 73.34 112.162 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.622 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 16.1 Cg_exo -70.15 148.88 63.52 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.356 2.037 . . . . 75.02 109.516 170.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.509 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 27.7 m-85 -69.59 140.31 53.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.199 -1.0 . . . . 70.01 108.588 175.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -101.57 115.04 29.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.74 -1.578 . . . . 74.33 106.74 -173.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.92 119.81 39.51 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.88 -1.054 . . . . 72.5 112.319 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 83.0 mt -128.57 143.9 51.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.242 -1.021 . . . . 75.4 108.242 172.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -111.17 -178.21 0.52 Allowed Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 107.525 -1.287 . . . . 50.25 107.525 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 37.3 Cg_endo . . . . . 0 CA--C 1.486 -1.922 0 CA-C-N 121.734 1.655 . . . . 61.4 114.678 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.477 -2.343 0 CA-C-O 118.128 -1.373 . . . . 72.32 113.751 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 34.8 Cg_exo -46.02 -22.76 1.51 Allowed 'Trans proline' 0 C--N 1.376 1.974 1 C-N-CA 126.511 4.807 . . . . 70.42 116.264 177.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.2 p90 179.91 166.76 1.24 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.97 0.508 . . . . 64.43 110.571 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 7.5 m-20 -139.53 108.97 6.15 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.069 0.856 . . . . 73.01 109.251 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -123.46 130.27 52.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.332 -0.547 . . . . 74.02 110.085 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -166.88 161.91 15.52 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 116.544 -0.298 . . . . 74.3 110.714 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 25.1 t -126.01 135.99 52.45 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.573 -1.269 . . . . 73.32 107.573 171.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.23 133.53 55.3 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.089 0.403 . . . . 74.22 112.089 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -86.14 -159.19 32.2 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.889 -0.596 . . . . 55.41 113.384 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -13.05 47.74 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.763 1.394 . . . . 71.54 114.763 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -94.95 -10.09 32.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 119.812 -0.755 . . . . 74.32 110.181 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.18 70.95 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.736 -0.665 . . . . 73.2 112.538 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -140.7 137.75 33.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.469 -0.938 . . . . 74.32 108.469 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.34 112.88 12.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.245 0.545 . . . . 62.3 109.62 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.44 -173.61 20.79 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 108.857 -1.697 . . . . 64.51 108.857 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.51 126.3 8.3 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 118.706 -1.711 . . . . 72.5 109.861 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.6 m 178.08 -178.67 0.26 Allowed 'General case' 0 C--O 1.251 1.146 0 C-N-CA 127.094 2.158 . . . . 75.32 106.713 -174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.01 -56.72 2.76 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.293 -0.563 . . . . 64.15 112.501 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -107.74 -23.64 12.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.239 -0.584 . . . . 75.33 111.391 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.11 -28.82 57.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 121.964 0.888 . . . . 63.1 109.242 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.8 159.41 25.14 Favored 'General case' 0 CA--C 1.47 -2.131 0 CA-C-N 113.572 -1.649 . . . . 73.44 111.033 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -76.65 135.5 39.13 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 107.027 -1.471 . . . . 54.02 107.027 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -97.71 128.85 48.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.394 -0.821 . . . . 74.41 110.295 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -172.55 -179.74 43.55 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 119.325 -1.417 . . . . 73.42 112.269 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.52 155.13 17.07 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.068 -1.456 . . . . 74.34 107.068 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.45 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 3.2 p90 -165.69 177.51 7.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.191 0.519 . . . . 73.2 111.435 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.402 ' OD2' ' HG2' ' A' ' 122' ' ' PRO . 29.7 t70 -116.1 125.59 52.59 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.398 -1.704 . . . . 61.14 106.398 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.491 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 41.0 t30 . . . . . 0 C--N 1.304 -1.388 0 N-CA-C 108.211 -1.033 . . . . 73.45 108.211 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.234 0.274 0 N-CA-C 108.549 -0.908 . . . . 72.3 108.549 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -107.14 82.3 1.66 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.297 0.57 . . . . 63.24 111.669 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -154.55 159.06 32.28 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.177 -1.786 . . . . 75.52 106.177 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.99 138.48 52.53 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.673 2.249 . . . . 72.12 111.305 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 72.99 -35.94 0.34 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.073 1.349 . . . . 72.15 113.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -74.19 -25.54 59.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.5 64.64 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.878 -1.055 . . . . 72.53 109.847 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -85.32 -25.62 27.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.093 -1.077 . . . . 71.13 108.093 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 86.4 t -74.63 -44.36 46.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.239 -0.891 . . . . 75.42 109.545 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -65.7 -25.45 67.32 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 115.145 -0.934 . . . . 75.32 111.659 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.5 -49.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.747 -0.835 . . . . 74.33 108.747 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 54' ' ' ILE . . . -64.44 -24.74 67.73 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.987 -1.006 . . . . 72.04 112.064 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.1 mmmt -65.74 -26.41 67.72 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.604 0.716 . . . . 75.14 110.762 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.2 -26.94 29.48 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 110.005 -1.238 . . . . 73.22 110.005 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.615 ' O ' HG13 ' A' ' 57' ' ' ILE . 65.7 m-20 -78.26 -38.13 43.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.432 -0.384 . . . . 75.02 110.687 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 50' ' ' ALA . 19.8 pt -66.61 -38.19 81.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.355 -0.216 . . . . 74.1 111.082 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -69.0 -26.72 65.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.002 0.43 . . . . 70.31 110.121 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -66.93 -45.16 78.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 75.41 110.242 174.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 53' ' ' ASP . 34.1 mt -64.73 -42.27 94.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.729 -0.669 . . . . 71.21 109.507 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.15 -28.4 66.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.865 -0.607 . . . . 53.33 111.235 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.62 -30.1 29.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 72.21 110.02 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.67 -28.1 30.87 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.712 -0.677 . . . . 73.14 110.366 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.48 -30.7 71.09 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.822 -1.177 . . . . 75.12 107.822 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.615 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.8 t70 -71.22 -23.25 61.98 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 122.183 0.992 . . . . 71.11 109.273 173.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 mtt -83.59 -28.43 28.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.726 -0.67 . . . . 64.43 110.724 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.531 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 70.8 t80 -71.55 -36.06 70.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.553 -1.277 . . . . 74.4 107.553 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.637 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 74.8 tttt -53.95 -36.09 62.46 Favored 'General case' 0 C--O 1.208 -1.114 0 CA-C-N 114.917 -1.038 . . . . 72.12 109.108 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.8 tp -76.48 -36.73 57.69 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.011 -0.541 . . . . 74.34 111.333 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.538 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 19.0 t70 -71.95 -23.77 61.5 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 112.035 0.383 . . . . 75.1 112.035 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.2 20.03 5.84 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 109.13 -0.693 . . . . 71.34 109.13 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 p90 42.95 32.96 0.46 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.999 1.437 . . . . 73.44 113.602 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 159.1 0.99 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.762 -0.829 . . . . 73.34 108.762 -172.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.637 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 23.7 m-85 -78.55 151.48 77.41 Favored Pre-proline 0 N--CA 1.425 -1.717 0 O-C-N 123.486 0.491 . . . . 75.41 111.23 173.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 30.8 Cg_endo -66.28 162.26 36.89 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.349 2.7 . . . . 74.52 111.055 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.433 ' HG ' ' HB2' ' A' ' 76' ' ' GLN . 69.5 p -98.62 156.33 16.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.27 -1.752 . . . . 65.24 106.27 174.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -12.58 60.9 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 119.656 1.116 . . . . 73.1 111.765 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -102.09 -64.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.979 -0.45 . . . . 75.22 110.742 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.433 ' HB2' ' HG ' ' A' ' 73' ' ' SER . 14.9 mm100 -74.12 -40.87 62.37 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 110.253 -0.277 . . . . 70.11 110.253 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -74.49 -20.94 79.43 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.088 -1.529 . . . . 74.25 113.458 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.0 -47.37 62.47 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.567 -1.642 . . . . 72.33 106.567 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 30.4 mt-10 -60.98 -33.48 73.29 Favored 'General case' 0 C--O 1.169 -3.175 0 CA-C-N 114.994 -1.003 . . . . 75.02 110.347 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.35 -7.05 55.44 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.629 . . . . 52.23 111.811 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -95.92 -18.5 20.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.932 -0.576 . . . . 73.45 110.322 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.86 -34.32 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 116.2 -0.454 . . . . 74.44 111.863 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 42.7 pttt -125.97 152.29 45.89 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.564 -2.013 . . . . 74.14 105.564 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -54.74 135.08 64.97 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 118.956 0.798 . . . . 73.13 111.813 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.531 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 18.3 Cg_endo -60.87 125.05 16.19 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.944 3.096 . . . . 74.41 113.352 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.0 t -84.1 139.92 32.14 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.429 -1.323 . . . . 73.53 107.429 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.13 -131.84 8.35 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.682 -1.767 . . . . 75.3 108.682 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.15 97.4 32.0 Favored Pre-proline 0 C--N 1.299 -1.591 0 CA-C-N 118.088 0.944 . . . . 74.31 111.966 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -92.46 150.25 2.94 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.335 1.356 . . . . 73.54 109.568 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -79.66 160.33 69.8 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.044 -1.095 . . . . 73.3 108.044 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.6 97.63 0.27 Allowed 'Trans proline' 0 C--O 1.249 1.056 0 CA-C-N 120.602 1.251 . . . . 74.44 109.64 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.538 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . 8.2 tmtm? -152.74 147.29 25.91 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.924 -2.25 . . . . 73.54 104.924 -175.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -81.76 92.7 6.68 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.278 -0.969 . . . . 73.44 111.051 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.478 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.9 t90 -54.9 143.69 25.25 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.288 1.035 . . . . 73.31 111.584 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.37 137.2 53.43 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.855 0.862 . . . . 74.41 109.003 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -84.71 -169.06 2.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.011 -0.737 . . . . 72.21 109.011 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t0 71.1 12.47 6.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.304 1.442 . . . . 71.0 110.535 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.52 14.98 30.93 Favored Glycine 0 N--CA 1.425 -2.061 0 CA-C-N 114.341 -1.3 . . . . 74.34 112.946 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.478 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.43 91.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 122.633 1.206 . . . . 74.2 109.533 -174.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -123.92 171.26 9.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 113.91 -1.495 . . . . 73.21 109.282 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -94.12 -168.57 1.89 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.396 -1.335 . . . . 73.32 107.396 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.73 70.85 3.26 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.716 1.246 . . . . 75.51 110.535 175.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.1 mt -130.34 147.63 66.59 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 115.064 -0.971 . . . . 73.14 110.715 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.7 -168.52 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.395 2.063 . . . . 75.13 110.526 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.592 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -86.13 173.8 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.556 -0.905 . . . . 75.42 108.556 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' A' ' 107' ' ' PRO . 4.1 p-10 -72.77 157.58 88.59 Favored Pre-proline 0 C--O 1.249 1.068 0 CA-C-N 118.654 0.661 . . . . 74.32 111.786 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 24.3 Cg_endo -59.8 171.47 2.79 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.615 2.21 . . . . 65.24 113.197 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 68.45 15.09 9.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.503 1.521 . . . . 73.43 110.482 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.2 69.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.135 -0.939 . . . . 64.43 114.132 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.18 142.29 40.96 Favored Pre-proline 0 C--O 1.253 1.249 0 CA-C-N 117.76 0.78 . . . . 74.44 111.26 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.592 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 84.0 Cg_endo -85.04 147.74 10.45 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.491 2.127 . . . . 71.42 111.681 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.33 141.94 56.97 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.564 0.697 . . . . 74.33 110.627 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -104.63 112.84 26.07 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.772 -1.195 . . . . 74.32 107.772 176.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -117.4 118.9 33.48 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.955 -1.02 . . . . 75.3 109.585 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 70.2 mt -127.55 154.56 45.03 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.347 -1.353 . . . . 71.41 107.347 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.436 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . . . -104.13 -178.39 0.62 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 116.592 -1.671 . . . . 64.05 108.669 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 16.8 Cg_endo -47.43 113.15 0.66 Allowed 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 123.269 2.646 . . . . 74.14 115.113 -165.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -89.29 -94.33 1.11 Allowed Glycine 0 N--CA 1.397 -3.901 0 CA-C-N 113.663 -1.608 . . . . 64.51 111.266 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.6 m -111.78 105.33 13.79 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 108.168 -1.049 . . . . 75.31 108.168 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 77.26 -33.07 0.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.483 1.513 . . . . 75.13 113.718 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -101.62 127.14 9.14 Favored Glycine 0 CA--C 1.474 -2.528 0 C-N-CA 118.933 -1.603 . . . . 72.12 114.334 -169.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.555 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 2.7 Cg_exo -39.78 -20.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.217 1 C-N-CA 126.941 5.094 . . . . 73.25 116.967 176.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 48.6 p90 -164.85 168.41 17.74 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.739 0.7 . . . . 73.14 112.134 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.5 m-20 -139.93 107.02 5.45 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.642 1.177 . . . . 74.11 109.662 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.85 140.95 44.56 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 117.363 -1.735 . . . . 72.52 111.998 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 24.4 p90 -166.52 170.08 13.15 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 72.04 111.727 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 m -124.33 151.22 44.57 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 107.596 -1.261 . . . . 75.44 107.596 174.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.0 mt -74.96 157.89 34.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.854 0.359 . . . . 74.2 110.989 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.85 179.21 49.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.506 -0.854 . . . . 62.22 112.209 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.44 63.11 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.812 0.845 . . . . 74.33 112.882 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -94.79 3.38 55.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.397 0.617 . . . . 73.32 110.844 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.81 34.74 55.77 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 116.246 -0.434 . . . . 75.4 112.585 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -139.96 147.92 41.18 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.827 -0.186 . . . . 75.45 110.526 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.47 105.8 17.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.189 0.995 . . . . 75.42 110.649 173.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.11 -173.25 20.24 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 115.162 -0.926 . . . . 75.41 111.075 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.38 127.02 8.14 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 108.479 -1.848 . . . . 71.54 108.479 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 57.9 m 179.18 -176.76 0.27 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.264 -1.754 . . . . 75.32 106.264 -171.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.19 -71.86 0.45 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.763 0.711 . . . . 71.2 110.186 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -99.04 -6.12 29.09 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.134 0.492 . . . . 74.43 111.231 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 10.3 m-20 -100.58 7.85 43.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.384 0.611 . . . . 75.12 110.197 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . -89.48 156.62 18.53 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.482 -0.781 . . . . 60.52 110.874 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.17 129.05 34.05 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.706 -2.331 . . . . 73.52 104.706 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 22.8 pt -114.19 113.79 44.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 CA-C-O 121.663 0.744 . . . . 74.22 110.88 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.05 -179.68 40.72 Favored Glycine 0 N--CA 1.408 -3.184 0 N-CA-C 110.949 -0.86 . . . . 62.04 110.949 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.51 156.19 40.04 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 109.888 -0.412 . . . . 72.35 109.888 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 7.1 p90 -155.69 177.25 11.6 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 115.3 -0.864 . . . . 74.23 109.226 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -129.93 136.39 49.42 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 123.894 0.746 . . . . 75.21 110.079 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.526 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 30.6 t30 . . . . . 0 C--O 1.255 1.347 0 O-C-N 125.833 1.958 . . . . 75.43 107.299 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 112.224 0.453 . . . . 73.42 112.224 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -100.36 80.63 2.26 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.901 -1.148 . . . . 70.15 107.901 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -145.53 158.08 51.01 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.311 -1.366 . . . . 64.12 107.311 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.53 123.24 10.98 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.113 2.542 . . . . 74.12 111.873 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t70 75.62 -32.47 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 126.824 2.05 . . . . 40.23 111.772 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -69.87 -13.9 62.48 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.833 -0.542 . . . . 75.22 110.804 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.42 -27.83 69.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.451 -0.795 . . . . 74.21 109.254 171.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -82.08 -25.72 34.28 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 108.183 -1.043 . . . . 75.55 108.183 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.9 t -75.11 -43.99 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.656 0.741 . . . . 73.11 110.015 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 t -66.63 -38.26 86.55 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.91 -1.041 . . . . 75.33 110.993 -174.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.09 -30.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 119.819 -0.752 . . . . 74.44 110.064 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.41 81.39 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 115.789 -0.641 . . . . 62.13 111.51 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.649 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 67.8 mttm -66.05 -25.43 67.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.211 0.529 . . . . 64.55 111.435 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.73 -34.36 25.08 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.037 -1.225 . . . . 72.12 110.037 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.551 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 m-20 -77.1 -32.95 56.98 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.083 0.771 . . . . 73.02 113.083 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.77 -34.79 62.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.162 -0.336 . . . . 71.12 111.414 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.649 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.2 mptp? -69.92 -30.19 67.54 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.531 0.682 . . . . 75.43 109.782 176.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.19 -44.5 91.81 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.175 -0.921 . . . . 64.43 110.21 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 53' ' ' ASP . 76.1 mt -60.9 -39.22 81.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.074 -0.967 . . . . 74.52 110.152 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HB3' ' ND2' ' A' ' 145' ' ' ASN . . . -57.73 -35.47 70.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.249 0.343 . . . . 73.44 111.529 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.14 -34.28 70.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.999 0.428 . . . . 73.44 110.112 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.26 -29.35 48.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.476 . . . . 71.34 110.26 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.19 -29.73 67.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.349 -1.352 . . . . 70.25 107.349 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.569 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 38.9 m-20 -69.79 -24.46 63.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.509 -0.769 . . . . 72.51 110.961 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.7 mtm -79.25 -34.35 42.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.426 -0.91 . . . . 72.12 109.954 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.434 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 90.5 t80 -65.43 -36.79 84.98 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 107.648 -1.242 . . . . 74.14 107.648 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 37.8 ttpt -54.32 -37.74 65.2 Favored 'General case' 0 C--O 1.203 -1.381 0 CA-C-N 115.419 -0.81 . . . . 73.55 110.103 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.04 -27.68 23.04 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.819 -0.752 . . . . 73.14 112.576 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.578 ' HA ' ' O ' ' A' ' 90' ' ' GLN . 12.7 t70 -76.41 -25.48 54.55 Favored 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 120.034 -0.666 . . . . 71.22 111.289 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -121.2 22.37 10.91 Favored 'General case' 0 CA--C 1.458 -2.573 0 O-C-N 120.92 -1.112 . . . . 72.42 110.257 174.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 p90 43.29 32.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 125.111 1.507 . . . . 74.12 113.366 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.5 157.35 0.47 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.797 -1.186 . . . . 65.03 107.797 -173.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 17.0 m-85 -76.07 156.03 84.23 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 109.067 -0.716 . . . . 73.1 109.067 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 36.3 Cg_endo -64.05 156.78 56.85 Favored 'Trans proline' 0 C--O 1.217 -0.557 0 C-N-CA 122.606 2.204 . . . . 73.43 112.2 -177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.406 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 62.8 p -93.49 155.38 17.37 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.992 -2.225 . . . . 65.25 104.992 171.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -8.48 55.19 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 119.716 1.144 . . . . 75.14 111.097 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -102.58 -66.01 0.96 Allowed 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.903 -0.589 . . . . 75.43 110.741 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -81.13 -35.53 31.44 Favored 'General case' 0 CA--C 1.467 -2.227 0 O-C-N 121.287 -0.883 . . . . 65.31 112.589 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -72.56 -21.58 79.45 Favored Glycine 0 N--CA 1.417 -2.631 0 C-N-CA 118.014 -2.041 . . . . 73.12 111.562 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.78 -43.62 62.58 Favored 'General case' 0 C--O 1.246 0.912 0 N-CA-C 105.995 -1.854 . . . . 73.11 105.995 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -61.44 -36.53 80.63 Favored 'General case' 0 C--O 1.192 -1.94 0 CA-C-N 114.473 -1.24 . . . . 74.01 110.349 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -84.54 -3.01 58.2 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.697 0.799 . . . . 74.3 112.598 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 58.0 mt -93.99 -27.31 16.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.498 -0.556 . . . . 73.24 109.498 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.07 -37.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.762 -0.654 . . . . 74.12 111.382 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.443 ' HB2' ' HZ2' ' A' ' 83' ' ' LYS . 4.9 ttmp? -118.65 149.22 41.77 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.48 -1.674 . . . . 73.23 106.48 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -54.69 132.98 65.05 Favored Pre-proline 0 C--O 1.245 0.83 0 CA-C-O 120.767 0.318 . . . . 71.55 111.246 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -58.41 153.26 48.74 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 124.792 3.661 . . . . 54.45 113.9 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.7 p -90.94 137.82 32.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.38 -0.827 . . . . 72.5 110.174 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.39 -161.33 18.99 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.997 -1.241 . . . . 72.52 109.997 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -111.75 105.08 56.59 Favored Pre-proline 0 N--CA 1.391 -3.378 0 N-CA-C 108.864 -0.791 . . . . 71.14 108.864 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 3.0 Cg_endo -86.31 162.56 9.82 Favored 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 122.954 2.436 . . . . 74.13 110.242 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' A' ' 67' ' ' ASP . 81.2 mm-40 -91.3 111.41 48.66 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 109.608 -0.515 . . . . 74.33 109.608 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -51.1 101.51 0.05 OUTLIER 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 124.336 3.357 . . . . 74.41 117.936 -166.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -135.84 83.52 2.02 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.254 -1.017 . . . . 74.32 108.254 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 16.01 84.16 0.01 OUTLIER 'General case' 0 C--O 1.247 0.929 0 C-N-CA 127.676 2.391 . . . . 73.5 114.058 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.674 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -55.68 137.56 49.13 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.085 0.469 . . . . 71.05 110.917 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.08 129.21 35.67 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.258 -0.883 . . . . 74.41 109.719 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.38 174.27 8.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.876 0.846 . . . . 74.33 110.929 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 66.02 28.55 10.41 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.924 -1.489 . . . . 72.1 110.407 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 99.41 16.38 29.71 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.054 -1.43 . . . . 62.54 115.313 165.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.674 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 2.5 m-85 63.04 90.15 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 122.492 1.139 . . . . 74.13 111.608 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 mt -117.64 171.8 7.78 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.82 -1.082 . . . . 72.45 112.224 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -93.47 -163.4 1.04 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 112.955 -1.93 . . . . 74.3 107.454 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.47 28.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.717 1.207 . . . . 73.15 112.944 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -107.36 148.14 36.57 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.766 -0.584 . . . . 74.22 111.342 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.15 -167.74 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.111 2.54 . . . . 71.25 110.041 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.97 167.89 2.12 Favored 'Isoleucine or valine' 0 C--O 1.258 1.527 0 N-CA-C 108.287 -1.005 . . . . 74.3 108.287 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.412 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 t70 -79.87 151.81 73.95 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 119.761 -0.776 . . . . 50.41 109.554 -171.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 59.7 Cg_exo -44.85 171.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 124.082 3.188 . . . . 54.43 113.953 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.466 ' CD1' ' HA ' ' A' ' 130' ' ' ALA . 2.3 m-90 69.91 14.28 7.93 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 126.127 1.771 . . . . 74.35 109.287 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.78 21.19 58.03 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 114.765 -1.107 . . . . 54.1 112.773 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -92.96 120.86 66.81 Favored Pre-proline 0 C--O 1.254 1.341 0 N-CA-C 112.881 0.697 . . . . 71.51 112.881 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.631 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.1 Cg_exo -59.6 143.91 99.55 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.592 2.195 . . . . 71.52 111.138 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 43.2 m-85 -69.39 143.1 53.76 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.605 -1.258 . . . . 73.23 107.605 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.507 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -103.07 119.65 39.25 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.196 -1.409 . . . . 75.24 107.196 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.26 117.93 34.97 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.289 0.566 . . . . 75.32 111.118 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.9 mt -128.8 153.7 47.15 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.525 -0.761 . . . . 65.35 109.044 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.449 ' HB2' ' HD2' ' A' ' 117' ' ' PRO . . . -113.91 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.408 -2.571 0 CA-C-O 117.89 -1.052 . . . . 71.43 109.597 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 32.2 Cg_endo -60.05 125.57 17.96 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.493 2.129 . . . . 75.1 114.699 -171.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.81 -76.54 0.11 Allowed Glycine 0 N--CA 1.415 -2.746 0 CA-C-N 114.169 -1.378 . . . . 74.01 112.002 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.3 m -95.11 95.29 8.47 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.684 -0.858 . . . . 74.5 108.684 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.515 ' HE2' ' OD1' ' A' ' 148' ' ' ASN . 0.1 OUTLIER 45.33 24.28 0.15 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.513 1.925 . . . . 73.35 115.634 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -137.47 121.8 2.37 Favored Glycine 0 CA--C 1.483 -1.937 0 CA-C-O 118.136 -1.369 . . . . 64.43 113.431 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 23.2 Cg_exo -41.37 -23.66 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.473 1 C-N-CA 126.905 5.07 . . . . 74.1 117.467 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 146' ' ' TRP . 54.8 p90 -179.51 170.14 1.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.364 0.529 . . . . 73.31 110.114 173.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -137.41 109.0 6.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.997 -0.742 . . . . 73.44 108.997 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.24 126.29 51.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.54 -0.911 . . . . 72.34 108.54 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 113' ' ' GLN . 29.8 p90 -166.92 162.77 15.96 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 122.851 0.094 . . . . 74.4 110.771 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.418 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 23.0 t -126.07 143.13 51.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.9 -1.518 . . . . 73.23 106.9 171.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.507 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 87.8 mt -60.07 136.27 57.97 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.351 0.407 . . . . 73.51 110.067 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 141' ' ' ALA . . . -75.32 -164.49 13.84 Favored Glycine 0 C--O 1.229 -0.195 0 C-N-CA 121.111 -0.566 . . . . 44.32 114.058 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 108' ' ' TRP . . . -55.37 -34.47 64.34 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.5 0.926 . . . . 73.04 113.5 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.13 -2.23 53.04 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.707 0.765 . . . . 70.03 109.348 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.73 17.22 80.08 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.8 -0.92 . . . . 74.34 110.8 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -100.46 144.85 28.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 112.072 0.397 . . . . 75.43 112.072 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.11 101.14 11.45 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 103.005 -2.961 . . . . 72.43 103.005 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.24 -173.02 22.76 Favored Glycine 0 CA--C 1.497 -1.093 0 CA-C-N 114.387 -1.278 . . . . 74.13 110.984 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.63 126.54 8.22 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 108.377 -1.889 . . . . 74.34 108.377 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.478 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 39.6 m 178.07 -178.7 0.26 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 126.746 2.019 . . . . 73.43 106.224 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.76 -58.29 2.14 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.683 -0.858 . . . . 73.11 108.683 171.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -89.09 -38.58 14.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.272 -0.876 . . . . 75.34 111.846 -175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -90.45 8.68 32.55 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.177 0.513 . . . . 73.52 111.313 -174.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.478 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -104.87 157.54 17.14 Favored 'General case' 0 CA--C 1.477 -1.835 0 CA-C-N 115.585 -0.734 . . . . 74.31 109.828 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.73 136.47 38.17 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 107.149 -1.426 . . . . 73.31 107.149 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.432 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -94.73 118.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 121.622 0.725 . . . . 65.4 109.274 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.19 157.0 25.9 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.595 -1.288 . . . . 74.12 114.421 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.513 ' ND2' ' HB3' ' A' ' 58' ' ' ALA . 4.4 t30 -148.92 129.53 14.03 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 125.208 1.403 . . . . 75.05 107.571 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.465 ' HA ' ' CE1' ' A' ' 123' ' ' PHE . 5.1 p90 -160.63 177.18 10.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.212 0.529 . . . . 72.14 111.439 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -115.63 134.27 55.21 Favored 'General case' 0 CA--C 1.472 -2.031 0 N-CA-C 107.725 -1.213 . . . . 64.44 107.725 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.515 ' OD1' ' HE2' ' A' ' 120' ' ' LYS . 24.9 t-20 . . . . . 0 C--N 1.292 -1.927 0 N-CA-C 107.713 -1.217 . . . . 74.21 107.713 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.431 ' H1 ' ' CB ' ' A' ' 48' ' ' THR . 1.4 mpt? . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.226 -0.657 . . . . 74.4 109.226 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 m -97.58 74.11 2.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.401 0.619 . . . . 53.25 110.339 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -148.49 158.5 40.42 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.054 -0.975 . . . . 75.14 108.472 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 44' ' ' GLN . 76.1 Cg_exo -50.63 121.25 7.63 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.633 2.889 . . . . 74.13 112.771 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t0 76.88 -26.4 0.19 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.023 1.729 . . . . 72.43 110.778 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.449 ' H ' ' C ' ' A' ' 42' ' ' PRO . 73.2 mm-40 -70.96 -17.0 62.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.204 -0.907 . . . . 73.15 108.702 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.37 68.91 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.231 -0.895 . . . . 74.32 109.75 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 55.3 mttp -83.75 -25.68 30.31 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 108.549 -0.908 . . . . 71.54 108.549 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 52.0 t -74.79 -43.03 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.615 0.722 . . . . 74.01 109.494 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.431 ' CB ' ' H1 ' ' A' ' 39' ' ' MET . 7.4 t -63.99 -31.85 73.18 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.034 -0.984 . . . . 72.25 111.718 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -79.8 -39.63 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 119.533 -0.867 . . . . 73.02 109.565 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.22 80.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.254 1.022 . . . . 71.23 112.356 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -65.72 -24.92 67.08 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.256 0.551 . . . . 73.45 111.141 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.21 -27.88 21.86 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.093 -0.803 . . . . 64.53 111.093 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.75 -38.98 57.94 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.168 0.509 . . . . 73.1 110.624 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 pt -66.31 -35.12 74.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.011 -0.541 . . . . 75.52 109.897 174.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 9.6 tptp -68.89 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 74.33 109.74 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.54 -40.73 97.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.31 -0.859 . . . . 70.44 109.614 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 99' ' ' TYR . 74.3 mt -66.14 -35.12 74.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 115.014 -0.994 . . . . 72.41 110.665 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -27.49 69.29 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.279 0.562 . . . . 75.54 111.018 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.19 -33.44 29.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.695 0.759 . . . . 71.34 109.413 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.12 53.71 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.562 -0.745 . . . . 61.31 110.886 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -68.27 -30.18 69.14 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 72.44 108.571 178.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.516 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 3.2 t70 -66.49 -30.43 70.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 71.43 109.64 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 88.8 mtp -74.66 -33.92 62.61 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.962 -0.563 . . . . 75.3 110.212 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -71.55 -36.18 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.219 -0.66 . . . . 74.25 109.219 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.602 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 15.5 pttp -67.74 -16.39 64.11 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 119.123 -1.031 . . . . 72.42 109.269 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.1 tp -88.65 -36.12 16.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.838 -1.074 . . . . 75.53 109.808 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 23.9 t70 -75.17 -24.55 57.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.026 0.38 . . . . 73.24 112.026 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.77 24.48 5.71 Favored 'General case' 0 CA--C 1.464 -2.361 0 C-N-CA 119.747 -0.781 . . . . 75.5 109.637 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.34 32.48 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.418 1.487 . . . . 74.43 113.925 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.03 161.23 0.57 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.701 -1.222 . . . . 73.33 107.701 -174.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.602 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 16.4 m-85 -77.14 155.07 82.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 123.475 0.485 . . . . 73.24 110.816 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.457 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.0 Cg_endo -63.59 162.12 29.11 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.142 2.561 . . . . 73.14 112.457 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.0 p -98.32 155.24 17.3 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 105.507 -2.034 . . . . 73.35 105.507 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.43 ' CA ' ' HB1' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.79 -11.55 60.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 119.56 1.073 . . . . 74.34 111.549 -173.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -102.02 -65.42 0.99 Allowed 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.855 -0.612 . . . . 72.31 110.295 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -77.14 -39.52 48.95 Favored 'General case' 0 CA--C 1.493 -1.222 0 O-C-N 122.079 -0.388 . . . . 74.32 111.044 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.587 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -77.18 -21.17 74.09 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 118.529 -1.796 . . . . 62.45 112.961 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 82' ' ' VAL . 6.3 tt -70.27 -49.99 44.16 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.644 -1.243 . . . . 74.13 107.644 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.3 -23.92 64.8 Favored 'General case' 0 C--O 1.188 -2.139 0 CA-C-N 115.289 -0.868 . . . . 75.5 110.104 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.21 -7.11 58.82 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.164 -0.471 . . . . 73.12 111.945 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 96.4 mt -91.56 -24.82 19.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.646 -0.872 . . . . 72.3 108.646 171.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 78' ' ' LEU . 21.8 t -90.84 -47.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.964 -1.016 . . . . 72.25 110.942 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -117.75 151.25 37.66 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 125.904 1.681 . . . . 73.13 108.411 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.435 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -53.34 129.49 51.66 Favored Pre-proline 0 C--O 1.249 1.059 0 N-CA-C 108.955 -0.757 . . . . 71.42 108.955 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -58.5 127.36 24.37 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 124.067 3.178 . . . . 62.32 113.05 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -93.16 107.94 19.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.503 -0.771 . . . . 74.42 110.155 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.49 -133.06 3.94 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 109.065 -1.614 . . . . 43.42 109.065 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -125.02 87.79 54.97 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 117.781 0.791 . . . . 63.44 112.733 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.85 163.0 6.13 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 122.818 2.345 . . . . 65.01 108.455 171.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -108.37 148.03 36.82 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 108.952 -0.759 . . . . 75.43 108.952 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.458 ' C ' ' HD2' ' A' ' 92' ' ' LYS . 74.5 Cg_exo -50.82 98.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.63 2.886 . . . . 62.45 116.089 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.458 ' HD2' ' C ' ' A' ' 91' ' ' PRO . 2.6 mptp? -147.27 148.75 31.76 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 127.641 2.377 . . . . 75.14 106.618 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -73.69 89.27 1.76 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 111.632 0.234 . . . . 73.03 111.632 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.614 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.2 t90 -54.96 143.76 25.29 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.59 1.156 . . . . 74.31 112.224 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.548 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 15.5 t-20 -126.39 137.02 53.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.158 -0.928 . . . . 73.03 111.137 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -86.23 173.79 9.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.659 0.742 . . . . 74.14 111.502 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.9 t70 69.08 15.32 8.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.497 -1.229 . . . . 64.05 112.435 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 119.6 8.81 8.84 Favored Glycine 0 CA--C 1.494 -1.276 0 C-N-CA 119.529 -1.319 . . . . 63.1 114.437 168.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.614 ' OH ' ' HA ' ' A' ' 94' ' ' TRP 0.268 0.3 OUTLIER 65.67 78.56 0.27 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 123.231 1.491 . . . . 75.12 110.787 -174.458 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -121.42 169.09 10.97 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 112.715 -2.038 . . . . 73.11 107.769 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.01 -164.5 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.26 -1.015 . . . . 73.33 108.26 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.45 68.34 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 122.655 1.217 . . . . 74.22 109.275 173.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 148.63 70.84 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 114.564 -1.198 . . . . 74.42 111.0 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -168.2 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.058 2.505 . . . . 72.11 110.795 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.636 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 9.6 p -79.59 166.47 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 108.95 -0.759 . . . . 72.52 108.95 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.37 153.88 76.63 Favored Pre-proline 0 C--O 1.252 1.194 0 N-CA-C 108.805 -0.813 . . . . 65.03 108.805 -172.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.0 172.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.432 2.755 . . . . 74.22 114.549 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.457 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 2.2 m-90 69.92 15.16 7.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.64 1.976 . . . . 73.32 109.66 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 13.67 52.77 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.83 -1.077 . . . . 72.43 114.152 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.15 132.96 43.81 Favored Pre-proline 0 N--CA 1.424 -1.769 0 CA-C-O 121.832 0.825 . . . . 74.53 111.595 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.636 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 71.8 Cg_endo -75.13 154.94 42.23 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 122.716 2.278 . . . . 70.53 111.142 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.68 136.37 48.99 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 106.898 -1.519 . . . . 74.44 106.898 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -102.66 114.06 27.97 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 105.225 -2.139 . . . . 73.42 105.225 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -104.4 118.35 36.4 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.303 -0.862 . . . . 65.02 109.996 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 93.5 mt -129.35 153.18 48.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.758 -0.83 . . . . 71.3 108.758 176.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -108.78 -177.31 0.46 Allowed Pre-proline 0 N--CA 1.412 -2.35 0 CA-C-O 116.588 -1.672 . . . . 74.35 107.633 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.735 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 18.2 Cg_endo -47.68 111.77 0.47 Allowed 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 122.653 2.235 . . . . 74.04 115.35 -165.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.74 -86.74 1.93 Allowed Glycine 0 N--CA 1.421 -2.362 0 CA-C-N 113.726 -1.579 . . . . 73.53 111.562 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 m -105.88 96.4 6.46 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 109.274 -0.639 . . . . 74.23 109.274 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 67.01 11.15 8.22 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.667 1.187 . . . . 64.41 114.195 172.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.735 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -140.98 132.08 5.21 Favored Glycine 0 CA--C 1.489 -1.561 0 C-N-CA 117.957 -2.068 . . . . 72.05 114.597 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.582 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -39.2 -20.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.062 1 C-N-CA 127.201 5.267 . . . . 64.32 118.025 177.415 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -170.98 165.65 7.57 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.605 0.639 . . . . 74.33 110.059 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 19.6 m-20 -135.08 110.37 8.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.487 -0.931 . . . . 75.03 108.487 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.404 HD11 ' C ' ' A' ' 125' ' ' LEU . 3.4 tm? -118.81 129.54 55.28 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.116 -0.698 . . . . 74.53 109.116 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -166.97 168.72 13.65 Favored 'General case' 0 C--O 1.204 -1.322 0 O-C-N 123.492 0.495 . . . . 72.44 109.9 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 15.6 m -124.13 142.28 51.35 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.354 -2.091 . . . . 74.03 105.354 171.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.44 143.09 50.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.932 -0.707 . . . . 71.52 111.748 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.68 174.48 11.09 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 116.026 -0.534 . . . . 75.12 113.826 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.96 5.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.593 1.331 . . . . 65.33 114.593 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.12 -10.18 34.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.365 -0.976 . . . . 71.03 108.365 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.74 88.16 Favored Glycine 0 CA--C 1.507 -0.434 0 CA-C-N 115.502 -0.772 . . . . 33.13 111.534 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -140.62 151.31 44.53 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 106.486 -1.672 . . . . 75.02 106.486 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.649 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -66.75 113.02 4.54 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.86 -0.422 . . . . 74.22 109.86 -173.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -140.52 -173.34 13.36 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 116.29 -0.414 . . . . 73.03 112.696 -174.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -139.8 127.84 3.72 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.333 -0.937 . . . . 42.11 111.782 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.519 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 74.2 m 178.81 -177.98 0.29 Allowed 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 128.38 2.672 . . . . 70.41 105.07 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.14 -54.0 47.31 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.862 1.21 . . . . 71.34 111.454 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.12 -14.63 15.33 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.629 -0.829 . . . . 74.33 112.468 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 16.7 m-20 -95.31 9.37 40.08 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.774 -0.77 . . . . 73.33 111.21 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . -87.41 155.08 20.18 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 109.059 -0.719 . . . . 61.23 109.059 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.649 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 42.1 m-20 -79.26 124.09 28.05 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.09 -1.818 . . . . 74.23 106.09 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.19 120.82 46.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 CA-C-N 115.956 -0.565 . . . . 73.24 109.95 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.28 177.54 40.61 Favored Glycine 0 N--CA 1.412 -2.964 0 C-N-CA 119.348 -1.406 . . . . 63.43 112.878 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.436 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -162.02 158.67 25.35 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.112 -1.81 . . . . 73.13 106.112 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -168.94 177.57 4.9 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.429 0.633 . . . . 65.44 112.623 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -109.88 121.61 45.62 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.611 -1.626 . . . . 74.04 106.611 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.342 0 O-C-N 124.24 0.962 . . . . 71.41 110.557 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 N-CA-C 106.135 -1.802 . . . . 74.23 106.135 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -113.47 83.38 1.83 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.828 0.677 . . . . 73.54 112.828 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -153.22 165.83 16.82 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.088 -1.449 . . . . 75.05 107.088 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -49.24 139.35 27.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.55 2.167 . . . . 74.12 111.043 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.15 -49.0 0.53 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.258 1.423 . . . . 63.25 110.0 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.439 ' OE1' ' HB3' ' A' ' 138' ' ' ASP . 74.8 mm-40 -68.52 -23.36 64.53 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.419 -1.264 . . . . 75.21 110.166 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.09 -26.37 68.19 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.504 0.722 . . . . 71.23 110.579 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -85.46 -24.19 27.51 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.39 -0.596 . . . . 72.03 109.39 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.18 -42.18 51.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.955 -0.757 . . . . 75.35 108.955 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.7 t -67.84 -25.88 65.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.471 -0.786 . . . . 74.33 112.387 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.8 -37.79 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 119.609 -0.836 . . . . 74.41 109.462 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 143' ' ' ILE . . . -58.73 -33.93 70.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.252 1.021 . . . . 72.33 111.505 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.503 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 73.7 mmtt -65.44 -26.15 67.83 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.801 0.81 . . . . 73.04 110.217 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.56 -33.31 10.34 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.378 -1.089 . . . . 71.2 110.378 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -71.95 -33.7 68.4 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.999 0.428 . . . . 63.51 111.718 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.474 HD12 ' C ' ' A' ' 144' ' ' GLY . 11.5 pt -68.04 -34.09 64.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.8 -0.36 . . . . 75.34 110.28 172.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 14.0 mptt -65.76 -29.79 70.34 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.997 0.427 . . . . 75.44 110.787 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.42 93.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 71.32 110.011 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.3 mt -67.15 -34.31 68.67 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-N 115.191 -0.913 . . . . 73.41 110.627 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' HB1' ' OD1' ' A' ' 145' ' ' ASN . . . -59.68 -35.63 74.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.944 0.402 . . . . 63.45 110.448 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.86 -31.9 63.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.298 0.571 . . . . 63.04 109.903 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.02 -28.3 43.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.801 -0.636 . . . . 74.12 110.601 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.79 -31.15 69.95 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.361 -1.348 . . . . 75.43 107.361 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.7 m-20 -72.79 -18.26 61.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.72 -0.673 . . . . 70.11 110.353 171.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.7 mtm -84.26 -31.16 25.1 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 121.995 -0.441 . . . . 74.11 111.632 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.64 -37.11 70.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.07 -1.456 . . . . 74.2 107.07 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HD2' ' CE1' ' A' ' 71' ' ' TYR . 86.0 tttt -54.94 -31.28 60.29 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.733 -1.121 . . . . 75.25 109.605 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.5 tp -83.5 -35.41 24.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.479 -0.782 . . . . 74.11 110.531 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.407 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 23.6 t70 -78.49 -25.55 45.74 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.209 0.448 . . . . 65.4 112.209 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.566 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.9 OUTLIER -125.94 22.35 7.39 Favored 'General case' 0 CA--C 1.461 -2.457 0 O-C-N 121.398 -0.814 . . . . 70.24 110.881 175.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 p90 43.18 34.16 0.65 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.858 1.263 . . . . 63.31 113.703 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.7 161.3 0.67 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.664 -1.236 . . . . 75.01 107.664 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 65' ' ' LYS . 12.3 m-85 -75.9 161.47 75.58 Favored Pre-proline 0 C--N 1.309 -1.172 0 O-C-N 123.367 0.417 . . . . 73.54 111.717 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.519 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 1.7 Cg_endo -78.44 164.11 26.58 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.226 1.951 . . . . 74.55 109.363 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 p -97.78 156.43 16.57 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.931 -1.877 . . . . 60.41 105.931 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -4.12 31.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.13 -1.428 . . . . 62.23 111.051 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -102.8 -67.65 0.87 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.772 -0.649 . . . . 75.11 109.648 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -80.58 -34.99 34.88 Favored 'General case' 0 CA--C 1.487 -1.481 0 CA-C-N 115.973 -0.558 . . . . 71.24 111.468 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.554 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.34 -20.51 78.78 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 118.225 -1.941 . . . . 71.35 112.696 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.97 -50.86 37.63 Favored 'General case' 0 C--O 1.26 1.606 0 N-CA-C 107.53 -1.285 . . . . 70.2 107.53 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 8.5 pt-20 -65.19 -28.25 69.26 Favored 'General case' 0 C--O 1.17 -3.09 0 CA-C-N 114.866 -1.061 . . . . 73.41 109.824 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -77.44 -6.16 52.44 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.629 0.603 . . . . 60.13 112.629 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 95.5 mt -95.38 -19.43 19.93 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.161 0.505 . . . . 65.34 110.014 172.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.5 t -98.53 -39.43 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.565 1.174 . . . . 73.2 110.715 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 25.1 tttm -121.29 148.3 44.49 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 127.521 2.328 . . . . 71.23 107.659 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -56.76 132.84 78.66 Favored Pre-proline 0 N--CA 1.475 0.775 0 O-C-N 123.141 0.275 . . . . 74.05 111.542 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 37.6 Cg_endo -63.44 128.74 23.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 123.327 2.684 . . . . 74.31 112.096 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -90.99 105.5 17.87 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.5 -0.773 . . . . 75.33 110.238 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.27 7.69 Favored Glycine 0 N--CA 1.418 -2.528 0 N-CA-C 109.906 -1.278 . . . . 73.12 109.906 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -118.62 88.2 33.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.936 0.368 . . . . 74.15 110.902 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.566 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 13.8 Cg_endo -92.69 159.4 2.86 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.707 1.605 . . . . 63.12 109.438 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -88.21 159.12 48.47 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.047 -0.723 . . . . 74.42 109.047 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.39 99.21 0.2 Allowed 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 121.692 1.595 . . . . 75.43 111.427 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.55 148.25 28.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.899 -1.889 . . . . 75.1 105.899 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.585 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 51.3 m-80 -65.48 91.36 0.12 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 122.373 -0.204 . . . . 74.44 111.503 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.509 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.2 t90 -66.6 140.27 57.93 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.483 -0.562 . . . . 74.32 109.483 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -127.95 134.47 49.31 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.811 -0.811 . . . . 72.15 108.811 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -75.58 -169.36 1.02 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.319 -0.993 . . . . 74.0 108.319 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.7 t70 67.64 15.3 9.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.973 0.892 . . . . 71.32 110.819 169.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 102.95 9.79 38.86 Favored Glycine 0 CA--C 1.495 -1.214 0 CA-C-N 114.995 -1.002 . . . . 73.33 113.855 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.509 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.2 OUTLIER 61.88 92.37 0.06 Allowed 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 122.085 0.945 . . . . 74.34 109.601 -173.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.422 HD22 ' H ' ' A' ' 101' ' ' LYS . 2.7 tt -128.91 155.63 44.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.014 -1.847 . . . . 74.44 106.014 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.422 ' H ' HD22 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.97 -171.93 0.35 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.053 -0.351 . . . . 64.25 110.053 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 28.81 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.797 1.036 . . . . 63.13 113.797 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 101' ' ' LYS . 3.5 mm? -105.41 147.99 35.55 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 109.296 -0.631 . . . . 75.4 109.296 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.98 -167.96 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.975 2.45 . . . . 71.34 111.897 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.582 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.0 175.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.417 -0.957 . . . . 73.35 108.417 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.584 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.7 t70 -78.73 159.92 73.04 Favored Pre-proline 0 C--O 1.256 1.44 0 CA-C-N 119.081 0.855 . . . . 72.12 109.173 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 4.0 Cg_endo -49.05 170.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 123.551 2.834 . . . . 53.42 113.242 173.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 66.71 14.56 9.83 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.437 1.895 . . . . 73.3 110.931 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 -0.65 34.86 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.804 -0.635 . . . . 74.31 114.002 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.9 135.45 87.6 Favored Pre-proline 0 C--O 1.263 1.791 0 CA-C-O 121.451 0.643 . . . . 74.34 112.077 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.582 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 92.2 Cg_endo -80.22 154.12 21.82 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 C-N-CA 122.118 1.879 . . . . 73.43 110.035 174.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -74.4 143.17 44.9 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.651 -1.24 . . . . 73.45 107.651 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -102.18 113.89 27.56 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 104.656 -2.35 . . . . 74.34 104.656 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.56 118.21 36.49 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.988 -1.006 . . . . 74.33 111.882 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 87.8 mt -129.11 144.19 51.12 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.107 -0.951 . . . . 74.02 109.242 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -101.59 -177.0 0.5 Allowed Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 104.404 -2.443 . . . . 75.21 104.404 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 10.2 Cg_endo -47.78 108.51 0.17 Allowed 'Trans proline' 0 C--N 1.385 2.491 0 CA-C-N 123.179 2.171 . . . . 73.34 113.015 -168.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -106.82 -86.12 1.84 Allowed Glycine 0 N--CA 1.405 -3.394 0 CA-C-N 114.46 -1.246 . . . . 53.35 112.051 -175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 m -96.26 95.53 8.16 Favored 'General case' 0 N--CA 1.406 -2.655 0 C-N-CA 118.448 -1.301 . . . . 63.01 109.836 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 66.25 4.45 3.17 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 125.418 1.487 . . . . 73.23 114.579 171.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -139.88 144.94 15.71 Favored Glycine 0 CA--C 1.491 -1.415 0 C-N-CA 118.73 -1.7 . . . . 74.22 114.112 -174.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.484 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 33.5 Cg_exo -38.61 -27.08 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.131 1 C-N-CA 127.163 5.242 . . . . 75.23 117.992 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -173.2 146.71 1.47 Allowed 'General case' 0 C--O 1.249 1.039 0 CA-C-N 119.071 0.85 . . . . 74.3 111.859 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 1.2 m-20 -118.48 106.61 12.86 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.142 -1.429 . . . . 71.43 107.142 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.3 129.52 46.45 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 120.886 -1.134 . . . . 74.04 110.76 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -165.21 166.46 18.88 Favored 'General case' 0 C--O 1.194 -1.832 0 CA-C-N 116.845 -0.161 . . . . 73.24 111.251 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.0 t -125.28 139.94 53.27 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 63.11 105.649 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.13 155.29 20.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.914 1.079 . . . . 74.12 113.914 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.75 165.15 37.76 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 110.774 -0.931 . . . . 71.41 110.774 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.46 -24.01 4.56 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 115.924 1.824 . . . . 75.33 115.924 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.27 -1.72 28.34 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.575 -0.703 . . . . 74.02 111.603 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.49 38.49 5.0 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.466 -0.873 . . . . 72.22 113.813 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -130.34 147.84 52.1 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.305 -0.628 . . . . 73.03 109.305 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 9.4 pt-20 -101.89 105.46 16.28 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.077 -1.453 . . . . 74.23 107.077 167.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.18 -173.73 21.39 Favored Glycine 0 C--N 1.29 -1.991 0 N-CA-C 110.395 -1.082 . . . . 55.2 110.395 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.91 129.78 10.01 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.687 -1.365 . . . . 65.45 109.687 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.558 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 39.9 t 179.59 -178.39 0.38 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.735 -1.58 . . . . 70.22 106.735 -172.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.439 ' HB3' ' OE1' ' A' ' 44' ' ' GLN . 4.3 m-20 -87.26 -66.8 0.87 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.345 -0.613 . . . . 74.35 109.345 173.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.83 -30.73 14.67 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.928 -1.033 . . . . 74.44 111.908 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.76 17.88 16.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.649 0.738 . . . . 70.04 110.907 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.558 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -100.67 155.75 17.71 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-N 114.943 -1.026 . . . . 71.11 109.554 176.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.8 p-10 -79.13 135.06 36.72 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.397 -1.334 . . . . 74.43 107.397 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.555 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -104.18 123.64 58.11 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-N 115.728 -0.669 . . . . 75.34 109.623 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -159.29 179.81 34.63 Favored Glycine 0 N--CA 1.412 -2.911 0 C-N-CA 118.878 -1.63 . . . . 74.41 112.702 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.511 ' OD1' ' HB1' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -137.5 150.4 47.52 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 105.774 -1.935 . . . . 63.41 105.774 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -143.87 144.54 31.79 Favored 'General case' 0 C--N 1.267 -3.013 0 C-N-CA 119.269 -0.972 . . . . 72.21 110.003 -165.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -127.38 95.68 4.34 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.87 -1.53 . . . . 65.45 106.87 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.6 t30 . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 113.816 -1.538 . . . . 72.22 107.676 -176.725 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.8 ttt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.55 -1.278 . . . . 71.14 107.55 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.9 m -104.94 86.66 2.49 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.902 0.704 . . . . 71.43 112.902 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -153.77 159.75 31.72 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.184 -1.413 . . . . 73.42 107.184 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.09 125.55 16.55 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.681 2.254 . . . . 74.34 111.787 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 75.95 -33.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.779 2.032 . . . . 64.1 111.55 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -70.0 -20.7 63.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.784 0.802 . . . . 73.2 109.217 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.85 64.29 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.715 -1.13 . . . . 72.02 110.13 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.432 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 91.6 mttt -89.25 -25.08 21.9 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.766 -0.827 . . . . 75.02 108.766 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.39 -43.89 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 108.34 -0.985 . . . . 75.21 108.34 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.0 t -66.26 -29.59 69.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.403 -1.271 . . . . 73.25 111.831 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -83.87 -33.75 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.039 -0.665 . . . . 73.41 110.248 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.95 -34.27 68.86 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.752 -0.658 . . . . 73.14 111.587 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.612 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 57.2 mtpt -70.39 -25.45 63.25 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.769 -0.772 . . . . 74.1 111.97 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.06 -26.21 45.6 Favored Glycine 0 C--O 1.246 0.88 0 N-CA-C 109.495 -1.442 . . . . 53.34 109.495 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.589 ' O ' HG13 ' A' ' 57' ' ' ILE . 20.7 t70 -77.32 -38.38 50.57 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.265 -0.967 . . . . 62.35 109.391 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 pt -65.92 -30.39 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 122.202 -0.311 . . . . 73.52 110.823 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.612 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.2 mptm? -71.08 -27.3 63.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.571 -0.452 . . . . 75.2 110.277 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -69.92 -48.87 56.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.568 -0.742 . . . . 60.42 110.243 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 53' ' ' ASP . 30.6 mt -61.06 -42.6 93.77 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 115.192 -0.913 . . . . 74.11 108.985 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -28.91 68.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.502 . . . . 61.12 111.876 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.04 -24.21 35.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.512 0.672 . . . . 73.14 109.606 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.05 29.76 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.754 -0.832 . . . . 51.55 108.754 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -68.77 -31.14 69.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.211 -1.403 . . . . 74.11 107.211 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.3 m-20 -68.92 -24.25 64.27 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.911 -0.586 . . . . 73.13 110.007 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 mmt -78.35 -34.98 48.06 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 120.889 -0.324 . . . . 71.21 111.305 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.541 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 58.7 t80 -69.8 -36.66 75.87 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.55 -1.278 . . . . 72.01 107.55 174.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.568 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 80.9 tttt -54.34 -35.36 62.64 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 114.876 -1.056 . . . . 72.41 110.485 173.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 62' ' ' ASP . 95.6 mt -87.0 -29.09 22.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 116.199 -0.455 . . . . 73.33 111.317 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t70 -78.2 -24.37 47.16 Favored 'General case' 0 C--O 1.201 -1.451 0 CA-C-O 120.632 0.253 . . . . 74.34 111.383 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -128.99 24.38 5.64 Favored 'General case' 0 CA--C 1.469 -2.14 0 N-CA-C 109.175 -0.676 . . . . 75.44 109.175 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.6 p90 42.97 31.44 0.33 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 126.131 1.772 . . . . 70.42 114.736 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.41 162.33 0.51 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.66 -1.237 . . . . 74.21 107.66 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.568 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.4 m-85 -76.6 153.57 83.54 Favored Pre-proline 0 C--N 1.296 -1.739 0 C-N-CA 120.252 -0.579 . . . . 70.42 110.274 173.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 20.8 Cg_endo -61.98 164.37 16.94 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 123.28 2.653 . . . . 65.14 110.904 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.422 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 37.8 p -95.05 155.36 16.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.354 -1.721 . . . . 74.13 106.354 173.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.05 -12.8 62.01 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 119.837 1.199 . . . . 61.31 110.503 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -102.48 -65.24 1.0 Allowed 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.938 -1.028 . . . . 75.15 110.746 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -84.79 -29.23 25.58 Favored 'General case' 0 CA--C 1.478 -1.797 0 O-C-N 121.885 -0.509 . . . . 74.45 111.387 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 72' ' ' PRO . . . -74.53 -20.79 79.46 Favored Glycine 0 N--CA 1.411 -3.022 0 C-N-CA 119.202 -1.475 . . . . 74.45 111.818 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.46 -46.14 70.58 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.226 -1.768 . . . . 74.42 106.226 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.96 -21.66 66.43 Favored 'General case' 0 C--O 1.17 -3.103 0 CA-C-N 114.762 -1.108 . . . . 74.14 110.814 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -89.89 -4.22 57.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.656 0.741 . . . . 73.15 111.351 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.409 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 4.7 mp -99.51 -21.21 16.03 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.521 -0.763 . . . . 73.22 110.086 174.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.412 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 35.9 t -108.01 -30.97 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 115.985 -0.552 . . . . 73.45 110.737 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.7 mptp? -122.57 150.5 42.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.018 1.327 . . . . 72.44 107.978 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.427 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 9.2 mtpm? -54.9 135.71 66.23 Favored Pre-proline 0 N--CA 1.48 1.05 0 CA-C-N 118.405 0.548 . . . . 73.22 111.351 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 13.5 Cg_endo -53.04 153.09 16.51 Favored 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 124.633 3.556 . . . . 75.44 114.1 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 p -98.96 132.49 44.24 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.788 -0.642 . . . . 63.43 109.844 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.79 -137.38 14.26 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.903 -1.279 . . . . 75.21 109.903 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -129.7 105.85 17.09 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 117.362 0.581 . . . . 73.02 110.364 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -85.54 162.94 10.94 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.072 1.848 . . . . 74.35 108.979 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.14 156.69 46.22 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.446 -0.946 . . . . 72.23 108.446 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -58.45 98.76 0.1 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.583 2.189 . . . . 75.44 116.08 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 67.5 mttm -151.32 148.52 28.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.545 1.938 . . . . 73.24 107.757 172.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -82.13 97.35 8.15 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.815 -0.354 . . . . 64.44 110.304 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.524 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.2 t90 -54.68 142.74 27.32 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.554 1.142 . . . . 73.11 112.696 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -123.85 136.96 54.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.956 -1.02 . . . . 74.03 109.212 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -81.09 -163.9 0.67 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 75.32 108.208 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 61.96 23.61 13.93 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.297 0.639 . . . . 74.41 110.915 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.409 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 78.54 24.41 62.94 Favored Glycine 0 CA--C 1.48 -2.12 0 CA-C-N 114.981 -1.009 . . . . 73.35 112.819 171.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.524 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 63.39 78.1 0.3 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 123.136 1.446 . . . . 70.0 109.138 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.0 tp -117.67 166.9 11.86 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.041 -1.89 . . . . 72.52 107.861 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.64 -174.72 5.43 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 75.13 109.299 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 35.35 1.03 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.516 1.151 . . . . 74.52 110.395 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.04 149.07 40.34 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 113.804 -1.543 . . . . 75.24 108.842 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.29 177.08 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.483 2.789 . . . . 75.12 113.835 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 5.1 p -79.39 175.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.41 -0.814 . . . . 75.51 109.066 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.3 p-10 -69.89 158.68 86.64 Favored Pre-proline 0 C--O 1.258 1.527 0 N-CA-C 113.496 0.924 . . . . 73.43 113.496 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.432 ' CB ' ' HB3' ' A' ' 46' ' ' LYS . 50.5 Cg_exo -58.0 171.73 1.51 Allowed 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.815 2.343 . . . . 74.51 111.47 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.498 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 3.2 m-90 65.94 14.49 9.62 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 125.033 1.333 . . . . 73.35 108.845 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.66 57.98 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.189 -1.369 . . . . 64.25 115.033 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.553 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 7.5 m-80 -92.91 152.62 41.69 Favored Pre-proline 0 C--O 1.264 1.824 0 CA-C-N 118.947 1.374 . . . . 75.45 108.573 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.469 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 58.8 Cg_endo -82.33 141.06 11.22 Favored 'Trans proline' 0 N--CA 1.425 -2.522 0 C-N-CA 121.32 1.347 . . . . 75.05 110.579 165.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 31.7 m-85 -68.07 144.76 54.94 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 109.743 -0.466 . . . . 74.41 109.743 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -102.36 119.3 38.58 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.212 -1.403 . . . . 74.14 107.212 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -107.77 118.1 35.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.249 -1.389 . . . . 74.33 107.249 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 95.7 mt -129.23 153.17 48.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.254 -0.647 . . . . 71.31 109.254 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 74' ' ' THR . . . -117.81 -178.37 0.53 Allowed Pre-proline 0 N--CA 1.414 -2.26 0 CA-C-O 117.319 -1.324 . . . . 72.24 108.273 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 36.5 Cg_endo -58.36 121.7 10.43 Favored 'Trans proline' 0 CA--C 1.492 -1.601 0 CA-C-N 122.041 1.765 . . . . 73.24 114.651 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -118.55 -84.03 0.92 Allowed Glycine 0 N--CA 1.418 -2.526 0 CA-C-N 114.266 -1.334 . . . . 54.51 111.021 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.5 m -110.04 107.17 16.94 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 107.906 -1.146 . . . . 73.31 107.906 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 70.96 -7.7 1.07 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.356 1.613 . . . . 73.31 115.356 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -132.3 126.6 4.61 Favored Glycine 0 CA--C 1.465 -3.045 0 C-N-CA 116.864 -2.589 . . . . 41.23 115.587 -171.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 39.8 Cg_exo -43.93 -23.71 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.168 1 C-N-CA 126.455 4.77 . . . . 73.03 115.711 176.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.0 p90 -176.12 169.35 2.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 118.023 0.374 . . . . 73.23 110.095 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 24.3 m-20 -136.79 112.24 9.27 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.4 -1.333 . . . . 74.02 107.4 174.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.511 HD23 ' HB ' ' A' ' 57' ' ' ILE . 47.5 tp -124.53 126.29 45.59 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.465 -0.494 . . . . 74.33 109.952 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 31.2 p90 -167.38 168.49 13.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.738 -0.385 . . . . 74.14 111.261 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.542 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 50.9 p -125.63 146.55 49.66 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.088 -1.078 . . . . 74.22 108.088 171.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.452 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 90.3 mt -66.69 145.38 55.62 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 110.341 -0.244 . . . . 74.5 110.341 175.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -81.1 -171.03 44.33 Favored Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.163 -1.017 . . . . 73.34 112.412 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.22 -8.21 5.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.896 1.073 . . . . 61.15 113.896 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -94.74 -9.71 33.85 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.133 0.492 . . . . 75.32 109.941 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.9 12.09 84.2 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 111.772 -0.531 . . . . 63.32 111.772 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -140.12 147.74 40.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.446 0.699 . . . . 74.24 109.17 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -81.72 114.3 20.28 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.29 0.567 . . . . 74.44 111.021 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.04 -174.23 21.1 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.216 -1.154 . . . . 55.4 110.216 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.18 126.63 8.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.639 -1.267 . . . . 74.31 110.078 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.466 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.3 m 177.92 -177.27 0.21 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.808 2.043 . . . . 73.25 106.134 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.45 -69.55 0.68 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.771 -1.172 . . . . 75.24 112.388 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -91.17 -21.99 20.88 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.126 0.489 . . . . 74.52 111.504 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.81 -6.72 59.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.125 0.488 . . . . 73.54 110.673 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.466 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -92.92 156.68 16.78 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.376 -0.829 . . . . 63.11 111.505 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.85 118.4 20.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.635 -1.246 . . . . 75.12 107.635 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.417 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.7 132.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.583 0 N-CA-C 108.525 -0.917 . . . . 72.23 108.525 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.0 176.79 42.47 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.248 -1.453 . . . . 73.34 112.072 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.66 145.98 24.78 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.477 -1.305 . . . . 71.2 107.477 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.486 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 7.4 p90 -161.35 175.47 12.2 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 116.072 -0.513 . . . . 75.42 110.477 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -113.61 122.62 47.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.921 -1.881 . . . . 72.23 105.921 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.305 -1.335 0 C-N-CA 124.587 1.155 . . . . 73.02 108.346 -178.501 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.501 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 20.1 mmt . . . . . 0 CA--C 1.505 -0.782 0 N-CA-C 110.467 -0.198 . . . . 72.35 110.467 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 m -107.29 73.79 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.054 0.454 . . . . 74.12 109.892 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -155.16 151.77 23.58 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 124.018 0.927 . . . . 74.23 109.42 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.87 131.42 38.2 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.534 2.823 . . . . 75.54 112.632 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 77.02 -36.14 0.24 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.321 2.249 . . . . 74.11 110.898 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.5 mm100 -68.92 -24.11 64.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.47 0.652 . . . . 71.01 109.569 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.412 ' O ' HG11 ' A' ' 49' ' ' VAL . . . -66.77 -27.1 67.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.472 -0.786 . . . . 74.11 109.543 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -79.19 -26.13 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.228 -0.656 . . . . 75.12 109.228 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.8 -43.15 46.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.292 -0.867 . . . . 73.22 109.139 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -69.87 -33.03 71.7 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.1 -0.954 . . . . 63.32 111.592 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 45' ' ' ALA . 11.2 m -73.92 -31.93 32.22 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 C-N-CA 119.361 -0.936 . . . . 74.02 109.694 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.28 82.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.793 -0.639 . . . . 74.34 110.408 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.557 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 96.2 mttt -69.95 -25.29 63.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.408 0.623 . . . . 74.33 111.561 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.6 -27.74 46.0 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 109.944 -1.262 . . . . 63.11 109.944 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.596 ' O ' HG13 ' A' ' 57' ' ' ILE . 5.2 t70 -73.99 -42.63 60.13 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.397 -0.902 . . . . 74.32 109.014 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.2 pt -63.93 -28.86 45.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 73.45 110.782 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.5 mptp? -70.74 -30.6 67.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.027 0.441 . . . . 74.43 110.346 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.73 -44.13 70.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 54.31 109.741 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 53' ' ' ASP . 36.8 mt -65.17 -39.77 86.6 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 CA-C-N 115.126 -0.943 . . . . 74.44 109.983 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.76 -31.56 66.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.345 -0.389 . . . . 73.24 111.007 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.24 46.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.222 0.534 . . . . 52.24 109.798 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.45 -26.64 38.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.019 -0.537 . . . . 70.43 109.917 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -30.44 69.98 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.132 -1.433 . . . . 74.24 107.132 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 68.9 m-20 -72.66 -18.54 61.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.484 -0.78 . . . . 75.43 109.817 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 mmt -82.11 -35.23 28.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.772 -0.649 . . . . 73.11 109.559 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 82.7 t80 -68.58 -34.71 76.27 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.386 -1.338 . . . . 71.04 107.386 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 85.9 tttt -55.87 -30.39 61.43 Favored 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 114.597 -1.183 . . . . 75.45 110.026 173.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.18 -34.41 20.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.804 0.298 . . . . 75.41 111.804 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.14 -23.74 61.35 Favored 'General case' 0 C--O 1.196 -1.763 0 CA-C-O 120.677 0.275 . . . . 61.35 111.273 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -129.51 20.56 5.64 Favored 'General case' 0 CA--C 1.452 -2.794 0 O-C-N 121.927 -0.483 . . . . 74.12 111.839 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 p90 42.69 32.68 0.4 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.87 1.356 . . . . 72.34 113.693 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 161.41 1.18 Allowed 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.898 -1.149 . . . . 72.44 107.898 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.3 m-85 -79.33 159.48 72.45 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 123.287 0.367 . . . . 63.42 111.557 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.437 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 58.3 Cg_endo -71.56 160.41 48.42 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.531 2.154 . . . . 75.3 112.377 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.6 p -96.28 155.33 16.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.232 -2.136 . . . . 74.43 105.232 171.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.437 ' CA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.48 -9.54 54.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 119.156 0.889 . . . . 64.51 110.777 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -102.7 -67.04 0.89 Allowed 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.737 -0.665 . . . . 71.41 110.629 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -81.56 -38.37 26.25 Favored 'General case' 0 CA--C 1.477 -1.837 0 C-N-CA 120.32 -0.552 . . . . 74.01 111.298 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 81' ' ' LEU . . . -71.95 -20.6 78.96 Favored Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 118.395 -1.86 . . . . 72.41 112.141 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.33 -47.0 53.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.539 -1.282 . . . . 63.51 107.539 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -65.02 -31.06 72.11 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-N 115.643 -0.708 . . . . 72.34 110.606 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -82.63 -5.12 58.64 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.186 0.517 . . . . 74.34 111.992 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 13.7 tp -96.33 -24.56 16.12 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.203 -1.036 . . . . 73.33 108.203 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.95 -38.14 5.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.135 -0.939 . . . . 73.41 110.751 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 61.9 mtpt -124.2 151.98 43.44 Favored 'General case' 0 C--O 1.204 -1.342 0 C-N-CA 125.552 1.541 . . . . 74.3 108.126 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -54.57 127.67 59.55 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 113.324 0.861 . . . . 74.11 113.324 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.7 123.07 12.91 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.97 3.78 . . . . 71.42 115.797 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -99.57 115.12 28.66 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.13 -1.395 . . . . 71.12 108.35 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 150.8 -116.76 0.79 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.091 -1.604 . . . . 41.3 109.091 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -137.65 90.97 14.19 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 117.558 0.679 . . . . 75.21 110.64 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.53 162.88 0.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.637 2.225 . . . . 73.42 112.448 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.251 0.6 OUTLIER -110.16 132.22 21.58 Favored Pre-proline 0 C--N 1.261 -3.261 0 CA-C-N 112.89 -1.959 . . . . 74.12 106.502 -171.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.91 99.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.688 2.925 . . . . 64.45 114.271 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -152.15 149.36 28.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.41 -1.7 . . . . 74.5 106.41 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.83 99.28 2.61 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 118.697 0.68 . . . . 73.44 111.201 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.502 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.5 t90 -61.97 144.11 55.55 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 125.028 1.331 . . . . 74.4 111.652 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.29 134.06 54.1 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.722 -0.672 . . . . 72.33 109.291 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.85 176.06 8.17 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.935 0.874 . . . . 74.01 111.354 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 57.78 28.97 16.71 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.436 -1.711 . . . . 74.34 112.858 168.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 120.65 -4.81 11.8 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.277 -1.439 . . . . 64.41 115.36 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.502 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.93 93.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.368 1.08 . . . . 74.4 109.411 -169.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.459 HD21 ' H ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -131.76 170.1 15.29 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.224 -2.139 . . . . 65.51 105.224 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.459 ' H ' HD21 ' A' ' 100' ' ' LEU . 96.4 mttt -88.93 -165.02 1.23 Allowed 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.725 -1.213 . . . . 71.04 107.725 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.23 32.54 0.45 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.893 0.854 . . . . 73.21 112.231 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.3 mp -94.77 149.61 36.67 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 125.028 1.331 . . . . 74.52 109.463 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.84 -167.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.643 2.895 . . . . 71.41 113.735 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 111' ' ' PRO . 4.5 p -101.28 176.12 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.813 -1.18 . . . . 71.42 107.813 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.43 144.87 95.0 Favored Pre-proline 0 C--O 1.255 1.384 0 CA-C-N 118.705 0.684 . . . . 73.34 111.29 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.39 171.78 0.13 Allowed 'Trans proline' 0 C--O 1.195 -1.633 0 C-N-CA 123.79 2.993 . . . . 73.02 112.597 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.433 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.2 m-90 62.54 14.97 7.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.921 1.289 . . . . 75.34 109.471 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.37 12.97 77.13 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 116.401 1.32 . . . . 73.13 116.401 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.433 ' ND2' ' HE3' ' A' ' 108' ' ' TRP . 14.9 m-80 -78.64 125.03 85.04 Favored Pre-proline 0 C--O 1.256 1.433 0 CA-C-N 120.15 1.975 . . . . 73.45 111.482 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.423 ' HA ' HG23 ' A' ' 105' ' ' VAL . 39.4 Cg_exo -67.53 146.71 74.97 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.093 1.862 . . . . 75.42 108.734 167.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.58 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 54.2 m-85 -68.93 145.33 53.74 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.381 0.61 . . . . 74.14 112.122 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.4 ' HG2' ' HA ' ' A' ' 127' ' ' SER . 2.5 mm100 -101.85 118.23 36.48 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.555 -2.017 . . . . 71.52 105.555 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.53 118.64 35.67 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.708 -0.678 . . . . 75.21 111.958 -177.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -129.81 154.0 47.69 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.294 -0.866 . . . . 73.14 109.838 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.496 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -101.76 -177.26 0.53 Allowed Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-O 116.572 -1.68 . . . . 64.41 107.817 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 10.1 Cg_endo -40.56 112.3 0.17 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.585 2.857 . . . . 74.52 115.48 -164.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.89 -88.51 1.12 Allowed Glycine 0 N--CA 1.421 -2.344 0 CA-C-N 114.338 -1.301 . . . . 72.14 111.725 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.9 m -108.07 95.76 5.9 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 108.456 -0.942 . . . . 71.41 108.456 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 65.6 -6.16 0.43 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.159 1.384 . . . . 75.3 113.329 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -111.41 127.0 7.97 Favored Glycine 0 N--CA 1.423 -2.23 0 CA-C-O 118.749 -1.028 . . . . 34.01 113.336 -174.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.59 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -35.07 -23.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.48 1 C-N-CA 127.339 5.36 . . . . 74.02 118.778 179.97 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.485 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 54.4 p90 -166.21 171.59 12.09 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 119.593 1.088 . . . . 72.13 112.042 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.86 106.57 6.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.009 0.924 . . . . 72.14 108.889 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.39 128.3 52.07 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.686 -0.857 . . . . 74.01 108.686 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.401 ' CB ' ' HA3' ' A' ' 144' ' ' GLY . 42.0 p90 -166.91 168.1 14.26 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 110.298 -0.26 . . . . 73.12 110.298 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.58 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 13.1 t -125.64 154.35 42.45 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.893 -1.521 . . . . 63.1 106.893 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.17 157.45 37.72 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.839 -0.344 . . . . 74.34 111.534 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.17 -169.94 29.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.235 -0.983 . . . . 61.21 112.999 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.03 -21.84 66.44 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.134 0.79 . . . . 73.04 113.134 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -94.43 -2.47 51.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.65 0.738 . . . . 75.44 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.72 45.68 73.92 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.042 -1.623 . . . . 75.44 109.042 -174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -135.28 144.34 46.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.849 -1.167 . . . . 73.45 107.849 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . 0.253 0.5 OUTLIER -102.86 106.7 17.33 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 121.982 0.896 . . . . 74.21 111.014 173.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.01 -173.34 20.26 Favored Glycine 0 C--N 1.294 -1.793 0 N-CA-C 111.066 -0.813 . . . . 64.03 111.066 -177.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -111.77 125.61 7.31 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 107.727 -2.149 . . . . 73.31 107.727 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.526 ' CB ' ' HB3' ' A' ' 140' ' ' ASP . 74.6 m 179.24 -176.34 0.26 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.897 1.279 . . . . 72.14 107.898 -167.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.21 -73.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.943 0.401 . . . . 73.32 110.412 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -107.22 -8.98 16.23 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.554 0.692 . . . . 74.24 110.12 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.526 ' HB3' ' CB ' ' A' ' 137' ' ' SER . 22.2 t70 -89.65 2.32 54.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 123.073 1.416 . . . . 73.3 108.871 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -92.36 155.8 17.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.73 -1.577 . . . . 73.31 110.595 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.73 122.46 29.13 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.775 -1.935 . . . . 63.45 105.775 171.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.509 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.29 113.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-O 121.982 0.896 . . . . 75.34 111.142 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' A' ' 126' ' ' TYR . . . -163.56 -179.8 38.16 Favored Glycine 0 N--CA 1.41 -3.087 0 C-N-CA 119.271 -1.442 . . . . 60.54 112.917 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.11 158.83 19.73 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.437 -1.32 . . . . 64.34 107.437 -177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.485 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 9.8 p90 -163.2 177.58 8.93 Favored 'General case' 0 C--N 1.279 -2.467 0 O-C-N 123.657 0.598 . . . . 75.1 110.629 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -105.33 120.58 41.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.229 -1.396 . . . . 73.21 107.229 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.298 -1.647 0 O-C-N 125.167 1.542 . . . . 72.34 106.87 178.842 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 25.7 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.134 0.492 . . . . 65.53 111.04 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -113.86 62.55 0.65 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.104 -0.702 . . . . 73.21 109.104 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -155.58 160.25 30.99 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.347 -0.983 . . . . 75.33 108.347 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -28.63 119.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 126.053 4.502 . . . . 70.13 116.341 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t70 65.33 -37.24 0.23 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 127.605 2.362 . . . . 74.23 113.912 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.76 -19.96 64.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.305 0.574 . . . . 74.35 110.123 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 39' ' ' MET . . . -64.1 -24.48 67.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.303 -0.862 . . . . 74.44 109.988 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.417 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 89.2 mttt -86.1 -25.0 26.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.019 -0.734 . . . . 74.41 109.019 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.431 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 58.0 t -74.25 -44.26 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-N 115.493 -0.776 . . . . 74.45 109.814 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.3 t -65.7 -36.04 82.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.063 -0.971 . . . . 75.4 111.512 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 m -74.21 -35.79 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 C-N-CA 119.917 -0.713 . . . . 73.42 109.74 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.9 74.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.932 -0.576 . . . . 73.04 110.378 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 73.7 mmtt -65.63 -25.9 67.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.431 0.634 . . . . 73.34 110.293 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.59 -31.52 18.44 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 110.595 -1.002 . . . . 61.13 110.595 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 57' ' ' ILE . 77.2 m-20 -76.53 -33.8 58.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.915 0.388 . . . . 74.43 110.323 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -67.11 -35.81 75.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.954 -0.387 . . . . 72.14 109.954 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -66.78 -30.7 70.97 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 120.878 0.371 . . . . 75.3 110.665 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.35 -45.39 88.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.338 -0.846 . . . . 72.55 110.046 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 53' ' ' ASP . 64.2 mt -64.81 -38.66 83.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 CA-C-N 115.267 -0.879 . . . . 73.34 110.161 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.48 68.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.999 0.428 . . . . 62.52 111.498 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.83 -33.21 27.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.566 0.698 . . . . 74.25 109.727 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.07 35.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.668 -0.697 . . . . 73.43 111.108 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.12 -30.35 71.28 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.778 -1.193 . . . . 75.35 107.778 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 18.9 t70 -73.71 -24.62 59.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.527 -0.76 . . . . 74.23 110.084 174.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.9 mtm -78.56 -25.77 45.45 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.789 -0.569 . . . . 74.15 110.465 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 31.1 t80 -72.04 -40.31 68.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.545 -1.65 . . . . 73.13 106.545 170.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 31.7 tttm -54.25 -37.29 64.5 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.307 -0.86 . . . . 74.4 110.354 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -73.01 -36.49 67.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.612 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.545 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.1 t70 -71.65 -23.46 61.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.327 0.651 . . . . 71.21 112.192 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.402 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.7 OUTLIER -128.48 20.29 6.18 Favored 'General case' 0 CA--C 1.457 -2.625 0 O-C-N 121.941 -0.474 . . . . 75.13 110.089 178.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.3 p90 42.9 31.65 0.34 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.118 1.511 . . . . 73.41 112.63 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.12 161.99 0.46 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.378 -1.341 . . . . 71.45 107.378 -171.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -74.67 158.96 84.31 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 112.746 0.647 . . . . 75.43 112.746 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.507 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 49.1 Cg_endo -72.69 159.27 49.01 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 123.164 2.576 . . . . 71.52 109.776 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.49 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 70.5 p -90.43 156.26 18.34 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.442 -1.318 . . . . 73.12 107.442 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 t -65.86 -17.78 64.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 119.767 1.167 . . . . 75.43 111.232 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.65 -65.9 0.94 Allowed 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.082 -0.387 . . . . 72.4 111.706 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.3 mm-40 -81.3 -32.63 33.04 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 120.959 -0.296 . . . . 74.23 111.573 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 72' ' ' PRO . . . -74.68 -20.85 79.37 Favored Glycine 0 N--CA 1.408 -3.188 0 C-N-CA 118.958 -1.591 . . . . 71.44 112.712 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.81 -46.41 68.71 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.484 -1.672 . . . . 73.41 106.484 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.16 -14.74 62.37 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 114.718 -1.128 . . . . 74.05 111.044 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.454 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . -89.84 -8.68 51.44 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.332 0.587 . . . . 72.45 110.16 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 88.9 mt -93.08 -22.68 18.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.841 -0.618 . . . . 74.42 109.634 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.31 -34.96 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 115.885 -0.598 . . . . 64.04 111.545 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -122.84 151.23 41.89 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.314 -1.736 . . . . 75.22 106.314 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -53.67 137.04 53.65 Favored Pre-proline 0 N--CA 1.49 1.542 0 CA-C-N 119.058 0.844 . . . . 74.25 111.636 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.553 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 17.9 Cg_endo -55.41 137.67 78.06 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 124.558 3.505 . . . . 73.35 117.071 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 p -89.74 -179.66 5.81 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 112.927 -1.942 . . . . 70.45 107.558 173.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 -131.15 13.22 Favored Glycine 0 C--O 1.249 1.042 0 C-N-CA 119.72 -1.229 . . . . 71.4 110.423 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -135.93 89.98 19.81 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 112.372 0.508 . . . . 74.24 112.372 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 96.7 Cg_endo -91.95 163.25 3.28 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.784 2.323 . . . . 75.24 109.523 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -99.86 158.63 31.75 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 108.477 -0.934 . . . . 75.24 108.477 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.83 99.28 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.038 1.826 . . . . 73.41 110.622 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.553 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 12.7 tmtt? -151.49 147.39 26.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.025 -1.472 . . . . 75.04 107.025 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 38.1 m-80 -63.34 89.52 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.025 0.75 . . . . 74.11 113.025 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.553 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 84.1 t90 -66.08 144.6 56.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.763 1.625 . . . . 73.33 111.326 175.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.53 130.39 52.36 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.359 -0.608 . . . . 71.02 109.359 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.457 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 62.5 pttt -83.3 -171.55 3.64 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.465 -0.894 . . . . 65.45 108.723 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.1 t0 66.27 28.72 9.86 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.243 1.021 . . . . 75.41 108.829 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 91.57 9.13 63.28 Favored Glycine 0 CA--C 1.473 -2.535 0 CA-C-N 114.021 -1.445 . . . . 73.5 114.114 167.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.7 OUTLIER 61.61 79.46 0.25 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.667 -1.234 . . . . 72.51 107.667 -172.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.426 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.5 tt -124.55 152.3 43.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.678 -1.601 . . . . 75.54 106.678 -171.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.72 179.71 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.675 -0.861 . . . . 74.24 108.675 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -80.66 67.08 6.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.386 1.088 . . . . 74.14 113.738 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.66 147.6 61.41 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 105.548 -2.019 . . . . 65.24 105.548 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.81 -168.84 0.25 Allowed 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.24 1.96 . . . . 75.12 112.139 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.37 173.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.687 -1.597 . . . . 75.35 106.687 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.9 p-10 -79.59 157.45 74.7 Favored Pre-proline 0 C--O 1.252 1.228 0 CA-C-N 119.155 0.889 . . . . 72.42 112.723 -170.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 10.3 Cg_endo -54.12 171.2 0.39 Allowed 'Trans proline' 0 C--O 1.201 -1.352 0 C-N-CA 123.571 2.848 . . . . 75.44 111.939 173.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 65.09 15.02 9.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.997 1.319 . . . . 65.23 109.559 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.73 27.87 64.7 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.234 -1.348 . . . . 75.22 114.804 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.506 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 4.5 m-80 -89.64 151.16 45.47 Favored Pre-proline 0 C--O 1.257 1.455 0 CA-C-N 119.24 1.52 . . . . 74.43 108.459 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 62.9 Cg_endo -82.14 144.91 13.54 Favored 'Trans proline' 0 N--CA 1.411 -3.379 0 N-CA-C 108.28 -1.469 . . . . 72.44 108.28 165.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 68.9 m-85 -67.28 143.01 56.68 Favored 'General case' 0 C--O 1.253 1.286 0 N-CA-C 106.535 -1.654 . . . . 73.54 106.535 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -101.2 114.47 28.46 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.167 -1.79 . . . . 72.21 106.167 -175.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -98.69 119.04 36.75 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.972 -1.122 . . . . 75.43 107.972 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.0 mt -128.46 153.14 47.44 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.463 -1.31 . . . . 71.01 107.463 175.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.455 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . . . -124.89 -179.05 0.77 Allowed Pre-proline 0 N--CA 1.395 -3.178 0 N-CA-C 107.605 -1.257 . . . . 73.32 107.605 -175.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 43.6 Cg_endo -64.23 132.06 32.55 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 121.512 1.474 . . . . 73.33 114.092 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.95 -67.47 0.02 OUTLIER Glycine 0 N--CA 1.425 -2.054 0 CA-C-N 114.471 -1.24 . . . . 74.05 111.484 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.3 p -95.6 95.89 8.67 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 122.653 -0.322 . . . . 75.25 110.179 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.41 21.69 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.366 1.617 . . . . 75.21 115.366 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.36 138.06 9.94 Favored Glycine 0 CA--C 1.466 -3.005 0 CA-C-O 118.871 -0.961 . . . . 72.44 113.528 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 147' ' ' ASP . 44.0 Cg_exo -64.26 -28.14 63.99 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.522 3.481 . . . . 74.14 111.99 165.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.5 p90 176.0 164.9 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.409 0.684 . . . . 75.1 110.024 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 32.6 m-20 -139.64 123.07 17.17 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.537 -0.542 . . . . 72.21 109.537 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -130.66 124.66 32.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.423 -0.954 . . . . 72.33 108.423 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.569 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 44.3 p90 -167.4 168.11 13.34 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-O 119.505 -0.284 . . . . 72.24 110.914 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -126.25 156.57 40.09 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.77 0.828 . . . . 74.44 109.636 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.16 151.59 46.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.418 -0.355 . . . . 72.2 111.363 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.28 -178.86 45.79 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.443 -0.884 . . . . 75.24 112.21 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.96 25.96 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.2 1.185 . . . . 61.11 114.2 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -94.48 -9.99 33.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.986 -0.685 . . . . 74.25 111.241 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.47 4.87 72.96 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.827 -0.909 . . . . 63.51 110.827 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -99.69 144.03 29.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.654 -0.869 . . . . 64.5 108.654 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.7 105.07 16.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.949 -1.13 . . . . 75.4 107.949 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.27 -173.55 20.63 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.079 -0.808 . . . . 63.2 111.079 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.77 127.63 9.27 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 108.312 -1.915 . . . . 62.23 108.312 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.4 m 179.53 -177.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 125.904 1.682 . . . . 75.32 107.53 -170.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.43 -72.96 0.45 Allowed 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.644 -0.822 . . . . 73.51 111.043 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -95.84 -14.65 23.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.01 0.433 . . . . 74.02 111.543 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -97.49 5.47 49.59 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.383 0.611 . . . . 71.33 110.353 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.23 156.96 18.93 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.329 -0.85 . . . . 74.01 112.597 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -78.76 112.94 16.41 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.45 -1.685 . . . . 74.13 106.45 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.505 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 119.06 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.083 0 CA-C-N 114.939 -1.028 . . . . 71.13 111.451 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -169.96 -179.2 41.45 Favored Glycine 0 N--CA 1.41 -3.043 0 C-N-CA 119.612 -1.28 . . . . 72.23 112.859 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.0 149.46 28.9 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.9 -1.518 . . . . 73.32 106.9 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.46 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 4.1 p90 -170.19 178.38 3.86 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.334 0.588 . . . . 73.31 110.19 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.551 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 36.1 t70 -118.3 137.02 53.35 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.511 -1.663 . . . . 64.33 106.511 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 3.7 p-10 . . . . . 0 C--O 1.253 1.24 0 O-C-N 124.586 1.179 . . . . 65.22 109.013 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 107.566 -1.272 . . . . 72.23 107.566 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -119.78 88.97 3.04 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.026 0.75 . . . . 72.14 113.026 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -156.29 170.73 8.36 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.191 -1.781 . . . . 74.14 106.191 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -43.1 125.57 4.28 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 123.434 2.756 . . . . 71.34 113.838 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.1 -33.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.61 1.564 . . . . 42.11 113.346 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -73.23 -28.93 62.44 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.709 -0.478 . . . . 75.22 109.709 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.01 72.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.008 -0.738 . . . . 75.23 109.008 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -74.7 -25.28 59.04 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.161 -0.927 . . . . 74.34 109.889 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.588 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 56.5 t -75.29 -44.57 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 71.15 109.09 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -73.62 -31.94 63.81 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.446 -0.797 . . . . 73.31 112.102 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -71.74 -36.17 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 119.404 -0.918 . . . . 72.43 109.034 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HB3' HD13 ' A' ' 143' ' ' ILE . . . -65.16 -31.67 72.97 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.344 -0.844 . . . . 71.31 111.251 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 31.5 mmmt -64.86 -25.75 68.03 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.239 0.542 . . . . 73.44 110.549 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.79 -33.5 15.58 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.953 -0.859 . . . . 73.5 110.953 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.263 19.8 m-20 -81.13 -26.35 36.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.377 0.88 . . . . 74.05 113.377 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.96 -31.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.867 -0.79 . . . . 72.14 108.867 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -70.41 -25.91 63.44 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.212 -0.662 . . . . 73.13 109.212 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.05 -47.3 71.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.087 -0.961 . . . . 73.42 109.868 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.84 -45.75 97.49 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.085 -0.961 . . . . 70.24 109.621 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.81 57.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.009 -0.541 . . . . 73.34 112.379 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.36 -39.6 16.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.879 0.371 . . . . 65.41 110.609 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 99' ' ' TYR . . . -77.42 -28.31 52.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.477 -0.489 . . . . 74.23 110.907 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.86 -26.66 66.14 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.6 -1.259 . . . . 75.12 107.6 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 t70 -76.12 -21.09 57.03 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.149 -0.932 . . . . 72.35 108.698 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.9 mtt -77.37 -37.44 52.19 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.616 -0.678 . . . . 75.51 109.465 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.433 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 73.4 t80 -61.98 -37.34 84.42 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.994 -1.113 . . . . 71.15 107.994 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.631 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.6 tttt -54.47 -39.47 67.52 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 114.638 -1.165 . . . . 70.44 109.796 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.64 -30.45 36.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.358 0.873 . . . . 74.11 113.358 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -71.14 -24.95 62.37 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.388 0.614 . . . . 73.41 110.873 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.4 23.15 5.96 Favored 'General case' 0 CA--C 1.454 -2.736 0 O-C-N 121.372 -0.83 . . . . 74.14 111.669 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 42.58 32.82 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.448 1.499 . . . . 74.25 113.67 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.34 151.41 0.27 Allowed 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.608 -0.886 . . . . 71.43 108.608 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.631 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 21.2 m-85 -74.79 152.55 87.0 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 123.266 0.354 . . . . 72.41 110.271 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 32.7 Cg_endo -62.01 164.9 15.56 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.562 2.841 . . . . 74.33 112.557 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.428 ' C ' ' HB2' ' A' ' 116' ' ' ALA . 58.2 p -102.46 154.98 18.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.614 -1.995 . . . . 64.44 105.614 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.494 ' N ' ' HB2' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.07 -8.21 43.1 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 119.312 0.96 . . . . 74.43 110.614 -175.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.37 -67.02 0.89 Allowed 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 116.046 -0.524 . . . . 73.54 109.996 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -77.95 -39.56 42.24 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 121.958 -0.464 . . . . 75.24 110.652 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.61 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.73 -21.03 77.59 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 118.675 -1.726 . . . . 65.33 113.157 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 tt -68.0 -49.06 63.83 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.257 -1.386 . . . . 74.31 107.257 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 17.9 mt-10 -68.03 -26.69 66.01 Favored 'General case' 0 C--O 1.166 -3.302 0 CA-C-N 114.767 -1.106 . . . . 70.23 111.386 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.18 -7.69 58.41 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.31 0.576 . . . . 73.25 111.35 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 81.7 mt -93.28 -22.72 18.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.788 -0.642 . . . . 74.14 109.604 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.45 -38.3 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 116.134 -0.485 . . . . 74.51 112.056 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 57.0 pttt -119.01 151.25 38.54 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.673 -1.603 . . . . 72.35 106.673 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -55.19 130.82 68.79 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 122.754 0.422 . . . . 74.13 110.373 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.436 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 30.6 Cg_endo -58.88 124.22 15.23 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.554 2.836 . . . . 65.43 112.493 -173.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.2 p -83.27 116.08 22.26 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.652 -0.704 . . . . 73.13 110.487 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.43 -136.46 6.73 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.889 -1.684 . . . . 74.21 108.889 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -133.91 94.12 19.2 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 117.296 0.548 . . . . 72.12 111.481 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.27 162.65 17.5 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 123.007 2.471 . . . . 75.23 108.868 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.4 108.59 34.66 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 108.823 -0.806 . . . . 73.41 108.823 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -29.08 98.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.254 1 C-N-CA 125.857 4.372 . . . . 73.11 117.643 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -138.77 149.48 45.05 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 125.971 1.708 . . . . 74.02 107.562 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.59 92.12 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.336 -0.393 . . . . 71.2 110.628 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.59 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 86.2 t90 -65.65 143.02 57.84 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 115.608 -0.724 . . . . 74.21 110.102 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -135.38 133.14 38.39 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.534 -0.757 . . . . 70.12 109.038 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -78.28 -171.53 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.327 -0.99 . . . . 74.53 108.327 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t0 66.89 25.25 9.52 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 122.189 0.995 . . . . 71.2 109.266 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 90.56 12.85 60.52 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 114.311 -1.313 . . . . 74.41 113.643 170.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.59 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.1 m-85 62.26 81.26 0.2 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.701 1.238 . . . . 74.43 107.811 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.0 tp -128.72 172.24 11.44 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.807 -1.542 . . . . 74.32 108.926 -171.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -77.29 -172.67 2.54 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.743 -1.206 . . . . 70.13 107.743 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -87.1 63.94 8.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.877 1.322 . . . . 73.52 108.966 177.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 tp -115.6 142.45 28.91 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.159 -1.837 . . . . 73.11 110.711 -172.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -68.37 -167.17 0.17 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.393 2.728 . . . . 75.02 110.826 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.693 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.83 173.17 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 109.114 -0.698 . . . . 71.21 109.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.521 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.6 t70 -80.73 161.57 63.38 Favored Pre-proline 0 C--O 1.255 1.35 0 N-CA-C 108.553 -0.906 . . . . 72.11 108.553 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 72.1 Cg_exo -47.24 170.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.067 2.511 . . . . 74.3 114.258 172.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.495 ' CG ' ' HA ' ' A' ' 130' ' ' ALA . 1.7 m-90 65.79 14.27 9.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.928 2.091 . . . . 74.51 111.034 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.52 -6.71 15.54 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.86 -0.609 . . . . 63.32 114.043 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.89 133.94 88.04 Favored Pre-proline 0 C--O 1.258 1.534 0 N-CA-C 113.019 0.748 . . . . 54.51 113.019 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.693 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 72.0 Cg_endo -75.58 145.86 29.99 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.659 2.239 . . . . 73.01 112.098 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -69.7 134.01 48.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.258 -1.386 . . . . 64.11 107.258 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -104.2 113.98 27.9 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.328 -0.851 . . . . 72.01 109.315 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.92 118.24 36.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.663 -1.606 . . . . 74.25 106.663 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.1 mt -128.82 153.59 47.28 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.687 -1.227 . . . . 72.24 107.687 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.494 ' HB2' ' N ' ' A' ' 74' ' ' THR . . . -109.77 -178.58 0.57 Allowed Pre-proline 0 N--CA 1.404 -2.745 0 CA-C-O 116.589 -1.672 . . . . 60.44 107.672 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 12.4 Cg_endo -47.12 108.86 0.18 Allowed 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 123.005 2.47 . . . . 75.15 115.488 -162.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.55 -89.65 0.6 Allowed Glycine 0 N--CA 1.414 -2.788 0 CA-C-N 113.862 -1.517 . . . . 64.03 112.03 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 m -112.73 96.87 6.21 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 110.231 -0.285 . . . . 75.34 110.231 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 69.59 -1.5 2.24 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.999 1.319 . . . . 75.42 113.13 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -121.22 125.21 6.09 Favored Glycine 0 N--CA 1.428 -1.898 0 CA-C-O 118.374 -1.237 . . . . 72.1 113.0 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.534 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 13.4 Cg_exo -37.85 -26.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 127.299 5.332 . . . . 73.14 118.559 -178.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.261 40.3 p90 -169.32 147.08 3.63 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.353 0.979 . . . . 75.11 113.12 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.6 m-20 -112.47 109.83 19.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.281 -1.327 . . . . 74.42 107.441 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.493 ' O ' ' HA3' ' A' ' 144' ' ' GLY . 3.2 tm? -124.7 129.93 51.44 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.957 -0.697 . . . . 74.54 109.655 -176.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 55.7 p90 -167.81 164.59 14.17 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 112.442 0.534 . . . . 72.42 112.442 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -125.8 136.67 53.38 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.386 -2.449 . . . . 73.14 104.386 166.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.88 154.27 12.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.483 0.659 . . . . 75.44 112.392 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.43 173.31 40.38 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.894 -1.048 . . . . 75.52 113.902 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.495 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -48.36 -28.81 3.41 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 116.732 2.123 . . . . 75.21 116.732 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.26 -7.37 42.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.447 0.567 . . . . 72.42 111.397 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.43 28.31 25.09 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.495 -0.86 . . . . 75.32 112.439 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -127.65 138.63 52.88 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.634 -0.876 . . . . 73.54 108.634 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.39 105.38 7.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.617 0.722 . . . . 72.13 109.741 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.41 -174.4 22.2 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.812 -0.709 . . . . 71.54 113.873 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -116.79 128.66 8.01 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.363 -1.495 . . . . 75.54 109.363 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 38.8 m -178.26 -177.36 0.58 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 125.758 1.623 . . . . 75.55 108.196 -170.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.38 -73.25 0.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.877 -0.515 . . . . 73.03 110.53 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.44 -6.96 29.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.188 0.518 . . . . 72.45 111.718 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -100.54 9.34 42.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.335 0.588 . . . . 71.5 110.917 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . -86.11 157.78 19.95 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.813 -0.631 . . . . 60.4 111.162 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.73 112.33 13.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.931 -1.877 . . . . 73.24 105.931 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.535 HD11 ' O ' ' A' ' 143' ' ' ILE . 2.6 pp -96.32 123.45 48.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.472 0.653 . . . . 73.13 111.067 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -175.11 177.24 47.17 Favored Glycine 0 N--CA 1.413 -2.869 0 N-CA-C 110.155 -1.178 . . . . 72.34 110.155 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -103.36 162.92 12.6 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.136 -1.802 . . . . 70.35 106.136 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -143.64 124.7 14.43 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.119 -1.067 . . . . 75.24 108.119 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -111.58 112.38 24.05 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.899 -1.519 . . . . 75.43 106.899 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--N 1.293 -1.88 0 N-CA-C 109.413 -0.588 . . . . 71.14 109.413 -177.424 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.458 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.8 mpt? . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.358 -0.608 . . . . 73.13 109.358 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -118.12 84.62 2.2 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.82 0.819 . . . . 74.52 110.501 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.407 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 99.1 mtt180 -153.07 165.78 16.88 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 106.292 -1.744 . . . . 70.11 106.292 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 44' ' ' GLN . 72.2 Cg_exo -53.94 130.25 38.32 Favored 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 122.515 2.143 . . . . 64.44 111.422 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 47' ' ' VAL . 33.5 m-20 72.85 -31.67 0.23 Allowed 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 125.393 1.477 . . . . 70.21 113.597 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 13.9 mm100 -68.93 -32.59 72.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.955 -0.757 . . . . 73.5 108.955 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.63 -17.89 64.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 74.44 110.747 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 57.0 mttp -89.44 -24.66 21.82 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.156 -0.683 . . . . 73.41 109.156 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 43' ' ' ASP . 59.5 t -75.0 -43.93 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.913 0.863 . . . . 73.54 108.698 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -64.65 -28.11 69.39 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.227 -1.351 . . . . 75.11 111.762 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.16 -37.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 119.597 -0.841 . . . . 74.22 110.146 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.677 -0.692 . . . . 71.44 110.667 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 55.0 mtpt -68.53 -22.47 64.51 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 121.379 0.609 . . . . 65.42 111.749 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.56 -31.1 46.63 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.618 -1.393 . . . . 73.11 109.618 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.6 m-20 -76.08 -31.15 58.6 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.223 -0.489 . . . . 72.41 111.359 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 pt -66.89 -30.82 50.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 C-N-CA 120.373 -0.531 . . . . 73.31 109.879 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 14.2 mptt -67.17 -31.83 72.51 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 120.075 -0.65 . . . . 75.5 109.984 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.4 71.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 73.14 110.83 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.453 HG12 HD13 ' A' ' 100' ' ' LEU . 44.1 mt -62.75 -43.15 98.49 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 116.013 -0.539 . . . . 74.24 109.715 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -22.72 66.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.02 0.438 . . . . 72.44 111.681 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 -33.96 20.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.397 0.618 . . . . 65.13 109.951 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 99' ' ' TYR . . . -81.9 -27.48 33.38 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.155 -0.475 . . . . 73.35 110.552 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.28 -30.33 71.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 106.927 -1.508 . . . . 74.32 106.927 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 20.0 t70 -73.92 -17.21 61.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.705 -1.134 . . . . 65.12 109.21 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.8 mtm -84.01 -32.17 25.08 Favored 'General case' 0 C--O 1.204 -1.307 0 O-C-N 121.638 -0.664 . . . . 73.24 109.428 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -63.61 -35.47 80.61 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.17 -1.789 . . . . 64.54 106.17 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.638 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 60.5 tttp -58.12 -38.01 75.69 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 115.594 -0.73 . . . . 74.23 110.569 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 tp -74.73 -36.22 62.66 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.492 0.663 . . . . 74.35 109.667 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 92' ' ' LYS . 13.8 t70 -74.37 -24.55 59.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.188 -0.914 . . . . 74.24 111.772 -174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.572 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -128.54 22.84 5.92 Favored 'General case' 0 CA--C 1.455 -2.699 0 O-C-N 121.549 -0.719 . . . . 73.13 110.62 177.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 42.44 31.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.501 1.52 . . . . 75.31 112.822 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.64 161.43 0.52 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.873 -1.158 . . . . 73.13 107.873 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.638 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 19.7 m-85 -75.74 155.07 85.27 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 123.301 0.376 . . . . 73.14 111.872 174.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.433 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 37.0 Cg_endo -66.7 157.8 59.22 Favored 'Trans proline' 0 C--O 1.211 -0.849 0 C-N-CA 122.693 2.262 . . . . 72.3 110.391 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 p -94.37 155.55 16.93 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 107.119 -1.437 . . . . 74.44 107.119 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -72.79 -4.54 32.2 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.013 1.279 . . . . 72.53 111.257 -176.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -102.75 -66.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 120.113 -0.635 . . . . 64.53 110.241 169.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -74.94 -45.99 38.68 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.531 -0.544 . . . . 71.31 109.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -72.16 -19.97 78.83 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 120.322 -0.942 . . . . 73.52 113.775 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tt -73.17 -48.66 33.4 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 107.841 -1.17 . . . . 75.13 107.841 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.53 -37.13 82.61 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 108.323 -0.991 . . . . 74.33 108.323 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -77.89 -5.61 51.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.041 0.756 . . . . 63.31 113.041 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 15.3 tp -94.43 -23.47 17.73 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.38 -0.97 . . . . 73.41 108.38 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.28 -38.78 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.924 -1.034 . . . . 63.52 110.562 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 43.8 tttm -124.06 150.69 44.68 Favored 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 126.598 1.959 . . . . 74.11 107.17 -174.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -54.11 141.66 49.5 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 113.242 0.83 . . . . 74.44 113.242 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 7.7 Cg_endo -45.15 136.47 10.67 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 125.104 3.87 . . . . 72.44 115.992 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -101.41 -11.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.63 -1.168 . . . . 73.25 108.989 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.84 -148.62 24.07 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.949 -0.861 . . . . 52.43 110.949 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -117.12 101.16 53.34 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-O 121.555 0.693 . . . . 75.13 111.345 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.572 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 95.6 Cg_endo -99.71 162.82 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.772 2.981 . . . . 74.41 112.447 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -87.54 159.04 50.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.822 -1.177 . . . . 74.21 107.822 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.75 98.42 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.612 1.541 . . . . 74.22 112.904 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HB2' ' OD2' ' A' ' 67' ' ' ASP . 2.3 mptp? -150.05 148.12 28.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.008 1.723 . . . . 74.33 106.46 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.57 98.01 5.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.004 0.431 . . . . 61.32 111.034 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.606 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 85.5 t90 -54.73 144.18 23.01 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.349 1.86 . . . . 73.14 113.042 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -116.65 135.33 53.88 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.526 1.13 . . . . 75.14 109.221 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -82.39 178.7 8.1 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 122.09 0.947 . . . . 74.4 110.909 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 55.63 45.92 23.76 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.894 -1.957 . . . . 70.1 111.905 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 105.7 -10.19 45.09 Favored Glycine 0 CA--C 1.477 -2.336 0 CA-C-N 114.427 -1.26 . . . . 62.05 114.856 163.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.606 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 64.55 96.15 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 122.182 0.991 . . . . 72.55 109.63 -171.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.453 HD13 HG12 ' A' ' 57' ' ' ILE . 59.3 tp -138.79 170.04 16.71 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.697 -1.138 . . . . 73.25 107.937 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.82 -170.32 2.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.747 -1.575 . . . . 74.43 106.747 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.71 75.91 10.27 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.606 -0.837 . . . . 74.44 109.996 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -130.85 147.85 67.86 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.379 -1.282 . . . . 74.04 108.753 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.59 178.01 7.26 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.538 2.159 . . . . 74.54 112.806 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 111' ' ' PRO . 3.9 p -85.5 175.75 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.716 -0.846 . . . . 73.41 108.716 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.8 p-10 -78.65 158.2 76.1 Favored Pre-proline 0 C--O 1.251 1.184 0 CA-C-N 119.381 0.991 . . . . 74.34 113.132 -170.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 7.8 Cg_endo -54.52 171.07 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.266 2.644 . . . . 74.55 112.654 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.508 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 3.1 m-90 64.01 14.69 8.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.559 1.544 . . . . 74.34 108.856 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.46 38.33 79.5 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 114.026 -1.443 . . . . 73.02 115.167 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.527 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 13.2 m-80 -91.68 146.32 32.88 Favored Pre-proline 0 C--O 1.266 1.924 0 CA-C-N 119.954 1.877 . . . . 73.35 108.898 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' HG23 ' A' ' 105' ' ' VAL . 36.6 Cg_endo -89.35 137.83 3.12 Favored 'Trans proline' 0 N--CA 1.428 -2.377 0 C-N-CA 122.053 1.835 . . . . 72.44 109.565 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.646 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 59.2 m-85 -68.04 143.41 55.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.883 0.373 . . . . 74.35 110.601 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.511 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -102.67 117.34 34.46 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.112 -1.44 . . . . 75.41 107.112 -176.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -104.14 120.65 41.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.876 -0.416 . . . . 74.13 109.876 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 92.6 mt -127.98 153.56 46.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.452 -0.573 . . . . 73.43 109.452 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.442 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -109.63 -176.61 0.41 Allowed Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 116.567 -1.683 . . . . 74.42 107.306 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.712 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 18.5 Cg_endo -49.89 115.96 2.13 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.383 2.055 . . . . 71.12 114.707 -169.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -107.0 -84.53 1.7 Allowed Glycine 0 N--CA 1.424 -2.163 0 CA-C-N 114.205 -1.361 . . . . 52.14 111.664 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.1 m -103.55 96.47 6.75 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.404 -0.961 . . . . 71.3 108.404 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.405 ' HZ1' ' HB2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER 53.43 12.05 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.606 1.962 . . . . 74.35 116.12 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.712 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -126.7 131.28 7.27 Favored Glycine 0 C--O 1.202 -1.894 0 C-N-CA 119.38 -1.39 . . . . 65.34 113.632 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.569 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 32.4 Cg_exo -40.3 -23.98 0.13 Allowed 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 126.782 4.988 . . . . 71.12 117.731 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 51.3 p90 -176.64 163.8 2.4 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 118.351 0.523 . . . . 73.32 109.682 176.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 146' ' ' TRP . 23.9 m-20 -139.86 118.45 12.28 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 124.279 0.987 . . . . 71.32 108.792 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . 0.26 4.4 pp -143.27 138.24 29.45 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.283 -1.367 . . . . 73.41 112.649 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.502 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 39.5 p90 -165.46 167.06 17.93 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.871 -1.059 . . . . 75.41 108.332 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.646 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 8.7 t -125.79 157.35 37.73 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.849 -1.167 . . . . 74.45 107.849 172.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.511 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 91.3 mt -67.33 154.13 42.05 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.835 0.709 . . . . 75.23 111.185 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.22 -164.58 21.89 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.342 -0.932 . . . . 71.22 114.16 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.9 -16.85 32.72 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.758 1.022 . . . . 75.2 113.758 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -106.29 1.55 26.01 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.625 0.726 . . . . 74.22 110.026 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 43.16 99.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.1 -0.8 . . . . 73.12 111.1 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 134' ' ' GLU . 8.8 tmtt? -141.15 147.16 37.99 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.231 -1.396 . . . . 75.03 107.231 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.538 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.72 106.55 18.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.795 0.807 . . . . 75.45 111.426 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.64 -178.85 24.97 Favored Glycine 0 C--N 1.291 -1.963 0 N-CA-C 110.722 -0.951 . . . . 70.0 110.722 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.89 127.09 8.81 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.468 -1.853 . . . . 70.45 108.468 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.46 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 53.3 m 179.28 -177.48 0.31 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.775 1.63 . . . . 74.02 107.507 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.96 -74.68 0.35 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.874 0.368 . . . . 63.34 110.638 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -94.0 -16.67 23.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.024 0.44 . . . . 65.25 111.086 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.99 3.95 53.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.56 0.695 . . . . 71.24 109.9 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.46 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -97.98 157.05 16.34 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 115.211 -0.904 . . . . 71.54 111.175 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.34 134.74 37.43 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.735 -1.209 . . . . 72.15 107.735 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -107.21 121.33 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 115.335 -0.848 . . . . 73.14 111.633 -175.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 126' ' ' TYR . . . -167.05 177.32 41.75 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 118.727 -1.702 . . . . 54.31 114.279 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.517 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -156.56 157.08 34.71 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.627 -0.786 . . . . 72.02 109.357 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.519 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 4.9 p90 -163.08 177.1 9.41 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.529 0.518 . . . . 75.2 111.204 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 122' ' ' PRO . 35.3 t70 -120.02 130.79 54.89 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.186 -1.783 . . . . 74.23 106.186 175.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 C--N 1.296 -1.728 0 O-C-N 124.387 1.054 . . . . 73.22 110.316 -174.861 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.45 ' H1 ' ' CB ' ' A' ' 48' ' ' THR . 2.0 mpt? . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 110.611 -0.144 . . . . 74.51 110.611 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -103.07 77.91 1.6 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.293 0.568 . . . . 74.25 112.342 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -155.43 158.93 32.03 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 107.203 -1.406 . . . . 72.12 107.203 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.92 143.93 69.8 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.277 1.985 . . . . 74.42 110.716 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 75.06 -52.25 0.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.85 1.26 . . . . 64.43 110.96 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 39' ' ' MET . 86.6 mt-30 -68.48 -17.96 64.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 75.24 110.601 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.42 -27.11 68.86 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.529 -0.759 . . . . 74.1 110.018 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.74 -25.04 24.9 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.523 -0.547 . . . . 72.21 109.523 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 92.3 t -74.09 -43.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.587 -0.733 . . . . 73.1 109.112 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.45 ' CB ' ' H1 ' ' A' ' 39' ' ' MET . 5.8 t -68.18 -29.84 68.81 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.056 -0.975 . . . . 75.33 111.504 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.0 t -76.36 -47.69 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.935 -0.395 . . . . 74.42 109.935 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.398 -0.819 . . . . 64.25 111.498 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 47.6 mtpt -67.4 -23.57 65.57 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.239 -0.584 . . . . 73.15 112.316 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.78 -37.68 38.74 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.896 -1.145 . . . . 73.11 110.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.54 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 m-20 -77.34 -24.16 50.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.426 -0.51 . . . . 75.45 111.813 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 51' ' ' LYS . 15.5 pt -72.69 -27.26 25.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.084 -0.646 . . . . 74.21 110.842 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 2.0 mptm? -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.49 -0.884 . . . . 73.45 109.58 173.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -65.53 -42.38 92.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.327 -0.851 . . . . 63.31 109.86 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 53' ' ' ASP . 73.7 mt -62.99 -34.29 65.57 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.655 -0.702 . . . . 64.23 110.111 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.03 -31.3 70.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.846 0.355 . . . . 75.11 110.766 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.51 42.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.261 0.553 . . . . 63.04 109.849 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.99 35.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.009 -0.541 . . . . 74.34 110.155 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -30.01 68.67 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.982 -1.488 . . . . 74.3 106.982 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 17.3 t70 -68.67 -29.01 67.38 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.111 -0.949 . . . . 72.44 109.963 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -71.99 -36.21 69.71 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.46 -0.496 . . . . 74.34 109.668 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -70.28 -38.03 74.96 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 107.794 -1.188 . . . . 75.34 107.794 174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 29.2 tttm -54.21 -35.89 62.9 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.646 -0.706 . . . . 71.33 110.661 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.37 -33.91 32.06 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.596 -0.274 . . . . 72.23 111.62 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.71 -24.25 62.61 Favored 'General case' 0 C--O 1.177 -2.76 0 CA-C-O 120.545 0.212 . . . . 74.11 111.1 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.521 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.9 OUTLIER -127.01 18.66 7.14 Favored 'General case' 0 CA--C 1.463 -2.401 0 O-C-N 120.778 -1.202 . . . . 71.53 111.428 177.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.19 32.44 0.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.066 1.346 . . . . 74.25 112.663 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.82 162.11 0.57 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.072 -1.455 . . . . 54.11 107.072 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -80.48 155.87 73.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 111.858 0.318 . . . . 75.44 111.858 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.451 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 31.8 Cg_endo -66.03 161.87 37.92 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.048 2.499 . . . . 74.33 110.64 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -97.85 156.61 16.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.301 -1.37 . . . . 71.33 107.301 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 t -66.61 -13.79 61.57 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 119.138 0.881 . . . . 74.44 110.94 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 -65.14 1.01 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.448 -0.342 . . . . 75.42 111.33 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -77.41 -33.88 54.88 Favored 'General case' 0 CA--C 1.481 -1.707 0 O-C-N 121.95 -0.468 . . . . 73.1 111.197 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.507 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -76.73 -20.9 75.75 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 118.881 -1.628 . . . . 73.13 112.554 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.78 -49.53 61.91 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 106.069 -1.826 . . . . 75.04 106.069 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.0 -33.59 73.49 Favored 'General case' 0 C--O 1.169 -3.174 0 CA-C-N 114.646 -1.161 . . . . 71.44 110.272 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -80.07 -5.37 55.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.802 0.668 . . . . 64.41 112.802 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 84.6 mt -96.42 -17.8 20.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.192 0.52 . . . . 75.01 109.858 173.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.53 -33.93 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.373 0.606 . . . . 74.23 111.441 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 83.8 tttt -122.67 148.79 44.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 126.357 1.863 . . . . 64.12 106.861 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -56.51 135.56 76.98 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 118.152 0.433 . . . . 74.45 111.157 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.47 150.75 87.71 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.825 3.017 . . . . 74.42 112.685 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -98.45 146.81 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.618 -0.433 . . . . 74.44 110.557 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.71 -146.39 18.55 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.932 -1.267 . . . . 64.54 109.932 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -126.72 86.43 58.61 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-O 121.663 0.744 . . . . 71.32 111.697 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 1.6 Cg_endo -82.17 154.76 16.84 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.975 2.45 . . . . 74.41 111.126 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.2 143.5 65.23 Favored Pre-proline 0 C--O 1.211 -0.927 0 C-N-CA 123.615 0.766 . . . . 63.11 110.087 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.65 100.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.178 3.252 . . . . 74.51 115.017 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -147.31 148.02 30.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.203 -1.777 . . . . 75.22 106.203 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.33 91.58 3.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.484 -0.562 . . . . 74.5 109.484 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.636 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.7 t90 -54.58 138.83 40.07 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 123.969 0.793 . . . . 74.41 111.514 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -126.72 134.4 50.67 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 114.966 -1.016 . . . . 72.13 109.965 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 24.1 pttm -90.95 -176.43 4.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.321 -0.552 . . . . 72.54 109.883 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 72.43 15.59 5.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.137 1.375 . . . . 74.1 109.958 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.39 5.17 28.4 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 114.709 -1.132 . . . . 72.54 114.769 170.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.636 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 67.84 93.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.276 1.036 . . . . 74.02 110.644 -175.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.7 tp -132.6 158.33 42.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.899 -1.046 . . . . 74.41 108.651 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -84.85 -171.76 3.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.419 -0.956 . . . . 72.43 108.419 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 70.62 4.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.599 1.19 . . . . 74.24 110.504 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.9 mt -126.83 147.65 62.04 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 114.694 -1.139 . . . . 73.13 109.442 -174.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.63 158.36 53.73 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.634 1.556 . . . . 74.32 109.663 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 111' ' ' PRO . 6.0 p -79.6 175.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.43 -0.581 . . . . 75.54 109.43 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 5.8 p-10 -71.38 158.19 88.48 Favored Pre-proline 0 C--O 1.249 1.062 0 N-CA-C 113.375 0.88 . . . . 74.32 113.375 -168.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.36 169.1 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.679 2.919 . . . . 71.01 112.06 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 64.13 15.27 9.18 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.842 1.257 . . . . 74.42 109.142 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.0 68.43 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 114.266 -1.334 . . . . 52.11 115.152 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.486 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 3.8 m-80 -91.78 154.18 43.8 Favored Pre-proline 0 C--O 1.262 1.733 0 CA-C-N 119.927 1.863 . . . . 74.22 109.04 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HA ' HG21 ' A' ' 105' ' ' VAL . 1.5 Cg_endo -85.73 152.08 10.08 Favored 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 121.801 1.667 . . . . 75.11 108.365 165.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 70.0 m-85 -69.16 143.96 53.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.907 0.384 . . . . 74.43 110.252 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 1.6 mm100 -101.47 120.86 40.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.48 -1.674 . . . . 72.22 106.48 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.38 118.93 37.95 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 73.15 112.693 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 89.2 mt -130.34 153.71 48.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.669 -0.863 . . . . 72.4 108.669 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.425 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -113.5 -177.8 0.47 Allowed Pre-proline 0 C--N 1.297 -1.71 0 CA-C-O 117.055 -1.45 . . . . 71.3 109.284 -176.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 19.0 Cg_endo -50.08 112.29 0.69 Allowed 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.956 2.437 . . . . 74.52 115.882 -166.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.59 -91.48 1.02 Allowed Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 113.731 -1.577 . . . . 70.43 110.81 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.3 m -106.93 96.81 6.7 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.207 -1.034 . . . . 71.14 108.207 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 68.47 -13.61 0.3 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.507 1.123 . . . . 74.24 113.734 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.683 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -102.95 116.64 5.53 Favored Glycine 0 CA--C 1.488 -1.628 0 CA-C-O 118.704 -1.053 . . . . 64.41 113.548 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 11.1 Cg_exo -37.85 -29.52 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.574 1 C-N-CA 126.857 5.038 . . . . 73.34 118.343 -179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -170.43 151.76 3.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.915 1.234 . . . . 71.3 113.856 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -113.65 106.66 14.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.703 1.601 . . . . 74.43 107.518 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.81 125.03 32.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.747 -0.781 . . . . 71.01 109.416 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.401 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 27.0 p90 -167.1 165.35 15.64 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 110.41 -0.218 . . . . 72.12 110.41 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.1 p -125.7 148.0 49.18 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.805 -0.813 . . . . 63.14 108.805 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.26 133.5 50.72 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.776 0.658 . . . . 74.13 112.776 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.95 173.18 31.8 Favored Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 111.202 -0.759 . . . . 74.54 111.202 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.21 -20.32 26.24 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 115.583 1.697 . . . . 74.42 115.583 -173.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.534 ' OD2' ' HE2' ' A' ' 133' ' ' LYS . 5.0 t70 -94.88 -0.99 53.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.722 0.773 . . . . 72.34 109.757 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.76 24.48 60.15 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 111.319 -0.713 . . . . 74.03 111.319 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.534 ' HE2' ' OD2' ' A' ' 131' ' ' ASP . 68.5 mttm -112.13 147.31 36.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.151 0.5 . . . . 74.22 111.771 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -100.71 102.33 13.41 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 102.751 -3.055 . . . . 75.25 102.751 165.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 -173.29 23.14 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.196 -1.366 . . . . 51.35 111.446 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.15 128.16 8.11 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 107.311 -2.316 . . . . 61.22 107.311 172.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.543 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 62.8 m -177.78 -179.04 0.75 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.022 1.329 . . . . 73.24 107.463 -171.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.62 -68.6 0.55 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.323 0.583 . . . . 62.43 110.156 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.48 -16.42 11.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.223 -0.899 . . . . 73.53 110.857 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -82.72 -9.92 59.14 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.244 -0.434 . . . . 70.01 110.762 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.543 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -86.96 155.13 20.31 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.211 -0.904 . . . . 74.22 110.849 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.88 136.16 36.61 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.869 -1.53 . . . . 75.1 106.869 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 143' ' ' ILE . 2.9 pp -97.84 130.86 45.96 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.66 -1.237 . . . . 60.35 107.66 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -143.26 153.25 24.68 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 118.712 -1.709 . . . . 64.42 114.294 -173.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -120.08 129.55 54.26 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.264 -2.125 . . . . 71.53 105.264 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -142.43 144.1 32.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.806 -0.813 . . . . 74.35 108.806 -168.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -130.47 115.13 16.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.97 -1.122 . . . . 75.2 107.97 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 107.34 -1.356 . . . . 55.4 107.34 179.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 109.378 -0.601 . . . . 64.34 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -92.4 62.02 3.91 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.906 0.706 . . . . 73.41 112.906 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -148.38 147.79 26.75 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 107.497 -1.297 . . . . 74.54 107.497 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.06 151.69 26.83 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.469 2.113 . . . . 73.43 109.835 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 76.76 -57.28 0.54 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.224 1.009 . . . . 72.23 109.389 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.79 -16.39 63.78 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.888 -0.508 . . . . 64.41 111.344 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 -25.89 67.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.872 -0.604 . . . . 61.3 109.386 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -83.49 -24.58 31.68 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 108.825 -0.806 . . . . 74.54 108.825 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.37 -43.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.82 -0.627 . . . . 75.24 110.233 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -66.43 -39.59 89.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.095 -0.502 . . . . 74.31 111.901 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.02 -34.79 51.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.786 0.327 . . . . 64.02 110.289 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.36 87.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.055 -0.521 . . . . 60.01 110.671 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 66.1 mttm -65.68 -25.6 67.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.357 0.598 . . . . 72.43 111.225 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 -32.31 35.5 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.762 -1.209 . . . . 74.33 110.538 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' ALA 0.354 70.4 m-20 -87.33 -20.62 26.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.268 1.21 . . . . 74.54 114.268 -175.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.416 HD13 ' C ' ' A' ' 144' ' ' GLY . 15.4 pt -71.64 -28.43 31.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.714 -0.847 . . . . 74.53 108.714 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.544 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -73.82 -27.03 60.9 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.844 -0.616 . . . . 75.42 110.565 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -62.5 -43.27 99.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.444 -0.798 . . . . 64.12 109.958 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 53' ' ' ASP . 27.3 mt -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.735 0 CA-C-N 115.232 -0.895 . . . . 73.11 109.681 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.69 -25.28 62.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.835 -0.62 . . . . 71.31 111.995 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.78 -35.12 20.92 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.196 0.522 . . . . 44.43 110.11 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 99' ' ' TYR . . . -80.58 -28.3 37.19 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.779 -0.368 . . . . 64.33 111.242 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.89 -26.85 64.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.883 -1.155 . . . . 72.32 107.883 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.3 t70 -69.09 -23.97 64.08 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.287 1.041 . . . . 65.04 109.232 173.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.417 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 51.1 ttm -78.76 -37.94 39.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.534 -0.757 . . . . 73.32 109.674 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.457 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 81.9 t80 -66.01 -38.12 87.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.063 -1.088 . . . . 75.54 108.063 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 75.9 tttt -54.54 -33.14 59.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.357 -1.292 . . . . 75.11 109.945 173.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 tp -83.13 -34.93 25.94 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.683 -0.407 . . . . 75.25 110.593 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.98 -25.61 62.78 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 120.901 0.381 . . . . 75.42 111.909 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.56 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -125.65 19.84 7.92 Favored 'General case' 0 CA--C 1.462 -2.427 0 O-C-N 121.068 -1.02 . . . . 65.51 110.949 175.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 p90 43.85 33.65 0.77 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 124.621 1.201 . . . . 73.23 113.549 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.85 160.36 1.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.739 -0.837 . . . . 75.54 108.739 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.54 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 27.6 m-85 -82.98 152.66 66.03 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.932 -0.396 . . . . 72.23 109.932 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.498 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.9 Cg_endo -63.82 164.73 20.67 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.972 3.114 . . . . 71.22 112.96 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.1 p -97.67 156.25 16.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 106.049 -1.834 . . . . 74.34 106.049 172.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.408 ' N ' ' HB1' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -66.15 -14.47 61.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.43 0.633 . . . . 75.14 110.566 -176.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.42 -66.19 0.94 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.385 -0.598 . . . . 71.35 109.385 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -79.66 -35.98 38.42 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 116.186 -0.461 . . . . 72.53 111.087 -173.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.574 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -76.77 -21.4 74.56 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 118.021 -2.037 . . . . 62.11 112.453 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.23 -46.85 66.37 Favored 'General case' 0 C--O 1.259 1.591 0 N-CA-C 106.491 -1.67 . . . . 73.31 106.491 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.8 mt-10 -60.37 -37.69 81.54 Favored 'General case' 0 C--O 1.171 -3.067 0 CA-C-N 114.603 -1.18 . . . . 72.11 109.401 174.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 85' ' ' PRO . . . -77.37 -3.26 39.22 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.862 0.689 . . . . 64.21 112.862 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 76.8 mt -95.18 -22.79 17.61 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.099 0.476 . . . . 72.34 110.168 173.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -107.78 -25.88 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.547 0.689 . . . . 74.14 111.222 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 85.0 tttt -127.03 147.39 50.14 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 126.432 1.893 . . . . 74.12 107.001 -175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -54.86 128.53 63.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.606 0.762 . . . . 75.12 111.78 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 37.1 Cg_endo -66.8 131.03 24.62 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.405 2.737 . . . . 74.23 111.701 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -94.68 -179.15 4.78 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.11 -0.7 . . . . 61.53 109.11 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.88 -125.12 8.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 108.207 -1.957 . . . . 74.41 108.207 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.8 80.21 14.2 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 118.093 0.946 . . . . 72.53 112.697 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.56 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 14.4 Cg_endo -82.94 142.54 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.205 1.936 . . . . 70.32 110.479 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -83.06 115.98 61.79 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 107.149 -1.426 . . . . 72.14 107.149 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.508 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 51.4 Cg_exo -51.18 98.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 123.409 2.74 . . . . 71.42 117.678 -168.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -111.19 148.93 31.71 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 101.995 -3.335 . . . . 72.45 101.995 163.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.54 99.6 0.11 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 120.108 -0.637 . . . . 71.04 109.736 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.595 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.2 t90 -62.16 141.88 57.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 124.42 1.088 . . . . 74.25 110.693 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.99 133.4 50.57 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.719 -0.673 . . . . 74.31 109.284 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -82.46 -176.92 6.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.15 0.5 . . . . 71.31 110.359 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.4 t70 71.36 15.71 6.22 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.498 1.119 . . . . 71.2 110.292 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 109.21 7.97 27.89 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.057 -0.974 . . . . 73.5 114.115 171.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.595 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 63.78 92.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.136 0.97 . . . . 71.05 109.139 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.514 HD21 ' N ' ' A' ' 101' ' ' LYS . 6.8 tt -138.21 168.01 20.64 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.978 -1.489 . . . . 72.21 106.978 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.514 ' N ' HD21 ' A' ' 100' ' ' LEU . 71.5 mmtt -72.44 179.8 3.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.216 -1.031 . . . . 72.22 108.216 176.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -80.41 77.21 7.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.172 0.987 . . . . 74.54 110.376 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.9 mt -131.41 149.89 74.86 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.806 -1.543 . . . . 75.24 108.394 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.49 -170.17 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.861 1.707 . . . . 73.45 111.035 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.598 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.5 p -83.93 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.705 -0.85 . . . . 65.03 108.705 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.547 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 t0 -75.38 156.79 85.24 Favored Pre-proline 0 C--O 1.251 1.175 0 N-CA-C 108.898 -0.778 . . . . 75.31 108.898 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.547 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 6.0 Cg_endo -49.15 170.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 123.689 2.926 . . . . 74.31 113.408 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.479 ' HB2' HD21 ' A' ' 110' ' ' ASN . 1.7 m-90 67.21 14.39 9.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.959 1.704 . . . . 74.42 110.467 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.87 22.8 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 115.467 -0.788 . . . . 71.11 114.25 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.479 HD21 ' HB2' ' A' ' 108' ' ' TRP . 56.7 m-80 -69.95 134.53 87.72 Favored Pre-proline 0 C--O 1.255 1.378 0 N-CA-C 113.319 0.859 . . . . 65.11 113.319 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.598 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.5 Cg_endo -71.51 154.12 60.36 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.429 2.086 . . . . 74.41 110.404 173.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -73.29 141.2 47.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.882 -1.525 . . . . 75.43 106.882 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.3 mm100 -102.89 113.83 27.6 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.417 -1.697 . . . . 63.51 106.417 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.57 120.02 40.05 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.72 -0.673 . . . . 71.21 112.518 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 97.5 mt -129.29 153.61 47.65 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.385 0.674 . . . . 74.35 109.246 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.418 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . . . -109.14 -179.1 0.63 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 117.104 -1.426 . . . . 74.01 108.364 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.723 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 25.0 Cg_endo -50.37 115.31 1.85 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.042 2.495 . . . . 72.43 116.785 -162.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.65 -90.17 2.14 Favored Glycine 0 N--CA 1.42 -2.407 0 CA-C-N 113.955 -1.475 . . . . 52.41 110.976 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.44 95.76 6.29 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.417 0.627 . . . . 73.12 111.836 -177.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 59.24 20.08 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.371 1.468 . . . . 71.13 112.763 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -134.88 115.52 1.42 Allowed Glycine 0 CA--C 1.479 -2.218 0 C-N-CA 119.154 -1.498 . . . . 65.13 113.248 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.512 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 11.8 Cg_exo -43.34 -24.67 0.61 Allowed 'Trans proline' 0 C--N 1.371 1.754 1 C-N-CA 126.052 4.502 . . . . 71.23 117.179 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -168.89 143.91 3.24 Favored 'General case' 0 C--O 1.254 1.308 0 CA-C-N 118.861 0.755 . . . . 74.12 112.18 173.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.3 m-20 -122.99 117.68 26.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.518 -1.29 . . . . 73.33 107.518 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 pp -145.42 140.03 27.32 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.742 -0.783 . . . . 63.44 111.671 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.462 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 45.8 p90 -166.23 167.88 15.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.295 -1.002 . . . . 74.54 108.295 -175.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.9 p -124.18 136.85 54.49 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.593 -0.891 . . . . 74.24 108.593 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.65 135.3 57.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.846 -0.742 . . . . 73.43 111.541 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.87 -172.2 9.74 Favored Glycine 0 CA--C 1.495 -1.173 0 CA-C-N 115.817 -0.629 . . . . 65.32 112.848 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.33 -7.81 10.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 114.101 1.148 . . . . 73.23 114.101 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.66 -7.05 41.91 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.091 -0.644 . . . . 74.2 110.149 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 22.16 76.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 121.124 -0.56 . . . . 73.24 111.764 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -140.53 143.51 35.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.625 -1.25 . . . . 74.35 107.625 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -81.66 108.93 15.62 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.712 0.767 . . . . 74.12 109.997 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.4 -173.94 20.41 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.265 -0.88 . . . . 70.15 111.526 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.62 128.11 8.31 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.735 -0.946 . . . . 71.03 110.735 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.512 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 19.4 m 178.17 -176.87 0.21 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 127.143 2.177 . . . . 72.44 105.962 -172.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -87.49 -58.36 2.61 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.931 -1.107 . . . . 75.4 110.827 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.71 -28.81 13.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.638 0.732 . . . . 75.14 111.408 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.95 9.17 23.11 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.761 -0.587 . . . . 73.51 111.753 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.512 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -99.29 155.75 17.35 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 115.845 -0.616 . . . . 62.34 110.782 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -80.47 125.6 30.15 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.174 -1.417 . . . . 73.15 107.174 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 2.6 pp -106.71 141.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.508 -0.923 . . . . 73.23 108.508 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.416 ' C ' HD13 ' A' ' 54' ' ' ILE . . . -173.78 170.85 44.01 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 118.212 -1.946 . . . . 71.24 114.41 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -113.72 137.26 51.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.847 -1.538 . . . . 74.2 106.847 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -141.79 124.53 15.99 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.562 . . . . 64.33 106.781 -170.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -102.73 114.2 28.24 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.053 -1.091 . . . . 71.23 108.053 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.3 p30 . . . . . 0 C--N 1.294 -1.814 0 N-CA-C 107.759 -1.2 . . . . 73.53 107.759 -178.881 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.459 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 1.2 mpt? . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.257 -0.645 . . . . 74.33 109.257 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.7 m -100.03 86.09 3.18 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.597 0.713 . . . . 74.33 112.077 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -148.14 163.6 26.06 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 106.35 -1.722 . . . . 73.15 106.35 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 44' ' ' GLN . 71.0 Cg_exo -52.88 130.14 36.18 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.681 2.254 . . . . 70.52 111.374 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.55 -34.21 0.28 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 126.004 1.721 . . . . 63.23 111.008 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 42' ' ' PRO . 15.8 mm100 -68.29 -20.49 64.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 75.1 109.37 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.53 -29.46 70.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.315 -0.857 . . . . 62.35 110.073 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -80.62 -26.55 37.68 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 108.108 -1.071 . . . . 75.54 108.108 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.3 t -75.35 -43.6 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.572 -0.74 . . . . 74.44 110.299 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 39' ' ' MET . 7.1 t -67.93 -37.05 81.18 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.584 -0.735 . . . . 73.34 111.309 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.87 -34.26 32.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 110.127 -0.323 . . . . 74.43 110.127 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.755 -0.657 . . . . 71.43 110.616 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 70.9 mmtt -65.28 -26.31 68.02 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.421 0.629 . . . . 74.25 111.05 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.29 -32.48 19.81 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.536 -1.025 . . . . 73.1 110.536 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.642 ' O ' HG13 ' A' ' 57' ' ' ILE . 70.1 m-20 -77.11 -33.58 56.88 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 120.917 -0.313 . . . . 72.43 111.465 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 pt -67.73 -29.74 46.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.701 -0.4 . . . . 72.32 110.313 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -73.23 -30.17 63.3 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.212 -0.662 . . . . 73.41 109.212 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 53' ' ' ASP . . . -64.43 -40.58 96.01 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.052 -0.976 . . . . 74.01 109.991 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 53' ' ' ASP . 28.8 mt -66.28 -40.18 86.16 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.628 0 CA-C-N 115.103 -0.953 . . . . 74.22 109.71 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.03 66.8 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.29 -0.413 . . . . 74.23 111.447 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.03 -29.69 26.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.154 0.502 . . . . 74.51 110.319 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.31 -28.13 23.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.078 0.466 . . . . 72.4 110.975 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.99 -28.29 65.4 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.812 -1.551 . . . . 72.44 106.812 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.9 t70 -70.06 -24.16 63.2 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.598 -1.183 . . . . 74.22 108.75 172.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.7 mmt -79.93 -34.73 38.64 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.468 -0.787 . . . . 73.31 110.216 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 49.0 t80 -67.69 -31.7 71.84 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 107.103 -1.443 . . . . 75.14 107.103 171.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 56.9 tttp -57.92 -32.5 67.82 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.654 -0.703 . . . . 75.54 110.326 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -77.01 -36.11 56.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.148 0.499 . . . . 72.41 110.206 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -71.06 -25.44 62.63 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-N 115.7 -0.682 . . . . 74.33 110.856 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.5 18.41 5.29 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.924 -0.56 . . . . 72.23 110.27 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 p90 42.89 31.35 0.31 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.014 1.326 . . . . 53.21 113.253 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.44 162.5 0.52 Allowed 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.516 -1.29 . . . . 71.12 107.516 -172.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 21.2 m-85 -78.63 151.63 77.32 Favored Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 120.305 -0.558 . . . . 74.55 111.31 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.466 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 14.1 Cg_endo -59.76 170.55 3.45 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 124.307 3.338 . . . . 74.32 112.725 177.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.43 ' C ' ' HB1' ' A' ' 116' ' ' ALA . 77.7 p -101.82 155.66 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.492 -1.67 . . . . 74.15 106.492 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.55 -15.07 62.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 119.796 1.18 . . . . 65.24 111.814 -173.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.48 -63.74 1.1 Allowed 'General case' 0 C--O 1.241 0.619 0 CA-C-N 116.311 -0.404 . . . . 72.31 110.886 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 48.8 mt-30 -76.08 -38.53 56.92 Favored 'General case' 0 CA--C 1.484 -1.584 0 C-N-CA 120.889 -0.325 . . . . 75.32 110.646 -174.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 72' ' ' PRO . . . -71.31 -21.23 78.56 Favored Glycine 0 N--CA 1.418 -2.512 0 C-N-CA 119.101 -1.523 . . . . 72.54 112.83 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.54 -45.5 75.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.728 -1.582 . . . . 75.05 106.728 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.6 mt-10 -79.88 -2.83 45.37 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.842 -1.072 . . . . 72.31 111.077 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.452 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -99.8 -8.16 24.53 Favored 'General case' 0 C--O 1.204 -1.33 0 CA-C-O 121.677 0.751 . . . . 74.04 109.326 174.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 77' ' ' GLY . 5.4 mp -98.52 -24.25 15.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.481 -0.781 . . . . 72.21 110.026 174.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.92 -27.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.913 -0.585 . . . . 63.01 111.129 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 87.8 tttt -130.04 151.49 50.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.558 -1.645 . . . . 63.34 106.558 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -53.55 135.08 53.77 Favored Pre-proline 0 N--CA 1.485 1.308 0 CA-C-N 118.7 0.682 . . . . 75.02 110.94 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 7.2 Cg_endo -47.99 130.05 19.18 Favored 'Trans proline' 0 C--O 1.246 0.885 1 C-N-CA 125.357 4.038 . . . . 75.35 116.355 -170.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -82.19 148.97 28.16 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.183 -1.414 . . . . 72.24 107.183 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.66 -157.28 22.29 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 109.634 -1.386 . . . . 41.12 109.634 -176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.43 99.69 29.69 Favored Pre-proline 1 N--CA 1.369 -4.521 0 CA-C-N 117.68 0.74 . . . . 74.43 110.195 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -95.41 162.64 1.54 Allowed 'Trans proline' 0 N--CA 1.443 -1.493 0 C-N-CA 122.126 1.884 . . . . 75.24 109.756 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -82.8 159.18 63.92 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.432 . . . . 75.5 109.835 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.35 99.9 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.904 1.736 . . . . 75.21 111.315 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -150.51 146.07 26.38 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.485 -1.302 . . . . 73.45 107.485 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.64 89.52 1.32 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 120.733 0.301 . . . . 73.32 111.088 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.455 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 88.7 t90 -54.91 139.48 40.27 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.954 -1.021 . . . . 74.31 111.733 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.43 130.01 56.69 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.788 -1.096 . . . . 75.54 108.961 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -74.38 177.62 5.79 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.933 0.873 . . . . 73.01 110.801 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 62.24 36.11 14.98 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.345 -1.752 . . . . 74.24 109.398 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.55 7.73 63.03 Favored Glycine 0 CA--C 1.488 -1.611 0 CA-C-N 113.749 -1.569 . . . . 63.41 115.224 165.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 63.12 85.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.253 1.025 . . . . 72.4 108.649 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.1 tt -138.8 155.63 48.01 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.517 -1.66 . . . . 74.32 106.517 -173.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -63.53 141.5 58.74 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.799 -1.186 . . . . 74.3 107.799 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -74.0 79.09 1.69 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.039 0.923 . . . . 74.21 112.323 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -130.35 149.21 72.71 Favored Pre-proline 0 C--N 1.288 -2.094 0 CA-C-N 113.773 -1.558 . . . . 74.2 108.061 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 171.82 1.21 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.792 2.328 . . . . 73.23 111.873 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.6 p -79.21 171.78 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.547 0 CA-C-N 116.342 -0.39 . . . . 71.42 110.082 -173.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.486 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.2 t70 -82.76 153.89 67.76 Favored Pre-proline 0 C--O 1.256 1.423 0 C-N-CA 119.579 -0.848 . . . . 71.32 109.67 -169.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 10.3 Cg_exo -42.81 171.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.867 3.044 . . . . 73.35 115.051 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.424 ' CG ' ' HA ' ' A' ' 130' ' ' ALA . 2.7 m-90 70.15 14.17 7.7 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.484 2.313 . . . . 74.04 109.175 -175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.15 19.09 56.63 Favored Glycine 0 N--CA 1.466 0.635 0 CA-C-N 114.967 -1.015 . . . . 65.03 113.176 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.05 128.26 65.97 Favored Pre-proline 0 C--O 1.27 2.139 0 CA-C-O 121.526 0.679 . . . . 73.25 111.84 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.546 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 73.7 Cg_endo -80.46 154.2 21.1 Favored 'Trans proline' 0 N--CA 1.419 -2.888 0 C-N-CA 122.264 1.976 . . . . 75.15 110.302 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 46.7 m-85 -80.75 139.49 36.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.823 -1.177 . . . . 72.43 107.823 172.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.51 ' OE1' HD12 ' A' ' 128' ' ' LEU . 1.2 mm100 -103.98 118.45 36.7 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.327 -1.36 . . . . 72.55 107.327 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -103.82 117.66 34.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.893 -1.151 . . . . 71.43 107.893 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.0 mt -129.57 153.42 48.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.413 -0.958 . . . . 72.31 108.413 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.488 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -109.56 179.63 0.81 Allowed Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-O 117.001 -1.475 . . . . 74.21 108.351 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 116' ' ' ALA . 9.1 Cg_endo -48.46 109.67 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.565 2.844 . . . . 71.52 114.796 -168.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -145.65 -63.99 0.01 OUTLIER Glycine 0 N--CA 1.405 -3.373 0 C-N-CA 119.563 -1.303 . . . . 65.34 112.449 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 11.4 m -83.85 104.98 14.38 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 108.399 -0.963 . . . . 72.42 108.399 -177.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 119' ' ' THR . 55.2 pttt 66.42 -26.26 0.11 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 127.51 2.324 . . . . 73.33 115.93 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -161.13 176.73 37.68 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 117.564 -2.255 . . . . 74.13 117.952 -173.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 7.2 Cg_exo -31.25 -26.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.502 1 C-N-CA 129.208 6.605 . . . . 74.31 119.505 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.285 47.6 p90 -169.9 149.03 3.61 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 119.717 1.144 . . . . 72.43 112.912 170.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.0 OUTLIER -112.66 106.29 14.65 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.483 -1.303 . . . . 73.12 107.483 -176.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.4 tm? -128.46 128.08 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.202 -0.936 . . . . 73.51 110.254 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -166.57 164.33 17.0 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 120.855 -0.338 . . . . 74.33 111.862 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.455 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 23.0 t -125.07 141.71 51.95 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.882 -2.266 . . . . 74.25 104.882 171.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 113' ' ' GLN . 5.3 mp -59.56 155.0 16.2 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.789 1.033 . . . . 72.41 113.789 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.7 172.85 53.79 Favored Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 115.561 -0.745 . . . . 70.02 112.292 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.424 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -47.52 -28.47 2.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 116.79 2.144 . . . . 62.32 116.79 -173.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.33 -2.06 52.8 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.837 0.744 . . . . 72.21 111.27 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.42 24.75 27.82 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.986 -0.626 . . . . 71.35 112.082 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -140.89 146.32 37.31 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.412 -0.588 . . . . 75.21 109.412 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -81.88 117.85 22.47 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 120.825 0.345 . . . . 64.32 110.777 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -149.47 -174.23 20.71 Favored Glycine 0 C--N 1.317 -0.497 0 N-CA-C 110.441 -1.064 . . . . 43.41 110.441 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.91 128.14 8.6 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 109.791 -1.324 . . . . 73.14 109.791 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 140' ' ' ASP . 23.2 t 178.02 -176.65 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.384 -0.969 . . . . 73.24 108.384 -171.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.41 -71.11 0.36 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.116 -0.698 . . . . 74.11 109.116 172.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -98.76 -17.06 18.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.303 0.573 . . . . 71.02 111.525 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 15.1 m-20 -91.67 9.24 33.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.683 0.754 . . . . 73.11 110.763 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -92.54 152.87 19.4 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.591 -0.731 . . . . 70.31 110.31 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.79 119.39 21.93 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.931 -1.877 . . . . 70.41 105.931 171.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.35 128.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 115.754 -0.657 . . . . 73.11 109.936 -174.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.13 -179.8 38.56 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 118.463 -1.827 . . . . 75.5 113.31 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 7.2 t30 -123.73 147.88 47.09 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 105.725 -1.954 . . . . 73.33 105.725 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -142.88 135.92 28.15 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.75 -1.204 . . . . 75.44 107.75 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.9 106.58 13.97 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.176 -1.009 . . . . 73.15 108.484 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.465 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 2.6 t-20 . . . . . 0 N--CA 1.419 -1.988 0 N-CA-C 107.087 -1.449 . . . . 73.32 107.087 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.7 ttt . . . . . 0 C--O 1.217 -0.65 0 N-CA-C 107.724 -1.213 . . . . 73.14 107.724 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -110.22 89.41 3.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.024 0.916 . . . . 64.45 110.426 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -155.89 161.29 29.79 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.191 -1.781 . . . . 72.03 106.191 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.02 120.53 0.54 Allowed 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 124.057 3.171 . . . . 74.34 114.68 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t0 74.36 -35.79 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 126.81 2.044 . . . . 64.14 112.186 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HA ' HG21 ' A' ' 47' ' ' VAL . 84.6 mm-40 -68.76 -24.39 64.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.504 0.668 . . . . 72.45 109.528 176.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.502 ' O ' HG11 ' A' ' 49' ' ' VAL . . . -62.11 -29.17 70.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.035 -0.984 . . . . 70.02 109.329 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.8 -23.73 39.05 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.118 -0.492 . . . . 74.33 110.249 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 44' ' ' GLN . 40.2 t -74.59 -44.01 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.189 -1.041 . . . . 74.44 108.189 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.6 t -67.96 -34.2 76.11 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.52 -0.763 . . . . 73.34 111.525 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 45' ' ' ALA . 19.8 m -69.22 -43.3 81.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 C-N-CA 119.434 -0.906 . . . . 74.13 109.566 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.74 91.01 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.128 0.971 . . . . 75.44 110.958 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 58.7 mtpt -66.6 -21.89 66.13 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.635 -0.711 . . . . 74.43 111.925 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.27 -31.71 18.86 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 110.105 -1.198 . . . . 73.53 110.105 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -70.42 -39.33 74.49 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.331 0.586 . . . . 75.53 110.622 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.6 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 17.6 pt -70.23 -25.5 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.942 -0.572 . . . . 71.45 110.673 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -68.41 -31.87 71.51 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.735 -0.839 . . . . 72.41 108.735 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -29.3 64.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.272 -0.876 . . . . 63.24 109.78 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 18.1 mm -59.88 -48.3 88.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 CA-C-N 115.03 -0.987 . . . . 74.32 108.731 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.421 ' HB1' HD22 ' A' ' 145' ' ' ASN . . . -58.22 -34.01 69.95 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.854 0.359 . . . . 63.21 111.314 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.53 -42.54 67.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.736 -0.665 . . . . 75.41 111.037 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.41 24.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.464 0.542 . . . . 64.43 112.464 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.31 -30.11 69.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.166 -1.42 . . . . 74.42 107.166 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.5 t70 -69.88 -27.61 64.96 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.289 1.042 . . . . 73.33 109.601 173.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 63.3 mtt -78.34 -30.21 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.707 -0.679 . . . . 74.53 110.331 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -71.3 -36.22 71.56 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.017 -1.105 . . . . 72.21 108.017 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 51.9 tttp -55.17 -31.59 61.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.316 -0.856 . . . . 73.44 109.93 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.93 -31.05 23.84 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.291 -0.868 . . . . 75.32 110.806 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.46 -27.12 56.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.925 0.393 . . . . 74.23 111.333 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.47 24.16 5.13 Favored 'General case' 0 CA--C 1.46 -2.513 0 N-CA-C 109.479 -0.563 . . . . 74.4 109.479 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.3 p90 43.26 33.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.417 1.087 . . . . 72.45 113.824 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 179.87 160.09 0.82 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.125 -0.694 . . . . 72.3 109.125 -173.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.509 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 24.4 m-85 -81.23 150.91 68.86 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 123.451 0.469 . . . . 75.1 110.131 171.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.546 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.8 Cg_endo -65.01 170.09 10.91 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.607 2.871 . . . . 74.42 113.255 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.3 p -110.01 153.98 23.82 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.196 -1.779 . . . . 74.45 106.196 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.412 ' N ' ' HB2' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -59.59 -20.98 59.62 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.433 0.635 . . . . 72.21 111.933 -178.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -98.38 -65.95 0.93 Allowed 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 122.055 -0.403 . . . . 73.14 111.313 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -75.99 -37.32 58.64 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 116.604 -0.271 . . . . 75.22 111.287 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.546 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -78.53 -21.41 69.5 Favored Glycine 0 N--CA 1.413 -2.865 0 C-N-CA 118.372 -1.871 . . . . 75.52 112.83 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.92 -44.64 65.74 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 106.324 -1.732 . . . . 72.11 106.324 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 10.1 mm-40 -60.47 -41.34 93.97 Favored 'General case' 0 C--O 1.162 -3.526 0 CA-C-N 114.7 -1.136 . . . . 65.53 109.828 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.55 1.37 19.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.942 0.719 . . . . 64.51 112.942 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 63.5 mt -101.64 -20.97 14.8 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.229 -0.295 . . . . 73.05 111.008 172.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.3 t -111.04 -26.42 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-O 121.822 0.82 . . . . 74.41 111.026 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 38.3 ttmt -122.87 146.65 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 126.972 2.109 . . . . 72.32 105.83 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.419 ' HG3' ' CE3' ' A' ' 94' ' ' TRP . 3.8 mppt? -55.95 141.86 66.27 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 118.517 0.599 . . . . 72.2 111.501 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.77 122.35 10.87 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 123.063 2.508 . . . . 74.31 112.397 -172.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.3 p -71.26 140.66 50.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.335 -1.302 . . . . 71.15 111.132 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.12 -116.55 5.61 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.54 -1.024 . . . . 75.11 110.54 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.24 92.53 7.48 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 112.872 0.693 . . . . 73.34 112.872 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.73 162.38 14.27 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.739 1.626 . . . . 73.33 107.954 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -74.87 158.97 84.03 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-O 118.608 -0.71 . . . . 75.24 109.392 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.42 98.3 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 121.56 1.507 . . . . 70.53 110.625 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 10.1 tmtt? -152.77 144.18 23.31 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.183 -1.784 . . . . 75.43 106.183 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.503 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 33.5 m-80 -78.7 94.76 5.14 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 118.239 0.472 . . . . 71.43 111.315 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.432 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.5 t90 -57.65 144.17 38.69 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.037 1.335 . . . . 75.21 112.519 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 2.5 t-20 -120.93 135.16 55.27 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.806 -1.088 . . . . 73.22 108.984 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -84.06 -174.3 5.2 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.435 -0.58 . . . . 75.41 109.435 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 58.91 34.64 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 114.241 1.2 . . . . 74.24 114.241 176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 89.87 6.55 69.59 Favored Glycine 0 CA--C 1.487 -1.717 0 CA-C-N 115.344 -0.844 . . . . 72.21 114.358 168.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.432 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.5 OUTLIER 66.18 91.9 0.08 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.311 1.053 . . . . 71.53 111.301 -176.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.3 tp -138.28 170.97 15.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.618 -1.173 . . . . 74.0 108.174 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.87 -165.54 1.22 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.729 -0.607 . . . . 74.24 109.617 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 39.83 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.893 0.854 . . . . 75.33 112.272 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.8 mt -102.13 148.59 35.59 Favored Pre-proline 0 C--N 1.294 -1.844 0 C-N-CA 124.328 1.051 . . . . 73.1 110.2 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.85 -166.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.908 3.072 . . . . 72.02 112.229 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.464 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 3.6 p -85.01 172.04 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 107.353 -1.351 . . . . 71.13 107.353 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.591 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -80.21 155.98 74.3 Favored Pre-proline 0 C--O 1.256 1.415 0 C-N-CA 119.723 -0.791 . . . . 74.32 109.847 -172.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 11.2 Cg_endo -54.3 171.54 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.562 2.842 . . . . 74.03 113.298 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.57 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 65.57 15.76 10.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.909 1.684 . . . . 71.13 109.738 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.63 29.76 75.86 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.921 -1.036 . . . . 74.34 113.926 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.57 ' ND2' ' HB2' ' A' ' 108' ' ' TRP . 58.1 m-80 -93.11 119.82 67.36 Favored Pre-proline 0 C--O 1.249 1.056 0 CA-C-N 117.672 0.736 . . . . 75.33 110.802 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.464 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 46.3 Cg_exo -62.91 143.12 90.77 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 121.955 1.77 . . . . 74.42 108.824 168.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -69.18 144.4 53.79 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.149 0.5 . . . . 75.02 110.332 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.644 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -102.62 114.77 29.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.403 -1.703 . . . . 74.13 106.403 -178.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.13 117.3 34.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.395 -1.335 . . . . 74.41 107.395 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.1 mt -129.67 154.02 47.56 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.239 0.542 . . . . 74.4 109.808 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -112.78 -178.63 0.54 Allowed Pre-proline 0 N--CA 1.401 -2.884 0 CA-C-O 116.109 -1.9 . . . . 54.44 106.959 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 9.5 Cg_endo -40.26 109.67 0.1 Allowed 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 123.146 2.564 . . . . 72.32 115.191 -164.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.73 -89.55 0.69 Allowed Glycine 0 N--CA 1.42 -2.42 0 CA-C-N 114.025 -1.443 . . . . 75.13 111.342 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 m -112.68 96.06 5.77 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.008 -0.738 . . . . 65.51 109.008 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 66.67 9.69 6.86 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.146 0.795 . . . . 72.34 113.146 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -126.59 132.15 7.61 Favored Glycine 0 CA--C 1.486 -1.723 0 CA-C-O 118.553 -1.137 . . . . 73.24 113.058 -176.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 34.9 Cg_exo -36.61 -29.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 1 C-N-CA 126.637 4.892 . . . . 74.32 118.352 -178.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.515 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 46.4 p90 -172.17 168.27 5.76 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.102 0.865 . . . . 73.52 111.247 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.6 106.33 5.63 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.835 0.854 . . . . 75.33 109.145 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.427 ' HG ' ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -125.48 127.31 46.28 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.579 -0.896 . . . . 73.13 108.579 -178.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.545 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 30.0 p90 -166.61 169.42 13.65 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.252 -0.579 . . . . 71.14 112.301 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.2 t -125.02 149.27 47.93 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.681 -1.229 . . . . 72.4 107.681 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.644 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 82.1 mt -69.16 154.6 41.78 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 110.355 -0.239 . . . . 73.12 110.355 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.36 -174.76 24.8 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 121.449 -0.405 . . . . 62.23 113.87 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -55.15 -24.37 26.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.906 1.446 . . . . 72.14 114.906 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -93.85 -6.04 46.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.21 -0.596 . . . . 74.51 110.946 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.4 ' O ' HD11 ' A' ' 128' ' ' LEU . . . 91.17 19.18 43.39 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.608 -0.806 . . . . 64.12 113.086 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -140.79 148.62 40.92 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.326 -0.62 . . . . 74.1 109.326 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.36 122.57 23.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.111 0.481 . . . . 74.45 110.55 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.62 -175.06 22.27 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 110.369 -1.092 . . . . 72.31 110.369 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -115.19 127.34 7.59 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 108.102 -1.999 . . . . 64.41 108.102 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 69.3 m 179.66 -177.15 0.33 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.617 1.167 . . . . 72.44 108.22 -169.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.94 -67.65 0.74 Allowed 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.95 0.156 . . . . 75.25 110.692 170.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.19 -21.34 17.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.137 0.494 . . . . 75.4 111.609 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -93.21 15.07 16.26 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.153 0.501 . . . . 75.01 111.077 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . -91.68 155.86 18.0 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 115.995 -0.548 . . . . 64.11 111.164 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.44 127.86 32.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.235 -1.765 . . . . 73.51 106.235 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.498 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -96.96 121.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 108.333 -0.988 . . . . 63.54 108.333 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -142.26 152.54 23.77 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.188 -1.482 . . . . 71.4 114.796 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 54' ' ' ILE . 3.6 t30 -130.25 120.08 23.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.536 -1.283 . . . . 63.11 107.536 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.515 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 2.5 p90 -160.24 177.57 10.51 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.722 0.772 . . . . 75.03 111.945 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.34 117.44 26.96 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 106.377 -1.712 . . . . 74.53 106.377 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 C--N 1.298 -1.641 0 N-CA-C 106.966 -1.494 . . . . 71.23 106.966 -176.908 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 108.444 -0.947 . . . . 72.1 108.444 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 m -121.64 80.12 1.64 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.361 0.6 . . . . 75.0 111.749 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -149.82 161.17 32.18 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.937 -1.875 . . . . 72.14 105.937 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -45.71 128.78 11.17 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.032 2.488 . . . . 71.23 112.088 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.266 20.6 m-20 75.99 -41.33 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.281 1.432 . . . . 64.2 113.705 -176.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.55 -23.03 64.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.265 0.555 . . . . 74.23 110.113 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.51 65.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.084 -0.962 . . . . 65.21 110.512 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -88.35 -26.56 22.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.212 -1.033 . . . . 73.41 108.212 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 39.1 t -75.71 -40.76 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.076 -0.966 . . . . 65.11 109.948 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -63.48 -29.55 70.81 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.487 -0.779 . . . . 74.22 110.861 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -73.63 -44.85 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 108.357 -0.979 . . . . 74.11 108.357 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB1' HD11 ' A' ' 143' ' ' ILE . . . -58.47 -42.33 87.25 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.937 -1.029 . . . . 74.45 111.532 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -66.7 -25.07 66.35 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 121.331 0.586 . . . . 74.41 111.944 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.81 -22.86 34.82 Favored Glycine 0 C--N 1.31 -0.889 0 N-CA-C 110.447 -1.061 . . . . 55.24 110.447 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 15.4 t70 -82.25 -38.33 24.62 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.296 -0.631 . . . . 74.45 109.296 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 pt -65.53 -34.56 71.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.231 -0.655 . . . . 74.33 109.231 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -66.98 -28.04 67.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.783 -0.451 . . . . 73.23 109.783 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 53' ' ' ASP . . . -65.82 -44.04 86.81 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.334 -0.617 . . . . 74.41 109.334 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.83 -38.94 84.01 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.238 -0.892 . . . . 74.22 109.863 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.4 ' HB1' ' OD1' ' A' ' 145' ' ' ASN . . . -59.62 -26.38 65.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.073 0.463 . . . . 72.15 111.573 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.7 -33.2 18.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.091 0.472 . . . . 75.41 110.204 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.501 ' HA ' ' SD ' ' A' ' 63' ' ' MET . . . -84.36 -26.83 28.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.033 -0.531 . . . . 74.21 111.898 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.1 -25.39 62.58 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.003 -1.48 . . . . 75.54 107.003 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 28.7 t70 -75.4 -20.1 59.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.827 -1.079 . . . . 72.51 109.193 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.501 ' SD ' ' HA ' ' A' ' 60' ' ' ALA . 72.3 mtp -81.29 -29.72 34.21 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.378 -0.828 . . . . 74.41 109.538 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.18 -39.36 71.89 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 106.246 -1.761 . . . . 73.11 106.246 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 32.8 tttm -56.26 -26.55 52.05 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.178 -0.919 . . . . 64.32 110.175 173.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.22 -36.58 19.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.853 -0.612 . . . . 70.45 110.418 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.473 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.8 t70 -74.23 -25.94 59.95 Favored 'General case' 0 C--O 1.209 -1.054 0 O-C-N 122.281 -0.262 . . . . 73.34 111.318 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.598 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -127.02 20.39 6.95 Favored 'General case' 0 CA--C 1.456 -2.668 0 CA-C-O 118.75 -0.643 . . . . 74.11 111.209 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 43.07 32.15 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.733 1.271 . . . . 75.11 113.191 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.95 161.44 0.56 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.776 -1.194 . . . . 73.12 107.776 -172.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 12.6 m-85 -76.93 157.15 81.97 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 123.361 0.413 . . . . 74.33 111.923 174.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 6.9 Cg_exo -72.86 170.41 19.73 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.838 2.358 . . . . 61.31 111.334 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 p -104.28 156.27 18.05 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.05 -1.463 . . . . 75.22 107.05 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -12.3 61.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 119.711 1.141 . . . . 62.53 110.492 -175.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -100.85 -65.09 0.99 Allowed 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.865 -0.607 . . . . 64.43 110.581 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -75.79 -39.55 56.73 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 120.548 -0.461 . . . . 74.34 110.133 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -73.83 -21.38 79.33 Favored Glycine 0 N--CA 1.415 -2.765 0 C-N-CA 119.091 -1.528 . . . . 74.03 113.785 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.65 -46.86 44.05 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 107.625 -1.25 . . . . 64.13 107.625 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.09 -29.99 70.7 Favored 'General case' 0 C--O 1.183 -2.41 0 CA-C-N 114.955 -1.021 . . . . 74.13 110.119 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -86.03 -0.27 55.12 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.488 0.493 . . . . 74.51 112.252 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 65.9 mt -97.01 -21.47 17.39 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.404 0.621 . . . . 74.4 110.058 172.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.79 -30.67 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 121.575 0.702 . . . . 74.42 110.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 99.2 mttt -125.35 151.49 46.02 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 125.942 1.697 . . . . 71.03 107.436 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -54.27 142.16 49.64 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 112.755 0.65 . . . . 63.53 112.755 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HA ' ' HB1' ' A' ' 80' ' ' ALA . 6.7 Cg_endo -45.42 131.64 12.13 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.961 3.774 . . . . 71.33 114.96 -175.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -95.07 -1.49 52.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.939 -1.028 . . . . 74.25 110.032 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.99 11.74 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.258 -0.883 . . . . 73.11 111.586 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -126.7 86.08 59.3 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-O 121.555 0.693 . . . . 74.2 110.642 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.598 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 88.4 Cg_endo -91.35 161.82 3.68 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.585 2.19 . . . . 73.33 112.911 -176.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.06 134.96 20.52 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.471 -0.937 . . . . 74.45 108.471 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -35.78 100.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 125.219 3.946 . . . . 74.14 115.014 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.85 147.3 27.08 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.018 -1.845 . . . . 74.13 106.018 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.523 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 3.7 m-20 -70.28 101.4 1.9 Allowed 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.501 0.667 . . . . 70.31 111.726 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.46 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 85.2 t90 -67.46 145.05 55.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.783 -1.099 . . . . 63.15 110.892 175.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -131.18 134.56 46.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.923 -0.769 . . . . 71.45 108.923 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -82.25 -165.84 1.11 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.486 -1.302 . . . . 75.24 107.486 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 66.15 19.05 11.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.533 1.158 . . . . 75.22 109.139 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 85.08 17.25 63.31 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.43 -1.259 . . . . 74.44 113.214 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.3 m-85 64.37 90.06 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.325 1.06 . . . . 75.4 110.602 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.3 tp -138.49 169.28 18.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.963 -1.125 . . . . 73.1 107.963 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -86.69 -171.94 3.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.948 -1.131 . . . . 71.22 107.948 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 70.05 2.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.661 1.22 . . . . 74.4 110.849 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -130.41 147.83 67.45 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.197 -1.365 . . . . 74.0 108.314 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.84 -168.98 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.835 2.357 . . . . 75.14 112.001 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 111' ' ' PRO . 4.7 p -88.45 174.64 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 107.847 -1.168 . . . . 73.33 107.847 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.448 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 9.4 t70 -78.7 152.67 77.95 Favored Pre-proline 0 C--O 1.256 1.444 0 CA-C-N 119.255 0.934 . . . . 62.3 110.359 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 90.0 Cg_exo -49.76 172.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.573 2.849 . . . . 73.34 114.162 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 68.88 14.43 8.9 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.746 2.018 . . . . 74.34 109.026 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.9 33.33 78.12 Favored Glycine 0 C--N 1.32 -0.325 0 CA-C-N 114.83 -1.077 . . . . 63.12 112.628 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -93.72 131.99 30.9 Favored Pre-proline 0 C--O 1.258 1.506 0 N-CA-C 111.934 0.346 . . . . 71.45 111.934 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.436 ' HA ' HG23 ' A' ' 105' ' ' VAL . 66.6 Cg_endo -78.32 151.09 26.05 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 122.264 1.976 . . . . 74.24 110.362 174.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 8.6 m-85 -78.51 142.39 37.47 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.789 0.328 . . . . 72.1 110.309 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.566 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -104.52 113.82 27.63 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 106.45 -1.685 . . . . 75.41 106.45 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.5 118.0 35.14 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.113 -1.81 . . . . 74.23 106.113 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 91.2 mt -129.35 145.4 51.39 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.188 -0.671 . . . . 73.54 109.188 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -106.81 -178.32 0.58 Allowed Pre-proline 0 N--CA 1.402 -2.838 0 CA-C-O 115.907 -1.996 . . . . 52.25 106.641 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 2.9 Cg_endo -40.36 107.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 123.049 2.499 . . . . 73.51 114.556 -162.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.6 -74.89 0.1 Allowed Glycine 0 N--CA 1.411 -2.991 0 C-N-CA 120.54 -0.838 . . . . 72.12 112.577 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.2 m -83.18 95.84 8.24 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 109.139 -0.689 . . . . 70.41 109.139 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.434 ' HB3' ' HZ3' ' A' ' 120' ' ' LYS . 1.0 OUTLIER 69.82 -16.8 0.26 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 126.037 1.735 . . . . 74.01 115.257 172.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -161.21 178.04 37.31 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 117.064 -2.493 . . . . 74.33 117.331 -170.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.532 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 44.6 Cg_exo -36.93 -37.24 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 127.629 5.553 . . . . 71.31 118.209 -175.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.289 29.3 p90 -161.28 144.73 12.84 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 117.829 -1.548 . . . . 74.15 114.776 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -113.79 105.87 13.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.586 -1.635 . . . . 54.02 106.586 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.42 126.9 41.51 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.863 -1.148 . . . . 74.15 109.865 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -167.39 166.13 14.62 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.218 0.324 . . . . 73.3 111.837 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.5 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 29.8 t -125.37 149.74 47.86 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.607 -1.998 . . . . 72.41 105.607 170.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.566 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 95.0 mt -63.68 145.09 56.39 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.719 0.295 . . . . 75.24 110.851 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.17 -169.67 45.98 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.416 -0.897 . . . . 74.32 111.404 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.5 -6.29 14.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 123.818 0.847 . . . . 71.45 113.101 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -96.0 -9.07 31.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.559 0.695 . . . . 74.41 110.101 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.53 7.88 70.01 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-N 115.815 -0.629 . . . . 73.22 113.301 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -140.05 147.55 40.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.827 -1.546 . . . . 74.03 106.827 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 119.81 21.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.668 -0.813 . . . . 62.44 111.643 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.75 -173.94 21.3 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.492 -1.043 . . . . 74.3 110.492 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.07 127.55 7.84 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.164 -1.574 . . . . 75.31 109.164 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.496 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 58.1 m 178.79 -177.54 0.27 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 126.421 1.888 . . . . 65.01 106.68 -171.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.85 -76.77 0.17 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.065 -0.654 . . . . 70.12 110.738 171.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -96.44 -14.7 22.22 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.731 -0.388 . . . . 74.32 111.708 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -90.13 3.28 53.86 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.334 0.587 . . . . 74.24 110.689 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.496 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -94.68 157.74 15.83 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 115.149 -0.932 . . . . 74.21 110.297 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.19 126.85 31.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.68 -1.6 . . . . 72.53 106.68 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -96.86 119.05 44.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.657 0.742 . . . . 74.43 111.287 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -174.44 162.35 32.57 Favored Glycine 0 N--CA 1.41 -3.096 0 C-N-CA 119.515 -1.326 . . . . 53.42 112.202 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.4 ' OD1' ' HB1' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -106.2 160.79 15.07 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.476 -0.935 . . . . 64.53 108.476 177.176 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -143.01 137.4 29.27 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.138 -1.06 . . . . 75.31 108.138 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -106.46 91.66 3.79 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.66 -1.216 . . . . 74.54 109.111 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.505 ' HB2' ' HA3' ' A' ' 121' ' ' GLY . 10.1 t30 . . . . . 0 CA--C 1.506 -0.732 0 O-C-N 126.282 2.239 . . . . 75.23 107.45 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 107.042 -1.466 . . . . 75.33 107.042 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -118.44 98.21 6.15 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.809 0.67 . . . . 75.45 112.809 -173.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -155.58 165.49 18.29 Favored Pre-proline 0 C--O 1.252 1.23 0 N-CA-C 104.9 -2.259 . . . . 74.51 104.9 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.7 124.57 12.53 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.747 2.298 . . . . 74.31 111.913 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 75.08 -26.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.969 2.108 . . . . 75.23 111.777 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -68.69 -19.23 64.37 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 121.659 -0.651 . . . . 74.55 109.47 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.17 65.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.159 -0.928 . . . . 75.33 110.188 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' O ' HG22 ' A' ' 49' ' ' VAL . 66.1 mttm -90.35 -25.58 20.38 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.041 -0.726 . . . . 73.43 109.041 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.6 t -73.93 -40.92 53.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.75 0.785 . . . . 74.21 109.018 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 t -65.43 -25.84 67.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.795 -1.093 . . . . 74.22 111.668 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 46' ' ' LYS . 6.0 m -82.69 -34.35 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 108.746 -0.835 . . . . 73.53 108.746 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' O ' HG12 ' A' ' 54' ' ' ILE . . . -61.84 -32.24 72.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.112 -0.949 . . . . 73.54 110.815 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.3 mmmt -65.14 -25.2 67.65 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.954 -0.567 . . . . 72.31 110.372 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.47 -27.29 18.11 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 111.164 -0.774 . . . . 52.02 111.164 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -79.19 -36.25 40.55 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.802 -0.444 . . . . 64.24 109.802 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 50' ' ' ALA . 26.6 pt -69.17 -31.02 48.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.595 -0.52 . . . . 73.22 109.595 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.5 tptt -65.79 -33.03 74.91 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.096 -0.705 . . . . 73.25 109.096 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.54 80.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.337 -0.847 . . . . 74.0 110.038 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.415 ' CG2' ' HG ' ' A' ' 125' ' ' LEU . 53.2 mt -68.27 -36.94 77.11 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 CA-C-N 115.829 -0.623 . . . . 73.22 110.238 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.39 66.81 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.032 0.444 . . . . 62.14 110.766 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -88.63 -36.03 16.5 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 115.482 -0.781 . . . . 61.3 110.202 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.1 -28.12 60.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.004 0.43 . . . . 72.12 111.186 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -29.45 68.56 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.598 -1.26 . . . . 75.44 107.598 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.4 t70 -72.84 -23.15 60.72 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.873 -1.058 . . . . 54.33 109.475 174.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 62.5 mtt -81.26 -39.65 24.97 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.943 -0.762 . . . . 75.25 108.943 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 87.7 t80 -64.39 -35.75 81.92 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.076 -1.083 . . . . 74.52 108.076 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.593 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 82.3 tttt -54.95 -31.78 60.86 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.052 -0.977 . . . . 75.23 111.215 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.9 -29.05 16.9 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.632 0.604 . . . . 73.42 112.632 172.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.499 ' OD1' ' HB2' ' A' ' 92' ' ' LYS . 19.4 t70 -72.15 -24.3 61.43 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.98 0.512 . . . . 73.03 111.311 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -128.48 18.84 6.32 Favored 'General case' 0 CA--C 1.455 -2.686 0 N-CA-C 108.071 -1.085 . . . . 75.11 108.071 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.0 p90 43.61 32.88 0.59 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.436 1.495 . . . . 72.55 114.134 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.15 161.09 1.09 Allowed 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.595 -0.891 . . . . 73.13 108.595 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.593 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 15.6 m-85 -78.12 154.02 79.88 Favored Pre-proline 0 N--CA 1.427 -1.62 0 O-C-N 123.713 0.633 . . . . 65.53 111.466 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.504 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 31.2 Cg_endo -66.87 165.76 24.87 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.108 2.539 . . . . 74.44 111.736 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.429 ' C ' ' HB1' ' A' ' 116' ' ' ALA . 41.4 p -100.27 155.45 17.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.75 -1.944 . . . . 70.23 105.75 170.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.438 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 1.3 t -67.23 -12.13 59.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 119.736 1.153 . . . . 74.04 111.664 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -102.63 -64.9 1.03 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.268 -0.423 . . . . 74.04 111.062 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.33 -34.54 48.52 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 122.113 -0.367 . . . . 74.42 110.455 -174.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -78.4 -20.71 71.41 Favored Glycine 0 N--CA 1.412 -2.901 0 C-N-CA 119.112 -1.518 . . . . 63.14 112.757 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.78 -44.57 66.39 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 105.361 -2.088 . . . . 74.55 105.361 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 13.5 mm-40 -65.51 -16.69 63.92 Favored 'General case' 0 C--O 1.189 -2.09 0 CA-C-N 114.141 -1.39 . . . . 73.51 111.454 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -98.37 -3.39 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.374 0.607 . . . . 74.41 111.391 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 mp -98.56 -15.56 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 73.53 108.773 173.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.04 -39.93 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.602 -0.726 . . . . 75.15 110.859 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 5.6 ttpm? -116.35 150.29 37.96 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.047 -1.464 . . . . 74.45 107.047 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -54.37 137.02 60.48 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 118.341 0.518 . . . . 72.53 111.474 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.79 140.59 81.03 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.49 2.793 . . . . 74.34 111.994 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.7 p -83.04 178.1 8.3 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.004 -0.544 . . . . 75.34 110.346 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.12 -114.58 4.58 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.12 -0.792 . . . . 73.35 111.12 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -148.56 116.41 3.93 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 120.611 -0.435 . . . . 74.53 110.931 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -103.5 162.94 0.24 Allowed 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 123.846 3.031 . . . . 73.54 111.088 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -76.65 159.29 79.59 Favored Pre-proline 0 C--O 1.207 -1.167 0 O-C-N 121.682 -0.636 . . . . 73.23 109.557 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -70.77 99.06 0.82 Allowed 'Trans proline' 0 C--O 1.248 1.015 0 C-N-CA 121.335 1.356 . . . . 75.15 112.586 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.499 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 67.6 mttm -146.66 148.56 32.17 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.818 -1.919 . . . . 75.41 105.818 174.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -76.41 92.99 3.43 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.628 -0.829 . . . . 72.53 110.372 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.6 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 79.4 t90 -53.69 143.53 20.24 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.237 1.415 . . . . 71.45 111.578 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -124.11 136.72 54.43 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.816 -1.083 . . . . 75.24 109.806 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 64.0 pttt -88.04 -168.75 2.31 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.631 -0.878 . . . . 75.34 108.631 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.66 16.3 6.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.708 1.242 . . . . 71.22 110.212 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.56 11.67 50.29 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.246 -1.343 . . . . 73.15 113.979 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.6 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.88 91.37 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.272 1.034 . . . . 70.43 111.181 -176.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 46.2 tp -138.94 156.09 47.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.551 -1.204 . . . . 74.11 108.414 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.488 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.5 mmmt -77.53 -177.63 4.84 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.45 -0.944 . . . . 75.22 108.45 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -82.29 74.22 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.5 -0.88 . . . . 64.53 110.86 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.88 147.83 67.8 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 125.133 1.373 . . . . 63.41 107.32 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.98 166.46 12.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.834 2.356 . . . . 73.42 113.704 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.428 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 6.2 p -79.36 176.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.408 -0.815 . . . . 75.43 109.138 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.29 146.09 96.4 Favored Pre-proline 0 C--O 1.257 1.466 0 N-CA-C 112.508 0.558 . . . . 75.32 112.508 -175.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.57 171.46 0.1 Allowed 'Trans proline' 0 C--O 1.197 -1.535 0 C-N-CA 124.118 3.212 . . . . 74.22 112.916 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.496 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.1 m-90 62.27 14.96 7.18 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.971 1.308 . . . . 75.05 109.298 -177.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.47 30.05 76.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.811 1.084 . . . . 73.41 115.811 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.496 ' ND2' ' HE3' ' A' ' 108' ' ' TRP . 15.4 m-80 -93.17 130.66 35.17 Favored Pre-proline 0 C--O 1.256 1.398 0 CA-C-N 119.085 1.443 . . . . 74.22 110.981 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 27.0 Cg_endo -70.98 148.57 57.45 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 121.434 1.423 . . . . 74.41 109.18 168.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.448 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 32.9 m-85 -69.45 143.86 53.45 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.07 0.462 . . . . 71.54 111.963 -177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.408 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -102.61 114.22 28.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.802 -1.925 . . . . 54.22 105.802 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.25 120.09 41.18 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.258 -0.883 . . . . 70.52 111.311 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.1 mt -127.72 153.57 46.36 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.629 -0.878 . . . . 75.11 108.629 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -114.85 -178.69 0.53 Allowed Pre-proline 0 N--CA 1.406 -2.666 0 CA-C-O 117.035 -1.46 . . . . 73.2 107.73 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 18.7 Cg_endo -51.75 118.92 4.91 Favored 'Trans proline' 0 CA--C 1.482 -2.083 0 C-N-CA 122.522 2.148 . . . . 71.41 115.116 -170.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -93.85 -93.76 1.57 Allowed Glycine 0 N--CA 1.408 -3.233 0 CA-C-N 113.633 -1.621 . . . . 64.2 109.549 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.63 100.75 8.96 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 109.07 -0.715 . . . . 73.43 109.07 -177.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 66.19 10.11 6.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.539 1.136 . . . . 74.13 113.29 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -124.87 112.89 1.83 Allowed Glycine 0 N--CA 1.432 -1.577 0 CA-C-O 118.337 -1.257 . . . . 72.42 112.53 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.546 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 20.2 Cg_exo -41.21 -25.04 0.22 Allowed 'Trans proline' 0 N--CA 1.504 2.112 1 C-N-CA 126.954 5.103 . . . . 74.32 118.852 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.0 p90 178.19 165.95 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.997 0.817 . . . . 71.52 109.766 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.437 ' HA ' ' CB ' ' A' ' 146' ' ' TRP . 2.6 m-20 -139.32 113.17 8.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.371 0.668 . . . . 73.11 109.424 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.431 ' H ' ' HB3' ' A' ' 146' ' ' TRP . 0.3 OUTLIER -125.29 124.58 41.93 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.786 -0.766 . . . . 74.51 110.371 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -164.43 166.43 20.58 Favored 'General case' 0 C--O 1.208 -1.109 0 O-C-N 123.087 0.242 . . . . 64.04 110.352 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.448 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 18.8 t -125.51 153.21 43.93 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.381 -1.34 . . . . 73.44 107.381 171.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.408 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 88.8 mt -66.26 128.6 36.77 Favored 'General case' 0 C--O 1.204 -1.316 0 O-C-N 123.227 0.329 . . . . 73.45 111.557 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.53 15.89 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.918 -0.658 . . . . 63.53 112.235 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.24 -16.74 9.02 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.82 1.415 . . . . 74.33 114.82 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.4 -9.38 35.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.15 0.976 . . . . 72.33 109.802 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.85 10.28 86.33 Favored Glycine 0 CA--C 1.505 -0.585 0 CA-C-N 115.334 -0.848 . . . . 74.14 112.281 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 5.2 mmpt? -124.77 147.89 48.43 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.58 0.352 . . . . 74.42 110.348 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.59 104.91 17.29 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 122.081 0.944 . . . . 74.22 108.733 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.85 -173.64 21.08 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.24 -0.891 . . . . 63.22 111.169 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.28 127.59 9.08 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.646 -1.782 . . . . 73.43 108.646 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.457 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 37.6 m 179.63 -177.91 0.36 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.207 -1.775 . . . . 73.2 106.207 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.54 -75.37 0.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 118.294 0.497 . . . . 62.41 110.32 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -99.76 -17.95 17.46 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.87 -0.604 . . . . 73.42 110.831 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.47 -8.21 59.02 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.466 0.65 . . . . 70.23 109.989 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.457 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -87.14 156.97 19.48 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 114.806 -1.088 . . . . 72.25 109.136 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -77.39 134.51 38.41 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.543 -1.28 . . . . 75.23 107.543 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.509 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.5 pp -96.82 119.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.893 -0.594 . . . . 73.31 110.719 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -174.33 167.2 39.49 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 118.818 -1.658 . . . . 75.5 113.116 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.59 150.1 36.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.977 -0.749 . . . . 75.43 108.977 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.587 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 13.7 p90 -165.11 179.23 6.47 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.768 -0.651 . . . . 75.41 109.831 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -119.43 122.23 41.26 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.55 -1.278 . . . . 64.31 107.55 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.06 -1.089 . . . . 71.33 108.06 177.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.471 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.4 mpt? . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.426 -0.953 . . . . 72.03 108.426 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.5 t -108.88 77.77 1.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.074 -0.65 . . . . 74.25 110.724 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -155.16 155.26 29.87 Favored Pre-proline 0 C--N 1.316 -0.871 0 C-N-CA 124.814 1.246 . . . . 75.11 107.986 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.59 138.56 75.23 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.684 2.256 . . . . 65.53 110.894 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t70 76.56 -37.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.716 2.007 . . . . 74.44 110.49 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 77.8 mt-30 -68.68 -21.07 64.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.66 0.743 . . . . 75.2 109.504 173.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.22 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 55.4 109.943 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 67.3 mttm -93.23 -24.47 18.18 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.954 -0.758 . . . . 73.43 108.954 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.65 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 97.7 t -71.48 -44.66 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 108.248 -1.019 . . . . 73.43 108.248 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -65.96 -15.9 63.4 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.069 -0.969 . . . . 72.14 111.248 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -84.08 -52.66 12.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.585 -0.894 . . . . 72.45 108.585 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.81 71.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.792 -1.094 . . . . 64.53 112.979 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 30.8 mmmt -65.36 -25.74 67.72 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.739 0.78 . . . . 72.32 109.982 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -27.97 24.92 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.836 -0.906 . . . . 75.22 110.836 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.409 ' OD1' HD12 ' A' ' 103' ' ' LEU . 77.5 m-20 -77.23 -34.67 55.95 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.137 0.494 . . . . 63.55 110.607 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.0 pt -68.1 -34.22 65.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 116.021 -0.536 . . . . 74.13 109.558 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -67.24 -29.36 68.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 74.21 109.811 178.133 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.52 75.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.337 -0.847 . . . . 74.31 109.5 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.479 HG12 ' HG ' ' A' ' 100' ' ' LEU . 66.8 mt -66.64 -34.81 72.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.568 0 CA-C-N 115.355 -0.838 . . . . 75.15 110.02 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.68 -26.61 68.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.117 0.485 . . . . 71.24 111.22 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -87.23 -34.36 18.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.119 0.485 . . . . 74.35 109.752 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.63 -28.55 33.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.632 0.604 . . . . 61.11 112.632 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.53 -29.84 68.51 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.216 -1.401 . . . . 74.41 107.216 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 32.4 t70 -71.89 -21.66 61.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.193 -1.367 . . . . 64.23 109.1 174.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.0 mtt -83.0 -30.29 28.28 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.754 -0.591 . . . . 75.13 109.607 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CD1' ' HD3' ' A' ' 72' ' ' PRO . 55.1 t80 -68.47 -35.62 77.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.955 -1.498 . . . . 73.33 106.955 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 83.9 tttt -55.02 -35.77 64.78 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.206 -0.906 . . . . 74.23 110.044 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.93 -36.43 56.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 73.12 111.813 172.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' HB2' ' HD3' ' A' ' 92' ' ' LYS . 13.4 t70 -71.02 -26.69 63.22 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.81 -0.632 . . . . 75.04 111.178 -172.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -130.47 22.42 5.13 Favored 'General case' 0 CA--C 1.449 -2.929 0 CA-C-O 118.975 -0.536 . . . . 71.42 112.009 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.7 p90 42.99 31.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.063 1.477 . . . . 74.31 113.495 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.18 161.44 0.6 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.683 -1.228 . . . . 74.31 107.683 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 26.0 m-85 -80.08 154.14 74.92 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 123.289 0.368 . . . . 73.34 111.062 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.517 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 22.9 Cg_endo -64.43 167.62 14.54 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 123.471 2.781 . . . . 73.15 111.803 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.404 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 53.2 p -98.21 155.71 17.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.635 -1.617 . . . . 75.11 106.635 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -66.13 -15.45 63.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 118.967 0.803 . . . . 64.43 111.283 -175.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -102.23 -64.49 1.06 Allowed 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 122.156 -0.34 . . . . 73.12 111.465 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -75.89 -39.65 56.01 Favored 'General case' 0 CA--C 1.486 -1.519 0 O-C-N 122.171 -0.33 . . . . 73.43 110.795 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.534 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -73.61 -20.85 79.86 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 118.614 -1.755 . . . . 72.14 113.169 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.5 -48.12 73.68 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 106.94 -1.504 . . . . 74.34 106.94 177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 48.4 mt-10 -71.22 -23.09 61.95 Favored 'General case' 0 C--O 1.18 -2.597 0 CA-C-N 114.553 -1.203 . . . . 74.15 111.019 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.414 ' HB1' ' HA2' ' A' ' 77' ' ' GLY . . . -82.76 -2.79 55.4 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.266 0.555 . . . . 73.21 111.125 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 70.8 mt -96.23 -28.24 14.63 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.479 -0.782 . . . . 70.41 110.217 173.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.77 -32.5 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.438 0.637 . . . . 70.34 111.183 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 35.8 ttpt -120.59 150.48 40.82 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.188 -1.782 . . . . 75.41 106.188 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -54.54 141.32 54.99 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 118.489 0.586 . . . . 74.4 111.118 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.64 136.32 64.39 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.539 2.826 . . . . 71.21 111.878 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -81.47 -21.67 38.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.694 -0.685 . . . . 70.3 111.138 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.03 -146.39 9.26 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.894 -1.282 . . . . 72.44 109.894 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -117.69 95.87 48.52 Favored Pre-proline 0 C--N 1.288 -2.104 0 O-C-N 122.397 -0.472 . . . . 74.43 110.795 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.93 162.08 32.49 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.727 1.618 . . . . 75.53 108.751 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -82.69 159.21 64.16 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-O 118.205 -0.902 . . . . 73.53 108.958 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.48 97.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.707 1.605 . . . . 74.2 111.41 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 55.5 tttm -152.09 147.33 26.34 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.894 -1.891 . . . . 74.41 105.894 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.88 91.55 3.56 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.936 -0.306 . . . . 73.34 111.153 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -54.53 144.03 22.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.003 1.321 . . . . 74.02 111.498 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 3.1 t-20 -123.43 135.19 53.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.516 -0.766 . . . . 74.44 109.99 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -84.88 176.34 8.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.47 0.652 . . . . 75.22 111.398 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 71.4 20.28 4.97 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.608 1.563 . . . . 62.02 111.388 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.527 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 103.16 12.13 32.29 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.904 -1.141 . . . . 63.43 112.718 171.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.434 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 0.5 OUTLIER 62.75 85.33 0.13 Allowed 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.552 1.168 . . . . 73.11 108.89 -173.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.479 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -133.32 150.4 51.87 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.485 -2.043 . . . . 71.44 105.485 -174.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' N ' HD22 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.03 -178.14 0.96 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.908 0.322 . . . . 73.32 110.738 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -77.62 53.02 1.04 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.882 1.325 . . . . 74.32 112.718 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.409 HD12 ' OD1' ' A' ' 53' ' ' ASP . 70.8 mt -118.55 148.57 44.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 113.578 -1.647 . . . . 73.3 107.858 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.01 -175.46 1.46 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.604 2.202 . . . . 74.14 113.188 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.1 p -79.71 173.44 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.261 1.68 0 N-CA-C 108.271 -1.011 . . . . 75.33 108.271 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.551 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 5.8 p-10 -79.8 160.34 69.41 Favored Pre-proline 0 C--O 1.252 1.198 0 N-CA-C 113.635 0.976 . . . . 74.21 113.635 -168.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.4 ' CB ' ' HB3' ' A' ' 46' ' ' LYS . 10.8 Cg_endo -56.11 169.53 1.43 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.358 2.705 . . . . 73.14 111.681 173.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 64.81 14.58 9.27 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.853 1.261 . . . . 64.34 109.127 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.19 25.33 62.2 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 114.014 -1.448 . . . . 74.42 115.381 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.551 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 8.2 m-80 -82.73 148.74 58.56 Favored Pre-proline 0 C--O 1.271 2.215 0 CA-C-N 119.497 1.649 . . . . 63.2 108.634 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.475 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 3.6 Cg_endo -88.89 148.47 5.8 Favored 'Trans proline' 0 N--CA 1.424 -2.57 0 C-N-CA 121.988 1.792 . . . . 64.23 109.087 168.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -68.2 142.49 55.66 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 120.48 -0.488 . . . . 71.21 110.136 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.0 mm100 -101.7 119.52 38.91 Favored 'General case' 0 C--O 1.266 1.928 0 N-CA-C 105.027 -2.212 . . . . 74.5 105.027 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 118.3 33.84 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.405 -1.332 . . . . 74.41 107.405 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 75.9 mt -129.98 150.36 51.29 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.01 -0.737 . . . . 75.1 109.01 169.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.461 ' HB2' ' HD2' ' A' ' 117' ' ' PRO . . . -122.24 -178.47 0.63 Allowed Pre-proline 0 N--CA 1.402 -2.836 0 N-CA-C 105.124 -2.176 . . . . 72.5 105.124 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.727 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 17.9 Cg_endo -54.12 116.72 3.23 Favored 'Trans proline' 0 CA--C 1.492 -1.589 0 CA-C-N 122.327 1.867 . . . . 74.42 114.094 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -104.23 -84.13 1.75 Allowed Glycine 0 N--CA 1.416 -2.638 0 CA-C-N 114.364 -1.289 . . . . 75.53 111.152 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.0 m -112.72 96.13 5.8 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 109.223 -0.658 . . . . 72.03 109.223 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt 63.13 19.54 11.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.928 1.291 . . . . 63.42 112.419 174.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -133.29 114.43 1.37 Allowed Glycine 0 CA--C 1.484 -1.893 0 CA-C-O 118.023 -1.432 . . . . 72.0 112.424 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.501 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 16.6 Cg_exo -41.51 -23.88 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.914 1 C-N-CA 126.667 4.911 . . . . 74.45 118.525 -177.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.604 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.6 p90 177.59 156.51 0.35 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.656 0.662 . . . . 74.43 110.285 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 2.7 m-20 -134.29 106.83 7.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.025 0.828 . . . . 75.13 108.789 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.8 126.55 53.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.856 -0.794 . . . . 65.04 108.856 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.549 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 23.9 p90 -168.2 168.61 11.52 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 120.571 -0.451 . . . . 74.24 111.554 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 67.6 m -125.78 152.25 45.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.524 -1.287 . . . . 73.42 107.524 166.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.424 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 96.5 mt -60.17 148.64 35.49 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.742 0.651 . . . . 72.42 111.562 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.02 -172.27 5.27 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.768 0.667 . . . . 71.12 114.768 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.47 -28.15 63.12 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 114.021 1.119 . . . . 73.35 114.021 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -94.23 -5.66 46.41 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.264 -0.574 . . . . 74.23 110.493 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.82 27.43 56.7 Favored Glycine 0 C--N 1.319 -0.386 0 N-CA-C 110.531 -1.028 . . . . 52.23 110.531 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -125.89 141.48 51.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.78 -1.193 . . . . 75.34 107.78 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.602 ' HA ' ' OD1' ' A' ' 142' ' ' ASP 0.271 0.0 OUTLIER -81.15 106.72 13.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.833 0.825 . . . . 73.33 112.767 178.556 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.09 173.27 29.82 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.347 -0.842 . . . . 73.54 113.315 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.4 129.61 9.88 Favored Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.586 -1.806 . . . . 73.13 108.586 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.633 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 23.8 m -178.76 -177.24 0.5 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.223 1.409 . . . . 74.31 107.513 -171.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -97.46 -49.9 4.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.045 -1.062 . . . . 71.45 108.887 171.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.448 ' HA ' HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -88.28 -41.65 12.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.679 -0.691 . . . . 74.2 110.673 -177.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.28 18.3 14.05 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.606 0.717 . . . . 73.11 110.8 -175.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . -81.2 156.88 25.44 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.259 -0.882 . . . . 72.21 109.922 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.602 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 36.4 m-20 -76.87 129.85 36.78 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 104.508 -2.404 . . . . 74.32 104.508 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.539 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -94.98 111.97 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 C-N-CA 118.59 -1.244 . . . . 73.01 108.37 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -175.09 176.69 47.2 Favored Glycine 1 N--CA 1.396 -4.027 0 CA-C-N 114.413 -1.267 . . . . 55.54 110.852 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.29 149.23 24.09 Favored 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 107.872 -1.158 . . . . 73.05 107.872 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.604 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 2.1 p90 -156.77 177.83 11.04 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 123.707 0.629 . . . . 72.12 112.082 -173.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -125.05 115.3 20.3 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.5 -0.926 . . . . 71.04 108.5 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 117.227 -1.368 . . . . 75.2 108.376 178.509 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.9 ttt . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 106.633 -1.618 . . . . 73.55 106.633 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.3 m -104.11 87.11 2.69 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.189 0.811 . . . . 72.32 113.189 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -154.54 154.16 28.96 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 104.835 -2.283 . . . . 74.11 104.835 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 44' ' ' GLN . 9.6 Cg_endo -54.1 141.07 70.04 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 122.167 1.911 . . . . 74.1 110.45 176.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 75.73 -36.13 0.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.299 1.44 . . . . 75.23 110.785 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 42' ' ' PRO . 78.2 mt-30 -77.16 -15.16 59.63 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.689 -0.632 . . . . 74.52 109.961 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.7 75.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.134 -0.939 . . . . 72.32 110.545 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -86.94 -22.11 25.83 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.816 -0.629 . . . . 74.35 110.871 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 49.1 t -73.09 -43.21 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 121.421 0.629 . . . . 74.12 109.599 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 t -64.52 -38.42 90.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.09 -0.505 . . . . 74.43 111.747 -177.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.2 t -70.35 -37.31 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 108.917 -0.772 . . . . 75.51 108.917 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -58.56 -40.67 83.7 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.908 -1.042 . . . . 65.35 111.151 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 13.8 mmmm -65.57 -25.66 67.51 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.163 -0.472 . . . . 72.52 111.182 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.22 -28.15 23.58 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.606 -0.807 . . . . 73.3 111.088 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -82.11 -30.1 31.38 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.008 0.433 . . . . 72.43 111.469 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 50' ' ' ALA . 17.2 pt -73.0 -27.21 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.305 -0.558 . . . . 74.12 109.943 172.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 28.5 tptt -72.58 -26.83 61.85 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.391 -0.596 . . . . 74.34 109.391 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.86 -44.34 81.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 73.24 109.16 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.9 mt -63.44 -34.62 68.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.684 0 CA-C-N 115.124 -0.944 . . . . 74.24 110.178 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.462 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . . . -60.71 -34.42 74.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.898 0.38 . . . . 73.54 111.135 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -80.81 -26.85 36.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.837 -0.62 . . . . 74.53 110.051 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.13 -29.25 24.97 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 120.926 0.393 . . . . 74.14 110.733 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -27.48 62.4 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.218 -1.401 . . . . 75.42 107.218 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 10.7 t70 -66.45 -32.26 73.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.613 -1.176 . . . . 73.52 108.71 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 67.1 mtt -76.2 -31.1 58.26 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 115.18 -0.918 . . . . 73.43 109.518 177.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -69.95 -37.97 76.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.52 -0.548 . . . . 73.33 109.52 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 19.4 pttp -66.36 -19.23 65.75 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 118.867 -1.133 . . . . 75.22 109.453 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.33 -38.21 17.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.545 -0.752 . . . . 74.05 110.471 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 15.9 t70 -73.3 -26.82 61.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.12 0.415 . . . . 73.14 112.12 -174.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.36 24.48 5.87 Favored 'General case' 0 CA--C 1.455 -2.676 0 N-CA-C 108.108 -1.071 . . . . 64.12 108.108 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 44.09 32.82 0.7 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.84 1.256 . . . . 73.42 113.731 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.35 155.98 0.41 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.755 -0.831 . . . . 61.03 108.755 -174.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.653 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 10.2 m-85 -77.14 157.73 80.7 Favored Pre-proline 0 N--CA 1.423 -1.779 0 O-C-N 123.572 0.545 . . . . 74.02 110.932 171.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.476 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 60.8 Cg_endo -70.78 163.25 39.74 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.756 2.304 . . . . 63.34 113.244 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.6 p -104.93 155.14 19.21 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.464 -2.05 . . . . 73.15 105.464 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.497 ' N ' ' HB3' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -67.44 -11.9 58.95 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.105 0.955 . . . . 74.32 111.504 -173.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -102.31 -65.58 0.98 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 121.795 -0.566 . . . . 71.23 110.377 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -77.72 -34.69 52.55 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 116.375 -0.375 . . . . 75.42 111.011 -170.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -84.26 -20.94 58.0 Favored Glycine 0 N--CA 1.417 -2.605 0 C-N-CA 118.664 -1.732 . . . . 75.15 112.658 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -73.7 -42.72 60.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.582 -1.636 . . . . 71.45 106.582 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.98 -27.4 67.42 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-N 115.435 -0.802 . . . . 73.25 110.826 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -84.79 -4.08 58.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.092 0.472 . . . . 75.13 111.515 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tp -95.79 -25.38 16.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.524 0.678 . . . . 75.52 109.297 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.05 -41.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.608 -0.724 . . . . 75.21 110.366 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -111.41 148.51 32.9 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.41 -0.959 . . . . 74.3 108.41 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.63 128.08 60.92 Favored Pre-proline 0 C--O 1.25 1.125 0 C-N-CA 124.067 0.947 . . . . 74.2 109.797 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.461 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 19.7 Cg_endo -53.62 126.39 21.67 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 124.503 3.469 . . . . 74.13 113.613 -171.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -74.44 117.91 16.79 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.667 -1.151 . . . . 73.35 110.566 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.67 -146.14 16.06 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 108.761 -1.736 . . . . 74.43 108.761 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -125.83 92.83 45.45 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 112.901 0.704 . . . . 70.14 112.901 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.461 ' HG3' ' HG2' ' A' ' 85' ' ' PRO . 85.8 Cg_endo -76.0 163.12 33.63 Favored 'Trans proline' 0 C--O 1.262 1.693 0 C-N-CA 122.649 2.233 . . . . 73.03 107.562 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.35 159.57 83.35 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 108.584 -0.895 . . . . 74.44 108.584 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.69 98.01 0.18 Allowed 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 121.11 1.207 . . . . 71.15 110.332 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.1 tmtm? -151.79 148.31 27.7 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.474 -2.046 . . . . 70.53 105.474 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.535 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 90.0 m-20 -72.85 93.76 1.74 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.909 0.707 . . . . 62.34 112.909 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.537 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.4 t90 -64.18 144.37 57.17 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.851 0.86 . . . . 73.4 110.472 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -131.81 135.5 46.79 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.162 -0.681 . . . . 65.14 109.162 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 63.5 pttt -85.09 -174.88 5.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.075 0.464 . . . . 74.13 109.777 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 70.2 15.04 7.6 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.473 1.109 . . . . 63.31 110.4 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.3 14.93 21.0 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.498 -1.228 . . . . 72.11 114.078 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 61.17 89.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.449 1.118 . . . . 75.25 110.975 -176.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 57.2 tp -128.01 170.82 12.46 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 124.756 1.222 . . . . 74.23 108.092 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.2 mmmt -88.04 179.47 6.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.549 -1.278 . . . . 73.22 107.549 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.26 0.0 OUTLIER -77.33 72.37 3.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.851 1.31 . . . . 72.55 110.959 175.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -130.73 148.21 69.2 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 113.643 -1.617 . . . . 72.4 107.808 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.18 170.41 13.28 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.871 1.714 . . . . 74.01 110.887 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 111' ' ' PRO . 5.3 p -79.73 171.7 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.774 -0.824 . . . . 74.12 108.774 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.503 ' OD2' ' HD2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -75.55 149.03 83.51 Favored Pre-proline 0 C--O 1.253 1.269 0 C-N-CA 119.884 -0.726 . . . . 74.41 112.364 -171.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.503 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 36.0 Cg_exo -47.09 171.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.373 3.382 . . . . 72.3 113.93 172.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 70.14 14.81 7.67 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 126.677 1.991 . . . . 75.23 108.596 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.91 32.29 59.12 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 114.174 -1.375 . . . . 73.24 113.057 -175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -92.27 125.67 55.54 Favored Pre-proline 0 C--O 1.263 1.796 0 CA-C-N 116.752 0.276 . . . . 73.13 111.212 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.469 ' HA ' HG21 ' A' ' 105' ' ' VAL . 7.9 Cg_exo -71.1 154.09 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.034 1.822 . . . . 60.12 108.522 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -71.75 142.75 49.74 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.969 -1.093 . . . . 74.12 108.806 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.569 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 2.1 mm100 -102.14 113.76 27.31 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 105.066 -2.198 . . . . 73.12 105.066 -178.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.62 118.46 36.64 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.823 -1.081 . . . . 74.43 111.318 -177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.2 mt -129.31 154.02 47.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.345 -0.843 . . . . 61.01 109.343 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 74' ' ' THR . . . -108.93 -177.38 0.47 Allowed Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-O 116.971 -1.49 . . . . 75.42 108.711 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.717 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 20.1 Cg_endo -46.45 115.99 1.4 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 123.19 2.593 . . . . 72.33 116.359 -162.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.98 -90.93 0.9 Allowed Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 113.817 -1.538 . . . . 52.51 109.948 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.6 m -108.32 96.59 6.46 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.234 -1.024 . . . . 62.21 108.234 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.294 0.0 OUTLIER 54.73 4.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 126.604 1.962 . . . . 64.2 116.26 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.717 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -106.62 115.82 4.84 Favored Glycine 0 N--CA 1.426 -1.981 0 CA-C-O 118.027 -1.43 . . . . 64.23 111.303 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.566 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -34.81 -27.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.033 1 C-N-CA 127.052 5.168 . . . . 73.45 118.027 -178.937 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 50.8 p90 -165.45 170.42 14.5 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 118.749 0.704 . . . . 74.43 111.156 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.7 m-20 -132.4 107.13 8.31 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.534 -1.284 . . . . 72.33 107.534 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.09 128.97 54.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.557 -0.905 . . . . 71.51 108.557 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -166.28 166.01 17.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.004 -0.369 . . . . 73.43 110.004 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.5 t -124.95 146.76 49.22 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.96 -1.867 . . . . 72.4 105.96 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.569 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 98.3 mt -64.23 155.97 30.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.788 0.328 . . . . 72.44 111.429 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -83.76 -166.19 39.89 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.577 -0.821 . . . . 73.2 112.368 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.69 -22.05 64.99 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.553 0.946 . . . . 62.0 113.553 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.86 -2.75 52.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.755 0.788 . . . . 75.31 110.527 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.421 ' O ' HD11 ' A' ' 128' ' ' LEU . . . 72.29 27.44 69.91 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.797 -0.716 . . . . 51.02 111.74 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -140.07 148.45 41.77 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 123.159 0.583 . . . . 65.22 110.553 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -84.87 109.18 17.94 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.433 0.635 . . . . 73.53 110.596 176.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -147.6 -173.22 18.48 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.851 -1.068 . . . . 61.21 110.67 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.27 128.21 8.12 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.849 -1.7 . . . . 74.44 108.849 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.2 m 179.95 -177.48 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.879 1.672 . . . . 72.0 106.698 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -78.66 -62.56 1.65 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.929 0.331 . . . . 61.22 110.229 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.52 -11.82 14.03 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.513 0.56 . . . . 72.53 112.513 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.69 11.71 28.09 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.757 0.789 . . . . 70.02 110.595 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.0 155.8 17.86 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.805 -1.089 . . . . 62.51 110.275 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.1 p-10 -79.67 135.66 36.6 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.31 -1.737 . . . . 74.15 106.31 173.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.524 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.34 113.11 29.92 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 108.041 -1.096 . . . . 74.03 108.041 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.65 151.5 18.98 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 119.368 -1.396 . . . . 73.3 114.582 -170.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 5.2 t30 -153.13 127.0 8.91 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 113.555 -1.323 . . . . 74.43 107.704 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.428 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 5.7 p90 -150.73 157.67 43.23 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 120.119 -0.632 . . . . 73.31 112.398 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -94.14 108.19 20.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.525 -1.657 . . . . 73.43 106.525 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.3 t30 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 114.534 -1.212 . . . . 65.32 108.696 -176.748 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.413 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 108.387 -0.968 . . . . 74.35 108.387 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -115.62 89.03 3.01 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.832 -0.747 . . . . 65.11 110.225 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -155.65 161.56 29.2 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 125.983 1.713 . . . . 73.42 106.426 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 44' ' ' GLN . 85.2 Cg_exo -51.49 133.17 42.72 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.463 2.109 . . . . 62.53 110.908 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 74.63 -37.25 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.98 1.312 . . . . 70.2 111.624 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.1 mm100 -68.69 -24.97 64.56 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.266 0.555 . . . . 70.15 109.931 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.77 -16.92 64.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.342 -0.845 . . . . 73.02 110.242 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.51 -25.89 22.32 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 108.369 -0.975 . . . . 74.32 108.369 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 47.4 t -75.82 -43.38 39.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.631 -0.713 . . . . 75.34 110.216 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -65.23 -29.02 69.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.27 -0.877 . . . . 74.1 111.585 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.7 m -84.03 -34.49 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.158 -0.617 . . . . 73.13 109.941 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.413 ' HB3' ' CD1' ' A' ' 143' ' ' ILE . . . -60.2 -37.84 81.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.465 -0.789 . . . . 55.12 110.451 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 70.2 mmtt -65.3 -26.23 67.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.704 -0.68 . . . . 75.11 110.423 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.99 -28.39 18.29 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.225 -0.988 . . . . 75.1 111.324 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.45 -27.26 32.01 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.04 0.385 . . . . 72.32 112.04 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 pt -72.06 -30.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.303 -0.559 . . . . 73.21 109.617 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 73.0 mmtt -71.52 -24.27 61.93 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 116.414 -0.357 . . . . 72.34 110.704 175.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.03 75.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.621 -0.718 . . . . 74.23 109.554 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.7 mt -68.99 -34.07 62.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.385 -0.825 . . . . 75.31 109.673 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.409 ' HB1' ' ND2' ' A' ' 145' ' ' ASN . . . -58.97 -33.98 71.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 62.05 110.783 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.494 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -82.36 -36.27 26.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.485 -0.779 . . . . 73.04 110.166 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.59 -28.92 41.06 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.042 0.386 . . . . 74.53 112.042 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -70.38 -30.14 66.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.964 -1.495 . . . . 73.14 106.964 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.7 t70 -71.08 -19.54 62.46 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.453 -1.249 . . . . 74.04 109.543 174.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.8 mtt -81.54 -41.04 22.22 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.921 -0.77 . . . . 61.03 108.921 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.58 -35.97 82.7 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 107.612 -1.255 . . . . 72.03 107.612 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.589 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.1 tttt -54.37 -40.07 67.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.908 -1.042 . . . . 72.0 110.631 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.22 -32.25 38.52 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.527 -0.469 . . . . 74.01 111.363 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.515 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 36.1 t70 -69.81 -24.03 63.41 Favored 'General case' 0 C--O 1.184 -2.37 0 C-N-CA 121.02 -0.272 . . . . 74.44 111.413 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -128.03 19.16 6.54 Favored 'General case' 0 CA--C 1.459 -2.527 0 O-C-N 121.137 -0.977 . . . . 65.11 110.909 176.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 43.58 34.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.893 1.371 . . . . 73.22 113.107 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.92 152.9 0.37 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.532 -1.213 . . . . 74.41 108.096 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.589 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.6 m-85 -76.38 148.65 80.76 Favored Pre-proline 0 N--CA 1.431 -1.401 0 O-C-N 123.496 0.498 . . . . 74.05 110.76 172.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 28.4 Cg_endo -61.41 162.27 21.13 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.811 3.007 . . . . 65.21 111.883 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -96.77 156.06 16.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.632 -1.618 . . . . 75.23 106.632 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 t -69.12 -11.58 60.92 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.287 0.948 . . . . 73.13 110.934 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -102.45 -65.84 0.97 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.096 -0.502 . . . . 75.43 110.99 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.33 -40.42 51.39 Favored 'General case' 0 CA--C 1.486 -1.505 0 O-C-N 122.141 -0.349 . . . . 72.4 110.393 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -74.7 -20.54 79.48 Favored Glycine 0 N--CA 1.41 -3.066 0 C-N-CA 119.25 -1.453 . . . . 43.13 113.076 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.38 -45.64 68.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.742 -1.577 . . . . 74.54 106.742 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.45 -8.68 57.09 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.18 -0.918 . . . . 64.44 111.733 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -96.88 -6.01 36.81 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.478 0.656 . . . . 71.13 110.209 175.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 86.4 mt -95.06 -19.81 19.84 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.791 -0.818 . . . . 74.43 108.791 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 t -106.11 -44.56 7.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.633 -0.712 . . . . 64.0 110.931 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.2 mppt? -108.82 148.69 30.19 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.216 -1.031 . . . . 73.23 108.216 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.54 133.05 63.71 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 123.82 0.848 . . . . 74.24 109.833 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 18.4 Cg_endo -55.3 121.05 9.23 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.688 2.925 . . . . 74.31 113.291 -172.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 t -87.12 -2.48 58.66 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.479 -1.237 . . . . 75.33 109.175 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.29 -147.75 12.61 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.768 -0.933 . . . . 74.01 110.768 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -115.63 99.13 52.16 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 117.7 0.75 . . . . 73.03 110.462 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.483 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 85.7 Cg_endo -102.85 162.2 0.28 Allowed 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 122.904 2.403 . . . . 71.53 112.887 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.44 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 45.5 mt-30 -105.54 98.55 17.56 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 106.0 -1.852 . . . . 74.41 106.0 174.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -36.69 99.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 125.186 3.924 . . . . 64.23 119.675 -167.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.515 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 4.1 mptp? -109.53 149.17 30.01 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 102.103 -3.295 . . . . 74.25 102.103 160.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.35 92.34 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 123.268 0.355 . . . . 73.22 110.277 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.567 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -54.95 140.85 35.89 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 124.969 1.308 . . . . 75.31 112.678 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.59 137.89 54.55 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.929 -1.032 . . . . 73.24 110.14 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -93.12 -178.1 4.68 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.736 0.779 . . . . 73.24 111.023 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t0 65.73 24.29 11.5 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.649 1.58 . . . . 74.1 110.846 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.91 27.58 Favored Glycine 0 CA--C 1.496 -1.132 0 CA-C-N 114.643 -1.162 . . . . 71.41 115.051 168.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.567 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.5 90.28 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.384 1.087 . . . . 74.25 110.775 -175.114 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.502 HD21 ' N ' ' A' ' 101' ' ' LYS . 5.7 tt -138.18 151.04 47.33 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.356 -2.461 . . . . 74.41 104.356 -179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.502 ' N ' HD21 ' A' ' 100' ' ' LEU . 55.8 mtmt -67.39 -172.47 0.23 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.357 -0.537 . . . . 74.51 111.597 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 67.94 6.42 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.094 0.95 . . . . 74.31 111.384 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.52 148.28 69.44 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 126.263 1.825 . . . . 62.43 107.488 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.19 -171.56 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.126 2.551 . . . . 74.04 113.289 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.2 p -85.66 175.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 N-CA-C 108.611 -0.885 . . . . 74.3 108.611 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.457 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.3 t70 -77.58 158.35 78.76 Favored Pre-proline 0 C--O 1.251 1.182 0 CA-C-N 118.89 0.768 . . . . 70.0 109.692 -170.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 68.4 Cg_exo -47.55 170.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.39 2.726 . . . . 74.33 113.855 173.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.685 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 1.2 m-90 65.13 15.46 10.01 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.018 1.727 . . . . 75.21 110.565 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.15 1.67 50.35 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.135 -0.939 . . . . 54.42 114.993 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.685 ' ND2' ' HB2' ' A' ' 108' ' ' TRP . 47.5 m-80 -70.51 128.08 91.46 Favored Pre-proline 0 C--O 1.258 1.544 0 N-CA-C 113.78 1.03 . . . . 70.32 113.78 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 21.1 Cg_exo -67.76 146.64 73.32 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.194 1.929 . . . . 74.42 108.706 166.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -69.64 144.42 52.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.869 -0.789 . . . . 74.03 108.869 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -100.63 113.65 26.68 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.058 -2.201 . . . . 75.31 105.058 -177.269 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.07 119.03 38.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.115 -0.948 . . . . 73.13 111.983 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 88.4 mt -129.33 153.23 48.05 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.251 -1.018 . . . . 71.44 108.251 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.499 ' CB ' ' HD2' ' A' ' 117' ' ' PRO . . . -104.25 -178.62 0.65 Allowed Pre-proline 0 N--CA 1.419 -2.017 0 CA-C-O 116.55 -1.691 . . . . 71.03 108.486 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 122' ' ' PRO . 6.9 Cg_endo -42.33 109.83 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.704 2.936 . . . . 72.04 115.623 -165.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -145.26 -63.04 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.05 -1.072 . . . . 64.53 113.807 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 m -84.65 96.91 9.35 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.509 -1.276 . . . . 71.2 109.105 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.6 mttt 74.7 -27.43 0.19 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.215 1.406 . . . . 74.51 114.254 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -161.22 177.23 37.64 Favored Glycine 0 N--CA 1.427 -1.956 0 C-N-CA 117.637 -2.221 . . . . 72.13 116.552 -170.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.564 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -34.3 -19.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.576 1 C-N-CA 128.608 6.205 . . . . 73.34 120.367 -178.789 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 147' ' ' ASP . 19.3 p90 -171.53 151.9 3.09 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.112 1.324 . . . . 72.43 113.698 171.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.51 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.1 m-20 -112.27 106.8 15.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.02 -1.474 . . . . 73.13 107.02 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.51 128.37 45.55 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.979 -0.688 . . . . 72.2 109.879 -177.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.511 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 33.9 p90 -165.94 165.34 18.17 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 111.927 0.343 . . . . 72.41 111.927 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 t -125.6 138.19 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.296 -1.372 . . . . 73.32 107.296 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.26 128.13 34.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 111.642 0.238 . . . . 75.4 111.642 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.86 171.32 22.51 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.389 -0.684 . . . . 64.33 111.389 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.31 -3.34 1.88 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 115.489 1.662 . . . . 75.43 115.489 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -100.33 -2.11 34.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.796 0.808 . . . . 73.35 109.739 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.95 38.86 64.4 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.037 -0.825 . . . . 73.33 111.037 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -138.84 147.87 43.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.056 -0.72 . . . . 74.2 109.056 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -97.99 103.33 15.26 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 105.976 -1.861 . . . . 74.44 105.976 165.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.53 -172.34 20.29 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.03 -1.441 . . . . 75.42 111.209 -171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.57 8.76 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.472 -1.051 . . . . 74.13 110.472 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.554 ' N ' ' HB3' ' A' ' 141' ' ' ALA . 13.4 m 177.82 -177.67 0.21 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 127.663 2.385 . . . . 70.12 105.895 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -66.49 0.92 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 119.03 0.832 . . . . 75.24 110.341 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.23 -27.71 22.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.108 0.956 . . . . 74.21 111.707 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 9.55 42.86 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.572 0.701 . . . . 63.22 111.448 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.554 ' HB3' ' N ' ' A' ' 137' ' ' SER . . . -103.36 157.41 17.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 115.129 -0.942 . . . . 71.32 109.466 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.45 127.23 31.88 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.991 -1.485 . . . . 74.45 106.991 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.448 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 133.45 37.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.811 -1.181 . . . . 73.23 107.811 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.03 169.59 34.74 Favored Glycine 0 N--CA 1.414 -2.814 0 C-N-CA 117.685 -2.198 . . . . 65.42 114.276 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.409 ' ND2' ' HB1' ' A' ' 58' ' ' ALA . 8.0 t30 -131.36 148.35 52.66 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.141 -1.8 . . . . 71.23 106.141 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -143.61 135.12 26.14 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.637 -0.825 . . . . 74.54 110.346 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.464 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 16.1 t0 -104.66 105.25 15.26 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 105.675 -1.972 . . . . 74.51 105.675 174.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 C--N 1.274 -2.696 0 N-CA-C 105.94 -1.874 . . . . 75.13 105.94 178.1 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.8 ttt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 73.24 109.449 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 m -96.18 91.3 5.85 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.676 0.75 . . . . 72.44 112.66 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 12.6 ptp180 -156.79 165.0 19.72 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 106.859 -1.534 . . . . 75.24 106.859 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -42.79 120.33 1.8 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.864 3.043 . . . . 74.14 114.608 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.65 -31.86 0.23 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 127.575 2.35 . . . . 65.22 113.048 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 10.7 mm100 -68.92 -22.78 64.14 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.967 -1.123 . . . . 75.1 107.967 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.74 -26.1 68.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.659 -1.155 . . . . 72.44 109.912 173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 63.3 mttp -80.6 -26.08 38.06 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.928 -0.768 . . . . 72.13 108.928 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 43.9 t -74.29 -44.57 48.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 122.054 0.931 . . . . 75.03 108.637 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 t -71.11 -30.99 67.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.474 -1.239 . . . . 75.34 112.071 -173.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.63 -40.21 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 120.321 -0.552 . . . . 73.44 110.124 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.53 -31.68 70.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.275 0.56 . . . . 61.41 111.122 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 29.6 mtpp -66.26 -25.43 66.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.989 0.899 . . . . 75.35 111.281 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.96 -30.49 31.55 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.737 -1.345 . . . . 63.45 109.737 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.669 ' O ' HG13 ' A' ' 57' ' ' ILE . 72.9 m-20 -73.33 -38.54 65.76 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.314 -0.443 . . . . 73.1 110.739 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.451 HD12 ' C ' ' A' ' 144' ' ' GLY . 19.0 pt -62.49 -36.2 73.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 121.209 -0.196 . . . . 64.34 111.052 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.87 -30.15 70.24 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.942 -0.703 . . . . 72.33 110.8 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -69.13 -44.35 72.54 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.677 -0.692 . . . . 72.44 111.048 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 53' ' ' ASP . 23.3 mt -63.52 -42.49 96.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-N 115.349 -0.841 . . . . 65.33 109.223 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.54 -27.71 67.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.863 -0.608 . . . . 73.05 111.618 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -76.91 -30.63 56.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.618 0.723 . . . . 73.23 109.416 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.88 -24.45 38.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.172 -0.467 . . . . 73.23 110.115 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.91 -31.25 71.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.37 -1.344 . . . . 74.13 107.37 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 4.5 t70 -66.08 -28.82 69.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.174 -0.921 . . . . 71.42 109.66 170.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.8 ttm -82.82 -28.24 30.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.914 -0.585 . . . . 73.14 110.166 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -72.46 -34.35 67.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.318 -1.364 . . . . 74.14 107.318 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 28.5 ttpp -57.5 -25.76 60.28 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.215 -0.902 . . . . 74.43 109.561 171.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.9 tp -87.3 -36.0 18.12 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 123.386 0.674 . . . . 75.24 111.365 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.51 -27.0 58.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.942 0.401 . . . . 75.11 110.398 -173.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -130.61 24.39 5.08 Favored 'General case' 0 CA--C 1.457 -2.621 0 N-CA-C 112.418 0.525 . . . . 73.31 112.418 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.1 p90 42.65 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 125.015 1.447 . . . . 75.35 113.948 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.24 161.74 1.13 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.747 -0.835 . . . . 63.15 108.747 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.505 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 13.4 m-85 -78.89 155.52 77.75 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 123.617 0.573 . . . . 75.42 110.501 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.513 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 51.0 Cg_endo -73.81 160.74 43.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.341 2.028 . . . . 75.52 110.917 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -92.58 155.74 17.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.096 -1.816 . . . . 73.24 106.096 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 t -70.1 -7.32 40.49 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.61 1.095 . . . . 74.11 111.421 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -103.02 -66.89 0.91 Allowed 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 121.934 -0.479 . . . . 71.44 110.877 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -84.17 -31.65 25.03 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.905 -0.589 . . . . 75.32 112.469 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -78.35 -21.32 70.25 Favored Glycine 0 N--CA 1.409 -3.126 0 C-N-CA 117.54 -2.267 . . . . 74.02 111.316 176.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.89 -46.67 70.99 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 106.602 -1.629 . . . . 75.42 106.602 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.0 -31.62 72.94 Favored 'General case' 0 N--CA 1.396 -3.174 0 CA-C-N 114.918 -1.037 . . . . 73.1 109.358 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.8 -2.21 42.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 73.51 111.917 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.542 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 63.3 mt -98.26 -24.56 15.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.915 -0.584 . . . . 75.21 110.28 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.42 -32.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.367 0.603 . . . . 64.11 110.687 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -117.66 146.43 43.7 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 125.266 1.426 . . . . 74.0 107.158 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -54.59 129.19 62.69 Favored Pre-proline 0 N--CA 1.433 -1.3 0 C-N-CA 123.506 0.722 . . . . 74.3 109.641 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -58.96 126.17 20.32 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 124.214 3.276 . . . . 75.12 113.163 -172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -96.62 91.49 5.77 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-O 122.051 0.929 . . . . 73.3 109.876 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.6 -126.33 1.18 Allowed Glycine 0 N--CA 1.422 -2.284 0 CA-C-N 114.365 -1.289 . . . . 74.13 110.03 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -126.56 91.93 46.29 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 117.208 0.504 . . . . 71.41 109.704 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -97.21 162.91 0.98 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.65 1.567 . . . . 71.31 110.632 172.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -90.33 159.08 42.56 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.41 -1.33 . . . . 74.45 107.41 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.05 98.18 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.441 1.427 . . . . 63.11 111.965 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -151.53 147.43 26.81 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.921 -2.251 . . . . 74.22 104.921 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.26 94.4 8.42 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.831 -0.748 . . . . 74.54 110.128 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -54.05 140.23 32.24 Favored 'General case' 0 C--O 1.251 1.156 0 C-N-CA 124.235 1.014 . . . . 75.1 112.665 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -115.6 132.25 56.69 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.052 -1.431 . . . . 74.12 109.56 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -79.15 -176.88 5.36 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 119.759 -0.776 . . . . 72.13 109.522 175.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' CG ' ' HH ' ' A' ' 114' ' ' TYR . 7.2 t70 69.34 31.06 3.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.437 -1.256 . . . . 73.13 109.477 170.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 92.02 7.15 64.46 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-N 114.469 -1.241 . . . . 75.12 113.534 167.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 62.91 87.57 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.817 -1.179 . . . . 75.1 107.817 -169.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.457 ' HG ' HG12 ' A' ' 57' ' ' ILE . 2.7 tt -129.96 149.88 51.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.902 -1.888 . . . . 74.54 105.902 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -73.8 -178.74 3.32 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.011 -0.366 . . . . 75.43 110.011 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -82.21 73.61 9.23 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.582 1.182 . . . . 74.1 109.504 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -130.64 148.59 70.65 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.859 -1.973 . . . . 72.43 107.256 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.57 177.28 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.05 1.833 . . . . 74.14 111.117 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 3.3 p -82.41 174.67 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.521 -0.918 . . . . 73.31 108.521 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.0 t70 -69.45 139.1 89.12 Favored Pre-proline 0 C--O 1.258 1.503 0 N-CA-C 110.579 -0.156 . . . . 64.22 110.579 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.437 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 6.3 Cg_endo -50.5 172.19 0.09 OUTLIER 'Trans proline' 0 C--O 1.193 -1.744 0 C-N-CA 124.13 3.22 . . . . 74.21 113.301 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.405 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 66.64 14.67 9.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.118 1.367 . . . . 74.33 109.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.21 32.17 81.38 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 55.21 114.671 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.472 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 90.8 m-20 -92.9 119.97 67.44 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 117.629 0.714 . . . . 73.13 110.698 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.465 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 36.8 Cg_exo -68.41 139.58 45.7 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.291 1.327 . . . . 75.23 108.669 167.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.63 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 56.0 m-85 -68.36 144.74 54.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.051 0.453 . . . . 74.01 110.317 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.558 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -102.3 114.06 27.9 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.839 -1.541 . . . . 72.44 106.839 -176.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.422 ' HH ' ' CG ' ' A' ' 97' ' ' ASP . 10.2 m-85 -99.41 118.47 36.11 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.656 -1.239 . . . . 71.42 107.656 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.77 153.64 47.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.763 0.664 . . . . 73.41 109.223 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.492 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . . . -121.85 -179.77 0.82 Allowed Pre-proline 0 N--CA 1.393 -3.302 0 N-CA-C 107.852 -1.166 . . . . 72.42 107.852 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 26.6 Cg_endo -57.82 128.43 29.04 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.066 1.844 . . . . 75.14 114.272 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.17 -89.3 0.44 Allowed Glycine 0 N--CA 1.411 -2.99 0 CA-C-N 114.131 -1.395 . . . . 73.05 111.051 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 p -108.85 101.75 10.83 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 123.028 0.531 . . . . 75.42 110.614 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp 72.63 -3.7 2.29 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.869 1.268 . . . . 71.11 112.444 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.3 123.55 7.29 Favored Glycine 0 N--CA 1.414 -2.792 0 CA-C-O 118.481 -1.177 . . . . 63.1 112.542 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 147' ' ' ASP . 54.4 Cg_exo -60.63 -26.43 82.89 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.109 3.206 . . . . 73.03 110.84 165.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.1 p90 -173.81 168.08 4.33 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.61 0.764 . . . . 72.31 110.019 166.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.61 112.56 8.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.904 -1.147 . . . . 62.54 107.904 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.417 HD22 ' HB ' ' A' ' 57' ' ' ILE . 52.9 tp -128.14 123.97 35.72 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.213 -0.929 . . . . 73.4 110.505 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -168.06 169.06 11.45 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 120.889 -0.324 . . . . 72.24 111.474 -174.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.63 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 22.2 t -125.14 160.69 28.53 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.844 -1.539 . . . . 75.22 106.844 170.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.558 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 89.5 mt -68.83 167.1 16.26 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.307 0.38 . . . . 74.11 110.636 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.65 -170.81 43.51 Favored Glycine 0 CA--C 1.496 -1.143 0 C-N-CA 119.419 -1.372 . . . . 73.3 111.77 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.65 -15.1 36.77 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.391 0.676 . . . . 72.31 112.731 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -94.45 -9.38 35.71 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.205 0.526 . . . . 74.15 110.714 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.8 23.73 66.29 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 121.109 -0.567 . . . . 73.54 112.167 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.01 148.62 42.12 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.47 -0.937 . . . . 70.31 108.47 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.44 105.98 18.06 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.693 0.759 . . . . 53.34 110.835 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.02 -174.32 21.16 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.148 -0.933 . . . . 73.12 111.234 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.74 129.58 9.94 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.577 -1.409 . . . . 61.25 109.577 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.3 m -177.74 -178.49 0.72 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 124.604 1.162 . . . . 63.41 108.275 -171.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -99.67 -25.99 14.21 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.754 -0.378 . . . . 72.21 111.933 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.88 -33.45 2.93 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.608 0.718 . . . . 53.14 110.038 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -95.38 15.21 20.1 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.909 -0.587 . . . . 70.11 110.897 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -87.27 155.32 20.12 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-N 115.994 -0.548 . . . . 63.41 110.043 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.73 129.11 34.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.901 -1.518 . . . . 74.01 106.901 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 143' ' ' ILE . 2.9 pp -96.48 115.92 37.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-O 121.472 0.653 . . . . 75.2 109.301 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -163.97 177.81 39.61 Favored Glycine 0 N--CA 1.417 -2.57 0 C-N-CA 118.756 -1.688 . . . . 72.3 113.719 -176.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.48 146.05 16.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.26 -1.385 . . . . 75.33 107.26 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 16.2 p90 -157.41 168.76 26.4 Favored 'General case' 0 C--N 1.267 -2.999 0 CA-C-O 120.972 0.415 . . . . 74.23 110.798 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 17.3 t70 -105.87 125.19 50.7 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.069 -1.456 . . . . 71.52 107.069 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.423 ' HA ' ' CD ' ' A' ' 122' ' ' PRO . 4.0 p-10 . . . . . 0 N--CA 1.421 -1.882 0 O-C-N 125.01 1.444 . . . . 71.05 108.553 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.5 tpp . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.692 0.282 . . . . 74.15 110.764 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -105.87 91.79 3.89 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.91 -0.494 . . . . 65.54 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -148.69 164.95 19.28 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 106.547 -1.649 . . . . 75.14 106.547 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 44' ' ' GLN . 51.7 Cg_exo -46.98 120.5 4.22 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.204 2.602 . . . . 70.43 112.939 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t70 73.34 -30.07 0.21 Allowed 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 127.135 2.174 . . . . 64.41 110.928 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 42' ' ' PRO . 14.0 mm100 -68.02 -25.17 65.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.224 -0.898 . . . . 74.3 109.516 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.48 65.37 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.314 -0.857 . . . . 71.12 110.328 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -87.65 -26.69 22.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.457 -0.942 . . . . 75.14 108.457 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 37.6 t -74.71 -44.6 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.71 0.767 . . . . 74.22 109.261 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.2 t -59.85 -38.18 81.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.326 -1.306 . . . . 73.33 112.889 -172.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -84.37 -34.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 119.88 -0.728 . . . . 74.45 110.442 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.2 -32.99 71.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.136 -0.484 . . . . 75.13 111.813 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 12.2 mmmm -65.73 -25.33 67.24 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.993 0.902 . . . . 75.43 110.048 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.6 -22.54 39.58 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.632 -0.987 . . . . 60.44 110.632 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 57' ' ' ILE . 75.5 m-20 -82.76 -38.48 23.15 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.671 0.272 . . . . 75.54 110.27 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.7 pt -64.02 -32.53 57.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.432 -0.581 . . . . 75.13 109.432 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -33.03 73.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.907 -0.588 . . . . 70.32 110.621 176.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.64 74.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.023 -0.535 . . . . 63.22 110.334 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 53' ' ' ASP . 55.3 mt -65.09 -37.83 81.21 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 CA-C-N 115.755 -0.657 . . . . 74.14 110.268 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.57 67.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.219 0.533 . . . . 74.04 111.06 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.27 -19.99 24.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.194 0.521 . . . . 34.22 110.251 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -29.02 21.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.226 0.536 . . . . 73.2 110.115 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.92 -30.27 67.64 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.688 -1.597 . . . . 74.55 106.688 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.592 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 31.8 t70 -73.15 -20.51 60.89 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.351 -1.295 . . . . 72.1 109.428 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.2 ttt -79.18 -34.32 43.14 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 115.747 -0.661 . . . . 75.42 109.367 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.429 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 1.3 t80 -64.05 -39.66 94.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.695 -1.595 . . . . 74.23 106.695 172.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.612 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 76.7 tttt -54.61 -33.02 59.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.813 -1.085 . . . . 75.02 110.304 175.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 99.3 mt -82.83 -36.2 25.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.137 -0.483 . . . . 74.53 111.522 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.16 -25.26 63.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.255 0.465 . . . . 70.11 112.255 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 12.0 m-80 -128.67 18.94 6.21 Favored 'General case' 0 CA--C 1.442 -3.209 0 O-C-N 121.962 -0.461 . . . . 74.44 111.062 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 p90 43.37 33.51 0.62 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 125.13 1.519 . . . . 74.11 112.558 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -177.52 156.3 1.16 Allowed 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.709 -1.219 . . . . 71.01 107.709 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.612 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.3 m-85 -78.83 148.6 72.72 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 123.254 0.347 . . . . 74.14 111.257 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 33.6 Cg_endo -66.4 158.41 55.4 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.892 2.394 . . . . 63.01 109.752 174.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.478 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 47.4 p -94.01 156.71 16.46 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.841 -1.17 . . . . 74.43 107.841 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t -66.38 -13.09 60.14 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 119.9 1.227 . . . . 74.11 111.165 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -102.21 -64.75 1.04 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 121.982 -0.449 . . . . 71.2 111.162 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -40.26 60.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 109.096 -0.705 . . . . 72.51 109.096 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.486 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -72.52 -20.75 79.61 Favored Glycine 0 N--CA 1.407 -3.27 0 C-N-CA 119.717 -1.23 . . . . 73.25 113.665 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.06 -47.31 62.49 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.349 -1.352 . . . . 74.24 107.349 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.56 -32.11 70.05 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 115.571 -0.74 . . . . 71.33 110.177 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -83.64 -5.54 59.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.786 0.661 . . . . 51.31 112.786 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 42.1 mt -93.14 -24.21 18.33 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.506 0.669 . . . . 65.31 109.822 174.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 t -102.72 -35.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.403 -0.817 . . . . 75.3 110.533 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 95.4 mttt -126.51 150.9 48.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.732 -1.581 . . . . 75.23 106.732 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -54.22 141.15 52.25 Favored Pre-proline 0 N--CA 1.48 1.063 0 N-CA-C 113.244 0.831 . . . . 74.14 113.244 -172.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.429 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 30.2 Cg_endo -61.15 152.66 70.23 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.974 3.116 . . . . 74.34 114.551 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -110.78 111.19 22.19 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 114.14 -1.391 . . . . 74.33 110.219 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.53 -121.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.769 -0.729 . . . . 70.44 111.583 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -136.96 91.91 14.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 C-N-CA 121.136 -0.226 . . . . 73.32 110.527 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.519 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 18.3 Cg_endo -95.27 161.54 1.6 Allowed 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 121.925 1.75 . . . . 74.21 110.596 172.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -87.63 159.26 49.92 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 106.76 -1.57 . . . . 73.21 106.76 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.55 99.31 0.31 Allowed 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 120.906 1.07 . . . . 73.54 110.684 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -150.84 149.33 29.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.571 -1.64 . . . . 74.11 106.571 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -66.01 97.58 0.38 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.007 0.743 . . . . 75.2 113.007 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.551 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.1 t90 -71.94 143.5 49.26 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.752 -0.658 . . . . 74.45 109.573 171.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -134.95 137.4 43.06 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.604 -0.517 . . . . 75.45 109.604 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -76.46 -166.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.142 -0.688 . . . . 75.14 109.142 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 66.32 8.65 5.8 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.437 1.095 . . . . 73.3 112.509 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 96.0 21.02 24.31 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 115.212 -0.904 . . . . 60.55 111.771 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.6 93.51 0.08 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.322 1.058 . . . . 74.31 111.101 -177.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.43 152.67 48.73 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.122 -0.944 . . . . 74.54 108.98 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.83 -169.05 2.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.976 -1.12 . . . . 74.23 107.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 70.69 0.98 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 122.747 1.261 . . . . 72.25 110.492 174.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.43 148.54 70.52 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 125.765 1.626 . . . . 72.31 108.331 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.63 -168.76 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.425 2.083 . . . . 73.14 110.754 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.622 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.7 p -86.41 174.25 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 106.576 -1.638 . . . . 64.41 106.576 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.433 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 4.3 t70 -97.37 151.59 37.75 Favored Pre-proline 0 C--O 1.252 1.193 0 C-N-CA 117.255 -1.778 . . . . 71.15 110.818 -173.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -38.79 171.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.824 3.683 . . . . 54.22 115.383 166.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.467 ' HB2' HD21 ' A' ' 110' ' ' ASN . 3.5 m-90 67.9 14.5 9.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.386 -1.733 . . . . 71.33 107.064 -171.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.31 29.22 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 114.052 -1.431 . . . . 72.44 114.497 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.467 HD21 ' HB2' ' A' ' 108' ' ' TRP . 54.1 m-80 -92.14 131.57 34.6 Favored Pre-proline 0 C--O 1.261 1.661 0 CA-C-N 117.941 0.871 . . . . 73.34 112.162 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.622 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 16.1 Cg_exo -70.15 148.88 63.52 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.356 2.037 . . . . 75.02 109.516 170.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.509 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 27.7 m-85 -69.59 140.31 53.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.199 -1.0 . . . . 70.01 108.588 175.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -101.57 115.04 29.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.74 -1.578 . . . . 74.33 106.74 -173.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.92 119.81 39.51 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.88 -1.054 . . . . 72.5 112.319 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 83.0 mt -128.57 143.9 51.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.242 -1.021 . . . . 75.4 108.242 172.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -111.17 -178.21 0.52 Allowed Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 107.525 -1.287 . . . . 50.25 107.525 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 37.3 Cg_endo -60.88 130.62 33.6 Favored 'Trans proline' 0 CA--C 1.486 -1.922 0 CA-C-N 121.734 1.655 . . . . 61.4 114.678 -175.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -121.15 -89.83 1.08 Allowed Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 113.028 -1.896 . . . . 72.12 110.889 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.3 m -105.06 106.25 16.65 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 107.675 -1.231 . . . . 71.21 107.675 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt 62.39 -16.22 0.05 Allowed 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 127.962 2.505 . . . . 74.2 115.348 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -102.22 113.15 4.52 Favored Glycine 0 CA--C 1.477 -2.343 0 CA-C-O 118.128 -1.373 . . . . 72.32 113.751 -174.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 34.8 Cg_exo -46.02 -22.76 1.51 Allowed 'Trans proline' 0 C--N 1.376 1.974 1 C-N-CA 126.511 4.807 . . . . 70.42 116.264 177.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.2 p90 179.91 166.76 1.24 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.97 0.508 . . . . 64.43 110.571 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 7.5 m-20 -139.53 108.97 6.15 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.069 0.856 . . . . 73.01 109.251 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -123.46 130.27 52.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.332 -0.547 . . . . 74.02 110.085 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -166.88 161.91 15.52 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 116.544 -0.298 . . . . 74.3 110.714 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 25.1 t -126.01 135.99 52.45 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.573 -1.269 . . . . 73.32 107.573 171.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.23 133.53 55.3 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.089 0.403 . . . . 74.22 112.089 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -86.14 -159.19 32.2 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.889 -0.596 . . . . 55.41 113.384 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -13.05 47.74 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.763 1.394 . . . . 71.54 114.763 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -94.95 -10.09 32.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 119.812 -0.755 . . . . 74.32 110.181 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.18 70.95 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.736 -0.665 . . . . 73.2 112.538 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -140.7 137.75 33.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.469 -0.938 . . . . 74.32 108.469 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.34 112.88 12.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.245 0.545 . . . . 62.3 109.62 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.44 -173.61 20.79 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 108.857 -1.697 . . . . 64.51 108.857 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.51 126.3 8.3 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 118.706 -1.711 . . . . 72.5 109.861 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.6 m 178.08 -178.67 0.26 Allowed 'General case' 0 C--O 1.251 1.146 0 C-N-CA 127.094 2.158 . . . . 75.32 106.713 -174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.01 -56.72 2.76 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.293 -0.563 . . . . 64.15 112.501 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -107.74 -23.64 12.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.239 -0.584 . . . . 75.33 111.391 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.11 -28.82 57.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 121.964 0.888 . . . . 63.1 109.242 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.8 159.41 25.14 Favored 'General case' 0 CA--C 1.47 -2.131 0 CA-C-N 113.572 -1.649 . . . . 73.44 111.033 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -76.65 135.5 39.13 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 107.027 -1.471 . . . . 54.02 107.027 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -97.71 128.85 48.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.394 -0.821 . . . . 74.41 110.295 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -172.55 -179.74 43.55 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 119.325 -1.417 . . . . 73.42 112.269 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.52 155.13 17.07 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.068 -1.456 . . . . 74.34 107.068 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.45 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 3.2 p90 -165.69 177.51 7.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.191 0.519 . . . . 73.2 111.435 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.402 ' OD2' ' HG2' ' A' ' 122' ' ' PRO . 29.7 t70 -116.1 125.59 52.59 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.398 -1.704 . . . . 61.14 106.398 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.491 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 41.0 t30 . . . . . 0 C--N 1.304 -1.388 0 N-CA-C 108.211 -1.033 . . . . 73.45 108.211 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.426 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.4 mpt? . . . . . 0 C--O 1.234 0.274 0 N-CA-C 108.549 -0.908 . . . . 71.04 108.549 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -107.14 82.3 1.66 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.297 0.57 . . . . 63.24 111.669 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -154.55 159.06 32.28 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.177 -1.786 . . . . 75.52 106.177 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.99 138.48 52.53 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.673 2.249 . . . . 72.1 111.305 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 72.99 -35.94 0.34 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.073 1.349 . . . . 72.15 113.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 66.0 mt-30 -74.19 -25.54 59.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.048 -1.093 . . . . 72.51 108.048 175.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.5 64.64 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.878 -1.055 . . . . 52.11 109.847 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HD2' ' HB3' ' A' ' 107' ' ' PRO . 44.0 mmtm -85.32 -25.62 27.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.093 -1.077 . . . . 71.13 108.093 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 86.4 t -74.63 -44.36 46.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.239 -0.891 . . . . 63.13 109.545 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -65.7 -25.45 67.32 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 115.145 -0.934 . . . . 71.12 111.659 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.5 -49.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.747 -0.835 . . . . 74.33 108.747 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' HB3' HD12 ' A' ' 143' ' ' ILE . . . -64.44 -24.74 67.73 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.987 -1.006 . . . . 72.04 112.064 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.1 mmmt -65.74 -26.41 67.72 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.604 0.716 . . . . 73.03 110.762 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.2 -26.94 29.48 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 110.005 -1.238 . . . . 72.22 110.005 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.623 ' O ' HG13 ' A' ' 57' ' ' ILE . 65.7 m-20 -78.26 -38.13 43.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.432 -0.384 . . . . 75.02 110.687 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.459 HG21 ' HA2' ' A' ' 144' ' ' GLY . 19.8 pt -66.61 -38.19 81.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.355 -0.216 . . . . 70.12 111.082 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.5 tptt -69.0 -26.72 65.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.002 0.43 . . . . 70.31 110.121 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -66.93 -45.16 78.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 63.43 110.242 174.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 53' ' ' ASP . 34.1 mt -64.73 -42.27 94.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.729 -0.669 . . . . 63.0 109.507 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.15 -28.4 66.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.865 -0.607 . . . . 53.33 111.235 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.62 -30.1 29.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 64.54 110.02 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.67 -28.1 30.87 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.712 -0.677 . . . . 73.14 110.366 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.48 -30.7 71.09 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.822 -1.177 . . . . 75.12 107.822 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.62 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.8 t70 -71.22 -23.25 61.98 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 122.183 0.992 . . . . 71.11 109.273 173.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 mtt -83.59 -28.43 28.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.726 -0.67 . . . . 64.43 110.724 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.545 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 70.8 t80 -71.55 -36.06 70.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.553 -1.277 . . . . 74.4 107.553 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.641 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 74.8 tttt -53.95 -36.09 62.46 Favored 'General case' 0 C--O 1.208 -1.114 0 CA-C-N 114.917 -1.038 . . . . 70.11 109.108 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.8 tp -76.48 -36.73 57.69 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.011 -0.541 . . . . 74.34 111.333 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.547 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 19.0 t70 -71.95 -23.77 61.5 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 112.035 0.383 . . . . 75.1 112.035 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -129.2 20.03 5.84 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 109.13 -0.693 . . . . 63.11 109.13 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 p90 42.95 32.96 0.46 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.999 1.437 . . . . 72.44 113.602 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 159.1 0.99 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.762 -0.829 . . . . 43.41 108.762 -172.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 23.7 m-85 -78.55 151.48 77.41 Favored Pre-proline 0 N--CA 1.425 -1.717 0 O-C-N 123.486 0.491 . . . . 63.54 111.23 173.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.5 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 30.8 Cg_endo -66.28 162.26 36.89 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.349 2.7 . . . . 73.34 111.055 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 76' ' ' GLN . 69.5 p -98.62 156.33 16.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.27 -1.752 . . . . 65.24 106.27 174.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -67.81 -12.58 60.9 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 119.656 1.116 . . . . 72.23 111.765 -175.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -102.09 -64.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.979 -0.45 . . . . 75.22 110.742 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.408 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 14.9 mm100 -74.12 -40.87 62.37 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 110.253 -0.277 . . . . 70.11 110.253 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.639 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.49 -20.94 79.43 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.088 -1.529 . . . . 64.22 113.458 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.0 -47.37 62.47 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.567 -1.642 . . . . 72.33 106.567 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 30.4 mt-10 -60.98 -33.48 73.29 Favored 'General case' 0 C--O 1.169 -3.175 0 CA-C-N 114.994 -1.003 . . . . 75.02 110.347 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.639 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.35 -7.05 55.44 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.629 . . . . 43.34 111.811 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -95.92 -18.5 20.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.932 -0.576 . . . . 73.45 110.322 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.86 -34.32 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 116.2 -0.454 . . . . 74.44 111.863 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 42.7 pttt -125.97 152.29 45.89 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.564 -2.013 . . . . 74.14 105.564 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 84' ' ' LYS . 3.9 mppt? -54.74 135.08 64.97 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 118.956 0.798 . . . . 73.13 111.813 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.545 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 18.3 Cg_endo -60.87 125.05 16.19 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.944 3.096 . . . . 74.41 113.352 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.0 t -84.1 139.92 32.14 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.429 -1.323 . . . . 73.42 107.429 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.13 -131.84 8.35 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.682 -1.767 . . . . 75.3 108.682 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -127.15 97.4 32.0 Favored Pre-proline 0 C--N 1.299 -1.591 0 CA-C-N 118.088 0.944 . . . . 71.24 111.966 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -92.46 150.25 2.94 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.335 1.356 . . . . 73.54 109.568 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -79.66 160.33 69.8 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.044 -1.095 . . . . 72.03 108.044 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.6 97.63 0.27 Allowed 'Trans proline' 0 C--O 1.249 1.056 0 CA-C-N 120.602 1.251 . . . . 65.2 109.64 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.547 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . 8.2 tmtm? -152.74 147.29 25.91 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.924 -2.25 . . . . 73.54 104.924 -175.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -81.76 92.7 6.68 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.278 -0.969 . . . . 73.44 111.051 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.492 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.9 t90 -54.9 143.69 25.25 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.288 1.035 . . . . 71.33 111.584 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.37 137.2 53.43 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.855 0.862 . . . . 74.41 109.003 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -84.71 -169.06 2.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.011 -0.737 . . . . 71.04 109.011 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t0 71.1 12.47 6.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.304 1.442 . . . . 71.0 110.535 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.52 14.98 30.93 Favored Glycine 0 N--CA 1.425 -2.061 0 CA-C-N 114.341 -1.3 . . . . 74.34 112.946 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.43 91.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 122.633 1.206 . . . . 71.24 109.533 -174.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -123.92 171.26 9.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 113.91 -1.495 . . . . 71.22 109.282 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HG3' ' HB1' ' A' ' 56' ' ' ALA . 73.9 mmtt -94.12 -168.57 1.89 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.396 -1.335 . . . . 72.44 107.396 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.73 70.85 3.26 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.716 1.246 . . . . 73.41 110.535 175.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.1 mt -130.34 147.63 66.59 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 115.064 -0.971 . . . . 54.01 110.715 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.7 -168.52 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.395 2.063 . . . . 75.13 110.526 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.612 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -86.13 173.8 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.556 -0.905 . . . . 75.42 108.556 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.482 ' HB2' ' HD2' ' A' ' 107' ' ' PRO . 4.1 p-10 -72.77 157.58 88.59 Favored Pre-proline 0 C--O 1.249 1.068 0 CA-C-N 118.654 0.661 . . . . 55.32 111.786 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 24.3 Cg_endo -59.8 171.47 2.79 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.615 2.21 . . . . 53.02 113.197 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 68.45 15.09 9.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.503 1.521 . . . . 73.14 110.482 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.2 69.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.135 -0.939 . . . . 64.11 114.132 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.18 142.29 40.96 Favored Pre-proline 0 C--O 1.253 1.249 0 CA-C-N 117.76 0.78 . . . . 74.44 111.26 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.612 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 84.0 Cg_endo -85.04 147.74 10.45 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.491 2.127 . . . . 44.32 111.681 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.33 141.94 56.97 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.564 0.697 . . . . 60.14 110.627 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -104.63 112.84 26.07 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.772 -1.195 . . . . 74.32 107.772 176.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -117.4 118.9 33.48 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.955 -1.02 . . . . 75.3 109.585 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 70.2 mt -127.55 154.56 45.03 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.347 -1.353 . . . . 71.41 107.347 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.734 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -104.13 -178.39 0.62 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 116.592 -1.671 . . . . 64.05 108.669 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.734 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 16.8 Cg_endo . . . . . 0 C--N 1.389 2.71 0 C-N-CA 123.269 2.646 . . . . 71.23 115.113 -165.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.474 -2.528 0 CA-C-O 119.095 -0.836 . . . . 72.12 114.334 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.592 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 2.7 Cg_exo -39.78 -20.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.217 1 C-N-CA 126.941 5.094 . . . . 53.12 116.967 176.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.506 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 48.6 p90 -164.85 168.41 17.74 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.739 0.7 . . . . 73.14 112.134 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.5 m-20 -139.93 107.02 5.45 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.642 1.177 . . . . 74.11 109.662 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.85 140.95 44.56 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 117.363 -1.735 . . . . 63.35 111.998 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.564 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 24.4 p90 -166.52 170.08 13.15 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 71.41 111.727 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 m -124.33 151.22 44.57 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 107.596 -1.261 . . . . 75.44 107.596 174.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.0 mt -74.96 157.89 34.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.854 0.359 . . . . 73.45 110.989 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.85 179.21 49.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.506 -0.854 . . . . 62.22 112.209 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.44 63.11 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.812 0.845 . . . . 73.14 112.882 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -94.79 3.38 55.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.397 0.617 . . . . 73.32 110.844 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.81 34.74 55.77 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 116.246 -0.434 . . . . 50.43 112.585 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -139.96 147.92 41.18 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.827 -0.186 . . . . 74.33 110.526 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -93.47 105.8 17.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.189 0.995 . . . . 75.42 110.649 173.046 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.11 -173.25 20.24 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 115.162 -0.926 . . . . 75.41 111.075 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.38 127.02 8.14 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 108.479 -1.848 . . . . 71.54 108.479 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 57.9 m 179.18 -176.76 0.27 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.264 -1.754 . . . . 72.55 106.264 -171.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.19 -71.86 0.45 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.763 0.711 . . . . 71.2 110.186 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -99.04 -6.12 29.09 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.134 0.492 . . . . 74.43 111.231 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 10.3 m-20 -100.58 7.85 43.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.384 0.611 . . . . 75.12 110.197 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -89.48 156.62 18.53 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.482 -0.781 . . . . 60.52 110.874 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 1.3 p-10 -79.17 129.05 34.05 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.706 -2.331 . . . . 73.52 104.706 172.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.502 HG21 HG13 ' A' ' 47' ' ' VAL . 22.8 pt -114.19 113.79 44.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 CA-C-O 121.663 0.744 . . . . 74.11 110.88 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 126' ' ' TYR . . . -168.05 -179.68 40.72 Favored Glycine 0 N--CA 1.408 -3.184 0 N-CA-C 110.949 -0.86 . . . . 51.01 110.949 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.416 ' C ' HD22 ' A' ' 145' ' ' ASN . 0.2 OUTLIER -151.51 156.19 40.04 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 109.888 -0.412 . . . . 65.44 109.888 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.506 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 7.1 p90 -155.69 177.25 11.6 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 115.3 -0.864 . . . . 74.23 109.226 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -129.93 136.39 49.42 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 123.894 0.746 . . . . 75.21 110.079 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.592 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 30.6 t30 . . . . . 0 C--O 1.255 1.347 0 O-C-N 125.833 1.958 . . . . 75.43 107.299 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.599 ' N ' ' HG1' ' A' ' 48' ' ' THR . 20.1 mmt . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 112.224 0.453 . . . . 71.43 112.224 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -100.36 80.63 2.26 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.901 -1.148 . . . . 52.22 107.901 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -145.53 158.08 51.01 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.311 -1.366 . . . . 40.33 107.311 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.53 123.24 10.98 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.113 2.542 . . . . 74.12 111.873 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t70 75.62 -32.47 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 126.824 2.05 . . . . 40.23 111.772 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.411 ' HA ' HG23 ' A' ' 47' ' ' VAL . 55.8 mt-30 -69.87 -13.9 62.48 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.833 -0.542 . . . . 75.22 110.804 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.42 -27.83 69.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.451 -0.795 . . . . 74.21 109.254 171.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -82.08 -25.72 34.28 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 108.183 -1.043 . . . . 74.13 108.183 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 139' ' ' ASN . 86.9 t -75.11 -43.99 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.656 0.741 . . . . 41.42 110.015 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.599 ' HG1' ' N ' ' A' ' 39' ' ' MET . 6.0 t -66.63 -38.26 86.55 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.91 -1.041 . . . . 65.24 110.993 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.09 -30.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 119.819 -0.752 . . . . 61.44 110.064 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.9 -39.41 81.39 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 115.789 -0.641 . . . . 24.21 111.51 -178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.66 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 67.8 mttm -66.05 -25.43 67.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.211 0.529 . . . . 64.43 111.435 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.73 -34.36 25.08 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.037 -1.225 . . . . 72.12 110.037 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.554 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 m-20 -77.1 -32.95 56.98 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.083 0.771 . . . . 73.02 113.083 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.77 -34.79 62.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.162 -0.336 . . . . 61.41 111.414 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.2 mptp? -69.92 -30.19 67.54 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.531 0.682 . . . . 75.43 109.782 176.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.19 -44.5 91.81 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.175 -0.921 . . . . 64.43 110.21 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 53' ' ' ASP . 76.1 mt -60.9 -39.22 81.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.074 -0.967 . . . . 74.52 110.152 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.527 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . . . -57.73 -35.47 70.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.249 0.343 . . . . 73.44 111.529 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.14 -34.28 70.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.999 0.428 . . . . 73.44 110.112 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.26 -29.35 48.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.476 . . . . 44.14 110.26 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.19 -29.73 67.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.349 -1.352 . . . . 64.43 107.349 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 38.9 m-20 -69.79 -24.46 63.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.509 -0.769 . . . . 72.41 110.961 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.7 mtm -79.25 -34.35 42.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.426 -0.91 . . . . 54.53 109.954 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 90.5 t80 -65.43 -36.79 84.98 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 107.648 -1.242 . . . . 74.14 107.648 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 37.8 ttpt -54.32 -37.74 65.2 Favored 'General case' 0 C--O 1.203 -1.381 0 CA-C-N 115.419 -0.81 . . . . 64.2 110.103 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.04 -27.68 23.04 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.819 -0.752 . . . . 52.23 112.576 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 90' ' ' GLN . 12.7 t70 -76.41 -25.48 54.55 Favored 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 120.034 -0.666 . . . . 71.22 111.289 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.402 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -121.2 22.37 10.91 Favored 'General case' 0 CA--C 1.458 -2.573 0 O-C-N 120.92 -1.112 . . . . 72.42 110.257 174.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 p90 43.29 32.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 125.111 1.507 . . . . 74.12 113.366 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.5 157.35 0.47 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.797 -1.186 . . . . 65.03 107.797 -173.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.53 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 17.0 m-85 -76.07 156.03 84.23 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 109.067 -0.716 . . . . 73.1 109.067 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.517 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 36.3 Cg_endo -64.05 156.78 56.85 Favored 'Trans proline' 0 C--O 1.217 -0.557 0 C-N-CA 122.606 2.204 . . . . 73.43 112.2 -177.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.422 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 62.8 p -93.49 155.38 17.37 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.992 -2.225 . . . . 65.25 104.992 171.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -72.38 -8.48 55.19 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 119.716 1.144 . . . . 64.34 111.097 -174.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -102.58 -66.01 0.96 Allowed 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.903 -0.589 . . . . 75.43 110.741 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -81.13 -35.53 31.44 Favored 'General case' 0 CA--C 1.467 -2.227 0 O-C-N 121.287 -0.883 . . . . 51.35 112.589 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.615 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -72.56 -21.58 79.45 Favored Glycine 0 N--CA 1.417 -2.631 0 C-N-CA 118.014 -2.041 . . . . 73.03 111.562 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.78 -43.62 62.58 Favored 'General case' 0 C--O 1.246 0.912 0 N-CA-C 105.995 -1.854 . . . . 73.11 105.995 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -61.44 -36.53 80.63 Favored 'General case' 0 C--O 1.192 -1.94 0 CA-C-N 114.473 -1.24 . . . . 62.22 110.349 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.457 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -84.54 -3.01 58.2 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.697 0.799 . . . . 55.14 112.598 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 58.0 mt -93.99 -27.31 16.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.498 -0.556 . . . . 73.24 109.498 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.07 -37.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.762 -0.654 . . . . 74.12 111.382 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.9 ttmp? -118.65 149.22 41.77 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.48 -1.674 . . . . 72.41 106.48 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -54.69 132.98 65.05 Favored Pre-proline 0 C--O 1.245 0.83 0 CA-C-O 120.767 0.318 . . . . 71.55 111.246 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -58.41 153.26 48.74 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 124.792 3.661 . . . . 54.45 113.9 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.7 p -90.94 137.82 32.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.38 -0.827 . . . . 72.1 110.174 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.39 -161.33 18.99 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.997 -1.241 . . . . 72.52 109.997 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -111.75 105.08 56.59 Favored Pre-proline 0 N--CA 1.391 -3.378 0 N-CA-C 108.864 -0.791 . . . . 71.14 108.864 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 3.0 Cg_endo -86.31 162.56 9.82 Favored 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 122.954 2.436 . . . . 74.13 110.242 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' A' ' 67' ' ' ASP . 81.2 mm-40 -91.3 111.41 48.66 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 109.608 -0.515 . . . . 74.33 109.608 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -51.1 101.51 0.05 OUTLIER 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 124.336 3.357 . . . . 74.41 117.936 -166.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -135.84 83.52 2.02 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.254 -1.017 . . . . 61.25 108.254 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 16.01 84.16 0.01 OUTLIER 'General case' 0 C--O 1.247 0.929 0 C-N-CA 127.676 2.391 . . . . 61.04 114.058 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.682 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -55.68 137.56 49.13 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.085 0.469 . . . . 65.3 110.917 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.08 129.21 35.67 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.258 -0.883 . . . . 74.41 109.719 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.38 174.27 8.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.876 0.846 . . . . 73.52 110.929 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 66.02 28.55 10.41 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.924 -1.489 . . . . 72.1 110.407 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 99.41 16.38 29.71 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.054 -1.43 . . . . 62.54 115.313 165.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.682 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 2.5 m-85 63.04 90.15 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 122.492 1.139 . . . . 74.13 111.608 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 mt -117.64 171.8 7.78 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.82 -1.082 . . . . 70.24 112.224 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.411 ' HB2' HD22 ' A' ' 103' ' ' LEU . 69.8 mmtt -93.47 -163.4 1.04 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 112.955 -1.93 . . . . 63.1 107.454 174.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.47 28.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.717 1.207 . . . . 73.15 112.944 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 103' ' ' LEU . 2.4 pt? -107.36 148.14 36.57 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.766 -0.584 . . . . 73.11 111.342 -174.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.15 -167.74 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.111 2.54 . . . . 71.25 110.041 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.66 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.97 167.89 2.12 Favored 'Isoleucine or valine' 0 C--O 1.258 1.527 0 N-CA-C 108.287 -1.005 . . . . 74.3 108.287 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 t70 -79.87 151.81 73.95 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 119.761 -0.776 . . . . 50.41 109.554 -171.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 59.7 Cg_exo -44.85 171.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 124.082 3.188 . . . . 54.43 113.953 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.451 ' CD1' ' HA ' ' A' ' 130' ' ' ALA . 2.3 m-90 69.91 14.28 7.93 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 126.127 1.771 . . . . 74.35 109.287 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.78 21.19 58.03 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 114.765 -1.107 . . . . 54.1 112.773 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -92.96 120.86 66.81 Favored Pre-proline 0 C--O 1.254 1.341 0 N-CA-C 112.881 0.697 . . . . 71.51 112.881 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.66 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.1 Cg_exo -59.6 143.91 99.55 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.592 2.195 . . . . 53.55 111.138 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 43.2 m-85 -69.39 143.1 53.76 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.605 -1.258 . . . . 73.23 107.605 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.519 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -103.07 119.65 39.25 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.196 -1.409 . . . . 75.24 107.196 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.26 117.93 34.97 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.289 0.566 . . . . 63.12 111.118 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 88.9 mt -128.8 153.7 47.15 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.525 -0.761 . . . . 65.35 109.044 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.779 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -113.91 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.408 -2.571 0 CA-C-O 117.89 -1.052 . . . . 63.12 109.597 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.779 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 32.2 Cg_endo . . . . . 0 C--N 1.377 2.075 0 C-N-CA 122.493 2.129 . . . . 75.1 114.699 -171.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.483 -1.937 0 CA-C-O 118.136 -1.369 . . . . 62.14 113.431 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 23.2 Cg_exo -41.37 -23.66 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.473 1 C-N-CA 126.905 5.07 . . . . 74.1 117.467 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 146' ' ' TRP . 54.8 p90 -179.51 170.14 1.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.364 0.529 . . . . 65.4 110.114 173.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 16.8 m-20 -137.41 109.0 6.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.997 -0.742 . . . . 73.44 108.997 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.24 126.29 51.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.54 -0.911 . . . . 60.43 108.54 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 113' ' ' GLN . 29.8 p90 -166.92 162.77 15.96 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 122.851 0.094 . . . . 71.04 110.771 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.496 ' HB3' HD11 ' A' ' 143' ' ' ILE . 23.0 t -126.07 143.13 51.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.9 -1.518 . . . . 73.23 106.9 171.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.519 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 87.8 mt -60.07 136.27 57.97 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.351 0.407 . . . . 73.51 110.067 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 141' ' ' ALA . . . -75.32 -164.49 13.84 Favored Glycine 0 C--O 1.229 -0.195 0 C-N-CA 121.111 -0.566 . . . . 35.52 114.058 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.451 ' HA ' ' CD1' ' A' ' 108' ' ' TRP . . . -55.37 -34.47 64.34 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.5 0.926 . . . . 73.04 113.5 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.13 -2.23 53.04 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.707 0.765 . . . . 70.03 109.348 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.73 17.22 80.08 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.8 -0.92 . . . . 43.21 110.8 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -100.46 144.85 28.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 112.072 0.397 . . . . 60.23 112.072 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.11 101.14 11.45 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 103.005 -2.961 . . . . 72.43 103.005 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.24 -173.02 22.76 Favored Glycine 0 CA--C 1.497 -1.093 0 CA-C-N 114.387 -1.278 . . . . 63.42 110.984 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.63 126.54 8.22 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 108.377 -1.889 . . . . 53.44 108.377 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.482 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.6 m 178.07 -178.7 0.26 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 126.746 2.019 . . . . 70.54 106.224 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.76 -58.29 2.14 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.683 -0.858 . . . . 63.02 108.683 171.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.51 ' HA ' HG21 ' A' ' 47' ' ' VAL . 3.0 t-20 -89.09 -38.58 14.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.272 -0.876 . . . . 75.34 111.846 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -90.45 8.68 32.55 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.177 0.513 . . . . 73.52 111.313 -174.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.482 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -104.87 157.54 17.14 Favored 'General case' 0 CA--C 1.477 -1.835 0 CA-C-N 115.585 -0.734 . . . . 71.42 109.828 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.73 136.47 38.17 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 107.149 -1.426 . . . . 72.3 107.149 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -94.73 118.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 121.622 0.725 . . . . 62.42 109.274 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.19 157.0 25.9 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.595 -1.288 . . . . 74.12 114.421 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 58' ' ' ALA . 4.4 t30 -148.92 129.53 14.03 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 125.208 1.403 . . . . 65.44 107.571 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.472 ' HA ' ' CE1' ' A' ' 123' ' ' PHE . 5.1 p90 -160.63 177.18 10.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.212 0.529 . . . . 72.14 111.439 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -115.63 134.27 55.21 Favored 'General case' 0 CA--C 1.472 -2.031 0 N-CA-C 107.725 -1.213 . . . . 53.24 107.725 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 24.9 t-20 . . . . . 0 C--N 1.292 -1.927 0 N-CA-C 107.713 -1.217 . . . . 72.45 107.713 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.653 ' N ' ' HG1' ' A' ' 48' ' ' THR . 1.4 mpt? . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.226 -0.657 . . . . 74.4 109.226 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 m -97.58 74.11 2.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.401 0.619 . . . . 53.25 110.339 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -148.49 158.5 40.42 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.054 -0.975 . . . . 75.11 108.472 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 44' ' ' GLN . 76.1 Cg_exo -50.63 121.25 7.63 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.633 2.889 . . . . 55.43 112.771 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t0 76.88 -26.4 0.19 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.023 1.729 . . . . 72.43 110.778 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 42' ' ' PRO . 15.5 mm100 -70.96 -17.0 62.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.204 -0.907 . . . . 65.24 108.702 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.37 68.91 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.231 -0.895 . . . . 74.32 109.75 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 55.3 mttp -83.75 -25.68 30.31 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 108.549 -0.908 . . . . 71.54 108.549 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 52.0 t -74.79 -43.03 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.615 0.722 . . . . 74.01 109.494 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.653 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.4 t -63.99 -31.85 73.18 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.034 -0.984 . . . . 72.25 111.718 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -79.8 -39.63 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 119.533 -0.867 . . . . 71.33 109.565 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.81 -39.22 80.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.254 1.022 . . . . 71.23 112.356 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -65.72 -24.92 67.08 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.256 0.551 . . . . 63.22 111.141 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.21 -27.88 21.86 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.093 -0.803 . . . . 64.53 111.093 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.75 -38.98 57.94 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.168 0.509 . . . . 73.1 110.624 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 pt -66.31 -35.12 74.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.011 -0.541 . . . . 75.52 109.897 174.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 9.6 tptp -68.89 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 73.12 109.74 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.54 -40.73 97.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.31 -0.859 . . . . 61.14 109.614 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 125' ' ' LEU . 74.3 mt -66.14 -35.12 74.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 115.014 -0.994 . . . . 72.32 110.665 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -27.49 69.29 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.279 0.562 . . . . 75.54 111.018 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.19 -33.44 29.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.695 0.759 . . . . 63.34 109.413 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.12 53.71 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.562 -0.745 . . . . 51.22 110.886 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.456 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -68.27 -30.18 69.14 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 72.44 108.571 178.366 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.528 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 3.2 t70 -66.49 -30.43 70.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 71.43 109.64 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 88.8 mtp -74.66 -33.92 62.61 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.962 -0.563 . . . . 73.2 110.212 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -71.55 -36.18 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.219 -0.66 . . . . 74.04 109.219 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 15.5 pttp -67.74 -16.39 64.11 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 119.123 -1.031 . . . . 71.43 109.269 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.1 tp -88.65 -36.12 16.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.838 -1.074 . . . . 75.53 109.808 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 23.9 t70 -75.17 -24.55 57.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.026 0.38 . . . . 63.12 112.026 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.77 24.48 5.71 Favored 'General case' 0 CA--C 1.464 -2.361 0 C-N-CA 119.747 -0.781 . . . . 75.5 109.637 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.34 32.48 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.418 1.487 . . . . 71.24 113.925 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.03 161.23 0.57 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.701 -1.222 . . . . 73.33 107.701 -174.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.615 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 16.4 m-85 -77.14 155.07 82.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 123.475 0.485 . . . . 73.24 110.816 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.46 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.0 Cg_endo -63.59 162.12 29.11 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.142 2.561 . . . . 73.14 112.457 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.0 p -98.32 155.24 17.3 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 105.507 -2.034 . . . . 73.35 105.507 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.71 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.79 -11.55 60.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 119.56 1.073 . . . . 72.34 111.549 -173.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -102.02 -65.42 0.99 Allowed 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.855 -0.612 . . . . 72.31 110.295 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -77.14 -39.52 48.95 Favored 'General case' 0 CA--C 1.493 -1.222 0 O-C-N 122.079 -0.388 . . . . 74.32 111.044 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.601 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -77.18 -21.17 74.09 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 118.529 -1.796 . . . . 62.45 112.961 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 82' ' ' VAL . 6.3 tt -70.27 -49.99 44.16 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.644 -1.243 . . . . 65.31 107.644 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.3 -23.92 64.8 Favored 'General case' 0 C--O 1.188 -2.139 0 CA-C-N 115.289 -0.868 . . . . 75.5 110.104 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.502 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -80.21 -7.11 58.82 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.164 -0.471 . . . . 73.12 111.945 176.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 96.4 mt -91.56 -24.82 19.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.646 -0.872 . . . . 71.11 108.646 171.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 78' ' ' LEU . 21.8 t -90.84 -47.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.964 -1.016 . . . . 72.25 110.942 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -117.75 151.25 37.66 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 125.904 1.681 . . . . 73.13 108.411 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -53.34 129.49 51.66 Favored Pre-proline 0 C--O 1.249 1.059 0 N-CA-C 108.955 -0.757 . . . . 62.51 108.955 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 29.8 Cg_endo -58.5 127.36 24.37 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 124.067 3.178 . . . . 62.32 113.05 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -93.16 107.94 19.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.503 -0.771 . . . . 74.42 110.155 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.49 -133.06 3.94 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 109.065 -1.614 . . . . 43.42 109.065 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -125.02 87.79 54.97 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 117.781 0.791 . . . . 63.44 112.733 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.85 163.0 6.13 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 122.818 2.345 . . . . 53.42 108.455 171.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -108.37 148.03 36.82 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 108.952 -0.759 . . . . 73.21 108.952 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.462 ' C ' ' HD2' ' A' ' 92' ' ' LYS . 74.5 Cg_exo -50.82 98.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.63 2.886 . . . . 62.45 116.089 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 2.6 mptp? -147.27 148.75 31.76 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 127.641 2.377 . . . . 61.54 106.618 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -73.69 89.27 1.76 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 111.632 0.234 . . . . 73.03 111.632 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.628 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.2 t90 -54.96 143.76 25.29 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.59 1.156 . . . . 73.43 112.224 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 15.5 t-20 -126.39 137.02 53.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.158 -0.928 . . . . 73.03 111.137 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -86.23 173.79 9.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.659 0.742 . . . . 74.14 111.502 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.9 t70 69.08 15.32 8.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.497 -1.229 . . . . 64.05 112.435 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 119.6 8.81 8.84 Favored Glycine 0 CA--C 1.494 -1.276 0 C-N-CA 119.529 -1.319 . . . . 63.1 114.437 168.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.628 ' OH ' ' HA ' ' A' ' 94' ' ' TRP 0.268 0.3 OUTLIER 65.67 78.56 0.27 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 123.231 1.491 . . . . 75.12 110.787 -174.458 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -121.42 169.09 10.97 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 112.715 -2.038 . . . . 73.11 107.769 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.01 -164.5 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.26 -1.015 . . . . 72.14 108.26 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.45 68.34 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 122.655 1.217 . . . . 74.22 109.275 173.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 148.63 70.84 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 114.564 -1.198 . . . . 73.52 111.0 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -168.2 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.058 2.505 . . . . 72.11 110.795 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.661 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 9.6 p -79.59 166.47 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 108.95 -0.759 . . . . 53.22 108.95 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.37 153.88 76.63 Favored Pre-proline 0 C--O 1.252 1.194 0 N-CA-C 108.805 -0.813 . . . . 65.03 108.805 -172.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.474 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 77.2 Cg_exo -50.0 172.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.432 2.755 . . . . 74.22 114.549 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.486 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 2.2 m-90 69.92 15.16 7.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.64 1.976 . . . . 64.22 109.66 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 13.67 52.77 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.83 -1.077 . . . . 60.24 114.152 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.15 132.96 43.81 Favored Pre-proline 0 N--CA 1.424 -1.769 0 CA-C-O 121.832 0.825 . . . . 74.41 111.595 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.661 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 71.8 Cg_endo -75.13 154.94 42.23 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 122.716 2.278 . . . . 70.53 111.142 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.68 136.37 48.99 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 106.898 -1.519 . . . . 74.44 106.898 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -102.66 114.06 27.97 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 105.225 -2.139 . . . . 73.42 105.225 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.443 ' CZ ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -104.4 118.35 36.4 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.303 -0.862 . . . . 65.02 109.996 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 93.5 mt -129.35 153.18 48.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.758 -0.83 . . . . 52.33 108.758 176.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.715 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -108.78 -177.31 0.46 Allowed Pre-proline 0 N--CA 1.412 -2.35 0 CA-C-O 116.588 -1.672 . . . . 63.25 107.633 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.715 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.2 Cg_endo . . . . . 0 C--N 1.386 2.54 0 C-N-CA 122.653 2.235 . . . . 74.04 115.35 -165.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.489 -1.561 0 CA-C-O 118.986 -0.897 . . . . 72.05 114.597 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.587 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -39.2 -20.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.062 1 C-N-CA 127.201 5.267 . . . . 53.3 118.025 177.415 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.3 p90 -170.98 165.65 7.57 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.605 0.639 . . . . 73.14 110.059 173.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 19.6 m-20 -135.08 110.37 8.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.487 -0.931 . . . . 74.02 108.487 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.522 HD11 HD12 ' A' ' 57' ' ' ILE . 3.4 tm? -118.81 129.54 55.28 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.116 -0.698 . . . . 74.53 109.116 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -166.97 168.72 13.65 Favored 'General case' 0 C--O 1.204 -1.322 0 O-C-N 123.492 0.495 . . . . 72.44 109.9 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 15.6 m -124.13 142.28 51.35 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.354 -2.091 . . . . 74.03 105.354 171.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.44 143.09 50.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.932 -0.707 . . . . 53.33 111.748 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.68 174.48 11.09 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 116.026 -0.534 . . . . 75.12 113.826 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.96 5.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.593 1.331 . . . . 65.33 114.593 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.12 -10.18 34.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.365 -0.976 . . . . 71.03 108.365 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.74 88.16 Favored Glycine 0 CA--C 1.507 -0.434 0 CA-C-N 115.502 -0.772 . . . . 33.13 111.534 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -140.62 151.31 44.53 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 106.486 -1.672 . . . . 62.42 106.486 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.645 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -66.75 113.02 4.54 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.86 -0.422 . . . . 70.33 109.86 -173.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -140.52 -173.34 13.36 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 116.29 -0.414 . . . . 73.03 112.696 -174.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -139.8 127.84 3.72 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.333 -0.937 . . . . 42.11 111.782 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 74.2 m 178.81 -177.98 0.29 Allowed 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 128.38 2.672 . . . . 60.22 105.07 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.14 -54.0 47.31 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.862 1.21 . . . . 71.02 111.454 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -105.12 -14.63 15.33 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.629 -0.829 . . . . 74.33 112.468 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 16.7 m-20 -95.31 9.37 40.08 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.774 -0.77 . . . . 73.33 111.21 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -87.41 155.08 20.18 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 109.059 -0.719 . . . . 61.23 109.059 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 42.1 m-20 -79.26 124.09 28.05 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.09 -1.818 . . . . 74.23 106.09 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.19 120.82 46.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 CA-C-N 115.956 -0.565 . . . . 73.24 109.95 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.28 177.54 40.61 Favored Glycine 0 N--CA 1.412 -2.964 0 C-N-CA 119.348 -1.406 . . . . 63.43 112.878 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -162.02 158.67 25.35 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.112 -1.81 . . . . 73.13 106.112 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 5.4 p90 -168.94 177.57 4.9 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.429 0.633 . . . . 65.4 112.623 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -109.88 121.61 45.62 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.611 -1.626 . . . . 74.04 106.611 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.342 0 O-C-N 124.24 0.962 . . . . 71.4 110.557 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 N-CA-C 106.135 -1.802 . . . . 74.23 106.135 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -113.47 83.38 1.83 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.828 0.677 . . . . 73.31 112.828 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -153.22 165.83 16.82 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.088 -1.449 . . . . 75.05 107.088 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -49.24 139.35 27.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.55 2.167 . . . . 73.12 111.043 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.15 -49.0 0.53 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.258 1.423 . . . . 61.21 110.0 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.447 ' OE1' ' HB3' ' A' ' 138' ' ' ASP . 74.8 mm-40 -68.52 -23.36 64.53 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.419 -1.264 . . . . 75.21 110.166 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.09 -26.37 68.19 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.504 0.722 . . . . 71.23 110.579 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -85.46 -24.19 27.51 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.39 -0.596 . . . . 72.03 109.39 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.18 -42.18 51.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.955 -0.757 . . . . 53.01 108.955 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.7 t -67.84 -25.88 65.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.471 -0.786 . . . . 73.43 112.387 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.8 -37.79 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 119.609 -0.836 . . . . 74.41 109.462 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -58.73 -33.93 70.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.252 1.021 . . . . 63.24 111.505 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 73.7 mmtt -65.44 -26.15 67.83 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.801 0.81 . . . . 73.04 110.217 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.56 -33.31 10.34 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.378 -1.089 . . . . 71.2 110.378 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 33.1 m-20 -71.95 -33.7 68.4 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.999 0.428 . . . . 61.21 111.718 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.466 HD12 ' C ' ' A' ' 144' ' ' GLY . 11.5 pt -68.04 -34.09 64.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.8 -0.36 . . . . 54.34 110.28 172.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 14.0 mptt -65.76 -29.79 70.34 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.997 0.427 . . . . 52.0 110.787 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.48 -40.42 93.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 44.44 110.011 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.405 HG12 ' HG ' ' A' ' 100' ' ' LEU . 70.3 mt -67.15 -34.31 68.67 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-N 115.191 -0.913 . . . . 73.41 110.627 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . . . -59.68 -35.63 74.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.944 0.402 . . . . 63.45 110.448 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.86 -31.9 63.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.298 0.571 . . . . 51.2 109.903 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.02 -28.3 43.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.801 -0.636 . . . . 64.23 110.601 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.79 -31.15 69.95 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.361 -1.348 . . . . 75.43 107.361 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.7 m-20 -72.79 -18.26 61.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.72 -0.673 . . . . 70.11 110.353 171.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.7 mtm -84.26 -31.16 25.1 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 121.995 -0.441 . . . . 74.11 111.632 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.64 -37.11 70.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.07 -1.456 . . . . 72.42 107.07 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.582 ' HD2' ' CE1' ' A' ' 71' ' ' TYR . 86.0 tttt -54.94 -31.28 60.29 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.733 -1.121 . . . . 75.25 109.605 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.5 tp -83.5 -35.41 24.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.479 -0.782 . . . . 73.45 110.531 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 23.6 t70 -78.49 -25.55 45.74 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.209 0.448 . . . . 65.4 112.209 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.444 HD22 ' HB2' ' A' ' 85' ' ' PRO . 2.8 m120 -125.94 22.35 7.39 Favored 'General case' 0 CA--C 1.461 -2.457 0 O-C-N 121.398 -0.814 . . . . 55.34 110.881 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 p90 43.18 34.16 0.65 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.858 1.263 . . . . 63.31 113.703 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.7 161.3 0.67 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.664 -1.236 . . . . 71.54 107.664 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.582 ' CE1' ' HD2' ' A' ' 65' ' ' LYS . 12.3 m-85 -75.9 161.47 75.58 Favored Pre-proline 0 C--N 1.309 -1.172 0 O-C-N 123.367 0.417 . . . . 73.54 111.717 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.532 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 1.7 Cg_endo -78.44 164.11 26.58 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.226 1.951 . . . . 73.44 109.363 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 p -97.78 156.43 16.57 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.931 -1.877 . . . . 51.01 105.931 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -4.12 31.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.13 -1.428 . . . . 53.5 111.051 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -102.8 -67.65 0.87 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.772 -0.649 . . . . 75.11 109.648 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -80.58 -34.99 34.88 Favored 'General case' 0 CA--C 1.487 -1.481 0 CA-C-N 115.973 -0.558 . . . . 71.24 111.468 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.568 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.34 -20.51 78.78 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 118.225 -1.941 . . . . 71.35 112.696 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.97 -50.86 37.63 Favored 'General case' 0 C--O 1.26 1.606 0 N-CA-C 107.53 -1.285 . . . . 62.45 107.53 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 8.5 pt-20 -65.19 -28.25 69.26 Favored 'General case' 0 C--O 1.17 -3.09 0 CA-C-N 114.866 -1.061 . . . . 73.41 109.824 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.526 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.44 -6.16 52.44 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.629 0.603 . . . . 60.13 112.629 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 95.5 mt -95.38 -19.43 19.93 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.161 0.505 . . . . 54.45 110.014 172.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.5 t -98.53 -39.43 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.565 1.174 . . . . 64.22 110.715 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 25.1 tttm -121.29 148.3 44.49 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 127.521 2.328 . . . . 70.43 107.659 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -56.76 132.84 78.66 Favored Pre-proline 0 N--CA 1.475 0.775 0 O-C-N 123.141 0.275 . . . . 72.24 111.542 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HB2' HD22 ' A' ' 68' ' ' ASN . 37.6 Cg_endo -63.44 128.74 23.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 123.327 2.684 . . . . 74.31 112.096 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -90.99 105.5 17.87 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.5 -0.773 . . . . 75.33 110.238 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.27 7.69 Favored Glycine 0 N--CA 1.418 -2.528 0 N-CA-C 109.906 -1.278 . . . . 73.12 109.906 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -118.62 88.2 33.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.936 0.368 . . . . 74.15 110.902 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 13.8 Cg_endo -92.69 159.4 2.86 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.707 1.605 . . . . 63.12 109.438 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -88.21 159.12 48.47 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.047 -0.723 . . . . 74.42 109.047 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.39 99.21 0.2 Allowed 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 121.692 1.595 . . . . 74.54 111.427 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.594 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.55 148.25 28.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.899 -1.889 . . . . 72.05 105.899 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.594 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 51.3 m-80 -65.48 91.36 0.12 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 122.373 -0.204 . . . . 74.44 111.503 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.507 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.2 t90 -66.6 140.27 57.93 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.483 -0.562 . . . . 72.34 109.483 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -127.95 134.47 49.31 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.811 -0.811 . . . . 55.41 108.811 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 65.3 pttt -75.58 -169.36 1.02 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.319 -0.993 . . . . 52.54 108.319 174.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.426 ' HB2' ' HG3' ' A' ' 96' ' ' LYS . 27.7 t70 67.64 15.3 9.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.973 0.892 . . . . 71.32 110.819 169.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 102.95 9.79 38.86 Favored Glycine 0 CA--C 1.495 -1.214 0 CA-C-N 114.995 -1.002 . . . . 72.43 113.855 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.2 OUTLIER 61.88 92.37 0.06 Allowed 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 122.085 0.945 . . . . 74.34 109.601 -173.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 101' ' ' LYS . 2.7 tt -128.91 155.63 44.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.014 -1.847 . . . . 72.54 106.014 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.447 ' H ' HD23 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.97 -171.93 0.35 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.053 -0.351 . . . . 64.25 110.053 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 28.81 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.797 1.036 . . . . 63.13 113.797 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.41 147.99 35.55 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 109.296 -0.631 . . . . 74.23 109.296 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.98 -167.96 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.975 2.45 . . . . 71.13 111.897 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.608 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.0 175.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.417 -0.957 . . . . 64.24 108.417 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.571 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.7 t70 -78.73 159.92 73.04 Favored Pre-proline 0 C--O 1.256 1.44 0 CA-C-N 119.081 0.855 . . . . 72.12 109.173 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.571 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 4.0 Cg_endo -49.05 170.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 123.551 2.834 . . . . 53.42 113.242 173.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 66.71 14.56 9.83 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.437 1.895 . . . . 72.21 110.931 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 -0.65 34.86 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.804 -0.635 . . . . 50.21 114.002 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.9 135.45 87.6 Favored Pre-proline 0 C--O 1.263 1.791 0 CA-C-O 121.451 0.643 . . . . 74.34 112.077 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.608 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 92.2 Cg_endo -80.22 154.12 21.82 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 C-N-CA 122.118 1.879 . . . . 73.43 110.035 174.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -74.4 143.17 44.9 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.651 -1.24 . . . . 73.31 107.651 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -102.18 113.89 27.56 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 104.656 -2.35 . . . . 74.34 104.656 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.56 118.21 36.49 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.988 -1.006 . . . . 70.32 111.882 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 87.8 mt -129.11 144.19 51.12 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.107 -0.951 . . . . 62.03 109.242 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -101.59 -177.0 0.5 Allowed Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 104.404 -2.443 . . . . 75.21 104.404 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 Cg_endo . . . . . 0 C--N 1.385 2.491 0 CA-C-N 123.179 2.171 . . . . 53.32 113.015 -168.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.491 -1.415 0 CA-C-O 118.887 -0.951 . . . . 70.42 114.112 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.5 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 33.5 Cg_exo -38.61 -27.08 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.131 1 C-N-CA 127.163 5.242 . . . . 54.42 117.992 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -173.2 146.71 1.47 Allowed 'General case' 0 C--O 1.249 1.039 0 CA-C-N 119.071 0.85 . . . . 74.3 111.859 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.2 m-20 -118.48 106.61 12.86 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.142 -1.429 . . . . 62.55 107.142 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.3 129.52 46.45 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 120.886 -1.134 . . . . 72.0 110.76 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -165.21 166.46 18.88 Favored 'General case' 0 C--O 1.194 -1.832 0 CA-C-N 116.845 -0.161 . . . . 73.24 111.251 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.0 t -125.28 139.94 53.27 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 63.11 105.649 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.13 155.29 20.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.914 1.079 . . . . 74.12 113.914 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.75 165.15 37.76 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 110.774 -0.931 . . . . 71.41 110.774 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.46 -24.01 4.56 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 115.924 1.824 . . . . 65.1 115.924 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.27 -1.72 28.34 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.575 -0.703 . . . . 74.02 111.603 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.49 38.49 5.0 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.466 -0.873 . . . . 72.22 113.813 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -130.34 147.84 52.1 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.305 -0.628 . . . . 72.11 109.305 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 9.4 pt-20 -101.89 105.46 16.28 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.077 -1.453 . . . . 74.01 107.077 167.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.18 -173.73 21.39 Favored Glycine 0 C--N 1.29 -1.991 0 N-CA-C 110.395 -1.082 . . . . 54.33 110.395 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.91 129.78 10.01 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.687 -1.365 . . . . 45.33 109.687 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.56 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.9 t 179.59 -178.39 0.38 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.735 -1.58 . . . . 70.22 106.735 -172.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.447 ' HB3' ' OE1' ' A' ' 44' ' ' GLN . 4.3 m-20 -87.26 -66.8 0.87 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.345 -0.613 . . . . 74.35 109.345 173.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.83 -30.73 14.67 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.928 -1.033 . . . . 74.43 111.908 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.76 17.88 16.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.649 0.738 . . . . 70.04 110.907 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.56 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -100.67 155.75 17.71 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-N 114.943 -1.026 . . . . 71.11 109.554 176.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.516 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.8 p-10 -79.13 135.06 36.72 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.397 -1.334 . . . . 65.23 107.397 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.59 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -104.18 123.64 58.11 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-N 115.728 -0.669 . . . . 75.24 109.623 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.466 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -159.29 179.81 34.63 Favored Glycine 0 N--CA 1.412 -2.911 0 C-N-CA 118.878 -1.63 . . . . 24.44 112.702 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.521 ' OD1' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -137.5 150.4 47.52 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 105.774 -1.935 . . . . 61.44 105.774 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -143.87 144.54 31.79 Favored 'General case' 0 C--N 1.267 -3.013 0 C-N-CA 119.269 -0.972 . . . . 72.12 110.003 -165.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -127.38 95.68 4.34 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.87 -1.53 . . . . 65.45 106.87 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.6 t30 . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 113.816 -1.538 . . . . 72.22 107.676 -176.725 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.571 ' N ' ' HG1' ' A' ' 48' ' ' THR . 11.8 ttt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.55 -1.278 . . . . 71.14 107.55 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.9 m -104.94 86.66 2.49 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.902 0.704 . . . . 71.43 112.902 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -153.77 159.75 31.72 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.184 -1.413 . . . . 73.42 107.184 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.09 125.55 16.55 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.681 2.254 . . . . 74.34 111.787 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 75.95 -33.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.779 2.032 . . . . 44.02 111.55 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HA ' HG23 ' A' ' 47' ' ' VAL . 63.7 mt-30 -70.0 -20.7 63.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.784 0.802 . . . . 55.42 109.217 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.85 64.29 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.715 -1.13 . . . . 72.02 110.13 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 91.6 mttt -89.25 -25.08 21.9 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.766 -0.827 . . . . 71.55 108.766 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' A' ' 44' ' ' GLN . 44.9 t -74.39 -43.89 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 108.34 -0.985 . . . . 73.23 108.34 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.571 ' HG1' ' N ' ' A' ' 39' ' ' MET . 12.0 t -66.26 -29.59 69.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.403 -1.271 . . . . 73.25 111.831 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -83.87 -33.75 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.039 -0.665 . . . . 71.1 110.248 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' A' ' 143' ' ' ILE . . . -71.95 -34.27 68.86 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.752 -0.658 . . . . 73.14 111.587 -176.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.624 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 57.2 mtpt -70.39 -25.45 63.25 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.769 -0.772 . . . . 73.12 111.97 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.06 -26.21 45.6 Favored Glycine 0 C--O 1.246 0.88 0 N-CA-C 109.495 -1.442 . . . . 53.34 109.495 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.593 ' O ' HG13 ' A' ' 57' ' ' ILE . 20.7 t70 -77.32 -38.38 50.57 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.265 -0.967 . . . . 61.34 109.391 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 51' ' ' LYS . 20.3 pt -65.92 -30.39 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 122.202 -0.311 . . . . 73.52 110.823 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.624 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.2 mptm? -71.08 -27.3 63.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.571 -0.452 . . . . 72.13 110.277 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -69.92 -48.87 56.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.568 -0.742 . . . . 60.42 110.243 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.65 ' HB ' HD21 ' A' ' 125' ' ' LEU . 30.6 mt -61.06 -42.6 93.77 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 115.192 -0.913 . . . . 73.01 108.985 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -28.91 68.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.502 . . . . 61.12 111.876 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.04 -24.21 35.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.512 0.672 . . . . 73.14 109.606 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.05 29.76 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.754 -0.832 . . . . 51.55 108.754 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -68.77 -31.14 69.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.211 -1.403 . . . . 73.53 107.211 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.3 m-20 -68.92 -24.25 64.27 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.911 -0.586 . . . . 72.3 110.007 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 mmt -78.35 -34.98 48.06 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 120.889 -0.324 . . . . 71.12 111.305 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.551 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 58.7 t80 -69.8 -36.66 75.87 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.55 -1.278 . . . . 72.01 107.55 174.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.56 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 80.9 tttt -54.34 -35.36 62.64 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 114.876 -1.056 . . . . 72.41 110.485 173.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 95.6 mt -87.0 -29.09 22.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 116.199 -0.455 . . . . 73.33 111.317 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t70 -78.2 -24.37 47.16 Favored 'General case' 0 C--O 1.201 -1.451 0 CA-C-O 120.632 0.253 . . . . 72.25 111.383 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -128.99 24.38 5.64 Favored 'General case' 0 CA--C 1.469 -2.14 0 N-CA-C 109.175 -0.676 . . . . 74.4 109.175 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.6 p90 42.97 31.44 0.33 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 126.131 1.772 . . . . 70.42 114.736 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.41 162.33 0.51 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.66 -1.237 . . . . 73.53 107.66 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.4 m-85 -76.6 153.57 83.54 Favored Pre-proline 0 C--N 1.296 -1.739 0 C-N-CA 120.252 -0.579 . . . . 63.12 110.274 173.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 20.8 Cg_endo -61.98 164.37 16.94 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 123.28 2.653 . . . . 42.53 110.904 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.428 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 37.8 p -95.05 155.36 16.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.354 -1.721 . . . . 64.5 106.354 173.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.608 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.05 -12.8 62.01 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 119.837 1.199 . . . . 61.31 110.503 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -102.48 -65.24 1.0 Allowed 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.938 -1.028 . . . . 75.15 110.746 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -84.79 -29.23 25.58 Favored 'General case' 0 CA--C 1.478 -1.797 0 O-C-N 121.885 -0.509 . . . . 74.45 111.387 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.53 -20.79 79.46 Favored Glycine 0 N--CA 1.411 -3.022 0 C-N-CA 119.202 -1.475 . . . . 64.14 111.818 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.46 -46.14 70.58 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.226 -1.768 . . . . 72.42 106.226 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.96 -21.66 66.43 Favored 'General case' 0 C--O 1.17 -3.103 0 CA-C-N 114.762 -1.108 . . . . 74.14 110.814 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.693 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -89.89 -4.22 57.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.656 0.741 . . . . 71.35 111.351 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.455 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 4.7 mp -99.51 -21.21 16.03 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.521 -0.763 . . . . 61.13 110.086 174.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 35.9 t -108.01 -30.97 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 115.985 -0.552 . . . . 73.45 110.737 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.7 mptp? -122.57 150.5 42.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.018 1.327 . . . . 71.05 107.978 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -54.9 135.71 66.23 Favored Pre-proline 0 N--CA 1.48 1.05 0 CA-C-N 118.405 0.548 . . . . 72.41 111.351 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.551 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 13.5 Cg_endo -53.04 153.09 16.51 Favored 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 124.633 3.556 . . . . 75.44 114.1 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 p -98.96 132.49 44.24 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.788 -0.642 . . . . 62.52 109.844 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.79 -137.38 14.26 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.903 -1.279 . . . . 71.43 109.903 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -129.7 105.85 17.09 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 117.362 0.581 . . . . 73.02 110.364 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -85.54 162.94 10.94 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.072 1.848 . . . . 74.35 108.979 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.14 156.69 46.22 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.446 -0.946 . . . . 71.34 108.446 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -58.45 98.76 0.1 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.583 2.189 . . . . 73.1 116.08 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 66' ' ' LEU . 67.5 mttm -151.32 148.52 28.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.545 1.938 . . . . 70.24 107.757 172.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -82.13 97.35 8.15 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.815 -0.354 . . . . 64.44 110.304 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.543 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.2 t90 -54.68 142.74 27.32 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.554 1.142 . . . . 65.54 112.696 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -123.85 136.96 54.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.956 -1.02 . . . . 72.23 109.212 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -81.09 -163.9 0.67 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 75.32 108.208 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 61.96 23.61 13.93 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.297 0.639 . . . . 74.41 110.915 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 78.54 24.41 62.94 Favored Glycine 0 CA--C 1.48 -2.12 0 CA-C-N 114.981 -1.009 . . . . 54.43 112.819 171.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 63.39 78.1 0.3 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 123.136 1.446 . . . . 70.0 109.138 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.438 HD12 HG12 ' A' ' 57' ' ' ILE . 63.0 tp -117.67 166.9 11.86 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.041 -1.89 . . . . 71.32 107.861 -172.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.64 -174.72 5.43 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 75.13 109.299 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 35.35 1.03 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.516 1.151 . . . . 63.24 110.395 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.04 149.07 40.34 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 113.804 -1.543 . . . . 54.1 108.842 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.29 177.08 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.483 2.789 . . . . 74.54 113.835 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.571 HG21 ' HA ' ' A' ' 111' ' ' PRO . 5.1 p -79.39 175.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.41 -0.814 . . . . 75.51 109.066 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.3 p-10 -69.89 158.68 86.64 Favored Pre-proline 0 C--O 1.258 1.527 0 N-CA-C 113.496 0.924 . . . . 64.04 113.496 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.438 ' CB ' ' HB3' ' A' ' 46' ' ' LYS . 50.5 Cg_exo -58.0 171.73 1.51 Allowed 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.815 2.343 . . . . 74.51 111.47 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 65.94 14.49 9.62 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 125.033 1.333 . . . . 65.51 108.845 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.66 57.98 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.189 -1.369 . . . . 64.25 115.033 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.547 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 6.9 m120 -92.91 152.62 41.69 Favored Pre-proline 0 C--O 1.264 1.824 0 CA-C-N 118.947 1.374 . . . . 75.45 108.573 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.571 ' HA ' HG21 ' A' ' 105' ' ' VAL . 58.8 Cg_endo -82.33 141.06 11.22 Favored 'Trans proline' 0 N--CA 1.425 -2.522 0 C-N-CA 121.32 1.347 . . . . 75.05 110.579 165.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 31.7 m-85 -68.07 144.76 54.94 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 109.743 -0.466 . . . . 74.41 109.743 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -102.36 119.3 38.58 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.212 -1.403 . . . . 74.14 107.212 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -107.77 118.1 35.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.249 -1.389 . . . . 74.33 107.249 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 95.7 mt -129.23 153.17 48.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.254 -0.647 . . . . 64.2 109.254 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -117.81 -178.37 0.53 Allowed Pre-proline 0 N--CA 1.414 -2.26 0 CA-C-O 117.319 -1.324 . . . . 72.24 108.273 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 36.5 Cg_endo . . . . . 0 CA--C 1.492 -1.601 0 CA-C-N 122.041 1.765 . . . . 73.24 114.651 -170.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.465 -3.045 0 CA-C-O 118.447 -1.196 . . . . 41.23 115.587 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.52 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 39.8 Cg_exo -43.93 -23.71 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.168 1 C-N-CA 126.455 4.77 . . . . 64.13 115.711 176.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.494 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.0 p90 -176.12 169.35 2.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 118.023 0.374 . . . . 73.23 110.095 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 24.3 m-20 -136.79 112.24 9.27 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.4 -1.333 . . . . 74.02 107.4 174.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 57' ' ' ILE . 47.5 tp -124.53 126.29 45.59 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.465 -0.494 . . . . 54.41 109.952 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 31.2 p90 -167.38 168.49 13.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.738 -0.385 . . . . 74.11 111.261 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.551 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 50.9 p -125.63 146.55 49.66 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.088 -1.078 . . . . 74.22 108.088 171.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 90.3 mt -66.69 145.38 55.62 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 110.341 -0.244 . . . . 54.34 110.341 175.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -81.1 -171.03 44.33 Favored Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.163 -1.017 . . . . 73.34 112.412 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.22 -8.21 5.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.896 1.073 . . . . 43.44 113.896 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -94.74 -9.71 33.85 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.133 0.492 . . . . 50.14 109.941 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.9 12.09 84.2 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 111.772 -0.531 . . . . 63.32 111.772 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -140.12 147.74 40.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.446 0.699 . . . . 73.13 109.17 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -81.72 114.3 20.28 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.29 0.567 . . . . 74.22 111.021 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.04 -174.23 21.1 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.216 -1.154 . . . . 55.4 110.216 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.18 126.63 8.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.639 -1.267 . . . . 73.52 110.078 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.487 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.3 m 177.92 -177.27 0.21 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.808 2.043 . . . . 70.42 106.134 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.45 -69.55 0.68 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.771 -1.172 . . . . 75.24 112.388 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -91.17 -21.99 20.88 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.126 0.489 . . . . 74.11 111.504 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.81 -6.72 59.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.125 0.488 . . . . 73.54 110.673 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -92.92 156.68 16.78 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.376 -0.829 . . . . 63.11 111.505 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.85 118.4 20.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.635 -1.246 . . . . 73.54 107.635 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.6 pp -96.7 132.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.583 0 N-CA-C 108.525 -0.917 . . . . 72.23 108.525 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.0 176.79 42.47 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.248 -1.453 . . . . 73.34 112.072 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -152.66 145.98 24.78 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.477 -1.305 . . . . 71.2 107.477 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 7.4 p90 -161.35 175.47 12.2 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 116.072 -0.513 . . . . 75.42 110.477 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -113.61 122.62 47.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.921 -1.881 . . . . 63.41 105.921 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.305 -1.335 0 C-N-CA 124.587 1.155 . . . . 73.02 108.346 -178.501 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.633 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 20.1 mmt . . . . . 0 CA--C 1.505 -0.782 0 N-CA-C 110.467 -0.198 . . . . 70.31 110.467 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 m -107.29 73.79 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.054 0.454 . . . . 70.2 109.892 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -155.16 151.77 23.58 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 124.018 0.927 . . . . 74.23 109.42 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.87 131.42 38.2 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.534 2.823 . . . . 74.41 112.632 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 77.02 -36.14 0.24 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.321 2.249 . . . . 74.11 110.898 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.633 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.5 mm100 -68.92 -24.11 64.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.47 0.652 . . . . 71.01 109.569 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -66.77 -27.1 67.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.472 -0.786 . . . . 74.11 109.543 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 98.1 mttt -79.19 -26.13 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.228 -0.656 . . . . 74.3 109.228 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.8 -43.15 46.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.292 -0.867 . . . . 73.22 109.139 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -69.87 -33.03 71.7 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.1 -0.954 . . . . 52.12 111.592 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 45' ' ' ALA . 11.2 m -73.92 -31.93 32.22 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 C-N-CA 119.361 -0.936 . . . . 45.2 109.694 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -68.25 -40.28 82.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.793 -0.639 . . . . 42.43 110.408 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 96.2 mttt -69.95 -25.29 63.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.408 0.623 . . . . 74.33 111.561 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.6 -27.74 46.0 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 109.944 -1.262 . . . . 63.11 109.944 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.596 ' O ' HG13 ' A' ' 57' ' ' ILE . 5.2 t70 -73.99 -42.63 60.13 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.397 -0.902 . . . . 74.32 109.014 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.2 pt -63.93 -28.86 45.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 63.52 110.782 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.5 mptp? -70.74 -30.6 67.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.027 0.441 . . . . 72.02 110.346 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.73 -44.13 70.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 54.31 109.741 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 53' ' ' ASP . 36.8 mt -65.17 -39.77 86.6 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 CA-C-N 115.126 -0.943 . . . . 74.44 109.983 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.76 -31.56 66.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.345 -0.389 . . . . 73.24 111.007 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.24 46.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.222 0.534 . . . . 52.24 109.798 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.45 -26.64 38.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.019 -0.537 . . . . 70.43 109.917 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -30.44 69.98 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.132 -1.433 . . . . 70.35 107.132 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 68.9 m-20 -72.66 -18.54 61.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.484 -0.78 . . . . 75.43 109.817 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 mmt -82.11 -35.23 28.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.772 -0.649 . . . . 73.03 109.559 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.4 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 82.7 t80 -68.58 -34.71 76.27 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.386 -1.338 . . . . 71.04 107.386 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.628 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 85.9 tttt -55.87 -30.39 61.43 Favored 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 114.597 -1.183 . . . . 71.02 110.026 173.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.18 -34.41 20.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.804 0.298 . . . . 70.43 111.804 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.14 -23.74 61.35 Favored 'General case' 0 C--O 1.196 -1.763 0 CA-C-O 120.677 0.275 . . . . 61.35 111.273 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.51 20.56 5.64 Favored 'General case' 0 CA--C 1.452 -2.794 0 O-C-N 121.927 -0.483 . . . . 52.1 111.839 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 p90 42.69 32.68 0.4 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.87 1.356 . . . . 72.34 113.693 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 161.41 1.18 Allowed 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.898 -1.149 . . . . 72.44 107.898 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.628 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.3 m-85 -79.33 159.48 72.45 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 123.287 0.367 . . . . 61.11 111.557 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.427 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 58.3 Cg_endo -71.56 160.41 48.42 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.531 2.154 . . . . 75.3 112.377 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 52.6 p -96.28 155.33 16.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.232 -2.136 . . . . 74.43 105.232 171.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.48 -9.54 54.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 119.156 0.889 . . . . 64.51 110.777 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -102.7 -67.04 0.89 Allowed 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.737 -0.665 . . . . 71.41 110.629 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -81.56 -38.37 26.25 Favored 'General case' 0 CA--C 1.477 -1.837 0 C-N-CA 120.32 -0.552 . . . . 63.24 111.298 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 81' ' ' LEU . . . -71.95 -20.6 78.96 Favored Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 118.395 -1.86 . . . . 72.41 112.141 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.33 -47.0 53.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.539 -1.282 . . . . 63.51 107.539 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -65.02 -31.06 72.11 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-N 115.643 -0.708 . . . . 72.34 110.606 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -82.63 -5.12 58.64 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.186 0.517 . . . . 62.31 111.992 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.57 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 13.7 tp -96.33 -24.56 16.12 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.203 -1.036 . . . . 73.33 108.203 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.95 -38.14 5.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.135 -0.939 . . . . 73.41 110.751 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 61.9 mtpt -124.2 151.98 43.44 Favored 'General case' 0 C--O 1.204 -1.342 0 C-N-CA 125.552 1.541 . . . . 74.3 108.126 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -54.57 127.67 59.55 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 113.324 0.861 . . . . 74.11 113.324 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.7 123.07 12.91 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.97 3.78 . . . . 61.11 115.797 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -99.57 115.12 28.66 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.13 -1.395 . . . . 71.12 108.35 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 150.8 -116.76 0.79 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.091 -1.604 . . . . 41.3 109.091 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -137.65 90.97 14.19 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 117.558 0.679 . . . . 72.03 110.64 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.53 162.88 0.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.637 2.225 . . . . 73.42 112.448 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.251 14.2 tm0? -110.16 132.22 21.58 Favored Pre-proline 0 C--N 1.261 -3.261 0 CA-C-N 112.89 -1.959 . . . . 71.25 106.502 -171.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.91 99.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.688 2.925 . . . . 55.3 114.271 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -152.15 149.36 28.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.41 -1.7 . . . . 73.13 106.41 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -72.83 99.28 2.61 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 118.697 0.68 . . . . 72.32 111.201 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.512 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.5 t90 -61.97 144.11 55.55 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 125.028 1.331 . . . . 64.31 111.652 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.29 134.06 54.1 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.722 -0.672 . . . . 72.33 109.291 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.85 176.06 8.17 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.935 0.874 . . . . 61.45 111.354 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 57.78 28.97 16.71 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.436 -1.711 . . . . 74.34 112.858 168.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.57 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 120.65 -4.81 11.8 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.277 -1.439 . . . . 63.44 115.36 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.93 93.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.368 1.08 . . . . 74.4 109.411 -169.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -131.76 170.1 15.29 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.224 -2.139 . . . . 64.44 105.224 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.526 ' H ' HD23 ' A' ' 100' ' ' LEU . 96.4 mttt -88.93 -165.02 1.23 Allowed 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.725 -1.213 . . . . 63.51 107.725 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.23 32.54 0.45 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.893 0.854 . . . . 73.21 112.231 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 101' ' ' LYS . 11.3 mp -94.77 149.61 36.67 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 125.028 1.331 . . . . 71.33 109.463 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.84 -167.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.643 2.895 . . . . 64.41 113.735 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.5 p -101.28 176.12 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.813 -1.18 . . . . 70.42 107.813 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.43 144.87 95.0 Favored Pre-proline 0 C--O 1.255 1.384 0 CA-C-N 118.705 0.684 . . . . 73.34 111.29 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.407 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 8.7 Cg_endo -51.39 171.78 0.13 Allowed 'Trans proline' 0 C--O 1.195 -1.633 0 C-N-CA 123.79 2.993 . . . . 73.02 112.597 174.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.435 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.2 m-90 62.54 14.97 7.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.921 1.289 . . . . 75.34 109.471 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.37 12.97 77.13 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 116.401 1.32 . . . . 44.01 116.401 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.435 ' ND2' ' HE3' ' A' ' 108' ' ' TRP . 14.9 m-80 -78.64 125.03 85.04 Favored Pre-proline 0 C--O 1.256 1.433 0 CA-C-N 120.15 1.975 . . . . 54.51 111.482 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.541 ' HA ' HG21 ' A' ' 105' ' ' VAL . 39.4 Cg_exo -67.53 146.71 74.97 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.093 1.862 . . . . 75.42 108.734 167.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.59 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 54.2 m-85 -68.93 145.33 53.74 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.381 0.61 . . . . 74.14 112.122 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.4 ' CD ' HD13 ' A' ' 128' ' ' LEU . 2.5 mm100 -101.85 118.23 36.48 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.555 -2.017 . . . . 71.33 105.555 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.53 118.64 35.67 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.708 -0.678 . . . . 75.21 111.958 -177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -129.81 154.0 47.69 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.294 -0.866 . . . . 62.11 109.838 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.809 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -101.76 -177.26 0.53 Allowed Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-O 116.572 -1.68 . . . . 64.41 107.817 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.809 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 10.1 Cg_endo . . . . . 0 C--N 1.393 2.896 0 C-N-CA 123.585 2.857 . . . . 63.03 115.48 -164.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.423 -2.23 0 CA-C-O 118.749 -1.028 . . . . 34.01 113.336 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.598 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -35.07 -23.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.48 1 C-N-CA 127.339 5.36 . . . . 62.21 118.778 179.97 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 54.4 p90 -166.21 171.59 12.09 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 119.593 1.088 . . . . 72.13 112.042 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.86 106.57 6.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.009 0.924 . . . . 71.33 108.889 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.39 128.3 52.07 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.686 -0.857 . . . . 33.34 108.686 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.417 ' HB3' ' HA3' ' A' ' 144' ' ' GLY . 42.0 p90 -166.91 168.1 14.26 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 110.298 -0.26 . . . . 73.12 110.298 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.59 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 13.1 t -125.64 154.35 42.45 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.893 -1.521 . . . . 63.1 106.893 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.4 HD13 ' CD ' ' A' ' 113' ' ' GLN . 7.5 mp -72.17 157.45 37.72 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.839 -0.344 . . . . 74.34 111.534 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.17 -169.94 29.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.235 -0.983 . . . . 42.33 112.999 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.03 -21.84 66.44 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.134 0.79 . . . . 73.04 113.134 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -94.43 -2.47 51.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.65 0.738 . . . . 71.03 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.72 45.68 73.92 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.042 -1.623 . . . . 75.44 109.042 -174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -135.28 144.34 46.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.849 -1.167 . . . . 73.45 107.849 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 142' ' ' ASP 0.253 0.5 OUTLIER -102.86 106.7 17.33 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 121.982 0.896 . . . . 72.2 111.014 173.971 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.01 -173.34 20.26 Favored Glycine 0 C--N 1.294 -1.793 0 N-CA-C 111.066 -0.813 . . . . 64.03 111.066 -177.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -111.77 125.61 7.31 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 107.727 -2.149 . . . . 25.2 107.727 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.536 ' CB ' ' HB3' ' A' ' 140' ' ' ASP . 74.6 m 179.24 -176.34 0.26 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.897 1.279 . . . . 72.14 107.898 -167.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.21 -73.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.943 0.401 . . . . 72.45 110.412 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -107.22 -8.98 16.23 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.554 0.692 . . . . 53.41 110.12 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 137' ' ' SER . 22.2 t70 -89.65 2.32 54.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 123.073 1.416 . . . . 64.34 108.871 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.36 155.8 17.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.73 -1.577 . . . . 73.31 110.595 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.6 p-10 -84.73 122.46 29.13 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.775 -1.935 . . . . 61.21 105.775 171.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.29 113.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-O 121.982 0.896 . . . . 70.33 111.142 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 126' ' ' TYR . . . -163.56 -179.8 38.16 Favored Glycine 0 N--CA 1.41 -3.087 0 C-N-CA 119.271 -1.442 . . . . 60.54 112.917 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.11 158.83 19.73 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.437 -1.32 . . . . 64.34 107.437 -177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.493 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 9.8 p90 -163.2 177.58 8.93 Favored 'General case' 0 C--N 1.279 -2.467 0 O-C-N 123.657 0.598 . . . . 75.1 110.629 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -105.33 120.58 41.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.229 -1.396 . . . . 73.21 107.229 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.298 -1.647 0 O-C-N 125.167 1.542 . . . . 63.03 106.87 178.842 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 25.7 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.134 0.492 . . . . 65.53 111.04 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -113.86 62.55 0.65 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.104 -0.702 . . . . 73.21 109.104 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.423 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 25.0 ptt180 -155.58 160.25 30.99 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.347 -0.983 . . . . 75.33 108.347 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' ARG . 11.9 Cg_exo -28.63 119.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 126.053 4.502 . . . . 70.13 116.341 -176.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t70 65.33 -37.24 0.23 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 127.605 2.362 . . . . 74.23 113.912 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 47' ' ' VAL . 92.4 mt-30 -68.76 -19.96 64.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.305 0.574 . . . . 71.22 110.123 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 39' ' ' MET . . . -64.1 -24.48 67.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.303 -0.862 . . . . 53.1 109.988 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HB3' ' HG3' ' A' ' 107' ' ' PRO . 89.2 mttt -86.1 -25.0 26.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.019 -0.734 . . . . 63.21 109.019 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 44' ' ' GLN . 58.0 t -74.25 -44.26 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-N 115.493 -0.776 . . . . 74.45 109.814 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.3 t -65.7 -36.04 82.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.063 -0.971 . . . . 63.13 111.512 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 m -74.21 -35.79 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 C-N-CA 119.917 -0.713 . . . . 73.1 109.74 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -65.24 -32.9 74.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.932 -0.576 . . . . 64.1 110.378 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 73.7 mmtt -65.63 -25.9 67.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.431 0.634 . . . . 73.34 110.293 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.59 -31.52 18.44 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 110.595 -1.002 . . . . 55.44 110.595 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 57' ' ' ILE . 77.2 m-20 -76.53 -33.8 58.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.915 0.388 . . . . 55.24 110.323 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -67.11 -35.81 75.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.954 -0.387 . . . . 64.02 109.954 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -66.78 -30.7 70.97 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 120.878 0.371 . . . . 75.3 110.665 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.35 -45.39 88.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.338 -0.846 . . . . 72.55 110.046 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 125' ' ' LEU . 64.2 mt -64.81 -38.66 83.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 CA-C-N 115.267 -0.879 . . . . 73.34 110.161 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.48 68.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.999 0.428 . . . . 62.52 111.498 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.83 -33.21 27.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.566 0.698 . . . . 73.33 109.727 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.07 35.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.668 -0.697 . . . . 73.43 111.108 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.12 -30.35 71.28 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.778 -1.193 . . . . 75.14 107.778 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 18.9 t70 -73.71 -24.62 59.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.527 -0.76 . . . . 64.52 110.084 174.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.9 mtm -78.56 -25.77 45.45 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.789 -0.569 . . . . 74.15 110.465 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.465 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 31.1 t80 -72.04 -40.31 68.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.545 -1.65 . . . . 72.24 106.545 170.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 31.7 tttm -54.25 -37.29 64.5 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.307 -0.86 . . . . 65.11 110.354 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -73.01 -36.49 67.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.612 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.1 t70 -71.65 -23.46 61.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.327 0.651 . . . . 71.21 112.192 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -128.48 20.29 6.18 Favored 'General case' 0 CA--C 1.457 -2.625 0 O-C-N 121.941 -0.474 . . . . 75.13 110.089 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.3 p90 42.9 31.65 0.34 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.118 1.511 . . . . 73.41 112.63 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.12 161.99 0.46 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.378 -1.341 . . . . 70.02 107.378 -171.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -74.67 158.96 84.31 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 112.746 0.647 . . . . 75.43 112.746 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.568 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 49.1 Cg_endo -72.69 159.27 49.01 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 123.164 2.576 . . . . 63.42 109.776 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.482 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 70.5 p -90.43 156.26 18.34 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.442 -1.318 . . . . 73.12 107.442 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.646 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 3.2 t -65.86 -17.78 64.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 119.767 1.167 . . . . 75.43 111.232 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.65 -65.9 0.94 Allowed 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.082 -0.387 . . . . 72.4 111.706 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.445 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.3 mm-40 -81.3 -32.63 33.04 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 120.959 -0.296 . . . . 74.23 111.573 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.68 -20.85 79.37 Favored Glycine 0 N--CA 1.408 -3.188 0 C-N-CA 118.958 -1.591 . . . . 71.44 112.712 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.81 -46.41 68.71 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.484 -1.672 . . . . 73.41 106.484 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.16 -14.74 62.37 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 114.718 -1.128 . . . . 74.05 111.044 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.632 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -89.84 -8.68 51.44 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.332 0.587 . . . . 61.31 110.16 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.539 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 88.9 mt -93.08 -22.68 18.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.841 -0.618 . . . . 65.03 109.634 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.31 -34.96 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 115.885 -0.598 . . . . 63.31 111.545 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 1.8 tpmt? -122.84 151.23 41.89 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.314 -1.736 . . . . 75.22 106.314 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -53.67 137.04 53.65 Favored Pre-proline 0 N--CA 1.49 1.542 0 CA-C-N 119.058 0.844 . . . . 73.34 111.636 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.564 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 17.9 Cg_endo -55.41 137.67 78.06 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 124.558 3.505 . . . . 73.11 117.071 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 p -89.74 -179.66 5.81 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 112.927 -1.942 . . . . 70.45 107.558 173.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 -131.15 13.22 Favored Glycine 0 C--O 1.249 1.042 0 C-N-CA 119.72 -1.229 . . . . 62.23 110.423 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -135.93 89.98 19.81 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 112.372 0.508 . . . . 65.31 112.372 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.95 163.25 3.28 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.784 2.323 . . . . 70.11 109.523 172.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -99.86 158.63 31.75 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 108.477 -0.934 . . . . 75.24 108.477 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.83 99.28 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.038 1.826 . . . . 72.03 110.622 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . 12.7 tmtt? -151.49 147.39 26.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.025 -1.472 . . . . 75.04 107.025 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.554 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 38.1 m-80 -63.34 89.52 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.025 0.75 . . . . 74.11 113.025 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.564 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 84.1 t90 -66.08 144.6 56.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.763 1.625 . . . . 73.33 111.326 175.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.53 130.39 52.36 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.359 -0.608 . . . . 63.1 109.359 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.448 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 62.5 pttt -83.3 -171.55 3.64 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.465 -0.894 . . . . 65.45 108.723 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.1 t0 66.27 28.72 9.86 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.243 1.021 . . . . 75.41 108.829 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 91.57 9.13 63.28 Favored Glycine 0 CA--C 1.473 -2.535 0 CA-C-N 114.021 -1.445 . . . . 62.33 114.114 167.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.7 OUTLIER 61.61 79.46 0.25 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.667 -1.234 . . . . 64.22 107.667 -172.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.5 tt -124.55 152.3 43.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.678 -1.601 . . . . 71.14 106.678 -171.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.72 179.71 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.675 -0.861 . . . . 62.24 108.675 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -80.66 67.08 6.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.386 1.088 . . . . 74.14 113.738 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.66 147.6 61.41 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 105.548 -2.019 . . . . 54.44 105.548 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.81 -168.84 0.25 Allowed 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.24 1.96 . . . . 75.12 112.139 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.555 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.37 173.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.687 -1.597 . . . . 74.11 106.687 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.9 p-10 -79.59 157.45 74.7 Favored Pre-proline 0 C--O 1.252 1.228 0 CA-C-N 119.155 0.889 . . . . 62.24 112.723 -170.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HG3' ' HB3' ' A' ' 46' ' ' LYS . 10.3 Cg_endo -54.12 171.2 0.39 Allowed 'Trans proline' 0 C--O 1.201 -1.352 0 C-N-CA 123.571 2.848 . . . . 63.34 111.939 173.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 65.09 15.02 9.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.997 1.319 . . . . 65.23 109.559 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.73 27.87 64.7 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.234 -1.348 . . . . 74.2 114.804 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.49 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 4.5 m-80 -89.64 151.16 45.47 Favored Pre-proline 0 C--O 1.257 1.455 0 CA-C-N 119.24 1.52 . . . . 73.03 108.459 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.555 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 62.9 Cg_endo -82.14 144.91 13.54 Favored 'Trans proline' 0 N--CA 1.411 -3.379 0 N-CA-C 108.28 -1.469 . . . . 72.44 108.28 165.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 68.9 m-85 -67.28 143.01 56.68 Favored 'General case' 0 C--O 1.253 1.286 0 N-CA-C 106.535 -1.654 . . . . 73.23 106.535 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -101.2 114.47 28.46 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.167 -1.79 . . . . 72.21 106.167 -175.226 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -98.69 119.04 36.75 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.972 -1.122 . . . . 75.43 107.972 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.0 mt -128.46 153.14 47.44 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.463 -1.31 . . . . 71.01 107.463 175.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.791 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -124.89 -179.05 0.77 Allowed Pre-proline 0 N--CA 1.395 -3.178 0 N-CA-C 107.605 -1.257 . . . . 73.32 107.605 -175.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.791 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 43.6 Cg_endo . . . . . 0 N--CA 1.44 -1.668 0 C-N-CA 121.512 1.474 . . . . 73.11 114.092 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.466 -3.005 0 CA-C-O 118.871 -0.961 . . . . 61.52 113.528 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 147' ' ' ASP . 44.0 Cg_exo -64.26 -28.14 63.99 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.522 3.481 . . . . 74.14 111.99 165.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.5 p90 176.0 164.9 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.409 0.684 . . . . 44.22 110.024 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 32.6 m-20 -139.64 123.07 17.17 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.537 -0.542 . . . . 72.21 109.537 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.569 HD11 HD12 ' A' ' 57' ' ' ILE . 3.4 tm? -130.66 124.66 32.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.423 -0.954 . . . . 42.33 108.423 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 44.3 p90 -167.4 168.11 13.34 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-O 119.505 -0.284 . . . . 72.24 110.914 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -126.25 156.57 40.09 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.77 0.828 . . . . 74.44 109.636 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.16 151.59 46.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.418 -0.355 . . . . 64.14 111.363 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.28 -178.86 45.79 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.443 -0.884 . . . . 72.24 112.21 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.96 25.96 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.2 1.185 . . . . 61.11 114.2 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -94.48 -9.99 33.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.986 -0.685 . . . . 74.25 111.241 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.47 4.87 72.96 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.827 -0.909 . . . . 63.51 110.827 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -99.69 144.03 29.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.654 -0.869 . . . . 64.5 108.654 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -100.7 105.07 16.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.949 -1.13 . . . . 75.4 107.949 172.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.27 -173.55 20.63 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.079 -0.808 . . . . 54.25 111.079 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.77 127.63 9.27 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 108.312 -1.915 . . . . 62.11 108.312 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.414 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 30.4 m 179.53 -177.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 125.904 1.682 . . . . 73.34 107.53 -170.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.43 -72.96 0.45 Allowed 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.644 -0.822 . . . . 73.51 111.043 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -95.84 -14.65 23.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.01 0.433 . . . . 72.52 111.543 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -97.49 5.47 49.59 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.383 0.611 . . . . 71.33 110.353 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -88.23 156.96 18.93 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.329 -0.85 . . . . 74.01 112.597 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 11.3 p-10 -78.76 112.94 16.41 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.45 -1.685 . . . . 74.13 106.45 172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 119.06 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.083 0 CA-C-N 114.939 -1.028 . . . . 63.22 111.451 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -169.96 -179.2 41.45 Favored Glycine 0 N--CA 1.41 -3.043 0 C-N-CA 119.612 -1.28 . . . . 62.11 112.859 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.0 149.46 28.9 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.9 -1.518 . . . . 70.53 106.9 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.464 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 4.1 p90 -170.19 178.38 3.86 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.334 0.588 . . . . 73.31 110.19 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 36.1 t70 -118.3 137.02 53.35 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.511 -1.663 . . . . 63.52 106.511 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.484 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 3.7 p-10 . . . . . 0 C--O 1.253 1.24 0 O-C-N 124.586 1.179 . . . . 65.22 109.013 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 107.566 -1.272 . . . . 72.23 107.566 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -119.78 88.97 3.04 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.026 0.75 . . . . 64.31 113.026 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 16.3 ptp180 -156.29 170.73 8.36 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.191 -1.781 . . . . 73.32 106.191 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 41' ' ' ARG . 54.4 Cg_exo -43.1 125.57 4.28 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 123.434 2.756 . . . . 62.2 113.838 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.1 -33.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.61 1.564 . . . . 42.11 113.346 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.628 HE22 ' HB3' ' A' ' 138' ' ' ASP . 14.9 mm100 -73.23 -28.93 62.44 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.709 -0.478 . . . . 75.22 109.709 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.01 72.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.008 -0.738 . . . . 75.23 109.008 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 107' ' ' PRO . 65.3 mttm -74.7 -25.28 59.04 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.161 -0.927 . . . . 53.13 109.889 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 56.5 t -75.29 -44.57 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 71.0 109.09 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -73.62 -31.94 63.81 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.446 -0.797 . . . . 62.13 112.102 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -71.74 -36.17 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 119.404 -0.918 . . . . 51.44 109.034 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -65.16 -31.67 72.97 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.344 -0.844 . . . . 71.31 111.251 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 31.5 mmmt -64.86 -25.75 68.03 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.239 0.542 . . . . 73.44 110.549 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.79 -33.5 15.58 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.953 -0.859 . . . . 44.21 110.953 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 56' ' ' ALA 0.263 19.8 m-20 -81.13 -26.35 36.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.377 0.88 . . . . 74.05 113.377 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.96 -31.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.867 -0.79 . . . . 72.14 108.867 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -70.41 -25.91 63.44 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.212 -0.662 . . . . 73.01 109.212 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -67.05 -47.3 71.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.087 -0.961 . . . . 63.0 109.868 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.444 HG12 HD13 ' A' ' 100' ' ' LEU . 70.2 mt -60.84 -45.75 97.49 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.085 -0.961 . . . . 70.24 109.621 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.81 57.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.009 -0.541 . . . . 72.01 112.379 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.36 -39.6 16.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.879 0.371 . . . . 33.43 110.609 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.42 -28.31 52.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.477 -0.489 . . . . 74.23 110.907 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.86 -26.66 66.14 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.6 -1.259 . . . . 75.12 107.6 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.606 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 t70 -76.12 -21.09 57.03 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.149 -0.932 . . . . 72.35 108.698 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.9 mtt -77.37 -37.44 52.19 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.616 -0.678 . . . . 75.51 109.465 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 73.4 t80 -61.98 -37.34 84.42 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.994 -1.113 . . . . 71.15 107.994 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.6 tttt -54.47 -39.47 67.52 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 114.638 -1.165 . . . . 65.35 109.796 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.449 ' HB3' ' HE3' ' A' ' 92' ' ' LYS . 4.5 mm? -80.64 -30.45 36.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.358 0.873 . . . . 53.32 113.358 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -71.14 -24.95 62.37 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.388 0.614 . . . . 73.41 110.873 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.4 23.15 5.96 Favored 'General case' 0 CA--C 1.454 -2.736 0 O-C-N 121.372 -0.83 . . . . 74.14 111.669 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 42.58 32.82 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.448 1.499 . . . . 64.34 113.67 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.34 151.41 0.27 Allowed 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.608 -0.886 . . . . 62.12 108.608 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.645 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 21.2 m-85 -74.79 152.55 87.0 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 123.266 0.354 . . . . 72.41 110.271 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 32.7 Cg_endo -62.01 164.9 15.56 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.562 2.841 . . . . 65.21 112.557 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.404 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 58.2 p -102.46 154.98 18.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.614 -1.995 . . . . 64.44 105.614 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.464 ' N ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.07 -8.21 43.1 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 119.312 0.96 . . . . 74.43 110.614 -175.055 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.4 mp0 -102.37 -67.02 0.89 Allowed 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 116.046 -0.524 . . . . 72.33 109.996 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -77.95 -39.56 42.24 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 121.958 -0.464 . . . . 75.24 110.652 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.617 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.73 -21.03 77.59 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 118.675 -1.726 . . . . 65.33 113.157 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 tt -68.0 -49.06 63.83 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.257 -1.386 . . . . 73.51 107.257 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 17.9 mt-10 -68.03 -26.69 66.01 Favored 'General case' 0 C--O 1.166 -3.302 0 CA-C-N 114.767 -1.106 . . . . 70.23 111.386 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.539 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -79.18 -7.69 58.41 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.31 0.576 . . . . 55.12 111.35 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 81.7 mt -93.28 -22.72 18.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.788 -0.642 . . . . 60.54 109.604 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.45 -38.3 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 116.134 -0.485 . . . . 74.51 112.056 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 57.0 pttt -119.01 151.25 38.54 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.673 -1.603 . . . . 72.35 106.673 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -55.19 130.82 68.79 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 122.754 0.422 . . . . 60.32 110.373 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 30.6 Cg_endo -58.88 124.22 15.23 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.554 2.836 . . . . 65.31 112.493 -173.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.2 p -83.27 116.08 22.26 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.652 -0.704 . . . . 73.01 110.487 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.43 -136.46 6.73 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.889 -1.684 . . . . 74.04 108.889 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -133.91 94.12 19.2 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 117.296 0.548 . . . . 63.11 111.481 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.27 162.65 17.5 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 123.007 2.471 . . . . 53.35 108.868 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -93.4 108.59 34.66 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 108.823 -0.806 . . . . 62.33 108.823 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -29.08 98.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.254 1 C-N-CA 125.857 4.372 . . . . 64.41 117.643 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 66' ' ' LEU . 54.9 mttm -138.77 149.48 45.05 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 125.971 1.708 . . . . 72.33 107.562 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.59 92.12 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.336 -0.393 . . . . 71.2 110.628 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.589 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 86.2 t90 -65.65 143.02 57.84 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 115.608 -0.724 . . . . 74.21 110.102 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -135.38 133.14 38.39 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.534 -0.757 . . . . 70.12 109.038 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -78.28 -171.53 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.327 -0.99 . . . . 74.53 108.327 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t0 66.89 25.25 9.52 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 122.189 0.995 . . . . 63.45 109.266 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 90.56 12.85 60.52 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 114.311 -1.313 . . . . 55.21 113.643 170.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.589 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.1 m-85 62.26 81.26 0.2 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.701 1.238 . . . . 73.05 107.811 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 57' ' ' ILE . 64.0 tp -128.72 172.24 11.44 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.807 -1.542 . . . . 64.1 108.926 -171.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 35.1 mmtp -77.29 -172.67 2.54 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.743 -1.206 . . . . 70.13 107.743 172.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -87.1 63.94 8.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.877 1.322 . . . . 72.22 108.966 177.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.405 HD12 ' HD2' ' A' ' 104' ' ' PRO . 28.9 tp -115.6 142.45 28.91 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.159 -1.837 . . . . 73.11 110.711 -172.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.405 ' HD2' HD12 ' A' ' 103' ' ' LEU . 26.4 Cg_exo -68.37 -167.17 0.17 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.393 2.728 . . . . 75.02 110.826 170.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.722 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.83 173.17 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 109.114 -0.698 . . . . 71.21 109.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.538 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.6 t70 -80.73 161.57 63.38 Favored Pre-proline 0 C--O 1.255 1.35 0 N-CA-C 108.553 -0.906 . . . . 72.11 108.553 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 72.1 Cg_exo -47.24 170.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.067 2.511 . . . . 74.3 114.258 172.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.453 ' CG ' ' HA ' ' A' ' 130' ' ' ALA . 1.7 m-90 65.79 14.27 9.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.928 2.091 . . . . 74.51 111.034 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.52 -6.71 15.54 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.86 -0.609 . . . . 63.32 114.043 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.89 133.94 88.04 Favored Pre-proline 0 C--O 1.258 1.534 0 N-CA-C 113.019 0.748 . . . . 54.51 113.019 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.722 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 72.0 Cg_endo -75.58 145.86 29.99 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.659 2.239 . . . . 71.0 112.098 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -69.7 134.01 48.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.258 -1.386 . . . . 63.22 107.258 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -104.2 113.98 27.9 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.328 -0.851 . . . . 72.01 109.315 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.92 118.24 36.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.663 -1.606 . . . . 74.21 106.663 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.1 mt -128.82 153.59 47.28 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.687 -1.227 . . . . 72.24 107.687 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.676 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.77 -178.58 0.57 Allowed Pre-proline 0 N--CA 1.404 -2.745 0 CA-C-O 116.589 -1.672 . . . . 54.24 107.672 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.676 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 12.4 Cg_endo . . . . . 0 C--N 1.389 2.681 0 C-N-CA 123.005 2.47 . . . . 71.2 115.488 -162.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.428 -1.898 0 CA-C-O 118.374 -1.237 . . . . 72.1 113.0 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.544 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 13.4 Cg_exo -37.85 -26.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 127.299 5.332 . . . . 62.34 118.559 -178.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.261 40.3 p90 -169.32 147.08 3.63 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.353 0.979 . . . . 75.11 113.12 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.6 m-20 -112.47 109.83 19.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.281 -1.327 . . . . 74.42 107.441 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.489 ' O ' ' HA3' ' A' ' 144' ' ' GLY . 3.2 tm? -124.7 129.93 51.44 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.957 -0.697 . . . . 71.13 109.655 -176.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.409 ' HA ' ' HA3' ' A' ' 144' ' ' GLY . 55.7 p90 -167.81 164.59 14.17 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 112.442 0.534 . . . . 72.34 112.442 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -125.8 136.67 53.38 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.386 -2.449 . . . . 51.33 104.386 166.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.88 154.27 12.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.483 0.659 . . . . 65.31 112.392 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.43 173.31 40.38 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.894 -1.048 . . . . 75.52 113.902 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.453 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -48.36 -28.81 3.41 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 116.732 2.123 . . . . 75.21 116.732 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.26 -7.37 42.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.447 0.567 . . . . 72.42 111.397 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.43 28.31 25.09 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.495 -0.86 . . . . 71.34 112.439 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -127.65 138.63 52.88 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.634 -0.876 . . . . 73.54 108.634 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.39 105.38 7.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.617 0.722 . . . . 72.13 109.741 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.41 -174.4 22.2 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.812 -0.709 . . . . 71.54 113.873 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -116.79 128.66 8.01 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.363 -1.495 . . . . 34.23 109.363 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 38.8 m -178.26 -177.36 0.58 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 125.758 1.623 . . . . 75.55 108.196 -170.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.628 ' HB3' HE22 ' A' ' 44' ' ' GLN . 2.8 m-20 -74.38 -73.25 0.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.877 -0.515 . . . . 70.34 110.53 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -98.44 -6.96 29.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.188 0.518 . . . . 72.45 111.718 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -100.54 9.34 42.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.335 0.588 . . . . 71.5 110.917 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -86.11 157.78 19.95 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.813 -0.631 . . . . 60.4 111.162 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.73 112.33 13.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.931 -1.877 . . . . 63.02 105.931 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.597 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.32 123.45 48.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.472 0.653 . . . . 72.41 111.067 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -175.11 177.24 47.17 Favored Glycine 0 N--CA 1.413 -2.869 0 N-CA-C 110.155 -1.178 . . . . 72.34 110.155 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -103.36 162.92 12.6 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.136 -1.802 . . . . 70.35 106.136 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -143.64 124.7 14.43 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.119 -1.067 . . . . 75.24 108.119 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -111.58 112.38 24.05 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.899 -1.519 . . . . 75.43 106.899 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.416 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 4.7 p-10 . . . . . 0 C--N 1.293 -1.88 0 N-CA-C 109.413 -0.588 . . . . 71.14 109.413 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.491 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.8 mpt? . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.358 -0.608 . . . . 73.13 109.358 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -118.12 84.62 2.2 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.82 0.819 . . . . 74.52 110.501 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 99.1 mtt180 -153.07 165.78 16.88 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 106.292 -1.744 . . . . 65.44 106.292 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.94 130.25 38.32 Favored 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 122.515 2.143 . . . . 63.31 111.422 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' VAL . 33.5 m-20 72.85 -31.67 0.23 Allowed 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 125.393 1.477 . . . . 70.21 113.597 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 13.9 mm100 -68.93 -32.59 72.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.955 -0.757 . . . . 73.5 108.955 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.63 -17.89 64.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 74.44 110.747 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 57.0 mttp -89.44 -24.66 21.82 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.156 -0.683 . . . . 73.41 109.156 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 43' ' ' ASP . 59.5 t -75.0 -43.93 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.913 0.863 . . . . 73.54 108.698 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -64.65 -28.11 69.39 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.227 -1.351 . . . . 72.14 111.762 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.16 -37.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 119.597 -0.841 . . . . 73.53 110.146 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.677 -0.692 . . . . 62.41 110.667 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.505 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 55.0 mtpt -68.53 -22.47 64.51 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 121.379 0.609 . . . . 65.42 111.749 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.56 -31.1 46.63 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.618 -1.393 . . . . 73.11 109.618 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.6 m-20 -76.08 -31.15 58.6 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.223 -0.489 . . . . 72.41 111.359 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.417 HG21 ' HA2' ' A' ' 144' ' ' GLY . 14.3 pt -66.89 -30.82 50.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 C-N-CA 120.373 -0.531 . . . . 71.44 109.879 173.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 14.2 mptt -67.17 -31.83 72.51 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 120.075 -0.65 . . . . 74.51 109.984 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.4 71.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 44.53 110.83 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.561 HG12 HD13 ' A' ' 100' ' ' LEU . 44.1 mt -62.75 -43.15 98.49 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 116.013 -0.539 . . . . 74.24 109.715 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -22.72 66.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.02 0.438 . . . . 72.44 111.681 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 -33.96 20.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.397 0.618 . . . . 65.13 109.951 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' TYR . . . -81.9 -27.48 33.38 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.155 -0.475 . . . . 73.35 110.552 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.28 -30.33 71.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 106.927 -1.508 . . . . 71.42 106.927 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 20.0 t70 -73.92 -17.21 61.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.705 -1.134 . . . . 65.12 109.21 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.8 mtm -84.01 -32.17 25.08 Favored 'General case' 0 C--O 1.204 -1.307 0 O-C-N 121.638 -0.664 . . . . 71.24 109.428 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -63.61 -35.47 80.61 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.17 -1.789 . . . . 64.54 106.17 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 60.5 tttp -58.12 -38.01 75.69 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 115.594 -0.73 . . . . 70.41 110.569 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 tp -74.73 -36.22 62.66 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.492 0.663 . . . . 73.23 109.667 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 13.8 t70 -74.37 -24.55 59.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.188 -0.914 . . . . 74.14 111.772 -174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 89' ' ' PRO . 2.5 m-20 -128.54 22.84 5.92 Favored 'General case' 0 CA--C 1.455 -2.699 0 O-C-N 121.549 -0.719 . . . . 73.13 110.62 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 42.44 31.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.501 1.52 . . . . 65.42 112.822 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.64 161.43 0.52 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.873 -1.158 . . . . 71.22 107.873 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.653 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 19.7 m-85 -75.74 155.07 85.27 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 123.301 0.376 . . . . 73.14 111.872 174.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 37.0 Cg_endo -66.7 157.8 59.22 Favored 'Trans proline' 0 C--O 1.211 -0.849 0 C-N-CA 122.693 2.262 . . . . 72.3 110.391 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 p -94.37 155.55 16.93 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 107.119 -1.437 . . . . 74.44 107.119 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.659 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -72.79 -4.54 32.2 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.013 1.279 . . . . 72.53 111.257 -176.361 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -102.75 -66.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 120.113 -0.635 . . . . 51.45 110.241 169.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -74.94 -45.99 38.68 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.531 -0.544 . . . . 71.31 109.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -72.16 -19.97 78.83 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 120.322 -0.942 . . . . 73.52 113.775 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tt -73.17 -48.66 33.4 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 107.841 -1.17 . . . . 72.43 107.841 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.53 -37.13 82.61 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 108.323 -0.991 . . . . 72.22 108.323 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -77.89 -5.61 51.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.041 0.756 . . . . 63.31 113.041 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.53 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 15.3 tp -94.43 -23.47 17.73 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.38 -0.97 . . . . 53.42 108.38 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.28 -38.78 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.924 -1.034 . . . . 63.52 110.562 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 43.8 tttm -124.06 150.69 44.68 Favored 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 126.598 1.959 . . . . 72.44 107.17 -174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -54.11 141.66 49.5 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 113.242 0.83 . . . . 74.23 113.242 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 7.7 Cg_endo -45.15 136.47 10.67 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 125.104 3.87 . . . . 54.34 115.992 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -101.41 -11.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.63 -1.168 . . . . 51.45 108.989 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.84 -148.62 24.07 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.949 -0.861 . . . . 52.43 110.949 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -117.12 101.16 53.34 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-O 121.555 0.693 . . . . 75.13 111.345 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.431 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 95.6 Cg_endo -99.71 162.82 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.772 2.981 . . . . 74.41 112.447 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -87.54 159.04 50.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.822 -1.177 . . . . 74.21 107.822 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.75 98.42 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.612 1.541 . . . . 74.22 112.904 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 2.3 mptp? -150.05 148.12 28.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.008 1.723 . . . . 35.33 106.46 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.57 98.01 5.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.004 0.431 . . . . 61.32 111.034 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.635 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 85.5 t90 -54.73 144.18 23.01 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.349 1.86 . . . . 73.14 113.042 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -116.65 135.33 53.88 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.526 1.13 . . . . 75.14 109.221 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -82.39 178.7 8.1 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 122.09 0.947 . . . . 74.4 110.909 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 55.63 45.92 23.76 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.894 -1.957 . . . . 65.12 111.905 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.53 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 105.7 -10.19 45.09 Favored Glycine 0 CA--C 1.477 -2.336 0 CA-C-N 114.427 -1.26 . . . . 62.05 114.856 163.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.635 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 64.55 96.15 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 122.182 0.991 . . . . 71.45 109.63 -171.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.561 HD13 HG12 ' A' ' 57' ' ' ILE . 59.3 tp -138.79 170.04 16.71 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.697 -1.138 . . . . 73.25 107.937 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.82 -170.32 2.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.747 -1.575 . . . . 64.35 106.747 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.71 75.91 10.27 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.606 -0.837 . . . . 71.13 109.996 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -130.85 147.85 67.86 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.379 -1.282 . . . . 74.04 108.753 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.59 178.01 7.26 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.538 2.159 . . . . 72.41 112.806 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 111' ' ' PRO . 3.9 p -85.5 175.75 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.716 -0.846 . . . . 73.41 108.716 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.8 p-10 -78.65 158.2 76.1 Favored Pre-proline 0 C--O 1.251 1.184 0 CA-C-N 119.381 0.991 . . . . 74.34 113.132 -170.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 7.8 Cg_endo -54.52 171.07 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.266 2.644 . . . . 73.41 112.654 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.52 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 3.1 m-90 64.01 14.69 8.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.559 1.544 . . . . 74.34 108.856 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.46 38.33 79.5 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 114.026 -1.443 . . . . 73.02 115.167 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.521 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 13.2 m-80 -91.68 146.32 32.88 Favored Pre-proline 0 C--O 1.266 1.924 0 CA-C-N 119.954 1.877 . . . . 73.35 108.898 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.528 ' HA ' HG21 ' A' ' 105' ' ' VAL . 36.6 Cg_endo -89.35 137.83 3.12 Favored 'Trans proline' 0 N--CA 1.428 -2.377 0 C-N-CA 122.053 1.835 . . . . 63.33 109.565 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 59.2 m-85 -68.04 143.41 55.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.883 0.373 . . . . 74.35 110.601 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.524 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -102.67 117.34 34.46 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.112 -1.44 . . . . 73.14 107.112 -176.261 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -104.14 120.65 41.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.876 -0.416 . . . . 73.13 109.876 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 92.6 mt -127.98 153.56 46.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.452 -0.573 . . . . 73.43 109.452 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.756 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.63 -176.61 0.41 Allowed Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 116.567 -1.683 . . . . 44.11 107.306 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.5 Cg_endo . . . . . 0 C--N 1.384 2.405 0 C-N-CA 122.383 2.055 . . . . 71.12 114.707 -169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 C--O 1.202 -1.894 0 CA-C-O 118.462 -1.188 . . . . 61.03 113.632 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.577 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 32.4 Cg_exo -40.3 -23.98 0.13 Allowed 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 126.782 4.988 . . . . 64.3 117.731 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.516 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 51.3 p90 -176.64 163.8 2.4 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 118.351 0.523 . . . . 73.32 109.682 176.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 146' ' ' TRP . 23.9 m-20 -139.86 118.45 12.28 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 124.279 0.987 . . . . 53.13 108.792 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . 0.26 4.4 pp -143.27 138.24 29.45 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.283 -1.367 . . . . 62.41 112.649 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 39.5 p90 -165.46 167.06 17.93 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.871 -1.059 . . . . 75.41 108.332 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.657 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 8.7 t -125.79 157.35 37.73 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.849 -1.167 . . . . 74.45 107.849 172.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.524 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 91.3 mt -67.33 154.13 42.05 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.835 0.709 . . . . 73.12 111.185 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.22 -164.58 21.89 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.342 -0.932 . . . . 71.22 114.16 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.9 -16.85 32.72 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.758 1.022 . . . . 75.2 113.758 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -106.29 1.55 26.01 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.625 0.726 . . . . 74.22 110.026 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 43.16 99.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.1 -0.8 . . . . 43.44 111.1 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 134' ' ' GLU . 8.8 tmtt? -141.15 147.16 37.99 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.231 -1.396 . . . . 72.31 107.231 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.72 106.55 18.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.795 0.807 . . . . 62.12 111.426 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.64 -178.85 24.97 Favored Glycine 0 C--N 1.291 -1.963 0 N-CA-C 110.722 -0.951 . . . . 15.51 110.722 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.89 127.09 8.81 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.468 -1.853 . . . . 45.32 108.468 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.491 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 53.3 m 179.28 -177.48 0.31 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.775 1.63 . . . . 64.11 107.507 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.96 -74.68 0.35 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.874 0.368 . . . . 63.34 110.638 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -94.0 -16.67 23.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.024 0.44 . . . . 65.25 111.086 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.99 3.95 53.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.56 0.695 . . . . 71.24 109.9 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.491 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -97.98 157.05 16.34 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 115.211 -0.904 . . . . 71.54 111.175 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.34 134.74 37.43 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.735 -1.209 . . . . 72.15 107.735 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.541 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -107.21 121.33 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 115.335 -0.848 . . . . 44.32 111.633 -175.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 126' ' ' TYR . . . -167.05 177.32 41.75 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 118.727 -1.702 . . . . 35.21 114.279 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.511 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -156.56 157.08 34.71 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.627 -0.786 . . . . 72.02 109.357 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.516 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 4.9 p90 -163.08 177.1 9.41 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.529 0.518 . . . . 75.2 111.204 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 122' ' ' PRO . 35.3 t70 -120.02 130.79 54.89 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.186 -1.783 . . . . 74.23 106.186 175.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.41 ' HA ' ' CA ' ' A' ' 121' ' ' GLY . 4.1 p-10 . . . . . 0 C--N 1.296 -1.728 0 O-C-N 124.387 1.054 . . . . 71.25 110.316 -174.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.646 ' N ' ' HG1' ' A' ' 48' ' ' THR . 2.0 mpt? . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 110.611 -0.144 . . . . 74.51 110.611 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -103.07 77.91 1.6 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.293 0.568 . . . . 74.25 112.342 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -155.43 158.93 32.03 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 107.203 -1.406 . . . . 72.12 107.203 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.92 143.93 69.8 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.277 1.985 . . . . 74.02 110.716 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 75.06 -52.25 0.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.85 1.26 . . . . 64.43 110.96 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 86.6 mt-30 -68.48 -17.96 64.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 70.32 110.601 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.42 -27.11 68.86 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.529 -0.759 . . . . 74.1 110.018 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.74 -25.04 24.9 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.523 -0.547 . . . . 63.51 109.523 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 92.3 t -74.09 -43.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.587 -0.733 . . . . 63.1 109.112 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.646 ' HG1' ' N ' ' A' ' 39' ' ' MET . 5.8 t -68.18 -29.84 68.81 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.056 -0.975 . . . . 71.32 111.504 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.0 t -76.36 -47.69 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.935 -0.395 . . . . 74.42 109.935 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.398 -0.819 . . . . 64.25 111.498 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 47.6 mtpt -67.4 -23.57 65.57 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.239 -0.584 . . . . 63.21 112.316 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.78 -37.68 38.74 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.896 -1.145 . . . . 71.32 110.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 m-20 -77.34 -24.16 50.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.426 -0.51 . . . . 75.45 111.813 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 51' ' ' LYS . 15.5 pt -72.69 -27.26 25.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.084 -0.646 . . . . 63.24 110.842 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 2.0 mptm? -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.49 -0.884 . . . . 73.45 109.58 173.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.53 -42.38 92.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.327 -0.851 . . . . 63.31 109.86 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 53' ' ' ASP . 73.7 mt -62.99 -34.29 65.57 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.655 -0.702 . . . . 64.23 110.111 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.03 -31.3 70.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.846 0.355 . . . . 75.11 110.766 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.51 42.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.261 0.553 . . . . 63.04 109.849 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.99 35.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.009 -0.541 . . . . 74.34 110.155 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -30.01 68.67 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.982 -1.488 . . . . 73.44 106.982 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 65' ' ' LYS . 17.3 t70 -68.67 -29.01 67.38 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.111 -0.949 . . . . 64.44 109.963 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -71.99 -36.21 69.71 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.46 -0.496 . . . . 72.23 109.668 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -70.28 -38.03 74.96 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 107.794 -1.188 . . . . 75.34 107.794 174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 29.2 tttm -54.21 -35.89 62.9 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.646 -0.706 . . . . 71.33 110.661 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.37 -33.91 32.06 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.596 -0.274 . . . . 72.23 111.62 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.71 -24.25 62.61 Favored 'General case' 0 C--O 1.177 -2.76 0 CA-C-O 120.545 0.212 . . . . 74.11 111.1 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -127.01 18.66 7.14 Favored 'General case' 0 CA--C 1.463 -2.401 0 O-C-N 120.778 -1.202 . . . . 71.53 111.428 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.19 32.44 0.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.066 1.346 . . . . 74.25 112.663 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.82 162.11 0.57 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.072 -1.455 . . . . 52.44 107.072 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.404 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.0 m-85 -80.48 155.87 73.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 111.858 0.318 . . . . 74.23 111.858 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.5 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 31.8 Cg_endo -66.03 161.87 37.92 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.048 2.499 . . . . 74.33 110.64 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -97.85 156.61 16.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.301 -1.37 . . . . 42.04 107.301 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.3 t -66.61 -13.79 61.57 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 119.138 0.881 . . . . 74.13 110.94 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 -65.14 1.01 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.448 -0.342 . . . . 62.55 111.33 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -77.41 -33.88 54.88 Favored 'General case' 0 CA--C 1.481 -1.707 0 O-C-N 121.95 -0.468 . . . . 73.1 111.197 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.583 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -76.73 -20.9 75.75 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 118.881 -1.628 . . . . 71.11 112.554 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.78 -49.53 61.91 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 106.069 -1.826 . . . . 75.04 106.069 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.0 -33.59 73.49 Favored 'General case' 0 C--O 1.169 -3.174 0 CA-C-N 114.646 -1.161 . . . . 71.44 110.272 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -80.07 -5.37 55.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.802 0.668 . . . . 64.41 112.802 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 84.6 mt -96.42 -17.8 20.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.192 0.52 . . . . 75.01 109.858 173.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.53 -33.93 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.373 0.606 . . . . 74.23 111.441 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 83.8 tttt -122.67 148.79 44.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 126.357 1.863 . . . . 64.12 106.861 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -56.51 135.56 76.98 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 118.152 0.433 . . . . 71.2 111.157 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 39.7 Cg_endo -63.47 150.75 87.71 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.825 3.017 . . . . 61.31 112.685 -174.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -98.45 146.81 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.618 -0.433 . . . . 74.31 110.557 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.71 -146.39 18.55 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.932 -1.267 . . . . 54.11 109.932 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -126.72 86.43 58.61 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-O 121.663 0.744 . . . . 71.32 111.697 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.17 154.76 16.84 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.975 2.45 . . . . 74.41 111.126 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.2 143.5 65.23 Favored Pre-proline 0 C--O 1.211 -0.927 0 C-N-CA 123.615 0.766 . . . . 61.12 110.087 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.65 100.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.178 3.252 . . . . 74.51 115.017 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -147.31 148.02 30.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.203 -1.777 . . . . 75.22 106.203 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.33 91.58 3.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.484 -0.562 . . . . 74.5 109.484 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.644 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.7 t90 -54.58 138.83 40.07 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 123.969 0.793 . . . . 74.41 111.514 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -126.72 134.4 50.67 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 114.966 -1.016 . . . . 72.13 109.965 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 24.1 pttm -90.95 -176.43 4.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.321 -0.552 . . . . 65.12 109.883 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 72.43 15.59 5.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.137 1.375 . . . . 70.01 109.958 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 110.39 5.17 28.4 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 114.709 -1.132 . . . . 71.14 114.769 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.644 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 67.84 93.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.276 1.036 . . . . 74.02 110.644 -175.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.7 tp -132.6 158.33 42.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.899 -1.046 . . . . 74.41 108.651 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -84.85 -171.76 3.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.419 -0.956 . . . . 54.5 108.419 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -78.61 70.62 4.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.599 1.19 . . . . 74.24 110.504 176.162 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.9 mt -126.83 147.65 62.04 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 114.694 -1.139 . . . . 73.13 109.442 -174.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.63 158.36 53.73 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.634 1.556 . . . . 71.11 109.663 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 111' ' ' PRO . 6.0 p -79.6 175.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.43 -0.581 . . . . 75.42 109.43 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 105' ' ' VAL . 5.8 p-10 -71.38 158.19 88.48 Favored Pre-proline 0 C--O 1.249 1.062 0 N-CA-C 113.375 0.88 . . . . 74.32 113.375 -168.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 10.1 Cg_endo -53.36 169.1 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.679 2.919 . . . . 71.01 112.06 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 64.13 15.27 9.18 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.842 1.257 . . . . 64.34 109.142 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.0 68.43 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 114.266 -1.334 . . . . 42.35 115.152 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.478 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 3.9 m120 -91.78 154.18 43.8 Favored Pre-proline 0 C--O 1.262 1.733 0 CA-C-N 119.927 1.863 . . . . 74.22 109.04 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.576 ' HA ' HG21 ' A' ' 105' ' ' VAL . 1.5 Cg_endo -85.73 152.08 10.08 Favored 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 121.801 1.667 . . . . 70.31 108.365 165.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 70.0 m-85 -69.16 143.96 53.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.907 0.384 . . . . 74.21 110.252 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 1.6 mm100 -101.47 120.86 40.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.48 -1.674 . . . . 71.52 106.48 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.38 118.93 37.95 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 72.03 112.693 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 89.2 mt -130.34 153.71 48.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.669 -0.863 . . . . 71.13 108.669 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -113.5 -177.8 0.47 Allowed Pre-proline 0 C--N 1.297 -1.71 0 CA-C-O 117.055 -1.45 . . . . 71.3 109.284 -176.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.742 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 19.0 Cg_endo . . . . . 0 C--N 1.382 2.33 0 C-N-CA 122.956 2.437 . . . . 43.24 115.882 -166.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.488 -1.628 0 CA-C-O 118.704 -1.053 . . . . 50.22 113.548 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.56 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 11.1 Cg_exo -37.85 -29.52 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.574 1 C-N-CA 126.857 5.038 . . . . 73.34 118.343 -179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -170.43 151.76 3.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.915 1.234 . . . . 62.02 113.856 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.695 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -113.65 106.66 14.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.703 1.601 . . . . 74.43 107.518 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.81 125.03 32.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.747 -0.781 . . . . 64.54 109.416 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 27.0 p90 -167.1 165.35 15.64 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 110.41 -0.218 . . . . 72.12 110.41 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.1 p -125.7 148.0 49.18 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.805 -0.813 . . . . 51.34 108.805 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.26 133.5 50.72 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.776 0.658 . . . . 71.33 112.776 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.95 173.18 31.8 Favored Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 111.202 -0.759 . . . . 55.31 111.202 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.21 -20.32 26.24 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 115.583 1.697 . . . . 51.04 115.583 -173.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.538 ' OD2' ' HE2' ' A' ' 133' ' ' LYS . 5.0 t70 -94.88 -0.99 53.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.722 0.773 . . . . 72.31 109.757 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.76 24.48 60.15 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 111.319 -0.713 . . . . 74.03 111.319 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.538 ' HE2' ' OD2' ' A' ' 131' ' ' ASP . 68.5 mttm -112.13 147.31 36.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.151 0.5 . . . . 65.2 111.771 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 2.7 tm-20 -100.71 102.33 13.41 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 102.751 -3.055 . . . . 75.25 102.751 165.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 -173.29 23.14 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.196 -1.366 . . . . 51.35 111.446 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.15 128.16 8.11 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 107.311 -2.316 . . . . 61.22 107.311 172.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.55 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 62.8 m -177.78 -179.04 0.75 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.022 1.329 . . . . 73.24 107.463 -171.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.62 -68.6 0.55 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.323 0.583 . . . . 62.43 110.156 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.48 -16.42 11.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.223 -0.899 . . . . 72.35 110.857 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -82.72 -9.92 59.14 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.244 -0.434 . . . . 63.11 110.762 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -86.96 155.13 20.31 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.211 -0.904 . . . . 74.22 110.849 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 8.8 p-10 -79.88 136.16 36.61 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.869 -1.53 . . . . 61.22 106.869 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -97.84 130.86 45.96 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.66 -1.237 . . . . 60.35 107.66 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -143.26 153.25 24.68 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 118.712 -1.709 . . . . 63.43 114.294 -173.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -120.08 129.55 54.26 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.264 -2.125 . . . . 71.53 105.264 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -142.43 144.1 32.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.806 -0.813 . . . . 74.35 108.806 -168.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -130.47 115.13 16.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.97 -1.122 . . . . 75.2 107.97 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 107.34 -1.356 . . . . 44.12 107.34 179.834 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.478 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.7 mpt? . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 109.378 -0.601 . . . . 64.03 109.378 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -92.4 62.02 3.91 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.906 0.706 . . . . 73.41 112.906 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -148.38 147.79 26.75 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 107.497 -1.297 . . . . 74.54 107.497 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.06 151.69 26.83 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.469 2.113 . . . . 64.4 109.835 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 76.76 -57.28 0.54 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.224 1.009 . . . . 65.12 109.389 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 49.3 mt-30 -68.79 -16.39 63.78 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.888 -0.508 . . . . 60.13 111.344 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 -25.89 67.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.872 -0.604 . . . . 61.3 109.386 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -83.49 -24.58 31.68 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 108.825 -0.806 . . . . 74.54 108.825 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 44' ' ' GLN . 69.4 t -74.37 -43.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.82 -0.627 . . . . 62.52 110.233 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -66.43 -39.59 89.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.095 -0.502 . . . . 62.41 111.901 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.02 -34.79 51.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.786 0.327 . . . . 64.02 110.289 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 143' ' ' ILE . . . -66.96 -39.36 87.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.055 -0.521 . . . . 60.01 110.671 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.554 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 66.1 mttm -65.68 -25.6 67.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.357 0.598 . . . . 64.21 111.225 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 -32.31 35.5 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.762 -1.209 . . . . 74.33 110.538 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 56' ' ' ALA 0.354 70.4 m-20 -87.33 -20.62 26.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.268 1.21 . . . . 74.54 114.268 -175.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 144' ' ' GLY . 15.4 pt -71.64 -28.43 31.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.714 -0.847 . . . . 74.53 108.714 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -73.82 -27.03 60.9 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.844 -0.616 . . . . 53.23 110.565 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -62.5 -43.27 99.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.444 -0.798 . . . . 53.1 109.958 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.463 HG12 ' HG ' ' A' ' 100' ' ' LEU . 27.3 mt -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.735 0 CA-C-N 115.232 -0.895 . . . . 73.11 109.681 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.69 -25.28 62.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.835 -0.62 . . . . 71.31 111.995 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.78 -35.12 20.92 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.196 0.522 . . . . 44.43 110.11 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 63' ' ' MET . . . -80.58 -28.3 37.19 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.779 -0.368 . . . . 64.33 111.242 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.89 -26.85 64.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.883 -1.155 . . . . 72.32 107.883 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.3 t70 -69.09 -23.97 64.08 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.287 1.041 . . . . 65.04 109.232 173.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.424 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 51.1 ttm -78.76 -37.94 39.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.534 -0.757 . . . . 73.32 109.674 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.481 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 81.9 t80 -66.01 -38.12 87.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.063 -1.088 . . . . 75.54 108.063 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.541 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 75.9 tttt -54.54 -33.14 59.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.357 -1.292 . . . . 74.15 109.945 173.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 tp -83.13 -34.93 25.94 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.683 -0.407 . . . . 75.25 110.593 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 29.7 t70 -70.98 -25.61 62.78 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 120.901 0.381 . . . . 63.31 111.909 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.416 ' OD1' ' HB3' ' A' ' 89' ' ' PRO . 2.7 m-20 -125.65 19.84 7.92 Favored 'General case' 0 CA--C 1.462 -2.427 0 O-C-N 121.068 -1.02 . . . . 65.51 110.949 175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 p90 43.85 33.65 0.77 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 124.621 1.201 . . . . 73.04 113.549 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.85 160.36 1.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.739 -0.837 . . . . 75.54 108.739 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.541 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 27.6 m-85 -82.98 152.66 66.03 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.932 -0.396 . . . . 72.23 109.932 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.502 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.9 Cg_endo -63.82 164.73 20.67 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.972 3.114 . . . . 70.34 112.96 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.1 p -97.67 156.25 16.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 106.049 -1.834 . . . . 74.34 106.049 172.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -66.15 -14.47 61.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.43 0.633 . . . . 62.12 110.566 -176.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.42 -66.19 0.94 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.385 -0.598 . . . . 71.35 109.385 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -79.66 -35.98 38.42 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 116.186 -0.461 . . . . 72.53 111.087 -173.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.588 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -76.77 -21.4 74.56 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 118.021 -2.037 . . . . 54.24 112.453 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.23 -46.85 66.37 Favored 'General case' 0 C--O 1.259 1.591 0 N-CA-C 106.491 -1.67 . . . . 73.2 106.491 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.8 mt-10 -60.37 -37.69 81.54 Favored 'General case' 0 C--O 1.171 -3.067 0 CA-C-N 114.603 -1.18 . . . . 72.11 109.401 174.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.554 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.37 -3.26 39.22 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.862 0.689 . . . . 41.22 112.862 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 76.8 mt -95.18 -22.79 17.61 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.099 0.476 . . . . 72.34 110.168 173.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -107.78 -25.88 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.547 0.689 . . . . 74.14 111.222 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 85.0 tttt -127.03 147.39 50.14 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 126.432 1.893 . . . . 63.54 107.001 -175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -54.86 128.53 63.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.606 0.762 . . . . 75.12 111.78 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 37.1 Cg_endo -66.8 131.03 24.62 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.405 2.737 . . . . 74.23 111.701 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -94.68 -179.15 4.78 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.11 -0.7 . . . . 61.34 109.11 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.88 -125.12 8.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 108.207 -1.957 . . . . 74.41 108.207 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.8 80.21 14.2 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 118.093 0.946 . . . . 72.53 112.697 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.416 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 14.4 Cg_endo -82.94 142.54 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.205 1.936 . . . . 70.32 110.479 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 50.8 mt-30 -83.06 115.98 61.79 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 107.149 -1.426 . . . . 43.51 107.149 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.521 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 51.4 Cg_exo -51.18 98.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 123.409 2.74 . . . . 65.34 117.678 -168.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HE2' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -111.19 148.93 31.71 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 101.995 -3.335 . . . . 53.15 101.995 163.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.54 99.6 0.11 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 120.108 -0.637 . . . . 71.04 109.736 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.593 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.2 t90 -62.16 141.88 57.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 124.42 1.088 . . . . 74.25 110.693 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.99 133.4 50.57 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.719 -0.673 . . . . 73.02 109.284 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -82.46 -176.92 6.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.15 0.5 . . . . 71.31 110.359 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.4 t70 71.36 15.71 6.22 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.498 1.119 . . . . 63.53 110.292 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 109.21 7.97 27.89 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.057 -0.974 . . . . 73.5 114.115 171.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.593 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 63.78 92.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.136 0.97 . . . . 71.05 109.139 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 101' ' ' LYS . 6.8 tt -138.21 168.01 20.64 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.978 -1.489 . . . . 72.21 106.978 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' N ' HD23 ' A' ' 100' ' ' LEU . 71.5 mmtt -72.44 179.8 3.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.216 -1.031 . . . . 72.14 108.216 176.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -80.41 77.21 7.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.172 0.987 . . . . 74.54 110.376 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.9 mt -131.41 149.89 74.86 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.806 -1.543 . . . . 75.05 108.394 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.49 -170.17 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.861 1.707 . . . . 73.45 111.035 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.627 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.5 p -83.93 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.705 -0.85 . . . . 62.22 108.705 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.543 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 t0 -75.38 156.79 85.24 Favored Pre-proline 0 C--O 1.251 1.175 0 N-CA-C 108.898 -0.778 . . . . 75.31 108.898 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 6.0 Cg_endo -49.15 170.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 123.689 2.926 . . . . 54.42 113.408 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 67.21 14.39 9.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.959 1.704 . . . . 74.24 110.467 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.87 22.8 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 115.467 -0.788 . . . . 63.01 114.25 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -69.95 134.53 87.72 Favored Pre-proline 0 C--O 1.255 1.378 0 N-CA-C 113.319 0.859 . . . . 65.04 113.319 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.627 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.5 Cg_endo -71.51 154.12 60.36 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.429 2.086 . . . . 64.52 110.404 173.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -73.29 141.2 47.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.882 -1.525 . . . . 74.21 106.882 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.3 mm100 -102.89 113.83 27.6 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.417 -1.697 . . . . 54.51 106.417 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.57 120.02 40.05 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.72 -0.673 . . . . 71.21 112.518 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 97.5 mt -129.29 153.61 47.65 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.385 0.674 . . . . 74.35 109.246 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.14 -179.1 0.63 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 117.104 -1.426 . . . . 74.01 108.364 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 25.0 Cg_endo . . . . . 0 C--N 1.384 2.416 0 C-N-CA 123.042 2.495 . . . . 72.12 116.785 -162.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.669 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.479 -2.218 0 CA-C-O 118.65 -1.083 . . . . 53.35 113.248 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.542 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 11.8 Cg_exo -43.34 -24.67 0.61 Allowed 'Trans proline' 0 C--N 1.371 1.754 1 C-N-CA 126.052 4.502 . . . . 71.23 117.179 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -168.89 143.91 3.24 Favored 'General case' 0 C--O 1.254 1.308 0 CA-C-N 118.861 0.755 . . . . 45.13 112.18 173.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.48 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.3 m-20 -122.99 117.68 26.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.518 -1.29 . . . . 64.5 107.518 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 pp -145.42 140.03 27.32 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.742 -0.783 . . . . 54.51 111.671 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.473 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 45.8 p90 -166.23 167.88 15.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.295 -1.002 . . . . 74.54 108.295 -175.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.9 p -124.18 136.85 54.49 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.593 -0.891 . . . . 71.23 108.593 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.65 135.3 57.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.846 -0.742 . . . . 73.43 111.541 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.87 -172.2 9.74 Favored Glycine 0 CA--C 1.495 -1.173 0 CA-C-N 115.817 -0.629 . . . . 65.32 112.848 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.33 -7.81 10.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 114.101 1.148 . . . . 64.14 114.101 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.66 -7.05 41.91 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.091 -0.644 . . . . 70.53 110.149 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 22.16 76.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 121.124 -0.56 . . . . 73.24 111.764 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -140.53 143.51 35.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.625 -1.25 . . . . 71.13 107.625 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -81.66 108.93 15.62 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.712 0.767 . . . . 72.1 109.997 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.4 -173.94 20.41 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.265 -0.88 . . . . 70.15 111.526 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.62 128.11 8.31 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.735 -0.946 . . . . 71.03 110.735 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.54 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 19.4 m 178.17 -176.87 0.21 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 127.143 2.177 . . . . 72.44 105.962 -172.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -87.49 -58.36 2.61 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.931 -1.107 . . . . 71.41 110.827 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.71 -28.81 13.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.638 0.732 . . . . 75.14 111.408 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.95 9.17 23.11 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.761 -0.587 . . . . 73.51 111.753 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.54 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -99.29 155.75 17.35 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 115.845 -0.616 . . . . 62.34 110.782 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -80.47 125.6 30.15 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.174 -1.417 . . . . 73.15 107.174 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.454 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.6 pp -106.71 141.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.508 -0.923 . . . . 72.04 108.508 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.421 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -173.78 170.85 44.01 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 118.212 -1.946 . . . . 71.24 114.41 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -113.72 137.26 51.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.847 -1.538 . . . . 74.01 106.847 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.404 ' CZ3' ' HB3' ' A' ' 124' ' ' ASP . 8.7 t-105 -141.79 124.53 15.99 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.562 . . . . 64.33 106.781 -170.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -102.73 114.2 28.24 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.053 -1.091 . . . . 71.23 108.053 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 4.7 p-10 . . . . . 0 C--N 1.294 -1.814 0 N-CA-C 107.759 -1.2 . . . . 73.53 107.759 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.595 ' N ' ' HG1' ' A' ' 48' ' ' THR . 1.2 mpt? . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.257 -0.645 . . . . 63.22 109.257 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.7 m -100.03 86.09 3.18 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.597 0.713 . . . . 63.03 112.077 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -148.14 163.6 26.06 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 106.35 -1.722 . . . . 62.41 106.35 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.88 130.14 36.18 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.681 2.254 . . . . 70.52 111.374 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.55 -34.21 0.28 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 126.004 1.721 . . . . 51.31 111.008 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -68.29 -20.49 64.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 75.1 109.37 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.53 -29.46 70.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.315 -0.857 . . . . 62.35 110.073 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -80.62 -26.55 37.68 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 108.108 -1.071 . . . . 74.41 108.108 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.419 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.3 t -75.35 -43.6 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.572 -0.74 . . . . 73.25 110.299 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.595 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.1 t -67.93 -37.05 81.18 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.584 -0.735 . . . . 54.4 111.309 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.87 -34.26 32.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 110.127 -0.323 . . . . 64.31 110.127 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.755 -0.657 . . . . 71.43 110.616 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 70.9 mmtt -65.28 -26.31 68.02 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.421 0.629 . . . . 72.41 111.05 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.29 -32.48 19.81 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.536 -1.025 . . . . 73.1 110.536 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 57' ' ' ILE . 70.1 m-20 -77.11 -33.58 56.88 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 120.917 -0.313 . . . . 72.43 111.465 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 pt -67.73 -29.74 46.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.701 -0.4 . . . . 60.52 110.313 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -73.23 -30.17 63.3 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.212 -0.662 . . . . 73.02 109.212 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.43 -40.58 96.01 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.052 -0.976 . . . . 74.01 109.991 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 53' ' ' ASP . 28.8 mt -66.28 -40.18 86.16 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.628 0 CA-C-N 115.103 -0.953 . . . . 71.43 109.71 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.03 66.8 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.29 -0.413 . . . . 62.44 111.447 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.03 -29.69 26.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.154 0.502 . . . . 62.21 110.319 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.31 -28.13 23.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.078 0.466 . . . . 72.4 110.975 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.99 -28.29 65.4 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.812 -1.551 . . . . 72.44 106.812 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.9 t70 -70.06 -24.16 63.2 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.598 -1.183 . . . . 74.22 108.75 172.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.7 mmt -79.93 -34.73 38.64 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.468 -0.787 . . . . 60.23 110.216 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.574 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 49.0 t80 -67.69 -31.7 71.84 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 107.103 -1.443 . . . . 75.14 107.103 171.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 56.9 tttp -57.92 -32.5 67.82 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.654 -0.703 . . . . 65.23 110.326 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -77.01 -36.11 56.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.148 0.499 . . . . 61.35 110.206 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -71.06 -25.44 62.63 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-N 115.7 -0.682 . . . . 74.33 110.856 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.5 18.41 5.29 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.924 -0.56 . . . . 72.23 110.27 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HD2' ' HG3' ' A' ' 90' ' ' GLN . 17.6 p90 42.89 31.35 0.31 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.014 1.326 . . . . 53.21 113.253 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.44 162.5 0.52 Allowed 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.516 -1.29 . . . . 71.12 107.516 -172.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 21.2 m-85 -78.63 151.63 77.32 Favored Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 120.305 -0.558 . . . . 73.2 111.31 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 14.1 Cg_endo -59.76 170.55 3.45 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 124.307 3.338 . . . . 73.24 112.725 177.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 76' ' ' GLN . 77.7 p -101.82 155.66 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.492 -1.67 . . . . 51.3 106.492 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -70.55 -15.07 62.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 119.796 1.18 . . . . 43.15 111.814 -173.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.48 -63.74 1.1 Allowed 'General case' 0 C--O 1.241 0.619 0 CA-C-N 116.311 -0.404 . . . . 72.31 110.886 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 48.8 mt-30 -76.08 -38.53 56.92 Favored 'General case' 0 CA--C 1.484 -1.584 0 C-N-CA 120.889 -0.325 . . . . 75.32 110.646 -174.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -71.31 -21.23 78.56 Favored Glycine 0 N--CA 1.418 -2.512 0 C-N-CA 119.101 -1.523 . . . . 72.54 112.83 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.54 -45.5 75.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.728 -1.582 . . . . 73.24 106.728 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.6 mt-10 -79.88 -2.83 45.37 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.842 -1.072 . . . . 72.31 111.077 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -99.8 -8.16 24.53 Favored 'General case' 0 C--O 1.204 -1.33 0 CA-C-O 121.677 0.751 . . . . 41.44 109.326 174.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 77' ' ' GLY . 5.4 mp -98.52 -24.25 15.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.481 -0.781 . . . . 65.41 110.026 174.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.92 -27.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.913 -0.585 . . . . 50.4 111.129 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 87.8 tttt -130.04 151.49 50.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.558 -1.645 . . . . 61.31 106.558 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -53.55 135.08 53.77 Favored Pre-proline 0 N--CA 1.485 1.308 0 CA-C-N 118.7 0.682 . . . . 75.02 110.94 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 7.2 Cg_endo -47.99 130.05 19.18 Favored 'Trans proline' 0 C--O 1.246 0.885 1 C-N-CA 125.357 4.038 . . . . 72.12 116.355 -170.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -82.19 148.97 28.16 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.183 -1.414 . . . . 44.23 107.183 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 89' ' ' PRO . . . 94.66 -157.28 22.29 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 109.634 -1.386 . . . . 35.43 109.634 -176.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -107.43 99.69 29.69 Favored Pre-proline 1 N--CA 1.369 -4.521 0 CA-C-N 117.68 0.74 . . . . 74.43 110.195 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 87' ' ' GLY . 96.4 Cg_endo -95.41 162.64 1.54 Allowed 'Trans proline' 0 N--CA 1.443 -1.493 0 C-N-CA 122.126 1.884 . . . . 75.03 109.756 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.408 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 25.8 mt-30 -82.8 159.18 63.92 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.432 . . . . 51.24 109.835 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.35 99.9 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.904 1.736 . . . . 75.03 111.315 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -150.51 146.07 26.38 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.485 -1.302 . . . . 52.33 107.485 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.64 89.52 1.32 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 120.733 0.301 . . . . 73.32 111.088 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.472 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 88.7 t90 -54.91 139.48 40.27 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.954 -1.021 . . . . 74.31 111.733 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.43 130.01 56.69 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.788 -1.096 . . . . 75.54 108.961 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -74.38 177.62 5.79 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.933 0.873 . . . . 65.25 110.801 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 62.24 36.11 14.98 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.345 -1.752 . . . . 44.14 109.398 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 92.55 7.73 63.03 Favored Glycine 0 CA--C 1.488 -1.611 0 CA-C-N 113.749 -1.569 . . . . 30.3 115.224 165.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 63.12 85.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.253 1.025 . . . . 72.4 108.649 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.1 tt -138.8 155.63 48.01 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.517 -1.66 . . . . 64.0 106.517 -173.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -63.53 141.5 58.74 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.799 -1.186 . . . . 64.11 107.799 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -74.0 79.09 1.69 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.039 0.923 . . . . 74.21 112.323 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -130.35 149.21 72.71 Favored Pre-proline 0 C--N 1.288 -2.094 0 CA-C-N 113.773 -1.558 . . . . 71.35 108.061 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 171.82 1.21 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.792 2.328 . . . . 73.23 111.873 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.694 HG21 ' HA ' ' A' ' 111' ' ' PRO . 2.6 p -79.21 171.78 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.547 0 CA-C-N 116.342 -0.39 . . . . 63.42 110.082 -173.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.49 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.2 t70 -82.76 153.89 67.76 Favored Pre-proline 0 C--O 1.256 1.423 0 C-N-CA 119.579 -0.848 . . . . 71.32 109.67 -169.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 10.3 Cg_exo -42.81 171.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.867 3.044 . . . . 72.43 115.051 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 70.15 14.17 7.7 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.484 2.313 . . . . 74.04 109.175 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.15 19.09 56.63 Favored Glycine 0 N--CA 1.466 0.635 0 CA-C-N 114.967 -1.015 . . . . 42.24 113.176 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.05 128.26 65.97 Favored Pre-proline 0 C--O 1.27 2.139 0 CA-C-O 121.526 0.679 . . . . 73.25 111.84 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.694 ' HA ' HG21 ' A' ' 105' ' ' VAL . 73.7 Cg_endo -80.46 154.2 21.1 Favored 'Trans proline' 0 N--CA 1.419 -2.888 0 C-N-CA 122.264 1.976 . . . . 71.02 110.302 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.463 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 46.7 m-85 -80.75 139.49 36.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.823 -1.177 . . . . 64.21 107.823 172.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.517 ' OE1' HD13 ' A' ' 128' ' ' LEU . 1.2 mm100 -103.98 118.45 36.7 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.327 -1.36 . . . . 72.55 107.327 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -103.82 117.66 34.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.893 -1.151 . . . . 65.11 107.893 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.0 mt -129.57 153.42 48.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.413 -0.958 . . . . 72.31 108.413 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.843 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.56 179.63 0.81 Allowed Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-O 117.001 -1.475 . . . . 74.21 108.351 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.843 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 9.1 Cg_endo . . . . . 0 C--N 1.38 2.2 0 C-N-CA 123.565 2.844 . . . . 71.52 114.796 -168.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.731 0 N-CA-C 117.952 1.941 . . . . 61.41 117.952 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 7.2 Cg_exo -31.25 -26.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.502 1 C-N-CA 129.208 6.605 . . . . 74.31 119.505 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.285 47.6 p90 -169.9 149.03 3.61 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 119.717 1.144 . . . . 53.21 112.912 170.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.0 OUTLIER -112.66 106.29 14.65 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.483 -1.303 . . . . 70.33 107.483 -176.083 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 57' ' ' ILE . 3.4 tm? -128.46 128.08 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.202 -0.936 . . . . 73.51 110.254 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -166.57 164.33 17.0 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 120.855 -0.338 . . . . 74.02 111.862 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.463 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 23.0 t -125.07 141.71 51.95 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.882 -2.266 . . . . 74.25 104.882 171.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.517 HD13 ' OE1' ' A' ' 113' ' ' GLN . 5.3 mp -59.56 155.0 16.2 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.789 1.033 . . . . 72.41 113.789 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.7 172.85 53.79 Favored Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 115.561 -0.745 . . . . 70.02 112.292 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.52 -28.47 2.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 116.79 2.144 . . . . 61.11 116.79 -173.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.33 -2.06 52.8 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.837 0.744 . . . . 71.35 111.27 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.42 24.75 27.82 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.986 -0.626 . . . . 53.23 112.082 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -140.89 146.32 37.31 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.412 -0.588 . . . . 75.21 109.412 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -81.88 117.85 22.47 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 120.825 0.345 . . . . 64.32 110.777 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -149.47 -174.23 20.71 Favored Glycine 0 C--N 1.317 -0.497 0 N-CA-C 110.441 -1.064 . . . . 34.23 110.441 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.91 128.14 8.6 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 109.791 -1.324 . . . . 73.14 109.791 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.507 ' H ' ' HB2' ' A' ' 141' ' ' ALA . 23.2 t 178.02 -176.65 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.384 -0.969 . . . . 73.24 108.384 -171.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.41 -71.11 0.36 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.116 -0.698 . . . . 74.11 109.116 172.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -98.76 -17.06 18.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.303 0.573 . . . . 71.02 111.525 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 15.1 m-20 -91.67 9.24 33.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.683 0.754 . . . . 73.11 110.763 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.507 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.54 152.87 19.4 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.591 -0.731 . . . . 63.33 110.31 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.79 119.39 21.93 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.931 -1.877 . . . . 51.4 105.931 171.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.563 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.35 128.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 115.754 -0.657 . . . . 73.11 109.936 -174.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.13 -179.8 38.56 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 118.463 -1.827 . . . . 75.5 113.31 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 7.2 t30 -123.73 147.88 47.09 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 105.725 -1.954 . . . . 73.33 105.725 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -142.88 135.92 28.15 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.75 -1.204 . . . . 75.44 107.75 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.9 106.58 13.97 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.176 -1.009 . . . . 73.15 108.484 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 40.1 t30 . . . . . 0 N--CA 1.419 -1.988 0 N-CA-C 107.087 -1.449 . . . . 65.41 107.087 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.7 ttt . . . . . 0 C--O 1.217 -0.65 0 N-CA-C 107.724 -1.213 . . . . 73.13 107.724 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -110.22 89.41 3.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.024 0.916 . . . . 32.43 110.426 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 12.7 ptm180 -155.89 161.29 29.79 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.191 -1.781 . . . . 70.2 106.191 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.02 120.53 0.54 Allowed 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 124.057 3.171 . . . . 74.34 114.68 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t0 74.36 -35.79 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 126.81 2.044 . . . . 64.14 112.186 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.548 ' HA ' HG23 ' A' ' 47' ' ' VAL . 84.6 mm-40 -68.76 -24.39 64.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.504 0.668 . . . . 72.45 109.528 176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -62.11 -29.17 70.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.035 -0.984 . . . . 61.31 109.329 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.8 -23.73 39.05 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.118 -0.492 . . . . 74.33 110.249 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.548 HG23 ' HA ' ' A' ' 44' ' ' GLN . 40.2 t -74.59 -44.01 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.189 -1.041 . . . . 52.42 108.189 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 45' ' ' ALA . 14.6 t -67.96 -34.2 76.11 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.52 -0.763 . . . . 54.33 111.525 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 45' ' ' ALA . 19.8 m -69.22 -43.3 81.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 C-N-CA 119.434 -0.906 . . . . 74.13 109.566 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.422 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -59.6 -41.74 91.01 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.128 0.971 . . . . 51.33 110.958 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 58.7 mtpt -66.6 -21.89 66.13 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.635 -0.711 . . . . 74.31 111.925 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.27 -31.71 18.86 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 110.105 -1.198 . . . . 72.22 110.105 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.4 ' OD1' HD13 ' A' ' 103' ' ' LEU . 24.2 m-20 -70.42 -39.33 74.49 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.331 0.586 . . . . 72.31 110.622 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.627 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 17.6 pt -70.23 -25.5 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.942 -0.572 . . . . 54.31 110.673 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -68.41 -31.87 71.51 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.735 -0.839 . . . . 63.3 108.735 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -29.3 64.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.272 -0.876 . . . . 63.24 109.78 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 18.1 mm -59.88 -48.3 88.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 CA-C-N 115.03 -0.987 . . . . 61.12 108.731 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB2' HD21 ' A' ' 145' ' ' ASN . . . -58.22 -34.01 69.95 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.854 0.359 . . . . 54.34 111.314 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.53 -42.54 67.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.736 -0.665 . . . . 75.25 111.037 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.41 24.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.464 0.542 . . . . 62.1 112.464 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.31 -30.11 69.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.166 -1.42 . . . . 74.42 107.166 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.5 t70 -69.88 -27.61 64.96 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.289 1.042 . . . . 73.33 109.601 173.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 63.3 mtt -78.34 -30.21 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.707 -0.679 . . . . 72.42 110.331 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -71.3 -36.22 71.56 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.017 -1.105 . . . . 72.21 108.017 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 51.9 tttp -55.17 -31.59 61.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.316 -0.856 . . . . 73.44 109.93 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.93 -31.05 23.84 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.291 -0.868 . . . . 73.24 110.806 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.46 -27.12 56.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.925 0.393 . . . . 74.23 111.333 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.47 24.16 5.13 Favored 'General case' 0 CA--C 1.46 -2.513 0 N-CA-C 109.479 -0.563 . . . . 62.25 109.479 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.3 p90 43.26 33.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.417 1.087 . . . . 64.33 113.824 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 179.87 160.09 0.82 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.125 -0.694 . . . . 72.3 109.125 -173.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 24.4 m-85 -81.23 150.91 68.86 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 123.451 0.469 . . . . 62.43 110.131 171.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.552 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.8 Cg_endo -65.01 170.09 10.91 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.607 2.871 . . . . 74.1 113.255 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 73.3 p -110.01 153.98 23.82 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.196 -1.779 . . . . 74.45 106.196 171.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.433 ' N ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -59.59 -20.98 59.62 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.433 0.635 . . . . 72.21 111.933 -178.112 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -98.38 -65.95 0.93 Allowed 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 122.055 -0.403 . . . . 73.14 111.313 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -75.99 -37.32 58.64 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 116.604 -0.271 . . . . 75.22 111.287 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -78.53 -21.41 69.5 Favored Glycine 0 N--CA 1.413 -2.865 0 C-N-CA 118.372 -1.871 . . . . 75.31 112.83 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.92 -44.64 65.74 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 106.324 -1.732 . . . . 72.11 106.324 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 10.1 mm-40 -60.47 -41.34 93.97 Favored 'General case' 0 C--O 1.162 -3.526 0 CA-C-N 114.7 -1.136 . . . . 65.53 109.828 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.55 1.37 19.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.942 0.719 . . . . 54.51 112.942 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 63.5 mt -101.64 -20.97 14.8 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.229 -0.295 . . . . 70.12 111.008 172.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.3 t -111.04 -26.42 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-O 121.822 0.82 . . . . 74.41 111.026 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 38.3 ttmt -122.87 146.65 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 126.972 2.109 . . . . 72.32 105.83 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' H ' ' HD3' ' A' ' 84' ' ' LYS . 3.8 mppt? -55.95 141.86 66.27 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 118.517 0.599 . . . . 71.54 111.501 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.77 122.35 10.87 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 123.063 2.508 . . . . 72.23 112.397 -172.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.3 p -71.26 140.66 50.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.335 -1.302 . . . . 60.12 111.132 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.12 -116.55 5.61 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.54 -1.024 . . . . 75.11 110.54 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.24 92.53 7.48 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 112.872 0.693 . . . . 73.34 112.872 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.73 162.38 14.27 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.739 1.626 . . . . 70.03 107.954 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -74.87 158.97 84.03 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-O 118.608 -0.71 . . . . 75.24 109.392 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.42 98.3 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 121.56 1.507 . . . . 70.53 110.625 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 10.1 tmtt? -152.77 144.18 23.31 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.183 -1.784 . . . . 74.33 106.183 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.513 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 33.5 m-80 -78.7 94.76 5.14 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 118.239 0.472 . . . . 71.43 111.315 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.456 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.5 t90 -57.65 144.17 38.69 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.037 1.335 . . . . 74.04 112.519 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.93 135.16 55.27 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.806 -1.088 . . . . 73.22 108.984 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -84.06 -174.3 5.2 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.435 -0.58 . . . . 75.03 109.435 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 58.91 34.64 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 114.241 1.2 . . . . 74.24 114.241 176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 89.87 6.55 69.59 Favored Glycine 0 CA--C 1.487 -1.717 0 CA-C-N 115.344 -0.844 . . . . 72.21 114.358 168.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.456 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.5 OUTLIER 66.18 91.9 0.08 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.311 1.053 . . . . 62.35 111.301 -176.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.3 tp -138.28 170.97 15.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.618 -1.173 . . . . 71.43 108.174 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.87 -165.54 1.22 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.729 -0.607 . . . . 61.52 109.617 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.525 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -70.39 39.83 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.893 0.854 . . . . 75.33 112.272 178.129 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.4 HD13 ' OD1' ' A' ' 53' ' ' ASP . 84.8 mt -102.13 148.59 35.59 Favored Pre-proline 0 C--N 1.294 -1.844 0 C-N-CA 124.328 1.051 . . . . 73.1 110.2 -175.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.85 -166.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.908 3.072 . . . . 72.02 112.229 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.487 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 3.6 p -85.01 172.04 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 107.353 -1.351 . . . . 71.13 107.353 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.597 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -80.21 155.98 74.3 Favored Pre-proline 0 C--O 1.256 1.415 0 C-N-CA 119.723 -0.791 . . . . 73.33 109.847 -172.626 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 11.2 Cg_endo -54.3 171.54 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.562 2.842 . . . . 73.22 113.298 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.584 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 65.57 15.76 10.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.909 1.684 . . . . 64.23 109.738 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.63 29.76 75.86 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.921 -1.036 . . . . 73.43 113.926 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.584 ' ND2' ' HB2' ' A' ' 108' ' ' TRP . 58.1 m-80 -93.11 119.82 67.36 Favored Pre-proline 0 C--O 1.249 1.056 0 CA-C-N 117.672 0.736 . . . . 74.21 110.802 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.487 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 46.3 Cg_exo -62.91 143.12 90.77 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 121.955 1.77 . . . . 74.42 108.824 168.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -69.18 144.4 53.79 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.149 0.5 . . . . 70.01 110.332 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.655 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -102.62 114.77 29.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.403 -1.703 . . . . 53.41 106.403 -178.2 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.13 117.3 34.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.395 -1.335 . . . . 73.45 107.395 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.1 mt -129.67 154.02 47.56 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.239 0.542 . . . . 72.15 109.808 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.744 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -112.78 -178.63 0.54 Allowed Pre-proline 0 N--CA 1.401 -2.884 0 CA-C-O 116.109 -1.9 . . . . 54.44 106.959 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.744 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 9.5 Cg_endo . . . . . 0 C--N 1.395 3.023 0 C-N-CA 123.146 2.564 . . . . 72.32 115.191 -164.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.486 -1.723 0 CA-C-O 118.553 -1.137 . . . . 71.23 113.058 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.52 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 34.9 Cg_exo -36.61 -29.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 1 C-N-CA 126.637 4.892 . . . . 74.32 118.352 -178.009 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.527 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 46.4 p90 -172.17 168.27 5.76 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.102 0.865 . . . . 73.52 111.247 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.6 106.33 5.63 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.835 0.854 . . . . 75.33 109.145 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -125.48 127.31 46.28 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.579 -0.896 . . . . 73.13 108.579 -178.396 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 30.0 p90 -166.61 169.42 13.65 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.252 -0.579 . . . . 71.14 112.301 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.2 t -125.02 149.27 47.93 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.681 -1.229 . . . . 55.24 107.681 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.655 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 82.1 mt -69.16 154.6 41.78 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 110.355 -0.239 . . . . 52.23 110.355 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.36 -174.76 24.8 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 121.449 -0.405 . . . . 52.34 113.87 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -55.15 -24.37 26.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.906 1.446 . . . . 72.14 114.906 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -93.85 -6.04 46.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.21 -0.596 . . . . 72.33 110.946 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 128' ' ' LEU . . . 91.17 19.18 43.39 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.608 -0.806 . . . . 64.12 113.086 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -140.79 148.62 40.92 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.326 -0.62 . . . . 71.54 109.326 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.36 122.57 23.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.111 0.481 . . . . 63.02 110.55 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.62 -175.06 22.27 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 110.369 -1.092 . . . . 72.31 110.369 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -115.19 127.34 7.59 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 108.102 -1.999 . . . . 45.2 108.102 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 69.3 m 179.66 -177.15 0.33 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.617 1.167 . . . . 72.44 108.22 -169.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.94 -67.65 0.74 Allowed 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.95 0.156 . . . . 75.25 110.692 170.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -96.19 -21.34 17.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.137 0.494 . . . . 75.4 111.609 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -93.21 15.07 16.26 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.153 0.501 . . . . 74.23 111.077 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -91.68 155.86 18.0 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 115.995 -0.548 . . . . 64.11 111.164 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.44 127.86 32.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.235 -1.765 . . . . 73.51 106.235 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -96.96 121.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 108.333 -0.988 . . . . 63.54 108.333 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -142.26 152.54 23.77 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.188 -1.482 . . . . 51.44 114.796 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.486 HD21 ' HB2' ' A' ' 58' ' ' ALA . 3.6 t30 -130.25 120.08 23.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.536 -1.283 . . . . 63.11 107.536 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.527 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 2.5 p90 -160.24 177.57 10.51 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.722 0.772 . . . . 75.03 111.945 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.34 117.44 26.96 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 106.377 -1.712 . . . . 74.53 106.377 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 C--N 1.298 -1.641 0 N-CA-C 106.966 -1.494 . . . . 71.23 106.966 -176.908 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 108.444 -0.947 . . . . 71.13 108.444 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 m -121.64 80.12 1.64 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.361 0.6 . . . . 71.21 111.749 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -149.82 161.17 32.18 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.937 -1.875 . . . . 71.13 105.937 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -45.71 128.78 11.17 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.032 2.488 . . . . 71.23 112.088 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.266 20.6 m-20 75.99 -41.33 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.281 1.432 . . . . 64.2 113.705 -176.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.55 -23.03 64.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.265 0.555 . . . . 73.55 110.113 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.51 65.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.084 -0.962 . . . . 65.21 110.512 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -88.35 -26.56 22.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.212 -1.033 . . . . 73.41 108.212 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.493 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 39.1 t -75.71 -40.76 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.076 -0.966 . . . . 62.11 109.948 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -63.48 -29.55 70.81 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.487 -0.779 . . . . 74.22 110.861 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -73.63 -44.85 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 108.357 -0.979 . . . . 73.21 108.357 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.47 -42.33 87.25 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.937 -1.029 . . . . 65.35 111.532 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -66.7 -25.07 66.35 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 121.331 0.586 . . . . 74.41 111.944 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.81 -22.86 34.82 Favored Glycine 0 C--N 1.31 -0.889 0 N-CA-C 110.447 -1.061 . . . . 55.24 110.447 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 15.4 t70 -82.25 -38.33 24.62 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.296 -0.631 . . . . 74.45 109.296 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.46 HG21 ' HA2' ' A' ' 144' ' ' GLY . 28.5 pt -65.53 -34.56 71.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.231 -0.655 . . . . 74.33 109.231 173.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -66.98 -28.04 67.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.783 -0.451 . . . . 73.23 109.783 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.82 -44.04 86.81 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.334 -0.617 . . . . 73.41 109.334 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.4 HG12 HD13 ' A' ' 100' ' ' LEU . 69.4 mt -64.83 -38.94 84.01 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.238 -0.892 . . . . 74.22 109.863 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . . . -59.62 -26.38 65.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.073 0.463 . . . . 62.53 111.573 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.7 -33.2 18.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.091 0.472 . . . . 73.55 110.204 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.507 ' HA ' ' SD ' ' A' ' 63' ' ' MET . . . -84.36 -26.83 28.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.033 -0.531 . . . . 74.21 111.898 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.1 -25.39 62.58 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.003 -1.48 . . . . 75.54 107.003 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 65' ' ' LYS . 28.7 t70 -75.4 -20.1 59.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.827 -1.079 . . . . 72.51 109.193 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.507 ' SD ' ' HA ' ' A' ' 60' ' ' ALA . 72.3 mtp -81.29 -29.72 34.21 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.378 -0.828 . . . . 73.04 109.538 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.18 -39.36 71.89 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 106.246 -1.761 . . . . 73.11 106.246 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 32.8 tttm -56.26 -26.55 52.05 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.178 -0.919 . . . . 62.02 110.175 173.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.22 -36.58 19.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.853 -0.612 . . . . 64.32 110.418 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.8 t70 -74.23 -25.94 59.95 Favored 'General case' 0 C--O 1.209 -1.054 0 O-C-N 122.281 -0.262 . . . . 63.32 111.318 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 89' ' ' PRO . 2.8 m120 -127.02 20.39 6.95 Favored 'General case' 0 CA--C 1.456 -2.668 0 CA-C-O 118.75 -0.643 . . . . 74.11 111.209 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 43.07 32.15 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.733 1.271 . . . . 75.11 113.191 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.95 161.44 0.56 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.776 -1.194 . . . . 73.12 107.776 -172.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 12.6 m-85 -76.93 157.15 81.97 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 123.361 0.413 . . . . 74.33 111.923 174.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.523 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 6.9 Cg_exo -72.86 170.41 19.73 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.838 2.358 . . . . 61.31 111.334 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 p -104.28 156.27 18.05 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.05 -1.463 . . . . 62.13 107.05 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -70.64 -12.3 61.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 119.711 1.141 . . . . 62.53 110.492 -175.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -100.85 -65.09 0.99 Allowed 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.865 -0.607 . . . . 52.31 110.581 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -75.79 -39.55 56.73 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 120.548 -0.461 . . . . 74.34 110.133 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -73.83 -21.38 79.33 Favored Glycine 0 N--CA 1.415 -2.765 0 C-N-CA 119.091 -1.528 . . . . 74.03 113.785 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.65 -46.86 44.05 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 107.625 -1.25 . . . . 44.32 107.625 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.09 -29.99 70.7 Favored 'General case' 0 C--O 1.183 -2.41 0 CA-C-N 114.955 -1.021 . . . . 74.13 110.119 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -86.03 -0.27 55.12 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.488 0.493 . . . . 53.12 112.252 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 65.9 mt -97.01 -21.47 17.39 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.404 0.621 . . . . 72.22 110.058 172.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.79 -30.67 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 121.575 0.702 . . . . 70.42 110.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 99.2 mttt -125.35 151.49 46.02 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 125.942 1.697 . . . . 70.33 107.436 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -54.27 142.16 49.64 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 112.755 0.65 . . . . 32.42 112.755 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 6.7 Cg_endo -45.42 131.64 12.13 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.961 3.774 . . . . 62.03 114.96 -175.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -95.07 -1.49 52.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.939 -1.028 . . . . 74.25 110.032 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.99 11.74 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.258 -0.883 . . . . 73.11 111.586 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -126.7 86.08 59.3 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-O 121.555 0.693 . . . . 74.2 110.642 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.454 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 88.4 Cg_endo -91.35 161.82 3.68 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.585 2.19 . . . . 73.03 112.911 -176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.06 134.96 20.52 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.471 -0.937 . . . . 74.45 108.471 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -35.78 100.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 125.219 3.946 . . . . 74.14 115.014 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.526 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.85 147.3 27.08 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.018 -1.845 . . . . 74.13 106.018 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.526 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 3.7 m-20 -70.28 101.4 1.9 Allowed 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.501 0.667 . . . . 70.31 111.726 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.478 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 85.2 t90 -67.46 145.05 55.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.783 -1.099 . . . . 63.15 110.892 175.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -131.18 134.56 46.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.923 -0.769 . . . . 71.13 108.923 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 47.7 pttt -82.25 -165.84 1.11 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.486 -1.302 . . . . 75.24 107.486 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 66.15 19.05 11.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.533 1.158 . . . . 61.23 109.139 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 85.08 17.25 63.31 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.43 -1.259 . . . . 74.44 113.214 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.3 m-85 64.37 90.06 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.325 1.06 . . . . 75.4 110.602 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.4 HD13 HG12 ' A' ' 57' ' ' ILE . 66.3 tp -138.49 169.28 18.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.963 -1.125 . . . . 70.13 107.963 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -86.69 -171.94 3.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.948 -1.131 . . . . 53.03 107.948 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -75.4 70.05 2.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.661 1.22 . . . . 74.4 110.849 177.657 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -130.41 147.83 67.45 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.197 -1.365 . . . . 64.03 108.314 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.84 -168.98 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.835 2.357 . . . . 75.14 112.001 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.7 p -88.45 174.64 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 107.847 -1.168 . . . . 73.33 107.847 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 9.4 t70 -78.7 152.67 77.95 Favored Pre-proline 0 C--O 1.256 1.444 0 CA-C-N 119.255 0.934 . . . . 62.3 110.359 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 90.0 Cg_exo -49.76 172.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.573 2.849 . . . . 61.43 114.162 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 68.88 14.43 8.9 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.746 2.018 . . . . 74.34 109.026 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.9 33.33 78.12 Favored Glycine 0 C--N 1.32 -0.325 0 CA-C-N 114.83 -1.077 . . . . 60.5 112.628 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -93.72 131.99 30.9 Favored Pre-proline 0 C--O 1.258 1.506 0 N-CA-C 111.934 0.346 . . . . 71.45 111.934 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.533 ' HA ' HG21 ' A' ' 105' ' ' VAL . 66.6 Cg_endo -78.32 151.09 26.05 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 122.264 1.976 . . . . 73.44 110.362 174.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 8.6 m-85 -78.51 142.39 37.47 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.789 0.328 . . . . 70.34 110.309 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.578 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -104.52 113.82 27.63 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 106.45 -1.685 . . . . 75.41 106.45 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.5 118.0 35.14 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.113 -1.81 . . . . 70.41 106.113 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 91.2 mt -129.35 145.4 51.39 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.188 -0.671 . . . . 72.13 109.188 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.746 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -106.81 -178.32 0.58 Allowed Pre-proline 0 N--CA 1.402 -2.838 0 CA-C-O 115.907 -1.996 . . . . 52.25 106.641 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.746 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 2.9 Cg_endo . . . . . 0 C--N 1.394 2.927 0 C-N-CA 123.049 2.499 . . . . 43.42 114.556 -162.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 148' ' ' ASN . . . . . . . . 0 N--CA 1.424 -2.107 0 N-CA-C 117.331 1.692 . . . . 74.33 117.331 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.543 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 44.6 Cg_exo -36.93 -37.24 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 127.629 5.553 . . . . 70.43 118.209 -175.401 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.289 29.3 p90 -161.28 144.73 12.84 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 117.829 -1.548 . . . . 73.3 114.776 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -113.79 105.87 13.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.586 -1.635 . . . . 42.23 106.586 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.42 126.9 41.51 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.863 -1.148 . . . . 74.15 109.865 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 34.0 p90 -167.39 166.13 14.62 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.218 0.324 . . . . 72.33 111.837 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.51 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 29.8 t -125.37 149.74 47.86 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.607 -1.998 . . . . 72.41 105.607 170.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.578 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 95.0 mt -63.68 145.09 56.39 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.719 0.295 . . . . 74.42 110.851 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.17 -169.67 45.98 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.416 -0.897 . . . . 74.32 111.404 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.5 -6.29 14.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 123.818 0.847 . . . . 71.45 113.101 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -96.0 -9.07 31.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.559 0.695 . . . . 53.14 110.101 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.53 7.88 70.01 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-N 115.815 -0.629 . . . . 52.52 113.301 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -140.05 147.55 40.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.827 -1.546 . . . . 51.23 106.827 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 119.81 21.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.668 -0.813 . . . . 62.44 111.643 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.75 -173.94 21.3 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.492 -1.043 . . . . 72.44 110.492 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.07 127.55 7.84 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.164 -1.574 . . . . 63.41 109.164 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.516 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 58.1 m 178.79 -177.54 0.27 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 126.421 1.888 . . . . 45.1 106.68 -171.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.85 -76.77 0.17 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.065 -0.654 . . . . 70.12 110.738 171.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -96.44 -14.7 22.22 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.731 -0.388 . . . . 73.22 111.708 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -90.13 3.28 53.86 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.334 0.587 . . . . 74.24 110.689 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -94.68 157.74 15.83 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 115.149 -0.932 . . . . 44.44 110.297 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.19 126.85 31.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.68 -1.6 . . . . 72.53 106.68 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -96.86 119.05 44.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.657 0.742 . . . . 72.35 111.287 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA2' HG21 ' A' ' 54' ' ' ILE . . . -174.44 162.35 32.57 Favored Glycine 0 N--CA 1.41 -3.096 0 C-N-CA 119.515 -1.326 . . . . 53.42 112.202 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -106.2 160.79 15.07 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.476 -0.935 . . . . 64.4 108.476 177.176 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -143.01 137.4 29.27 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.138 -1.06 . . . . 72.41 108.138 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -106.46 91.66 3.79 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.66 -1.216 . . . . 74.54 109.111 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.568 ' HB2' ' HA3' ' A' ' 121' ' ' GLY . 10.1 t30 . . . . . 0 CA--C 1.506 -0.732 0 O-C-N 126.282 2.239 . . . . 75.23 107.45 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.638 ' N ' ' HG1' ' A' ' 48' ' ' THR . 8.2 tpt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 107.042 -1.466 . . . . 65.22 107.042 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -118.44 98.21 6.15 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.809 0.67 . . . . 73.32 112.809 -173.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -155.58 165.49 18.29 Favored Pre-proline 0 C--O 1.252 1.23 0 N-CA-C 104.9 -2.259 . . . . 74.51 104.9 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.7 124.57 12.53 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.747 2.298 . . . . 74.31 111.913 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 75.08 -26.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.969 2.108 . . . . 62.35 111.777 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.411 ' HA ' HG23 ' A' ' 47' ' ' VAL . 62.5 mt-30 -68.69 -19.23 64.37 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 121.659 -0.651 . . . . 74.41 109.47 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.17 65.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.159 -0.928 . . . . 75.33 110.188 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' O ' HG22 ' A' ' 49' ' ' VAL . 66.1 mttm -90.35 -25.58 20.38 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.041 -0.726 . . . . 71.13 109.041 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.6 t -73.93 -40.92 53.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.75 0.785 . . . . 74.21 109.018 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.638 ' HG1' ' N ' ' A' ' 39' ' ' MET . 10.9 t -65.43 -25.84 67.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.795 -1.093 . . . . 74.22 111.668 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 46' ' ' LYS . 6.0 m -82.69 -34.35 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 108.746 -0.835 . . . . 73.53 108.746 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 54' ' ' ILE . . . -61.84 -32.24 72.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.112 -0.949 . . . . 65.03 110.815 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.3 mmmt -65.14 -25.2 67.65 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.954 -0.567 . . . . 54.11 110.372 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.47 -27.29 18.11 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 111.164 -0.774 . . . . 52.02 111.164 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -79.19 -36.25 40.55 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.802 -0.444 . . . . 64.24 109.802 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 50' ' ' ALA . 26.6 pt -69.17 -31.02 48.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.595 -0.52 . . . . 73.22 109.595 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.5 tptt -65.79 -33.03 74.91 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.096 -0.705 . . . . 72.33 109.096 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.54 80.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.337 -0.847 . . . . 74.0 110.038 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.485 HG12 HD13 ' A' ' 100' ' ' LEU . 53.2 mt -68.27 -36.94 77.11 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 CA-C-N 115.829 -0.623 . . . . 72.1 110.238 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.39 66.81 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.032 0.444 . . . . 62.14 110.766 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -88.63 -36.03 16.5 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 115.482 -0.781 . . . . 54.43 110.202 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.1 -28.12 60.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.004 0.43 . . . . 72.05 111.186 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -67.88 -29.45 68.56 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.598 -1.26 . . . . 75.44 107.598 177.177 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.4 t70 -72.84 -23.15 60.72 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.873 -1.058 . . . . 54.12 109.475 174.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 62.5 mtt -81.26 -39.65 24.97 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.943 -0.762 . . . . 75.25 108.943 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 87.7 t80 -64.39 -35.75 81.92 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.076 -1.083 . . . . 74.52 108.076 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.598 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 82.3 tttt -54.95 -31.78 60.86 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.052 -0.977 . . . . 65.43 111.215 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.9 -29.05 16.9 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.632 0.604 . . . . 71.31 112.632 172.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.521 ' HB3' ' HA ' ' A' ' 64' ' ' TYR . 19.4 t70 -72.15 -24.3 61.43 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.98 0.512 . . . . 73.03 111.311 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -128.48 18.84 6.32 Favored 'General case' 0 CA--C 1.455 -2.686 0 N-CA-C 108.071 -1.085 . . . . 73.24 108.071 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.0 p90 43.61 32.88 0.59 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.436 1.495 . . . . 72.15 114.134 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.15 161.09 1.09 Allowed 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.595 -0.891 . . . . 71.3 108.595 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.598 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 15.6 m-85 -78.12 154.02 79.88 Favored Pre-proline 0 N--CA 1.427 -1.62 0 O-C-N 123.713 0.633 . . . . 65.53 111.466 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.504 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 31.2 Cg_endo -66.87 165.76 24.87 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.108 2.539 . . . . 72.31 111.736 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.43 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 41.4 p -100.27 155.45 17.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.75 -1.944 . . . . 70.23 105.75 170.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.668 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.3 t -67.23 -12.13 59.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 119.736 1.153 . . . . 62.12 111.664 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -102.63 -64.9 1.03 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.268 -0.423 . . . . 74.04 111.062 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.33 -34.54 48.52 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 122.113 -0.367 . . . . 74.42 110.455 -174.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.657 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -78.4 -20.71 71.41 Favored Glycine 0 N--CA 1.412 -2.901 0 C-N-CA 119.112 -1.518 . . . . 63.14 112.757 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.78 -44.57 66.39 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 105.361 -2.088 . . . . 74.55 105.361 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 13.5 mm-40 -65.51 -16.69 63.92 Favored 'General case' 0 C--O 1.189 -2.09 0 CA-C-N 114.141 -1.39 . . . . 73.51 111.454 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.657 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -98.37 -3.39 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.374 0.607 . . . . 74.41 111.391 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 mp -98.56 -15.56 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 61.31 108.773 173.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.04 -39.93 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.602 -0.726 . . . . 75.15 110.859 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 5.6 ttpm? -116.35 150.29 37.96 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.047 -1.464 . . . . 74.45 107.047 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -54.37 137.02 60.48 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 118.341 0.518 . . . . 64.51 111.474 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.79 140.59 81.03 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.49 2.793 . . . . 74.34 111.994 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.7 p -83.04 178.1 8.3 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.004 -0.544 . . . . 75.34 110.346 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.12 -114.58 4.58 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.12 -0.792 . . . . 73.35 111.12 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -148.56 116.41 3.93 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 120.611 -0.435 . . . . 74.53 110.931 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -103.5 162.94 0.24 Allowed 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 123.846 3.031 . . . . 73.54 111.088 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -76.65 159.29 79.59 Favored Pre-proline 0 C--O 1.207 -1.167 0 O-C-N 121.682 -0.636 . . . . 71.34 109.557 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -70.77 99.06 0.82 Allowed 'Trans proline' 0 C--O 1.248 1.015 0 C-N-CA 121.335 1.356 . . . . 61.11 112.586 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 67.6 mttm -146.66 148.56 32.17 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.818 -1.919 . . . . 74.43 105.818 174.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -76.41 92.99 3.43 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.628 -0.829 . . . . 70.41 110.372 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.617 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 79.4 t90 -53.69 143.53 20.24 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.237 1.415 . . . . 70.31 111.578 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -124.11 136.72 54.43 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.816 -1.083 . . . . 71.11 109.806 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 64.0 pttt -88.04 -168.75 2.31 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.631 -0.878 . . . . 75.25 108.631 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.66 16.3 6.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.708 1.242 . . . . 71.22 110.212 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.56 11.67 50.29 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.246 -1.343 . . . . 73.15 113.979 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.88 91.37 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.272 1.034 . . . . 70.43 111.181 -176.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 46.2 tp -138.94 156.09 47.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.551 -1.204 . . . . 71.25 108.414 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.499 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.5 mmmt -77.53 -177.63 4.84 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.45 -0.944 . . . . 75.22 108.45 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -82.29 74.22 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.5 -0.88 . . . . 44.51 110.86 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.88 147.83 67.8 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 125.133 1.373 . . . . 63.24 107.32 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.98 166.46 12.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.834 2.356 . . . . 72.44 113.704 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' A' ' 111' ' ' PRO . 6.2 p -79.36 176.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.408 -0.815 . . . . 72.13 109.138 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.483 ' H ' HG22 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -69.29 146.09 96.4 Favored Pre-proline 0 C--O 1.257 1.466 0 N-CA-C 112.508 0.558 . . . . 75.32 112.508 -175.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.414 ' HG3' ' HB3' ' A' ' 46' ' ' LYS . 5.8 Cg_endo -50.57 171.46 0.1 Allowed 'Trans proline' 0 C--O 1.197 -1.535 0 C-N-CA 124.118 3.212 . . . . 74.22 112.916 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 62.27 14.96 7.18 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.971 1.308 . . . . 75.05 109.298 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.47 30.05 76.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.811 1.084 . . . . 61.23 115.811 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -93.17 130.66 35.17 Favored Pre-proline 0 C--O 1.256 1.398 0 CA-C-N 119.085 1.443 . . . . 73.15 110.981 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.542 ' HA ' HG21 ' A' ' 105' ' ' VAL . 27.0 Cg_endo -70.98 148.57 57.45 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 121.434 1.423 . . . . 72.1 109.18 168.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 32.9 m-85 -69.45 143.86 53.45 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.07 0.462 . . . . 71.31 111.963 -177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.418 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -102.61 114.22 28.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.802 -1.925 . . . . 52.44 105.802 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.25 120.09 41.18 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.258 -0.883 . . . . 70.52 111.311 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.1 mt -127.72 153.57 46.36 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.629 -0.878 . . . . 75.11 108.629 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -114.85 -178.69 0.53 Allowed Pre-proline 0 N--CA 1.406 -2.666 0 CA-C-O 117.035 -1.46 . . . . 73.2 107.73 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.7 Cg_endo . . . . . 0 CA--C 1.482 -2.083 0 C-N-CA 122.522 2.148 . . . . 71.41 115.116 -170.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.432 -1.577 0 CA-C-O 118.337 -1.257 . . . . 72.42 112.53 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.567 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 20.2 Cg_exo -41.21 -25.04 0.22 Allowed 'Trans proline' 0 N--CA 1.504 2.112 1 C-N-CA 126.954 5.103 . . . . 74.32 118.852 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.589 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.0 p90 178.19 165.95 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.997 0.817 . . . . 71.52 109.766 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 2.6 m-20 -139.32 113.17 8.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.371 0.668 . . . . 73.11 109.424 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.472 ' HG ' HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -125.29 124.58 41.93 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.786 -0.766 . . . . 73.45 110.371 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -164.43 166.43 20.58 Favored 'General case' 0 C--O 1.208 -1.109 0 O-C-N 123.087 0.242 . . . . 64.04 110.352 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.46 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 18.8 t -125.51 153.21 43.93 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.381 -1.34 . . . . 71.54 107.381 171.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.418 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 88.8 mt -66.26 128.6 36.77 Favored 'General case' 0 C--O 1.204 -1.316 0 O-C-N 123.227 0.329 . . . . 73.13 111.557 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.53 15.89 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.918 -0.658 . . . . 63.53 112.235 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.24 -16.74 9.02 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.82 1.415 . . . . 74.33 114.82 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.4 -9.38 35.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.15 0.976 . . . . 72.33 109.802 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.85 10.28 86.33 Favored Glycine 0 CA--C 1.505 -0.585 0 CA-C-N 115.334 -0.848 . . . . 72.13 112.281 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 5.2 mmpt? -124.77 147.89 48.43 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.58 0.352 . . . . 74.42 110.348 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.59 104.91 17.29 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 122.081 0.944 . . . . 74.22 108.733 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.85 -173.64 21.08 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.24 -0.891 . . . . 63.22 111.169 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.28 127.59 9.08 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.646 -1.782 . . . . 53.34 108.646 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.464 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 37.6 m 179.63 -177.91 0.36 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.207 -1.775 . . . . 44.33 106.207 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.54 -75.37 0.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 118.294 0.497 . . . . 62.41 110.32 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -99.76 -17.95 17.46 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.87 -0.604 . . . . 73.42 110.831 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.47 -8.21 59.02 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.466 0.65 . . . . 70.23 109.989 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -87.14 156.97 19.48 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 114.806 -1.088 . . . . 62.44 109.136 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -77.39 134.51 38.41 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.543 -1.28 . . . . 73.03 107.543 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.5 pp -96.82 119.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.893 -0.594 . . . . 65.04 110.719 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 54' ' ' ILE . . . -174.33 167.2 39.49 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 118.818 -1.658 . . . . 72.13 113.116 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.59 150.1 36.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.977 -0.749 . . . . 75.43 108.977 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.589 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 13.7 p90 -165.11 179.23 6.47 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.768 -0.651 . . . . 75.41 109.831 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -119.43 122.23 41.26 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.55 -1.278 . . . . 50.24 107.55 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.06 -1.089 . . . . 71.33 108.06 177.862 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.592 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.4 mpt? . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.426 -0.953 . . . . 71.53 108.426 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.5 t -108.88 77.77 1.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.074 -0.65 . . . . 74.25 110.724 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -155.16 155.26 29.87 Favored Pre-proline 0 C--N 1.316 -0.871 0 C-N-CA 124.814 1.246 . . . . 74.51 107.986 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.59 138.56 75.23 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.684 2.256 . . . . 41.1 110.894 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t70 76.56 -37.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.716 2.007 . . . . 74.44 110.49 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.592 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 77.8 mt-30 -68.68 -21.07 64.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.66 0.743 . . . . 73.34 109.504 173.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.22 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 55.4 109.943 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 67.3 mttm -93.23 -24.47 18.18 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.954 -0.758 . . . . 64.44 108.954 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 97.7 t -71.48 -44.66 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 108.248 -1.019 . . . . 73.43 108.248 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -65.96 -15.9 63.4 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.069 -0.969 . . . . 72.14 111.248 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -84.08 -52.66 12.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.585 -0.894 . . . . 72.12 108.585 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.97 -33.81 71.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.792 -1.094 . . . . 51.52 112.979 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 30.8 mmmt -65.36 -25.74 67.72 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.739 0.78 . . . . 65.13 109.982 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -27.97 24.92 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.836 -0.906 . . . . 75.22 110.836 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.418 ' OD1' HD13 ' A' ' 103' ' ' LEU . 77.5 m-20 -77.23 -34.67 55.95 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.137 0.494 . . . . 62.13 110.607 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.0 pt -68.1 -34.22 65.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 116.021 -0.536 . . . . 73.33 109.558 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -67.24 -29.36 68.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 71.31 109.811 178.133 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.52 75.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.337 -0.847 . . . . 64.44 109.5 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.567 HG12 ' HG ' ' A' ' 100' ' ' LEU . 66.8 mt -66.64 -34.81 72.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.568 0 CA-C-N 115.355 -0.838 . . . . 75.15 110.02 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.68 -26.61 68.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.117 0.485 . . . . 71.24 111.22 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -87.23 -34.36 18.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.119 0.485 . . . . 73.14 109.752 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.63 -28.55 33.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.632 0.604 . . . . 61.11 112.632 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.53 -29.84 68.51 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.216 -1.401 . . . . 74.41 107.216 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 32.4 t70 -71.89 -21.66 61.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.193 -1.367 . . . . 64.23 109.1 174.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.474 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.0 mtt -83.0 -30.29 28.28 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.754 -0.591 . . . . 73.22 109.607 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CD1' ' HD3' ' A' ' 72' ' ' PRO . 55.1 t80 -68.47 -35.62 77.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.955 -1.498 . . . . 73.33 106.955 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 83.9 tttt -55.02 -35.77 64.78 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.206 -0.906 . . . . 74.23 110.044 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.93 -36.43 56.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 73.12 111.813 172.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 92' ' ' LYS . 13.4 t70 -71.02 -26.69 63.22 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.81 -0.632 . . . . 62.42 111.178 -172.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -130.47 22.42 5.13 Favored 'General case' 0 CA--C 1.449 -2.929 0 CA-C-O 118.975 -0.536 . . . . 71.42 112.009 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.7 p90 42.99 31.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.063 1.477 . . . . 74.31 113.495 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.18 161.44 0.6 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.683 -1.228 . . . . 74.31 107.683 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 26.0 m-85 -80.08 154.14 74.92 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 123.289 0.368 . . . . 73.34 111.062 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 22.9 Cg_endo -64.43 167.62 14.54 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 123.471 2.781 . . . . 62.13 111.803 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.407 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 53.2 p -98.21 155.71 17.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.635 -1.617 . . . . 75.11 106.635 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.543 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -66.13 -15.45 63.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 118.967 0.803 . . . . 64.0 111.283 -175.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -102.23 -64.49 1.06 Allowed 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 122.156 -0.34 . . . . 73.12 111.465 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -75.89 -39.65 56.01 Favored 'General case' 0 CA--C 1.486 -1.519 0 O-C-N 122.171 -0.33 . . . . 73.43 110.795 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -73.61 -20.85 79.86 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 118.614 -1.755 . . . . 60.15 113.169 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.5 -48.12 73.68 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 106.94 -1.504 . . . . 73.31 106.94 177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 48.4 mt-10 -71.22 -23.09 61.95 Favored 'General case' 0 C--O 1.18 -2.597 0 CA-C-N 114.553 -1.203 . . . . 74.15 111.019 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.624 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -82.76 -2.79 55.4 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.266 0.555 . . . . 73.21 111.125 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.581 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 70.8 mt -96.23 -28.24 14.63 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.479 -0.782 . . . . 70.41 110.217 173.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.77 -32.5 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.438 0.637 . . . . 51.45 111.183 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 35.8 ttpt -120.59 150.48 40.82 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.188 -1.782 . . . . 75.41 106.188 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -54.54 141.32 54.99 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 118.489 0.586 . . . . 74.4 111.118 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.64 136.32 64.39 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.539 2.826 . . . . 63.14 111.878 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -81.47 -21.67 38.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.694 -0.685 . . . . 70.3 111.138 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.03 -146.39 9.26 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.894 -1.282 . . . . 64.42 109.894 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -117.69 95.87 48.52 Favored Pre-proline 0 C--N 1.288 -2.104 0 O-C-N 122.397 -0.472 . . . . 64.24 110.795 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.93 162.08 32.49 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.727 1.618 . . . . 75.53 108.751 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -82.69 159.21 64.16 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-O 118.205 -0.902 . . . . 73.53 108.958 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.48 97.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.707 1.605 . . . . 74.04 111.41 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 55.5 tttm -152.09 147.33 26.34 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.894 -1.891 . . . . 54.41 105.894 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.88 91.55 3.56 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.936 -0.306 . . . . 73.34 111.153 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -54.53 144.03 22.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.003 1.321 . . . . 73.32 111.498 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 3.1 t-20 -123.43 135.19 53.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.516 -0.766 . . . . 60.3 109.99 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -84.88 176.34 8.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.47 0.652 . . . . 75.22 111.398 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 71.4 20.28 4.97 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.608 1.563 . . . . 62.02 111.388 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 103.16 12.13 32.29 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.904 -1.141 . . . . 52.21 112.718 171.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 0.5 OUTLIER 62.75 85.33 0.13 Allowed 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.552 1.168 . . . . 73.11 108.89 -173.28 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.567 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -133.32 150.4 51.87 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.485 -2.043 . . . . 71.04 105.485 -174.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.48 ' N ' HD23 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.03 -178.14 0.96 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.908 0.322 . . . . 73.15 110.738 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -77.62 53.02 1.04 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.882 1.325 . . . . 54.22 112.718 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 ' OD1' ' A' ' 53' ' ' ASP . 70.8 mt -118.55 148.57 44.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 113.578 -1.647 . . . . 73.3 107.858 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.01 -175.46 1.46 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.604 2.202 . . . . 74.14 113.188 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.1 p -79.71 173.44 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.261 1.68 0 N-CA-C 108.271 -1.011 . . . . 44.22 108.271 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 5.8 p-10 -79.8 160.34 69.41 Favored Pre-proline 0 C--O 1.252 1.198 0 N-CA-C 113.635 0.976 . . . . 72.24 113.635 -168.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 10.8 Cg_endo -56.11 169.53 1.43 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.358 2.705 . . . . 73.14 111.681 173.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 64.81 14.58 9.27 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.853 1.261 . . . . 64.34 109.127 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.19 25.33 62.2 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 114.014 -1.448 . . . . 74.42 115.381 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.543 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 7.0 m120 -82.73 148.74 58.56 Favored Pre-proline 0 C--O 1.271 2.215 0 CA-C-N 119.497 1.649 . . . . 63.2 108.634 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.491 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 3.6 Cg_endo -88.89 148.47 5.8 Favored 'Trans proline' 0 N--CA 1.424 -2.57 0 C-N-CA 121.988 1.792 . . . . 63.31 109.087 168.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -68.2 142.49 55.66 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 120.48 -0.488 . . . . 70.22 110.136 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.0 mm100 -101.7 119.52 38.91 Favored 'General case' 0 C--O 1.266 1.928 0 N-CA-C 105.027 -2.212 . . . . 74.5 105.027 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 118.3 33.84 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.405 -1.332 . . . . 73.33 107.405 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 75.9 mt -129.98 150.36 51.29 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.01 -0.737 . . . . 75.1 109.01 169.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.707 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -122.24 -178.47 0.63 Allowed Pre-proline 0 N--CA 1.402 -2.836 0 N-CA-C 105.124 -2.176 . . . . 33.2 105.124 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.709 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 17.9 Cg_endo . . . . . 0 CA--C 1.492 -1.589 0 CA-C-N 122.327 1.867 . . . . 73.31 114.094 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.484 -1.893 0 CA-C-O 118.023 -1.432 . . . . 72.0 112.424 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.519 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 16.6 Cg_exo -41.51 -23.88 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.914 1 C-N-CA 126.667 4.911 . . . . 74.45 118.525 -177.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.6 p90 177.59 156.51 0.35 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.656 0.662 . . . . 74.43 110.285 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 2.7 m-20 -134.29 106.83 7.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.025 0.828 . . . . 74.42 108.789 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 57' ' ' ILE . 3.1 tm? -116.8 126.55 53.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.856 -0.794 . . . . 63.42 108.856 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.547 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 23.9 p90 -168.2 168.61 11.52 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 120.571 -0.451 . . . . 65.41 111.554 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.449 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 67.6 m -125.78 152.25 45.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.524 -1.287 . . . . 52.11 107.524 166.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.435 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 96.5 mt -60.17 148.64 35.49 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.742 0.651 . . . . 72.3 111.562 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.02 -172.27 5.27 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.768 0.667 . . . . 51.23 114.768 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.434 ' H ' ' HA ' ' A' ' 140' ' ' ASP . . . -57.47 -28.15 63.12 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 114.021 1.119 . . . . 52.05 114.021 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -94.23 -5.66 46.41 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.264 -0.574 . . . . 74.23 110.493 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.82 27.43 56.7 Favored Glycine 0 C--N 1.319 -0.386 0 N-CA-C 110.531 -1.028 . . . . 52.23 110.531 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -125.89 141.48 51.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.78 -1.193 . . . . 72.33 107.78 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.652 ' HA ' ' OD1' ' A' ' 142' ' ' ASP 0.271 0.0 OUTLIER -81.15 106.72 13.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.833 0.825 . . . . 63.41 112.767 178.556 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.09 173.27 29.82 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.347 -0.842 . . . . 73.54 113.315 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.4 129.61 9.88 Favored Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.586 -1.806 . . . . 73.13 108.586 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.642 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 23.8 m -178.76 -177.24 0.5 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.223 1.409 . . . . 74.31 107.513 -171.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -97.46 -49.9 4.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.045 -1.062 . . . . 62.11 108.887 171.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.544 ' HA ' HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -88.28 -41.65 12.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.679 -0.691 . . . . 74.2 110.673 -177.403 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.434 ' HA ' ' H ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER -96.28 18.3 14.05 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.606 0.717 . . . . 73.11 110.8 -175.331 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -81.2 156.88 25.44 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.259 -0.882 . . . . 70.12 109.922 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.652 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 36.4 m-20 -76.87 129.85 36.78 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 104.508 -2.404 . . . . 74.32 104.508 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.56 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -94.98 111.97 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 C-N-CA 118.59 -1.244 . . . . 73.01 108.37 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -175.09 176.69 47.2 Favored Glycine 1 N--CA 1.396 -4.027 0 CA-C-N 114.413 -1.267 . . . . 55.54 110.852 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.29 149.23 24.09 Favored 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 107.872 -1.158 . . . . 73.05 107.872 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.614 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 2.1 p90 -156.77 177.83 11.04 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 123.707 0.629 . . . . 72.12 112.082 -173.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -125.05 115.3 20.3 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.5 -0.926 . . . . 71.04 108.5 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 117.227 -1.368 . . . . 75.2 108.376 178.509 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.577 ' N ' ' HG1' ' A' ' 48' ' ' THR . 9.9 ttt . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 106.633 -1.618 . . . . 72.43 106.633 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.3 m -104.11 87.11 2.69 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.189 0.811 . . . . 72.32 113.189 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -154.54 154.16 28.96 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 104.835 -2.283 . . . . 74.11 104.835 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.1 141.07 70.04 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 122.167 1.911 . . . . 64.22 110.45 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 75.73 -36.13 0.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.299 1.44 . . . . 75.23 110.785 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.41 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . 78.2 mt-30 -77.16 -15.16 59.63 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.689 -0.632 . . . . 73.45 109.961 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.7 75.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.134 -0.939 . . . . 65.13 110.545 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -86.94 -22.11 25.83 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.816 -0.629 . . . . 62.42 110.871 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 49.1 t -73.09 -43.21 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 121.421 0.629 . . . . 74.12 109.599 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.577 ' HG1' ' N ' ' A' ' 39' ' ' MET . 14.8 t -64.52 -38.42 90.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.09 -0.505 . . . . 74.43 111.747 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.2 t -70.35 -37.31 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 108.917 -0.772 . . . . 73.5 108.917 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -58.56 -40.67 83.7 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.908 -1.042 . . . . 34.22 111.151 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 13.8 mmmm -65.57 -25.66 67.51 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.163 -0.472 . . . . 71.25 111.182 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.22 -28.15 23.58 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.606 -0.807 . . . . 73.3 111.088 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -82.11 -30.1 31.38 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.008 0.433 . . . . 72.43 111.469 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 50' ' ' ALA . 17.2 pt -73.0 -27.21 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.305 -0.558 . . . . 71.45 109.943 172.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 28.5 tptt -72.58 -26.83 61.85 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.391 -0.596 . . . . 71.33 109.391 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.86 -44.34 81.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 71.02 109.16 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 125' ' ' LEU . 74.9 mt -63.44 -34.62 68.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.684 0 CA-C-N 115.124 -0.944 . . . . 72.14 110.178 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HB2' HD21 ' A' ' 145' ' ' ASN . . . -60.71 -34.42 74.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.898 0.38 . . . . 73.33 111.135 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -80.81 -26.85 36.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.837 -0.62 . . . . 72.24 110.051 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.13 -29.25 24.97 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 120.926 0.393 . . . . 74.14 110.733 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -27.48 62.4 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.218 -1.401 . . . . 75.42 107.218 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 10.7 t70 -66.45 -32.26 73.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.613 -1.176 . . . . 73.52 108.71 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 67.1 mtt -76.2 -31.1 58.26 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 115.18 -0.918 . . . . 73.14 109.518 177.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -69.95 -37.97 76.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.52 -0.548 . . . . 73.33 109.52 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 19.4 pttp -66.36 -19.23 65.75 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 118.867 -1.133 . . . . 75.22 109.453 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.33 -38.21 17.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.545 -0.752 . . . . 74.05 110.471 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 15.9 t70 -73.3 -26.82 61.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.12 0.415 . . . . 71.11 112.12 -174.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.36 24.48 5.87 Favored 'General case' 0 CA--C 1.455 -2.676 0 N-CA-C 108.108 -1.071 . . . . 61.13 108.108 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 44.09 32.82 0.7 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.84 1.256 . . . . 64.11 113.731 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.35 155.98 0.41 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.755 -0.831 . . . . 54.52 108.755 -174.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 10.2 m-85 -77.14 157.73 80.7 Favored Pre-proline 0 N--CA 1.423 -1.779 0 O-C-N 123.572 0.545 . . . . 74.02 110.932 171.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.475 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 60.8 Cg_endo -70.78 163.25 39.74 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.756 2.304 . . . . 63.34 113.244 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.6 p -104.93 155.14 19.21 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.464 -2.05 . . . . 61.21 105.464 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -67.44 -11.9 58.95 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.105 0.955 . . . . 63.14 111.504 -173.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -102.31 -65.58 0.98 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 121.795 -0.566 . . . . 64.54 110.377 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -77.72 -34.69 52.55 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 116.375 -0.375 . . . . 72.33 111.011 -170.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -84.26 -20.94 58.0 Favored Glycine 0 N--CA 1.417 -2.605 0 C-N-CA 118.664 -1.732 . . . . 75.15 112.658 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -73.7 -42.72 60.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.582 -1.636 . . . . 71.45 106.582 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.98 -27.4 67.42 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-N 115.435 -0.802 . . . . 73.25 110.826 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.564 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -84.79 -4.08 58.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.092 0.472 . . . . 75.13 111.515 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 114' ' ' TYR . 1.2 tp -95.79 -25.38 16.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.524 0.678 . . . . 75.52 109.297 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.05 -41.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.608 -0.724 . . . . 63.54 110.366 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -111.41 148.51 32.9 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.41 -0.959 . . . . 74.3 108.41 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.63 128.08 60.92 Favored Pre-proline 0 C--O 1.25 1.125 0 C-N-CA 124.067 0.947 . . . . 74.2 109.797 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.532 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 19.7 Cg_endo -53.62 126.39 21.67 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 124.503 3.469 . . . . 61.03 113.613 -171.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -74.44 117.91 16.79 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.667 -1.151 . . . . 60.51 110.566 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.67 -146.14 16.06 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 108.761 -1.736 . . . . 72.22 108.761 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -125.83 92.83 45.45 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 112.901 0.704 . . . . 70.14 112.901 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HG3' ' HG2' ' A' ' 85' ' ' PRO . 85.8 Cg_endo -76.0 163.12 33.63 Favored 'Trans proline' 0 C--O 1.262 1.693 0 C-N-CA 122.649 2.233 . . . . 70.43 107.562 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.35 159.57 83.35 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 108.584 -0.895 . . . . 74.33 108.584 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.69 98.01 0.18 Allowed 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 121.11 1.207 . . . . 71.15 110.332 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.1 tmtm? -151.79 148.31 27.7 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.474 -2.046 . . . . 70.53 105.474 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.546 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 90.0 m-20 -72.85 93.76 1.74 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.909 0.707 . . . . 62.34 112.909 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.544 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.4 t90 -64.18 144.37 57.17 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.851 0.86 . . . . 73.04 110.472 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -131.81 135.5 46.79 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.162 -0.681 . . . . 60.5 109.162 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 63.5 pttt -85.09 -174.88 5.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.075 0.464 . . . . 74.13 109.777 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 70.2 15.04 7.6 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.473 1.109 . . . . 63.31 110.4 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.3 14.93 21.0 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.498 -1.228 . . . . 72.11 114.078 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.544 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 61.17 89.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.449 1.118 . . . . 75.25 110.975 -176.093 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 57.2 tp -128.01 170.82 12.46 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 124.756 1.222 . . . . 70.15 108.092 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.2 mmmt -88.04 179.47 6.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.549 -1.278 . . . . 53.45 107.549 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.52 ' HD3' ' H ' ' A' ' 102' ' ' LYS 0.26 0.0 OUTLIER -77.33 72.37 3.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.851 1.31 . . . . 72.55 110.959 175.861 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -130.73 148.21 69.2 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 113.643 -1.617 . . . . 72.4 107.808 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.18 170.41 13.28 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.871 1.714 . . . . 74.01 110.887 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 111' ' ' PRO . 5.3 p -79.73 171.7 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.774 -0.824 . . . . 74.12 108.774 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.511 ' OD2' ' HD2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -75.55 149.03 83.51 Favored Pre-proline 0 C--O 1.253 1.269 0 C-N-CA 119.884 -0.726 . . . . 73.24 112.364 -171.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.511 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 36.0 Cg_exo -47.09 171.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.373 3.382 . . . . 72.3 113.93 172.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 70.14 14.81 7.67 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 126.677 1.991 . . . . 75.23 108.596 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.91 32.29 59.12 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 114.174 -1.375 . . . . 73.24 113.057 -175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -92.27 125.67 55.54 Favored Pre-proline 0 C--O 1.263 1.796 0 CA-C-N 116.752 0.276 . . . . 72.34 111.212 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.64 ' HA ' HG21 ' A' ' 105' ' ' VAL . 7.9 Cg_exo -71.1 154.09 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.034 1.822 . . . . 53.42 108.522 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -71.75 142.75 49.74 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.969 -1.093 . . . . 74.12 108.806 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.58 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 2.1 mm100 -102.14 113.76 27.31 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 105.066 -2.198 . . . . 62.14 105.066 -178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.409 ' HB2' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -104.62 118.46 36.64 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.823 -1.081 . . . . 74.43 111.318 -177.744 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.2 mt -129.31 154.02 47.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.345 -0.843 . . . . 61.01 109.343 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.721 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -108.93 -177.38 0.47 Allowed Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-O 116.971 -1.49 . . . . 75.42 108.711 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 20.1 Cg_endo . . . . . 0 C--N 1.389 2.696 0 C-N-CA 123.19 2.593 . . . . 72.33 116.359 -162.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.426 -1.981 0 CA-C-O 118.027 -1.43 . . . . 63.11 111.303 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.569 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -34.81 -27.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.033 1 C-N-CA 127.052 5.168 . . . . 73.45 118.027 -178.937 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 50.8 p90 -165.45 170.42 14.5 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 118.749 0.704 . . . . 73.33 111.156 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.7 m-20 -132.4 107.13 8.31 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.534 -1.284 . . . . 72.33 107.534 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.09 128.97 54.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.557 -0.905 . . . . 64.23 108.557 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -166.28 166.01 17.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.004 -0.369 . . . . 73.22 110.004 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.515 ' HB3' HD11 ' A' ' 143' ' ' ILE . 18.5 t -124.95 146.76 49.22 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.96 -1.867 . . . . 72.4 105.96 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.58 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 98.3 mt -64.23 155.97 30.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.788 0.328 . . . . 70.24 111.429 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -83.76 -166.19 39.89 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.577 -0.821 . . . . 60.41 112.368 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.69 -22.05 64.99 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.553 0.946 . . . . 62.0 113.553 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.86 -2.75 52.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.755 0.788 . . . . 74.35 110.527 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.433 ' O ' HD13 ' A' ' 128' ' ' LEU . . . 72.29 27.44 69.91 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.797 -0.716 . . . . 51.02 111.74 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -140.07 148.45 41.77 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 123.159 0.583 . . . . 64.34 110.553 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -84.87 109.18 17.94 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.433 0.635 . . . . 64.1 110.596 176.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -147.6 -173.22 18.48 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.851 -1.068 . . . . 61.21 110.67 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.27 128.21 8.12 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.849 -1.7 . . . . 74.44 108.849 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 141' ' ' ALA . 60.2 m 179.95 -177.48 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.879 1.672 . . . . 72.0 106.698 -170.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -78.66 -62.56 1.65 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.929 0.331 . . . . 54.15 110.229 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -111.52 -11.82 14.03 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.513 0.56 . . . . 72.53 112.513 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.69 11.71 28.09 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.757 0.789 . . . . 70.02 110.595 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.441 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.0 155.8 17.86 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.805 -1.089 . . . . 62.51 110.275 178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.1 p-10 -79.67 135.66 36.6 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.31 -1.737 . . . . 64.53 106.31 173.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.59 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.34 113.11 29.92 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 108.041 -1.096 . . . . 73.45 108.041 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.65 151.5 18.98 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 119.368 -1.396 . . . . 54.41 114.582 -170.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.535 HD21 ' HB2' ' A' ' 58' ' ' ALA . 5.2 t30 -153.13 127.0 8.91 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 113.555 -1.323 . . . . 74.43 107.704 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.436 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 5.7 p90 -150.73 157.67 43.23 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 120.119 -0.632 . . . . 71.35 112.398 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -94.14 108.19 20.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.525 -1.657 . . . . 73.42 106.525 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.3 t30 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 114.534 -1.212 . . . . 61.41 108.696 -176.748 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 108.387 -0.968 . . . . 34.44 108.387 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -115.62 89.03 3.01 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.832 -0.747 . . . . 52.24 110.225 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -155.65 161.56 29.2 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 125.983 1.713 . . . . 73.42 106.426 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.49 133.17 42.72 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.463 2.109 . . . . 60.02 110.908 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 74.63 -37.25 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.98 1.312 . . . . 64.25 111.624 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.1 mm100 -68.69 -24.97 64.56 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.266 0.555 . . . . 54.53 109.931 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.77 -16.92 64.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.342 -0.845 . . . . 63.22 110.242 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.51 -25.89 22.32 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 108.369 -0.975 . . . . 74.32 108.369 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 47.4 t -75.82 -43.38 39.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.631 -0.713 . . . . 71.13 110.216 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -65.23 -29.02 69.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.27 -0.877 . . . . 74.1 111.585 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.7 m -84.03 -34.49 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.158 -0.617 . . . . 73.13 109.941 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -60.2 -37.84 81.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.465 -0.789 . . . . 44.14 110.451 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 70.2 mmtt -65.3 -26.23 67.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.704 -0.68 . . . . 74.51 110.423 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.99 -28.39 18.29 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.225 -0.988 . . . . 72.21 111.324 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.45 -27.26 32.01 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.04 0.385 . . . . 60.53 112.04 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 pt -72.06 -30.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.303 -0.559 . . . . 71.32 109.617 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 73.0 mmtt -71.52 -24.27 61.93 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 116.414 -0.357 . . . . 30.3 110.704 175.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.03 75.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.621 -0.718 . . . . 74.23 109.554 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.414 HG12 ' HG ' ' A' ' 100' ' ' LEU . 71.7 mt -68.99 -34.07 62.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.385 -0.825 . . . . 75.31 109.673 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.438 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . . . -58.97 -33.98 71.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 62.05 110.783 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -82.36 -36.27 26.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.485 -0.779 . . . . 73.04 110.166 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.59 -28.92 41.06 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.042 0.386 . . . . 74.53 112.042 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.456 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -70.38 -30.14 66.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.964 -1.495 . . . . 44.11 106.964 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.7 t70 -71.08 -19.54 62.46 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.453 -1.249 . . . . 74.04 109.543 174.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.8 mtt -81.54 -41.04 22.22 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.921 -0.77 . . . . 61.03 108.921 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' HD2' ' CE1' ' A' ' 99' ' ' TYR . 46.4 t80 -64.58 -35.97 82.7 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 107.612 -1.255 . . . . 72.03 107.612 173.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.599 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.1 tttt -54.37 -40.07 67.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.908 -1.042 . . . . 72.0 110.631 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.22 -32.25 38.52 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.527 -0.469 . . . . 54.53 111.363 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.605 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 36.1 t70 -69.81 -24.03 63.41 Favored 'General case' 0 C--O 1.184 -2.37 0 C-N-CA 121.02 -0.272 . . . . 74.44 111.413 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -128.03 19.16 6.54 Favored 'General case' 0 CA--C 1.459 -2.527 0 O-C-N 121.137 -0.977 . . . . 65.11 110.909 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 43.58 34.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.893 1.371 . . . . 73.22 113.107 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.92 152.9 0.37 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.532 -1.213 . . . . 74.41 108.096 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.599 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.6 m-85 -76.38 148.65 80.76 Favored Pre-proline 0 N--CA 1.431 -1.401 0 O-C-N 123.496 0.498 . . . . 73.41 110.76 172.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 28.4 Cg_endo -61.41 162.27 21.13 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.811 3.007 . . . . 52.4 111.883 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -96.77 156.06 16.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.632 -1.618 . . . . 75.23 106.632 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.1 t -69.12 -11.58 60.92 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.287 0.948 . . . . 61.21 110.934 -175.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -102.45 -65.84 0.97 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.096 -0.502 . . . . 75.43 110.99 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.33 -40.42 51.39 Favored 'General case' 0 CA--C 1.486 -1.505 0 O-C-N 122.141 -0.349 . . . . 72.4 110.393 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.7 -20.54 79.48 Favored Glycine 0 N--CA 1.41 -3.066 0 C-N-CA 119.25 -1.453 . . . . 32.34 113.076 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.38 -45.64 68.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.742 -1.577 . . . . 41.54 106.742 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.45 -8.68 57.09 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.18 -0.918 . . . . 64.44 111.733 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.586 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -96.88 -6.01 36.81 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.478 0.656 . . . . 71.13 110.209 175.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 86.4 mt -95.06 -19.81 19.84 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.791 -0.818 . . . . 70.43 108.791 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 t -106.11 -44.56 7.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.633 -0.712 . . . . 54.34 110.931 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.2 mppt? -108.82 148.69 30.19 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.216 -1.031 . . . . 73.23 108.216 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.54 133.05 63.71 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 123.82 0.848 . . . . 74.24 109.833 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.458 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 18.4 Cg_endo -55.3 121.05 9.23 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.688 2.925 . . . . 72.21 113.291 -172.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 t -87.12 -2.48 58.66 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.479 -1.237 . . . . 73.41 109.175 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.29 -147.75 12.61 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.768 -0.933 . . . . 32.33 110.768 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -115.63 99.13 52.16 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 117.7 0.75 . . . . 73.03 110.462 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -102.85 162.2 0.28 Allowed 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 122.904 2.403 . . . . 71.53 112.887 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.428 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 45.5 mt-30 -105.54 98.55 17.56 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 106.0 -1.852 . . . . 74.41 106.0 174.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -36.69 99.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 125.186 3.924 . . . . 64.23 119.675 -167.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.605 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 4.1 mptp? -109.53 149.17 30.01 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 102.103 -3.295 . . . . 55.22 102.103 160.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.35 92.34 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 123.268 0.355 . . . . 73.22 110.277 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.585 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -54.95 140.85 35.89 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 124.969 1.308 . . . . 73.1 112.678 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.59 137.89 54.55 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.929 -1.032 . . . . 61.3 110.14 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -93.12 -178.1 4.68 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.736 0.779 . . . . 72.33 111.023 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t0 65.73 24.29 11.5 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.649 1.58 . . . . 74.1 110.846 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.91 27.58 Favored Glycine 0 CA--C 1.496 -1.132 0 CA-C-N 114.643 -1.162 . . . . 54.21 115.051 168.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.585 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.5 90.28 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.384 1.087 . . . . 74.25 110.775 -175.114 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 101' ' ' LYS . 5.7 tt -138.18 151.04 47.33 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.356 -2.461 . . . . 74.41 104.356 -179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.509 ' N ' HD23 ' A' ' 100' ' ' LEU . 55.8 mtmt -67.39 -172.47 0.23 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.357 -0.537 . . . . 74.51 111.597 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 67.94 6.42 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.094 0.95 . . . . 74.31 111.384 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.52 148.28 69.44 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 126.263 1.825 . . . . 62.43 107.488 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.19 -171.56 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.126 2.551 . . . . 73.44 113.289 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.2 p -85.66 175.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 N-CA-C 108.611 -0.885 . . . . 74.3 108.611 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.471 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.3 t70 -77.58 158.35 78.76 Favored Pre-proline 0 C--O 1.251 1.182 0 CA-C-N 118.89 0.768 . . . . 70.0 109.692 -170.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 68.4 Cg_exo -47.55 170.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.39 2.726 . . . . 74.33 113.855 173.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.567 ' HB2' ' OD1' ' A' ' 110' ' ' ASN . 1.2 m-90 65.13 15.46 10.01 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.018 1.727 . . . . 75.21 110.565 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.15 1.67 50.35 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.135 -0.939 . . . . 21.3 114.993 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.567 ' OD1' ' HB2' ' A' ' 108' ' ' TRP . 25.5 m120 -70.51 128.08 91.46 Favored Pre-proline 0 C--O 1.258 1.544 0 N-CA-C 113.78 1.03 . . . . 70.32 113.78 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.556 ' HA ' HG21 ' A' ' 105' ' ' VAL . 21.1 Cg_exo -67.76 146.64 73.32 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.194 1.929 . . . . 35.33 108.706 166.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -69.64 144.42 52.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.869 -0.789 . . . . 74.03 108.869 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -100.63 113.65 26.68 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.058 -2.201 . . . . 73.35 105.058 -177.269 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.07 119.03 38.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.115 -0.948 . . . . 73.13 111.983 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 88.4 mt -129.33 153.23 48.05 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.251 -1.018 . . . . 70.42 108.251 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.839 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -104.25 -178.62 0.65 Allowed Pre-proline 0 N--CA 1.419 -2.017 0 CA-C-O 116.55 -1.691 . . . . 71.03 108.486 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.839 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 6.9 Cg_endo . . . . . 0 C--N 1.384 2.437 0 C-N-CA 123.704 2.936 . . . . 63.53 115.623 -165.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.956 0 N-CA-C 116.552 1.381 . . . . 65.14 116.552 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -34.3 -19.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.576 1 C-N-CA 128.608 6.205 . . . . 73.34 120.367 -178.789 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' A' ' 147' ' ' ASP . 19.3 p90 -171.53 151.9 3.09 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.112 1.324 . . . . 63.11 113.698 171.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.1 m-20 -112.27 106.8 15.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.02 -1.474 . . . . 73.13 107.02 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.51 128.37 45.55 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.979 -0.688 . . . . 72.2 109.879 -177.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 33.9 p90 -165.94 165.34 18.17 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 111.927 0.343 . . . . 72.41 111.927 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 143' ' ' ILE . 46.7 t -125.6 138.19 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.296 -1.372 . . . . 54.21 107.296 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.26 128.13 34.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 111.642 0.238 . . . . 75.4 111.642 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.86 171.32 22.51 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.389 -0.684 . . . . 53.52 111.389 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 108' ' ' TRP . . . -63.31 -3.34 1.88 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 115.489 1.662 . . . . 75.43 115.489 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -100.33 -2.11 34.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.796 0.808 . . . . 73.35 109.739 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.95 38.86 64.4 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.037 -0.825 . . . . 62.12 111.037 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -138.84 147.87 43.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.056 -0.72 . . . . 74.2 109.056 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 7.2 pt-20 -97.99 103.33 15.26 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 105.976 -1.861 . . . . 74.21 105.976 165.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.53 -172.34 20.29 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.03 -1.441 . . . . 75.42 111.209 -171.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.57 8.76 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.472 -1.051 . . . . 74.13 110.472 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.562 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 13.4 m 177.82 -177.67 0.21 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 127.663 2.385 . . . . 70.12 105.895 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -66.49 0.92 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 119.03 0.832 . . . . 73.12 110.341 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 130' ' ' ALA . 5.1 t30 -87.23 -27.71 22.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.108 0.956 . . . . 74.21 111.707 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 9.55 42.86 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.572 0.701 . . . . 63.22 111.448 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.562 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -103.36 157.41 17.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 115.129 -0.942 . . . . 31.23 109.466 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 8.9 p-10 -78.45 127.23 31.88 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.991 -1.485 . . . . 74.45 106.991 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 133.45 37.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.811 -1.181 . . . . 73.23 107.811 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.03 169.59 34.74 Favored Glycine 0 N--CA 1.414 -2.814 0 C-N-CA 117.685 -2.198 . . . . 62.23 114.276 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 58' ' ' ALA . 8.0 t30 -131.36 148.35 52.66 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.141 -1.8 . . . . 71.23 106.141 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -143.61 135.12 26.14 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.637 -0.825 . . . . 74.41 110.346 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.487 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 16.1 t0 -104.66 105.25 15.26 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 105.675 -1.972 . . . . 74.51 105.675 174.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.274 -2.696 0 N-CA-C 105.94 -1.874 . . . . 63.54 105.94 178.1 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.674 ' N ' ' HG1' ' A' ' 48' ' ' THR . 19.8 ttt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 65.04 109.449 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 m -96.18 91.3 5.85 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.676 0.75 . . . . 72.44 112.66 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 12.6 ptp180 -156.79 165.0 19.72 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 106.859 -1.534 . . . . 62.35 106.859 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -42.79 120.33 1.8 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.864 3.043 . . . . 74.14 114.608 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.65 -31.86 0.23 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 127.575 2.35 . . . . 65.22 113.048 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.498 ' HA ' HG23 ' A' ' 47' ' ' VAL . 10.7 mm100 -68.92 -22.78 64.14 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.967 -1.123 . . . . 70.44 107.967 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 48' ' ' THR . . . -63.74 -26.1 68.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.659 -1.155 . . . . 70.32 109.912 173.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 63.3 mttp -80.6 -26.08 38.06 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.928 -0.768 . . . . 72.13 108.928 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.539 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 43.9 t -74.29 -44.57 48.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 122.054 0.931 . . . . 72.33 108.637 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.674 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.4 t -71.11 -30.99 67.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.474 -1.239 . . . . 75.34 112.071 -173.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.63 -40.21 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 120.321 -0.552 . . . . 73.44 110.124 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -60.53 -31.68 70.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.275 0.56 . . . . 61.41 111.122 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 29.6 mtpp -66.26 -25.43 66.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.989 0.899 . . . . 61.12 111.281 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.96 -30.49 31.55 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.737 -1.345 . . . . 63.45 109.737 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.688 ' O ' HG13 ' A' ' 57' ' ' ILE . 72.9 m-20 -73.33 -38.54 65.76 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.314 -0.443 . . . . 73.1 110.739 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.466 HD12 ' C ' ' A' ' 144' ' ' GLY . 19.0 pt -62.49 -36.2 73.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 121.209 -0.196 . . . . 64.34 111.052 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.87 -30.15 70.24 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.942 -0.703 . . . . 61.23 110.8 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -69.13 -44.35 72.54 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.677 -0.692 . . . . 72.44 111.048 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.688 HG13 ' O ' ' A' ' 53' ' ' ASP . 23.3 mt -63.52 -42.49 96.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-N 115.349 -0.841 . . . . 61.5 109.223 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.54 -27.71 67.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.863 -0.608 . . . . 72.13 111.618 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -76.91 -30.63 56.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.618 0.723 . . . . 64.11 109.416 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.88 -24.45 38.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.172 -0.467 . . . . 73.23 110.115 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.91 -31.25 71.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.37 -1.344 . . . . 74.13 107.37 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 4.5 t70 -66.08 -28.82 69.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.174 -0.921 . . . . 71.42 109.66 170.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.8 ttm -82.82 -28.24 30.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.914 -0.585 . . . . 71.15 110.166 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -72.46 -34.35 67.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.318 -1.364 . . . . 74.14 107.318 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 28.5 ttpp -57.5 -25.76 60.28 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.215 -0.902 . . . . 55.31 109.561 171.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.9 tp -87.3 -36.0 18.12 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 123.386 0.674 . . . . 75.21 111.365 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.51 -27.0 58.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.942 0.401 . . . . 75.11 110.398 -173.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -130.61 24.39 5.08 Favored 'General case' 0 CA--C 1.457 -2.621 0 N-CA-C 112.418 0.525 . . . . 71.1 112.418 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.1 p90 42.65 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 125.015 1.447 . . . . 75.35 113.948 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.24 161.74 1.13 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.747 -0.835 . . . . 63.15 108.747 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.54 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 13.4 m-85 -78.89 155.52 77.75 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 123.617 0.573 . . . . 75.42 110.501 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.542 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 51.0 Cg_endo -73.81 160.74 43.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.341 2.028 . . . . 75.52 110.917 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -92.58 155.74 17.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.096 -1.816 . . . . 73.24 106.096 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.575 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.2 t -70.1 -7.32 40.49 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.61 1.095 . . . . 74.11 111.421 -176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -103.02 -66.89 0.91 Allowed 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 121.934 -0.479 . . . . 61.34 110.877 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -84.17 -31.65 25.03 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.905 -0.589 . . . . 73.14 112.469 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -78.35 -21.32 70.25 Favored Glycine 0 N--CA 1.409 -3.126 0 C-N-CA 117.54 -2.267 . . . . 74.02 111.316 176.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.89 -46.67 70.99 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 106.602 -1.629 . . . . 64.24 106.602 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.0 -31.62 72.94 Favored 'General case' 0 N--CA 1.396 -3.174 0 CA-C-N 114.918 -1.037 . . . . 73.1 109.358 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.603 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -79.8 -2.21 42.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 73.51 111.917 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.611 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 63.3 mt -98.26 -24.56 15.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.915 -0.584 . . . . 55.31 110.28 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.42 -32.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.367 0.603 . . . . 51.23 110.687 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -117.66 146.43 43.7 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 125.266 1.426 . . . . 71.31 107.158 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -54.59 129.19 62.69 Favored Pre-proline 0 N--CA 1.433 -1.3 0 C-N-CA 123.506 0.722 . . . . 74.3 109.641 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -58.96 126.17 20.32 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 124.214 3.276 . . . . 75.12 113.163 -172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -96.62 91.49 5.77 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-O 122.051 0.929 . . . . 73.14 109.876 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.6 -126.33 1.18 Allowed Glycine 0 N--CA 1.422 -2.284 0 CA-C-N 114.365 -1.289 . . . . 72.12 110.03 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -126.56 91.93 46.29 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 117.208 0.504 . . . . 71.41 109.704 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -97.21 162.91 0.98 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.65 1.567 . . . . 71.31 110.632 172.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -90.33 159.08 42.56 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.41 -1.33 . . . . 63.42 107.41 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.05 98.18 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.441 1.427 . . . . 54.22 111.965 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -151.53 147.43 26.81 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.921 -2.251 . . . . 74.22 104.921 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.26 94.4 8.42 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.831 -0.748 . . . . 74.54 110.128 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -54.05 140.23 32.24 Favored 'General case' 0 C--O 1.251 1.156 0 C-N-CA 124.235 1.014 . . . . 70.3 112.665 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -115.6 132.25 56.69 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.052 -1.431 . . . . 72.34 109.56 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 14.8 ptmm? -79.15 -176.88 5.36 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 119.759 -0.776 . . . . 71.3 109.522 175.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 96' ' ' LYS . 7.2 t70 69.34 31.06 3.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.437 -1.256 . . . . 62.35 109.477 170.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 92.02 7.15 64.46 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-N 114.469 -1.241 . . . . 61.02 113.534 167.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 62.91 87.57 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.817 -1.179 . . . . 70.33 107.817 -169.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HG ' HG12 ' A' ' 57' ' ' ILE . 2.7 tt -129.96 149.88 51.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.902 -1.888 . . . . 73.51 105.902 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -73.8 -178.74 3.32 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.011 -0.366 . . . . 75.43 110.011 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -82.21 73.61 9.23 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.582 1.182 . . . . 72.34 109.504 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -130.64 148.59 70.65 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.859 -1.973 . . . . 72.43 107.256 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.57 177.28 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.05 1.833 . . . . 73.41 111.117 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.545 HG21 ' HA ' ' A' ' 111' ' ' PRO . 3.3 p -82.41 174.67 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.521 -0.918 . . . . 73.31 108.521 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.0 t70 -69.45 139.1 89.12 Favored Pre-proline 0 C--O 1.258 1.503 0 N-CA-C 110.579 -0.156 . . . . 42.43 110.579 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.449 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 6.3 Cg_endo -50.5 172.19 0.09 OUTLIER 'Trans proline' 0 C--O 1.193 -1.744 0 C-N-CA 124.13 3.22 . . . . 64.43 113.301 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.406 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 66.64 14.67 9.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.118 1.367 . . . . 71.21 109.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.21 32.17 81.38 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 55.21 114.671 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.482 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 90.8 m-20 -92.9 119.97 67.44 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 117.629 0.714 . . . . 73.13 110.698 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 105' ' ' VAL . 36.8 Cg_exo -68.41 139.58 45.7 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.291 1.327 . . . . 75.04 108.669 167.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.642 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 56.0 m-85 -68.36 144.74 54.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.051 0.453 . . . . 64.15 110.317 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.569 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -102.3 114.06 27.9 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.839 -1.541 . . . . 61.23 106.839 -176.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.41 118.47 36.11 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.656 -1.239 . . . . 64.15 107.656 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.77 153.64 47.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.763 0.664 . . . . 71.13 109.223 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.788 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -121.85 -179.77 0.82 Allowed Pre-proline 0 N--CA 1.393 -3.302 0 N-CA-C 107.852 -1.166 . . . . 72.42 107.852 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.788 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 26.6 Cg_endo . . . . . 0 N--CA 1.449 -1.144 0 C-N-CA 122.066 1.844 . . . . 75.14 114.272 -174.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.792 0 CA-C-O 118.481 -1.177 . . . . 63.1 112.542 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 54.4 Cg_exo -60.63 -26.43 82.89 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.109 3.206 . . . . 73.03 110.84 165.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.1 p90 -173.81 168.08 4.33 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.61 0.764 . . . . 70.15 110.019 166.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.61 112.56 8.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.904 -1.147 . . . . 62.54 107.904 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.507 HD21 ' HB ' ' A' ' 57' ' ' ILE . 52.9 tp -128.14 123.97 35.72 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.213 -0.929 . . . . 64.12 110.505 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.439 ' HB3' ' HA3' ' A' ' 144' ' ' GLY . 53.5 p90 -168.06 169.06 11.45 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 120.889 -0.324 . . . . 55.11 111.474 -174.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.642 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 22.2 t -125.14 160.69 28.53 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.844 -1.539 . . . . 75.22 106.844 170.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.569 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 89.5 mt -68.83 167.1 16.26 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.307 0.38 . . . . 73.34 110.636 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.65 -170.81 43.51 Favored Glycine 0 CA--C 1.496 -1.143 0 C-N-CA 119.419 -1.372 . . . . 73.3 111.77 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.65 -15.1 36.77 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.391 0.676 . . . . 71.34 112.731 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -94.45 -9.38 35.71 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.205 0.526 . . . . 74.15 110.714 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.8 23.73 66.29 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 121.109 -0.567 . . . . 73.41 112.167 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.01 148.62 42.12 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.47 -0.937 . . . . 62.41 108.47 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.44 105.98 18.06 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.693 0.759 . . . . 53.34 110.835 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.02 -174.32 21.16 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.148 -0.933 . . . . 52.05 111.234 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.74 129.58 9.94 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.577 -1.409 . . . . 61.25 109.577 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.3 m -177.74 -178.49 0.72 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 124.604 1.162 . . . . 63.41 108.275 -171.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -99.67 -25.99 14.21 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.754 -0.378 . . . . 72.21 111.933 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.88 -33.45 2.93 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.608 0.718 . . . . 43.33 110.038 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -95.38 15.21 20.1 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.909 -0.587 . . . . 63.12 110.897 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -87.27 155.32 20.12 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-N 115.994 -0.548 . . . . 63.41 110.043 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.73 129.11 34.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.901 -1.518 . . . . 74.01 106.901 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.571 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -96.48 115.92 37.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-O 121.472 0.653 . . . . 75.2 109.301 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.466 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -163.97 177.81 39.61 Favored Glycine 0 N--CA 1.417 -2.57 0 C-N-CA 118.756 -1.688 . . . . 72.3 113.719 -176.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.48 146.05 16.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.26 -1.385 . . . . 72.22 107.26 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 16.2 p90 -157.41 168.76 26.4 Favored 'General case' 0 C--N 1.267 -2.999 0 CA-C-O 120.972 0.415 . . . . 74.23 110.798 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 17.3 t70 -105.87 125.19 50.7 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.069 -1.456 . . . . 43.5 107.069 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.524 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 4.0 p-10 . . . . . 0 N--CA 1.421 -1.882 0 O-C-N 125.01 1.444 . . . . 61.41 108.553 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.643 ' N ' ' HG1' ' A' ' 48' ' ' THR . 46.5 tpp . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.692 0.282 . . . . 64.31 110.764 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -105.87 91.79 3.89 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.91 -0.494 . . . . 65.54 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -148.69 164.95 19.28 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 106.547 -1.649 . . . . 72.33 106.547 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 44' ' ' GLN . 51.7 Cg_exo -46.98 120.5 4.22 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.204 2.602 . . . . 70.43 112.939 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t70 73.34 -30.07 0.21 Allowed 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 127.135 2.174 . . . . 64.41 110.928 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.481 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 14.0 mm100 -68.02 -25.17 65.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.224 -0.898 . . . . 74.3 109.516 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.48 65.37 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.314 -0.857 . . . . 71.12 110.328 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -87.65 -26.69 22.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.457 -0.942 . . . . 64.32 108.457 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 37.6 t -74.71 -44.6 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.71 0.767 . . . . 41.2 109.261 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.643 ' HG1' ' N ' ' A' ' 39' ' ' MET . 14.2 t -59.85 -38.18 81.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.326 -1.306 . . . . 73.33 112.889 -172.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -84.37 -34.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 119.88 -0.728 . . . . 44.3 110.442 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -60.2 -32.99 71.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.136 -0.484 . . . . 75.13 111.813 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 12.2 mmmm -65.73 -25.33 67.24 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.993 0.902 . . . . 75.43 110.048 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.6 -22.54 39.58 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.632 -0.987 . . . . 60.44 110.632 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 57' ' ' ILE . 75.5 m-20 -82.76 -38.48 23.15 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.671 0.272 . . . . 75.54 110.27 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.7 pt -64.02 -32.53 57.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.432 -0.581 . . . . 75.13 109.432 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -33.03 73.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.907 -0.588 . . . . 65.33 110.621 176.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.64 74.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.023 -0.535 . . . . 63.22 110.334 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 53' ' ' ASP . 55.3 mt -65.09 -37.83 81.21 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 CA-C-N 115.755 -0.657 . . . . 72.32 110.268 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.57 67.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.219 0.533 . . . . 74.04 111.06 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.27 -19.99 24.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.194 0.521 . . . . 34.22 110.251 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -29.02 21.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.226 0.536 . . . . 73.2 110.115 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.92 -30.27 67.64 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.688 -1.597 . . . . 73.24 106.688 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 31.8 t70 -73.15 -20.51 60.89 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.351 -1.295 . . . . 72.1 109.428 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.2 ttt -79.18 -34.32 43.14 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 115.747 -0.661 . . . . 75.42 109.367 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.438 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 1.3 t80 -64.05 -39.66 94.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.695 -1.595 . . . . 74.23 106.695 172.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 76.7 tttt -54.61 -33.02 59.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.813 -1.085 . . . . 64.41 110.304 175.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 99.3 mt -82.83 -36.2 25.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.137 -0.483 . . . . 74.44 111.522 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.16 -25.26 63.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.255 0.465 . . . . 62.14 112.255 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -128.67 18.94 6.21 Favored 'General case' 0 CA--C 1.442 -3.209 0 O-C-N 121.962 -0.461 . . . . 64.32 111.062 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 p90 43.37 33.51 0.62 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 125.13 1.519 . . . . 74.11 112.558 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -177.52 156.3 1.16 Allowed 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.709 -1.219 . . . . 64.11 107.709 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.3 m-85 -78.83 148.6 72.72 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 123.254 0.347 . . . . 64.01 111.257 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.587 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 33.6 Cg_endo -66.4 158.41 55.4 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.892 2.394 . . . . 43.24 109.752 174.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.464 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 47.4 p -94.01 156.71 16.46 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.841 -1.17 . . . . 74.43 107.841 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.5 t -66.38 -13.09 60.14 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 119.9 1.227 . . . . 72.43 111.165 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -102.21 -64.75 1.04 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 121.982 -0.449 . . . . 61.04 111.162 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -40.26 60.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 109.096 -0.705 . . . . 61.53 109.096 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -72.52 -20.75 79.61 Favored Glycine 0 N--CA 1.407 -3.27 0 C-N-CA 119.717 -1.23 . . . . 14.34 113.665 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.06 -47.31 62.49 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.349 -1.352 . . . . 74.24 107.349 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.56 -32.11 70.05 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 115.571 -0.74 . . . . 65.54 110.177 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.611 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -83.64 -5.54 59.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.786 0.661 . . . . 51.31 112.786 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 42.1 mt -93.14 -24.21 18.33 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.506 0.669 . . . . 65.31 109.822 174.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 t -102.72 -35.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.403 -0.817 . . . . 75.3 110.533 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 95.4 mttt -126.51 150.9 48.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.732 -1.581 . . . . 54.44 106.732 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -54.22 141.15 52.25 Favored Pre-proline 0 N--CA 1.48 1.063 0 N-CA-C 113.244 0.831 . . . . 74.14 113.244 -172.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 30.2 Cg_endo -61.15 152.66 70.23 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.974 3.116 . . . . 45.44 114.551 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -110.78 111.19 22.19 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 114.14 -1.391 . . . . 65.02 110.219 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.53 -121.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.769 -0.729 . . . . 70.44 111.583 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -136.96 91.91 14.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 C-N-CA 121.136 -0.226 . . . . 73.32 110.527 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -95.27 161.54 1.6 Allowed 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 121.925 1.75 . . . . 74.21 110.596 172.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -87.63 159.26 49.92 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 106.76 -1.57 . . . . 71.23 106.76 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.55 99.31 0.31 Allowed 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 120.906 1.07 . . . . 73.54 110.684 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -150.84 149.33 29.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.571 -1.64 . . . . 74.11 106.571 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -66.01 97.58 0.38 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.007 0.743 . . . . 74.32 113.007 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.558 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.1 t90 -71.94 143.5 49.26 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.752 -0.658 . . . . 74.45 109.573 171.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -134.95 137.4 43.06 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.604 -0.517 . . . . 73.43 109.604 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' HG3' ' OD2' ' A' ' 97' ' ' ASP . 22.4 pttp -76.46 -166.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.142 -0.688 . . . . 74.35 109.142 175.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' A' ' 96' ' ' LYS . 41.0 m-20 66.32 8.65 5.8 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.437 1.095 . . . . 73.3 112.509 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 96.0 21.02 24.31 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 115.212 -0.904 . . . . 33.05 111.771 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.6 93.51 0.08 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.322 1.058 . . . . 63.22 111.101 -177.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.43 152.67 48.73 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.122 -0.944 . . . . 63.04 108.98 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.83 -169.05 2.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.976 -1.12 . . . . 74.23 107.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -72.75 70.69 0.98 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 122.747 1.261 . . . . 65.22 110.492 174.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.43 148.54 70.52 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 125.765 1.626 . . . . 62.13 108.331 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.63 -168.76 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.425 2.083 . . . . 73.14 110.754 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.649 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.7 p -86.41 174.25 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 106.576 -1.638 . . . . 61.34 106.576 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.424 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 4.3 t70 -97.37 151.59 37.75 Favored Pre-proline 0 C--O 1.252 1.193 0 C-N-CA 117.255 -1.778 . . . . 71.15 110.818 -173.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -38.79 171.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.824 3.683 . . . . 54.22 115.383 166.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 67.9 14.5 9.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.386 -1.733 . . . . 71.33 107.064 -171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.31 29.22 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 114.052 -1.431 . . . . 72.44 114.497 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -92.14 131.57 34.6 Favored Pre-proline 0 C--O 1.261 1.661 0 CA-C-N 117.941 0.871 . . . . 73.34 112.162 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.649 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 16.1 Cg_exo -70.15 148.88 63.52 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.356 2.037 . . . . 75.02 109.516 170.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.519 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 27.7 m-85 -69.59 140.31 53.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.199 -1.0 . . . . 70.01 108.588 175.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -101.57 115.04 29.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.74 -1.578 . . . . 74.33 106.74 -173.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.92 119.81 39.51 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.88 -1.054 . . . . 72.5 112.319 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 83.0 mt -128.57 143.9 51.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.242 -1.021 . . . . 75.4 108.242 172.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.758 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -111.17 -178.21 0.52 Allowed Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 107.525 -1.287 . . . . 50.25 107.525 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.758 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 37.3 Cg_endo . . . . . 0 CA--C 1.486 -1.922 0 CA-C-N 121.734 1.655 . . . . 61.4 114.678 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.477 -2.343 0 CA-C-O 118.128 -1.373 . . . . 72.32 113.751 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 34.8 Cg_exo -46.02 -22.76 1.51 Allowed 'Trans proline' 0 C--N 1.376 1.974 1 C-N-CA 126.511 4.807 . . . . 70.04 116.264 177.577 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.2 p90 179.91 166.76 1.24 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.97 0.508 . . . . 64.43 110.571 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 7.5 m-20 -139.53 108.97 6.15 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.069 0.856 . . . . 73.01 109.251 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -123.46 130.27 52.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.332 -0.547 . . . . 72.24 110.085 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -166.88 161.91 15.52 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 116.544 -0.298 . . . . 74.3 110.714 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.519 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 25.1 t -126.01 135.99 52.45 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.573 -1.269 . . . . 73.32 107.573 171.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.23 133.53 55.3 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.089 0.403 . . . . 62.43 112.089 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -86.14 -159.19 32.2 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.889 -0.596 . . . . 55.41 113.384 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -13.05 47.74 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.763 1.394 . . . . 71.54 114.763 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 140' ' ' ASP . 36.7 t70 -94.95 -10.09 32.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 119.812 -0.755 . . . . 70.52 110.181 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.18 70.95 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.736 -0.665 . . . . 73.2 112.538 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -140.7 137.75 33.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.469 -0.938 . . . . 73.14 108.469 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.34 112.88 12.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.245 0.545 . . . . 61.15 109.62 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.44 -173.61 20.79 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 108.857 -1.697 . . . . 32.52 108.857 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.51 126.3 8.3 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 118.706 -1.711 . . . . 71.22 109.861 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 141' ' ' ALA . 28.6 m 178.08 -178.67 0.26 Allowed 'General case' 0 C--O 1.251 1.146 0 C-N-CA 127.094 2.158 . . . . 73.42 106.713 -174.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.01 -56.72 2.76 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.293 -0.563 . . . . 63.41 112.501 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -107.74 -23.64 12.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.239 -0.584 . . . . 74.42 111.391 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 10.4 m-20 -76.11 -28.82 57.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 121.964 0.888 . . . . 62.41 109.242 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 137' ' ' SER . . . -80.8 159.41 25.14 Favored 'General case' 0 CA--C 1.47 -2.131 0 CA-C-N 113.572 -1.649 . . . . 44.33 111.033 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -76.65 135.5 39.13 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 107.027 -1.471 . . . . 54.02 107.027 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.506 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -97.71 128.85 48.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.394 -0.821 . . . . 65.21 110.295 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -172.55 -179.74 43.55 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 119.325 -1.417 . . . . 73.42 112.269 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.52 155.13 17.07 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.068 -1.456 . . . . 64.54 107.068 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.456 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 3.2 p90 -165.69 177.51 7.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.191 0.519 . . . . 73.14 111.435 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -116.1 125.59 52.59 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.398 -1.704 . . . . 61.14 106.398 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.537 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 41.0 t30 . . . . . 0 C--N 1.304 -1.388 0 N-CA-C 108.211 -1.033 . . . . 73.45 108.211 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.426 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.4 mpt? . . . . . 0 C--O 1.234 0.274 0 N-CA-C 108.549 -0.908 . . . . 71.04 108.549 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -107.14 82.3 1.66 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.297 0.57 . . . . 63.24 111.669 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -154.55 159.06 32.28 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.177 -1.786 . . . . 75.52 106.177 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.99 138.48 52.53 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.673 2.249 . . . . 72.1 111.305 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 72.99 -35.94 0.34 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.073 1.349 . . . . 72.15 113.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 66.0 mt-30 -74.19 -25.54 59.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.048 -1.093 . . . . 72.51 108.048 175.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.5 64.64 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.878 -1.055 . . . . 52.11 109.847 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HD2' ' HB3' ' A' ' 107' ' ' PRO . 44.0 mmtm -85.32 -25.62 27.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.093 -1.077 . . . . 71.13 108.093 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 86.4 t -74.63 -44.36 46.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.239 -0.891 . . . . 63.13 109.545 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -65.7 -25.45 67.32 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 115.145 -0.934 . . . . 71.12 111.659 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.5 -49.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.747 -0.835 . . . . 74.33 108.747 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' HB3' HD12 ' A' ' 143' ' ' ILE . . . -64.44 -24.74 67.73 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.987 -1.006 . . . . 72.04 112.064 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.1 mmmt -65.74 -26.41 67.72 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.604 0.716 . . . . 73.03 110.762 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.2 -26.94 29.48 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 110.005 -1.238 . . . . 72.22 110.005 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.623 ' O ' HG13 ' A' ' 57' ' ' ILE . 65.7 m-20 -78.26 -38.13 43.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.432 -0.384 . . . . 75.02 110.687 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.459 HG21 ' HA2' ' A' ' 144' ' ' GLY . 19.8 pt -66.61 -38.19 81.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.355 -0.216 . . . . 70.12 111.082 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.5 tptt -69.0 -26.72 65.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.002 0.43 . . . . 70.31 110.121 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -66.93 -45.16 78.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 63.43 110.242 174.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 53' ' ' ASP . 34.1 mt -64.73 -42.27 94.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.729 -0.669 . . . . 63.0 109.507 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.15 -28.4 66.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.865 -0.607 . . . . 53.33 111.235 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.62 -30.1 29.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 64.54 110.02 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.67 -28.1 30.87 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.712 -0.677 . . . . 73.14 110.366 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.48 -30.7 71.09 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.822 -1.177 . . . . 75.12 107.822 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.62 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.8 t70 -71.22 -23.25 61.98 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 122.183 0.992 . . . . 71.11 109.273 173.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 mtt -83.59 -28.43 28.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.726 -0.67 . . . . 64.43 110.724 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.545 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 70.8 t80 -71.55 -36.06 70.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.553 -1.277 . . . . 74.4 107.553 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.641 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 74.8 tttt -53.95 -36.09 62.46 Favored 'General case' 0 C--O 1.208 -1.114 0 CA-C-N 114.917 -1.038 . . . . 70.11 109.108 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.8 tp -76.48 -36.73 57.69 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.011 -0.541 . . . . 74.34 111.333 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.547 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 19.0 t70 -71.95 -23.77 61.5 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 112.035 0.383 . . . . 75.1 112.035 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -129.2 20.03 5.84 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 109.13 -0.693 . . . . 63.11 109.13 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 p90 42.95 32.96 0.46 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.999 1.437 . . . . 72.44 113.602 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 159.1 0.99 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.762 -0.829 . . . . 43.41 108.762 -172.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 23.7 m-85 -78.55 151.48 77.41 Favored Pre-proline 0 N--CA 1.425 -1.717 0 O-C-N 123.486 0.491 . . . . 63.54 111.23 173.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.5 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 30.8 Cg_endo -66.28 162.26 36.89 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.349 2.7 . . . . 73.34 111.055 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 76' ' ' GLN . 69.5 p -98.62 156.33 16.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.27 -1.752 . . . . 65.24 106.27 174.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -67.81 -12.58 60.9 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 119.656 1.116 . . . . 72.23 111.765 -175.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -102.09 -64.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.979 -0.45 . . . . 75.22 110.742 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.408 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 14.9 mm100 -74.12 -40.87 62.37 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 110.253 -0.277 . . . . 70.11 110.253 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.639 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.49 -20.94 79.43 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.088 -1.529 . . . . 64.22 113.458 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.0 -47.37 62.47 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.567 -1.642 . . . . 72.33 106.567 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 30.4 mt-10 -60.98 -33.48 73.29 Favored 'General case' 0 C--O 1.169 -3.175 0 CA-C-N 114.994 -1.003 . . . . 75.02 110.347 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.639 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.35 -7.05 55.44 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.629 . . . . 43.34 111.811 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -95.92 -18.5 20.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.932 -0.576 . . . . 73.45 110.322 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.86 -34.32 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 116.2 -0.454 . . . . 74.44 111.863 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 42.7 pttt -125.97 152.29 45.89 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.564 -2.013 . . . . 74.14 105.564 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 84' ' ' LYS . 3.9 mppt? -54.74 135.08 64.97 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 118.956 0.798 . . . . 73.13 111.813 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.545 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 18.3 Cg_endo -60.87 125.05 16.19 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.944 3.096 . . . . 74.41 113.352 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.0 t -84.1 139.92 32.14 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.429 -1.323 . . . . 73.42 107.429 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.13 -131.84 8.35 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.682 -1.767 . . . . 75.3 108.682 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -127.15 97.4 32.0 Favored Pre-proline 0 C--N 1.299 -1.591 0 CA-C-N 118.088 0.944 . . . . 71.24 111.966 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -92.46 150.25 2.94 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.335 1.356 . . . . 73.54 109.568 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -79.66 160.33 69.8 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.044 -1.095 . . . . 72.03 108.044 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.6 97.63 0.27 Allowed 'Trans proline' 0 C--O 1.249 1.056 0 CA-C-N 120.602 1.251 . . . . 65.2 109.64 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.547 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . 8.2 tmtm? -152.74 147.29 25.91 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.924 -2.25 . . . . 73.54 104.924 -175.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -81.76 92.7 6.68 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.278 -0.969 . . . . 73.44 111.051 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.492 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.9 t90 -54.9 143.69 25.25 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.288 1.035 . . . . 71.33 111.584 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.37 137.2 53.43 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.855 0.862 . . . . 74.41 109.003 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -84.71 -169.06 2.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.011 -0.737 . . . . 71.04 109.011 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t0 71.1 12.47 6.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.304 1.442 . . . . 71.0 110.535 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.52 14.98 30.93 Favored Glycine 0 N--CA 1.425 -2.061 0 CA-C-N 114.341 -1.3 . . . . 74.34 112.946 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.43 91.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 122.633 1.206 . . . . 71.24 109.533 -174.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -123.92 171.26 9.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 113.91 -1.495 . . . . 71.22 109.282 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HG3' ' HB1' ' A' ' 56' ' ' ALA . 73.9 mmtt -94.12 -168.57 1.89 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.396 -1.335 . . . . 72.44 107.396 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.73 70.85 3.26 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.716 1.246 . . . . 73.41 110.535 175.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.1 mt -130.34 147.63 66.59 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 115.064 -0.971 . . . . 54.01 110.715 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.7 -168.52 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.395 2.063 . . . . 75.13 110.526 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.612 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -86.13 173.8 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.556 -0.905 . . . . 75.42 108.556 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.482 ' HB2' ' HD2' ' A' ' 107' ' ' PRO . 4.1 p-10 -72.77 157.58 88.59 Favored Pre-proline 0 C--O 1.249 1.068 0 CA-C-N 118.654 0.661 . . . . 55.32 111.786 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 24.3 Cg_endo -59.8 171.47 2.79 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.615 2.21 . . . . 53.02 113.197 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 68.45 15.09 9.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.503 1.521 . . . . 73.14 110.482 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.2 69.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.135 -0.939 . . . . 64.11 114.132 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.18 142.29 40.96 Favored Pre-proline 0 C--O 1.253 1.249 0 CA-C-N 117.76 0.78 . . . . 74.44 111.26 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.612 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 84.0 Cg_endo -85.04 147.74 10.45 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.491 2.127 . . . . 44.32 111.681 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.33 141.94 56.97 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.564 0.697 . . . . 60.14 110.627 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -104.63 112.84 26.07 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.772 -1.195 . . . . 74.32 107.772 176.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -117.4 118.9 33.48 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.955 -1.02 . . . . 75.3 109.585 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 70.2 mt -127.55 154.56 45.03 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.347 -1.353 . . . . 71.41 107.347 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.734 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -104.13 -178.39 0.62 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 116.592 -1.671 . . . . 64.05 108.669 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.734 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 16.8 Cg_endo -47.43 113.15 0.66 Allowed 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 123.269 2.646 . . . . 71.23 115.113 -165.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -89.29 -94.33 1.11 Allowed Glycine 0 N--CA 1.397 -3.901 0 CA-C-N 113.663 -1.608 . . . . 64.51 111.266 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.6 m -111.78 105.33 13.79 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 108.168 -1.049 . . . . 74.32 108.168 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 77.26 -33.07 0.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.483 1.513 . . . . 54.31 113.718 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -101.62 127.14 9.14 Favored Glycine 0 CA--C 1.474 -2.528 0 C-N-CA 118.933 -1.603 . . . . 72.12 114.334 -169.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.592 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 2.7 Cg_exo -39.78 -20.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.217 1 C-N-CA 126.941 5.094 . . . . 53.12 116.967 176.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.506 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 48.6 p90 -164.85 168.41 17.74 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.739 0.7 . . . . 73.14 112.134 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.5 m-20 -139.93 107.02 5.45 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.642 1.177 . . . . 74.11 109.662 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.85 140.95 44.56 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 117.363 -1.735 . . . . 63.35 111.998 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.564 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 24.4 p90 -166.52 170.08 13.15 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 71.41 111.727 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 m -124.33 151.22 44.57 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 107.596 -1.261 . . . . 75.44 107.596 174.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.0 mt -74.96 157.89 34.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.854 0.359 . . . . 73.45 110.989 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.85 179.21 49.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.506 -0.854 . . . . 62.22 112.209 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.44 63.11 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.812 0.845 . . . . 73.14 112.882 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -94.79 3.38 55.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.397 0.617 . . . . 73.32 110.844 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.81 34.74 55.77 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 116.246 -0.434 . . . . 50.43 112.585 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -139.96 147.92 41.18 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.827 -0.186 . . . . 74.33 110.526 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -93.47 105.8 17.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.189 0.995 . . . . 75.42 110.649 173.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.11 -173.25 20.24 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 115.162 -0.926 . . . . 75.41 111.075 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.38 127.02 8.14 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 108.479 -1.848 . . . . 71.54 108.479 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 57.9 m 179.18 -176.76 0.27 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.264 -1.754 . . . . 72.55 106.264 -171.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.19 -71.86 0.45 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.763 0.711 . . . . 71.2 110.186 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -99.04 -6.12 29.09 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.134 0.492 . . . . 74.43 111.231 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 10.3 m-20 -100.58 7.85 43.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.384 0.611 . . . . 75.12 110.197 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -89.48 156.62 18.53 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.482 -0.781 . . . . 60.52 110.874 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 1.3 p-10 -79.17 129.05 34.05 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.706 -2.331 . . . . 73.52 104.706 172.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.502 HG21 HG13 ' A' ' 47' ' ' VAL . 22.8 pt -114.19 113.79 44.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 CA-C-O 121.663 0.744 . . . . 74.11 110.88 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 126' ' ' TYR . . . -168.05 -179.68 40.72 Favored Glycine 0 N--CA 1.408 -3.184 0 N-CA-C 110.949 -0.86 . . . . 51.01 110.949 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.416 ' C ' HD22 ' A' ' 145' ' ' ASN . 0.2 OUTLIER -151.51 156.19 40.04 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 109.888 -0.412 . . . . 65.44 109.888 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.506 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 7.1 p90 -155.69 177.25 11.6 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 115.3 -0.864 . . . . 74.23 109.226 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -129.93 136.39 49.42 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 123.894 0.746 . . . . 75.21 110.079 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.592 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 30.6 t30 . . . . . 0 C--O 1.255 1.347 0 O-C-N 125.833 1.958 . . . . 75.43 107.299 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.599 ' N ' ' HG1' ' A' ' 48' ' ' THR . 20.1 mmt . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 112.224 0.453 . . . . 71.43 112.224 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -100.36 80.63 2.26 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.901 -1.148 . . . . 52.22 107.901 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -145.53 158.08 51.01 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.311 -1.366 . . . . 40.33 107.311 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.53 123.24 10.98 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.113 2.542 . . . . 74.12 111.873 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t70 75.62 -32.47 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 126.824 2.05 . . . . 40.23 111.772 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.411 ' HA ' HG23 ' A' ' 47' ' ' VAL . 55.8 mt-30 -69.87 -13.9 62.48 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.833 -0.542 . . . . 75.22 110.804 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.42 -27.83 69.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.451 -0.795 . . . . 74.21 109.254 171.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -82.08 -25.72 34.28 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 108.183 -1.043 . . . . 74.13 108.183 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 139' ' ' ASN . 86.9 t -75.11 -43.99 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.656 0.741 . . . . 41.42 110.015 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.599 ' HG1' ' N ' ' A' ' 39' ' ' MET . 6.0 t -66.63 -38.26 86.55 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.91 -1.041 . . . . 65.24 110.993 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.09 -30.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 119.819 -0.752 . . . . 61.44 110.064 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.9 -39.41 81.39 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 115.789 -0.641 . . . . 24.21 111.51 -178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.66 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 67.8 mttm -66.05 -25.43 67.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.211 0.529 . . . . 64.43 111.435 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.73 -34.36 25.08 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.037 -1.225 . . . . 72.12 110.037 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.554 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 m-20 -77.1 -32.95 56.98 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.083 0.771 . . . . 73.02 113.083 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.77 -34.79 62.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.162 -0.336 . . . . 61.41 111.414 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.2 mptp? -69.92 -30.19 67.54 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.531 0.682 . . . . 75.43 109.782 176.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.19 -44.5 91.81 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.175 -0.921 . . . . 64.43 110.21 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 53' ' ' ASP . 76.1 mt -60.9 -39.22 81.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.074 -0.967 . . . . 74.52 110.152 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.527 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . . . -57.73 -35.47 70.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.249 0.343 . . . . 73.44 111.529 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.14 -34.28 70.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.999 0.428 . . . . 73.44 110.112 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.26 -29.35 48.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.476 . . . . 44.14 110.26 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.19 -29.73 67.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.349 -1.352 . . . . 64.43 107.349 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 38.9 m-20 -69.79 -24.46 63.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.509 -0.769 . . . . 72.41 110.961 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.7 mtm -79.25 -34.35 42.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.426 -0.91 . . . . 54.53 109.954 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 90.5 t80 -65.43 -36.79 84.98 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 107.648 -1.242 . . . . 74.14 107.648 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 37.8 ttpt -54.32 -37.74 65.2 Favored 'General case' 0 C--O 1.203 -1.381 0 CA-C-N 115.419 -0.81 . . . . 64.2 110.103 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.04 -27.68 23.04 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.819 -0.752 . . . . 52.23 112.576 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 90' ' ' GLN . 12.7 t70 -76.41 -25.48 54.55 Favored 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 120.034 -0.666 . . . . 71.22 111.289 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.402 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -121.2 22.37 10.91 Favored 'General case' 0 CA--C 1.458 -2.573 0 O-C-N 120.92 -1.112 . . . . 72.42 110.257 174.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 p90 43.29 32.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 125.111 1.507 . . . . 74.12 113.366 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.5 157.35 0.47 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.797 -1.186 . . . . 65.03 107.797 -173.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.53 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 17.0 m-85 -76.07 156.03 84.23 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 109.067 -0.716 . . . . 73.1 109.067 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.517 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 36.3 Cg_endo -64.05 156.78 56.85 Favored 'Trans proline' 0 C--O 1.217 -0.557 0 C-N-CA 122.606 2.204 . . . . 73.43 112.2 -177.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.422 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 62.8 p -93.49 155.38 17.37 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.992 -2.225 . . . . 65.25 104.992 171.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -72.38 -8.48 55.19 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 119.716 1.144 . . . . 64.34 111.097 -174.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -102.58 -66.01 0.96 Allowed 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.903 -0.589 . . . . 75.43 110.741 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -81.13 -35.53 31.44 Favored 'General case' 0 CA--C 1.467 -2.227 0 O-C-N 121.287 -0.883 . . . . 51.35 112.589 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.615 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -72.56 -21.58 79.45 Favored Glycine 0 N--CA 1.417 -2.631 0 C-N-CA 118.014 -2.041 . . . . 73.03 111.562 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.78 -43.62 62.58 Favored 'General case' 0 C--O 1.246 0.912 0 N-CA-C 105.995 -1.854 . . . . 73.11 105.995 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -61.44 -36.53 80.63 Favored 'General case' 0 C--O 1.192 -1.94 0 CA-C-N 114.473 -1.24 . . . . 62.22 110.349 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.457 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -84.54 -3.01 58.2 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.697 0.799 . . . . 55.14 112.598 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 58.0 mt -93.99 -27.31 16.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.498 -0.556 . . . . 73.24 109.498 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.07 -37.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.762 -0.654 . . . . 74.12 111.382 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.9 ttmp? -118.65 149.22 41.77 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.48 -1.674 . . . . 72.41 106.48 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -54.69 132.98 65.05 Favored Pre-proline 0 C--O 1.245 0.83 0 CA-C-O 120.767 0.318 . . . . 71.55 111.246 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -58.41 153.26 48.74 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 124.792 3.661 . . . . 54.45 113.9 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.7 p -90.94 137.82 32.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.38 -0.827 . . . . 72.1 110.174 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.39 -161.33 18.99 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.997 -1.241 . . . . 72.52 109.997 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -111.75 105.08 56.59 Favored Pre-proline 0 N--CA 1.391 -3.378 0 N-CA-C 108.864 -0.791 . . . . 71.14 108.864 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 3.0 Cg_endo -86.31 162.56 9.82 Favored 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 122.954 2.436 . . . . 74.13 110.242 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' A' ' 67' ' ' ASP . 81.2 mm-40 -91.3 111.41 48.66 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 109.608 -0.515 . . . . 74.33 109.608 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -51.1 101.51 0.05 OUTLIER 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 124.336 3.357 . . . . 74.41 117.936 -166.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -135.84 83.52 2.02 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.254 -1.017 . . . . 61.25 108.254 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 16.01 84.16 0.01 OUTLIER 'General case' 0 C--O 1.247 0.929 0 C-N-CA 127.676 2.391 . . . . 61.04 114.058 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.682 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -55.68 137.56 49.13 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.085 0.469 . . . . 65.3 110.917 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.08 129.21 35.67 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.258 -0.883 . . . . 74.41 109.719 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.38 174.27 8.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.876 0.846 . . . . 73.52 110.929 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 66.02 28.55 10.41 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.924 -1.489 . . . . 72.1 110.407 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 99.41 16.38 29.71 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.054 -1.43 . . . . 62.54 115.313 165.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.682 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 2.5 m-85 63.04 90.15 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 122.492 1.139 . . . . 74.13 111.608 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 mt -117.64 171.8 7.78 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.82 -1.082 . . . . 70.24 112.224 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.411 ' HB2' HD22 ' A' ' 103' ' ' LEU . 69.8 mmtt -93.47 -163.4 1.04 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 112.955 -1.93 . . . . 63.1 107.454 174.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.47 28.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.717 1.207 . . . . 73.15 112.944 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 103' ' ' LEU . 2.4 pt? -107.36 148.14 36.57 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.766 -0.584 . . . . 73.11 111.342 -174.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.15 -167.74 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.111 2.54 . . . . 71.25 110.041 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.66 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.97 167.89 2.12 Favored 'Isoleucine or valine' 0 C--O 1.258 1.527 0 N-CA-C 108.287 -1.005 . . . . 74.3 108.287 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 t70 -79.87 151.81 73.95 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 119.761 -0.776 . . . . 50.41 109.554 -171.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 59.7 Cg_exo -44.85 171.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 124.082 3.188 . . . . 54.43 113.953 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.451 ' CD1' ' HA ' ' A' ' 130' ' ' ALA . 2.3 m-90 69.91 14.28 7.93 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 126.127 1.771 . . . . 74.35 109.287 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.78 21.19 58.03 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 114.765 -1.107 . . . . 54.1 112.773 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -92.96 120.86 66.81 Favored Pre-proline 0 C--O 1.254 1.341 0 N-CA-C 112.881 0.697 . . . . 71.51 112.881 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.66 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.1 Cg_exo -59.6 143.91 99.55 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.592 2.195 . . . . 53.55 111.138 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 43.2 m-85 -69.39 143.1 53.76 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.605 -1.258 . . . . 73.23 107.605 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.519 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -103.07 119.65 39.25 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.196 -1.409 . . . . 75.24 107.196 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.26 117.93 34.97 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.289 0.566 . . . . 63.12 111.118 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 88.9 mt -128.8 153.7 47.15 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.525 -0.761 . . . . 65.35 109.044 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.779 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -113.91 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.408 -2.571 0 CA-C-O 117.89 -1.052 . . . . 63.12 109.597 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.779 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 32.2 Cg_endo -60.05 125.57 17.96 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.493 2.129 . . . . 75.1 114.699 -171.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.81 -76.54 0.11 Allowed Glycine 0 N--CA 1.415 -2.746 0 CA-C-N 114.169 -1.378 . . . . 71.3 112.002 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.3 m -95.11 95.29 8.47 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.684 -0.858 . . . . 74.5 108.684 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.527 ' HE2' ' OD1' ' A' ' 148' ' ' ASN . 0.1 OUTLIER 45.33 24.28 0.15 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.513 1.925 . . . . 61.02 115.634 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -137.47 121.8 2.37 Favored Glycine 0 CA--C 1.483 -1.937 0 CA-C-O 118.136 -1.369 . . . . 62.14 113.431 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 23.2 Cg_exo -41.37 -23.66 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.473 1 C-N-CA 126.905 5.07 . . . . 74.1 117.467 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 146' ' ' TRP . 54.8 p90 -179.51 170.14 1.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.364 0.529 . . . . 65.4 110.114 173.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 16.8 m-20 -137.41 109.0 6.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.997 -0.742 . . . . 73.44 108.997 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.24 126.29 51.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.54 -0.911 . . . . 60.43 108.54 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 113' ' ' GLN . 29.8 p90 -166.92 162.77 15.96 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 122.851 0.094 . . . . 71.04 110.771 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.496 ' HB3' HD11 ' A' ' 143' ' ' ILE . 23.0 t -126.07 143.13 51.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.9 -1.518 . . . . 73.23 106.9 171.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.519 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 87.8 mt -60.07 136.27 57.97 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.351 0.407 . . . . 73.51 110.067 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 141' ' ' ALA . . . -75.32 -164.49 13.84 Favored Glycine 0 C--O 1.229 -0.195 0 C-N-CA 121.111 -0.566 . . . . 35.52 114.058 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.451 ' HA ' ' CD1' ' A' ' 108' ' ' TRP . . . -55.37 -34.47 64.34 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.5 0.926 . . . . 73.04 113.5 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.13 -2.23 53.04 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.707 0.765 . . . . 70.03 109.348 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.73 17.22 80.08 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.8 -0.92 . . . . 43.21 110.8 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -100.46 144.85 28.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 112.072 0.397 . . . . 60.23 112.072 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.11 101.14 11.45 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 103.005 -2.961 . . . . 72.43 103.005 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.24 -173.02 22.76 Favored Glycine 0 CA--C 1.497 -1.093 0 CA-C-N 114.387 -1.278 . . . . 63.42 110.984 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.63 126.54 8.22 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 108.377 -1.889 . . . . 53.44 108.377 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.482 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.6 m 178.07 -178.7 0.26 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 126.746 2.019 . . . . 70.54 106.224 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.76 -58.29 2.14 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.683 -0.858 . . . . 63.02 108.683 171.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.51 ' HA ' HG21 ' A' ' 47' ' ' VAL . 3.0 t-20 -89.09 -38.58 14.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.272 -0.876 . . . . 75.34 111.846 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -90.45 8.68 32.55 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.177 0.513 . . . . 73.52 111.313 -174.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.482 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -104.87 157.54 17.14 Favored 'General case' 0 CA--C 1.477 -1.835 0 CA-C-N 115.585 -0.734 . . . . 71.42 109.828 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.73 136.47 38.17 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 107.149 -1.426 . . . . 72.3 107.149 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -94.73 118.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 121.622 0.725 . . . . 62.42 109.274 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.19 157.0 25.9 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.595 -1.288 . . . . 74.12 114.421 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 58' ' ' ALA . 4.4 t30 -148.92 129.53 14.03 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 125.208 1.403 . . . . 65.44 107.571 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.472 ' HA ' ' CE1' ' A' ' 123' ' ' PHE . 5.1 p90 -160.63 177.18 10.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.212 0.529 . . . . 72.14 111.439 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -115.63 134.27 55.21 Favored 'General case' 0 CA--C 1.472 -2.031 0 N-CA-C 107.725 -1.213 . . . . 53.24 107.725 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.527 ' OD1' ' HE2' ' A' ' 120' ' ' LYS . 24.9 t-20 . . . . . 0 C--N 1.292 -1.927 0 N-CA-C 107.713 -1.217 . . . . 72.45 107.713 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.653 ' N ' ' HG1' ' A' ' 48' ' ' THR . 1.4 mpt? . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.226 -0.657 . . . . 74.4 109.226 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 m -97.58 74.11 2.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.401 0.619 . . . . 53.25 110.339 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -148.49 158.5 40.42 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.054 -0.975 . . . . 75.11 108.472 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 44' ' ' GLN . 76.1 Cg_exo -50.63 121.25 7.63 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.633 2.889 . . . . 55.43 112.771 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t0 76.88 -26.4 0.19 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.023 1.729 . . . . 72.43 110.778 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 42' ' ' PRO . 15.5 mm100 -70.96 -17.0 62.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.204 -0.907 . . . . 65.24 108.702 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.37 68.91 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.231 -0.895 . . . . 74.32 109.75 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 55.3 mttp -83.75 -25.68 30.31 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 108.549 -0.908 . . . . 71.54 108.549 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 52.0 t -74.79 -43.03 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.615 0.722 . . . . 74.01 109.494 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.653 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.4 t -63.99 -31.85 73.18 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.034 -0.984 . . . . 72.25 111.718 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -79.8 -39.63 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 119.533 -0.867 . . . . 71.33 109.565 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.81 -39.22 80.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.254 1.022 . . . . 71.23 112.356 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -65.72 -24.92 67.08 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.256 0.551 . . . . 63.22 111.141 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.21 -27.88 21.86 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.093 -0.803 . . . . 64.53 111.093 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.75 -38.98 57.94 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.168 0.509 . . . . 73.1 110.624 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 pt -66.31 -35.12 74.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.011 -0.541 . . . . 75.52 109.897 174.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 9.6 tptp -68.89 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 73.12 109.74 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.54 -40.73 97.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.31 -0.859 . . . . 61.14 109.614 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 125' ' ' LEU . 74.3 mt -66.14 -35.12 74.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 115.014 -0.994 . . . . 72.32 110.665 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -27.49 69.29 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.279 0.562 . . . . 75.54 111.018 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.19 -33.44 29.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.695 0.759 . . . . 63.34 109.413 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.12 53.71 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.562 -0.745 . . . . 51.22 110.886 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.456 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -68.27 -30.18 69.14 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 72.44 108.571 178.366 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.528 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 3.2 t70 -66.49 -30.43 70.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 71.43 109.64 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 88.8 mtp -74.66 -33.92 62.61 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.962 -0.563 . . . . 73.2 110.212 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -71.55 -36.18 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.219 -0.66 . . . . 74.04 109.219 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 15.5 pttp -67.74 -16.39 64.11 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 119.123 -1.031 . . . . 71.43 109.269 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.1 tp -88.65 -36.12 16.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.838 -1.074 . . . . 75.53 109.808 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 23.9 t70 -75.17 -24.55 57.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.026 0.38 . . . . 63.12 112.026 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.77 24.48 5.71 Favored 'General case' 0 CA--C 1.464 -2.361 0 C-N-CA 119.747 -0.781 . . . . 75.5 109.637 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.34 32.48 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.418 1.487 . . . . 71.24 113.925 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.03 161.23 0.57 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.701 -1.222 . . . . 73.33 107.701 -174.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.615 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 16.4 m-85 -77.14 155.07 82.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 123.475 0.485 . . . . 73.24 110.816 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.46 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.0 Cg_endo -63.59 162.12 29.11 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.142 2.561 . . . . 73.14 112.457 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.0 p -98.32 155.24 17.3 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 105.507 -2.034 . . . . 73.35 105.507 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.71 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.79 -11.55 60.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 119.56 1.073 . . . . 72.34 111.549 -173.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -102.02 -65.42 0.99 Allowed 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.855 -0.612 . . . . 72.31 110.295 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -77.14 -39.52 48.95 Favored 'General case' 0 CA--C 1.493 -1.222 0 O-C-N 122.079 -0.388 . . . . 74.32 111.044 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.601 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -77.18 -21.17 74.09 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 118.529 -1.796 . . . . 62.45 112.961 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 82' ' ' VAL . 6.3 tt -70.27 -49.99 44.16 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.644 -1.243 . . . . 65.31 107.644 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.3 -23.92 64.8 Favored 'General case' 0 C--O 1.188 -2.139 0 CA-C-N 115.289 -0.868 . . . . 75.5 110.104 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.502 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -80.21 -7.11 58.82 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.164 -0.471 . . . . 73.12 111.945 176.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 96.4 mt -91.56 -24.82 19.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.646 -0.872 . . . . 71.11 108.646 171.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 78' ' ' LEU . 21.8 t -90.84 -47.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.964 -1.016 . . . . 72.25 110.942 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -117.75 151.25 37.66 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 125.904 1.681 . . . . 73.13 108.411 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -53.34 129.49 51.66 Favored Pre-proline 0 C--O 1.249 1.059 0 N-CA-C 108.955 -0.757 . . . . 62.51 108.955 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 29.8 Cg_endo -58.5 127.36 24.37 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 124.067 3.178 . . . . 62.32 113.05 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -93.16 107.94 19.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.503 -0.771 . . . . 74.42 110.155 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.49 -133.06 3.94 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 109.065 -1.614 . . . . 43.42 109.065 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -125.02 87.79 54.97 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 117.781 0.791 . . . . 63.44 112.733 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.85 163.0 6.13 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 122.818 2.345 . . . . 53.42 108.455 171.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -108.37 148.03 36.82 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 108.952 -0.759 . . . . 73.21 108.952 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.462 ' C ' ' HD2' ' A' ' 92' ' ' LYS . 74.5 Cg_exo -50.82 98.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.63 2.886 . . . . 62.45 116.089 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 2.6 mptp? -147.27 148.75 31.76 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 127.641 2.377 . . . . 61.54 106.618 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -73.69 89.27 1.76 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 111.632 0.234 . . . . 73.03 111.632 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.628 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.2 t90 -54.96 143.76 25.29 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.59 1.156 . . . . 73.43 112.224 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 15.5 t-20 -126.39 137.02 53.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.158 -0.928 . . . . 73.03 111.137 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -86.23 173.79 9.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.659 0.742 . . . . 74.14 111.502 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.9 t70 69.08 15.32 8.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.497 -1.229 . . . . 64.05 112.435 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 119.6 8.81 8.84 Favored Glycine 0 CA--C 1.494 -1.276 0 C-N-CA 119.529 -1.319 . . . . 63.1 114.437 168.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.628 ' OH ' ' HA ' ' A' ' 94' ' ' TRP 0.268 0.3 OUTLIER 65.67 78.56 0.27 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 123.231 1.491 . . . . 75.12 110.787 -174.458 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -121.42 169.09 10.97 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 112.715 -2.038 . . . . 73.11 107.769 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.01 -164.5 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.26 -1.015 . . . . 72.14 108.26 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.45 68.34 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 122.655 1.217 . . . . 74.22 109.275 173.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 148.63 70.84 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 114.564 -1.198 . . . . 73.52 111.0 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -168.2 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.058 2.505 . . . . 72.11 110.795 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.661 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 9.6 p -79.59 166.47 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 108.95 -0.759 . . . . 53.22 108.95 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.37 153.88 76.63 Favored Pre-proline 0 C--O 1.252 1.194 0 N-CA-C 108.805 -0.813 . . . . 65.03 108.805 -172.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.474 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 77.2 Cg_exo -50.0 172.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.432 2.755 . . . . 74.22 114.549 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.486 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 2.2 m-90 69.92 15.16 7.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.64 1.976 . . . . 64.22 109.66 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 13.67 52.77 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.83 -1.077 . . . . 60.24 114.152 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.15 132.96 43.81 Favored Pre-proline 0 N--CA 1.424 -1.769 0 CA-C-O 121.832 0.825 . . . . 74.41 111.595 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.661 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 71.8 Cg_endo -75.13 154.94 42.23 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 122.716 2.278 . . . . 70.53 111.142 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.68 136.37 48.99 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 106.898 -1.519 . . . . 74.44 106.898 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -102.66 114.06 27.97 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 105.225 -2.139 . . . . 73.42 105.225 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.443 ' CZ ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -104.4 118.35 36.4 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.303 -0.862 . . . . 65.02 109.996 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 93.5 mt -129.35 153.18 48.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.758 -0.83 . . . . 52.33 108.758 176.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.715 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -108.78 -177.31 0.46 Allowed Pre-proline 0 N--CA 1.412 -2.35 0 CA-C-O 116.588 -1.672 . . . . 63.25 107.633 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.715 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.2 Cg_endo -47.68 111.77 0.47 Allowed 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 122.653 2.235 . . . . 74.04 115.35 -165.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.74 -86.74 1.93 Allowed Glycine 0 N--CA 1.421 -2.362 0 CA-C-N 113.726 -1.579 . . . . 73.53 111.562 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 m -105.88 96.4 6.46 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 109.274 -0.639 . . . . 64.12 109.274 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 67.01 11.15 8.22 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.667 1.187 . . . . 64.41 114.195 172.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -140.98 132.08 5.21 Favored Glycine 0 CA--C 1.489 -1.561 0 C-N-CA 117.957 -2.068 . . . . 72.05 114.597 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.587 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -39.2 -20.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.062 1 C-N-CA 127.201 5.267 . . . . 53.3 118.025 177.415 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.3 p90 -170.98 165.65 7.57 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.605 0.639 . . . . 73.14 110.059 173.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 19.6 m-20 -135.08 110.37 8.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.487 -0.931 . . . . 74.02 108.487 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.522 HD11 HD12 ' A' ' 57' ' ' ILE . 3.4 tm? -118.81 129.54 55.28 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.116 -0.698 . . . . 74.53 109.116 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -166.97 168.72 13.65 Favored 'General case' 0 C--O 1.204 -1.322 0 O-C-N 123.492 0.495 . . . . 72.44 109.9 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 15.6 m -124.13 142.28 51.35 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.354 -2.091 . . . . 74.03 105.354 171.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.44 143.09 50.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.932 -0.707 . . . . 53.33 111.748 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.68 174.48 11.09 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 116.026 -0.534 . . . . 75.12 113.826 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.96 5.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.593 1.331 . . . . 65.33 114.593 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.12 -10.18 34.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.365 -0.976 . . . . 71.03 108.365 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.74 88.16 Favored Glycine 0 CA--C 1.507 -0.434 0 CA-C-N 115.502 -0.772 . . . . 33.13 111.534 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -140.62 151.31 44.53 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 106.486 -1.672 . . . . 62.42 106.486 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.645 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -66.75 113.02 4.54 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.86 -0.422 . . . . 70.33 109.86 -173.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -140.52 -173.34 13.36 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 116.29 -0.414 . . . . 73.03 112.696 -174.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -139.8 127.84 3.72 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.333 -0.937 . . . . 42.11 111.782 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 74.2 m 178.81 -177.98 0.29 Allowed 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 128.38 2.672 . . . . 60.22 105.07 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.14 -54.0 47.31 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.862 1.21 . . . . 71.02 111.454 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -105.12 -14.63 15.33 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.629 -0.829 . . . . 74.33 112.468 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 16.7 m-20 -95.31 9.37 40.08 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.774 -0.77 . . . . 73.33 111.21 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -87.41 155.08 20.18 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 109.059 -0.719 . . . . 61.23 109.059 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 42.1 m-20 -79.26 124.09 28.05 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.09 -1.818 . . . . 74.23 106.09 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.19 120.82 46.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 CA-C-N 115.956 -0.565 . . . . 73.24 109.95 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.28 177.54 40.61 Favored Glycine 0 N--CA 1.412 -2.964 0 C-N-CA 119.348 -1.406 . . . . 63.43 112.878 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -162.02 158.67 25.35 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.112 -1.81 . . . . 73.13 106.112 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 5.4 p90 -168.94 177.57 4.9 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.429 0.633 . . . . 65.4 112.623 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -109.88 121.61 45.62 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.611 -1.626 . . . . 74.04 106.611 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.342 0 O-C-N 124.24 0.962 . . . . 71.4 110.557 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 N-CA-C 106.135 -1.802 . . . . 74.23 106.135 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -113.47 83.38 1.83 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.828 0.677 . . . . 73.31 112.828 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -153.22 165.83 16.82 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.088 -1.449 . . . . 75.05 107.088 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -49.24 139.35 27.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.55 2.167 . . . . 73.12 111.043 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.15 -49.0 0.53 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.258 1.423 . . . . 61.21 110.0 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' OE1' ' HB3' ' A' ' 138' ' ' ASP . 74.8 mm-40 -68.52 -23.36 64.53 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.419 -1.264 . . . . 75.21 110.166 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.09 -26.37 68.19 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.504 0.722 . . . . 71.23 110.579 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -85.46 -24.19 27.51 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.39 -0.596 . . . . 72.03 109.39 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.18 -42.18 51.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.955 -0.757 . . . . 53.01 108.955 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.7 t -67.84 -25.88 65.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.471 -0.786 . . . . 73.43 112.387 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.8 -37.79 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 119.609 -0.836 . . . . 74.41 109.462 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -58.73 -33.93 70.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.252 1.021 . . . . 63.24 111.505 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 73.7 mmtt -65.44 -26.15 67.83 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.801 0.81 . . . . 73.04 110.217 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.56 -33.31 10.34 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.378 -1.089 . . . . 71.2 110.378 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 33.1 m-20 -71.95 -33.7 68.4 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.999 0.428 . . . . 61.21 111.718 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.466 HD12 ' C ' ' A' ' 144' ' ' GLY . 11.5 pt -68.04 -34.09 64.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.8 -0.36 . . . . 54.34 110.28 172.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 14.0 mptt -65.76 -29.79 70.34 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.997 0.427 . . . . 52.0 110.787 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.48 -40.42 93.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 44.44 110.011 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.405 HG12 ' HG ' ' A' ' 100' ' ' LEU . 70.3 mt -67.15 -34.31 68.67 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-N 115.191 -0.913 . . . . 73.41 110.627 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . . . -59.68 -35.63 74.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.944 0.402 . . . . 63.45 110.448 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.86 -31.9 63.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.298 0.571 . . . . 51.2 109.903 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.02 -28.3 43.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.801 -0.636 . . . . 64.23 110.601 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.79 -31.15 69.95 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.361 -1.348 . . . . 75.43 107.361 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.7 m-20 -72.79 -18.26 61.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.72 -0.673 . . . . 70.11 110.353 171.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.7 mtm -84.26 -31.16 25.1 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 121.995 -0.441 . . . . 74.11 111.632 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.64 -37.11 70.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.07 -1.456 . . . . 72.42 107.07 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.582 ' HD2' ' CE1' ' A' ' 71' ' ' TYR . 86.0 tttt -54.94 -31.28 60.29 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.733 -1.121 . . . . 75.25 109.605 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.5 tp -83.5 -35.41 24.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.479 -0.782 . . . . 73.45 110.531 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 23.6 t70 -78.49 -25.55 45.74 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.209 0.448 . . . . 65.4 112.209 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.444 HD22 ' HB2' ' A' ' 85' ' ' PRO . 2.8 m120 -125.94 22.35 7.39 Favored 'General case' 0 CA--C 1.461 -2.457 0 O-C-N 121.398 -0.814 . . . . 55.34 110.881 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 p90 43.18 34.16 0.65 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.858 1.263 . . . . 63.31 113.703 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.7 161.3 0.67 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.664 -1.236 . . . . 71.54 107.664 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.582 ' CE1' ' HD2' ' A' ' 65' ' ' LYS . 12.3 m-85 -75.9 161.47 75.58 Favored Pre-proline 0 C--N 1.309 -1.172 0 O-C-N 123.367 0.417 . . . . 73.54 111.717 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.532 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 1.7 Cg_endo -78.44 164.11 26.58 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.226 1.951 . . . . 73.44 109.363 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 p -97.78 156.43 16.57 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.931 -1.877 . . . . 51.01 105.931 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -4.12 31.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.13 -1.428 . . . . 53.5 111.051 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -102.8 -67.65 0.87 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.772 -0.649 . . . . 75.11 109.648 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -80.58 -34.99 34.88 Favored 'General case' 0 CA--C 1.487 -1.481 0 CA-C-N 115.973 -0.558 . . . . 71.24 111.468 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.568 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.34 -20.51 78.78 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 118.225 -1.941 . . . . 71.35 112.696 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.97 -50.86 37.63 Favored 'General case' 0 C--O 1.26 1.606 0 N-CA-C 107.53 -1.285 . . . . 62.45 107.53 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 8.5 pt-20 -65.19 -28.25 69.26 Favored 'General case' 0 C--O 1.17 -3.09 0 CA-C-N 114.866 -1.061 . . . . 73.41 109.824 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.526 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.44 -6.16 52.44 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.629 0.603 . . . . 60.13 112.629 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 95.5 mt -95.38 -19.43 19.93 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.161 0.505 . . . . 54.45 110.014 172.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.5 t -98.53 -39.43 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.565 1.174 . . . . 64.22 110.715 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 25.1 tttm -121.29 148.3 44.49 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 127.521 2.328 . . . . 70.43 107.659 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -56.76 132.84 78.66 Favored Pre-proline 0 N--CA 1.475 0.775 0 O-C-N 123.141 0.275 . . . . 72.24 111.542 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HB2' HD22 ' A' ' 68' ' ' ASN . 37.6 Cg_endo -63.44 128.74 23.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 123.327 2.684 . . . . 74.31 112.096 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -90.99 105.5 17.87 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.5 -0.773 . . . . 75.33 110.238 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.27 7.69 Favored Glycine 0 N--CA 1.418 -2.528 0 N-CA-C 109.906 -1.278 . . . . 73.12 109.906 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -118.62 88.2 33.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.936 0.368 . . . . 74.15 110.902 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 13.8 Cg_endo -92.69 159.4 2.86 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.707 1.605 . . . . 63.12 109.438 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -88.21 159.12 48.47 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.047 -0.723 . . . . 74.42 109.047 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.39 99.21 0.2 Allowed 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 121.692 1.595 . . . . 74.54 111.427 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.594 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.55 148.25 28.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.899 -1.889 . . . . 72.05 105.899 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.594 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 51.3 m-80 -65.48 91.36 0.12 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 122.373 -0.204 . . . . 74.44 111.503 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.507 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.2 t90 -66.6 140.27 57.93 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.483 -0.562 . . . . 72.34 109.483 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -127.95 134.47 49.31 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.811 -0.811 . . . . 55.41 108.811 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 65.3 pttt -75.58 -169.36 1.02 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.319 -0.993 . . . . 52.54 108.319 174.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.426 ' HB2' ' HG3' ' A' ' 96' ' ' LYS . 27.7 t70 67.64 15.3 9.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.973 0.892 . . . . 71.32 110.819 169.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 102.95 9.79 38.86 Favored Glycine 0 CA--C 1.495 -1.214 0 CA-C-N 114.995 -1.002 . . . . 72.43 113.855 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.2 OUTLIER 61.88 92.37 0.06 Allowed 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 122.085 0.945 . . . . 74.34 109.601 -173.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 101' ' ' LYS . 2.7 tt -128.91 155.63 44.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.014 -1.847 . . . . 72.54 106.014 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' H ' HD23 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.97 -171.93 0.35 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.053 -0.351 . . . . 64.25 110.053 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 28.81 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.797 1.036 . . . . 63.13 113.797 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.41 147.99 35.55 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 109.296 -0.631 . . . . 74.23 109.296 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.98 -167.96 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.975 2.45 . . . . 71.13 111.897 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.608 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.0 175.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.417 -0.957 . . . . 64.24 108.417 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.571 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.7 t70 -78.73 159.92 73.04 Favored Pre-proline 0 C--O 1.256 1.44 0 CA-C-N 119.081 0.855 . . . . 72.12 109.173 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.571 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 4.0 Cg_endo -49.05 170.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 123.551 2.834 . . . . 53.42 113.242 173.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 66.71 14.56 9.83 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.437 1.895 . . . . 72.21 110.931 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 -0.65 34.86 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.804 -0.635 . . . . 50.21 114.002 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.9 135.45 87.6 Favored Pre-proline 0 C--O 1.263 1.791 0 CA-C-O 121.451 0.643 . . . . 74.34 112.077 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.608 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 92.2 Cg_endo -80.22 154.12 21.82 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 C-N-CA 122.118 1.879 . . . . 73.43 110.035 174.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -74.4 143.17 44.9 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.651 -1.24 . . . . 73.31 107.651 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -102.18 113.89 27.56 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 104.656 -2.35 . . . . 74.34 104.656 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.56 118.21 36.49 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.988 -1.006 . . . . 70.32 111.882 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 87.8 mt -129.11 144.19 51.12 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.107 -0.951 . . . . 62.03 109.242 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -101.59 -177.0 0.5 Allowed Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 104.404 -2.443 . . . . 75.21 104.404 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 Cg_endo -47.78 108.51 0.17 Allowed 'Trans proline' 0 C--N 1.385 2.491 0 CA-C-N 123.179 2.171 . . . . 53.32 113.015 -168.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -106.82 -86.12 1.84 Allowed Glycine 0 N--CA 1.405 -3.394 0 CA-C-N 114.46 -1.246 . . . . 53.35 112.051 -175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 m -96.26 95.53 8.16 Favored 'General case' 0 N--CA 1.406 -2.655 0 C-N-CA 118.448 -1.301 . . . . 63.01 109.836 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 66.25 4.45 3.17 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 125.418 1.487 . . . . 73.23 114.579 171.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -139.88 144.94 15.71 Favored Glycine 0 CA--C 1.491 -1.415 0 C-N-CA 118.73 -1.7 . . . . 70.42 114.112 -174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.5 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 33.5 Cg_exo -38.61 -27.08 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.131 1 C-N-CA 127.163 5.242 . . . . 54.42 117.992 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -173.2 146.71 1.47 Allowed 'General case' 0 C--O 1.249 1.039 0 CA-C-N 119.071 0.85 . . . . 74.3 111.859 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.2 m-20 -118.48 106.61 12.86 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.142 -1.429 . . . . 62.55 107.142 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.3 129.52 46.45 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 120.886 -1.134 . . . . 72.0 110.76 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -165.21 166.46 18.88 Favored 'General case' 0 C--O 1.194 -1.832 0 CA-C-N 116.845 -0.161 . . . . 73.24 111.251 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.0 t -125.28 139.94 53.27 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 63.11 105.649 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.13 155.29 20.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.914 1.079 . . . . 74.12 113.914 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.75 165.15 37.76 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 110.774 -0.931 . . . . 71.41 110.774 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.46 -24.01 4.56 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 115.924 1.824 . . . . 65.1 115.924 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.27 -1.72 28.34 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.575 -0.703 . . . . 74.02 111.603 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.49 38.49 5.0 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.466 -0.873 . . . . 72.22 113.813 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -130.34 147.84 52.1 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.305 -0.628 . . . . 72.11 109.305 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 9.4 pt-20 -101.89 105.46 16.28 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.077 -1.453 . . . . 74.01 107.077 167.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.18 -173.73 21.39 Favored Glycine 0 C--N 1.29 -1.991 0 N-CA-C 110.395 -1.082 . . . . 54.33 110.395 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.91 129.78 10.01 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.687 -1.365 . . . . 45.33 109.687 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.56 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.9 t 179.59 -178.39 0.38 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.735 -1.58 . . . . 70.22 106.735 -172.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.447 ' HB3' ' OE1' ' A' ' 44' ' ' GLN . 4.3 m-20 -87.26 -66.8 0.87 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.345 -0.613 . . . . 74.35 109.345 173.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.83 -30.73 14.67 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.928 -1.033 . . . . 74.43 111.908 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.76 17.88 16.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.649 0.738 . . . . 70.04 110.907 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.56 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -100.67 155.75 17.71 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-N 114.943 -1.026 . . . . 71.11 109.554 176.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.516 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.8 p-10 -79.13 135.06 36.72 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.397 -1.334 . . . . 65.23 107.397 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.59 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -104.18 123.64 58.11 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-N 115.728 -0.669 . . . . 75.24 109.623 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.466 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -159.29 179.81 34.63 Favored Glycine 0 N--CA 1.412 -2.911 0 C-N-CA 118.878 -1.63 . . . . 24.44 112.702 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.521 ' OD1' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -137.5 150.4 47.52 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 105.774 -1.935 . . . . 61.44 105.774 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -143.87 144.54 31.79 Favored 'General case' 0 C--N 1.267 -3.013 0 C-N-CA 119.269 -0.972 . . . . 72.12 110.003 -165.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -127.38 95.68 4.34 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.87 -1.53 . . . . 65.45 106.87 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.6 t30 . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 113.816 -1.538 . . . . 72.22 107.676 -176.725 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.571 ' N ' ' HG1' ' A' ' 48' ' ' THR . 11.8 ttt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.55 -1.278 . . . . 71.14 107.55 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.9 m -104.94 86.66 2.49 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.902 0.704 . . . . 71.43 112.902 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -153.77 159.75 31.72 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.184 -1.413 . . . . 73.42 107.184 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.09 125.55 16.55 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.681 2.254 . . . . 74.34 111.787 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 75.95 -33.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.779 2.032 . . . . 44.02 111.55 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HA ' HG23 ' A' ' 47' ' ' VAL . 63.7 mt-30 -70.0 -20.7 63.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.784 0.802 . . . . 55.42 109.217 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.85 64.29 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.715 -1.13 . . . . 72.02 110.13 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 91.6 mttt -89.25 -25.08 21.9 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.766 -0.827 . . . . 71.55 108.766 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' A' ' 44' ' ' GLN . 44.9 t -74.39 -43.89 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 108.34 -0.985 . . . . 73.23 108.34 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.571 ' HG1' ' N ' ' A' ' 39' ' ' MET . 12.0 t -66.26 -29.59 69.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.403 -1.271 . . . . 73.25 111.831 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -83.87 -33.75 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.039 -0.665 . . . . 71.1 110.248 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' A' ' 143' ' ' ILE . . . -71.95 -34.27 68.86 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.752 -0.658 . . . . 73.14 111.587 -176.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.624 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 57.2 mtpt -70.39 -25.45 63.25 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.769 -0.772 . . . . 73.12 111.97 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.06 -26.21 45.6 Favored Glycine 0 C--O 1.246 0.88 0 N-CA-C 109.495 -1.442 . . . . 53.34 109.495 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.593 ' O ' HG13 ' A' ' 57' ' ' ILE . 20.7 t70 -77.32 -38.38 50.57 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.265 -0.967 . . . . 61.34 109.391 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 51' ' ' LYS . 20.3 pt -65.92 -30.39 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 122.202 -0.311 . . . . 73.52 110.823 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.624 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.2 mptm? -71.08 -27.3 63.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.571 -0.452 . . . . 72.13 110.277 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -69.92 -48.87 56.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.568 -0.742 . . . . 60.42 110.243 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.65 ' HB ' HD21 ' A' ' 125' ' ' LEU . 30.6 mt -61.06 -42.6 93.77 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 115.192 -0.913 . . . . 73.01 108.985 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -28.91 68.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.502 . . . . 61.12 111.876 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.04 -24.21 35.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.512 0.672 . . . . 73.14 109.606 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.05 29.76 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.754 -0.832 . . . . 51.55 108.754 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -68.77 -31.14 69.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.211 -1.403 . . . . 73.53 107.211 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.3 m-20 -68.92 -24.25 64.27 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.911 -0.586 . . . . 72.3 110.007 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 mmt -78.35 -34.98 48.06 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 120.889 -0.324 . . . . 71.12 111.305 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.551 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 58.7 t80 -69.8 -36.66 75.87 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.55 -1.278 . . . . 72.01 107.55 174.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.56 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 80.9 tttt -54.34 -35.36 62.64 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 114.876 -1.056 . . . . 72.41 110.485 173.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 95.6 mt -87.0 -29.09 22.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 116.199 -0.455 . . . . 73.33 111.317 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t70 -78.2 -24.37 47.16 Favored 'General case' 0 C--O 1.201 -1.451 0 CA-C-O 120.632 0.253 . . . . 72.25 111.383 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -128.99 24.38 5.64 Favored 'General case' 0 CA--C 1.469 -2.14 0 N-CA-C 109.175 -0.676 . . . . 74.4 109.175 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.6 p90 42.97 31.44 0.33 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 126.131 1.772 . . . . 70.42 114.736 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.41 162.33 0.51 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.66 -1.237 . . . . 73.53 107.66 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.4 m-85 -76.6 153.57 83.54 Favored Pre-proline 0 C--N 1.296 -1.739 0 C-N-CA 120.252 -0.579 . . . . 63.12 110.274 173.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 20.8 Cg_endo -61.98 164.37 16.94 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 123.28 2.653 . . . . 42.53 110.904 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.428 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 37.8 p -95.05 155.36 16.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.354 -1.721 . . . . 64.5 106.354 173.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.608 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.05 -12.8 62.01 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 119.837 1.199 . . . . 61.31 110.503 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -102.48 -65.24 1.0 Allowed 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.938 -1.028 . . . . 75.15 110.746 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -84.79 -29.23 25.58 Favored 'General case' 0 CA--C 1.478 -1.797 0 O-C-N 121.885 -0.509 . . . . 74.45 111.387 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.53 -20.79 79.46 Favored Glycine 0 N--CA 1.411 -3.022 0 C-N-CA 119.202 -1.475 . . . . 64.14 111.818 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.46 -46.14 70.58 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.226 -1.768 . . . . 72.42 106.226 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.96 -21.66 66.43 Favored 'General case' 0 C--O 1.17 -3.103 0 CA-C-N 114.762 -1.108 . . . . 74.14 110.814 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.693 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -89.89 -4.22 57.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.656 0.741 . . . . 71.35 111.351 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.455 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 4.7 mp -99.51 -21.21 16.03 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.521 -0.763 . . . . 61.13 110.086 174.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 35.9 t -108.01 -30.97 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 115.985 -0.552 . . . . 73.45 110.737 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.7 mptp? -122.57 150.5 42.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.018 1.327 . . . . 71.05 107.978 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -54.9 135.71 66.23 Favored Pre-proline 0 N--CA 1.48 1.05 0 CA-C-N 118.405 0.548 . . . . 72.41 111.351 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.551 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 13.5 Cg_endo -53.04 153.09 16.51 Favored 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 124.633 3.556 . . . . 75.44 114.1 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 p -98.96 132.49 44.24 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.788 -0.642 . . . . 62.52 109.844 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.79 -137.38 14.26 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.903 -1.279 . . . . 71.43 109.903 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -129.7 105.85 17.09 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 117.362 0.581 . . . . 73.02 110.364 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -85.54 162.94 10.94 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.072 1.848 . . . . 74.35 108.979 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.14 156.69 46.22 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.446 -0.946 . . . . 71.34 108.446 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -58.45 98.76 0.1 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.583 2.189 . . . . 73.1 116.08 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 66' ' ' LEU . 67.5 mttm -151.32 148.52 28.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.545 1.938 . . . . 70.24 107.757 172.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -82.13 97.35 8.15 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.815 -0.354 . . . . 64.44 110.304 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.543 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.2 t90 -54.68 142.74 27.32 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.554 1.142 . . . . 65.54 112.696 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -123.85 136.96 54.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.956 -1.02 . . . . 72.23 109.212 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -81.09 -163.9 0.67 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 75.32 108.208 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 61.96 23.61 13.93 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.297 0.639 . . . . 74.41 110.915 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 78.54 24.41 62.94 Favored Glycine 0 CA--C 1.48 -2.12 0 CA-C-N 114.981 -1.009 . . . . 54.43 112.819 171.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 63.39 78.1 0.3 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 123.136 1.446 . . . . 70.0 109.138 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.438 HD12 HG12 ' A' ' 57' ' ' ILE . 63.0 tp -117.67 166.9 11.86 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.041 -1.89 . . . . 71.32 107.861 -172.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.64 -174.72 5.43 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 75.13 109.299 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 35.35 1.03 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.516 1.151 . . . . 63.24 110.395 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.04 149.07 40.34 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 113.804 -1.543 . . . . 54.1 108.842 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.29 177.08 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.483 2.789 . . . . 74.54 113.835 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.571 HG21 ' HA ' ' A' ' 111' ' ' PRO . 5.1 p -79.39 175.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.41 -0.814 . . . . 75.51 109.066 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.3 p-10 -69.89 158.68 86.64 Favored Pre-proline 0 C--O 1.258 1.527 0 N-CA-C 113.496 0.924 . . . . 64.04 113.496 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.438 ' CB ' ' HB3' ' A' ' 46' ' ' LYS . 50.5 Cg_exo -58.0 171.73 1.51 Allowed 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.815 2.343 . . . . 74.51 111.47 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 65.94 14.49 9.62 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 125.033 1.333 . . . . 65.51 108.845 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.66 57.98 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.189 -1.369 . . . . 64.25 115.033 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.547 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 6.9 m120 -92.91 152.62 41.69 Favored Pre-proline 0 C--O 1.264 1.824 0 CA-C-N 118.947 1.374 . . . . 75.45 108.573 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.571 ' HA ' HG21 ' A' ' 105' ' ' VAL . 58.8 Cg_endo -82.33 141.06 11.22 Favored 'Trans proline' 0 N--CA 1.425 -2.522 0 C-N-CA 121.32 1.347 . . . . 75.05 110.579 165.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 31.7 m-85 -68.07 144.76 54.94 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 109.743 -0.466 . . . . 74.41 109.743 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -102.36 119.3 38.58 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.212 -1.403 . . . . 74.14 107.212 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -107.77 118.1 35.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.249 -1.389 . . . . 74.33 107.249 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 95.7 mt -129.23 153.17 48.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.254 -0.647 . . . . 64.2 109.254 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -117.81 -178.37 0.53 Allowed Pre-proline 0 N--CA 1.414 -2.26 0 CA-C-O 117.319 -1.324 . . . . 72.24 108.273 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 36.5 Cg_endo -58.36 121.7 10.43 Favored 'Trans proline' 0 CA--C 1.492 -1.601 0 CA-C-N 122.041 1.765 . . . . 73.24 114.651 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -118.55 -84.03 0.92 Allowed Glycine 0 N--CA 1.418 -2.526 0 CA-C-N 114.266 -1.334 . . . . 40.32 111.021 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.5 m -110.04 107.17 16.94 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 107.906 -1.146 . . . . 73.31 107.906 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 70.96 -7.7 1.07 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.356 1.613 . . . . 73.31 115.356 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -132.3 126.6 4.61 Favored Glycine 0 CA--C 1.465 -3.045 0 C-N-CA 116.864 -2.589 . . . . 41.23 115.587 -171.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.52 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 39.8 Cg_exo -43.93 -23.71 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.168 1 C-N-CA 126.455 4.77 . . . . 64.13 115.711 176.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.494 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.0 p90 -176.12 169.35 2.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 118.023 0.374 . . . . 73.23 110.095 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 24.3 m-20 -136.79 112.24 9.27 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.4 -1.333 . . . . 74.02 107.4 174.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 57' ' ' ILE . 47.5 tp -124.53 126.29 45.59 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.465 -0.494 . . . . 54.41 109.952 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 31.2 p90 -167.38 168.49 13.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.738 -0.385 . . . . 74.11 111.261 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.551 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 50.9 p -125.63 146.55 49.66 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.088 -1.078 . . . . 74.22 108.088 171.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 90.3 mt -66.69 145.38 55.62 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 110.341 -0.244 . . . . 54.34 110.341 175.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -81.1 -171.03 44.33 Favored Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.163 -1.017 . . . . 73.34 112.412 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.22 -8.21 5.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.896 1.073 . . . . 43.44 113.896 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -94.74 -9.71 33.85 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.133 0.492 . . . . 50.14 109.941 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.9 12.09 84.2 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 111.772 -0.531 . . . . 63.32 111.772 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -140.12 147.74 40.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.446 0.699 . . . . 73.13 109.17 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -81.72 114.3 20.28 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.29 0.567 . . . . 74.22 111.021 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.04 -174.23 21.1 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.216 -1.154 . . . . 55.4 110.216 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.18 126.63 8.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.639 -1.267 . . . . 73.52 110.078 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.487 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.3 m 177.92 -177.27 0.21 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.808 2.043 . . . . 70.42 106.134 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.45 -69.55 0.68 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.771 -1.172 . . . . 75.24 112.388 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -91.17 -21.99 20.88 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.126 0.489 . . . . 74.11 111.504 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.81 -6.72 59.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.125 0.488 . . . . 73.54 110.673 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -92.92 156.68 16.78 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.376 -0.829 . . . . 63.11 111.505 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.85 118.4 20.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.635 -1.246 . . . . 73.54 107.635 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.6 pp -96.7 132.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.583 0 N-CA-C 108.525 -0.917 . . . . 72.23 108.525 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.0 176.79 42.47 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.248 -1.453 . . . . 73.34 112.072 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -152.66 145.98 24.78 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.477 -1.305 . . . . 71.2 107.477 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 7.4 p90 -161.35 175.47 12.2 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 116.072 -0.513 . . . . 75.42 110.477 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -113.61 122.62 47.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.921 -1.881 . . . . 63.41 105.921 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.305 -1.335 0 C-N-CA 124.587 1.155 . . . . 73.02 108.346 -178.501 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.633 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 20.1 mmt . . . . . 0 CA--C 1.505 -0.782 0 N-CA-C 110.467 -0.198 . . . . 70.31 110.467 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 m -107.29 73.79 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.054 0.454 . . . . 70.2 109.892 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -155.16 151.77 23.58 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 124.018 0.927 . . . . 74.23 109.42 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.87 131.42 38.2 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.534 2.823 . . . . 74.41 112.632 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 77.02 -36.14 0.24 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.321 2.249 . . . . 74.11 110.898 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.633 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.5 mm100 -68.92 -24.11 64.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.47 0.652 . . . . 71.01 109.569 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -66.77 -27.1 67.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.472 -0.786 . . . . 74.11 109.543 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 98.1 mttt -79.19 -26.13 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.228 -0.656 . . . . 74.3 109.228 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.8 -43.15 46.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.292 -0.867 . . . . 73.22 109.139 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -69.87 -33.03 71.7 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.1 -0.954 . . . . 52.12 111.592 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 45' ' ' ALA . 11.2 m -73.92 -31.93 32.22 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 C-N-CA 119.361 -0.936 . . . . 45.2 109.694 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -68.25 -40.28 82.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.793 -0.639 . . . . 42.43 110.408 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 96.2 mttt -69.95 -25.29 63.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.408 0.623 . . . . 74.33 111.561 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.6 -27.74 46.0 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 109.944 -1.262 . . . . 63.11 109.944 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.596 ' O ' HG13 ' A' ' 57' ' ' ILE . 5.2 t70 -73.99 -42.63 60.13 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.397 -0.902 . . . . 74.32 109.014 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.2 pt -63.93 -28.86 45.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 63.52 110.782 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.5 mptp? -70.74 -30.6 67.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.027 0.441 . . . . 72.02 110.346 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.73 -44.13 70.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 54.31 109.741 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 53' ' ' ASP . 36.8 mt -65.17 -39.77 86.6 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 CA-C-N 115.126 -0.943 . . . . 74.44 109.983 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.76 -31.56 66.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.345 -0.389 . . . . 73.24 111.007 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.24 46.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.222 0.534 . . . . 52.24 109.798 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.45 -26.64 38.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.019 -0.537 . . . . 70.43 109.917 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -30.44 69.98 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.132 -1.433 . . . . 70.35 107.132 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 68.9 m-20 -72.66 -18.54 61.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.484 -0.78 . . . . 75.43 109.817 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 mmt -82.11 -35.23 28.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.772 -0.649 . . . . 73.03 109.559 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.4 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 82.7 t80 -68.58 -34.71 76.27 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.386 -1.338 . . . . 71.04 107.386 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.628 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 85.9 tttt -55.87 -30.39 61.43 Favored 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 114.597 -1.183 . . . . 71.02 110.026 173.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.18 -34.41 20.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.804 0.298 . . . . 70.43 111.804 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.14 -23.74 61.35 Favored 'General case' 0 C--O 1.196 -1.763 0 CA-C-O 120.677 0.275 . . . . 61.35 111.273 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.51 20.56 5.64 Favored 'General case' 0 CA--C 1.452 -2.794 0 O-C-N 121.927 -0.483 . . . . 52.1 111.839 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 p90 42.69 32.68 0.4 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.87 1.356 . . . . 72.34 113.693 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 161.41 1.18 Allowed 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.898 -1.149 . . . . 72.44 107.898 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.628 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.3 m-85 -79.33 159.48 72.45 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 123.287 0.367 . . . . 61.11 111.557 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 58.3 Cg_endo -71.56 160.41 48.42 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.531 2.154 . . . . 75.3 112.377 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 52.6 p -96.28 155.33 16.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.232 -2.136 . . . . 74.43 105.232 171.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.48 -9.54 54.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 119.156 0.889 . . . . 64.51 110.777 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -102.7 -67.04 0.89 Allowed 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.737 -0.665 . . . . 71.41 110.629 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -81.56 -38.37 26.25 Favored 'General case' 0 CA--C 1.477 -1.837 0 C-N-CA 120.32 -0.552 . . . . 63.24 111.298 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 81' ' ' LEU . . . -71.95 -20.6 78.96 Favored Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 118.395 -1.86 . . . . 72.41 112.141 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.33 -47.0 53.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.539 -1.282 . . . . 63.51 107.539 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -65.02 -31.06 72.11 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-N 115.643 -0.708 . . . . 72.34 110.606 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -82.63 -5.12 58.64 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.186 0.517 . . . . 62.31 111.992 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.57 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 13.7 tp -96.33 -24.56 16.12 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.203 -1.036 . . . . 73.33 108.203 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.95 -38.14 5.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.135 -0.939 . . . . 73.41 110.751 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 61.9 mtpt -124.2 151.98 43.44 Favored 'General case' 0 C--O 1.204 -1.342 0 C-N-CA 125.552 1.541 . . . . 74.3 108.126 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -54.57 127.67 59.55 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 113.324 0.861 . . . . 74.11 113.324 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.7 123.07 12.91 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.97 3.78 . . . . 61.11 115.797 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -99.57 115.12 28.66 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.13 -1.395 . . . . 71.12 108.35 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 150.8 -116.76 0.79 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.091 -1.604 . . . . 41.3 109.091 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -137.65 90.97 14.19 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 117.558 0.679 . . . . 72.03 110.64 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.53 162.88 0.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.637 2.225 . . . . 73.42 112.448 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.251 14.2 tm0? -110.16 132.22 21.58 Favored Pre-proline 0 C--N 1.261 -3.261 0 CA-C-N 112.89 -1.959 . . . . 71.25 106.502 -171.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.91 99.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.688 2.925 . . . . 55.3 114.271 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -152.15 149.36 28.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.41 -1.7 . . . . 73.13 106.41 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -72.83 99.28 2.61 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 118.697 0.68 . . . . 72.32 111.201 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.512 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.5 t90 -61.97 144.11 55.55 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 125.028 1.331 . . . . 64.31 111.652 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.29 134.06 54.1 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.722 -0.672 . . . . 72.33 109.291 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.85 176.06 8.17 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.935 0.874 . . . . 61.45 111.354 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 57.78 28.97 16.71 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.436 -1.711 . . . . 74.34 112.858 168.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.57 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 120.65 -4.81 11.8 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.277 -1.439 . . . . 63.44 115.36 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.93 93.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.368 1.08 . . . . 74.4 109.411 -169.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -131.76 170.1 15.29 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.224 -2.139 . . . . 64.44 105.224 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.526 ' H ' HD23 ' A' ' 100' ' ' LEU . 96.4 mttt -88.93 -165.02 1.23 Allowed 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.725 -1.213 . . . . 63.51 107.725 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.23 32.54 0.45 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.893 0.854 . . . . 73.21 112.231 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 101' ' ' LYS . 11.3 mp -94.77 149.61 36.67 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 125.028 1.331 . . . . 71.33 109.463 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.84 -167.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.643 2.895 . . . . 64.41 113.735 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.5 p -101.28 176.12 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.813 -1.18 . . . . 70.42 107.813 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.43 144.87 95.0 Favored Pre-proline 0 C--O 1.255 1.384 0 CA-C-N 118.705 0.684 . . . . 73.34 111.29 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 8.7 Cg_endo -51.39 171.78 0.13 Allowed 'Trans proline' 0 C--O 1.195 -1.633 0 C-N-CA 123.79 2.993 . . . . 73.02 112.597 174.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.435 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.2 m-90 62.54 14.97 7.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.921 1.289 . . . . 75.34 109.471 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.37 12.97 77.13 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 116.401 1.32 . . . . 44.01 116.401 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.435 ' ND2' ' HE3' ' A' ' 108' ' ' TRP . 14.9 m-80 -78.64 125.03 85.04 Favored Pre-proline 0 C--O 1.256 1.433 0 CA-C-N 120.15 1.975 . . . . 54.51 111.482 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.541 ' HA ' HG21 ' A' ' 105' ' ' VAL . 39.4 Cg_exo -67.53 146.71 74.97 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.093 1.862 . . . . 75.42 108.734 167.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.59 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 54.2 m-85 -68.93 145.33 53.74 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.381 0.61 . . . . 74.14 112.122 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.4 ' CD ' HD13 ' A' ' 128' ' ' LEU . 2.5 mm100 -101.85 118.23 36.48 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.555 -2.017 . . . . 71.33 105.555 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.53 118.64 35.67 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.708 -0.678 . . . . 75.21 111.958 -177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -129.81 154.0 47.69 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.294 -0.866 . . . . 62.11 109.838 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.809 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -101.76 -177.26 0.53 Allowed Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-O 116.572 -1.68 . . . . 64.41 107.817 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.809 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 10.1 Cg_endo -40.56 112.3 0.17 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.585 2.857 . . . . 63.03 115.48 -164.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.89 -88.51 1.12 Allowed Glycine 0 N--CA 1.421 -2.344 0 CA-C-N 114.338 -1.301 . . . . 72.14 111.725 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.9 m -108.07 95.76 5.9 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 108.456 -0.942 . . . . 62.41 108.456 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 65.6 -6.16 0.43 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.159 1.384 . . . . 71.0 113.329 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -111.41 127.0 7.97 Favored Glycine 0 N--CA 1.423 -2.23 0 CA-C-O 118.749 -1.028 . . . . 34.01 113.336 -174.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.598 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -35.07 -23.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.48 1 C-N-CA 127.339 5.36 . . . . 62.21 118.778 179.97 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 54.4 p90 -166.21 171.59 12.09 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 119.593 1.088 . . . . 72.13 112.042 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.86 106.57 6.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.009 0.924 . . . . 71.33 108.889 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.39 128.3 52.07 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.686 -0.857 . . . . 33.34 108.686 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.417 ' HB3' ' HA3' ' A' ' 144' ' ' GLY . 42.0 p90 -166.91 168.1 14.26 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 110.298 -0.26 . . . . 73.12 110.298 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.59 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 13.1 t -125.64 154.35 42.45 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.893 -1.521 . . . . 63.1 106.893 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.4 HD13 ' CD ' ' A' ' 113' ' ' GLN . 7.5 mp -72.17 157.45 37.72 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.839 -0.344 . . . . 74.34 111.534 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.17 -169.94 29.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.235 -0.983 . . . . 42.33 112.999 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.03 -21.84 66.44 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.134 0.79 . . . . 73.04 113.134 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -94.43 -2.47 51.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.65 0.738 . . . . 71.03 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.72 45.68 73.92 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.042 -1.623 . . . . 75.44 109.042 -174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -135.28 144.34 46.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.849 -1.167 . . . . 73.45 107.849 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 142' ' ' ASP 0.253 0.5 OUTLIER -102.86 106.7 17.33 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 121.982 0.896 . . . . 72.2 111.014 173.971 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.01 -173.34 20.26 Favored Glycine 0 C--N 1.294 -1.793 0 N-CA-C 111.066 -0.813 . . . . 64.03 111.066 -177.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -111.77 125.61 7.31 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 107.727 -2.149 . . . . 25.2 107.727 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.536 ' CB ' ' HB3' ' A' ' 140' ' ' ASP . 74.6 m 179.24 -176.34 0.26 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.897 1.279 . . . . 72.14 107.898 -167.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.21 -73.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.943 0.401 . . . . 72.45 110.412 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -107.22 -8.98 16.23 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.554 0.692 . . . . 53.41 110.12 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 137' ' ' SER . 22.2 t70 -89.65 2.32 54.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 123.073 1.416 . . . . 64.34 108.871 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.36 155.8 17.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.73 -1.577 . . . . 73.31 110.595 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.6 p-10 -84.73 122.46 29.13 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.775 -1.935 . . . . 61.21 105.775 171.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.29 113.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-O 121.982 0.896 . . . . 70.33 111.142 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 126' ' ' TYR . . . -163.56 -179.8 38.16 Favored Glycine 0 N--CA 1.41 -3.087 0 C-N-CA 119.271 -1.442 . . . . 60.54 112.917 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.11 158.83 19.73 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.437 -1.32 . . . . 64.34 107.437 -177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.493 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 9.8 p90 -163.2 177.58 8.93 Favored 'General case' 0 C--N 1.279 -2.467 0 O-C-N 123.657 0.598 . . . . 75.1 110.629 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -105.33 120.58 41.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.229 -1.396 . . . . 73.21 107.229 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.298 -1.647 0 O-C-N 125.167 1.542 . . . . 63.03 106.87 178.842 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 25.7 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.134 0.492 . . . . 65.53 111.04 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -113.86 62.55 0.65 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.104 -0.702 . . . . 73.21 109.104 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 25.0 ptt180 -155.58 160.25 30.99 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.347 -0.983 . . . . 75.33 108.347 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' ARG . 11.9 Cg_exo -28.63 119.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 126.053 4.502 . . . . 70.13 116.341 -176.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t70 65.33 -37.24 0.23 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 127.605 2.362 . . . . 74.23 113.912 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 47' ' ' VAL . 92.4 mt-30 -68.76 -19.96 64.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.305 0.574 . . . . 71.22 110.123 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 39' ' ' MET . . . -64.1 -24.48 67.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.303 -0.862 . . . . 53.1 109.988 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HB3' ' HG3' ' A' ' 107' ' ' PRO . 89.2 mttt -86.1 -25.0 26.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.019 -0.734 . . . . 63.21 109.019 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 44' ' ' GLN . 58.0 t -74.25 -44.26 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-N 115.493 -0.776 . . . . 74.45 109.814 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.3 t -65.7 -36.04 82.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.063 -0.971 . . . . 63.13 111.512 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 m -74.21 -35.79 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 C-N-CA 119.917 -0.713 . . . . 73.1 109.74 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -65.24 -32.9 74.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.932 -0.576 . . . . 64.1 110.378 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 73.7 mmtt -65.63 -25.9 67.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.431 0.634 . . . . 73.34 110.293 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.59 -31.52 18.44 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 110.595 -1.002 . . . . 55.44 110.595 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 57' ' ' ILE . 77.2 m-20 -76.53 -33.8 58.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.915 0.388 . . . . 55.24 110.323 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -67.11 -35.81 75.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.954 -0.387 . . . . 64.02 109.954 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -66.78 -30.7 70.97 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 120.878 0.371 . . . . 75.3 110.665 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.35 -45.39 88.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.338 -0.846 . . . . 72.55 110.046 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 125' ' ' LEU . 64.2 mt -64.81 -38.66 83.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 CA-C-N 115.267 -0.879 . . . . 73.34 110.161 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.48 68.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.999 0.428 . . . . 62.52 111.498 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.83 -33.21 27.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.566 0.698 . . . . 73.33 109.727 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.07 35.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.668 -0.697 . . . . 73.43 111.108 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.12 -30.35 71.28 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.778 -1.193 . . . . 75.14 107.778 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 18.9 t70 -73.71 -24.62 59.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.527 -0.76 . . . . 64.52 110.084 174.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.9 mtm -78.56 -25.77 45.45 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.789 -0.569 . . . . 74.15 110.465 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.465 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 31.1 t80 -72.04 -40.31 68.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.545 -1.65 . . . . 72.24 106.545 170.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 31.7 tttm -54.25 -37.29 64.5 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.307 -0.86 . . . . 65.11 110.354 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -73.01 -36.49 67.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.612 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.1 t70 -71.65 -23.46 61.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.327 0.651 . . . . 71.21 112.192 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -128.48 20.29 6.18 Favored 'General case' 0 CA--C 1.457 -2.625 0 O-C-N 121.941 -0.474 . . . . 75.13 110.089 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.3 p90 42.9 31.65 0.34 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.118 1.511 . . . . 73.41 112.63 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.12 161.99 0.46 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.378 -1.341 . . . . 70.02 107.378 -171.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -74.67 158.96 84.31 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 112.746 0.647 . . . . 75.43 112.746 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.568 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 49.1 Cg_endo -72.69 159.27 49.01 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 123.164 2.576 . . . . 63.42 109.776 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.482 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 70.5 p -90.43 156.26 18.34 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.442 -1.318 . . . . 73.12 107.442 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.646 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 3.2 t -65.86 -17.78 64.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 119.767 1.167 . . . . 75.43 111.232 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.65 -65.9 0.94 Allowed 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.082 -0.387 . . . . 72.4 111.706 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.445 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.3 mm-40 -81.3 -32.63 33.04 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 120.959 -0.296 . . . . 74.23 111.573 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.68 -20.85 79.37 Favored Glycine 0 N--CA 1.408 -3.188 0 C-N-CA 118.958 -1.591 . . . . 71.44 112.712 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.81 -46.41 68.71 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.484 -1.672 . . . . 73.41 106.484 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.16 -14.74 62.37 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 114.718 -1.128 . . . . 74.05 111.044 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.632 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -89.84 -8.68 51.44 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.332 0.587 . . . . 61.31 110.16 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.539 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 88.9 mt -93.08 -22.68 18.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.841 -0.618 . . . . 65.03 109.634 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.31 -34.96 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 115.885 -0.598 . . . . 63.31 111.545 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 1.8 tpmt? -122.84 151.23 41.89 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.314 -1.736 . . . . 75.22 106.314 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -53.67 137.04 53.65 Favored Pre-proline 0 N--CA 1.49 1.542 0 CA-C-N 119.058 0.844 . . . . 73.34 111.636 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.564 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 17.9 Cg_endo -55.41 137.67 78.06 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 124.558 3.505 . . . . 73.11 117.071 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 p -89.74 -179.66 5.81 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 112.927 -1.942 . . . . 70.45 107.558 173.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 -131.15 13.22 Favored Glycine 0 C--O 1.249 1.042 0 C-N-CA 119.72 -1.229 . . . . 62.23 110.423 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -135.93 89.98 19.81 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 112.372 0.508 . . . . 65.31 112.372 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.95 163.25 3.28 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.784 2.323 . . . . 70.11 109.523 172.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -99.86 158.63 31.75 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 108.477 -0.934 . . . . 75.24 108.477 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.83 99.28 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.038 1.826 . . . . 72.03 110.622 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . 12.7 tmtt? -151.49 147.39 26.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.025 -1.472 . . . . 75.04 107.025 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.554 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 38.1 m-80 -63.34 89.52 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.025 0.75 . . . . 74.11 113.025 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.564 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 84.1 t90 -66.08 144.6 56.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.763 1.625 . . . . 73.33 111.326 175.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.53 130.39 52.36 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.359 -0.608 . . . . 63.1 109.359 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.448 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 62.5 pttt -83.3 -171.55 3.64 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.465 -0.894 . . . . 65.45 108.723 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.1 t0 66.27 28.72 9.86 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.243 1.021 . . . . 75.41 108.829 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 91.57 9.13 63.28 Favored Glycine 0 CA--C 1.473 -2.535 0 CA-C-N 114.021 -1.445 . . . . 62.33 114.114 167.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.7 OUTLIER 61.61 79.46 0.25 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.667 -1.234 . . . . 64.22 107.667 -172.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.5 tt -124.55 152.3 43.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.678 -1.601 . . . . 71.14 106.678 -171.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.72 179.71 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.675 -0.861 . . . . 62.24 108.675 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -80.66 67.08 6.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.386 1.088 . . . . 74.14 113.738 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.66 147.6 61.41 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 105.548 -2.019 . . . . 54.44 105.548 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.81 -168.84 0.25 Allowed 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.24 1.96 . . . . 75.12 112.139 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.555 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.37 173.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.687 -1.597 . . . . 74.11 106.687 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.9 p-10 -79.59 157.45 74.7 Favored Pre-proline 0 C--O 1.252 1.228 0 CA-C-N 119.155 0.889 . . . . 62.24 112.723 -170.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HG3' ' HB3' ' A' ' 46' ' ' LYS . 10.3 Cg_endo -54.12 171.2 0.39 Allowed 'Trans proline' 0 C--O 1.201 -1.352 0 C-N-CA 123.571 2.848 . . . . 63.34 111.939 173.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 65.09 15.02 9.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.997 1.319 . . . . 65.23 109.559 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.73 27.87 64.7 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.234 -1.348 . . . . 74.2 114.804 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.49 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 4.5 m-80 -89.64 151.16 45.47 Favored Pre-proline 0 C--O 1.257 1.455 0 CA-C-N 119.24 1.52 . . . . 73.03 108.459 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.555 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 62.9 Cg_endo -82.14 144.91 13.54 Favored 'Trans proline' 0 N--CA 1.411 -3.379 0 N-CA-C 108.28 -1.469 . . . . 72.44 108.28 165.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 68.9 m-85 -67.28 143.01 56.68 Favored 'General case' 0 C--O 1.253 1.286 0 N-CA-C 106.535 -1.654 . . . . 73.23 106.535 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -101.2 114.47 28.46 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.167 -1.79 . . . . 72.21 106.167 -175.226 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -98.69 119.04 36.75 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.972 -1.122 . . . . 75.43 107.972 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.0 mt -128.46 153.14 47.44 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.463 -1.31 . . . . 71.01 107.463 175.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.791 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -124.89 -179.05 0.77 Allowed Pre-proline 0 N--CA 1.395 -3.178 0 N-CA-C 107.605 -1.257 . . . . 73.32 107.605 -175.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.791 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 43.6 Cg_endo -64.23 132.06 32.55 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 121.512 1.474 . . . . 73.11 114.092 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.95 -67.47 0.02 OUTLIER Glycine 0 N--CA 1.425 -2.054 0 CA-C-N 114.471 -1.24 . . . . 74.05 111.484 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.3 p -95.6 95.89 8.67 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 122.653 -0.322 . . . . 75.25 110.179 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.41 21.69 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.366 1.617 . . . . 75.21 115.366 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.36 138.06 9.94 Favored Glycine 0 CA--C 1.466 -3.005 0 CA-C-O 118.871 -0.961 . . . . 61.52 113.528 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 147' ' ' ASP . 44.0 Cg_exo -64.26 -28.14 63.99 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.522 3.481 . . . . 74.14 111.99 165.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.5 p90 176.0 164.9 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.409 0.684 . . . . 44.22 110.024 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 32.6 m-20 -139.64 123.07 17.17 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.537 -0.542 . . . . 72.21 109.537 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.569 HD11 HD12 ' A' ' 57' ' ' ILE . 3.4 tm? -130.66 124.66 32.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.423 -0.954 . . . . 42.33 108.423 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 44.3 p90 -167.4 168.11 13.34 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-O 119.505 -0.284 . . . . 72.24 110.914 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -126.25 156.57 40.09 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.77 0.828 . . . . 74.44 109.636 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.16 151.59 46.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.418 -0.355 . . . . 64.14 111.363 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.28 -178.86 45.79 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.443 -0.884 . . . . 72.24 112.21 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.96 25.96 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.2 1.185 . . . . 61.11 114.2 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -94.48 -9.99 33.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.986 -0.685 . . . . 74.25 111.241 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.47 4.87 72.96 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.827 -0.909 . . . . 63.51 110.827 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -99.69 144.03 29.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.654 -0.869 . . . . 64.5 108.654 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -100.7 105.07 16.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.949 -1.13 . . . . 75.4 107.949 172.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.27 -173.55 20.63 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.079 -0.808 . . . . 54.25 111.079 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.77 127.63 9.27 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 108.312 -1.915 . . . . 62.11 108.312 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.414 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 30.4 m 179.53 -177.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 125.904 1.682 . . . . 73.34 107.53 -170.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.43 -72.96 0.45 Allowed 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.644 -0.822 . . . . 73.51 111.043 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -95.84 -14.65 23.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.01 0.433 . . . . 72.52 111.543 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -97.49 5.47 49.59 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.383 0.611 . . . . 71.33 110.353 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -88.23 156.96 18.93 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.329 -0.85 . . . . 74.01 112.597 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 11.3 p-10 -78.76 112.94 16.41 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.45 -1.685 . . . . 74.13 106.45 172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 119.06 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.083 0 CA-C-N 114.939 -1.028 . . . . 63.22 111.451 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -169.96 -179.2 41.45 Favored Glycine 0 N--CA 1.41 -3.043 0 C-N-CA 119.612 -1.28 . . . . 62.11 112.859 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.0 149.46 28.9 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.9 -1.518 . . . . 70.53 106.9 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.464 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 4.1 p90 -170.19 178.38 3.86 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.334 0.588 . . . . 73.31 110.19 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 36.1 t70 -118.3 137.02 53.35 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.511 -1.663 . . . . 63.52 106.511 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.484 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 3.7 p-10 . . . . . 0 C--O 1.253 1.24 0 O-C-N 124.586 1.179 . . . . 65.22 109.013 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 107.566 -1.272 . . . . 72.23 107.566 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -119.78 88.97 3.04 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.026 0.75 . . . . 64.31 113.026 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 16.3 ptp180 -156.29 170.73 8.36 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.191 -1.781 . . . . 73.32 106.191 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 41' ' ' ARG . 54.4 Cg_exo -43.1 125.57 4.28 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 123.434 2.756 . . . . 62.2 113.838 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.1 -33.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.61 1.564 . . . . 42.11 113.346 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.628 HE22 ' HB3' ' A' ' 138' ' ' ASP . 14.9 mm100 -73.23 -28.93 62.44 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.709 -0.478 . . . . 75.22 109.709 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.01 72.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.008 -0.738 . . . . 75.23 109.008 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 107' ' ' PRO . 65.3 mttm -74.7 -25.28 59.04 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.161 -0.927 . . . . 53.13 109.889 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 56.5 t -75.29 -44.57 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 71.0 109.09 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -73.62 -31.94 63.81 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.446 -0.797 . . . . 62.13 112.102 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -71.74 -36.17 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 119.404 -0.918 . . . . 51.44 109.034 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -65.16 -31.67 72.97 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.344 -0.844 . . . . 71.31 111.251 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 31.5 mmmt -64.86 -25.75 68.03 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.239 0.542 . . . . 73.44 110.549 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.79 -33.5 15.58 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.953 -0.859 . . . . 44.21 110.953 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 56' ' ' ALA 0.263 19.8 m-20 -81.13 -26.35 36.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.377 0.88 . . . . 74.05 113.377 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.96 -31.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.867 -0.79 . . . . 72.14 108.867 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -70.41 -25.91 63.44 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.212 -0.662 . . . . 73.01 109.212 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -67.05 -47.3 71.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.087 -0.961 . . . . 63.0 109.868 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.444 HG12 HD13 ' A' ' 100' ' ' LEU . 70.2 mt -60.84 -45.75 97.49 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.085 -0.961 . . . . 70.24 109.621 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.81 57.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.009 -0.541 . . . . 72.01 112.379 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.36 -39.6 16.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.879 0.371 . . . . 33.43 110.609 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.42 -28.31 52.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.477 -0.489 . . . . 74.23 110.907 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.86 -26.66 66.14 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.6 -1.259 . . . . 75.12 107.6 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.606 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 t70 -76.12 -21.09 57.03 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.149 -0.932 . . . . 72.35 108.698 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.9 mtt -77.37 -37.44 52.19 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.616 -0.678 . . . . 75.51 109.465 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 73.4 t80 -61.98 -37.34 84.42 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.994 -1.113 . . . . 71.15 107.994 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.6 tttt -54.47 -39.47 67.52 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 114.638 -1.165 . . . . 65.35 109.796 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.449 ' HB3' ' HE3' ' A' ' 92' ' ' LYS . 4.5 mm? -80.64 -30.45 36.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.358 0.873 . . . . 53.32 113.358 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -71.14 -24.95 62.37 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.388 0.614 . . . . 73.41 110.873 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.4 23.15 5.96 Favored 'General case' 0 CA--C 1.454 -2.736 0 O-C-N 121.372 -0.83 . . . . 74.14 111.669 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 42.58 32.82 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.448 1.499 . . . . 64.34 113.67 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.34 151.41 0.27 Allowed 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.608 -0.886 . . . . 62.12 108.608 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.645 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 21.2 m-85 -74.79 152.55 87.0 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 123.266 0.354 . . . . 72.41 110.271 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 32.7 Cg_endo -62.01 164.9 15.56 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.562 2.841 . . . . 65.21 112.557 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.404 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 58.2 p -102.46 154.98 18.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.614 -1.995 . . . . 64.44 105.614 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.464 ' N ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.07 -8.21 43.1 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 119.312 0.96 . . . . 74.43 110.614 -175.055 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.4 mp0 -102.37 -67.02 0.89 Allowed 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 116.046 -0.524 . . . . 72.33 109.996 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -77.95 -39.56 42.24 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 121.958 -0.464 . . . . 75.24 110.652 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.617 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.73 -21.03 77.59 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 118.675 -1.726 . . . . 65.33 113.157 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 tt -68.0 -49.06 63.83 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.257 -1.386 . . . . 73.51 107.257 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 17.9 mt-10 -68.03 -26.69 66.01 Favored 'General case' 0 C--O 1.166 -3.302 0 CA-C-N 114.767 -1.106 . . . . 70.23 111.386 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.539 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -79.18 -7.69 58.41 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.31 0.576 . . . . 55.12 111.35 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 81.7 mt -93.28 -22.72 18.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.788 -0.642 . . . . 60.54 109.604 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.45 -38.3 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 116.134 -0.485 . . . . 74.51 112.056 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 57.0 pttt -119.01 151.25 38.54 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.673 -1.603 . . . . 72.35 106.673 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -55.19 130.82 68.79 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 122.754 0.422 . . . . 60.32 110.373 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 30.6 Cg_endo -58.88 124.22 15.23 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.554 2.836 . . . . 65.31 112.493 -173.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.2 p -83.27 116.08 22.26 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.652 -0.704 . . . . 73.01 110.487 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.43 -136.46 6.73 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.889 -1.684 . . . . 74.04 108.889 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -133.91 94.12 19.2 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 117.296 0.548 . . . . 63.11 111.481 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.27 162.65 17.5 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 123.007 2.471 . . . . 53.35 108.868 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -93.4 108.59 34.66 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 108.823 -0.806 . . . . 62.33 108.823 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -29.08 98.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.254 1 C-N-CA 125.857 4.372 . . . . 64.41 117.643 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 66' ' ' LEU . 54.9 mttm -138.77 149.48 45.05 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 125.971 1.708 . . . . 72.33 107.562 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.59 92.12 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.336 -0.393 . . . . 71.2 110.628 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.589 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 86.2 t90 -65.65 143.02 57.84 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 115.608 -0.724 . . . . 74.21 110.102 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -135.38 133.14 38.39 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.534 -0.757 . . . . 70.12 109.038 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -78.28 -171.53 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.327 -0.99 . . . . 74.53 108.327 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t0 66.89 25.25 9.52 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 122.189 0.995 . . . . 63.45 109.266 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 90.56 12.85 60.52 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 114.311 -1.313 . . . . 55.21 113.643 170.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.589 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.1 m-85 62.26 81.26 0.2 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.701 1.238 . . . . 73.05 107.811 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 57' ' ' ILE . 64.0 tp -128.72 172.24 11.44 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.807 -1.542 . . . . 64.1 108.926 -171.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 35.1 mmtp -77.29 -172.67 2.54 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.743 -1.206 . . . . 70.13 107.743 172.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -87.1 63.94 8.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.877 1.322 . . . . 72.22 108.966 177.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.405 HD12 ' HD2' ' A' ' 104' ' ' PRO . 28.9 tp -115.6 142.45 28.91 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.159 -1.837 . . . . 73.11 110.711 -172.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.405 ' HD2' HD12 ' A' ' 103' ' ' LEU . 26.4 Cg_exo -68.37 -167.17 0.17 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.393 2.728 . . . . 75.02 110.826 170.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.722 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.83 173.17 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 109.114 -0.698 . . . . 71.21 109.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.538 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.6 t70 -80.73 161.57 63.38 Favored Pre-proline 0 C--O 1.255 1.35 0 N-CA-C 108.553 -0.906 . . . . 72.11 108.553 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 72.1 Cg_exo -47.24 170.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.067 2.511 . . . . 74.3 114.258 172.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.453 ' CG ' ' HA ' ' A' ' 130' ' ' ALA . 1.7 m-90 65.79 14.27 9.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.928 2.091 . . . . 74.51 111.034 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.52 -6.71 15.54 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.86 -0.609 . . . . 63.32 114.043 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.89 133.94 88.04 Favored Pre-proline 0 C--O 1.258 1.534 0 N-CA-C 113.019 0.748 . . . . 54.51 113.019 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.722 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 72.0 Cg_endo -75.58 145.86 29.99 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.659 2.239 . . . . 71.0 112.098 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -69.7 134.01 48.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.258 -1.386 . . . . 63.22 107.258 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -104.2 113.98 27.9 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.328 -0.851 . . . . 72.01 109.315 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.92 118.24 36.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.663 -1.606 . . . . 74.21 106.663 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.1 mt -128.82 153.59 47.28 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.687 -1.227 . . . . 72.24 107.687 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.676 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.77 -178.58 0.57 Allowed Pre-proline 0 N--CA 1.404 -2.745 0 CA-C-O 116.589 -1.672 . . . . 54.24 107.672 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.676 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 12.4 Cg_endo -47.12 108.86 0.18 Allowed 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 123.005 2.47 . . . . 71.2 115.488 -162.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.55 -89.65 0.6 Allowed Glycine 0 N--CA 1.414 -2.788 0 CA-C-N 113.862 -1.517 . . . . 64.03 112.03 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 m -112.73 96.87 6.21 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 110.231 -0.285 . . . . 73.3 110.231 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 69.59 -1.5 2.24 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.999 1.319 . . . . 71.43 113.13 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -121.22 125.21 6.09 Favored Glycine 0 N--CA 1.428 -1.898 0 CA-C-O 118.374 -1.237 . . . . 72.1 113.0 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.544 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 13.4 Cg_exo -37.85 -26.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 127.299 5.332 . . . . 62.34 118.559 -178.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.261 40.3 p90 -169.32 147.08 3.63 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.353 0.979 . . . . 75.11 113.12 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.6 m-20 -112.47 109.83 19.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.281 -1.327 . . . . 74.42 107.441 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.489 ' O ' ' HA3' ' A' ' 144' ' ' GLY . 3.2 tm? -124.7 129.93 51.44 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.957 -0.697 . . . . 71.13 109.655 -176.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.409 ' HA ' ' HA3' ' A' ' 144' ' ' GLY . 55.7 p90 -167.81 164.59 14.17 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 112.442 0.534 . . . . 72.34 112.442 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -125.8 136.67 53.38 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.386 -2.449 . . . . 51.33 104.386 166.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.88 154.27 12.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.483 0.659 . . . . 65.31 112.392 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.43 173.31 40.38 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.894 -1.048 . . . . 75.52 113.902 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.453 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -48.36 -28.81 3.41 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 116.732 2.123 . . . . 75.21 116.732 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.26 -7.37 42.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.447 0.567 . . . . 72.42 111.397 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.43 28.31 25.09 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.495 -0.86 . . . . 71.34 112.439 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -127.65 138.63 52.88 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.634 -0.876 . . . . 73.54 108.634 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.39 105.38 7.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.617 0.722 . . . . 72.13 109.741 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.41 -174.4 22.2 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.812 -0.709 . . . . 71.54 113.873 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -116.79 128.66 8.01 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.363 -1.495 . . . . 34.23 109.363 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 38.8 m -178.26 -177.36 0.58 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 125.758 1.623 . . . . 75.55 108.196 -170.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.628 ' HB3' HE22 ' A' ' 44' ' ' GLN . 2.8 m-20 -74.38 -73.25 0.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.877 -0.515 . . . . 70.34 110.53 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -98.44 -6.96 29.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.188 0.518 . . . . 72.45 111.718 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -100.54 9.34 42.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.335 0.588 . . . . 71.5 110.917 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -86.11 157.78 19.95 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.813 -0.631 . . . . 60.4 111.162 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.73 112.33 13.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.931 -1.877 . . . . 63.02 105.931 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.597 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.32 123.45 48.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.472 0.653 . . . . 72.41 111.067 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -175.11 177.24 47.17 Favored Glycine 0 N--CA 1.413 -2.869 0 N-CA-C 110.155 -1.178 . . . . 72.34 110.155 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -103.36 162.92 12.6 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.136 -1.802 . . . . 70.35 106.136 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -143.64 124.7 14.43 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.119 -1.067 . . . . 75.24 108.119 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -111.58 112.38 24.05 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.899 -1.519 . . . . 75.43 106.899 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.416 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 4.7 p-10 . . . . . 0 C--N 1.293 -1.88 0 N-CA-C 109.413 -0.588 . . . . 71.14 109.413 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.491 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.8 mpt? . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.358 -0.608 . . . . 73.13 109.358 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -118.12 84.62 2.2 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.82 0.819 . . . . 74.52 110.501 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 99.1 mtt180 -153.07 165.78 16.88 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 106.292 -1.744 . . . . 65.44 106.292 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.94 130.25 38.32 Favored 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 122.515 2.143 . . . . 63.31 111.422 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' VAL . 33.5 m-20 72.85 -31.67 0.23 Allowed 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 125.393 1.477 . . . . 70.21 113.597 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 13.9 mm100 -68.93 -32.59 72.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.955 -0.757 . . . . 73.5 108.955 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.63 -17.89 64.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 74.44 110.747 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 57.0 mttp -89.44 -24.66 21.82 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.156 -0.683 . . . . 73.41 109.156 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 43' ' ' ASP . 59.5 t -75.0 -43.93 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.913 0.863 . . . . 73.54 108.698 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -64.65 -28.11 69.39 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.227 -1.351 . . . . 72.14 111.762 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.16 -37.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 119.597 -0.841 . . . . 73.53 110.146 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.677 -0.692 . . . . 62.41 110.667 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.505 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 55.0 mtpt -68.53 -22.47 64.51 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 121.379 0.609 . . . . 65.42 111.749 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.56 -31.1 46.63 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.618 -1.393 . . . . 73.11 109.618 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.6 m-20 -76.08 -31.15 58.6 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.223 -0.489 . . . . 72.41 111.359 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.417 HG21 ' HA2' ' A' ' 144' ' ' GLY . 14.3 pt -66.89 -30.82 50.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 C-N-CA 120.373 -0.531 . . . . 71.44 109.879 173.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 14.2 mptt -67.17 -31.83 72.51 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 120.075 -0.65 . . . . 74.51 109.984 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.4 71.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 44.53 110.83 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.561 HG12 HD13 ' A' ' 100' ' ' LEU . 44.1 mt -62.75 -43.15 98.49 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 116.013 -0.539 . . . . 74.24 109.715 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -22.72 66.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.02 0.438 . . . . 72.44 111.681 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 -33.96 20.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.397 0.618 . . . . 65.13 109.951 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' TYR . . . -81.9 -27.48 33.38 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.155 -0.475 . . . . 73.35 110.552 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.28 -30.33 71.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 106.927 -1.508 . . . . 71.42 106.927 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 20.0 t70 -73.92 -17.21 61.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.705 -1.134 . . . . 65.12 109.21 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.8 mtm -84.01 -32.17 25.08 Favored 'General case' 0 C--O 1.204 -1.307 0 O-C-N 121.638 -0.664 . . . . 71.24 109.428 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -63.61 -35.47 80.61 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.17 -1.789 . . . . 64.54 106.17 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 60.5 tttp -58.12 -38.01 75.69 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 115.594 -0.73 . . . . 70.41 110.569 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 tp -74.73 -36.22 62.66 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.492 0.663 . . . . 73.23 109.667 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 13.8 t70 -74.37 -24.55 59.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.188 -0.914 . . . . 74.14 111.772 -174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 89' ' ' PRO . 2.5 m-20 -128.54 22.84 5.92 Favored 'General case' 0 CA--C 1.455 -2.699 0 O-C-N 121.549 -0.719 . . . . 73.13 110.62 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 42.44 31.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.501 1.52 . . . . 65.42 112.822 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.64 161.43 0.52 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.873 -1.158 . . . . 71.22 107.873 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.653 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 19.7 m-85 -75.74 155.07 85.27 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 123.301 0.376 . . . . 73.14 111.872 174.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 37.0 Cg_endo -66.7 157.8 59.22 Favored 'Trans proline' 0 C--O 1.211 -0.849 0 C-N-CA 122.693 2.262 . . . . 72.3 110.391 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 p -94.37 155.55 16.93 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 107.119 -1.437 . . . . 74.44 107.119 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.659 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -72.79 -4.54 32.2 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.013 1.279 . . . . 72.53 111.257 -176.361 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -102.75 -66.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 120.113 -0.635 . . . . 51.45 110.241 169.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -74.94 -45.99 38.68 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.531 -0.544 . . . . 71.31 109.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -72.16 -19.97 78.83 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 120.322 -0.942 . . . . 73.52 113.775 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tt -73.17 -48.66 33.4 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 107.841 -1.17 . . . . 72.43 107.841 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.53 -37.13 82.61 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 108.323 -0.991 . . . . 72.22 108.323 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -77.89 -5.61 51.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.041 0.756 . . . . 63.31 113.041 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.53 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 15.3 tp -94.43 -23.47 17.73 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.38 -0.97 . . . . 53.42 108.38 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.28 -38.78 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.924 -1.034 . . . . 63.52 110.562 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 43.8 tttm -124.06 150.69 44.68 Favored 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 126.598 1.959 . . . . 72.44 107.17 -174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -54.11 141.66 49.5 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 113.242 0.83 . . . . 74.23 113.242 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 7.7 Cg_endo -45.15 136.47 10.67 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 125.104 3.87 . . . . 54.34 115.992 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -101.41 -11.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.63 -1.168 . . . . 51.45 108.989 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.84 -148.62 24.07 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.949 -0.861 . . . . 52.43 110.949 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -117.12 101.16 53.34 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-O 121.555 0.693 . . . . 75.13 111.345 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.431 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 95.6 Cg_endo -99.71 162.82 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.772 2.981 . . . . 74.41 112.447 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -87.54 159.04 50.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.822 -1.177 . . . . 74.21 107.822 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.75 98.42 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.612 1.541 . . . . 74.22 112.904 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 2.3 mptp? -150.05 148.12 28.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.008 1.723 . . . . 35.33 106.46 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.57 98.01 5.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.004 0.431 . . . . 61.32 111.034 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.635 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 85.5 t90 -54.73 144.18 23.01 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.349 1.86 . . . . 73.14 113.042 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -116.65 135.33 53.88 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.526 1.13 . . . . 75.14 109.221 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -82.39 178.7 8.1 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 122.09 0.947 . . . . 74.4 110.909 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 55.63 45.92 23.76 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.894 -1.957 . . . . 65.12 111.905 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.53 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 105.7 -10.19 45.09 Favored Glycine 0 CA--C 1.477 -2.336 0 CA-C-N 114.427 -1.26 . . . . 62.05 114.856 163.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.635 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 64.55 96.15 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 122.182 0.991 . . . . 71.45 109.63 -171.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.561 HD13 HG12 ' A' ' 57' ' ' ILE . 59.3 tp -138.79 170.04 16.71 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.697 -1.138 . . . . 73.25 107.937 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.82 -170.32 2.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.747 -1.575 . . . . 64.35 106.747 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.71 75.91 10.27 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.606 -0.837 . . . . 71.13 109.996 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -130.85 147.85 67.86 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.379 -1.282 . . . . 74.04 108.753 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.59 178.01 7.26 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.538 2.159 . . . . 72.41 112.806 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 111' ' ' PRO . 3.9 p -85.5 175.75 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.716 -0.846 . . . . 73.41 108.716 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.8 p-10 -78.65 158.2 76.1 Favored Pre-proline 0 C--O 1.251 1.184 0 CA-C-N 119.381 0.991 . . . . 74.34 113.132 -170.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 7.8 Cg_endo -54.52 171.07 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.266 2.644 . . . . 73.41 112.654 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.52 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 3.1 m-90 64.01 14.69 8.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.559 1.544 . . . . 74.34 108.856 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.46 38.33 79.5 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 114.026 -1.443 . . . . 73.02 115.167 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.521 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 13.2 m-80 -91.68 146.32 32.88 Favored Pre-proline 0 C--O 1.266 1.924 0 CA-C-N 119.954 1.877 . . . . 73.35 108.898 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.528 ' HA ' HG21 ' A' ' 105' ' ' VAL . 36.6 Cg_endo -89.35 137.83 3.12 Favored 'Trans proline' 0 N--CA 1.428 -2.377 0 C-N-CA 122.053 1.835 . . . . 63.33 109.565 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 59.2 m-85 -68.04 143.41 55.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.883 0.373 . . . . 74.35 110.601 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.524 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -102.67 117.34 34.46 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.112 -1.44 . . . . 73.14 107.112 -176.261 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -104.14 120.65 41.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.876 -0.416 . . . . 73.13 109.876 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 92.6 mt -127.98 153.56 46.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.452 -0.573 . . . . 73.43 109.452 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.756 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.63 -176.61 0.41 Allowed Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 116.567 -1.683 . . . . 44.11 107.306 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.5 Cg_endo -49.89 115.96 2.13 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.383 2.055 . . . . 71.12 114.707 -169.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -107.0 -84.53 1.7 Allowed Glycine 0 N--CA 1.424 -2.163 0 CA-C-N 114.205 -1.361 . . . . 51.42 111.664 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.1 m -103.55 96.47 6.75 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.404 -0.961 . . . . 71.3 108.404 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.43 12.05 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.606 1.962 . . . . 74.35 116.12 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -126.7 131.28 7.27 Favored Glycine 0 C--O 1.202 -1.894 0 C-N-CA 119.38 -1.39 . . . . 61.03 113.632 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.577 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 32.4 Cg_exo -40.3 -23.98 0.13 Allowed 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 126.782 4.988 . . . . 64.3 117.731 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.516 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 51.3 p90 -176.64 163.8 2.4 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 118.351 0.523 . . . . 73.32 109.682 176.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 146' ' ' TRP . 23.9 m-20 -139.86 118.45 12.28 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 124.279 0.987 . . . . 53.13 108.792 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . 0.26 4.4 pp -143.27 138.24 29.45 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.283 -1.367 . . . . 62.41 112.649 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 39.5 p90 -165.46 167.06 17.93 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.871 -1.059 . . . . 75.41 108.332 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.657 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 8.7 t -125.79 157.35 37.73 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.849 -1.167 . . . . 74.45 107.849 172.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.524 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 91.3 mt -67.33 154.13 42.05 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.835 0.709 . . . . 73.12 111.185 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.22 -164.58 21.89 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.342 -0.932 . . . . 71.22 114.16 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.9 -16.85 32.72 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.758 1.022 . . . . 75.2 113.758 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -106.29 1.55 26.01 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.625 0.726 . . . . 74.22 110.026 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 43.16 99.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.1 -0.8 . . . . 43.44 111.1 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 134' ' ' GLU . 8.8 tmtt? -141.15 147.16 37.99 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.231 -1.396 . . . . 72.31 107.231 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.72 106.55 18.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.795 0.807 . . . . 62.12 111.426 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.64 -178.85 24.97 Favored Glycine 0 C--N 1.291 -1.963 0 N-CA-C 110.722 -0.951 . . . . 15.51 110.722 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.89 127.09 8.81 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.468 -1.853 . . . . 45.32 108.468 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.491 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 53.3 m 179.28 -177.48 0.31 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.775 1.63 . . . . 64.11 107.507 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.96 -74.68 0.35 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.874 0.368 . . . . 63.34 110.638 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -94.0 -16.67 23.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.024 0.44 . . . . 65.25 111.086 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.99 3.95 53.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.56 0.695 . . . . 71.24 109.9 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.491 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -97.98 157.05 16.34 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 115.211 -0.904 . . . . 71.54 111.175 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.34 134.74 37.43 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.735 -1.209 . . . . 72.15 107.735 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.541 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -107.21 121.33 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 115.335 -0.848 . . . . 44.32 111.633 -175.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 126' ' ' TYR . . . -167.05 177.32 41.75 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 118.727 -1.702 . . . . 35.21 114.279 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.511 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -156.56 157.08 34.71 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.627 -0.786 . . . . 72.02 109.357 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.516 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 4.9 p90 -163.08 177.1 9.41 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.529 0.518 . . . . 75.2 111.204 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 122' ' ' PRO . 35.3 t70 -120.02 130.79 54.89 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.186 -1.783 . . . . 74.23 106.186 175.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.41 ' HA ' ' CA ' ' A' ' 121' ' ' GLY . 4.1 p-10 . . . . . 0 C--N 1.296 -1.728 0 O-C-N 124.387 1.054 . . . . 71.25 110.316 -174.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.646 ' N ' ' HG1' ' A' ' 48' ' ' THR . 2.0 mpt? . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 110.611 -0.144 . . . . 74.51 110.611 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -103.07 77.91 1.6 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.293 0.568 . . . . 74.25 112.342 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -155.43 158.93 32.03 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 107.203 -1.406 . . . . 72.12 107.203 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.92 143.93 69.8 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.277 1.985 . . . . 74.02 110.716 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 75.06 -52.25 0.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.85 1.26 . . . . 64.43 110.96 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 86.6 mt-30 -68.48 -17.96 64.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 70.32 110.601 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.42 -27.11 68.86 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.529 -0.759 . . . . 74.1 110.018 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.74 -25.04 24.9 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.523 -0.547 . . . . 63.51 109.523 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 92.3 t -74.09 -43.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.587 -0.733 . . . . 63.1 109.112 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.646 ' HG1' ' N ' ' A' ' 39' ' ' MET . 5.8 t -68.18 -29.84 68.81 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.056 -0.975 . . . . 71.32 111.504 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.0 t -76.36 -47.69 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.935 -0.395 . . . . 74.42 109.935 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.398 -0.819 . . . . 64.25 111.498 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 47.6 mtpt -67.4 -23.57 65.57 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.239 -0.584 . . . . 63.21 112.316 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.78 -37.68 38.74 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.896 -1.145 . . . . 71.32 110.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 m-20 -77.34 -24.16 50.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.426 -0.51 . . . . 75.45 111.813 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 51' ' ' LYS . 15.5 pt -72.69 -27.26 25.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.084 -0.646 . . . . 63.24 110.842 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 2.0 mptm? -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.49 -0.884 . . . . 73.45 109.58 173.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.53 -42.38 92.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.327 -0.851 . . . . 63.31 109.86 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 53' ' ' ASP . 73.7 mt -62.99 -34.29 65.57 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.655 -0.702 . . . . 64.23 110.111 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.03 -31.3 70.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.846 0.355 . . . . 75.11 110.766 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.51 42.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.261 0.553 . . . . 63.04 109.849 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.99 35.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.009 -0.541 . . . . 74.34 110.155 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -30.01 68.67 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.982 -1.488 . . . . 73.44 106.982 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 65' ' ' LYS . 17.3 t70 -68.67 -29.01 67.38 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.111 -0.949 . . . . 64.44 109.963 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -71.99 -36.21 69.71 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.46 -0.496 . . . . 72.23 109.668 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -70.28 -38.03 74.96 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 107.794 -1.188 . . . . 75.34 107.794 174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 29.2 tttm -54.21 -35.89 62.9 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.646 -0.706 . . . . 71.33 110.661 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.37 -33.91 32.06 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.596 -0.274 . . . . 72.23 111.62 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.71 -24.25 62.61 Favored 'General case' 0 C--O 1.177 -2.76 0 CA-C-O 120.545 0.212 . . . . 74.11 111.1 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -127.01 18.66 7.14 Favored 'General case' 0 CA--C 1.463 -2.401 0 O-C-N 120.778 -1.202 . . . . 71.53 111.428 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.19 32.44 0.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.066 1.346 . . . . 74.25 112.663 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.82 162.11 0.57 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.072 -1.455 . . . . 52.44 107.072 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.404 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.0 m-85 -80.48 155.87 73.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 111.858 0.318 . . . . 74.23 111.858 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.5 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 31.8 Cg_endo -66.03 161.87 37.92 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.048 2.499 . . . . 74.33 110.64 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -97.85 156.61 16.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.301 -1.37 . . . . 42.04 107.301 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.3 t -66.61 -13.79 61.57 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 119.138 0.881 . . . . 74.13 110.94 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 -65.14 1.01 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.448 -0.342 . . . . 62.55 111.33 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -77.41 -33.88 54.88 Favored 'General case' 0 CA--C 1.481 -1.707 0 O-C-N 121.95 -0.468 . . . . 73.1 111.197 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.583 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -76.73 -20.9 75.75 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 118.881 -1.628 . . . . 71.11 112.554 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.78 -49.53 61.91 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 106.069 -1.826 . . . . 75.04 106.069 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.0 -33.59 73.49 Favored 'General case' 0 C--O 1.169 -3.174 0 CA-C-N 114.646 -1.161 . . . . 71.44 110.272 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -80.07 -5.37 55.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.802 0.668 . . . . 64.41 112.802 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 84.6 mt -96.42 -17.8 20.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.192 0.52 . . . . 75.01 109.858 173.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.53 -33.93 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.373 0.606 . . . . 74.23 111.441 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 83.8 tttt -122.67 148.79 44.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 126.357 1.863 . . . . 64.12 106.861 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -56.51 135.56 76.98 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 118.152 0.433 . . . . 71.2 111.157 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 39.7 Cg_endo -63.47 150.75 87.71 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.825 3.017 . . . . 61.31 112.685 -174.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -98.45 146.81 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.618 -0.433 . . . . 74.31 110.557 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.71 -146.39 18.55 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.932 -1.267 . . . . 54.11 109.932 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -126.72 86.43 58.61 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-O 121.663 0.744 . . . . 71.32 111.697 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.17 154.76 16.84 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.975 2.45 . . . . 74.41 111.126 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.2 143.5 65.23 Favored Pre-proline 0 C--O 1.211 -0.927 0 C-N-CA 123.615 0.766 . . . . 61.12 110.087 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.65 100.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.178 3.252 . . . . 74.51 115.017 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -147.31 148.02 30.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.203 -1.777 . . . . 75.22 106.203 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.33 91.58 3.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.484 -0.562 . . . . 74.5 109.484 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.644 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.7 t90 -54.58 138.83 40.07 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 123.969 0.793 . . . . 74.41 111.514 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -126.72 134.4 50.67 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 114.966 -1.016 . . . . 72.13 109.965 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 24.1 pttm -90.95 -176.43 4.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.321 -0.552 . . . . 65.12 109.883 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 72.43 15.59 5.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.137 1.375 . . . . 70.01 109.958 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 110.39 5.17 28.4 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 114.709 -1.132 . . . . 71.14 114.769 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.644 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 67.84 93.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.276 1.036 . . . . 74.02 110.644 -175.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.7 tp -132.6 158.33 42.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.899 -1.046 . . . . 74.41 108.651 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -84.85 -171.76 3.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.419 -0.956 . . . . 54.5 108.419 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -78.61 70.62 4.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.599 1.19 . . . . 74.24 110.504 176.162 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.9 mt -126.83 147.65 62.04 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 114.694 -1.139 . . . . 73.13 109.442 -174.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.63 158.36 53.73 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.634 1.556 . . . . 71.11 109.663 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 111' ' ' PRO . 6.0 p -79.6 175.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.43 -0.581 . . . . 75.42 109.43 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 105' ' ' VAL . 5.8 p-10 -71.38 158.19 88.48 Favored Pre-proline 0 C--O 1.249 1.062 0 N-CA-C 113.375 0.88 . . . . 74.32 113.375 -168.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 10.1 Cg_endo -53.36 169.1 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.679 2.919 . . . . 71.01 112.06 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 64.13 15.27 9.18 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.842 1.257 . . . . 64.34 109.142 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.0 68.43 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 114.266 -1.334 . . . . 42.35 115.152 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.478 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 3.9 m120 -91.78 154.18 43.8 Favored Pre-proline 0 C--O 1.262 1.733 0 CA-C-N 119.927 1.863 . . . . 74.22 109.04 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.576 ' HA ' HG21 ' A' ' 105' ' ' VAL . 1.5 Cg_endo -85.73 152.08 10.08 Favored 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 121.801 1.667 . . . . 70.31 108.365 165.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 70.0 m-85 -69.16 143.96 53.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.907 0.384 . . . . 74.21 110.252 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 1.6 mm100 -101.47 120.86 40.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.48 -1.674 . . . . 71.52 106.48 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.38 118.93 37.95 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 72.03 112.693 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 89.2 mt -130.34 153.71 48.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.669 -0.863 . . . . 71.13 108.669 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -113.5 -177.8 0.47 Allowed Pre-proline 0 C--N 1.297 -1.71 0 CA-C-O 117.055 -1.45 . . . . 71.3 109.284 -176.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.742 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 19.0 Cg_endo -50.08 112.29 0.69 Allowed 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.956 2.437 . . . . 43.24 115.882 -166.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.59 -91.48 1.02 Allowed Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 113.731 -1.577 . . . . 70.43 110.81 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.3 m -106.93 96.81 6.7 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.207 -1.034 . . . . 71.14 108.207 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 68.47 -13.61 0.3 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.507 1.123 . . . . 72.25 113.734 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -102.95 116.64 5.53 Favored Glycine 0 CA--C 1.488 -1.628 0 CA-C-O 118.704 -1.053 . . . . 50.22 113.548 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.56 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 11.1 Cg_exo -37.85 -29.52 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.574 1 C-N-CA 126.857 5.038 . . . . 73.34 118.343 -179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -170.43 151.76 3.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.915 1.234 . . . . 62.02 113.856 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.695 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -113.65 106.66 14.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.703 1.601 . . . . 74.43 107.518 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.81 125.03 32.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.747 -0.781 . . . . 64.54 109.416 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 27.0 p90 -167.1 165.35 15.64 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 110.41 -0.218 . . . . 72.12 110.41 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.1 p -125.7 148.0 49.18 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.805 -0.813 . . . . 51.34 108.805 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.26 133.5 50.72 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.776 0.658 . . . . 71.33 112.776 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.95 173.18 31.8 Favored Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 111.202 -0.759 . . . . 55.31 111.202 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.21 -20.32 26.24 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 115.583 1.697 . . . . 51.04 115.583 -173.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.538 ' OD2' ' HE2' ' A' ' 133' ' ' LYS . 5.0 t70 -94.88 -0.99 53.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.722 0.773 . . . . 72.31 109.757 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.76 24.48 60.15 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 111.319 -0.713 . . . . 74.03 111.319 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.538 ' HE2' ' OD2' ' A' ' 131' ' ' ASP . 68.5 mttm -112.13 147.31 36.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.151 0.5 . . . . 65.2 111.771 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 2.7 tm-20 -100.71 102.33 13.41 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 102.751 -3.055 . . . . 75.25 102.751 165.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 -173.29 23.14 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.196 -1.366 . . . . 51.35 111.446 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.15 128.16 8.11 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 107.311 -2.316 . . . . 61.22 107.311 172.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.55 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 62.8 m -177.78 -179.04 0.75 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.022 1.329 . . . . 73.24 107.463 -171.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.62 -68.6 0.55 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.323 0.583 . . . . 62.43 110.156 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.48 -16.42 11.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.223 -0.899 . . . . 72.35 110.857 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -82.72 -9.92 59.14 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.244 -0.434 . . . . 63.11 110.762 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -86.96 155.13 20.31 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.211 -0.904 . . . . 74.22 110.849 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 8.8 p-10 -79.88 136.16 36.61 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.869 -1.53 . . . . 61.22 106.869 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -97.84 130.86 45.96 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.66 -1.237 . . . . 60.35 107.66 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -143.26 153.25 24.68 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 118.712 -1.709 . . . . 63.43 114.294 -173.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -120.08 129.55 54.26 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.264 -2.125 . . . . 71.53 105.264 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -142.43 144.1 32.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.806 -0.813 . . . . 74.35 108.806 -168.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -130.47 115.13 16.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.97 -1.122 . . . . 75.2 107.97 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 107.34 -1.356 . . . . 44.12 107.34 179.834 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.478 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.7 mpt? . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 109.378 -0.601 . . . . 64.03 109.378 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -92.4 62.02 3.91 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.906 0.706 . . . . 73.41 112.906 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -148.38 147.79 26.75 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 107.497 -1.297 . . . . 74.54 107.497 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.06 151.69 26.83 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.469 2.113 . . . . 64.4 109.835 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 76.76 -57.28 0.54 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.224 1.009 . . . . 65.12 109.389 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 49.3 mt-30 -68.79 -16.39 63.78 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.888 -0.508 . . . . 60.13 111.344 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 -25.89 67.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.872 -0.604 . . . . 61.3 109.386 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -83.49 -24.58 31.68 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 108.825 -0.806 . . . . 74.54 108.825 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 44' ' ' GLN . 69.4 t -74.37 -43.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.82 -0.627 . . . . 62.52 110.233 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -66.43 -39.59 89.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.095 -0.502 . . . . 62.41 111.901 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.02 -34.79 51.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.786 0.327 . . . . 64.02 110.289 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 143' ' ' ILE . . . -66.96 -39.36 87.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.055 -0.521 . . . . 60.01 110.671 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.554 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 66.1 mttm -65.68 -25.6 67.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.357 0.598 . . . . 64.21 111.225 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 -32.31 35.5 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.762 -1.209 . . . . 74.33 110.538 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 56' ' ' ALA 0.354 70.4 m-20 -87.33 -20.62 26.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.268 1.21 . . . . 74.54 114.268 -175.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 144' ' ' GLY . 15.4 pt -71.64 -28.43 31.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.714 -0.847 . . . . 74.53 108.714 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -73.82 -27.03 60.9 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.844 -0.616 . . . . 53.23 110.565 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -62.5 -43.27 99.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.444 -0.798 . . . . 53.1 109.958 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.463 HG12 ' HG ' ' A' ' 100' ' ' LEU . 27.3 mt -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.735 0 CA-C-N 115.232 -0.895 . . . . 73.11 109.681 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.69 -25.28 62.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.835 -0.62 . . . . 71.31 111.995 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.78 -35.12 20.92 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.196 0.522 . . . . 44.43 110.11 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 63' ' ' MET . . . -80.58 -28.3 37.19 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.779 -0.368 . . . . 64.33 111.242 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.89 -26.85 64.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.883 -1.155 . . . . 72.32 107.883 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.3 t70 -69.09 -23.97 64.08 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.287 1.041 . . . . 65.04 109.232 173.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.424 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 51.1 ttm -78.76 -37.94 39.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.534 -0.757 . . . . 73.32 109.674 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.481 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 81.9 t80 -66.01 -38.12 87.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.063 -1.088 . . . . 75.54 108.063 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.541 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 75.9 tttt -54.54 -33.14 59.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.357 -1.292 . . . . 74.15 109.945 173.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 tp -83.13 -34.93 25.94 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.683 -0.407 . . . . 75.25 110.593 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 29.7 t70 -70.98 -25.61 62.78 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 120.901 0.381 . . . . 63.31 111.909 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.416 ' OD1' ' HB3' ' A' ' 89' ' ' PRO . 2.7 m-20 -125.65 19.84 7.92 Favored 'General case' 0 CA--C 1.462 -2.427 0 O-C-N 121.068 -1.02 . . . . 65.51 110.949 175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 p90 43.85 33.65 0.77 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 124.621 1.201 . . . . 73.04 113.549 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.85 160.36 1.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.739 -0.837 . . . . 75.54 108.739 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.541 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 27.6 m-85 -82.98 152.66 66.03 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.932 -0.396 . . . . 72.23 109.932 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.502 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.9 Cg_endo -63.82 164.73 20.67 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.972 3.114 . . . . 70.34 112.96 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.1 p -97.67 156.25 16.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 106.049 -1.834 . . . . 74.34 106.049 172.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -66.15 -14.47 61.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.43 0.633 . . . . 62.12 110.566 -176.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.42 -66.19 0.94 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.385 -0.598 . . . . 71.35 109.385 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -79.66 -35.98 38.42 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 116.186 -0.461 . . . . 72.53 111.087 -173.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.588 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -76.77 -21.4 74.56 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 118.021 -2.037 . . . . 54.24 112.453 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.23 -46.85 66.37 Favored 'General case' 0 C--O 1.259 1.591 0 N-CA-C 106.491 -1.67 . . . . 73.2 106.491 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.8 mt-10 -60.37 -37.69 81.54 Favored 'General case' 0 C--O 1.171 -3.067 0 CA-C-N 114.603 -1.18 . . . . 72.11 109.401 174.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.554 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.37 -3.26 39.22 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.862 0.689 . . . . 41.22 112.862 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 76.8 mt -95.18 -22.79 17.61 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.099 0.476 . . . . 72.34 110.168 173.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -107.78 -25.88 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.547 0.689 . . . . 74.14 111.222 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 85.0 tttt -127.03 147.39 50.14 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 126.432 1.893 . . . . 63.54 107.001 -175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -54.86 128.53 63.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.606 0.762 . . . . 75.12 111.78 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 37.1 Cg_endo -66.8 131.03 24.62 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.405 2.737 . . . . 74.23 111.701 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -94.68 -179.15 4.78 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.11 -0.7 . . . . 61.34 109.11 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.88 -125.12 8.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 108.207 -1.957 . . . . 74.41 108.207 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.8 80.21 14.2 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 118.093 0.946 . . . . 72.53 112.697 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.416 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 14.4 Cg_endo -82.94 142.54 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.205 1.936 . . . . 70.32 110.479 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 50.8 mt-30 -83.06 115.98 61.79 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 107.149 -1.426 . . . . 43.51 107.149 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 51.4 Cg_exo -51.18 98.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 123.409 2.74 . . . . 65.34 117.678 -168.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HE2' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -111.19 148.93 31.71 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 101.995 -3.335 . . . . 53.15 101.995 163.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.54 99.6 0.11 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 120.108 -0.637 . . . . 71.04 109.736 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.593 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.2 t90 -62.16 141.88 57.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 124.42 1.088 . . . . 74.25 110.693 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.99 133.4 50.57 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.719 -0.673 . . . . 73.02 109.284 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -82.46 -176.92 6.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.15 0.5 . . . . 71.31 110.359 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.4 t70 71.36 15.71 6.22 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.498 1.119 . . . . 63.53 110.292 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 109.21 7.97 27.89 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.057 -0.974 . . . . 73.5 114.115 171.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.593 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 63.78 92.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.136 0.97 . . . . 71.05 109.139 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 101' ' ' LYS . 6.8 tt -138.21 168.01 20.64 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.978 -1.489 . . . . 72.21 106.978 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' N ' HD23 ' A' ' 100' ' ' LEU . 71.5 mmtt -72.44 179.8 3.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.216 -1.031 . . . . 72.14 108.216 176.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -80.41 77.21 7.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.172 0.987 . . . . 74.54 110.376 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.9 mt -131.41 149.89 74.86 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.806 -1.543 . . . . 75.05 108.394 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.49 -170.17 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.861 1.707 . . . . 73.45 111.035 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.627 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.5 p -83.93 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.705 -0.85 . . . . 62.22 108.705 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.543 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 t0 -75.38 156.79 85.24 Favored Pre-proline 0 C--O 1.251 1.175 0 N-CA-C 108.898 -0.778 . . . . 75.31 108.898 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 6.0 Cg_endo -49.15 170.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 123.689 2.926 . . . . 54.42 113.408 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 67.21 14.39 9.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.959 1.704 . . . . 74.24 110.467 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.87 22.8 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 115.467 -0.788 . . . . 63.01 114.25 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -69.95 134.53 87.72 Favored Pre-proline 0 C--O 1.255 1.378 0 N-CA-C 113.319 0.859 . . . . 65.04 113.319 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.627 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.5 Cg_endo -71.51 154.12 60.36 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.429 2.086 . . . . 64.52 110.404 173.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -73.29 141.2 47.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.882 -1.525 . . . . 74.21 106.882 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.3 mm100 -102.89 113.83 27.6 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.417 -1.697 . . . . 54.51 106.417 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.57 120.02 40.05 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.72 -0.673 . . . . 71.21 112.518 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 97.5 mt -129.29 153.61 47.65 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.385 0.674 . . . . 74.35 109.246 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.14 -179.1 0.63 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 117.104 -1.426 . . . . 74.01 108.364 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 25.0 Cg_endo -50.37 115.31 1.85 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.042 2.495 . . . . 72.12 116.785 -162.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.65 -90.17 2.14 Favored Glycine 0 N--CA 1.42 -2.407 0 CA-C-N 113.955 -1.475 . . . . 35.23 110.976 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.44 95.76 6.29 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.417 0.627 . . . . 73.12 111.836 -177.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 59.24 20.08 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.371 1.468 . . . . 62.43 112.763 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.669 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -134.88 115.52 1.42 Allowed Glycine 0 CA--C 1.479 -2.218 0 C-N-CA 119.154 -1.498 . . . . 53.35 113.248 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.542 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 11.8 Cg_exo -43.34 -24.67 0.61 Allowed 'Trans proline' 0 C--N 1.371 1.754 1 C-N-CA 126.052 4.502 . . . . 71.23 117.179 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -168.89 143.91 3.24 Favored 'General case' 0 C--O 1.254 1.308 0 CA-C-N 118.861 0.755 . . . . 45.13 112.18 173.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.48 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.3 m-20 -122.99 117.68 26.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.518 -1.29 . . . . 64.5 107.518 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 pp -145.42 140.03 27.32 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.742 -0.783 . . . . 54.51 111.671 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.473 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 45.8 p90 -166.23 167.88 15.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.295 -1.002 . . . . 74.54 108.295 -175.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.9 p -124.18 136.85 54.49 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.593 -0.891 . . . . 71.23 108.593 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.65 135.3 57.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.846 -0.742 . . . . 73.43 111.541 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.87 -172.2 9.74 Favored Glycine 0 CA--C 1.495 -1.173 0 CA-C-N 115.817 -0.629 . . . . 65.32 112.848 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.33 -7.81 10.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 114.101 1.148 . . . . 64.14 114.101 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.66 -7.05 41.91 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.091 -0.644 . . . . 70.53 110.149 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 22.16 76.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 121.124 -0.56 . . . . 73.24 111.764 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -140.53 143.51 35.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.625 -1.25 . . . . 71.13 107.625 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -81.66 108.93 15.62 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.712 0.767 . . . . 72.1 109.997 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.4 -173.94 20.41 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.265 -0.88 . . . . 70.15 111.526 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.62 128.11 8.31 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.735 -0.946 . . . . 71.03 110.735 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.54 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 19.4 m 178.17 -176.87 0.21 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 127.143 2.177 . . . . 72.44 105.962 -172.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -87.49 -58.36 2.61 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.931 -1.107 . . . . 71.41 110.827 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.71 -28.81 13.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.638 0.732 . . . . 75.14 111.408 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.95 9.17 23.11 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.761 -0.587 . . . . 73.51 111.753 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.54 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -99.29 155.75 17.35 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 115.845 -0.616 . . . . 62.34 110.782 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -80.47 125.6 30.15 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.174 -1.417 . . . . 73.15 107.174 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.454 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.6 pp -106.71 141.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.508 -0.923 . . . . 72.04 108.508 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.421 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -173.78 170.85 44.01 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 118.212 -1.946 . . . . 71.24 114.41 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -113.72 137.26 51.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.847 -1.538 . . . . 74.01 106.847 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.404 ' CZ3' ' HB3' ' A' ' 124' ' ' ASP . 8.7 t-105 -141.79 124.53 15.99 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.562 . . . . 64.33 106.781 -170.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -102.73 114.2 28.24 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.053 -1.091 . . . . 71.23 108.053 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 4.7 p-10 . . . . . 0 C--N 1.294 -1.814 0 N-CA-C 107.759 -1.2 . . . . 73.53 107.759 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.595 ' N ' ' HG1' ' A' ' 48' ' ' THR . 1.2 mpt? . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.257 -0.645 . . . . 63.22 109.257 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.7 m -100.03 86.09 3.18 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.597 0.713 . . . . 63.03 112.077 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -148.14 163.6 26.06 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 106.35 -1.722 . . . . 62.41 106.35 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.88 130.14 36.18 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.681 2.254 . . . . 70.52 111.374 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.55 -34.21 0.28 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 126.004 1.721 . . . . 51.31 111.008 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -68.29 -20.49 64.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 75.1 109.37 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.53 -29.46 70.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.315 -0.857 . . . . 62.35 110.073 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -80.62 -26.55 37.68 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 108.108 -1.071 . . . . 74.41 108.108 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.419 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.3 t -75.35 -43.6 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.572 -0.74 . . . . 73.25 110.299 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.595 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.1 t -67.93 -37.05 81.18 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.584 -0.735 . . . . 54.4 111.309 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.87 -34.26 32.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 110.127 -0.323 . . . . 64.31 110.127 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.755 -0.657 . . . . 71.43 110.616 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 70.9 mmtt -65.28 -26.31 68.02 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.421 0.629 . . . . 72.41 111.05 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.29 -32.48 19.81 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.536 -1.025 . . . . 73.1 110.536 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 57' ' ' ILE . 70.1 m-20 -77.11 -33.58 56.88 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 120.917 -0.313 . . . . 72.43 111.465 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 pt -67.73 -29.74 46.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.701 -0.4 . . . . 60.52 110.313 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -73.23 -30.17 63.3 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.212 -0.662 . . . . 73.02 109.212 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.43 -40.58 96.01 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.052 -0.976 . . . . 74.01 109.991 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 53' ' ' ASP . 28.8 mt -66.28 -40.18 86.16 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.628 0 CA-C-N 115.103 -0.953 . . . . 71.43 109.71 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.03 66.8 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.29 -0.413 . . . . 62.44 111.447 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.03 -29.69 26.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.154 0.502 . . . . 62.21 110.319 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.31 -28.13 23.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.078 0.466 . . . . 72.4 110.975 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.99 -28.29 65.4 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.812 -1.551 . . . . 72.44 106.812 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.9 t70 -70.06 -24.16 63.2 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.598 -1.183 . . . . 74.22 108.75 172.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.7 mmt -79.93 -34.73 38.64 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.468 -0.787 . . . . 60.23 110.216 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.574 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 49.0 t80 -67.69 -31.7 71.84 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 107.103 -1.443 . . . . 75.14 107.103 171.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 56.9 tttp -57.92 -32.5 67.82 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.654 -0.703 . . . . 65.23 110.326 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -77.01 -36.11 56.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.148 0.499 . . . . 61.35 110.206 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -71.06 -25.44 62.63 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-N 115.7 -0.682 . . . . 74.33 110.856 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.5 18.41 5.29 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.924 -0.56 . . . . 72.23 110.27 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HD2' ' HG3' ' A' ' 90' ' ' GLN . 17.6 p90 42.89 31.35 0.31 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.014 1.326 . . . . 53.21 113.253 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.44 162.5 0.52 Allowed 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.516 -1.29 . . . . 71.12 107.516 -172.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 21.2 m-85 -78.63 151.63 77.32 Favored Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 120.305 -0.558 . . . . 73.2 111.31 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 14.1 Cg_endo -59.76 170.55 3.45 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 124.307 3.338 . . . . 73.24 112.725 177.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 76' ' ' GLN . 77.7 p -101.82 155.66 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.492 -1.67 . . . . 51.3 106.492 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -70.55 -15.07 62.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 119.796 1.18 . . . . 43.15 111.814 -173.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.48 -63.74 1.1 Allowed 'General case' 0 C--O 1.241 0.619 0 CA-C-N 116.311 -0.404 . . . . 72.31 110.886 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 48.8 mt-30 -76.08 -38.53 56.92 Favored 'General case' 0 CA--C 1.484 -1.584 0 C-N-CA 120.889 -0.325 . . . . 75.32 110.646 -174.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -71.31 -21.23 78.56 Favored Glycine 0 N--CA 1.418 -2.512 0 C-N-CA 119.101 -1.523 . . . . 72.54 112.83 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.54 -45.5 75.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.728 -1.582 . . . . 73.24 106.728 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.6 mt-10 -79.88 -2.83 45.37 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.842 -1.072 . . . . 72.31 111.077 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -99.8 -8.16 24.53 Favored 'General case' 0 C--O 1.204 -1.33 0 CA-C-O 121.677 0.751 . . . . 41.44 109.326 174.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 77' ' ' GLY . 5.4 mp -98.52 -24.25 15.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.481 -0.781 . . . . 65.41 110.026 174.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.92 -27.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.913 -0.585 . . . . 50.4 111.129 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 87.8 tttt -130.04 151.49 50.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.558 -1.645 . . . . 61.31 106.558 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -53.55 135.08 53.77 Favored Pre-proline 0 N--CA 1.485 1.308 0 CA-C-N 118.7 0.682 . . . . 75.02 110.94 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 7.2 Cg_endo -47.99 130.05 19.18 Favored 'Trans proline' 0 C--O 1.246 0.885 1 C-N-CA 125.357 4.038 . . . . 72.12 116.355 -170.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -82.19 148.97 28.16 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.183 -1.414 . . . . 44.23 107.183 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 89' ' ' PRO . . . 94.66 -157.28 22.29 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 109.634 -1.386 . . . . 35.43 109.634 -176.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -107.43 99.69 29.69 Favored Pre-proline 1 N--CA 1.369 -4.521 0 CA-C-N 117.68 0.74 . . . . 74.43 110.195 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 87' ' ' GLY . 96.4 Cg_endo -95.41 162.64 1.54 Allowed 'Trans proline' 0 N--CA 1.443 -1.493 0 C-N-CA 122.126 1.884 . . . . 75.03 109.756 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.408 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 25.8 mt-30 -82.8 159.18 63.92 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.432 . . . . 51.24 109.835 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.35 99.9 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.904 1.736 . . . . 75.03 111.315 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -150.51 146.07 26.38 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.485 -1.302 . . . . 52.33 107.485 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.64 89.52 1.32 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 120.733 0.301 . . . . 73.32 111.088 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.472 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 88.7 t90 -54.91 139.48 40.27 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.954 -1.021 . . . . 74.31 111.733 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.43 130.01 56.69 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.788 -1.096 . . . . 75.54 108.961 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -74.38 177.62 5.79 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.933 0.873 . . . . 65.25 110.801 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 62.24 36.11 14.98 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.345 -1.752 . . . . 44.14 109.398 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 92.55 7.73 63.03 Favored Glycine 0 CA--C 1.488 -1.611 0 CA-C-N 113.749 -1.569 . . . . 30.3 115.224 165.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 63.12 85.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.253 1.025 . . . . 72.4 108.649 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.1 tt -138.8 155.63 48.01 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.517 -1.66 . . . . 64.0 106.517 -173.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -63.53 141.5 58.74 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.799 -1.186 . . . . 64.11 107.799 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -74.0 79.09 1.69 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.039 0.923 . . . . 74.21 112.323 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -130.35 149.21 72.71 Favored Pre-proline 0 C--N 1.288 -2.094 0 CA-C-N 113.773 -1.558 . . . . 71.35 108.061 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 171.82 1.21 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.792 2.328 . . . . 73.23 111.873 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.694 HG21 ' HA ' ' A' ' 111' ' ' PRO . 2.6 p -79.21 171.78 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.547 0 CA-C-N 116.342 -0.39 . . . . 63.42 110.082 -173.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.49 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.2 t70 -82.76 153.89 67.76 Favored Pre-proline 0 C--O 1.256 1.423 0 C-N-CA 119.579 -0.848 . . . . 71.32 109.67 -169.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 10.3 Cg_exo -42.81 171.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.867 3.044 . . . . 72.43 115.051 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 70.15 14.17 7.7 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.484 2.313 . . . . 74.04 109.175 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.15 19.09 56.63 Favored Glycine 0 N--CA 1.466 0.635 0 CA-C-N 114.967 -1.015 . . . . 42.24 113.176 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.05 128.26 65.97 Favored Pre-proline 0 C--O 1.27 2.139 0 CA-C-O 121.526 0.679 . . . . 73.25 111.84 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.694 ' HA ' HG21 ' A' ' 105' ' ' VAL . 73.7 Cg_endo -80.46 154.2 21.1 Favored 'Trans proline' 0 N--CA 1.419 -2.888 0 C-N-CA 122.264 1.976 . . . . 71.02 110.302 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.463 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 46.7 m-85 -80.75 139.49 36.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.823 -1.177 . . . . 64.21 107.823 172.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.517 ' OE1' HD13 ' A' ' 128' ' ' LEU . 1.2 mm100 -103.98 118.45 36.7 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.327 -1.36 . . . . 72.55 107.327 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -103.82 117.66 34.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.893 -1.151 . . . . 65.11 107.893 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.0 mt -129.57 153.42 48.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.413 -0.958 . . . . 72.31 108.413 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.843 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.56 179.63 0.81 Allowed Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-O 117.001 -1.475 . . . . 74.21 108.351 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.843 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 9.1 Cg_endo -48.46 109.67 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.565 2.844 . . . . 71.52 114.796 -168.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -145.65 -63.99 0.01 OUTLIER Glycine 0 N--CA 1.405 -3.373 0 C-N-CA 119.563 -1.303 . . . . 65.34 112.449 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.555 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 11.4 m -83.85 104.98 14.38 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 108.399 -0.963 . . . . 72.31 108.399 -177.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 119' ' ' THR . 55.2 pttt 66.42 -26.26 0.11 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 127.51 2.324 . . . . 72.31 115.93 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -161.13 176.73 37.68 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 117.564 -2.255 . . . . 61.41 117.952 -173.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 7.2 Cg_exo -31.25 -26.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.502 1 C-N-CA 129.208 6.605 . . . . 74.31 119.505 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.285 47.6 p90 -169.9 149.03 3.61 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 119.717 1.144 . . . . 53.21 112.912 170.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.0 OUTLIER -112.66 106.29 14.65 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.483 -1.303 . . . . 70.33 107.483 -176.083 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 57' ' ' ILE . 3.4 tm? -128.46 128.08 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.202 -0.936 . . . . 73.51 110.254 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -166.57 164.33 17.0 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 120.855 -0.338 . . . . 74.02 111.862 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.463 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 23.0 t -125.07 141.71 51.95 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.882 -2.266 . . . . 74.25 104.882 171.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.517 HD13 ' OE1' ' A' ' 113' ' ' GLN . 5.3 mp -59.56 155.0 16.2 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.789 1.033 . . . . 72.41 113.789 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.7 172.85 53.79 Favored Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 115.561 -0.745 . . . . 70.02 112.292 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.52 -28.47 2.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 116.79 2.144 . . . . 61.11 116.79 -173.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.33 -2.06 52.8 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.837 0.744 . . . . 71.35 111.27 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.42 24.75 27.82 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.986 -0.626 . . . . 53.23 112.082 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -140.89 146.32 37.31 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.412 -0.588 . . . . 75.21 109.412 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -81.88 117.85 22.47 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 120.825 0.345 . . . . 64.32 110.777 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -149.47 -174.23 20.71 Favored Glycine 0 C--N 1.317 -0.497 0 N-CA-C 110.441 -1.064 . . . . 34.23 110.441 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.91 128.14 8.6 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 109.791 -1.324 . . . . 73.14 109.791 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.507 ' H ' ' HB2' ' A' ' 141' ' ' ALA . 23.2 t 178.02 -176.65 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.384 -0.969 . . . . 73.24 108.384 -171.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.41 -71.11 0.36 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.116 -0.698 . . . . 74.11 109.116 172.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -98.76 -17.06 18.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.303 0.573 . . . . 71.02 111.525 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 15.1 m-20 -91.67 9.24 33.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.683 0.754 . . . . 73.11 110.763 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.507 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.54 152.87 19.4 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.591 -0.731 . . . . 63.33 110.31 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.79 119.39 21.93 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.931 -1.877 . . . . 51.4 105.931 171.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.563 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.35 128.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 115.754 -0.657 . . . . 73.11 109.936 -174.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.13 -179.8 38.56 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 118.463 -1.827 . . . . 75.5 113.31 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 7.2 t30 -123.73 147.88 47.09 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 105.725 -1.954 . . . . 73.33 105.725 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -142.88 135.92 28.15 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.75 -1.204 . . . . 75.44 107.75 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.9 106.58 13.97 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.176 -1.009 . . . . 73.15 108.484 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 40.1 t30 . . . . . 0 N--CA 1.419 -1.988 0 N-CA-C 107.087 -1.449 . . . . 65.41 107.087 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.7 ttt . . . . . 0 C--O 1.217 -0.65 0 N-CA-C 107.724 -1.213 . . . . 73.13 107.724 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -110.22 89.41 3.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.024 0.916 . . . . 32.43 110.426 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 12.7 ptm180 -155.89 161.29 29.79 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.191 -1.781 . . . . 70.2 106.191 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.02 120.53 0.54 Allowed 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 124.057 3.171 . . . . 74.34 114.68 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t0 74.36 -35.79 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 126.81 2.044 . . . . 64.14 112.186 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.548 ' HA ' HG23 ' A' ' 47' ' ' VAL . 84.6 mm-40 -68.76 -24.39 64.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.504 0.668 . . . . 72.45 109.528 176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -62.11 -29.17 70.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.035 -0.984 . . . . 61.31 109.329 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.8 -23.73 39.05 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.118 -0.492 . . . . 74.33 110.249 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.548 HG23 ' HA ' ' A' ' 44' ' ' GLN . 40.2 t -74.59 -44.01 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.189 -1.041 . . . . 52.42 108.189 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 45' ' ' ALA . 14.6 t -67.96 -34.2 76.11 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.52 -0.763 . . . . 54.33 111.525 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 45' ' ' ALA . 19.8 m -69.22 -43.3 81.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 C-N-CA 119.434 -0.906 . . . . 74.13 109.566 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.422 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -59.6 -41.74 91.01 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.128 0.971 . . . . 51.33 110.958 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 58.7 mtpt -66.6 -21.89 66.13 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.635 -0.711 . . . . 74.31 111.925 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.27 -31.71 18.86 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 110.105 -1.198 . . . . 72.22 110.105 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.4 ' OD1' HD13 ' A' ' 103' ' ' LEU . 24.2 m-20 -70.42 -39.33 74.49 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.331 0.586 . . . . 72.31 110.622 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.627 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 17.6 pt -70.23 -25.5 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.942 -0.572 . . . . 54.31 110.673 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -68.41 -31.87 71.51 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.735 -0.839 . . . . 63.3 108.735 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -29.3 64.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.272 -0.876 . . . . 63.24 109.78 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 18.1 mm -59.88 -48.3 88.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 CA-C-N 115.03 -0.987 . . . . 61.12 108.731 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB2' HD21 ' A' ' 145' ' ' ASN . . . -58.22 -34.01 69.95 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.854 0.359 . . . . 54.34 111.314 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.53 -42.54 67.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.736 -0.665 . . . . 75.25 111.037 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.41 24.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.464 0.542 . . . . 62.1 112.464 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.31 -30.11 69.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.166 -1.42 . . . . 74.42 107.166 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.5 t70 -69.88 -27.61 64.96 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.289 1.042 . . . . 73.33 109.601 173.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 63.3 mtt -78.34 -30.21 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.707 -0.679 . . . . 72.42 110.331 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -71.3 -36.22 71.56 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.017 -1.105 . . . . 72.21 108.017 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 51.9 tttp -55.17 -31.59 61.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.316 -0.856 . . . . 73.44 109.93 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.93 -31.05 23.84 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.291 -0.868 . . . . 73.24 110.806 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.46 -27.12 56.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.925 0.393 . . . . 74.23 111.333 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.47 24.16 5.13 Favored 'General case' 0 CA--C 1.46 -2.513 0 N-CA-C 109.479 -0.563 . . . . 62.25 109.479 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.3 p90 43.26 33.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.417 1.087 . . . . 64.33 113.824 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 179.87 160.09 0.82 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.125 -0.694 . . . . 72.3 109.125 -173.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 24.4 m-85 -81.23 150.91 68.86 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 123.451 0.469 . . . . 62.43 110.131 171.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.552 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.8 Cg_endo -65.01 170.09 10.91 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.607 2.871 . . . . 74.1 113.255 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 73.3 p -110.01 153.98 23.82 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.196 -1.779 . . . . 74.45 106.196 171.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.433 ' N ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -59.59 -20.98 59.62 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.433 0.635 . . . . 72.21 111.933 -178.112 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -98.38 -65.95 0.93 Allowed 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 122.055 -0.403 . . . . 73.14 111.313 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -75.99 -37.32 58.64 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 116.604 -0.271 . . . . 75.22 111.287 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -78.53 -21.41 69.5 Favored Glycine 0 N--CA 1.413 -2.865 0 C-N-CA 118.372 -1.871 . . . . 75.31 112.83 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.92 -44.64 65.74 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 106.324 -1.732 . . . . 72.11 106.324 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 10.1 mm-40 -60.47 -41.34 93.97 Favored 'General case' 0 C--O 1.162 -3.526 0 CA-C-N 114.7 -1.136 . . . . 65.53 109.828 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.55 1.37 19.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.942 0.719 . . . . 54.51 112.942 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 63.5 mt -101.64 -20.97 14.8 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.229 -0.295 . . . . 70.12 111.008 172.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.3 t -111.04 -26.42 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-O 121.822 0.82 . . . . 74.41 111.026 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 38.3 ttmt -122.87 146.65 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 126.972 2.109 . . . . 72.32 105.83 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' H ' ' HD3' ' A' ' 84' ' ' LYS . 3.8 mppt? -55.95 141.86 66.27 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 118.517 0.599 . . . . 71.54 111.501 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.77 122.35 10.87 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 123.063 2.508 . . . . 72.23 112.397 -172.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.3 p -71.26 140.66 50.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.335 -1.302 . . . . 60.12 111.132 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.12 -116.55 5.61 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.54 -1.024 . . . . 75.11 110.54 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.24 92.53 7.48 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 112.872 0.693 . . . . 73.34 112.872 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.73 162.38 14.27 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.739 1.626 . . . . 70.03 107.954 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -74.87 158.97 84.03 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-O 118.608 -0.71 . . . . 75.24 109.392 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.42 98.3 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 121.56 1.507 . . . . 70.53 110.625 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 10.1 tmtt? -152.77 144.18 23.31 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.183 -1.784 . . . . 74.33 106.183 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.513 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 33.5 m-80 -78.7 94.76 5.14 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 118.239 0.472 . . . . 71.43 111.315 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.456 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.5 t90 -57.65 144.17 38.69 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.037 1.335 . . . . 74.04 112.519 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.93 135.16 55.27 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.806 -1.088 . . . . 73.22 108.984 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -84.06 -174.3 5.2 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.435 -0.58 . . . . 75.03 109.435 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 58.91 34.64 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 114.241 1.2 . . . . 74.24 114.241 176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 89.87 6.55 69.59 Favored Glycine 0 CA--C 1.487 -1.717 0 CA-C-N 115.344 -0.844 . . . . 72.21 114.358 168.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.456 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.5 OUTLIER 66.18 91.9 0.08 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.311 1.053 . . . . 62.35 111.301 -176.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.3 tp -138.28 170.97 15.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.618 -1.173 . . . . 71.43 108.174 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.87 -165.54 1.22 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.729 -0.607 . . . . 61.52 109.617 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.525 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -70.39 39.83 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.893 0.854 . . . . 75.33 112.272 178.129 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.4 HD13 ' OD1' ' A' ' 53' ' ' ASP . 84.8 mt -102.13 148.59 35.59 Favored Pre-proline 0 C--N 1.294 -1.844 0 C-N-CA 124.328 1.051 . . . . 73.1 110.2 -175.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.85 -166.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.908 3.072 . . . . 72.02 112.229 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.487 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 3.6 p -85.01 172.04 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 107.353 -1.351 . . . . 71.13 107.353 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.597 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -80.21 155.98 74.3 Favored Pre-proline 0 C--O 1.256 1.415 0 C-N-CA 119.723 -0.791 . . . . 73.33 109.847 -172.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 11.2 Cg_endo -54.3 171.54 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.562 2.842 . . . . 73.22 113.298 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.584 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 65.57 15.76 10.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.909 1.684 . . . . 64.23 109.738 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.63 29.76 75.86 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.921 -1.036 . . . . 73.43 113.926 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.584 ' ND2' ' HB2' ' A' ' 108' ' ' TRP . 58.1 m-80 -93.11 119.82 67.36 Favored Pre-proline 0 C--O 1.249 1.056 0 CA-C-N 117.672 0.736 . . . . 74.21 110.802 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.487 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 46.3 Cg_exo -62.91 143.12 90.77 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 121.955 1.77 . . . . 74.42 108.824 168.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -69.18 144.4 53.79 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.149 0.5 . . . . 70.01 110.332 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.655 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -102.62 114.77 29.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.403 -1.703 . . . . 53.41 106.403 -178.2 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.13 117.3 34.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.395 -1.335 . . . . 73.45 107.395 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.1 mt -129.67 154.02 47.56 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.239 0.542 . . . . 72.15 109.808 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.744 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -112.78 -178.63 0.54 Allowed Pre-proline 0 N--CA 1.401 -2.884 0 CA-C-O 116.109 -1.9 . . . . 54.44 106.959 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.744 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 9.5 Cg_endo -40.26 109.67 0.1 Allowed 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 123.146 2.564 . . . . 72.32 115.191 -164.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.73 -89.55 0.69 Allowed Glycine 0 N--CA 1.42 -2.42 0 CA-C-N 114.025 -1.443 . . . . 65.33 111.342 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 m -112.68 96.06 5.77 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.008 -0.738 . . . . 44.43 109.008 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 66.67 9.69 6.86 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.146 0.795 . . . . 71.53 113.146 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -126.59 132.15 7.61 Favored Glycine 0 CA--C 1.486 -1.723 0 CA-C-O 118.553 -1.137 . . . . 71.23 113.058 -176.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.52 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 34.9 Cg_exo -36.61 -29.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 1 C-N-CA 126.637 4.892 . . . . 74.32 118.352 -178.009 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.527 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 46.4 p90 -172.17 168.27 5.76 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.102 0.865 . . . . 73.52 111.247 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.6 106.33 5.63 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.835 0.854 . . . . 75.33 109.145 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -125.48 127.31 46.28 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.579 -0.896 . . . . 73.13 108.579 -178.396 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 30.0 p90 -166.61 169.42 13.65 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.252 -0.579 . . . . 71.14 112.301 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.2 t -125.02 149.27 47.93 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.681 -1.229 . . . . 55.24 107.681 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.655 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 82.1 mt -69.16 154.6 41.78 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 110.355 -0.239 . . . . 52.23 110.355 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.36 -174.76 24.8 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 121.449 -0.405 . . . . 52.34 113.87 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -55.15 -24.37 26.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.906 1.446 . . . . 72.14 114.906 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -93.85 -6.04 46.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.21 -0.596 . . . . 72.33 110.946 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 128' ' ' LEU . . . 91.17 19.18 43.39 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.608 -0.806 . . . . 64.12 113.086 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -140.79 148.62 40.92 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.326 -0.62 . . . . 71.54 109.326 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.36 122.57 23.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.111 0.481 . . . . 63.02 110.55 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.62 -175.06 22.27 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 110.369 -1.092 . . . . 72.31 110.369 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -115.19 127.34 7.59 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 108.102 -1.999 . . . . 45.2 108.102 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 69.3 m 179.66 -177.15 0.33 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.617 1.167 . . . . 72.44 108.22 -169.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.94 -67.65 0.74 Allowed 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.95 0.156 . . . . 75.25 110.692 170.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -96.19 -21.34 17.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.137 0.494 . . . . 75.4 111.609 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -93.21 15.07 16.26 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.153 0.501 . . . . 74.23 111.077 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -91.68 155.86 18.0 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 115.995 -0.548 . . . . 64.11 111.164 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.44 127.86 32.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.235 -1.765 . . . . 73.51 106.235 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -96.96 121.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 108.333 -0.988 . . . . 63.54 108.333 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -142.26 152.54 23.77 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.188 -1.482 . . . . 51.44 114.796 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.486 HD21 ' HB2' ' A' ' 58' ' ' ALA . 3.6 t30 -130.25 120.08 23.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.536 -1.283 . . . . 63.11 107.536 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.527 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 2.5 p90 -160.24 177.57 10.51 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.722 0.772 . . . . 75.03 111.945 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.34 117.44 26.96 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 106.377 -1.712 . . . . 74.53 106.377 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 C--N 1.298 -1.641 0 N-CA-C 106.966 -1.494 . . . . 71.23 106.966 -176.908 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 108.444 -0.947 . . . . 71.13 108.444 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 m -121.64 80.12 1.64 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.361 0.6 . . . . 71.21 111.749 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -149.82 161.17 32.18 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.937 -1.875 . . . . 71.13 105.937 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -45.71 128.78 11.17 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.032 2.488 . . . . 71.23 112.088 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.266 20.6 m-20 75.99 -41.33 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.281 1.432 . . . . 64.2 113.705 -176.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.55 -23.03 64.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.265 0.555 . . . . 73.55 110.113 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.51 65.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.084 -0.962 . . . . 65.21 110.512 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -88.35 -26.56 22.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.212 -1.033 . . . . 73.41 108.212 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.493 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 39.1 t -75.71 -40.76 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.076 -0.966 . . . . 62.11 109.948 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -63.48 -29.55 70.81 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.487 -0.779 . . . . 74.22 110.861 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -73.63 -44.85 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 108.357 -0.979 . . . . 73.21 108.357 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.47 -42.33 87.25 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.937 -1.029 . . . . 65.35 111.532 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -66.7 -25.07 66.35 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 121.331 0.586 . . . . 74.41 111.944 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.81 -22.86 34.82 Favored Glycine 0 C--N 1.31 -0.889 0 N-CA-C 110.447 -1.061 . . . . 55.24 110.447 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 15.4 t70 -82.25 -38.33 24.62 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.296 -0.631 . . . . 74.45 109.296 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.46 HG21 ' HA2' ' A' ' 144' ' ' GLY . 28.5 pt -65.53 -34.56 71.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.231 -0.655 . . . . 74.33 109.231 173.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -66.98 -28.04 67.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.783 -0.451 . . . . 73.23 109.783 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.82 -44.04 86.81 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.334 -0.617 . . . . 73.41 109.334 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.4 HG12 HD13 ' A' ' 100' ' ' LEU . 69.4 mt -64.83 -38.94 84.01 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.238 -0.892 . . . . 74.22 109.863 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . . . -59.62 -26.38 65.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.073 0.463 . . . . 62.53 111.573 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.7 -33.2 18.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.091 0.472 . . . . 73.55 110.204 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.507 ' HA ' ' SD ' ' A' ' 63' ' ' MET . . . -84.36 -26.83 28.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.033 -0.531 . . . . 74.21 111.898 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.1 -25.39 62.58 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.003 -1.48 . . . . 75.54 107.003 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 65' ' ' LYS . 28.7 t70 -75.4 -20.1 59.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.827 -1.079 . . . . 72.51 109.193 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.507 ' SD ' ' HA ' ' A' ' 60' ' ' ALA . 72.3 mtp -81.29 -29.72 34.21 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.378 -0.828 . . . . 73.04 109.538 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.18 -39.36 71.89 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 106.246 -1.761 . . . . 73.11 106.246 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 32.8 tttm -56.26 -26.55 52.05 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.178 -0.919 . . . . 62.02 110.175 173.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.22 -36.58 19.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.853 -0.612 . . . . 64.32 110.418 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.8 t70 -74.23 -25.94 59.95 Favored 'General case' 0 C--O 1.209 -1.054 0 O-C-N 122.281 -0.262 . . . . 63.32 111.318 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 89' ' ' PRO . 2.8 m120 -127.02 20.39 6.95 Favored 'General case' 0 CA--C 1.456 -2.668 0 CA-C-O 118.75 -0.643 . . . . 74.11 111.209 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 43.07 32.15 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.733 1.271 . . . . 75.11 113.191 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.95 161.44 0.56 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.776 -1.194 . . . . 73.12 107.776 -172.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 12.6 m-85 -76.93 157.15 81.97 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 123.361 0.413 . . . . 74.33 111.923 174.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.523 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 6.9 Cg_exo -72.86 170.41 19.73 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.838 2.358 . . . . 61.31 111.334 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 p -104.28 156.27 18.05 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.05 -1.463 . . . . 62.13 107.05 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -70.64 -12.3 61.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 119.711 1.141 . . . . 62.53 110.492 -175.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -100.85 -65.09 0.99 Allowed 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.865 -0.607 . . . . 52.31 110.581 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -75.79 -39.55 56.73 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 120.548 -0.461 . . . . 74.34 110.133 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -73.83 -21.38 79.33 Favored Glycine 0 N--CA 1.415 -2.765 0 C-N-CA 119.091 -1.528 . . . . 74.03 113.785 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.65 -46.86 44.05 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 107.625 -1.25 . . . . 44.32 107.625 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.09 -29.99 70.7 Favored 'General case' 0 C--O 1.183 -2.41 0 CA-C-N 114.955 -1.021 . . . . 74.13 110.119 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -86.03 -0.27 55.12 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.488 0.493 . . . . 53.12 112.252 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 65.9 mt -97.01 -21.47 17.39 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.404 0.621 . . . . 72.22 110.058 172.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.79 -30.67 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 121.575 0.702 . . . . 70.42 110.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 99.2 mttt -125.35 151.49 46.02 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 125.942 1.697 . . . . 70.33 107.436 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -54.27 142.16 49.64 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 112.755 0.65 . . . . 32.42 112.755 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 6.7 Cg_endo -45.42 131.64 12.13 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.961 3.774 . . . . 62.03 114.96 -175.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -95.07 -1.49 52.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.939 -1.028 . . . . 74.25 110.032 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.99 11.74 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.258 -0.883 . . . . 73.11 111.586 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -126.7 86.08 59.3 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-O 121.555 0.693 . . . . 74.2 110.642 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.454 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 88.4 Cg_endo -91.35 161.82 3.68 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.585 2.19 . . . . 73.03 112.911 -176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.06 134.96 20.52 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.471 -0.937 . . . . 74.45 108.471 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -35.78 100.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 125.219 3.946 . . . . 74.14 115.014 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.526 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.85 147.3 27.08 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.018 -1.845 . . . . 74.13 106.018 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.526 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 3.7 m-20 -70.28 101.4 1.9 Allowed 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.501 0.667 . . . . 70.31 111.726 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.478 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 85.2 t90 -67.46 145.05 55.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.783 -1.099 . . . . 63.15 110.892 175.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -131.18 134.56 46.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.923 -0.769 . . . . 71.13 108.923 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 47.7 pttt -82.25 -165.84 1.11 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.486 -1.302 . . . . 75.24 107.486 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 66.15 19.05 11.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.533 1.158 . . . . 61.23 109.139 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 85.08 17.25 63.31 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.43 -1.259 . . . . 74.44 113.214 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.3 m-85 64.37 90.06 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.325 1.06 . . . . 75.4 110.602 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.4 HD13 HG12 ' A' ' 57' ' ' ILE . 66.3 tp -138.49 169.28 18.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.963 -1.125 . . . . 70.13 107.963 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -86.69 -171.94 3.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.948 -1.131 . . . . 53.03 107.948 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -75.4 70.05 2.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.661 1.22 . . . . 74.4 110.849 177.657 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -130.41 147.83 67.45 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.197 -1.365 . . . . 64.03 108.314 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.84 -168.98 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.835 2.357 . . . . 75.14 112.001 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.7 p -88.45 174.64 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 107.847 -1.168 . . . . 73.33 107.847 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 9.4 t70 -78.7 152.67 77.95 Favored Pre-proline 0 C--O 1.256 1.444 0 CA-C-N 119.255 0.934 . . . . 62.3 110.359 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 90.0 Cg_exo -49.76 172.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.573 2.849 . . . . 61.43 114.162 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 68.88 14.43 8.9 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.746 2.018 . . . . 74.34 109.026 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.9 33.33 78.12 Favored Glycine 0 C--N 1.32 -0.325 0 CA-C-N 114.83 -1.077 . . . . 60.5 112.628 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -93.72 131.99 30.9 Favored Pre-proline 0 C--O 1.258 1.506 0 N-CA-C 111.934 0.346 . . . . 71.45 111.934 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.533 ' HA ' HG21 ' A' ' 105' ' ' VAL . 66.6 Cg_endo -78.32 151.09 26.05 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 122.264 1.976 . . . . 73.44 110.362 174.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 8.6 m-85 -78.51 142.39 37.47 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.789 0.328 . . . . 70.34 110.309 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.578 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -104.52 113.82 27.63 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 106.45 -1.685 . . . . 75.41 106.45 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.5 118.0 35.14 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.113 -1.81 . . . . 70.41 106.113 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 91.2 mt -129.35 145.4 51.39 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.188 -0.671 . . . . 72.13 109.188 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.746 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -106.81 -178.32 0.58 Allowed Pre-proline 0 N--CA 1.402 -2.838 0 CA-C-O 115.907 -1.996 . . . . 52.25 106.641 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.746 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 2.9 Cg_endo -40.36 107.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 123.049 2.499 . . . . 43.42 114.556 -162.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.6 -74.89 0.1 Allowed Glycine 0 N--CA 1.411 -2.991 0 C-N-CA 120.54 -0.838 . . . . 71.23 112.577 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.429 HG22 ' HG2' ' A' ' 120' ' ' LYS . 9.2 m -83.18 95.84 8.24 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 109.139 -0.689 . . . . 70.41 109.139 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 119' ' ' THR . 1.0 OUTLIER 69.82 -16.8 0.26 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 126.037 1.735 . . . . 64.23 115.257 172.16 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 148' ' ' ASN . . . -161.21 178.04 37.31 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 117.064 -2.493 . . . . 74.33 117.331 -170.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.543 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 44.6 Cg_exo -36.93 -37.24 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 127.629 5.553 . . . . 70.43 118.209 -175.401 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.289 29.3 p90 -161.28 144.73 12.84 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 117.829 -1.548 . . . . 73.3 114.776 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -113.79 105.87 13.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.586 -1.635 . . . . 42.23 106.586 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.42 126.9 41.51 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.863 -1.148 . . . . 74.15 109.865 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 34.0 p90 -167.39 166.13 14.62 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.218 0.324 . . . . 72.33 111.837 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.51 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 29.8 t -125.37 149.74 47.86 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.607 -1.998 . . . . 72.41 105.607 170.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.578 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 95.0 mt -63.68 145.09 56.39 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.719 0.295 . . . . 74.42 110.851 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.17 -169.67 45.98 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.416 -0.897 . . . . 74.32 111.404 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.5 -6.29 14.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 123.818 0.847 . . . . 71.45 113.101 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -96.0 -9.07 31.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.559 0.695 . . . . 53.14 110.101 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.53 7.88 70.01 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-N 115.815 -0.629 . . . . 52.52 113.301 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -140.05 147.55 40.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.827 -1.546 . . . . 51.23 106.827 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 119.81 21.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.668 -0.813 . . . . 62.44 111.643 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.75 -173.94 21.3 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.492 -1.043 . . . . 72.44 110.492 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.07 127.55 7.84 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.164 -1.574 . . . . 63.41 109.164 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.516 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 58.1 m 178.79 -177.54 0.27 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 126.421 1.888 . . . . 45.1 106.68 -171.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.85 -76.77 0.17 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.065 -0.654 . . . . 70.12 110.738 171.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -96.44 -14.7 22.22 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.731 -0.388 . . . . 73.22 111.708 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -90.13 3.28 53.86 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.334 0.587 . . . . 74.24 110.689 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -94.68 157.74 15.83 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 115.149 -0.932 . . . . 44.44 110.297 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.19 126.85 31.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.68 -1.6 . . . . 72.53 106.68 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -96.86 119.05 44.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.657 0.742 . . . . 72.35 111.287 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA2' HG21 ' A' ' 54' ' ' ILE . . . -174.44 162.35 32.57 Favored Glycine 0 N--CA 1.41 -3.096 0 C-N-CA 119.515 -1.326 . . . . 53.42 112.202 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -106.2 160.79 15.07 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.476 -0.935 . . . . 64.4 108.476 177.176 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -143.01 137.4 29.27 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.138 -1.06 . . . . 72.41 108.138 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -106.46 91.66 3.79 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.66 -1.216 . . . . 74.54 109.111 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.568 ' HB2' ' HA3' ' A' ' 121' ' ' GLY . 10.1 t30 . . . . . 0 CA--C 1.506 -0.732 0 O-C-N 126.282 2.239 . . . . 75.23 107.45 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.638 ' N ' ' HG1' ' A' ' 48' ' ' THR . 8.2 tpt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 107.042 -1.466 . . . . 65.22 107.042 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -118.44 98.21 6.15 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.809 0.67 . . . . 73.32 112.809 -173.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -155.58 165.49 18.29 Favored Pre-proline 0 C--O 1.252 1.23 0 N-CA-C 104.9 -2.259 . . . . 74.51 104.9 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.7 124.57 12.53 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.747 2.298 . . . . 74.31 111.913 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 75.08 -26.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.969 2.108 . . . . 62.35 111.777 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.411 ' HA ' HG23 ' A' ' 47' ' ' VAL . 62.5 mt-30 -68.69 -19.23 64.37 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 121.659 -0.651 . . . . 74.41 109.47 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.17 65.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.159 -0.928 . . . . 75.33 110.188 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' O ' HG22 ' A' ' 49' ' ' VAL . 66.1 mttm -90.35 -25.58 20.38 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.041 -0.726 . . . . 71.13 109.041 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.6 t -73.93 -40.92 53.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.75 0.785 . . . . 74.21 109.018 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.638 ' HG1' ' N ' ' A' ' 39' ' ' MET . 10.9 t -65.43 -25.84 67.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.795 -1.093 . . . . 74.22 111.668 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 46' ' ' LYS . 6.0 m -82.69 -34.35 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 108.746 -0.835 . . . . 73.53 108.746 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 54' ' ' ILE . . . -61.84 -32.24 72.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.112 -0.949 . . . . 65.03 110.815 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.3 mmmt -65.14 -25.2 67.65 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.954 -0.567 . . . . 54.11 110.372 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.47 -27.29 18.11 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 111.164 -0.774 . . . . 52.02 111.164 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -79.19 -36.25 40.55 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.802 -0.444 . . . . 64.24 109.802 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 50' ' ' ALA . 26.6 pt -69.17 -31.02 48.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.595 -0.52 . . . . 73.22 109.595 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.5 tptt -65.79 -33.03 74.91 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.096 -0.705 . . . . 72.33 109.096 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.54 80.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.337 -0.847 . . . . 74.0 110.038 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.485 HG12 HD13 ' A' ' 100' ' ' LEU . 53.2 mt -68.27 -36.94 77.11 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 CA-C-N 115.829 -0.623 . . . . 72.1 110.238 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.39 66.81 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.032 0.444 . . . . 62.14 110.766 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -88.63 -36.03 16.5 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 115.482 -0.781 . . . . 54.43 110.202 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.1 -28.12 60.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.004 0.43 . . . . 72.05 111.186 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -67.88 -29.45 68.56 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.598 -1.26 . . . . 75.44 107.598 177.177 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.4 t70 -72.84 -23.15 60.72 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.873 -1.058 . . . . 54.12 109.475 174.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 62.5 mtt -81.26 -39.65 24.97 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.943 -0.762 . . . . 75.25 108.943 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 87.7 t80 -64.39 -35.75 81.92 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.076 -1.083 . . . . 74.52 108.076 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.598 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 82.3 tttt -54.95 -31.78 60.86 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.052 -0.977 . . . . 65.43 111.215 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.9 -29.05 16.9 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.632 0.604 . . . . 71.31 112.632 172.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.521 ' HB3' ' HA ' ' A' ' 64' ' ' TYR . 19.4 t70 -72.15 -24.3 61.43 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.98 0.512 . . . . 73.03 111.311 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -128.48 18.84 6.32 Favored 'General case' 0 CA--C 1.455 -2.686 0 N-CA-C 108.071 -1.085 . . . . 73.24 108.071 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.0 p90 43.61 32.88 0.59 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.436 1.495 . . . . 72.15 114.134 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.15 161.09 1.09 Allowed 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.595 -0.891 . . . . 71.3 108.595 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.598 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 15.6 m-85 -78.12 154.02 79.88 Favored Pre-proline 0 N--CA 1.427 -1.62 0 O-C-N 123.713 0.633 . . . . 65.53 111.466 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.504 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 31.2 Cg_endo -66.87 165.76 24.87 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.108 2.539 . . . . 72.31 111.736 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.43 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 41.4 p -100.27 155.45 17.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.75 -1.944 . . . . 70.23 105.75 170.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.668 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.3 t -67.23 -12.13 59.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 119.736 1.153 . . . . 62.12 111.664 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -102.63 -64.9 1.03 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.268 -0.423 . . . . 74.04 111.062 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.33 -34.54 48.52 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 122.113 -0.367 . . . . 74.42 110.455 -174.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.657 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -78.4 -20.71 71.41 Favored Glycine 0 N--CA 1.412 -2.901 0 C-N-CA 119.112 -1.518 . . . . 63.14 112.757 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.78 -44.57 66.39 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 105.361 -2.088 . . . . 74.55 105.361 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 13.5 mm-40 -65.51 -16.69 63.92 Favored 'General case' 0 C--O 1.189 -2.09 0 CA-C-N 114.141 -1.39 . . . . 73.51 111.454 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.657 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -98.37 -3.39 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.374 0.607 . . . . 74.41 111.391 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 mp -98.56 -15.56 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 61.31 108.773 173.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.04 -39.93 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.602 -0.726 . . . . 75.15 110.859 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 5.6 ttpm? -116.35 150.29 37.96 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.047 -1.464 . . . . 74.45 107.047 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -54.37 137.02 60.48 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 118.341 0.518 . . . . 64.51 111.474 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.79 140.59 81.03 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.49 2.793 . . . . 74.34 111.994 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.7 p -83.04 178.1 8.3 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.004 -0.544 . . . . 75.34 110.346 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.12 -114.58 4.58 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.12 -0.792 . . . . 73.35 111.12 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -148.56 116.41 3.93 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 120.611 -0.435 . . . . 74.53 110.931 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -103.5 162.94 0.24 Allowed 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 123.846 3.031 . . . . 73.54 111.088 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -76.65 159.29 79.59 Favored Pre-proline 0 C--O 1.207 -1.167 0 O-C-N 121.682 -0.636 . . . . 71.34 109.557 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -70.77 99.06 0.82 Allowed 'Trans proline' 0 C--O 1.248 1.015 0 C-N-CA 121.335 1.356 . . . . 61.11 112.586 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 67.6 mttm -146.66 148.56 32.17 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.818 -1.919 . . . . 74.43 105.818 174.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -76.41 92.99 3.43 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.628 -0.829 . . . . 70.41 110.372 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.617 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 79.4 t90 -53.69 143.53 20.24 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.237 1.415 . . . . 70.31 111.578 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -124.11 136.72 54.43 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.816 -1.083 . . . . 71.11 109.806 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 64.0 pttt -88.04 -168.75 2.31 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.631 -0.878 . . . . 75.25 108.631 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.66 16.3 6.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.708 1.242 . . . . 71.22 110.212 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.56 11.67 50.29 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.246 -1.343 . . . . 73.15 113.979 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.88 91.37 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.272 1.034 . . . . 70.43 111.181 -176.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 46.2 tp -138.94 156.09 47.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.551 -1.204 . . . . 71.25 108.414 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.499 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.5 mmmt -77.53 -177.63 4.84 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.45 -0.944 . . . . 75.22 108.45 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -82.29 74.22 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.5 -0.88 . . . . 44.51 110.86 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.88 147.83 67.8 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 125.133 1.373 . . . . 63.24 107.32 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.98 166.46 12.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.834 2.356 . . . . 72.44 113.704 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' A' ' 111' ' ' PRO . 6.2 p -79.36 176.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.408 -0.815 . . . . 72.13 109.138 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.483 ' H ' HG22 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -69.29 146.09 96.4 Favored Pre-proline 0 C--O 1.257 1.466 0 N-CA-C 112.508 0.558 . . . . 75.32 112.508 -175.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.414 ' HG3' ' HB3' ' A' ' 46' ' ' LYS . 5.8 Cg_endo -50.57 171.46 0.1 Allowed 'Trans proline' 0 C--O 1.197 -1.535 0 C-N-CA 124.118 3.212 . . . . 74.22 112.916 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 62.27 14.96 7.18 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.971 1.308 . . . . 75.05 109.298 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.47 30.05 76.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.811 1.084 . . . . 61.23 115.811 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -93.17 130.66 35.17 Favored Pre-proline 0 C--O 1.256 1.398 0 CA-C-N 119.085 1.443 . . . . 73.15 110.981 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.542 ' HA ' HG21 ' A' ' 105' ' ' VAL . 27.0 Cg_endo -70.98 148.57 57.45 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 121.434 1.423 . . . . 72.1 109.18 168.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 32.9 m-85 -69.45 143.86 53.45 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.07 0.462 . . . . 71.31 111.963 -177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.418 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -102.61 114.22 28.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.802 -1.925 . . . . 52.44 105.802 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.25 120.09 41.18 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.258 -0.883 . . . . 70.52 111.311 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.1 mt -127.72 153.57 46.36 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.629 -0.878 . . . . 75.11 108.629 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -114.85 -178.69 0.53 Allowed Pre-proline 0 N--CA 1.406 -2.666 0 CA-C-O 117.035 -1.46 . . . . 73.2 107.73 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.7 Cg_endo -51.75 118.92 4.91 Favored 'Trans proline' 0 CA--C 1.482 -2.083 0 C-N-CA 122.522 2.148 . . . . 71.41 115.116 -170.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -93.85 -93.76 1.57 Allowed Glycine 0 N--CA 1.408 -3.233 0 CA-C-N 113.633 -1.621 . . . . 64.2 109.549 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.63 100.75 8.96 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 109.07 -0.715 . . . . 70.03 109.07 -177.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 66.19 10.11 6.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.539 1.136 . . . . 63.42 113.29 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -124.87 112.89 1.83 Allowed Glycine 0 N--CA 1.432 -1.577 0 CA-C-O 118.337 -1.257 . . . . 72.42 112.53 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.567 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 20.2 Cg_exo -41.21 -25.04 0.22 Allowed 'Trans proline' 0 N--CA 1.504 2.112 1 C-N-CA 126.954 5.103 . . . . 74.32 118.852 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.589 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.0 p90 178.19 165.95 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.997 0.817 . . . . 71.52 109.766 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 2.6 m-20 -139.32 113.17 8.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.371 0.668 . . . . 73.11 109.424 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.472 ' HG ' HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -125.29 124.58 41.93 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.786 -0.766 . . . . 73.45 110.371 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -164.43 166.43 20.58 Favored 'General case' 0 C--O 1.208 -1.109 0 O-C-N 123.087 0.242 . . . . 64.04 110.352 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.46 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 18.8 t -125.51 153.21 43.93 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.381 -1.34 . . . . 71.54 107.381 171.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.418 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 88.8 mt -66.26 128.6 36.77 Favored 'General case' 0 C--O 1.204 -1.316 0 O-C-N 123.227 0.329 . . . . 73.13 111.557 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.53 15.89 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.918 -0.658 . . . . 63.53 112.235 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.24 -16.74 9.02 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.82 1.415 . . . . 74.33 114.82 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.4 -9.38 35.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.15 0.976 . . . . 72.33 109.802 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.85 10.28 86.33 Favored Glycine 0 CA--C 1.505 -0.585 0 CA-C-N 115.334 -0.848 . . . . 72.13 112.281 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' A' ' 133' ' ' LYS . 5.2 mmpt? -124.77 147.89 48.43 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.58 0.352 . . . . 74.42 110.348 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.59 104.91 17.29 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 122.081 0.944 . . . . 74.22 108.733 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.85 -173.64 21.08 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.24 -0.891 . . . . 63.22 111.169 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.28 127.59 9.08 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.646 -1.782 . . . . 53.34 108.646 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.464 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 37.6 m 179.63 -177.91 0.36 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.207 -1.775 . . . . 44.33 106.207 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.54 -75.37 0.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 118.294 0.497 . . . . 62.41 110.32 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -99.76 -17.95 17.46 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.87 -0.604 . . . . 73.42 110.831 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.47 -8.21 59.02 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.466 0.65 . . . . 70.23 109.989 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -87.14 156.97 19.48 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 114.806 -1.088 . . . . 62.44 109.136 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -77.39 134.51 38.41 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.543 -1.28 . . . . 73.03 107.543 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.5 pp -96.82 119.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.893 -0.594 . . . . 65.04 110.719 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 54' ' ' ILE . . . -174.33 167.2 39.49 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 118.818 -1.658 . . . . 72.13 113.116 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.59 150.1 36.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.977 -0.749 . . . . 75.43 108.977 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.589 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 13.7 p90 -165.11 179.23 6.47 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.768 -0.651 . . . . 75.41 109.831 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -119.43 122.23 41.26 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.55 -1.278 . . . . 50.24 107.55 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.06 -1.089 . . . . 71.33 108.06 177.862 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.592 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.4 mpt? . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.426 -0.953 . . . . 71.53 108.426 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.5 t -108.88 77.77 1.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.074 -0.65 . . . . 74.25 110.724 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -155.16 155.26 29.87 Favored Pre-proline 0 C--N 1.316 -0.871 0 C-N-CA 124.814 1.246 . . . . 74.51 107.986 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.59 138.56 75.23 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.684 2.256 . . . . 41.1 110.894 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t70 76.56 -37.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.716 2.007 . . . . 74.44 110.49 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.592 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 77.8 mt-30 -68.68 -21.07 64.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.66 0.743 . . . . 73.34 109.504 173.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.22 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 55.4 109.943 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 67.3 mttm -93.23 -24.47 18.18 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.954 -0.758 . . . . 64.44 108.954 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 97.7 t -71.48 -44.66 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 108.248 -1.019 . . . . 73.43 108.248 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -65.96 -15.9 63.4 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.069 -0.969 . . . . 72.14 111.248 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -84.08 -52.66 12.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.585 -0.894 . . . . 72.12 108.585 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.97 -33.81 71.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.792 -1.094 . . . . 51.52 112.979 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 30.8 mmmt -65.36 -25.74 67.72 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.739 0.78 . . . . 65.13 109.982 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -27.97 24.92 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.836 -0.906 . . . . 75.22 110.836 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.418 ' OD1' HD13 ' A' ' 103' ' ' LEU . 77.5 m-20 -77.23 -34.67 55.95 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.137 0.494 . . . . 62.13 110.607 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.0 pt -68.1 -34.22 65.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 116.021 -0.536 . . . . 73.33 109.558 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -67.24 -29.36 68.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 71.31 109.811 178.133 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.52 75.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.337 -0.847 . . . . 64.44 109.5 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.567 HG12 ' HG ' ' A' ' 100' ' ' LEU . 66.8 mt -66.64 -34.81 72.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.568 0 CA-C-N 115.355 -0.838 . . . . 75.15 110.02 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.68 -26.61 68.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.117 0.485 . . . . 71.24 111.22 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -87.23 -34.36 18.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.119 0.485 . . . . 73.14 109.752 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.63 -28.55 33.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.632 0.604 . . . . 61.11 112.632 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.53 -29.84 68.51 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.216 -1.401 . . . . 74.41 107.216 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 32.4 t70 -71.89 -21.66 61.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.193 -1.367 . . . . 64.23 109.1 174.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.474 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.0 mtt -83.0 -30.29 28.28 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.754 -0.591 . . . . 73.22 109.607 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CD1' ' HD3' ' A' ' 72' ' ' PRO . 55.1 t80 -68.47 -35.62 77.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.955 -1.498 . . . . 73.33 106.955 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 83.9 tttt -55.02 -35.77 64.78 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.206 -0.906 . . . . 74.23 110.044 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.93 -36.43 56.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 73.12 111.813 172.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 92' ' ' LYS . 13.4 t70 -71.02 -26.69 63.22 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.81 -0.632 . . . . 62.42 111.178 -172.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -130.47 22.42 5.13 Favored 'General case' 0 CA--C 1.449 -2.929 0 CA-C-O 118.975 -0.536 . . . . 71.42 112.009 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.7 p90 42.99 31.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.063 1.477 . . . . 74.31 113.495 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.18 161.44 0.6 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.683 -1.228 . . . . 74.31 107.683 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 26.0 m-85 -80.08 154.14 74.92 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 123.289 0.368 . . . . 73.34 111.062 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 22.9 Cg_endo -64.43 167.62 14.54 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 123.471 2.781 . . . . 62.13 111.803 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.407 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 53.2 p -98.21 155.71 17.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.635 -1.617 . . . . 75.11 106.635 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.543 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -66.13 -15.45 63.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 118.967 0.803 . . . . 64.0 111.283 -175.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -102.23 -64.49 1.06 Allowed 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 122.156 -0.34 . . . . 73.12 111.465 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -75.89 -39.65 56.01 Favored 'General case' 0 CA--C 1.486 -1.519 0 O-C-N 122.171 -0.33 . . . . 73.43 110.795 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -73.61 -20.85 79.86 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 118.614 -1.755 . . . . 60.15 113.169 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.5 -48.12 73.68 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 106.94 -1.504 . . . . 73.31 106.94 177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 48.4 mt-10 -71.22 -23.09 61.95 Favored 'General case' 0 C--O 1.18 -2.597 0 CA-C-N 114.553 -1.203 . . . . 74.15 111.019 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.624 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -82.76 -2.79 55.4 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.266 0.555 . . . . 73.21 111.125 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.581 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 70.8 mt -96.23 -28.24 14.63 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.479 -0.782 . . . . 70.41 110.217 173.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.77 -32.5 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.438 0.637 . . . . 51.45 111.183 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 35.8 ttpt -120.59 150.48 40.82 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.188 -1.782 . . . . 75.41 106.188 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -54.54 141.32 54.99 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 118.489 0.586 . . . . 74.4 111.118 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.64 136.32 64.39 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.539 2.826 . . . . 63.14 111.878 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -81.47 -21.67 38.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.694 -0.685 . . . . 70.3 111.138 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.03 -146.39 9.26 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.894 -1.282 . . . . 64.42 109.894 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -117.69 95.87 48.52 Favored Pre-proline 0 C--N 1.288 -2.104 0 O-C-N 122.397 -0.472 . . . . 64.24 110.795 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.93 162.08 32.49 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.727 1.618 . . . . 75.53 108.751 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -82.69 159.21 64.16 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-O 118.205 -0.902 . . . . 73.53 108.958 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.48 97.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.707 1.605 . . . . 74.04 111.41 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 55.5 tttm -152.09 147.33 26.34 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.894 -1.891 . . . . 54.41 105.894 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.88 91.55 3.56 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.936 -0.306 . . . . 73.34 111.153 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -54.53 144.03 22.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.003 1.321 . . . . 73.32 111.498 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 3.1 t-20 -123.43 135.19 53.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.516 -0.766 . . . . 60.3 109.99 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -84.88 176.34 8.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.47 0.652 . . . . 75.22 111.398 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 71.4 20.28 4.97 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.608 1.563 . . . . 62.02 111.388 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 103.16 12.13 32.29 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.904 -1.141 . . . . 52.21 112.718 171.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 0.5 OUTLIER 62.75 85.33 0.13 Allowed 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.552 1.168 . . . . 73.11 108.89 -173.28 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.567 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -133.32 150.4 51.87 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.485 -2.043 . . . . 71.04 105.485 -174.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' N ' HD23 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.03 -178.14 0.96 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.908 0.322 . . . . 73.15 110.738 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -77.62 53.02 1.04 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.882 1.325 . . . . 54.22 112.718 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 ' OD1' ' A' ' 53' ' ' ASP . 70.8 mt -118.55 148.57 44.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 113.578 -1.647 . . . . 73.3 107.858 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.01 -175.46 1.46 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.604 2.202 . . . . 74.14 113.188 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.1 p -79.71 173.44 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.261 1.68 0 N-CA-C 108.271 -1.011 . . . . 44.22 108.271 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 5.8 p-10 -79.8 160.34 69.41 Favored Pre-proline 0 C--O 1.252 1.198 0 N-CA-C 113.635 0.976 . . . . 72.24 113.635 -168.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 10.8 Cg_endo -56.11 169.53 1.43 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.358 2.705 . . . . 73.14 111.681 173.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 64.81 14.58 9.27 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.853 1.261 . . . . 64.34 109.127 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.19 25.33 62.2 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 114.014 -1.448 . . . . 74.42 115.381 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.543 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 7.0 m120 -82.73 148.74 58.56 Favored Pre-proline 0 C--O 1.271 2.215 0 CA-C-N 119.497 1.649 . . . . 63.2 108.634 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.491 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 3.6 Cg_endo -88.89 148.47 5.8 Favored 'Trans proline' 0 N--CA 1.424 -2.57 0 C-N-CA 121.988 1.792 . . . . 63.31 109.087 168.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -68.2 142.49 55.66 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 120.48 -0.488 . . . . 70.22 110.136 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.0 mm100 -101.7 119.52 38.91 Favored 'General case' 0 C--O 1.266 1.928 0 N-CA-C 105.027 -2.212 . . . . 74.5 105.027 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 118.3 33.84 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.405 -1.332 . . . . 73.33 107.405 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 75.9 mt -129.98 150.36 51.29 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.01 -0.737 . . . . 75.1 109.01 169.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.707 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -122.24 -178.47 0.63 Allowed Pre-proline 0 N--CA 1.402 -2.836 0 N-CA-C 105.124 -2.176 . . . . 33.2 105.124 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.709 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 17.9 Cg_endo -54.12 116.72 3.23 Favored 'Trans proline' 0 CA--C 1.492 -1.589 0 CA-C-N 122.327 1.867 . . . . 73.31 114.094 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -104.23 -84.13 1.75 Allowed Glycine 0 N--CA 1.416 -2.638 0 CA-C-N 114.364 -1.289 . . . . 75.53 111.152 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.0 m -112.72 96.13 5.8 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 109.223 -0.658 . . . . 60.24 109.223 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt 63.13 19.54 11.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.928 1.291 . . . . 63.21 112.419 174.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -133.29 114.43 1.37 Allowed Glycine 0 CA--C 1.484 -1.893 0 CA-C-O 118.023 -1.432 . . . . 72.0 112.424 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.519 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 16.6 Cg_exo -41.51 -23.88 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.914 1 C-N-CA 126.667 4.911 . . . . 74.45 118.525 -177.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.6 p90 177.59 156.51 0.35 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.656 0.662 . . . . 74.43 110.285 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 2.7 m-20 -134.29 106.83 7.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.025 0.828 . . . . 74.42 108.789 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 57' ' ' ILE . 3.1 tm? -116.8 126.55 53.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.856 -0.794 . . . . 63.42 108.856 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.547 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 23.9 p90 -168.2 168.61 11.52 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 120.571 -0.451 . . . . 65.41 111.554 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.449 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 67.6 m -125.78 152.25 45.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.524 -1.287 . . . . 52.11 107.524 166.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.435 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 96.5 mt -60.17 148.64 35.49 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.742 0.651 . . . . 72.3 111.562 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.02 -172.27 5.27 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.768 0.667 . . . . 51.23 114.768 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.434 ' H ' ' HA ' ' A' ' 140' ' ' ASP . . . -57.47 -28.15 63.12 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 114.021 1.119 . . . . 52.05 114.021 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -94.23 -5.66 46.41 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.264 -0.574 . . . . 74.23 110.493 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.82 27.43 56.7 Favored Glycine 0 C--N 1.319 -0.386 0 N-CA-C 110.531 -1.028 . . . . 52.23 110.531 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -125.89 141.48 51.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.78 -1.193 . . . . 72.33 107.78 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.652 ' HA ' ' OD1' ' A' ' 142' ' ' ASP 0.271 0.0 OUTLIER -81.15 106.72 13.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.833 0.825 . . . . 63.41 112.767 178.556 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.09 173.27 29.82 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.347 -0.842 . . . . 73.54 113.315 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.4 129.61 9.88 Favored Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.586 -1.806 . . . . 73.13 108.586 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.642 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 23.8 m -178.76 -177.24 0.5 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.223 1.409 . . . . 74.31 107.513 -171.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -97.46 -49.9 4.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.045 -1.062 . . . . 62.11 108.887 171.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.544 ' HA ' HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -88.28 -41.65 12.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.679 -0.691 . . . . 74.2 110.673 -177.403 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.434 ' HA ' ' H ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER -96.28 18.3 14.05 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.606 0.717 . . . . 73.11 110.8 -175.331 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -81.2 156.88 25.44 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.259 -0.882 . . . . 70.12 109.922 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.652 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 36.4 m-20 -76.87 129.85 36.78 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 104.508 -2.404 . . . . 74.32 104.508 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.56 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -94.98 111.97 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 C-N-CA 118.59 -1.244 . . . . 73.01 108.37 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -175.09 176.69 47.2 Favored Glycine 1 N--CA 1.396 -4.027 0 CA-C-N 114.413 -1.267 . . . . 55.54 110.852 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.29 149.23 24.09 Favored 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 107.872 -1.158 . . . . 73.05 107.872 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.614 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 2.1 p90 -156.77 177.83 11.04 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 123.707 0.629 . . . . 72.12 112.082 -173.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -125.05 115.3 20.3 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.5 -0.926 . . . . 71.04 108.5 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 117.227 -1.368 . . . . 75.2 108.376 178.509 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.577 ' N ' ' HG1' ' A' ' 48' ' ' THR . 9.9 ttt . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 106.633 -1.618 . . . . 72.43 106.633 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.3 m -104.11 87.11 2.69 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.189 0.811 . . . . 72.32 113.189 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -154.54 154.16 28.96 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 104.835 -2.283 . . . . 74.11 104.835 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.1 141.07 70.04 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 122.167 1.911 . . . . 64.22 110.45 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 75.73 -36.13 0.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.299 1.44 . . . . 75.23 110.785 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.41 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . 78.2 mt-30 -77.16 -15.16 59.63 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.689 -0.632 . . . . 73.45 109.961 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.7 75.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.134 -0.939 . . . . 65.13 110.545 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -86.94 -22.11 25.83 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.816 -0.629 . . . . 62.42 110.871 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 49.1 t -73.09 -43.21 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 121.421 0.629 . . . . 74.12 109.599 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.577 ' HG1' ' N ' ' A' ' 39' ' ' MET . 14.8 t -64.52 -38.42 90.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.09 -0.505 . . . . 74.43 111.747 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.2 t -70.35 -37.31 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 108.917 -0.772 . . . . 73.5 108.917 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -58.56 -40.67 83.7 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.908 -1.042 . . . . 34.22 111.151 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 13.8 mmmm -65.57 -25.66 67.51 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.163 -0.472 . . . . 71.25 111.182 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.22 -28.15 23.58 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.606 -0.807 . . . . 73.3 111.088 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -82.11 -30.1 31.38 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.008 0.433 . . . . 72.43 111.469 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 50' ' ' ALA . 17.2 pt -73.0 -27.21 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.305 -0.558 . . . . 71.45 109.943 172.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 28.5 tptt -72.58 -26.83 61.85 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.391 -0.596 . . . . 71.33 109.391 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.86 -44.34 81.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 71.02 109.16 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 125' ' ' LEU . 74.9 mt -63.44 -34.62 68.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.684 0 CA-C-N 115.124 -0.944 . . . . 72.14 110.178 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HB2' HD21 ' A' ' 145' ' ' ASN . . . -60.71 -34.42 74.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.898 0.38 . . . . 73.33 111.135 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -80.81 -26.85 36.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.837 -0.62 . . . . 72.24 110.051 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.13 -29.25 24.97 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 120.926 0.393 . . . . 74.14 110.733 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -27.48 62.4 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.218 -1.401 . . . . 75.42 107.218 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 10.7 t70 -66.45 -32.26 73.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.613 -1.176 . . . . 73.52 108.71 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 67.1 mtt -76.2 -31.1 58.26 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 115.18 -0.918 . . . . 73.14 109.518 177.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -69.95 -37.97 76.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.52 -0.548 . . . . 73.33 109.52 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 19.4 pttp -66.36 -19.23 65.75 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 118.867 -1.133 . . . . 75.22 109.453 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.33 -38.21 17.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.545 -0.752 . . . . 74.05 110.471 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 15.9 t70 -73.3 -26.82 61.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.12 0.415 . . . . 71.11 112.12 -174.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.36 24.48 5.87 Favored 'General case' 0 CA--C 1.455 -2.676 0 N-CA-C 108.108 -1.071 . . . . 61.13 108.108 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 44.09 32.82 0.7 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.84 1.256 . . . . 64.11 113.731 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.35 155.98 0.41 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.755 -0.831 . . . . 54.52 108.755 -174.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 10.2 m-85 -77.14 157.73 80.7 Favored Pre-proline 0 N--CA 1.423 -1.779 0 O-C-N 123.572 0.545 . . . . 74.02 110.932 171.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.475 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 60.8 Cg_endo -70.78 163.25 39.74 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.756 2.304 . . . . 63.34 113.244 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.6 p -104.93 155.14 19.21 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.464 -2.05 . . . . 61.21 105.464 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -67.44 -11.9 58.95 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.105 0.955 . . . . 63.14 111.504 -173.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -102.31 -65.58 0.98 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 121.795 -0.566 . . . . 64.54 110.377 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -77.72 -34.69 52.55 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 116.375 -0.375 . . . . 72.33 111.011 -170.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -84.26 -20.94 58.0 Favored Glycine 0 N--CA 1.417 -2.605 0 C-N-CA 118.664 -1.732 . . . . 75.15 112.658 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -73.7 -42.72 60.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.582 -1.636 . . . . 71.45 106.582 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.98 -27.4 67.42 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-N 115.435 -0.802 . . . . 73.25 110.826 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.564 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -84.79 -4.08 58.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.092 0.472 . . . . 75.13 111.515 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 114' ' ' TYR . 1.2 tp -95.79 -25.38 16.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.524 0.678 . . . . 75.52 109.297 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.05 -41.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.608 -0.724 . . . . 63.54 110.366 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -111.41 148.51 32.9 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.41 -0.959 . . . . 74.3 108.41 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.63 128.08 60.92 Favored Pre-proline 0 C--O 1.25 1.125 0 C-N-CA 124.067 0.947 . . . . 74.2 109.797 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.532 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 19.7 Cg_endo -53.62 126.39 21.67 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 124.503 3.469 . . . . 61.03 113.613 -171.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -74.44 117.91 16.79 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.667 -1.151 . . . . 60.51 110.566 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.67 -146.14 16.06 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 108.761 -1.736 . . . . 72.22 108.761 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -125.83 92.83 45.45 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 112.901 0.704 . . . . 70.14 112.901 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HG3' ' HG2' ' A' ' 85' ' ' PRO . 85.8 Cg_endo -76.0 163.12 33.63 Favored 'Trans proline' 0 C--O 1.262 1.693 0 C-N-CA 122.649 2.233 . . . . 70.43 107.562 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.35 159.57 83.35 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 108.584 -0.895 . . . . 74.33 108.584 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.69 98.01 0.18 Allowed 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 121.11 1.207 . . . . 71.15 110.332 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.1 tmtm? -151.79 148.31 27.7 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.474 -2.046 . . . . 70.53 105.474 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.546 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 90.0 m-20 -72.85 93.76 1.74 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.909 0.707 . . . . 62.34 112.909 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.544 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.4 t90 -64.18 144.37 57.17 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.851 0.86 . . . . 73.04 110.472 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -131.81 135.5 46.79 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.162 -0.681 . . . . 60.5 109.162 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 63.5 pttt -85.09 -174.88 5.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.075 0.464 . . . . 74.13 109.777 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 70.2 15.04 7.6 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.473 1.109 . . . . 63.31 110.4 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.3 14.93 21.0 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.498 -1.228 . . . . 72.11 114.078 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.544 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 61.17 89.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.449 1.118 . . . . 75.25 110.975 -176.093 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 57.2 tp -128.01 170.82 12.46 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 124.756 1.222 . . . . 70.15 108.092 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.2 mmmt -88.04 179.47 6.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.549 -1.278 . . . . 53.45 107.549 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.52 ' HD3' ' H ' ' A' ' 102' ' ' LYS 0.26 0.0 OUTLIER -77.33 72.37 3.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.851 1.31 . . . . 72.55 110.959 175.861 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -130.73 148.21 69.2 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 113.643 -1.617 . . . . 72.4 107.808 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.18 170.41 13.28 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.871 1.714 . . . . 74.01 110.887 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 111' ' ' PRO . 5.3 p -79.73 171.7 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.774 -0.824 . . . . 74.12 108.774 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.511 ' OD2' ' HD2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -75.55 149.03 83.51 Favored Pre-proline 0 C--O 1.253 1.269 0 C-N-CA 119.884 -0.726 . . . . 73.24 112.364 -171.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.511 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 36.0 Cg_exo -47.09 171.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.373 3.382 . . . . 72.3 113.93 172.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 70.14 14.81 7.67 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 126.677 1.991 . . . . 75.23 108.596 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.91 32.29 59.12 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 114.174 -1.375 . . . . 73.24 113.057 -175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -92.27 125.67 55.54 Favored Pre-proline 0 C--O 1.263 1.796 0 CA-C-N 116.752 0.276 . . . . 72.34 111.212 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.64 ' HA ' HG21 ' A' ' 105' ' ' VAL . 7.9 Cg_exo -71.1 154.09 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.034 1.822 . . . . 53.42 108.522 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -71.75 142.75 49.74 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.969 -1.093 . . . . 74.12 108.806 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.58 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 2.1 mm100 -102.14 113.76 27.31 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 105.066 -2.198 . . . . 62.14 105.066 -178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.409 ' HB2' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -104.62 118.46 36.64 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.823 -1.081 . . . . 74.43 111.318 -177.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.2 mt -129.31 154.02 47.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.345 -0.843 . . . . 61.01 109.343 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.721 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -108.93 -177.38 0.47 Allowed Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-O 116.971 -1.49 . . . . 75.42 108.711 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 20.1 Cg_endo -46.45 115.99 1.4 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 123.19 2.593 . . . . 72.33 116.359 -162.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.98 -90.93 0.9 Allowed Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 113.817 -1.538 . . . . 52.51 109.948 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.6 m -108.32 96.59 6.46 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.234 -1.024 . . . . 54.33 108.234 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.294 0.0 OUTLIER 54.73 4.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 126.604 1.962 . . . . 64.2 116.26 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -106.62 115.82 4.84 Favored Glycine 0 N--CA 1.426 -1.981 0 CA-C-O 118.027 -1.43 . . . . 63.11 111.303 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.569 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -34.81 -27.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.033 1 C-N-CA 127.052 5.168 . . . . 73.45 118.027 -178.937 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 50.8 p90 -165.45 170.42 14.5 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 118.749 0.704 . . . . 73.33 111.156 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.7 m-20 -132.4 107.13 8.31 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.534 -1.284 . . . . 72.33 107.534 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.09 128.97 54.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.557 -0.905 . . . . 64.23 108.557 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -166.28 166.01 17.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.004 -0.369 . . . . 73.22 110.004 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.515 ' HB3' HD11 ' A' ' 143' ' ' ILE . 18.5 t -124.95 146.76 49.22 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.96 -1.867 . . . . 72.4 105.96 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.58 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 98.3 mt -64.23 155.97 30.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.788 0.328 . . . . 70.24 111.429 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -83.76 -166.19 39.89 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.577 -0.821 . . . . 60.41 112.368 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.69 -22.05 64.99 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.553 0.946 . . . . 62.0 113.553 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.86 -2.75 52.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.755 0.788 . . . . 74.35 110.527 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.433 ' O ' HD13 ' A' ' 128' ' ' LEU . . . 72.29 27.44 69.91 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.797 -0.716 . . . . 51.02 111.74 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -140.07 148.45 41.77 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 123.159 0.583 . . . . 64.34 110.553 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -84.87 109.18 17.94 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.433 0.635 . . . . 64.1 110.596 176.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -147.6 -173.22 18.48 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.851 -1.068 . . . . 61.21 110.67 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.27 128.21 8.12 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.849 -1.7 . . . . 74.44 108.849 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 141' ' ' ALA . 60.2 m 179.95 -177.48 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.879 1.672 . . . . 72.0 106.698 -170.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -78.66 -62.56 1.65 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.929 0.331 . . . . 54.15 110.229 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -111.52 -11.82 14.03 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.513 0.56 . . . . 72.53 112.513 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.69 11.71 28.09 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.757 0.789 . . . . 70.02 110.595 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.441 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.0 155.8 17.86 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.805 -1.089 . . . . 62.51 110.275 178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.1 p-10 -79.67 135.66 36.6 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.31 -1.737 . . . . 64.53 106.31 173.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.59 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.34 113.11 29.92 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 108.041 -1.096 . . . . 73.45 108.041 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.65 151.5 18.98 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 119.368 -1.396 . . . . 54.41 114.582 -170.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.535 HD21 ' HB2' ' A' ' 58' ' ' ALA . 5.2 t30 -153.13 127.0 8.91 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 113.555 -1.323 . . . . 74.43 107.704 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.436 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 5.7 p90 -150.73 157.67 43.23 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 120.119 -0.632 . . . . 71.35 112.398 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -94.14 108.19 20.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.525 -1.657 . . . . 73.42 106.525 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.3 t30 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 114.534 -1.212 . . . . 61.41 108.696 -176.748 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 108.387 -0.968 . . . . 34.44 108.387 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -115.62 89.03 3.01 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.832 -0.747 . . . . 52.24 110.225 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -155.65 161.56 29.2 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 125.983 1.713 . . . . 73.42 106.426 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.49 133.17 42.72 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.463 2.109 . . . . 60.02 110.908 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 74.63 -37.25 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.98 1.312 . . . . 64.25 111.624 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.1 mm100 -68.69 -24.97 64.56 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.266 0.555 . . . . 54.53 109.931 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.77 -16.92 64.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.342 -0.845 . . . . 63.22 110.242 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.51 -25.89 22.32 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 108.369 -0.975 . . . . 74.32 108.369 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 47.4 t -75.82 -43.38 39.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.631 -0.713 . . . . 71.13 110.216 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -65.23 -29.02 69.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.27 -0.877 . . . . 74.1 111.585 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.7 m -84.03 -34.49 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.158 -0.617 . . . . 73.13 109.941 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -60.2 -37.84 81.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.465 -0.789 . . . . 44.14 110.451 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 70.2 mmtt -65.3 -26.23 67.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.704 -0.68 . . . . 74.51 110.423 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.99 -28.39 18.29 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.225 -0.988 . . . . 72.21 111.324 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.45 -27.26 32.01 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.04 0.385 . . . . 60.53 112.04 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 pt -72.06 -30.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.303 -0.559 . . . . 71.32 109.617 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 73.0 mmtt -71.52 -24.27 61.93 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 116.414 -0.357 . . . . 30.3 110.704 175.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.03 75.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.621 -0.718 . . . . 74.23 109.554 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.414 HG12 ' HG ' ' A' ' 100' ' ' LEU . 71.7 mt -68.99 -34.07 62.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.385 -0.825 . . . . 75.31 109.673 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.438 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . . . -58.97 -33.98 71.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 62.05 110.783 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -82.36 -36.27 26.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.485 -0.779 . . . . 73.04 110.166 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.59 -28.92 41.06 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.042 0.386 . . . . 74.53 112.042 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.456 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -70.38 -30.14 66.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.964 -1.495 . . . . 44.11 106.964 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.7 t70 -71.08 -19.54 62.46 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.453 -1.249 . . . . 74.04 109.543 174.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.8 mtt -81.54 -41.04 22.22 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.921 -0.77 . . . . 61.03 108.921 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' HD2' ' CE1' ' A' ' 99' ' ' TYR . 46.4 t80 -64.58 -35.97 82.7 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 107.612 -1.255 . . . . 72.03 107.612 173.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.599 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.1 tttt -54.37 -40.07 67.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.908 -1.042 . . . . 72.0 110.631 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.22 -32.25 38.52 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.527 -0.469 . . . . 54.53 111.363 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.605 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 36.1 t70 -69.81 -24.03 63.41 Favored 'General case' 0 C--O 1.184 -2.37 0 C-N-CA 121.02 -0.272 . . . . 74.44 111.413 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -128.03 19.16 6.54 Favored 'General case' 0 CA--C 1.459 -2.527 0 O-C-N 121.137 -0.977 . . . . 65.11 110.909 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 43.58 34.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.893 1.371 . . . . 73.22 113.107 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.92 152.9 0.37 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.532 -1.213 . . . . 74.41 108.096 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.599 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.6 m-85 -76.38 148.65 80.76 Favored Pre-proline 0 N--CA 1.431 -1.401 0 O-C-N 123.496 0.498 . . . . 73.41 110.76 172.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 28.4 Cg_endo -61.41 162.27 21.13 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.811 3.007 . . . . 52.4 111.883 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -96.77 156.06 16.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.632 -1.618 . . . . 75.23 106.632 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.1 t -69.12 -11.58 60.92 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.287 0.948 . . . . 61.21 110.934 -175.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -102.45 -65.84 0.97 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.096 -0.502 . . . . 75.43 110.99 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.33 -40.42 51.39 Favored 'General case' 0 CA--C 1.486 -1.505 0 O-C-N 122.141 -0.349 . . . . 72.4 110.393 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.7 -20.54 79.48 Favored Glycine 0 N--CA 1.41 -3.066 0 C-N-CA 119.25 -1.453 . . . . 32.34 113.076 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.38 -45.64 68.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.742 -1.577 . . . . 41.54 106.742 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.45 -8.68 57.09 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.18 -0.918 . . . . 64.44 111.733 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.586 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -96.88 -6.01 36.81 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.478 0.656 . . . . 71.13 110.209 175.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 86.4 mt -95.06 -19.81 19.84 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.791 -0.818 . . . . 70.43 108.791 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 t -106.11 -44.56 7.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.633 -0.712 . . . . 54.34 110.931 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.2 mppt? -108.82 148.69 30.19 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.216 -1.031 . . . . 73.23 108.216 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.54 133.05 63.71 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 123.82 0.848 . . . . 74.24 109.833 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.458 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 18.4 Cg_endo -55.3 121.05 9.23 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.688 2.925 . . . . 72.21 113.291 -172.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 t -87.12 -2.48 58.66 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.479 -1.237 . . . . 73.41 109.175 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.29 -147.75 12.61 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.768 -0.933 . . . . 32.33 110.768 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -115.63 99.13 52.16 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 117.7 0.75 . . . . 73.03 110.462 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -102.85 162.2 0.28 Allowed 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 122.904 2.403 . . . . 71.53 112.887 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.428 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 45.5 mt-30 -105.54 98.55 17.56 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 106.0 -1.852 . . . . 74.41 106.0 174.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -36.69 99.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 125.186 3.924 . . . . 64.23 119.675 -167.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.605 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 4.1 mptp? -109.53 149.17 30.01 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 102.103 -3.295 . . . . 55.22 102.103 160.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.35 92.34 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 123.268 0.355 . . . . 73.22 110.277 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.585 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -54.95 140.85 35.89 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 124.969 1.308 . . . . 73.1 112.678 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.59 137.89 54.55 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.929 -1.032 . . . . 61.3 110.14 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -93.12 -178.1 4.68 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.736 0.779 . . . . 72.33 111.023 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t0 65.73 24.29 11.5 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.649 1.58 . . . . 74.1 110.846 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.91 27.58 Favored Glycine 0 CA--C 1.496 -1.132 0 CA-C-N 114.643 -1.162 . . . . 54.21 115.051 168.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.585 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.5 90.28 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.384 1.087 . . . . 74.25 110.775 -175.114 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 101' ' ' LYS . 5.7 tt -138.18 151.04 47.33 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.356 -2.461 . . . . 74.41 104.356 -179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.509 ' N ' HD23 ' A' ' 100' ' ' LEU . 55.8 mtmt -67.39 -172.47 0.23 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.357 -0.537 . . . . 74.51 111.597 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 67.94 6.42 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.094 0.95 . . . . 74.31 111.384 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.52 148.28 69.44 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 126.263 1.825 . . . . 62.43 107.488 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.19 -171.56 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.126 2.551 . . . . 73.44 113.289 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.2 p -85.66 175.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 N-CA-C 108.611 -0.885 . . . . 74.3 108.611 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.471 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.3 t70 -77.58 158.35 78.76 Favored Pre-proline 0 C--O 1.251 1.182 0 CA-C-N 118.89 0.768 . . . . 70.0 109.692 -170.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 68.4 Cg_exo -47.55 170.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.39 2.726 . . . . 74.33 113.855 173.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.567 ' HB2' ' OD1' ' A' ' 110' ' ' ASN . 1.2 m-90 65.13 15.46 10.01 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.018 1.727 . . . . 75.21 110.565 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.15 1.67 50.35 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.135 -0.939 . . . . 21.3 114.993 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.567 ' OD1' ' HB2' ' A' ' 108' ' ' TRP . 25.5 m120 -70.51 128.08 91.46 Favored Pre-proline 0 C--O 1.258 1.544 0 N-CA-C 113.78 1.03 . . . . 70.32 113.78 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.556 ' HA ' HG21 ' A' ' 105' ' ' VAL . 21.1 Cg_exo -67.76 146.64 73.32 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.194 1.929 . . . . 35.33 108.706 166.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -69.64 144.42 52.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.869 -0.789 . . . . 74.03 108.869 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -100.63 113.65 26.68 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.058 -2.201 . . . . 73.35 105.058 -177.269 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.07 119.03 38.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.115 -0.948 . . . . 73.13 111.983 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 88.4 mt -129.33 153.23 48.05 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.251 -1.018 . . . . 70.42 108.251 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.839 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -104.25 -178.62 0.65 Allowed Pre-proline 0 N--CA 1.419 -2.017 0 CA-C-O 116.55 -1.691 . . . . 71.03 108.486 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.839 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 6.9 Cg_endo -42.33 109.83 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.704 2.936 . . . . 63.53 115.623 -165.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -145.26 -63.04 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.05 -1.072 . . . . 64.53 113.807 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 m -84.65 96.91 9.35 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.509 -1.276 . . . . 71.2 109.105 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.6 mttt 74.7 -27.43 0.19 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.215 1.406 . . . . 74.51 114.254 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -161.22 177.23 37.64 Favored Glycine 0 N--CA 1.427 -1.956 0 C-N-CA 117.637 -2.221 . . . . 65.14 116.552 -170.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -34.3 -19.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.576 1 C-N-CA 128.608 6.205 . . . . 73.34 120.367 -178.789 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' A' ' 147' ' ' ASP . 19.3 p90 -171.53 151.9 3.09 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.112 1.324 . . . . 63.11 113.698 171.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.1 m-20 -112.27 106.8 15.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.02 -1.474 . . . . 73.13 107.02 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.51 128.37 45.55 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.979 -0.688 . . . . 72.2 109.879 -177.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 33.9 p90 -165.94 165.34 18.17 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 111.927 0.343 . . . . 72.41 111.927 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 143' ' ' ILE . 46.7 t -125.6 138.19 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.296 -1.372 . . . . 54.21 107.296 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.26 128.13 34.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 111.642 0.238 . . . . 75.4 111.642 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.86 171.32 22.51 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.389 -0.684 . . . . 53.52 111.389 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 108' ' ' TRP . . . -63.31 -3.34 1.88 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 115.489 1.662 . . . . 75.43 115.489 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -100.33 -2.11 34.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.796 0.808 . . . . 73.35 109.739 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.95 38.86 64.4 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.037 -0.825 . . . . 62.12 111.037 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -138.84 147.87 43.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.056 -0.72 . . . . 74.2 109.056 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 7.2 pt-20 -97.99 103.33 15.26 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 105.976 -1.861 . . . . 74.21 105.976 165.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.53 -172.34 20.29 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.03 -1.441 . . . . 75.42 111.209 -171.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.57 8.76 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.472 -1.051 . . . . 74.13 110.472 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.562 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 13.4 m 177.82 -177.67 0.21 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 127.663 2.385 . . . . 70.12 105.895 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -66.49 0.92 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 119.03 0.832 . . . . 73.12 110.341 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 130' ' ' ALA . 5.1 t30 -87.23 -27.71 22.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.108 0.956 . . . . 74.21 111.707 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 9.55 42.86 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.572 0.701 . . . . 63.22 111.448 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.562 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -103.36 157.41 17.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 115.129 -0.942 . . . . 31.23 109.466 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 8.9 p-10 -78.45 127.23 31.88 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.991 -1.485 . . . . 74.45 106.991 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 133.45 37.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.811 -1.181 . . . . 73.23 107.811 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.03 169.59 34.74 Favored Glycine 0 N--CA 1.414 -2.814 0 C-N-CA 117.685 -2.198 . . . . 62.23 114.276 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 58' ' ' ALA . 8.0 t30 -131.36 148.35 52.66 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.141 -1.8 . . . . 71.23 106.141 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -143.61 135.12 26.14 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.637 -0.825 . . . . 74.41 110.346 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.487 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 16.1 t0 -104.66 105.25 15.26 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 105.675 -1.972 . . . . 74.51 105.675 174.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.274 -2.696 0 N-CA-C 105.94 -1.874 . . . . 63.54 105.94 178.1 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.674 ' N ' ' HG1' ' A' ' 48' ' ' THR . 19.8 ttt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 65.04 109.449 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 m -96.18 91.3 5.85 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.676 0.75 . . . . 72.44 112.66 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 12.6 ptp180 -156.79 165.0 19.72 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 106.859 -1.534 . . . . 62.35 106.859 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -42.79 120.33 1.8 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.864 3.043 . . . . 74.14 114.608 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.65 -31.86 0.23 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 127.575 2.35 . . . . 65.22 113.048 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.498 ' HA ' HG23 ' A' ' 47' ' ' VAL . 10.7 mm100 -68.92 -22.78 64.14 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.967 -1.123 . . . . 70.44 107.967 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 48' ' ' THR . . . -63.74 -26.1 68.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.659 -1.155 . . . . 70.32 109.912 173.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 63.3 mttp -80.6 -26.08 38.06 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.928 -0.768 . . . . 72.13 108.928 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.539 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 43.9 t -74.29 -44.57 48.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 122.054 0.931 . . . . 72.33 108.637 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.674 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.4 t -71.11 -30.99 67.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.474 -1.239 . . . . 75.34 112.071 -173.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.63 -40.21 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 120.321 -0.552 . . . . 73.44 110.124 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -60.53 -31.68 70.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.275 0.56 . . . . 61.41 111.122 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 29.6 mtpp -66.26 -25.43 66.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.989 0.899 . . . . 61.12 111.281 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.96 -30.49 31.55 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.737 -1.345 . . . . 63.45 109.737 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.688 ' O ' HG13 ' A' ' 57' ' ' ILE . 72.9 m-20 -73.33 -38.54 65.76 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.314 -0.443 . . . . 73.1 110.739 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.466 HD12 ' C ' ' A' ' 144' ' ' GLY . 19.0 pt -62.49 -36.2 73.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 121.209 -0.196 . . . . 64.34 111.052 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.87 -30.15 70.24 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.942 -0.703 . . . . 61.23 110.8 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -69.13 -44.35 72.54 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.677 -0.692 . . . . 72.44 111.048 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.688 HG13 ' O ' ' A' ' 53' ' ' ASP . 23.3 mt -63.52 -42.49 96.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-N 115.349 -0.841 . . . . 61.5 109.223 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.54 -27.71 67.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.863 -0.608 . . . . 72.13 111.618 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -76.91 -30.63 56.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.618 0.723 . . . . 64.11 109.416 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.88 -24.45 38.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.172 -0.467 . . . . 73.23 110.115 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.91 -31.25 71.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.37 -1.344 . . . . 74.13 107.37 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 4.5 t70 -66.08 -28.82 69.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.174 -0.921 . . . . 71.42 109.66 170.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.8 ttm -82.82 -28.24 30.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.914 -0.585 . . . . 71.15 110.166 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -72.46 -34.35 67.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.318 -1.364 . . . . 74.14 107.318 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 28.5 ttpp -57.5 -25.76 60.28 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.215 -0.902 . . . . 55.31 109.561 171.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.9 tp -87.3 -36.0 18.12 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 123.386 0.674 . . . . 75.21 111.365 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.51 -27.0 58.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.942 0.401 . . . . 75.11 110.398 -173.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -130.61 24.39 5.08 Favored 'General case' 0 CA--C 1.457 -2.621 0 N-CA-C 112.418 0.525 . . . . 71.1 112.418 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.1 p90 42.65 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 125.015 1.447 . . . . 75.35 113.948 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.24 161.74 1.13 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.747 -0.835 . . . . 63.15 108.747 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.54 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 13.4 m-85 -78.89 155.52 77.75 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 123.617 0.573 . . . . 75.42 110.501 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.542 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 51.0 Cg_endo -73.81 160.74 43.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.341 2.028 . . . . 75.52 110.917 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -92.58 155.74 17.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.096 -1.816 . . . . 73.24 106.096 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.575 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.2 t -70.1 -7.32 40.49 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.61 1.095 . . . . 74.11 111.421 -176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -103.02 -66.89 0.91 Allowed 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 121.934 -0.479 . . . . 61.34 110.877 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -84.17 -31.65 25.03 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.905 -0.589 . . . . 73.14 112.469 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -78.35 -21.32 70.25 Favored Glycine 0 N--CA 1.409 -3.126 0 C-N-CA 117.54 -2.267 . . . . 74.02 111.316 176.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.89 -46.67 70.99 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 106.602 -1.629 . . . . 64.24 106.602 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.0 -31.62 72.94 Favored 'General case' 0 N--CA 1.396 -3.174 0 CA-C-N 114.918 -1.037 . . . . 73.1 109.358 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.603 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -79.8 -2.21 42.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 73.51 111.917 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.611 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 63.3 mt -98.26 -24.56 15.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.915 -0.584 . . . . 55.31 110.28 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.42 -32.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.367 0.603 . . . . 51.23 110.687 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -117.66 146.43 43.7 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 125.266 1.426 . . . . 71.31 107.158 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -54.59 129.19 62.69 Favored Pre-proline 0 N--CA 1.433 -1.3 0 C-N-CA 123.506 0.722 . . . . 74.3 109.641 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -58.96 126.17 20.32 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 124.214 3.276 . . . . 75.12 113.163 -172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -96.62 91.49 5.77 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-O 122.051 0.929 . . . . 73.14 109.876 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.6 -126.33 1.18 Allowed Glycine 0 N--CA 1.422 -2.284 0 CA-C-N 114.365 -1.289 . . . . 72.12 110.03 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -126.56 91.93 46.29 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 117.208 0.504 . . . . 71.41 109.704 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -97.21 162.91 0.98 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.65 1.567 . . . . 71.31 110.632 172.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -90.33 159.08 42.56 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.41 -1.33 . . . . 63.42 107.41 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.05 98.18 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.441 1.427 . . . . 54.22 111.965 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -151.53 147.43 26.81 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.921 -2.251 . . . . 74.22 104.921 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.26 94.4 8.42 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.831 -0.748 . . . . 74.54 110.128 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -54.05 140.23 32.24 Favored 'General case' 0 C--O 1.251 1.156 0 C-N-CA 124.235 1.014 . . . . 70.3 112.665 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -115.6 132.25 56.69 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.052 -1.431 . . . . 72.34 109.56 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 14.8 ptmm? -79.15 -176.88 5.36 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 119.759 -0.776 . . . . 71.3 109.522 175.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 96' ' ' LYS . 7.2 t70 69.34 31.06 3.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.437 -1.256 . . . . 62.35 109.477 170.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 92.02 7.15 64.46 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-N 114.469 -1.241 . . . . 61.02 113.534 167.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 62.91 87.57 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.817 -1.179 . . . . 70.33 107.817 -169.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HG ' HG12 ' A' ' 57' ' ' ILE . 2.7 tt -129.96 149.88 51.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.902 -1.888 . . . . 73.51 105.902 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -73.8 -178.74 3.32 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.011 -0.366 . . . . 75.43 110.011 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -82.21 73.61 9.23 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.582 1.182 . . . . 72.34 109.504 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -130.64 148.59 70.65 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.859 -1.973 . . . . 72.43 107.256 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.57 177.28 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.05 1.833 . . . . 73.41 111.117 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.545 HG21 ' HA ' ' A' ' 111' ' ' PRO . 3.3 p -82.41 174.67 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.521 -0.918 . . . . 73.31 108.521 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.0 t70 -69.45 139.1 89.12 Favored Pre-proline 0 C--O 1.258 1.503 0 N-CA-C 110.579 -0.156 . . . . 42.43 110.579 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.449 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 6.3 Cg_endo -50.5 172.19 0.09 OUTLIER 'Trans proline' 0 C--O 1.193 -1.744 0 C-N-CA 124.13 3.22 . . . . 64.43 113.301 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.406 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 66.64 14.67 9.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.118 1.367 . . . . 71.21 109.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.21 32.17 81.38 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 55.21 114.671 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.482 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 90.8 m-20 -92.9 119.97 67.44 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 117.629 0.714 . . . . 73.13 110.698 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 105' ' ' VAL . 36.8 Cg_exo -68.41 139.58 45.7 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.291 1.327 . . . . 75.04 108.669 167.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.642 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 56.0 m-85 -68.36 144.74 54.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.051 0.453 . . . . 64.15 110.317 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.569 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -102.3 114.06 27.9 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.839 -1.541 . . . . 61.23 106.839 -176.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.41 118.47 36.11 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.656 -1.239 . . . . 64.15 107.656 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.77 153.64 47.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.763 0.664 . . . . 71.13 109.223 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.788 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -121.85 -179.77 0.82 Allowed Pre-proline 0 N--CA 1.393 -3.302 0 N-CA-C 107.852 -1.166 . . . . 72.42 107.852 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.788 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 26.6 Cg_endo -57.82 128.43 29.04 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.066 1.844 . . . . 75.14 114.272 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.17 -89.3 0.44 Allowed Glycine 0 N--CA 1.411 -2.99 0 CA-C-N 114.131 -1.395 . . . . 61.22 111.051 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 p -108.85 101.75 10.83 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 123.028 0.531 . . . . 75.42 110.614 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp 72.63 -3.7 2.29 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.869 1.268 . . . . 63.44 112.444 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.3 123.55 7.29 Favored Glycine 0 N--CA 1.414 -2.792 0 CA-C-O 118.481 -1.177 . . . . 63.1 112.542 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 54.4 Cg_exo -60.63 -26.43 82.89 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.109 3.206 . . . . 73.03 110.84 165.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.1 p90 -173.81 168.08 4.33 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.61 0.764 . . . . 70.15 110.019 166.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.61 112.56 8.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.904 -1.147 . . . . 62.54 107.904 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.507 HD21 ' HB ' ' A' ' 57' ' ' ILE . 52.9 tp -128.14 123.97 35.72 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.213 -0.929 . . . . 64.12 110.505 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.439 ' HB3' ' HA3' ' A' ' 144' ' ' GLY . 53.5 p90 -168.06 169.06 11.45 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 120.889 -0.324 . . . . 55.11 111.474 -174.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.642 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 22.2 t -125.14 160.69 28.53 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.844 -1.539 . . . . 75.22 106.844 170.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.569 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 89.5 mt -68.83 167.1 16.26 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.307 0.38 . . . . 73.34 110.636 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.65 -170.81 43.51 Favored Glycine 0 CA--C 1.496 -1.143 0 C-N-CA 119.419 -1.372 . . . . 73.3 111.77 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.65 -15.1 36.77 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.391 0.676 . . . . 71.34 112.731 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -94.45 -9.38 35.71 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.205 0.526 . . . . 74.15 110.714 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.8 23.73 66.29 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 121.109 -0.567 . . . . 73.41 112.167 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.01 148.62 42.12 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.47 -0.937 . . . . 62.41 108.47 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.44 105.98 18.06 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.693 0.759 . . . . 53.34 110.835 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.02 -174.32 21.16 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.148 -0.933 . . . . 52.05 111.234 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.74 129.58 9.94 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.577 -1.409 . . . . 61.25 109.577 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.3 m -177.74 -178.49 0.72 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 124.604 1.162 . . . . 63.41 108.275 -171.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -99.67 -25.99 14.21 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.754 -0.378 . . . . 72.21 111.933 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.88 -33.45 2.93 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.608 0.718 . . . . 43.33 110.038 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -95.38 15.21 20.1 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.909 -0.587 . . . . 63.12 110.897 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -87.27 155.32 20.12 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-N 115.994 -0.548 . . . . 63.41 110.043 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.73 129.11 34.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.901 -1.518 . . . . 74.01 106.901 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.571 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -96.48 115.92 37.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-O 121.472 0.653 . . . . 75.2 109.301 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.466 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -163.97 177.81 39.61 Favored Glycine 0 N--CA 1.417 -2.57 0 C-N-CA 118.756 -1.688 . . . . 72.3 113.719 -176.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.48 146.05 16.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.26 -1.385 . . . . 72.22 107.26 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 16.2 p90 -157.41 168.76 26.4 Favored 'General case' 0 C--N 1.267 -2.999 0 CA-C-O 120.972 0.415 . . . . 74.23 110.798 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 17.3 t70 -105.87 125.19 50.7 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.069 -1.456 . . . . 43.5 107.069 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.524 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 4.0 p-10 . . . . . 0 N--CA 1.421 -1.882 0 O-C-N 125.01 1.444 . . . . 61.41 108.553 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.643 ' N ' ' HG1' ' A' ' 48' ' ' THR . 46.5 tpp . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.692 0.282 . . . . 64.31 110.764 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -105.87 91.79 3.89 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.91 -0.494 . . . . 65.54 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -148.69 164.95 19.28 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 106.547 -1.649 . . . . 72.33 106.547 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 44' ' ' GLN . 51.7 Cg_exo -46.98 120.5 4.22 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.204 2.602 . . . . 70.43 112.939 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t70 73.34 -30.07 0.21 Allowed 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 127.135 2.174 . . . . 64.41 110.928 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.481 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 14.0 mm100 -68.02 -25.17 65.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.224 -0.898 . . . . 74.3 109.516 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.48 65.37 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.314 -0.857 . . . . 71.12 110.328 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -87.65 -26.69 22.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.457 -0.942 . . . . 64.32 108.457 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 37.6 t -74.71 -44.6 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.71 0.767 . . . . 41.2 109.261 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.643 ' HG1' ' N ' ' A' ' 39' ' ' MET . 14.2 t -59.85 -38.18 81.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.326 -1.306 . . . . 73.33 112.889 -172.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -84.37 -34.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 119.88 -0.728 . . . . 44.3 110.442 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -60.2 -32.99 71.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.136 -0.484 . . . . 75.13 111.813 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 12.2 mmmm -65.73 -25.33 67.24 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.993 0.902 . . . . 75.43 110.048 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.6 -22.54 39.58 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.632 -0.987 . . . . 60.44 110.632 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 57' ' ' ILE . 75.5 m-20 -82.76 -38.48 23.15 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.671 0.272 . . . . 75.54 110.27 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.7 pt -64.02 -32.53 57.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.432 -0.581 . . . . 75.13 109.432 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -33.03 73.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.907 -0.588 . . . . 65.33 110.621 176.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.64 74.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.023 -0.535 . . . . 63.22 110.334 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 53' ' ' ASP . 55.3 mt -65.09 -37.83 81.21 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 CA-C-N 115.755 -0.657 . . . . 72.32 110.268 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.57 67.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.219 0.533 . . . . 74.04 111.06 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.27 -19.99 24.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.194 0.521 . . . . 34.22 110.251 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -29.02 21.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.226 0.536 . . . . 73.2 110.115 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.92 -30.27 67.64 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.688 -1.597 . . . . 73.24 106.688 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 31.8 t70 -73.15 -20.51 60.89 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.351 -1.295 . . . . 72.1 109.428 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.2 ttt -79.18 -34.32 43.14 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 115.747 -0.661 . . . . 75.42 109.367 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.438 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 1.3 t80 -64.05 -39.66 94.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.695 -1.595 . . . . 74.23 106.695 172.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 76.7 tttt -54.61 -33.02 59.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.813 -1.085 . . . . 64.41 110.304 175.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 99.3 mt -82.83 -36.2 25.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.137 -0.483 . . . . 74.44 111.522 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.16 -25.26 63.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.255 0.465 . . . . 62.14 112.255 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -128.67 18.94 6.21 Favored 'General case' 0 CA--C 1.442 -3.209 0 O-C-N 121.962 -0.461 . . . . 64.32 111.062 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 p90 43.37 33.51 0.62 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 125.13 1.519 . . . . 74.11 112.558 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -177.52 156.3 1.16 Allowed 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.709 -1.219 . . . . 64.11 107.709 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.3 m-85 -78.83 148.6 72.72 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 123.254 0.347 . . . . 64.01 111.257 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.587 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 33.6 Cg_endo -66.4 158.41 55.4 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.892 2.394 . . . . 43.24 109.752 174.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.464 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 47.4 p -94.01 156.71 16.46 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.841 -1.17 . . . . 74.43 107.841 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.5 t -66.38 -13.09 60.14 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 119.9 1.227 . . . . 72.43 111.165 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -102.21 -64.75 1.04 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 121.982 -0.449 . . . . 61.04 111.162 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -40.26 60.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 109.096 -0.705 . . . . 61.53 109.096 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -72.52 -20.75 79.61 Favored Glycine 0 N--CA 1.407 -3.27 0 C-N-CA 119.717 -1.23 . . . . 14.34 113.665 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.06 -47.31 62.49 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.349 -1.352 . . . . 74.24 107.349 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.56 -32.11 70.05 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 115.571 -0.74 . . . . 65.54 110.177 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.611 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -83.64 -5.54 59.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.786 0.661 . . . . 51.31 112.786 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 42.1 mt -93.14 -24.21 18.33 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.506 0.669 . . . . 65.31 109.822 174.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 t -102.72 -35.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.403 -0.817 . . . . 75.3 110.533 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 95.4 mttt -126.51 150.9 48.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.732 -1.581 . . . . 54.44 106.732 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -54.22 141.15 52.25 Favored Pre-proline 0 N--CA 1.48 1.063 0 N-CA-C 113.244 0.831 . . . . 74.14 113.244 -172.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 30.2 Cg_endo -61.15 152.66 70.23 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.974 3.116 . . . . 45.44 114.551 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -110.78 111.19 22.19 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 114.14 -1.391 . . . . 65.02 110.219 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.53 -121.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.769 -0.729 . . . . 70.44 111.583 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -136.96 91.91 14.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 C-N-CA 121.136 -0.226 . . . . 73.32 110.527 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -95.27 161.54 1.6 Allowed 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 121.925 1.75 . . . . 74.21 110.596 172.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -87.63 159.26 49.92 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 106.76 -1.57 . . . . 71.23 106.76 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.55 99.31 0.31 Allowed 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 120.906 1.07 . . . . 73.54 110.684 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -150.84 149.33 29.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.571 -1.64 . . . . 74.11 106.571 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -66.01 97.58 0.38 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.007 0.743 . . . . 74.32 113.007 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.558 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.1 t90 -71.94 143.5 49.26 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.752 -0.658 . . . . 74.45 109.573 171.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -134.95 137.4 43.06 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.604 -0.517 . . . . 73.43 109.604 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' HG3' ' OD2' ' A' ' 97' ' ' ASP . 22.4 pttp -76.46 -166.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.142 -0.688 . . . . 74.35 109.142 175.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' A' ' 96' ' ' LYS . 41.0 m-20 66.32 8.65 5.8 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.437 1.095 . . . . 73.3 112.509 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 96.0 21.02 24.31 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 115.212 -0.904 . . . . 33.05 111.771 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.6 93.51 0.08 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.322 1.058 . . . . 63.22 111.101 -177.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.43 152.67 48.73 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.122 -0.944 . . . . 63.04 108.98 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.83 -169.05 2.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.976 -1.12 . . . . 74.23 107.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -72.75 70.69 0.98 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 122.747 1.261 . . . . 65.22 110.492 174.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.43 148.54 70.52 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 125.765 1.626 . . . . 62.13 108.331 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.63 -168.76 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.425 2.083 . . . . 73.14 110.754 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.649 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.7 p -86.41 174.25 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 106.576 -1.638 . . . . 61.34 106.576 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.424 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 4.3 t70 -97.37 151.59 37.75 Favored Pre-proline 0 C--O 1.252 1.193 0 C-N-CA 117.255 -1.778 . . . . 71.15 110.818 -173.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -38.79 171.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.824 3.683 . . . . 54.22 115.383 166.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 67.9 14.5 9.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.386 -1.733 . . . . 71.33 107.064 -171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.31 29.22 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 114.052 -1.431 . . . . 72.44 114.497 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -92.14 131.57 34.6 Favored Pre-proline 0 C--O 1.261 1.661 0 CA-C-N 117.941 0.871 . . . . 73.34 112.162 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.649 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 16.1 Cg_exo -70.15 148.88 63.52 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.356 2.037 . . . . 75.02 109.516 170.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.519 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 27.7 m-85 -69.59 140.31 53.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.199 -1.0 . . . . 70.01 108.588 175.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -101.57 115.04 29.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.74 -1.578 . . . . 74.33 106.74 -173.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.92 119.81 39.51 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.88 -1.054 . . . . 72.5 112.319 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 83.0 mt -128.57 143.9 51.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.242 -1.021 . . . . 75.4 108.242 172.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.758 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -111.17 -178.21 0.52 Allowed Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 107.525 -1.287 . . . . 50.25 107.525 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.758 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 37.3 Cg_endo -60.88 130.62 33.6 Favored 'Trans proline' 0 CA--C 1.486 -1.922 0 CA-C-N 121.734 1.655 . . . . 61.4 114.678 -175.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -121.15 -89.83 1.08 Allowed Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 113.028 -1.896 . . . . 42.34 110.889 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.3 m -105.06 106.25 16.65 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 107.675 -1.231 . . . . 71.21 107.675 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt 62.39 -16.22 0.05 Allowed 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 127.962 2.505 . . . . 65.1 115.348 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -102.22 113.15 4.52 Favored Glycine 0 CA--C 1.477 -2.343 0 CA-C-O 118.128 -1.373 . . . . 72.32 113.751 -174.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 34.8 Cg_exo -46.02 -22.76 1.51 Allowed 'Trans proline' 0 C--N 1.376 1.974 1 C-N-CA 126.511 4.807 . . . . 70.04 116.264 177.577 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.2 p90 179.91 166.76 1.24 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.97 0.508 . . . . 64.43 110.571 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 7.5 m-20 -139.53 108.97 6.15 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.069 0.856 . . . . 73.01 109.251 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -123.46 130.27 52.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.332 -0.547 . . . . 72.24 110.085 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -166.88 161.91 15.52 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 116.544 -0.298 . . . . 74.3 110.714 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.519 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 25.1 t -126.01 135.99 52.45 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.573 -1.269 . . . . 73.32 107.573 171.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.23 133.53 55.3 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.089 0.403 . . . . 62.43 112.089 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -86.14 -159.19 32.2 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.889 -0.596 . . . . 55.41 113.384 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -13.05 47.74 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.763 1.394 . . . . 71.54 114.763 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 140' ' ' ASP . 36.7 t70 -94.95 -10.09 32.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 119.812 -0.755 . . . . 70.52 110.181 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.18 70.95 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.736 -0.665 . . . . 73.2 112.538 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -140.7 137.75 33.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.469 -0.938 . . . . 73.14 108.469 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.34 112.88 12.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.245 0.545 . . . . 61.15 109.62 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.44 -173.61 20.79 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 108.857 -1.697 . . . . 32.52 108.857 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.51 126.3 8.3 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 118.706 -1.711 . . . . 71.22 109.861 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 141' ' ' ALA . 28.6 m 178.08 -178.67 0.26 Allowed 'General case' 0 C--O 1.251 1.146 0 C-N-CA 127.094 2.158 . . . . 73.42 106.713 -174.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.01 -56.72 2.76 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.293 -0.563 . . . . 63.41 112.501 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -107.74 -23.64 12.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.239 -0.584 . . . . 74.42 111.391 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 10.4 m-20 -76.11 -28.82 57.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 121.964 0.888 . . . . 62.41 109.242 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 137' ' ' SER . . . -80.8 159.41 25.14 Favored 'General case' 0 CA--C 1.47 -2.131 0 CA-C-N 113.572 -1.649 . . . . 44.33 111.033 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -76.65 135.5 39.13 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 107.027 -1.471 . . . . 54.02 107.027 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.506 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -97.71 128.85 48.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.394 -0.821 . . . . 65.21 110.295 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -172.55 -179.74 43.55 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 119.325 -1.417 . . . . 73.42 112.269 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.52 155.13 17.07 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.068 -1.456 . . . . 64.54 107.068 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.456 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 3.2 p90 -165.69 177.51 7.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.191 0.519 . . . . 73.14 111.435 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -116.1 125.59 52.59 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.398 -1.704 . . . . 61.14 106.398 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.537 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 41.0 t30 . . . . . 0 C--N 1.304 -1.388 0 N-CA-C 108.211 -1.033 . . . . 73.45 108.211 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.426 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.4 mpt? . . . . . 0 C--O 1.234 0.274 0 N-CA-C 108.549 -0.908 . . . . 71.040000000000006 108.549 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -107.14 82.3 1.66 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.297 0.57 . . . . 63.240000000000002 111.669 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -154.55 159.06 32.28 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.177 -1.786 . . . . 75.519999999999996 106.177 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.99 138.48 52.53 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.673 2.249 . . . . 72.099999999999994 111.305 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 72.99 -35.94 0.34 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.073 1.349 . . . . 72.150000000000006 113.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 66.0 mt-30 -74.19 -25.54 59.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.048 -1.093 . . . . 72.510000000000005 108.048 175.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.5 64.64 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.878 -1.055 . . . . 52.109999999999999 109.847 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HD2' ' HB3' ' A' ' 107' ' ' PRO . 44.0 mmtm -85.32 -25.62 27.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.093 -1.077 . . . . 71.129999999999995 108.093 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 86.4 t -74.63 -44.36 46.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.239 -0.891 . . . . 63.130000000000003 109.545 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -65.7 -25.45 67.32 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 115.145 -0.934 . . . . 71.120000000000005 111.659 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.5 -49.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.747 -0.835 . . . . 74.329999999999998 108.747 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' HB3' HD12 ' A' ' 143' ' ' ILE . . . -64.44 -24.74 67.73 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.987 -1.006 . . . . 72.040000000000006 112.064 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.1 mmmt -65.74 -26.41 67.72 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.604 0.716 . . . . 73.030000000000001 110.762 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.2 -26.94 29.48 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 110.005 -1.238 . . . . 72.219999999999999 110.005 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.623 ' O ' HG13 ' A' ' 57' ' ' ILE . 65.7 m-20 -78.26 -38.13 43.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.432 -0.384 . . . . 75.019999999999996 110.687 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.459 HG21 ' HA2' ' A' ' 144' ' ' GLY . 19.8 pt -66.61 -38.19 81.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.355 -0.216 . . . . 70.120000000000005 111.082 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.5 tptt -69.0 -26.72 65.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.002 0.43 . . . . 70.310000000000002 110.121 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -66.93 -45.16 78.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 63.43 110.242 174.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 53' ' ' ASP . 34.1 mt -64.73 -42.27 94.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.729 -0.669 . . . . 63.0 109.507 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.15 -28.4 66.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.865 -0.607 . . . . 53.329999999999998 111.235 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.62 -30.1 29.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 64.540000000000006 110.02 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.67 -28.1 30.87 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.712 -0.677 . . . . 73.140000000000001 110.366 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.48 -30.7 71.09 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.822 -1.177 . . . . 75.120000000000005 107.822 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.62 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.8 t70 -71.22 -23.25 61.98 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 122.183 0.992 . . . . 71.109999999999999 109.273 173.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 mtt -83.59 -28.43 28.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.726 -0.67 . . . . 64.430000000000007 110.724 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.545 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 70.8 t80 -71.55 -36.06 70.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.553 -1.277 . . . . 74.400000000000006 107.553 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.641 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 74.8 tttt -53.95 -36.09 62.46 Favored 'General case' 0 C--O 1.208 -1.114 0 CA-C-N 114.917 -1.038 . . . . 70.109999999999999 109.108 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.8 tp -76.48 -36.73 57.69 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.011 -0.541 . . . . 74.340000000000003 111.333 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.547 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 19.0 t70 -71.95 -23.77 61.5 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 112.035 0.383 . . . . 75.099999999999994 112.035 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.2 20.03 5.84 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 109.13 -0.693 . . . . 63.109999999999999 109.13 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 p90 42.95 32.96 0.46 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.999 1.437 . . . . 72.439999999999998 113.602 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 159.1 0.99 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.762 -0.829 . . . . 43.409999999999997 108.762 -172.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 23.7 m-85 -78.55 151.48 77.41 Favored Pre-proline 0 N--CA 1.425 -1.717 0 O-C-N 123.486 0.491 . . . . 63.539999999999999 111.23 173.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.5 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 30.8 Cg_endo -66.28 162.26 36.89 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.349 2.7 . . . . 73.340000000000003 111.055 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 76' ' ' GLN . 69.5 p -98.62 156.33 16.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.27 -1.752 . . . . 65.239999999999995 106.27 174.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -67.81 -12.58 60.9 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 119.656 1.116 . . . . 72.230000000000004 111.765 -175.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -102.09 -64.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.979 -0.45 . . . . 75.219999999999999 110.742 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.408 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 14.9 mm100 -74.12 -40.87 62.37 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 110.253 -0.277 . . . . 70.109999999999999 110.253 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.639 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.49 -20.94 79.43 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.088 -1.529 . . . . 64.219999999999999 113.458 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.0 -47.37 62.47 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.567 -1.642 . . . . 72.329999999999998 106.567 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 30.4 mt-10 -60.98 -33.48 73.29 Favored 'General case' 0 C--O 1.169 -3.175 0 CA-C-N 114.994 -1.003 . . . . 75.019999999999996 110.347 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.639 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.35 -7.05 55.44 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.629 . . . . 43.340000000000003 111.811 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -95.92 -18.5 20.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.932 -0.576 . . . . 73.450000000000003 110.322 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.86 -34.32 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 116.2 -0.454 . . . . 74.439999999999998 111.863 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 42.7 pttt -125.97 152.29 45.89 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.564 -2.013 . . . . 74.140000000000001 105.564 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 84' ' ' LYS . 3.9 mppt? -54.74 135.08 64.97 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 118.956 0.798 . . . . 73.129999999999995 111.813 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.545 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 18.3 Cg_endo -60.87 125.05 16.19 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.944 3.096 . . . . 74.409999999999997 113.352 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.0 t -84.1 139.92 32.14 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.429 -1.323 . . . . 73.420000000000002 107.429 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.13 -131.84 8.35 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.682 -1.767 . . . . 75.299999999999997 108.682 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.15 97.4 32.0 Favored Pre-proline 0 C--N 1.299 -1.591 0 CA-C-N 118.088 0.944 . . . . 71.239999999999995 111.966 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -92.46 150.25 2.94 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.335 1.356 . . . . 73.540000000000006 109.568 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -79.66 160.33 69.8 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.044 -1.095 . . . . 72.030000000000001 108.044 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.6 97.63 0.27 Allowed 'Trans proline' 0 C--O 1.249 1.056 0 CA-C-N 120.602 1.251 . . . . 65.200000000000003 109.64 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.547 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . 8.2 tmtm? -152.74 147.29 25.91 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.924 -2.25 . . . . 73.540000000000006 104.924 -175.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -81.76 92.7 6.68 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.278 -0.969 . . . . 73.439999999999998 111.051 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.492 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.9 t90 -54.9 143.69 25.25 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.288 1.035 . . . . 71.329999999999998 111.584 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.37 137.2 53.43 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.855 0.862 . . . . 74.409999999999997 109.003 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -84.71 -169.06 2.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.011 -0.737 . . . . 71.040000000000006 109.011 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t0 71.1 12.47 6.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.304 1.442 . . . . 71.0 110.535 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.52 14.98 30.93 Favored Glycine 0 N--CA 1.425 -2.061 0 CA-C-N 114.341 -1.3 . . . . 74.340000000000003 112.946 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.43 91.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 122.633 1.206 . . . . 71.239999999999995 109.533 -174.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -123.92 171.26 9.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 113.91 -1.495 . . . . 71.219999999999999 109.282 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HG3' ' HB1' ' A' ' 56' ' ' ALA . 73.9 mmtt -94.12 -168.57 1.89 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.396 -1.335 . . . . 72.439999999999998 107.396 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.73 70.85 3.26 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.716 1.246 . . . . 73.409999999999997 110.535 175.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.1 mt -130.34 147.63 66.59 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 115.064 -0.971 . . . . 54.009999999999998 110.715 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.7 -168.52 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.395 2.063 . . . . 75.129999999999995 110.526 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.612 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -86.13 173.8 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.556 -0.905 . . . . 75.420000000000002 108.556 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.482 ' HB2' ' HD2' ' A' ' 107' ' ' PRO . 4.1 p-10 -72.77 157.58 88.59 Favored Pre-proline 0 C--O 1.249 1.068 0 CA-C-N 118.654 0.661 . . . . 55.32 111.786 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 24.3 Cg_endo -59.8 171.47 2.79 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.615 2.21 . . . . 53.020000000000003 113.197 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 68.45 15.09 9.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.503 1.521 . . . . 73.140000000000001 110.482 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.2 69.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.135 -0.939 . . . . 64.109999999999999 114.132 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.18 142.29 40.96 Favored Pre-proline 0 C--O 1.253 1.249 0 CA-C-N 117.76 0.78 . . . . 74.439999999999998 111.26 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.612 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 84.0 Cg_endo -85.04 147.74 10.45 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.491 2.127 . . . . 44.32 111.681 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.33 141.94 56.97 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.564 0.697 . . . . 60.140000000000001 110.627 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -104.63 112.84 26.07 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.772 -1.195 . . . . 74.319999999999993 107.772 176.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -117.4 118.9 33.48 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.955 -1.02 . . . . 75.299999999999997 109.585 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 70.2 mt -127.55 154.56 45.03 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.347 -1.353 . . . . 71.409999999999997 107.347 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.734 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -104.13 -178.39 0.62 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 116.592 -1.671 . . . . 64.049999999999997 108.669 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.734 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 16.8 Cg_endo . . . . . 0 C--N 1.389 2.71 0 C-N-CA 123.269 2.646 . . . . 71.230000000000004 115.113 -165.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.474 -2.528 0 CA-C-O 119.095 -0.836 . . . . 72.120000000000005 114.334 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.592 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 2.7 Cg_exo -39.78 -20.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.217 1 C-N-CA 126.941 5.094 . . . . 53.119999999999997 116.967 176.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.506 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 48.6 p90 -164.85 168.41 17.74 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.739 0.7 . . . . 73.140000000000001 112.134 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.5 m-20 -139.93 107.02 5.45 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.642 1.177 . . . . 74.109999999999999 109.662 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.85 140.95 44.56 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 117.363 -1.735 . . . . 63.350000000000001 111.998 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.564 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 24.4 p90 -166.52 170.08 13.15 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 71.409999999999997 111.727 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 m -124.33 151.22 44.57 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 107.596 -1.261 . . . . 75.439999999999998 107.596 174.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.0 mt -74.96 157.89 34.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.854 0.359 . . . . 73.450000000000003 110.989 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.85 179.21 49.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.506 -0.854 . . . . 62.219999999999999 112.209 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.44 63.11 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.812 0.845 . . . . 73.140000000000001 112.882 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -94.79 3.38 55.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.397 0.617 . . . . 73.319999999999993 110.844 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.81 34.74 55.77 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 116.246 -0.434 . . . . 50.43 112.585 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -139.96 147.92 41.18 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.827 -0.186 . . . . 74.329999999999998 110.526 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -93.47 105.8 17.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.189 0.995 . . . . 75.420000000000002 110.649 173.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.11 -173.25 20.24 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 115.162 -0.926 . . . . 75.409999999999997 111.075 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.38 127.02 8.14 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 108.479 -1.848 . . . . 71.540000000000006 108.479 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 57.9 m 179.18 -176.76 0.27 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.264 -1.754 . . . . 72.549999999999997 106.264 -171.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.19 -71.86 0.45 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.763 0.711 . . . . 71.200000000000003 110.186 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -99.04 -6.12 29.09 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.134 0.492 . . . . 74.430000000000007 111.231 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 10.3 m-20 -100.58 7.85 43.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.384 0.611 . . . . 75.120000000000005 110.197 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -89.48 156.62 18.53 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.482 -0.781 . . . . 60.520000000000003 110.874 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 1.3 p-10 -79.17 129.05 34.05 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.706 -2.331 . . . . 73.519999999999996 104.706 172.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.502 HG21 HG13 ' A' ' 47' ' ' VAL . 22.8 pt -114.19 113.79 44.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 CA-C-O 121.663 0.744 . . . . 74.109999999999999 110.88 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 126' ' ' TYR . . . -168.05 -179.68 40.72 Favored Glycine 0 N--CA 1.408 -3.184 0 N-CA-C 110.949 -0.86 . . . . 51.009999999999998 110.949 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.416 ' C ' HD22 ' A' ' 145' ' ' ASN . 0.2 OUTLIER -151.51 156.19 40.04 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 109.888 -0.412 . . . . 65.439999999999998 109.888 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.506 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 7.1 p90 -155.69 177.25 11.6 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 115.3 -0.864 . . . . 74.230000000000004 109.226 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -129.93 136.39 49.42 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 123.894 0.746 . . . . 75.209999999999994 110.079 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.592 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 30.6 t30 . . . . . 0 C--O 1.255 1.347 0 O-C-N 125.833 1.958 . . . . 75.430000000000007 107.299 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.599 ' N ' ' HG1' ' A' ' 48' ' ' THR . 20.1 mmt . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 112.224 0.453 . . . . 71.430000000000007 112.224 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -100.36 80.63 2.26 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.901 -1.148 . . . . 52.219999999999999 107.901 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -145.53 158.08 51.01 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.311 -1.366 . . . . 40.329999999999998 107.311 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.53 123.24 10.98 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.113 2.542 . . . . 74.120000000000005 111.873 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t70 75.62 -32.47 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 126.824 2.05 . . . . 40.229999999999997 111.772 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.411 ' HA ' HG23 ' A' ' 47' ' ' VAL . 55.8 mt-30 -69.87 -13.9 62.48 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.833 -0.542 . . . . 75.219999999999999 110.804 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.42 -27.83 69.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.451 -0.795 . . . . 74.209999999999994 109.254 171.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -82.08 -25.72 34.28 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 108.183 -1.043 . . . . 74.129999999999995 108.183 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 139' ' ' ASN . 86.9 t -75.11 -43.99 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.656 0.741 . . . . 41.420000000000002 110.015 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.599 ' HG1' ' N ' ' A' ' 39' ' ' MET . 6.0 t -66.63 -38.26 86.55 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.91 -1.041 . . . . 65.239999999999995 110.993 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.09 -30.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 119.819 -0.752 . . . . 61.439999999999998 110.064 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.9 -39.41 81.39 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 115.789 -0.641 . . . . 24.210000000000001 111.51 -178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.66 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 67.8 mttm -66.05 -25.43 67.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.211 0.529 . . . . 64.430000000000007 111.435 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.73 -34.36 25.08 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.037 -1.225 . . . . 72.120000000000005 110.037 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.554 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 m-20 -77.1 -32.95 56.98 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.083 0.771 . . . . 73.019999999999996 113.083 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.77 -34.79 62.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.162 -0.336 . . . . 61.409999999999997 111.414 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.2 mptp? -69.92 -30.19 67.54 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.531 0.682 . . . . 75.430000000000007 109.782 176.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.19 -44.5 91.81 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.175 -0.921 . . . . 64.430000000000007 110.21 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 53' ' ' ASP . 76.1 mt -60.9 -39.22 81.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.074 -0.967 . . . . 74.519999999999996 110.152 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.527 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . . . -57.73 -35.47 70.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.249 0.343 . . . . 73.439999999999998 111.529 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.14 -34.28 70.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.999 0.428 . . . . 73.439999999999998 110.112 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.26 -29.35 48.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.476 . . . . 44.140000000000001 110.26 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.19 -29.73 67.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.349 -1.352 . . . . 64.430000000000007 107.349 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 38.9 m-20 -69.79 -24.46 63.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.509 -0.769 . . . . 72.409999999999997 110.961 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.7 mtm -79.25 -34.35 42.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.426 -0.91 . . . . 54.530000000000001 109.954 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 90.5 t80 -65.43 -36.79 84.98 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 107.648 -1.242 . . . . 74.140000000000001 107.648 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 37.8 ttpt -54.32 -37.74 65.2 Favored 'General case' 0 C--O 1.203 -1.381 0 CA-C-N 115.419 -0.81 . . . . 64.200000000000003 110.103 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.04 -27.68 23.04 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.819 -0.752 . . . . 52.229999999999997 112.576 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 90' ' ' GLN . 12.7 t70 -76.41 -25.48 54.55 Favored 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 120.034 -0.666 . . . . 71.219999999999999 111.289 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.402 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -121.2 22.37 10.91 Favored 'General case' 0 CA--C 1.458 -2.573 0 O-C-N 120.92 -1.112 . . . . 72.420000000000002 110.257 174.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 p90 43.29 32.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 125.111 1.507 . . . . 74.120000000000005 113.366 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.5 157.35 0.47 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.797 -1.186 . . . . 65.030000000000001 107.797 -173.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.53 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 17.0 m-85 -76.07 156.03 84.23 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 109.067 -0.716 . . . . 73.099999999999994 109.067 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.517 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 36.3 Cg_endo -64.05 156.78 56.85 Favored 'Trans proline' 0 C--O 1.217 -0.557 0 C-N-CA 122.606 2.204 . . . . 73.430000000000007 112.2 -177.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.422 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 62.8 p -93.49 155.38 17.37 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.992 -2.225 . . . . 65.25 104.992 171.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -72.38 -8.48 55.19 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 119.716 1.144 . . . . 64.340000000000003 111.097 -174.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -102.58 -66.01 0.96 Allowed 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.903 -0.589 . . . . 75.430000000000007 110.741 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -81.13 -35.53 31.44 Favored 'General case' 0 CA--C 1.467 -2.227 0 O-C-N 121.287 -0.883 . . . . 51.350000000000001 112.589 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.615 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -72.56 -21.58 79.45 Favored Glycine 0 N--CA 1.417 -2.631 0 C-N-CA 118.014 -2.041 . . . . 73.030000000000001 111.562 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.78 -43.62 62.58 Favored 'General case' 0 C--O 1.246 0.912 0 N-CA-C 105.995 -1.854 . . . . 73.109999999999999 105.995 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -61.44 -36.53 80.63 Favored 'General case' 0 C--O 1.192 -1.94 0 CA-C-N 114.473 -1.24 . . . . 62.219999999999999 110.349 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.457 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -84.54 -3.01 58.2 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.697 0.799 . . . . 55.140000000000001 112.598 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 58.0 mt -93.99 -27.31 16.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.498 -0.556 . . . . 73.239999999999995 109.498 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.07 -37.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.762 -0.654 . . . . 74.120000000000005 111.382 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.9 ttmp? -118.65 149.22 41.77 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.48 -1.674 . . . . 72.409999999999997 106.48 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -54.69 132.98 65.05 Favored Pre-proline 0 C--O 1.245 0.83 0 CA-C-O 120.767 0.318 . . . . 71.549999999999997 111.246 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -58.41 153.26 48.74 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 124.792 3.661 . . . . 54.450000000000003 113.9 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.7 p -90.94 137.82 32.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.38 -0.827 . . . . 72.099999999999994 110.174 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.39 -161.33 18.99 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.997 -1.241 . . . . 72.519999999999996 109.997 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -111.75 105.08 56.59 Favored Pre-proline 0 N--CA 1.391 -3.378 0 N-CA-C 108.864 -0.791 . . . . 71.140000000000001 108.864 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 3.0 Cg_endo -86.31 162.56 9.82 Favored 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 122.954 2.436 . . . . 74.129999999999995 110.242 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' A' ' 67' ' ' ASP . 81.2 mm-40 -91.3 111.41 48.66 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 109.608 -0.515 . . . . 74.329999999999998 109.608 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -51.1 101.51 0.05 OUTLIER 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 124.336 3.357 . . . . 74.409999999999997 117.936 -166.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -135.84 83.52 2.02 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.254 -1.017 . . . . 61.25 108.254 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 16.01 84.16 0.01 OUTLIER 'General case' 0 C--O 1.247 0.929 0 C-N-CA 127.676 2.391 . . . . 61.039999999999999 114.058 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.682 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -55.68 137.56 49.13 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.085 0.469 . . . . 65.299999999999997 110.917 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.08 129.21 35.67 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.258 -0.883 . . . . 74.409999999999997 109.719 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.38 174.27 8.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.876 0.846 . . . . 73.519999999999996 110.929 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 66.02 28.55 10.41 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.924 -1.489 . . . . 72.099999999999994 110.407 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 99.41 16.38 29.71 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.054 -1.43 . . . . 62.539999999999999 115.313 165.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.682 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 2.5 m-85 63.04 90.15 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 122.492 1.139 . . . . 74.129999999999995 111.608 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 mt -117.64 171.8 7.78 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.82 -1.082 . . . . 70.239999999999995 112.224 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.411 ' HB2' HD22 ' A' ' 103' ' ' LEU . 69.8 mmtt -93.47 -163.4 1.04 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 112.955 -1.93 . . . . 63.100000000000001 107.454 174.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.47 28.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.717 1.207 . . . . 73.150000000000006 112.944 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 103' ' ' LEU . 2.4 pt? -107.36 148.14 36.57 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.766 -0.584 . . . . 73.109999999999999 111.342 -174.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.15 -167.74 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.111 2.54 . . . . 71.25 110.041 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.66 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.97 167.89 2.12 Favored 'Isoleucine or valine' 0 C--O 1.258 1.527 0 N-CA-C 108.287 -1.005 . . . . 74.299999999999997 108.287 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 t70 -79.87 151.81 73.95 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 119.761 -0.776 . . . . 50.409999999999997 109.554 -171.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 59.7 Cg_exo -44.85 171.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 124.082 3.188 . . . . 54.43 113.953 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.451 ' CD1' ' HA ' ' A' ' 130' ' ' ALA . 2.3 m-90 69.91 14.28 7.93 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 126.127 1.771 . . . . 74.349999999999994 109.287 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.78 21.19 58.03 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 114.765 -1.107 . . . . 54.100000000000001 112.773 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -92.96 120.86 66.81 Favored Pre-proline 0 C--O 1.254 1.341 0 N-CA-C 112.881 0.697 . . . . 71.510000000000005 112.881 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.66 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.1 Cg_exo -59.6 143.91 99.55 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.592 2.195 . . . . 53.549999999999997 111.138 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 43.2 m-85 -69.39 143.1 53.76 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.605 -1.258 . . . . 73.230000000000004 107.605 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.519 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -103.07 119.65 39.25 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.196 -1.409 . . . . 75.239999999999995 107.196 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.26 117.93 34.97 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.289 0.566 . . . . 63.119999999999997 111.118 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 88.9 mt -128.8 153.7 47.15 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.525 -0.761 . . . . 65.349999999999994 109.044 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.779 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -113.91 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.408 -2.571 0 CA-C-O 117.89 -1.052 . . . . 63.119999999999997 109.597 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.779 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 32.2 Cg_endo . . . . . 0 C--N 1.377 2.075 0 C-N-CA 122.493 2.129 . . . . 75.099999999999994 114.699 -171.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.483 -1.937 0 CA-C-O 118.136 -1.369 . . . . 62.140000000000001 113.431 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 23.2 Cg_exo -41.37 -23.66 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.473 1 C-N-CA 126.905 5.07 . . . . 74.099999999999994 117.467 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 146' ' ' TRP . 54.8 p90 -179.51 170.14 1.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.364 0.529 . . . . 65.400000000000006 110.114 173.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 16.8 m-20 -137.41 109.0 6.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.997 -0.742 . . . . 73.439999999999998 108.997 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.24 126.29 51.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.54 -0.911 . . . . 60.43 108.54 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 113' ' ' GLN . 29.8 p90 -166.92 162.77 15.96 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 122.851 0.094 . . . . 71.040000000000006 110.771 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.496 ' HB3' HD11 ' A' ' 143' ' ' ILE . 23.0 t -126.07 143.13 51.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.9 -1.518 . . . . 73.230000000000004 106.9 171.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.519 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 87.8 mt -60.07 136.27 57.97 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.351 0.407 . . . . 73.510000000000005 110.067 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 141' ' ' ALA . . . -75.32 -164.49 13.84 Favored Glycine 0 C--O 1.229 -0.195 0 C-N-CA 121.111 -0.566 . . . . 35.520000000000003 114.058 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.451 ' HA ' ' CD1' ' A' ' 108' ' ' TRP . . . -55.37 -34.47 64.34 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.5 0.926 . . . . 73.040000000000006 113.5 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.13 -2.23 53.04 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.707 0.765 . . . . 70.030000000000001 109.348 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.73 17.22 80.08 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.8 -0.92 . . . . 43.210000000000001 110.8 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -100.46 144.85 28.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 112.072 0.397 . . . . 60.229999999999997 112.072 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.11 101.14 11.45 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 103.005 -2.961 . . . . 72.430000000000007 103.005 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.24 -173.02 22.76 Favored Glycine 0 CA--C 1.497 -1.093 0 CA-C-N 114.387 -1.278 . . . . 63.420000000000002 110.984 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.63 126.54 8.22 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 108.377 -1.889 . . . . 53.439999999999998 108.377 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.482 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.6 m 178.07 -178.7 0.26 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 126.746 2.019 . . . . 70.540000000000006 106.224 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.76 -58.29 2.14 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.683 -0.858 . . . . 63.020000000000003 108.683 171.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.51 ' HA ' HG21 ' A' ' 47' ' ' VAL . 3.0 t-20 -89.09 -38.58 14.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.272 -0.876 . . . . 75.340000000000003 111.846 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -90.45 8.68 32.55 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.177 0.513 . . . . 73.519999999999996 111.313 -174.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.482 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -104.87 157.54 17.14 Favored 'General case' 0 CA--C 1.477 -1.835 0 CA-C-N 115.585 -0.734 . . . . 71.420000000000002 109.828 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.73 136.47 38.17 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 107.149 -1.426 . . . . 72.299999999999997 107.149 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -94.73 118.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 121.622 0.725 . . . . 62.420000000000002 109.274 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.19 157.0 25.9 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.595 -1.288 . . . . 74.120000000000005 114.421 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 58' ' ' ALA . 4.4 t30 -148.92 129.53 14.03 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 125.208 1.403 . . . . 65.439999999999998 107.571 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.472 ' HA ' ' CE1' ' A' ' 123' ' ' PHE . 5.1 p90 -160.63 177.18 10.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.212 0.529 . . . . 72.140000000000001 111.439 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -115.63 134.27 55.21 Favored 'General case' 0 CA--C 1.472 -2.031 0 N-CA-C 107.725 -1.213 . . . . 53.240000000000002 107.725 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 24.9 t-20 . . . . . 0 C--N 1.292 -1.927 0 N-CA-C 107.713 -1.217 . . . . 72.450000000000003 107.713 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.653 ' N ' ' HG1' ' A' ' 48' ' ' THR . 1.4 mpt? . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.226 -0.657 . . . . 74.400000000000006 109.226 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 m -97.58 74.11 2.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.401 0.619 . . . . 53.25 110.339 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -148.49 158.5 40.42 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.054 -0.975 . . . . 75.109999999999999 108.472 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 44' ' ' GLN . 76.1 Cg_exo -50.63 121.25 7.63 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.633 2.889 . . . . 55.43 112.771 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t0 76.88 -26.4 0.19 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.023 1.729 . . . . 72.430000000000007 110.778 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 42' ' ' PRO . 73.2 mm-40 -70.96 -17.0 62.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.204 -0.907 . . . . 65.239999999999995 108.702 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.37 68.91 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.231 -0.895 . . . . 74.319999999999993 109.75 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 55.3 mttp -83.75 -25.68 30.31 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 108.549 -0.908 . . . . 71.540000000000006 108.549 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 52.0 t -74.79 -43.03 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.615 0.722 . . . . 74.010000000000005 109.494 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.653 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.4 t -63.99 -31.85 73.18 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.034 -0.984 . . . . 72.25 111.718 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -79.8 -39.63 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 119.533 -0.867 . . . . 71.329999999999998 109.565 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.81 -39.22 80.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.254 1.022 . . . . 71.230000000000004 112.356 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -65.72 -24.92 67.08 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.256 0.551 . . . . 63.219999999999999 111.141 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.21 -27.88 21.86 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.093 -0.803 . . . . 64.530000000000001 111.093 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.75 -38.98 57.94 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.168 0.509 . . . . 73.099999999999994 110.624 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 pt -66.31 -35.12 74.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.011 -0.541 . . . . 75.519999999999996 109.897 174.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 9.6 tptp -68.89 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 73.120000000000005 109.74 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.54 -40.73 97.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.31 -0.859 . . . . 61.140000000000001 109.614 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 125' ' ' LEU . 74.3 mt -66.14 -35.12 74.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 115.014 -0.994 . . . . 72.319999999999993 110.665 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -27.49 69.29 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.279 0.562 . . . . 75.540000000000006 111.018 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.19 -33.44 29.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.695 0.759 . . . . 63.340000000000003 109.413 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.12 53.71 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.562 -0.745 . . . . 51.219999999999999 110.886 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.456 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -68.27 -30.18 69.14 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 72.439999999999998 108.571 178.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.528 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 3.2 t70 -66.49 -30.43 70.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 71.430000000000007 109.64 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 88.8 mtp -74.66 -33.92 62.61 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.962 -0.563 . . . . 73.200000000000003 110.212 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -71.55 -36.18 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.219 -0.66 . . . . 74.040000000000006 109.219 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 15.5 pttp -67.74 -16.39 64.11 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 119.123 -1.031 . . . . 71.430000000000007 109.269 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.1 tp -88.65 -36.12 16.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.838 -1.074 . . . . 75.530000000000001 109.808 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 23.9 t70 -75.17 -24.55 57.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.026 0.38 . . . . 63.119999999999997 112.026 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.77 24.48 5.71 Favored 'General case' 0 CA--C 1.464 -2.361 0 C-N-CA 119.747 -0.781 . . . . 75.5 109.637 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.34 32.48 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.418 1.487 . . . . 71.239999999999995 113.925 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.03 161.23 0.57 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.701 -1.222 . . . . 73.329999999999998 107.701 -174.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.615 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 16.4 m-85 -77.14 155.07 82.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 123.475 0.485 . . . . 73.239999999999995 110.816 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.46 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.0 Cg_endo -63.59 162.12 29.11 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.142 2.561 . . . . 73.140000000000001 112.457 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.0 p -98.32 155.24 17.3 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 105.507 -2.034 . . . . 73.349999999999994 105.507 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.71 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.79 -11.55 60.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 119.56 1.073 . . . . 72.340000000000003 111.549 -173.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -102.02 -65.42 0.99 Allowed 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.855 -0.612 . . . . 72.310000000000002 110.295 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -77.14 -39.52 48.95 Favored 'General case' 0 CA--C 1.493 -1.222 0 O-C-N 122.079 -0.388 . . . . 74.319999999999993 111.044 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.601 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -77.18 -21.17 74.09 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 118.529 -1.796 . . . . 62.450000000000003 112.961 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 82' ' ' VAL . 6.3 tt -70.27 -49.99 44.16 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.644 -1.243 . . . . 65.310000000000002 107.644 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.3 -23.92 64.8 Favored 'General case' 0 C--O 1.188 -2.139 0 CA-C-N 115.289 -0.868 . . . . 75.5 110.104 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.502 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -80.21 -7.11 58.82 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 111.945 176.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 96.4 mt -91.56 -24.82 19.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.646 -0.872 . . . . 71.109999999999999 108.646 171.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 78' ' ' LEU . 21.8 t -90.84 -47.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.964 -1.016 . . . . 72.25 110.942 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -117.75 151.25 37.66 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 125.904 1.681 . . . . 73.129999999999995 108.411 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -53.34 129.49 51.66 Favored Pre-proline 0 C--O 1.249 1.059 0 N-CA-C 108.955 -0.757 . . . . 62.509999999999998 108.955 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 29.8 Cg_endo -58.5 127.36 24.37 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 124.067 3.178 . . . . 62.32 113.05 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -93.16 107.94 19.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.503 -0.771 . . . . 74.420000000000002 110.155 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.49 -133.06 3.94 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 109.065 -1.614 . . . . 43.420000000000002 109.065 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -125.02 87.79 54.97 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 117.781 0.791 . . . . 63.439999999999998 112.733 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.85 163.0 6.13 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 122.818 2.345 . . . . 53.420000000000002 108.455 171.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -108.37 148.03 36.82 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 108.952 -0.759 . . . . 73.209999999999994 108.952 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.462 ' C ' ' HD2' ' A' ' 92' ' ' LYS . 74.5 Cg_exo -50.82 98.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.63 2.886 . . . . 62.450000000000003 116.089 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 2.6 mptp? -147.27 148.75 31.76 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 127.641 2.377 . . . . 61.539999999999999 106.618 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -73.69 89.27 1.76 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 111.632 0.234 . . . . 73.030000000000001 111.632 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.628 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.2 t90 -54.96 143.76 25.29 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.59 1.156 . . . . 73.430000000000007 112.224 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 15.5 t-20 -126.39 137.02 53.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.158 -0.928 . . . . 73.030000000000001 111.137 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -86.23 173.79 9.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.659 0.742 . . . . 74.140000000000001 111.502 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.9 t70 69.08 15.32 8.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.497 -1.229 . . . . 64.049999999999997 112.435 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 119.6 8.81 8.84 Favored Glycine 0 CA--C 1.494 -1.276 0 C-N-CA 119.529 -1.319 . . . . 63.100000000000001 114.437 168.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.628 ' OH ' ' HA ' ' A' ' 94' ' ' TRP 0.268 0.3 OUTLIER 65.67 78.56 0.27 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 123.231 1.491 . . . . 75.120000000000005 110.787 -174.458 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -121.42 169.09 10.97 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 112.715 -2.038 . . . . 73.109999999999999 107.769 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.01 -164.5 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.26 -1.015 . . . . 72.140000000000001 108.26 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.45 68.34 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 122.655 1.217 . . . . 74.219999999999999 109.275 173.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 148.63 70.84 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 114.564 -1.198 . . . . 73.519999999999996 111.0 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -168.2 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.058 2.505 . . . . 72.109999999999999 110.795 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.661 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 9.6 p -79.59 166.47 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 108.95 -0.759 . . . . 53.219999999999999 108.95 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.37 153.88 76.63 Favored Pre-proline 0 C--O 1.252 1.194 0 N-CA-C 108.805 -0.813 . . . . 65.030000000000001 108.805 -172.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.474 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 77.2 Cg_exo -50.0 172.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.432 2.755 . . . . 74.219999999999999 114.549 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.486 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 2.2 m-90 69.92 15.16 7.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.64 1.976 . . . . 64.219999999999999 109.66 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 13.67 52.77 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.83 -1.077 . . . . 60.240000000000002 114.152 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.15 132.96 43.81 Favored Pre-proline 0 N--CA 1.424 -1.769 0 CA-C-O 121.832 0.825 . . . . 74.409999999999997 111.595 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.661 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 71.8 Cg_endo -75.13 154.94 42.23 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 122.716 2.278 . . . . 70.530000000000001 111.142 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.68 136.37 48.99 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 106.898 -1.519 . . . . 74.439999999999998 106.898 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -102.66 114.06 27.97 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 105.225 -2.139 . . . . 73.420000000000002 105.225 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.443 ' CZ ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -104.4 118.35 36.4 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.303 -0.862 . . . . 65.019999999999996 109.996 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 93.5 mt -129.35 153.18 48.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.758 -0.83 . . . . 52.329999999999998 108.758 176.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.715 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -108.78 -177.31 0.46 Allowed Pre-proline 0 N--CA 1.412 -2.35 0 CA-C-O 116.588 -1.672 . . . . 63.25 107.633 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.715 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.2 Cg_endo . . . . . 0 C--N 1.386 2.54 0 C-N-CA 122.653 2.235 . . . . 74.040000000000006 115.35 -165.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.489 -1.561 0 CA-C-O 118.986 -0.897 . . . . 72.049999999999997 114.597 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.587 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -39.2 -20.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.062 1 C-N-CA 127.201 5.267 . . . . 53.299999999999997 118.025 177.415 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.3 p90 -170.98 165.65 7.57 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.605 0.639 . . . . 73.140000000000001 110.059 173.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 19.6 m-20 -135.08 110.37 8.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.487 -0.931 . . . . 74.019999999999996 108.487 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.522 HD11 HD12 ' A' ' 57' ' ' ILE . 3.4 tm? -118.81 129.54 55.28 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.116 -0.698 . . . . 74.530000000000001 109.116 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -166.97 168.72 13.65 Favored 'General case' 0 C--O 1.204 -1.322 0 O-C-N 123.492 0.495 . . . . 72.439999999999998 109.9 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 15.6 m -124.13 142.28 51.35 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.354 -2.091 . . . . 74.030000000000001 105.354 171.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.44 143.09 50.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.932 -0.707 . . . . 53.329999999999998 111.748 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.68 174.48 11.09 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 116.026 -0.534 . . . . 75.120000000000005 113.826 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.414 ' HB3' HD22 ' A' ' 139' ' ' ASN . . . -63.96 5.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.593 1.331 . . . . 65.329999999999998 114.593 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.12 -10.18 34.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.365 -0.976 . . . . 71.030000000000001 108.365 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.74 88.16 Favored Glycine 0 CA--C 1.507 -0.434 0 CA-C-N 115.502 -0.772 . . . . 33.130000000000003 111.534 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -140.62 151.31 44.53 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 106.486 -1.672 . . . . 62.420000000000002 106.486 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.645 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -66.75 113.02 4.54 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.86 -0.422 . . . . 70.329999999999998 109.86 -173.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -140.52 -173.34 13.36 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 116.29 -0.414 . . . . 73.030000000000001 112.696 -174.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -139.8 127.84 3.72 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.333 -0.937 . . . . 42.109999999999999 111.782 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 74.2 m 178.81 -177.98 0.29 Allowed 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 128.38 2.672 . . . . 60.219999999999999 105.07 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.14 -54.0 47.31 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.862 1.21 . . . . 71.019999999999996 111.454 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.414 HD22 ' HB3' ' A' ' 130' ' ' ALA . 3.1 p-10 -105.12 -14.63 15.33 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.629 -0.829 . . . . 74.329999999999998 112.468 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 16.7 m-20 -95.31 9.37 40.08 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.774 -0.77 . . . . 73.329999999999998 111.21 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -87.41 155.08 20.18 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 109.059 -0.719 . . . . 61.229999999999997 109.059 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 42.1 m-20 -79.26 124.09 28.05 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.09 -1.818 . . . . 74.230000000000004 106.09 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.19 120.82 46.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 CA-C-N 115.956 -0.565 . . . . 73.239999999999995 109.95 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.28 177.54 40.61 Favored Glycine 0 N--CA 1.412 -2.964 0 C-N-CA 119.348 -1.406 . . . . 63.43 112.878 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -162.02 158.67 25.35 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.112 -1.81 . . . . 73.129999999999995 106.112 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 5.4 p90 -168.94 177.57 4.9 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.429 0.633 . . . . 65.400000000000006 112.623 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -109.88 121.61 45.62 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.611 -1.626 . . . . 74.040000000000006 106.611 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.342 0 O-C-N 124.24 0.962 . . . . 71.400000000000006 110.557 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 N-CA-C 106.135 -1.802 . . . . 74.230000000000004 106.135 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -113.47 83.38 1.83 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.828 0.677 . . . . 73.310000000000002 112.828 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -153.22 165.83 16.82 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.088 -1.449 . . . . 75.049999999999997 107.088 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -49.24 139.35 27.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.55 2.167 . . . . 73.120000000000005 111.043 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.15 -49.0 0.53 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.258 1.423 . . . . 61.210000000000001 110.0 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.447 ' OE1' ' HB3' ' A' ' 138' ' ' ASP . 74.8 mm-40 -68.52 -23.36 64.53 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.419 -1.264 . . . . 75.209999999999994 110.166 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.09 -26.37 68.19 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.504 0.722 . . . . 71.230000000000004 110.579 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -85.46 -24.19 27.51 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.39 -0.596 . . . . 72.030000000000001 109.39 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.18 -42.18 51.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.955 -0.757 . . . . 53.009999999999998 108.955 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.7 t -67.84 -25.88 65.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.471 -0.786 . . . . 73.430000000000007 112.387 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.8 -37.79 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 119.609 -0.836 . . . . 74.409999999999997 109.462 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -58.73 -33.93 70.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.252 1.021 . . . . 63.240000000000002 111.505 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 73.7 mmtt -65.44 -26.15 67.83 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.801 0.81 . . . . 73.040000000000006 110.217 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.56 -33.31 10.34 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.378 -1.089 . . . . 71.200000000000003 110.378 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 33.1 m-20 -71.95 -33.7 68.4 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.999 0.428 . . . . 61.210000000000001 111.718 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.466 HD12 ' C ' ' A' ' 144' ' ' GLY . 11.5 pt -68.04 -34.09 64.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.8 -0.36 . . . . 54.340000000000003 110.28 172.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 14.0 mptt -65.76 -29.79 70.34 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.997 0.427 . . . . 52.0 110.787 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.48 -40.42 93.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 44.439999999999998 110.011 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.405 HG12 ' HG ' ' A' ' 100' ' ' LEU . 70.3 mt -67.15 -34.31 68.67 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-N 115.191 -0.913 . . . . 73.409999999999997 110.627 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . . . -59.68 -35.63 74.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.944 0.402 . . . . 63.450000000000003 110.448 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.86 -31.9 63.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.298 0.571 . . . . 51.200000000000003 109.903 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.02 -28.3 43.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.801 -0.636 . . . . 64.230000000000004 110.601 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.79 -31.15 69.95 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.361 -1.348 . . . . 75.430000000000007 107.361 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.7 m-20 -72.79 -18.26 61.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.72 -0.673 . . . . 70.109999999999999 110.353 171.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.7 mtm -84.26 -31.16 25.1 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 121.995 -0.441 . . . . 74.109999999999999 111.632 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.64 -37.11 70.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.07 -1.456 . . . . 72.420000000000002 107.07 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.582 ' HD2' ' CE1' ' A' ' 71' ' ' TYR . 86.0 tttt -54.94 -31.28 60.29 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.733 -1.121 . . . . 75.25 109.605 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.5 tp -83.5 -35.41 24.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.479 -0.782 . . . . 73.450000000000003 110.531 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 23.6 t70 -78.49 -25.55 45.74 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.209 0.448 . . . . 65.400000000000006 112.209 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.569 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.9 OUTLIER -125.94 22.35 7.39 Favored 'General case' 0 CA--C 1.461 -2.457 0 O-C-N 121.398 -0.814 . . . . 55.340000000000003 110.881 175.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 p90 43.18 34.16 0.65 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.858 1.263 . . . . 63.310000000000002 113.703 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.7 161.3 0.67 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.664 -1.236 . . . . 71.540000000000006 107.664 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.582 ' CE1' ' HD2' ' A' ' 65' ' ' LYS . 12.3 m-85 -75.9 161.47 75.58 Favored Pre-proline 0 C--N 1.309 -1.172 0 O-C-N 123.367 0.417 . . . . 73.540000000000006 111.717 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.532 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 1.7 Cg_endo -78.44 164.11 26.58 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.226 1.951 . . . . 73.439999999999998 109.363 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 p -97.78 156.43 16.57 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.931 -1.877 . . . . 51.009999999999998 105.931 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -4.12 31.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.13 -1.428 . . . . 53.5 111.051 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -102.8 -67.65 0.87 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.772 -0.649 . . . . 75.109999999999999 109.648 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -80.58 -34.99 34.88 Favored 'General case' 0 CA--C 1.487 -1.481 0 CA-C-N 115.973 -0.558 . . . . 71.239999999999995 111.468 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.568 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.34 -20.51 78.78 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 118.225 -1.941 . . . . 71.349999999999994 112.696 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.97 -50.86 37.63 Favored 'General case' 0 C--O 1.26 1.606 0 N-CA-C 107.53 -1.285 . . . . 62.450000000000003 107.53 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 8.5 pt-20 -65.19 -28.25 69.26 Favored 'General case' 0 C--O 1.17 -3.09 0 CA-C-N 114.866 -1.061 . . . . 73.409999999999997 109.824 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.526 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.44 -6.16 52.44 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.629 0.603 . . . . 60.130000000000003 112.629 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 95.5 mt -95.38 -19.43 19.93 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.161 0.505 . . . . 54.450000000000003 110.014 172.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.5 t -98.53 -39.43 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.565 1.174 . . . . 64.219999999999999 110.715 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 25.1 tttm -121.29 148.3 44.49 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 127.521 2.328 . . . . 70.430000000000007 107.659 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -56.76 132.84 78.66 Favored Pre-proline 0 N--CA 1.475 0.775 0 O-C-N 123.141 0.275 . . . . 72.239999999999995 111.542 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.426 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 37.6 Cg_endo -63.44 128.74 23.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 123.327 2.684 . . . . 74.310000000000002 112.096 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -90.99 105.5 17.87 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.5 -0.773 . . . . 75.329999999999998 110.238 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.27 7.69 Favored Glycine 0 N--CA 1.418 -2.528 0 N-CA-C 109.906 -1.278 . . . . 73.120000000000005 109.906 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -118.62 88.2 33.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.936 0.368 . . . . 74.150000000000006 110.902 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.569 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 13.8 Cg_endo -92.69 159.4 2.86 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.707 1.605 . . . . 63.119999999999997 109.438 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -88.21 159.12 48.47 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.047 -0.723 . . . . 74.420000000000002 109.047 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.39 99.21 0.2 Allowed 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 121.692 1.595 . . . . 74.540000000000006 111.427 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.594 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.55 148.25 28.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.899 -1.889 . . . . 72.049999999999997 105.899 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.594 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 51.3 m-80 -65.48 91.36 0.12 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 122.373 -0.204 . . . . 74.439999999999998 111.503 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.507 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.2 t90 -66.6 140.27 57.93 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.483 -0.562 . . . . 72.340000000000003 109.483 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -127.95 134.47 49.31 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.811 -0.811 . . . . 55.409999999999997 108.811 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 65.3 pttt -75.58 -169.36 1.02 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.319 -0.993 . . . . 52.539999999999999 108.319 174.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.426 ' HB2' ' HG3' ' A' ' 96' ' ' LYS . 27.7 t70 67.64 15.3 9.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.973 0.892 . . . . 71.319999999999993 110.819 169.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 102.95 9.79 38.86 Favored Glycine 0 CA--C 1.495 -1.214 0 CA-C-N 114.995 -1.002 . . . . 72.430000000000007 113.855 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.2 OUTLIER 61.88 92.37 0.06 Allowed 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 122.085 0.945 . . . . 74.340000000000003 109.601 -173.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 101' ' ' LYS . 2.7 tt -128.91 155.63 44.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.014 -1.847 . . . . 72.540000000000006 106.014 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.447 ' H ' HD23 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.97 -171.93 0.35 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.053 -0.351 . . . . 64.25 110.053 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 28.81 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.797 1.036 . . . . 63.130000000000003 113.797 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.41 147.99 35.55 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 109.296 -0.631 . . . . 74.230000000000004 109.296 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.98 -167.96 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.975 2.45 . . . . 71.129999999999995 111.897 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.608 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.0 175.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.417 -0.957 . . . . 64.239999999999995 108.417 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.571 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.7 t70 -78.73 159.92 73.04 Favored Pre-proline 0 C--O 1.256 1.44 0 CA-C-N 119.081 0.855 . . . . 72.120000000000005 109.173 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.571 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 4.0 Cg_endo -49.05 170.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 123.551 2.834 . . . . 53.420000000000002 113.242 173.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 66.71 14.56 9.83 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.437 1.895 . . . . 72.209999999999994 110.931 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 -0.65 34.86 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.804 -0.635 . . . . 50.210000000000001 114.002 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.9 135.45 87.6 Favored Pre-proline 0 C--O 1.263 1.791 0 CA-C-O 121.451 0.643 . . . . 74.340000000000003 112.077 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.608 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 92.2 Cg_endo -80.22 154.12 21.82 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 C-N-CA 122.118 1.879 . . . . 73.430000000000007 110.035 174.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -74.4 143.17 44.9 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.651 -1.24 . . . . 73.310000000000002 107.651 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -102.18 113.89 27.56 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 104.656 -2.35 . . . . 74.340000000000003 104.656 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.56 118.21 36.49 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.988 -1.006 . . . . 70.319999999999993 111.882 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 87.8 mt -129.11 144.19 51.12 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.107 -0.951 . . . . 62.030000000000001 109.242 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -101.59 -177.0 0.5 Allowed Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 104.404 -2.443 . . . . 75.209999999999994 104.404 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 Cg_endo . . . . . 0 C--N 1.385 2.491 0 CA-C-N 123.179 2.171 . . . . 53.32 113.015 -168.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.491 -1.415 0 CA-C-O 118.887 -0.951 . . . . 70.420000000000002 114.112 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.5 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 33.5 Cg_exo -38.61 -27.08 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.131 1 C-N-CA 127.163 5.242 . . . . 54.420000000000002 117.992 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -173.2 146.71 1.47 Allowed 'General case' 0 C--O 1.249 1.039 0 CA-C-N 119.071 0.85 . . . . 74.299999999999997 111.859 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.2 m-20 -118.48 106.61 12.86 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.142 -1.429 . . . . 62.549999999999997 107.142 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.3 129.52 46.45 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 120.886 -1.134 . . . . 72.0 110.76 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -165.21 166.46 18.88 Favored 'General case' 0 C--O 1.194 -1.832 0 CA-C-N 116.845 -0.161 . . . . 73.239999999999995 111.251 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.0 t -125.28 139.94 53.27 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 63.109999999999999 105.649 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.13 155.29 20.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.914 1.079 . . . . 74.120000000000005 113.914 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.75 165.15 37.76 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 110.774 -0.931 . . . . 71.409999999999997 110.774 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.46 -24.01 4.56 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 115.924 1.824 . . . . 65.099999999999994 115.924 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.27 -1.72 28.34 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.575 -0.703 . . . . 74.019999999999996 111.603 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.49 38.49 5.0 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.466 -0.873 . . . . 72.219999999999999 113.813 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -130.34 147.84 52.1 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.305 -0.628 . . . . 72.109999999999999 109.305 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 9.4 pt-20 -101.89 105.46 16.28 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.077 -1.453 . . . . 74.010000000000005 107.077 167.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.18 -173.73 21.39 Favored Glycine 0 C--N 1.29 -1.991 0 N-CA-C 110.395 -1.082 . . . . 54.329999999999998 110.395 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.91 129.78 10.01 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.687 -1.365 . . . . 45.329999999999998 109.687 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.56 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.9 t 179.59 -178.39 0.38 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.735 -1.58 . . . . 70.219999999999999 106.735 -172.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.447 ' HB3' ' OE1' ' A' ' 44' ' ' GLN . 4.3 m-20 -87.26 -66.8 0.87 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.345 -0.613 . . . . 74.349999999999994 109.345 173.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.83 -30.73 14.67 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.928 -1.033 . . . . 74.430000000000007 111.908 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.76 17.88 16.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.649 0.738 . . . . 70.040000000000006 110.907 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.56 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -100.67 155.75 17.71 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-N 114.943 -1.026 . . . . 71.109999999999999 109.554 176.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.516 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.8 p-10 -79.13 135.06 36.72 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.397 -1.334 . . . . 65.230000000000004 107.397 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.59 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -104.18 123.64 58.11 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-N 115.728 -0.669 . . . . 75.239999999999995 109.623 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.466 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -159.29 179.81 34.63 Favored Glycine 0 N--CA 1.412 -2.911 0 C-N-CA 118.878 -1.63 . . . . 24.440000000000001 112.702 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.521 ' OD1' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -137.5 150.4 47.52 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 105.774 -1.935 . . . . 61.439999999999998 105.774 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -143.87 144.54 31.79 Favored 'General case' 0 C--N 1.267 -3.013 0 C-N-CA 119.269 -0.972 . . . . 72.120000000000005 110.003 -165.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -127.38 95.68 4.34 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.87 -1.53 . . . . 65.450000000000003 106.87 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.6 t30 . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 113.816 -1.538 . . . . 72.219999999999999 107.676 -176.725 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.571 ' N ' ' HG1' ' A' ' 48' ' ' THR . 11.8 ttt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.55 -1.278 . . . . 71.140000000000001 107.55 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.9 m -104.94 86.66 2.49 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.902 0.704 . . . . 71.430000000000007 112.902 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -153.77 159.75 31.72 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.184 -1.413 . . . . 73.420000000000002 107.184 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.09 125.55 16.55 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.681 2.254 . . . . 74.340000000000003 111.787 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 75.95 -33.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.779 2.032 . . . . 44.020000000000003 111.55 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HA ' HG23 ' A' ' 47' ' ' VAL . 63.7 mt-30 -70.0 -20.7 63.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.784 0.802 . . . . 55.420000000000002 109.217 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.85 64.29 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.715 -1.13 . . . . 72.019999999999996 110.13 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 91.6 mttt -89.25 -25.08 21.9 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.766 -0.827 . . . . 71.549999999999997 108.766 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' A' ' 44' ' ' GLN . 44.9 t -74.39 -43.89 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 108.34 -0.985 . . . . 73.230000000000004 108.34 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.571 ' HG1' ' N ' ' A' ' 39' ' ' MET . 12.0 t -66.26 -29.59 69.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.403 -1.271 . . . . 73.25 111.831 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -83.87 -33.75 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.039 -0.665 . . . . 71.099999999999994 110.248 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' A' ' 143' ' ' ILE . . . -71.95 -34.27 68.86 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.752 -0.658 . . . . 73.140000000000001 111.587 -176.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.624 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 57.2 mtpt -70.39 -25.45 63.25 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.769 -0.772 . . . . 73.120000000000005 111.97 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.06 -26.21 45.6 Favored Glycine 0 C--O 1.246 0.88 0 N-CA-C 109.495 -1.442 . . . . 53.340000000000003 109.495 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.593 ' O ' HG13 ' A' ' 57' ' ' ILE . 20.7 t70 -77.32 -38.38 50.57 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.265 -0.967 . . . . 61.340000000000003 109.391 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 51' ' ' LYS . 20.3 pt -65.92 -30.39 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 122.202 -0.311 . . . . 73.519999999999996 110.823 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.624 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.2 mptm? -71.08 -27.3 63.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.571 -0.452 . . . . 72.129999999999995 110.277 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -69.92 -48.87 56.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.568 -0.742 . . . . 60.420000000000002 110.243 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.65 ' HB ' HD21 ' A' ' 125' ' ' LEU . 30.6 mt -61.06 -42.6 93.77 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 115.192 -0.913 . . . . 73.010000000000005 108.985 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -28.91 68.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.502 . . . . 61.119999999999997 111.876 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.04 -24.21 35.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.512 0.672 . . . . 73.140000000000001 109.606 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.05 29.76 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.754 -0.832 . . . . 51.549999999999997 108.754 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -68.77 -31.14 69.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.211 -1.403 . . . . 73.530000000000001 107.211 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.3 m-20 -68.92 -24.25 64.27 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.911 -0.586 . . . . 72.299999999999997 110.007 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 mmt -78.35 -34.98 48.06 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 120.889 -0.324 . . . . 71.120000000000005 111.305 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.551 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 58.7 t80 -69.8 -36.66 75.87 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.55 -1.278 . . . . 72.010000000000005 107.55 174.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.56 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 80.9 tttt -54.34 -35.36 62.64 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 114.876 -1.056 . . . . 72.409999999999997 110.485 173.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 95.6 mt -87.0 -29.09 22.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 111.317 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t70 -78.2 -24.37 47.16 Favored 'General case' 0 C--O 1.201 -1.451 0 CA-C-O 120.632 0.253 . . . . 72.25 111.383 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -128.99 24.38 5.64 Favored 'General case' 0 CA--C 1.469 -2.14 0 N-CA-C 109.175 -0.676 . . . . 74.400000000000006 109.175 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.6 p90 42.97 31.44 0.33 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 126.131 1.772 . . . . 70.420000000000002 114.736 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.41 162.33 0.51 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.66 -1.237 . . . . 73.530000000000001 107.66 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.4 m-85 -76.6 153.57 83.54 Favored Pre-proline 0 C--N 1.296 -1.739 0 C-N-CA 120.252 -0.579 . . . . 63.119999999999997 110.274 173.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 20.8 Cg_endo -61.98 164.37 16.94 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 123.28 2.653 . . . . 42.530000000000001 110.904 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.428 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 37.8 p -95.05 155.36 16.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.354 -1.721 . . . . 64.5 106.354 173.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.608 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.05 -12.8 62.01 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 119.837 1.199 . . . . 61.310000000000002 110.503 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -102.48 -65.24 1.0 Allowed 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.938 -1.028 . . . . 75.150000000000006 110.746 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -84.79 -29.23 25.58 Favored 'General case' 0 CA--C 1.478 -1.797 0 O-C-N 121.885 -0.509 . . . . 74.450000000000003 111.387 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.53 -20.79 79.46 Favored Glycine 0 N--CA 1.411 -3.022 0 C-N-CA 119.202 -1.475 . . . . 64.140000000000001 111.818 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.46 -46.14 70.58 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.226 -1.768 . . . . 72.420000000000002 106.226 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.96 -21.66 66.43 Favored 'General case' 0 C--O 1.17 -3.103 0 CA-C-N 114.762 -1.108 . . . . 74.140000000000001 110.814 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.693 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -89.89 -4.22 57.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.656 0.741 . . . . 71.349999999999994 111.351 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.455 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 4.7 mp -99.51 -21.21 16.03 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.521 -0.763 . . . . 61.130000000000003 110.086 174.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 35.9 t -108.01 -30.97 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 115.985 -0.552 . . . . 73.450000000000003 110.737 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.7 mptp? -122.57 150.5 42.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.018 1.327 . . . . 71.049999999999997 107.978 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -54.9 135.71 66.23 Favored Pre-proline 0 N--CA 1.48 1.05 0 CA-C-N 118.405 0.548 . . . . 72.409999999999997 111.351 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.551 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 13.5 Cg_endo -53.04 153.09 16.51 Favored 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 124.633 3.556 . . . . 75.439999999999998 114.1 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 p -98.96 132.49 44.24 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.788 -0.642 . . . . 62.520000000000003 109.844 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.79 -137.38 14.26 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.903 -1.279 . . . . 71.430000000000007 109.903 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -129.7 105.85 17.09 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 117.362 0.581 . . . . 73.019999999999996 110.364 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -85.54 162.94 10.94 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.072 1.848 . . . . 74.349999999999994 108.979 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.14 156.69 46.22 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.446 -0.946 . . . . 71.340000000000003 108.446 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -58.45 98.76 0.1 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.583 2.189 . . . . 73.099999999999994 116.08 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 66' ' ' LEU . 67.5 mttm -151.32 148.52 28.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.545 1.938 . . . . 70.239999999999995 107.757 172.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -82.13 97.35 8.15 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.815 -0.354 . . . . 64.439999999999998 110.304 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.543 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.2 t90 -54.68 142.74 27.32 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.554 1.142 . . . . 65.540000000000006 112.696 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -123.85 136.96 54.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.956 -1.02 . . . . 72.230000000000004 109.212 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -81.09 -163.9 0.67 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 75.319999999999993 108.208 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 61.96 23.61 13.93 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.297 0.639 . . . . 74.409999999999997 110.915 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 78.54 24.41 62.94 Favored Glycine 0 CA--C 1.48 -2.12 0 CA-C-N 114.981 -1.009 . . . . 54.43 112.819 171.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 63.39 78.1 0.3 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 123.136 1.446 . . . . 70.0 109.138 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.438 HD12 HG12 ' A' ' 57' ' ' ILE . 63.0 tp -117.67 166.9 11.86 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.041 -1.89 . . . . 71.319999999999993 107.861 -172.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.64 -174.72 5.43 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 75.129999999999995 109.299 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 35.35 1.03 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.516 1.151 . . . . 63.240000000000002 110.395 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.04 149.07 40.34 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 113.804 -1.543 . . . . 54.100000000000001 108.842 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.29 177.08 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.483 2.789 . . . . 74.540000000000006 113.835 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.571 HG21 ' HA ' ' A' ' 111' ' ' PRO . 5.1 p -79.39 175.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.41 -0.814 . . . . 75.510000000000005 109.066 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.3 p-10 -69.89 158.68 86.64 Favored Pre-proline 0 C--O 1.258 1.527 0 N-CA-C 113.496 0.924 . . . . 64.040000000000006 113.496 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.438 ' CB ' ' HB3' ' A' ' 46' ' ' LYS . 50.5 Cg_exo -58.0 171.73 1.51 Allowed 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.815 2.343 . . . . 74.510000000000005 111.47 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.515 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 3.2 m-90 65.94 14.49 9.62 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 125.033 1.333 . . . . 65.510000000000005 108.845 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.66 57.98 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.189 -1.369 . . . . 64.25 115.033 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.547 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 7.5 m-80 -92.91 152.62 41.69 Favored Pre-proline 0 C--O 1.264 1.824 0 CA-C-N 118.947 1.374 . . . . 75.450000000000003 108.573 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.571 ' HA ' HG21 ' A' ' 105' ' ' VAL . 58.8 Cg_endo -82.33 141.06 11.22 Favored 'Trans proline' 0 N--CA 1.425 -2.522 0 C-N-CA 121.32 1.347 . . . . 75.049999999999997 110.579 165.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 31.7 m-85 -68.07 144.76 54.94 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 109.743 -0.466 . . . . 74.409999999999997 109.743 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -102.36 119.3 38.58 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.212 -1.403 . . . . 74.140000000000001 107.212 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -107.77 118.1 35.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.249 -1.389 . . . . 74.329999999999998 107.249 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 95.7 mt -129.23 153.17 48.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.254 -0.647 . . . . 64.200000000000003 109.254 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -117.81 -178.37 0.53 Allowed Pre-proline 0 N--CA 1.414 -2.26 0 CA-C-O 117.319 -1.324 . . . . 72.239999999999995 108.273 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 36.5 Cg_endo . . . . . 0 CA--C 1.492 -1.601 0 CA-C-N 122.041 1.765 . . . . 73.239999999999995 114.651 -170.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.465 -3.045 0 CA-C-O 118.447 -1.196 . . . . 41.229999999999997 115.587 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.52 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 39.8 Cg_exo -43.93 -23.71 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.168 1 C-N-CA 126.455 4.77 . . . . 64.129999999999995 115.711 176.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.494 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.0 p90 -176.12 169.35 2.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 118.023 0.374 . . . . 73.230000000000004 110.095 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 24.3 m-20 -136.79 112.24 9.27 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.4 -1.333 . . . . 74.019999999999996 107.4 174.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 57' ' ' ILE . 47.5 tp -124.53 126.29 45.59 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.465 -0.494 . . . . 54.409999999999997 109.952 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 31.2 p90 -167.38 168.49 13.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.738 -0.385 . . . . 74.109999999999999 111.261 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.551 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 50.9 p -125.63 146.55 49.66 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.088 -1.078 . . . . 74.219999999999999 108.088 171.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 90.3 mt -66.69 145.38 55.62 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 110.341 -0.244 . . . . 54.340000000000003 110.341 175.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -81.1 -171.03 44.33 Favored Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.163 -1.017 . . . . 73.340000000000003 112.412 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.22 -8.21 5.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.896 1.073 . . . . 43.439999999999998 113.896 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -94.74 -9.71 33.85 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.133 0.492 . . . . 50.140000000000001 109.941 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.9 12.09 84.2 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 111.772 -0.531 . . . . 63.32 111.772 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -140.12 147.74 40.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.446 0.699 . . . . 73.129999999999995 109.17 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -81.72 114.3 20.28 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.29 0.567 . . . . 74.219999999999999 111.021 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.04 -174.23 21.1 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.216 -1.154 . . . . 55.399999999999999 110.216 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.18 126.63 8.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.639 -1.267 . . . . 73.519999999999996 110.078 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.487 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.3 m 177.92 -177.27 0.21 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.808 2.043 . . . . 70.420000000000002 106.134 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.45 -69.55 0.68 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.771 -1.172 . . . . 75.239999999999995 112.388 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -91.17 -21.99 20.88 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.126 0.489 . . . . 74.109999999999999 111.504 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.81 -6.72 59.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.125 0.488 . . . . 73.540000000000006 110.673 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -92.92 156.68 16.78 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.376 -0.829 . . . . 63.109999999999999 111.505 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.85 118.4 20.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.635 -1.246 . . . . 73.540000000000006 107.635 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.6 pp -96.7 132.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.583 0 N-CA-C 108.525 -0.917 . . . . 72.230000000000004 108.525 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.0 176.79 42.47 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.248 -1.453 . . . . 73.340000000000003 112.072 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.66 145.98 24.78 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.477 -1.305 . . . . 71.200000000000003 107.477 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 7.4 p90 -161.35 175.47 12.2 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 116.072 -0.513 . . . . 75.420000000000002 110.477 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -113.61 122.62 47.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.921 -1.881 . . . . 63.409999999999997 105.921 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.305 -1.335 0 C-N-CA 124.587 1.155 . . . . 73.019999999999996 108.346 -178.501 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.633 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 20.1 mmt . . . . . 0 CA--C 1.505 -0.782 0 N-CA-C 110.467 -0.198 . . . . 70.310000000000002 110.467 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 m -107.29 73.79 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.054 0.454 . . . . 70.200000000000003 109.892 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -155.16 151.77 23.58 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 124.018 0.927 . . . . 74.230000000000004 109.42 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.87 131.42 38.2 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.534 2.823 . . . . 74.409999999999997 112.632 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 77.02 -36.14 0.24 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.321 2.249 . . . . 74.109999999999999 110.898 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.633 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.5 mm100 -68.92 -24.11 64.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.47 0.652 . . . . 71.010000000000005 109.569 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -66.77 -27.1 67.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.472 -0.786 . . . . 74.109999999999999 109.543 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 98.1 mttt -79.19 -26.13 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.228 -0.656 . . . . 74.299999999999997 109.228 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.8 -43.15 46.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.292 -0.867 . . . . 73.219999999999999 109.139 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -69.87 -33.03 71.7 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.1 -0.954 . . . . 52.119999999999997 111.592 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 45' ' ' ALA . 11.2 m -73.92 -31.93 32.22 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 C-N-CA 119.361 -0.936 . . . . 45.200000000000003 109.694 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -68.25 -40.28 82.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.793 -0.639 . . . . 42.43 110.408 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 96.2 mttt -69.95 -25.29 63.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.408 0.623 . . . . 74.329999999999998 111.561 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.6 -27.74 46.0 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 109.944 -1.262 . . . . 63.109999999999999 109.944 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.596 ' O ' HG13 ' A' ' 57' ' ' ILE . 5.2 t70 -73.99 -42.63 60.13 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.397 -0.902 . . . . 74.319999999999993 109.014 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.2 pt -63.93 -28.86 45.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 63.520000000000003 110.782 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.5 mptp? -70.74 -30.6 67.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.027 0.441 . . . . 72.019999999999996 110.346 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.73 -44.13 70.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 54.310000000000002 109.741 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 53' ' ' ASP . 36.8 mt -65.17 -39.77 86.6 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 CA-C-N 115.126 -0.943 . . . . 74.439999999999998 109.983 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.76 -31.56 66.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.345 -0.389 . . . . 73.239999999999995 111.007 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.24 46.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.222 0.534 . . . . 52.240000000000002 109.798 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.45 -26.64 38.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.019 -0.537 . . . . 70.430000000000007 109.917 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -30.44 69.98 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.132 -1.433 . . . . 70.349999999999994 107.132 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 68.9 m-20 -72.66 -18.54 61.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.484 -0.78 . . . . 75.430000000000007 109.817 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 mmt -82.11 -35.23 28.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.772 -0.649 . . . . 73.030000000000001 109.559 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.4 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 82.7 t80 -68.58 -34.71 76.27 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.386 -1.338 . . . . 71.040000000000006 107.386 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.628 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 85.9 tttt -55.87 -30.39 61.43 Favored 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 114.597 -1.183 . . . . 71.019999999999996 110.026 173.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.18 -34.41 20.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.804 0.298 . . . . 70.430000000000007 111.804 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.14 -23.74 61.35 Favored 'General case' 0 C--O 1.196 -1.763 0 CA-C-O 120.677 0.275 . . . . 61.350000000000001 111.273 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -129.51 20.56 5.64 Favored 'General case' 0 CA--C 1.452 -2.794 0 O-C-N 121.927 -0.483 . . . . 52.100000000000001 111.839 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 p90 42.69 32.68 0.4 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.87 1.356 . . . . 72.340000000000003 113.693 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 161.41 1.18 Allowed 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.898 -1.149 . . . . 72.439999999999998 107.898 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.628 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.3 m-85 -79.33 159.48 72.45 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 123.287 0.367 . . . . 61.109999999999999 111.557 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.427 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 58.3 Cg_endo -71.56 160.41 48.42 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.531 2.154 . . . . 75.299999999999997 112.377 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 52.6 p -96.28 155.33 16.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.232 -2.136 . . . . 74.430000000000007 105.232 171.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.48 -9.54 54.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 119.156 0.889 . . . . 64.510000000000005 110.777 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -102.7 -67.04 0.89 Allowed 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.737 -0.665 . . . . 71.409999999999997 110.629 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -81.56 -38.37 26.25 Favored 'General case' 0 CA--C 1.477 -1.837 0 C-N-CA 120.32 -0.552 . . . . 63.240000000000002 111.298 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 81' ' ' LEU . . . -71.95 -20.6 78.96 Favored Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 118.395 -1.86 . . . . 72.409999999999997 112.141 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.33 -47.0 53.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.539 -1.282 . . . . 63.509999999999998 107.539 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -65.02 -31.06 72.11 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-N 115.643 -0.708 . . . . 72.340000000000003 110.606 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -82.63 -5.12 58.64 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.186 0.517 . . . . 62.310000000000002 111.992 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.57 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 13.7 tp -96.33 -24.56 16.12 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.203 -1.036 . . . . 73.329999999999998 108.203 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.95 -38.14 5.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.135 -0.939 . . . . 73.409999999999997 110.751 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 61.9 mtpt -124.2 151.98 43.44 Favored 'General case' 0 C--O 1.204 -1.342 0 C-N-CA 125.552 1.541 . . . . 74.299999999999997 108.126 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -54.57 127.67 59.55 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 113.324 0.861 . . . . 74.109999999999999 113.324 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.7 123.07 12.91 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.97 3.78 . . . . 61.109999999999999 115.797 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -99.57 115.12 28.66 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.13 -1.395 . . . . 71.120000000000005 108.35 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 150.8 -116.76 0.79 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.091 -1.604 . . . . 41.299999999999997 109.091 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -137.65 90.97 14.19 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 117.558 0.679 . . . . 72.030000000000001 110.64 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.53 162.88 0.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.637 2.225 . . . . 73.420000000000002 112.448 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.251 0.6 OUTLIER -110.16 132.22 21.58 Favored Pre-proline 0 C--N 1.261 -3.261 0 CA-C-N 112.89 -1.959 . . . . 71.25 106.502 -171.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.91 99.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.688 2.925 . . . . 55.299999999999997 114.271 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -152.15 149.36 28.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.41 -1.7 . . . . 73.129999999999995 106.41 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.83 99.28 2.61 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 118.697 0.68 . . . . 72.319999999999993 111.201 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.512 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.5 t90 -61.97 144.11 55.55 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 125.028 1.331 . . . . 64.310000000000002 111.652 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.29 134.06 54.1 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.722 -0.672 . . . . 72.329999999999998 109.291 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.85 176.06 8.17 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.935 0.874 . . . . 61.450000000000003 111.354 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 57.78 28.97 16.71 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.436 -1.711 . . . . 74.340000000000003 112.858 168.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.57 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 120.65 -4.81 11.8 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.277 -1.439 . . . . 63.439999999999998 115.36 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.93 93.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.368 1.08 . . . . 74.400000000000006 109.411 -169.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -131.76 170.1 15.29 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.224 -2.139 . . . . 64.439999999999998 105.224 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.526 ' H ' HD23 ' A' ' 100' ' ' LEU . 96.4 mttt -88.93 -165.02 1.23 Allowed 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.725 -1.213 . . . . 63.509999999999998 107.725 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.23 32.54 0.45 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.893 0.854 . . . . 73.209999999999994 112.231 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 101' ' ' LYS . 11.3 mp -94.77 149.61 36.67 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 125.028 1.331 . . . . 71.329999999999998 109.463 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.84 -167.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.643 2.895 . . . . 64.409999999999997 113.735 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.5 p -101.28 176.12 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.813 -1.18 . . . . 70.420000000000002 107.813 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.43 144.87 95.0 Favored Pre-proline 0 C--O 1.255 1.384 0 CA-C-N 118.705 0.684 . . . . 73.340000000000003 111.29 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.407 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 8.7 Cg_endo -51.39 171.78 0.13 Allowed 'Trans proline' 0 C--O 1.195 -1.633 0 C-N-CA 123.79 2.993 . . . . 73.019999999999996 112.597 174.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.435 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.2 m-90 62.54 14.97 7.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.921 1.289 . . . . 75.340000000000003 109.471 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.37 12.97 77.13 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 116.401 1.32 . . . . 44.009999999999998 116.401 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.435 ' ND2' ' HE3' ' A' ' 108' ' ' TRP . 14.9 m-80 -78.64 125.03 85.04 Favored Pre-proline 0 C--O 1.256 1.433 0 CA-C-N 120.15 1.975 . . . . 54.509999999999998 111.482 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.541 ' HA ' HG21 ' A' ' 105' ' ' VAL . 39.4 Cg_exo -67.53 146.71 74.97 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.093 1.862 . . . . 75.420000000000002 108.734 167.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.59 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 54.2 m-85 -68.93 145.33 53.74 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.381 0.61 . . . . 74.140000000000001 112.122 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.4 ' CD ' HD13 ' A' ' 128' ' ' LEU . 2.5 mm100 -101.85 118.23 36.48 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.555 -2.017 . . . . 71.329999999999998 105.555 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.53 118.64 35.67 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.708 -0.678 . . . . 75.209999999999994 111.958 -177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -129.81 154.0 47.69 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.294 -0.866 . . . . 62.109999999999999 109.838 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.809 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -101.76 -177.26 0.53 Allowed Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-O 116.572 -1.68 . . . . 64.409999999999997 107.817 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.809 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 10.1 Cg_endo . . . . . 0 C--N 1.393 2.896 0 C-N-CA 123.585 2.857 . . . . 63.030000000000001 115.48 -164.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.423 -2.23 0 CA-C-O 118.749 -1.028 . . . . 34.009999999999998 113.336 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.598 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -35.07 -23.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.48 1 C-N-CA 127.339 5.36 . . . . 62.210000000000001 118.778 179.97 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 54.4 p90 -166.21 171.59 12.09 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 119.593 1.088 . . . . 72.129999999999995 112.042 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.86 106.57 6.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.009 0.924 . . . . 71.329999999999998 108.889 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.39 128.3 52.07 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.686 -0.857 . . . . 33.340000000000003 108.686 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.417 ' HB3' ' HA3' ' A' ' 144' ' ' GLY . 42.0 p90 -166.91 168.1 14.26 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 110.298 -0.26 . . . . 73.120000000000005 110.298 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.59 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 13.1 t -125.64 154.35 42.45 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.893 -1.521 . . . . 63.100000000000001 106.893 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.4 HD13 ' CD ' ' A' ' 113' ' ' GLN . 7.5 mp -72.17 157.45 37.72 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.839 -0.344 . . . . 74.340000000000003 111.534 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.17 -169.94 29.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.235 -0.983 . . . . 42.329999999999998 112.999 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.03 -21.84 66.44 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.134 0.79 . . . . 73.040000000000006 113.134 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -94.43 -2.47 51.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.65 0.738 . . . . 71.030000000000001 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.72 45.68 73.92 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.042 -1.623 . . . . 75.439999999999998 109.042 -174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -135.28 144.34 46.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.849 -1.167 . . . . 73.450000000000003 107.849 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 142' ' ' ASP 0.253 0.5 OUTLIER -102.86 106.7 17.33 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 121.982 0.896 . . . . 72.200000000000003 111.014 173.971 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.01 -173.34 20.26 Favored Glycine 0 C--N 1.294 -1.793 0 N-CA-C 111.066 -0.813 . . . . 64.030000000000001 111.066 -177.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -111.77 125.61 7.31 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 107.727 -2.149 . . . . 25.199999999999999 107.727 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.536 ' CB ' ' HB3' ' A' ' 140' ' ' ASP . 74.6 m 179.24 -176.34 0.26 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.897 1.279 . . . . 72.140000000000001 107.898 -167.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.21 -73.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.943 0.401 . . . . 72.450000000000003 110.412 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -107.22 -8.98 16.23 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.554 0.692 . . . . 53.409999999999997 110.12 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 137' ' ' SER . 22.2 t70 -89.65 2.32 54.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 123.073 1.416 . . . . 64.340000000000003 108.871 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.36 155.8 17.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.73 -1.577 . . . . 73.310000000000002 110.595 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.6 p-10 -84.73 122.46 29.13 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.775 -1.935 . . . . 61.210000000000001 105.775 171.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.29 113.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-O 121.982 0.896 . . . . 70.329999999999998 111.142 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 126' ' ' TYR . . . -163.56 -179.8 38.16 Favored Glycine 0 N--CA 1.41 -3.087 0 C-N-CA 119.271 -1.442 . . . . 60.539999999999999 112.917 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.11 158.83 19.73 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.437 -1.32 . . . . 64.340000000000003 107.437 -177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.493 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 9.8 p90 -163.2 177.58 8.93 Favored 'General case' 0 C--N 1.279 -2.467 0 O-C-N 123.657 0.598 . . . . 75.099999999999994 110.629 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -105.33 120.58 41.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.229 -1.396 . . . . 73.209999999999994 107.229 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.298 -1.647 0 O-C-N 125.167 1.542 . . . . 63.030000000000001 106.87 178.842 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 25.7 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.134 0.492 . . . . 65.530000000000001 111.04 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -113.86 62.55 0.65 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.104 -0.702 . . . . 73.209999999999994 109.104 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.423 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 25.0 ptt180 -155.58 160.25 30.99 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.347 -0.983 . . . . 75.329999999999998 108.347 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' ARG . 11.9 Cg_exo -28.63 119.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 126.053 4.502 . . . . 70.129999999999995 116.341 -176.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t70 65.33 -37.24 0.23 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 127.605 2.362 . . . . 74.230000000000004 113.912 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 47' ' ' VAL . 92.4 mt-30 -68.76 -19.96 64.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.305 0.574 . . . . 71.219999999999999 110.123 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 39' ' ' MET . . . -64.1 -24.48 67.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.303 -0.862 . . . . 53.100000000000001 109.988 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HB3' ' HG3' ' A' ' 107' ' ' PRO . 89.2 mttt -86.1 -25.0 26.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.019 -0.734 . . . . 63.210000000000001 109.019 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 44' ' ' GLN . 58.0 t -74.25 -44.26 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-N 115.493 -0.776 . . . . 74.450000000000003 109.814 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.3 t -65.7 -36.04 82.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.063 -0.971 . . . . 63.130000000000003 111.512 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 m -74.21 -35.79 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 C-N-CA 119.917 -0.713 . . . . 73.099999999999994 109.74 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -65.24 -32.9 74.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.932 -0.576 . . . . 64.099999999999994 110.378 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 73.7 mmtt -65.63 -25.9 67.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.431 0.634 . . . . 73.340000000000003 110.293 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.59 -31.52 18.44 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 110.595 -1.002 . . . . 55.439999999999998 110.595 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 57' ' ' ILE . 77.2 m-20 -76.53 -33.8 58.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.915 0.388 . . . . 55.240000000000002 110.323 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -67.11 -35.81 75.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.954 -0.387 . . . . 64.019999999999996 109.954 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -66.78 -30.7 70.97 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 120.878 0.371 . . . . 75.299999999999997 110.665 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.35 -45.39 88.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.338 -0.846 . . . . 72.549999999999997 110.046 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 125' ' ' LEU . 64.2 mt -64.81 -38.66 83.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 CA-C-N 115.267 -0.879 . . . . 73.340000000000003 110.161 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.48 68.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.999 0.428 . . . . 62.520000000000003 111.498 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.83 -33.21 27.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.566 0.698 . . . . 73.329999999999998 109.727 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.07 35.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.668 -0.697 . . . . 73.430000000000007 111.108 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.12 -30.35 71.28 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.778 -1.193 . . . . 75.140000000000001 107.778 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 18.9 t70 -73.71 -24.62 59.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.527 -0.76 . . . . 64.519999999999996 110.084 174.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.9 mtm -78.56 -25.77 45.45 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.789 -0.569 . . . . 74.150000000000006 110.465 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.465 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 31.1 t80 -72.04 -40.31 68.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.545 -1.65 . . . . 72.239999999999995 106.545 170.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 31.7 tttm -54.25 -37.29 64.5 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.307 -0.86 . . . . 65.109999999999999 110.354 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -73.01 -36.49 67.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.612 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.1 t70 -71.65 -23.46 61.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.327 0.651 . . . . 71.209999999999994 112.192 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.418 HD22 ' C ' ' A' ' 67' ' ' ASP . 0.7 OUTLIER -128.48 20.29 6.18 Favored 'General case' 0 CA--C 1.457 -2.625 0 O-C-N 121.941 -0.474 . . . . 75.129999999999995 110.089 178.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.3 p90 42.9 31.65 0.34 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.118 1.511 . . . . 73.409999999999997 112.63 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.12 161.99 0.46 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.378 -1.341 . . . . 70.019999999999996 107.378 -171.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -74.67 158.96 84.31 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 112.746 0.647 . . . . 75.430000000000007 112.746 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.568 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 49.1 Cg_endo -72.69 159.27 49.01 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 123.164 2.576 . . . . 63.420000000000002 109.776 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.482 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 70.5 p -90.43 156.26 18.34 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.442 -1.318 . . . . 73.120000000000005 107.442 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.646 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 3.2 t -65.86 -17.78 64.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 119.767 1.167 . . . . 75.430000000000007 111.232 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.65 -65.9 0.94 Allowed 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.082 -0.387 . . . . 72.400000000000006 111.706 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.445 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.3 mm-40 -81.3 -32.63 33.04 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 120.959 -0.296 . . . . 74.230000000000004 111.573 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.68 -20.85 79.37 Favored Glycine 0 N--CA 1.408 -3.188 0 C-N-CA 118.958 -1.591 . . . . 71.439999999999998 112.712 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.81 -46.41 68.71 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.484 -1.672 . . . . 73.409999999999997 106.484 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.16 -14.74 62.37 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 114.718 -1.128 . . . . 74.049999999999997 111.044 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.632 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -89.84 -8.68 51.44 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.332 0.587 . . . . 61.310000000000002 110.16 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.539 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 88.9 mt -93.08 -22.68 18.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.841 -0.618 . . . . 65.030000000000001 109.634 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.31 -34.96 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 115.885 -0.598 . . . . 63.310000000000002 111.545 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 1.8 tpmt? -122.84 151.23 41.89 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.314 -1.736 . . . . 75.219999999999999 106.314 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -53.67 137.04 53.65 Favored Pre-proline 0 N--CA 1.49 1.542 0 CA-C-N 119.058 0.844 . . . . 73.340000000000003 111.636 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.564 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 17.9 Cg_endo -55.41 137.67 78.06 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 124.558 3.505 . . . . 73.109999999999999 117.071 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 p -89.74 -179.66 5.81 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 112.927 -1.942 . . . . 70.450000000000003 107.558 173.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 -131.15 13.22 Favored Glycine 0 C--O 1.249 1.042 0 C-N-CA 119.72 -1.229 . . . . 62.229999999999997 110.423 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -135.93 89.98 19.81 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 112.372 0.508 . . . . 65.310000000000002 112.372 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 96.7 Cg_endo -91.95 163.25 3.28 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.784 2.323 . . . . 70.109999999999999 109.523 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -99.86 158.63 31.75 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 108.477 -0.934 . . . . 75.239999999999995 108.477 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.83 99.28 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.038 1.826 . . . . 72.030000000000001 110.622 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . 12.7 tmtt? -151.49 147.39 26.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.025 -1.472 . . . . 75.040000000000006 107.025 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.554 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 38.1 m-80 -63.34 89.52 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.025 0.75 . . . . 74.109999999999999 113.025 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.564 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 84.1 t90 -66.08 144.6 56.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.763 1.625 . . . . 73.329999999999998 111.326 175.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.53 130.39 52.36 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.359 -0.608 . . . . 63.100000000000001 109.359 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.448 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 62.5 pttt -83.3 -171.55 3.64 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.465 -0.894 . . . . 65.450000000000003 108.723 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.1 t0 66.27 28.72 9.86 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.243 1.021 . . . . 75.409999999999997 108.829 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 91.57 9.13 63.28 Favored Glycine 0 CA--C 1.473 -2.535 0 CA-C-N 114.021 -1.445 . . . . 62.329999999999998 114.114 167.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.7 OUTLIER 61.61 79.46 0.25 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.667 -1.234 . . . . 64.219999999999999 107.667 -172.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.5 tt -124.55 152.3 43.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.678 -1.601 . . . . 71.140000000000001 106.678 -171.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.72 179.71 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.675 -0.861 . . . . 62.240000000000002 108.675 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -80.66 67.08 6.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.386 1.088 . . . . 74.140000000000001 113.738 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.66 147.6 61.41 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 105.548 -2.019 . . . . 54.439999999999998 105.548 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.81 -168.84 0.25 Allowed 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.24 1.96 . . . . 75.120000000000005 112.139 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.555 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.37 173.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.687 -1.597 . . . . 74.109999999999999 106.687 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.9 p-10 -79.59 157.45 74.7 Favored Pre-proline 0 C--O 1.252 1.228 0 CA-C-N 119.155 0.889 . . . . 62.240000000000002 112.723 -170.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HG3' ' HB3' ' A' ' 46' ' ' LYS . 10.3 Cg_endo -54.12 171.2 0.39 Allowed 'Trans proline' 0 C--O 1.201 -1.352 0 C-N-CA 123.571 2.848 . . . . 63.340000000000003 111.939 173.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 65.09 15.02 9.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.997 1.319 . . . . 65.230000000000004 109.559 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.73 27.87 64.7 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.234 -1.348 . . . . 74.200000000000003 114.804 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.49 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 4.5 m-80 -89.64 151.16 45.47 Favored Pre-proline 0 C--O 1.257 1.455 0 CA-C-N 119.24 1.52 . . . . 73.030000000000001 108.459 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.555 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 62.9 Cg_endo -82.14 144.91 13.54 Favored 'Trans proline' 0 N--CA 1.411 -3.379 0 N-CA-C 108.28 -1.469 . . . . 72.439999999999998 108.28 165.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 68.9 m-85 -67.28 143.01 56.68 Favored 'General case' 0 C--O 1.253 1.286 0 N-CA-C 106.535 -1.654 . . . . 73.230000000000004 106.535 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -101.2 114.47 28.46 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.167 -1.79 . . . . 72.209999999999994 106.167 -175.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -98.69 119.04 36.75 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.972 -1.122 . . . . 75.430000000000007 107.972 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.0 mt -128.46 153.14 47.44 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.463 -1.31 . . . . 71.010000000000005 107.463 175.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.791 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -124.89 -179.05 0.77 Allowed Pre-proline 0 N--CA 1.395 -3.178 0 N-CA-C 107.605 -1.257 . . . . 73.319999999999993 107.605 -175.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.791 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 43.6 Cg_endo . . . . . 0 N--CA 1.44 -1.668 0 C-N-CA 121.512 1.474 . . . . 73.109999999999999 114.092 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.466 -3.005 0 CA-C-O 118.871 -0.961 . . . . 61.520000000000003 113.528 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 147' ' ' ASP . 44.0 Cg_exo -64.26 -28.14 63.99 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.522 3.481 . . . . 74.140000000000001 111.99 165.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.5 p90 176.0 164.9 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.409 0.684 . . . . 44.219999999999999 110.024 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 32.6 m-20 -139.64 123.07 17.17 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.537 -0.542 . . . . 72.209999999999994 109.537 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.569 HD11 HD12 ' A' ' 57' ' ' ILE . 3.4 tm? -130.66 124.66 32.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.423 -0.954 . . . . 42.329999999999998 108.423 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 44.3 p90 -167.4 168.11 13.34 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-O 119.505 -0.284 . . . . 72.239999999999995 110.914 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -126.25 156.57 40.09 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.77 0.828 . . . . 74.439999999999998 109.636 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.16 151.59 46.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.418 -0.355 . . . . 64.140000000000001 111.363 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.28 -178.86 45.79 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.443 -0.884 . . . . 72.239999999999995 112.21 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.96 25.96 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.2 1.185 . . . . 61.109999999999999 114.2 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -94.48 -9.99 33.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.986 -0.685 . . . . 74.25 111.241 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.47 4.87 72.96 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.827 -0.909 . . . . 63.509999999999998 110.827 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -99.69 144.03 29.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.654 -0.869 . . . . 64.5 108.654 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -100.7 105.07 16.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.949 -1.13 . . . . 75.400000000000006 107.949 172.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.27 -173.55 20.63 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.079 -0.808 . . . . 54.25 111.079 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.77 127.63 9.27 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 108.312 -1.915 . . . . 62.109999999999999 108.312 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.414 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 30.4 m 179.53 -177.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 125.904 1.682 . . . . 73.340000000000003 107.53 -170.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.43 -72.96 0.45 Allowed 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.644 -0.822 . . . . 73.510000000000005 111.043 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -95.84 -14.65 23.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.01 0.433 . . . . 72.519999999999996 111.543 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -97.49 5.47 49.59 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.383 0.611 . . . . 71.329999999999998 110.353 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -88.23 156.96 18.93 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.329 -0.85 . . . . 74.010000000000005 112.597 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 11.3 p-10 -78.76 112.94 16.41 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.45 -1.685 . . . . 74.129999999999995 106.45 172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 119.06 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.083 0 CA-C-N 114.939 -1.028 . . . . 63.219999999999999 111.451 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -169.96 -179.2 41.45 Favored Glycine 0 N--CA 1.41 -3.043 0 C-N-CA 119.612 -1.28 . . . . 62.109999999999999 112.859 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.0 149.46 28.9 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.9 -1.518 . . . . 70.530000000000001 106.9 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.464 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 4.1 p90 -170.19 178.38 3.86 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.334 0.588 . . . . 73.310000000000002 110.19 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 36.1 t70 -118.3 137.02 53.35 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.511 -1.663 . . . . 63.520000000000003 106.511 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.484 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 3.7 p-10 . . . . . 0 C--O 1.253 1.24 0 O-C-N 124.586 1.179 . . . . 65.219999999999999 109.013 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 107.566 -1.272 . . . . 72.230000000000004 107.566 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -119.78 88.97 3.04 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.026 0.75 . . . . 64.310000000000002 113.026 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 16.3 ptp180 -156.29 170.73 8.36 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.191 -1.781 . . . . 73.319999999999993 106.191 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 41' ' ' ARG . 54.4 Cg_exo -43.1 125.57 4.28 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 123.434 2.756 . . . . 62.200000000000003 113.838 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.1 -33.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.61 1.564 . . . . 42.109999999999999 113.346 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -73.23 -28.93 62.44 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.709 -0.478 . . . . 75.219999999999999 109.709 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.01 72.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.008 -0.738 . . . . 75.230000000000004 109.008 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 107' ' ' PRO . 65.3 mttm -74.7 -25.28 59.04 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.161 -0.927 . . . . 53.130000000000003 109.889 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 56.5 t -75.29 -44.57 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 71.0 109.09 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -73.62 -31.94 63.81 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.446 -0.797 . . . . 62.130000000000003 112.102 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -71.74 -36.17 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 119.404 -0.918 . . . . 51.439999999999998 109.034 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -65.16 -31.67 72.97 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.344 -0.844 . . . . 71.310000000000002 111.251 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 31.5 mmmt -64.86 -25.75 68.03 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.239 0.542 . . . . 73.439999999999998 110.549 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.79 -33.5 15.58 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.953 -0.859 . . . . 44.210000000000001 110.953 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 56' ' ' ALA 0.263 19.8 m-20 -81.13 -26.35 36.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.377 0.88 . . . . 74.049999999999997 113.377 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.96 -31.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.867 -0.79 . . . . 72.140000000000001 108.867 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -70.41 -25.91 63.44 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.212 -0.662 . . . . 73.010000000000005 109.212 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -67.05 -47.3 71.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.087 -0.961 . . . . 63.0 109.868 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.444 HG12 HD13 ' A' ' 100' ' ' LEU . 70.2 mt -60.84 -45.75 97.49 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.085 -0.961 . . . . 70.239999999999995 109.621 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.81 57.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.009 -0.541 . . . . 72.010000000000005 112.379 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.36 -39.6 16.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.879 0.371 . . . . 33.43 110.609 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.42 -28.31 52.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.477 -0.489 . . . . 74.230000000000004 110.907 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.86 -26.66 66.14 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.6 -1.259 . . . . 75.120000000000005 107.6 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.606 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 t70 -76.12 -21.09 57.03 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.149 -0.932 . . . . 72.349999999999994 108.698 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.9 mtt -77.37 -37.44 52.19 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.616 -0.678 . . . . 75.510000000000005 109.465 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 73.4 t80 -61.98 -37.34 84.42 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.994 -1.113 . . . . 71.150000000000006 107.994 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.6 tttt -54.47 -39.47 67.52 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 114.638 -1.165 . . . . 65.349999999999994 109.796 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.449 ' HB3' ' HE3' ' A' ' 92' ' ' LYS . 4.5 mm? -80.64 -30.45 36.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.358 0.873 . . . . 53.32 113.358 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -71.14 -24.95 62.37 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.388 0.614 . . . . 73.409999999999997 110.873 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.4 23.15 5.96 Favored 'General case' 0 CA--C 1.454 -2.736 0 O-C-N 121.372 -0.83 . . . . 74.140000000000001 111.669 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 42.58 32.82 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.448 1.499 . . . . 64.340000000000003 113.67 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.34 151.41 0.27 Allowed 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.608 -0.886 . . . . 62.119999999999997 108.608 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.645 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 21.2 m-85 -74.79 152.55 87.0 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 123.266 0.354 . . . . 72.409999999999997 110.271 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 32.7 Cg_endo -62.01 164.9 15.56 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.562 2.841 . . . . 65.209999999999994 112.557 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.404 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 58.2 p -102.46 154.98 18.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.614 -1.995 . . . . 64.439999999999998 105.614 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.464 ' N ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.07 -8.21 43.1 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 119.312 0.96 . . . . 74.430000000000007 110.614 -175.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.37 -67.02 0.89 Allowed 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 116.046 -0.524 . . . . 72.329999999999998 109.996 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -77.95 -39.56 42.24 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 121.958 -0.464 . . . . 75.239999999999995 110.652 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.617 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.73 -21.03 77.59 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 118.675 -1.726 . . . . 65.329999999999998 113.157 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 tt -68.0 -49.06 63.83 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.257 -1.386 . . . . 73.510000000000005 107.257 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 17.9 mt-10 -68.03 -26.69 66.01 Favored 'General case' 0 C--O 1.166 -3.302 0 CA-C-N 114.767 -1.106 . . . . 70.230000000000004 111.386 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.539 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -79.18 -7.69 58.41 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.31 0.576 . . . . 55.119999999999997 111.35 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 81.7 mt -93.28 -22.72 18.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.788 -0.642 . . . . 60.539999999999999 109.604 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.45 -38.3 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 116.134 -0.485 . . . . 74.510000000000005 112.056 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 57.0 pttt -119.01 151.25 38.54 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.673 -1.603 . . . . 72.349999999999994 106.673 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -55.19 130.82 68.79 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 122.754 0.422 . . . . 60.32 110.373 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 30.6 Cg_endo -58.88 124.22 15.23 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.554 2.836 . . . . 65.310000000000002 112.493 -173.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.2 p -83.27 116.08 22.26 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.652 -0.704 . . . . 73.010000000000005 110.487 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.43 -136.46 6.73 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.889 -1.684 . . . . 74.040000000000006 108.889 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -133.91 94.12 19.2 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 117.296 0.548 . . . . 63.109999999999999 111.481 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.27 162.65 17.5 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 123.007 2.471 . . . . 53.350000000000001 108.868 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.4 108.59 34.66 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 108.823 -0.806 . . . . 62.329999999999998 108.823 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -29.08 98.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.254 1 C-N-CA 125.857 4.372 . . . . 64.409999999999997 117.643 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 66' ' ' LEU . 54.9 mttm -138.77 149.48 45.05 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 125.971 1.708 . . . . 72.329999999999998 107.562 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.59 92.12 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.336 -0.393 . . . . 71.200000000000003 110.628 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.589 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 86.2 t90 -65.65 143.02 57.84 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 115.608 -0.724 . . . . 74.209999999999994 110.102 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -135.38 133.14 38.39 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.534 -0.757 . . . . 70.120000000000005 109.038 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -78.28 -171.53 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.327 -0.99 . . . . 74.530000000000001 108.327 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t0 66.89 25.25 9.52 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 122.189 0.995 . . . . 63.450000000000003 109.266 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 90.56 12.85 60.52 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 114.311 -1.313 . . . . 55.210000000000001 113.643 170.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.589 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.1 m-85 62.26 81.26 0.2 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.701 1.238 . . . . 73.049999999999997 107.811 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 57' ' ' ILE . 64.0 tp -128.72 172.24 11.44 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.807 -1.542 . . . . 64.099999999999994 108.926 -171.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 35.1 mmtp -77.29 -172.67 2.54 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.743 -1.206 . . . . 70.129999999999995 107.743 172.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -87.1 63.94 8.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.877 1.322 . . . . 72.219999999999999 108.966 177.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.405 HD12 ' HD2' ' A' ' 104' ' ' PRO . 28.9 tp -115.6 142.45 28.91 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.159 -1.837 . . . . 73.109999999999999 110.711 -172.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.405 ' HD2' HD12 ' A' ' 103' ' ' LEU . 26.4 Cg_exo -68.37 -167.17 0.17 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.393 2.728 . . . . 75.019999999999996 110.826 170.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.722 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.83 173.17 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 109.114 -0.698 . . . . 71.209999999999994 109.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.538 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.6 t70 -80.73 161.57 63.38 Favored Pre-proline 0 C--O 1.255 1.35 0 N-CA-C 108.553 -0.906 . . . . 72.109999999999999 108.553 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 72.1 Cg_exo -47.24 170.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.067 2.511 . . . . 74.299999999999997 114.258 172.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.453 ' CG ' ' HA ' ' A' ' 130' ' ' ALA . 1.7 m-90 65.79 14.27 9.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.928 2.091 . . . . 74.510000000000005 111.034 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.52 -6.71 15.54 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.86 -0.609 . . . . 63.32 114.043 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.89 133.94 88.04 Favored Pre-proline 0 C--O 1.258 1.534 0 N-CA-C 113.019 0.748 . . . . 54.509999999999998 113.019 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.722 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 72.0 Cg_endo -75.58 145.86 29.99 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.659 2.239 . . . . 71.0 112.098 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -69.7 134.01 48.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.258 -1.386 . . . . 63.219999999999999 107.258 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -104.2 113.98 27.9 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.328 -0.851 . . . . 72.010000000000005 109.315 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.92 118.24 36.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.663 -1.606 . . . . 74.209999999999994 106.663 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.1 mt -128.82 153.59 47.28 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.687 -1.227 . . . . 72.239999999999995 107.687 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.676 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.77 -178.58 0.57 Allowed Pre-proline 0 N--CA 1.404 -2.745 0 CA-C-O 116.589 -1.672 . . . . 54.240000000000002 107.672 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.676 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 12.4 Cg_endo . . . . . 0 C--N 1.389 2.681 0 C-N-CA 123.005 2.47 . . . . 71.200000000000003 115.488 -162.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.428 -1.898 0 CA-C-O 118.374 -1.237 . . . . 72.099999999999994 113.0 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.544 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 13.4 Cg_exo -37.85 -26.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 127.299 5.332 . . . . 62.340000000000003 118.559 -178.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.261 40.3 p90 -169.32 147.08 3.63 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.353 0.979 . . . . 75.109999999999999 113.12 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.6 m-20 -112.47 109.83 19.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.281 -1.327 . . . . 74.420000000000002 107.441 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.489 ' O ' ' HA3' ' A' ' 144' ' ' GLY . 3.2 tm? -124.7 129.93 51.44 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.957 -0.697 . . . . 71.129999999999995 109.655 -176.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.409 ' HA ' ' HA3' ' A' ' 144' ' ' GLY . 55.7 p90 -167.81 164.59 14.17 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 112.442 0.534 . . . . 72.340000000000003 112.442 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -125.8 136.67 53.38 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.386 -2.449 . . . . 51.329999999999998 104.386 166.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.88 154.27 12.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.483 0.659 . . . . 65.310000000000002 112.392 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.43 173.31 40.38 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.894 -1.048 . . . . 75.519999999999996 113.902 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.453 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -48.36 -28.81 3.41 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 116.732 2.123 . . . . 75.209999999999994 116.732 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.26 -7.37 42.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.447 0.567 . . . . 72.420000000000002 111.397 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.43 28.31 25.09 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.495 -0.86 . . . . 71.340000000000003 112.439 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -127.65 138.63 52.88 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.634 -0.876 . . . . 73.540000000000006 108.634 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.39 105.38 7.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.617 0.722 . . . . 72.129999999999995 109.741 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.41 -174.4 22.2 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.812 -0.709 . . . . 71.540000000000006 113.873 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -116.79 128.66 8.01 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.363 -1.495 . . . . 34.229999999999997 109.363 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 38.8 m -178.26 -177.36 0.58 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 125.758 1.623 . . . . 75.549999999999997 108.196 -170.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.38 -73.25 0.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.877 -0.515 . . . . 70.340000000000003 110.53 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.44 -6.96 29.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.188 0.518 . . . . 72.450000000000003 111.718 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -100.54 9.34 42.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.335 0.588 . . . . 71.5 110.917 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -86.11 157.78 19.95 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.813 -0.631 . . . . 60.399999999999999 111.162 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.73 112.33 13.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.931 -1.877 . . . . 63.020000000000003 105.931 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.597 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.32 123.45 48.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.472 0.653 . . . . 72.409999999999997 111.067 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -175.11 177.24 47.17 Favored Glycine 0 N--CA 1.413 -2.869 0 N-CA-C 110.155 -1.178 . . . . 72.340000000000003 110.155 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -103.36 162.92 12.6 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.136 -1.802 . . . . 70.349999999999994 106.136 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -143.64 124.7 14.43 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.119 -1.067 . . . . 75.239999999999995 108.119 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -111.58 112.38 24.05 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.899 -1.519 . . . . 75.430000000000007 106.899 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.416 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 4.7 p-10 . . . . . 0 C--N 1.293 -1.88 0 N-CA-C 109.413 -0.588 . . . . 71.140000000000001 109.413 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.491 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.8 mpt? . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.358 -0.608 . . . . 73.129999999999995 109.358 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -118.12 84.62 2.2 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.82 0.819 . . . . 74.519999999999996 110.501 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 99.1 mtt180 -153.07 165.78 16.88 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 106.292 -1.744 . . . . 65.439999999999998 106.292 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.94 130.25 38.32 Favored 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 122.515 2.143 . . . . 63.310000000000002 111.422 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' VAL . 33.5 m-20 72.85 -31.67 0.23 Allowed 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 125.393 1.477 . . . . 70.209999999999994 113.597 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 13.9 mm100 -68.93 -32.59 72.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.955 -0.757 . . . . 73.5 108.955 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.63 -17.89 64.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 74.439999999999998 110.747 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 57.0 mttp -89.44 -24.66 21.82 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.156 -0.683 . . . . 73.409999999999997 109.156 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 43' ' ' ASP . 59.5 t -75.0 -43.93 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.913 0.863 . . . . 73.540000000000006 108.698 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -64.65 -28.11 69.39 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.227 -1.351 . . . . 72.140000000000001 111.762 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.16 -37.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 119.597 -0.841 . . . . 73.530000000000001 110.146 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.677 -0.692 . . . . 62.409999999999997 110.667 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.505 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 55.0 mtpt -68.53 -22.47 64.51 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 121.379 0.609 . . . . 65.420000000000002 111.749 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.56 -31.1 46.63 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.618 -1.393 . . . . 73.109999999999999 109.618 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.6 m-20 -76.08 -31.15 58.6 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.223 -0.489 . . . . 72.409999999999997 111.359 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.417 HG21 ' HA2' ' A' ' 144' ' ' GLY . 14.3 pt -66.89 -30.82 50.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 C-N-CA 120.373 -0.531 . . . . 71.439999999999998 109.879 173.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 14.2 mptt -67.17 -31.83 72.51 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 120.075 -0.65 . . . . 74.510000000000005 109.984 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.4 71.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 44.530000000000001 110.83 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.561 HG12 HD13 ' A' ' 100' ' ' LEU . 44.1 mt -62.75 -43.15 98.49 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 116.013 -0.539 . . . . 74.239999999999995 109.715 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -22.72 66.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.02 0.438 . . . . 72.439999999999998 111.681 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 -33.96 20.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.397 0.618 . . . . 65.129999999999995 109.951 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' TYR . . . -81.9 -27.48 33.38 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 110.552 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.28 -30.33 71.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 106.927 -1.508 . . . . 71.420000000000002 106.927 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 20.0 t70 -73.92 -17.21 61.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.705 -1.134 . . . . 65.120000000000005 109.21 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.8 mtm -84.01 -32.17 25.08 Favored 'General case' 0 C--O 1.204 -1.307 0 O-C-N 121.638 -0.664 . . . . 71.239999999999995 109.428 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -63.61 -35.47 80.61 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.17 -1.789 . . . . 64.540000000000006 106.17 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 60.5 tttp -58.12 -38.01 75.69 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 115.594 -0.73 . . . . 70.409999999999997 110.569 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 tp -74.73 -36.22 62.66 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.492 0.663 . . . . 73.230000000000004 109.667 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 13.8 t70 -74.37 -24.55 59.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.188 -0.914 . . . . 74.140000000000001 111.772 -174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -128.54 22.84 5.92 Favored 'General case' 0 CA--C 1.455 -2.699 0 O-C-N 121.549 -0.719 . . . . 73.129999999999995 110.62 177.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 42.44 31.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.501 1.52 . . . . 65.420000000000002 112.822 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.64 161.43 0.52 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.873 -1.158 . . . . 71.219999999999999 107.873 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.653 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 19.7 m-85 -75.74 155.07 85.27 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 123.301 0.376 . . . . 73.140000000000001 111.872 174.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 37.0 Cg_endo -66.7 157.8 59.22 Favored 'Trans proline' 0 C--O 1.211 -0.849 0 C-N-CA 122.693 2.262 . . . . 72.299999999999997 110.391 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 p -94.37 155.55 16.93 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 107.119 -1.437 . . . . 74.439999999999998 107.119 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.659 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -72.79 -4.54 32.2 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.013 1.279 . . . . 72.530000000000001 111.257 -176.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -102.75 -66.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 120.113 -0.635 . . . . 51.450000000000003 110.241 169.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -74.94 -45.99 38.68 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.531 -0.544 . . . . 71.310000000000002 109.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -72.16 -19.97 78.83 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 120.322 -0.942 . . . . 73.519999999999996 113.775 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tt -73.17 -48.66 33.4 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 107.841 -1.17 . . . . 72.430000000000007 107.841 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.53 -37.13 82.61 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 108.323 -0.991 . . . . 72.219999999999999 108.323 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -77.89 -5.61 51.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.041 0.756 . . . . 63.310000000000002 113.041 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.53 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 15.3 tp -94.43 -23.47 17.73 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.38 -0.97 . . . . 53.420000000000002 108.38 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.28 -38.78 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.924 -1.034 . . . . 63.520000000000003 110.562 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 43.8 tttm -124.06 150.69 44.68 Favored 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 126.598 1.959 . . . . 72.439999999999998 107.17 -174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -54.11 141.66 49.5 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 113.242 0.83 . . . . 74.230000000000004 113.242 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 7.7 Cg_endo -45.15 136.47 10.67 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 125.104 3.87 . . . . 54.340000000000003 115.992 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -101.41 -11.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.63 -1.168 . . . . 51.450000000000003 108.989 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.84 -148.62 24.07 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.949 -0.861 . . . . 52.43 110.949 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -117.12 101.16 53.34 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-O 121.555 0.693 . . . . 75.129999999999995 111.345 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.581 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 95.6 Cg_endo -99.71 162.82 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.772 2.981 . . . . 74.409999999999997 112.447 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -87.54 159.04 50.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.822 -1.177 . . . . 74.209999999999994 107.822 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.75 98.42 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.612 1.541 . . . . 74.219999999999999 112.904 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 2.3 mptp? -150.05 148.12 28.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.008 1.723 . . . . 35.329999999999998 106.46 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.57 98.01 5.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.004 0.431 . . . . 61.32 111.034 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.635 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 85.5 t90 -54.73 144.18 23.01 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.349 1.86 . . . . 73.140000000000001 113.042 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -116.65 135.33 53.88 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.526 1.13 . . . . 75.140000000000001 109.221 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -82.39 178.7 8.1 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 122.09 0.947 . . . . 74.400000000000006 110.909 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 55.63 45.92 23.76 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.894 -1.957 . . . . 65.120000000000005 111.905 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.53 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 105.7 -10.19 45.09 Favored Glycine 0 CA--C 1.477 -2.336 0 CA-C-N 114.427 -1.26 . . . . 62.049999999999997 114.856 163.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.635 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 64.55 96.15 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 122.182 0.991 . . . . 71.450000000000003 109.63 -171.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.561 HD13 HG12 ' A' ' 57' ' ' ILE . 59.3 tp -138.79 170.04 16.71 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.697 -1.138 . . . . 73.25 107.937 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.82 -170.32 2.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.747 -1.575 . . . . 64.349999999999994 106.747 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.71 75.91 10.27 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.606 -0.837 . . . . 71.129999999999995 109.996 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -130.85 147.85 67.86 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.379 -1.282 . . . . 74.040000000000006 108.753 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.59 178.01 7.26 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.538 2.159 . . . . 72.409999999999997 112.806 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 111' ' ' PRO . 3.9 p -85.5 175.75 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.716 -0.846 . . . . 73.409999999999997 108.716 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.8 p-10 -78.65 158.2 76.1 Favored Pre-proline 0 C--O 1.251 1.184 0 CA-C-N 119.381 0.991 . . . . 74.340000000000003 113.132 -170.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 7.8 Cg_endo -54.52 171.07 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.266 2.644 . . . . 73.409999999999997 112.654 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.52 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 3.1 m-90 64.01 14.69 8.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.559 1.544 . . . . 74.340000000000003 108.856 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.46 38.33 79.5 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 114.026 -1.443 . . . . 73.019999999999996 115.167 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.521 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 13.2 m-80 -91.68 146.32 32.88 Favored Pre-proline 0 C--O 1.266 1.924 0 CA-C-N 119.954 1.877 . . . . 73.349999999999994 108.898 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.528 ' HA ' HG21 ' A' ' 105' ' ' VAL . 36.6 Cg_endo -89.35 137.83 3.12 Favored 'Trans proline' 0 N--CA 1.428 -2.377 0 C-N-CA 122.053 1.835 . . . . 63.329999999999998 109.565 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 59.2 m-85 -68.04 143.41 55.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.883 0.373 . . . . 74.349999999999994 110.601 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.524 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -102.67 117.34 34.46 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.112 -1.44 . . . . 73.140000000000001 107.112 -176.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -104.14 120.65 41.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.876 -0.416 . . . . 73.129999999999995 109.876 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 92.6 mt -127.98 153.56 46.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.452 -0.573 . . . . 73.430000000000007 109.452 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.756 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.63 -176.61 0.41 Allowed Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 116.567 -1.683 . . . . 44.109999999999999 107.306 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.5 Cg_endo . . . . . 0 C--N 1.384 2.405 0 C-N-CA 122.383 2.055 . . . . 71.120000000000005 114.707 -169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 C--O 1.202 -1.894 0 CA-C-O 118.462 -1.188 . . . . 61.030000000000001 113.632 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.577 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 32.4 Cg_exo -40.3 -23.98 0.13 Allowed 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 126.782 4.988 . . . . 64.299999999999997 117.731 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.516 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 51.3 p90 -176.64 163.8 2.4 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 118.351 0.523 . . . . 73.319999999999993 109.682 176.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 146' ' ' TRP . 23.9 m-20 -139.86 118.45 12.28 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 124.279 0.987 . . . . 53.130000000000003 108.792 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . 0.26 4.4 pp -143.27 138.24 29.45 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.283 -1.367 . . . . 62.409999999999997 112.649 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 39.5 p90 -165.46 167.06 17.93 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.871 -1.059 . . . . 75.409999999999997 108.332 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.657 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 8.7 t -125.79 157.35 37.73 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.849 -1.167 . . . . 74.450000000000003 107.849 172.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.524 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 91.3 mt -67.33 154.13 42.05 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.835 0.709 . . . . 73.120000000000005 111.185 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.22 -164.58 21.89 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.342 -0.932 . . . . 71.219999999999999 114.16 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.9 -16.85 32.72 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.758 1.022 . . . . 75.200000000000003 113.758 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -106.29 1.55 26.01 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.625 0.726 . . . . 74.219999999999999 110.026 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 43.16 99.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.1 -0.8 . . . . 43.439999999999998 111.1 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 134' ' ' GLU . 8.8 tmtt? -141.15 147.16 37.99 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.231 -1.396 . . . . 72.310000000000002 107.231 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.72 106.55 18.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.795 0.807 . . . . 62.119999999999997 111.426 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.64 -178.85 24.97 Favored Glycine 0 C--N 1.291 -1.963 0 N-CA-C 110.722 -0.951 . . . . 15.51 110.722 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.89 127.09 8.81 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.468 -1.853 . . . . 45.32 108.468 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.491 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 53.3 m 179.28 -177.48 0.31 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.775 1.63 . . . . 64.109999999999999 107.507 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.96 -74.68 0.35 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.874 0.368 . . . . 63.340000000000003 110.638 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -94.0 -16.67 23.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.024 0.44 . . . . 65.25 111.086 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.99 3.95 53.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.56 0.695 . . . . 71.239999999999995 109.9 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.491 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -97.98 157.05 16.34 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 115.211 -0.904 . . . . 71.540000000000006 111.175 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.34 134.74 37.43 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.735 -1.209 . . . . 72.150000000000006 107.735 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.541 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -107.21 121.33 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 115.335 -0.848 . . . . 44.32 111.633 -175.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 126' ' ' TYR . . . -167.05 177.32 41.75 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 118.727 -1.702 . . . . 35.210000000000001 114.279 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.511 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -156.56 157.08 34.71 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.627 -0.786 . . . . 72.019999999999996 109.357 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.516 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 4.9 p90 -163.08 177.1 9.41 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.529 0.518 . . . . 75.200000000000003 111.204 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 122' ' ' PRO . 35.3 t70 -120.02 130.79 54.89 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.186 -1.783 . . . . 74.230000000000004 106.186 175.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.41 ' HA ' ' CA ' ' A' ' 121' ' ' GLY . 4.1 p-10 . . . . . 0 C--N 1.296 -1.728 0 O-C-N 124.387 1.054 . . . . 71.25 110.316 -174.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.646 ' N ' ' HG1' ' A' ' 48' ' ' THR . 2.0 mpt? . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 110.611 -0.144 . . . . 74.510000000000005 110.611 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -103.07 77.91 1.6 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.293 0.568 . . . . 74.25 112.342 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -155.43 158.93 32.03 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 107.203 -1.406 . . . . 72.120000000000005 107.203 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.92 143.93 69.8 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.277 1.985 . . . . 74.019999999999996 110.716 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 75.06 -52.25 0.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.85 1.26 . . . . 64.430000000000007 110.96 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 86.6 mt-30 -68.48 -17.96 64.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 70.319999999999993 110.601 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.42 -27.11 68.86 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.529 -0.759 . . . . 74.099999999999994 110.018 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.74 -25.04 24.9 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.523 -0.547 . . . . 63.509999999999998 109.523 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 92.3 t -74.09 -43.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.587 -0.733 . . . . 63.100000000000001 109.112 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.646 ' HG1' ' N ' ' A' ' 39' ' ' MET . 5.8 t -68.18 -29.84 68.81 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.056 -0.975 . . . . 71.319999999999993 111.504 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.0 t -76.36 -47.69 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.935 -0.395 . . . . 74.420000000000002 109.935 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.398 -0.819 . . . . 64.25 111.498 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 47.6 mtpt -67.4 -23.57 65.57 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.239 -0.584 . . . . 63.210000000000001 112.316 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.78 -37.68 38.74 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.896 -1.145 . . . . 71.319999999999993 110.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 m-20 -77.34 -24.16 50.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.426 -0.51 . . . . 75.450000000000003 111.813 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 51' ' ' LYS . 15.5 pt -72.69 -27.26 25.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.084 -0.646 . . . . 63.240000000000002 110.842 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 2.0 mptm? -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.49 -0.884 . . . . 73.450000000000003 109.58 173.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.53 -42.38 92.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.327 -0.851 . . . . 63.310000000000002 109.86 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 53' ' ' ASP . 73.7 mt -62.99 -34.29 65.57 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.655 -0.702 . . . . 64.230000000000004 110.111 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.03 -31.3 70.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.846 0.355 . . . . 75.109999999999999 110.766 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.51 42.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.261 0.553 . . . . 63.039999999999999 109.849 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.99 35.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.009 -0.541 . . . . 74.340000000000003 110.155 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -30.01 68.67 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.982 -1.488 . . . . 73.439999999999998 106.982 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 65' ' ' LYS . 17.3 t70 -68.67 -29.01 67.38 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.111 -0.949 . . . . 64.439999999999998 109.963 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -71.99 -36.21 69.71 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.46 -0.496 . . . . 72.230000000000004 109.668 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -70.28 -38.03 74.96 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 107.794 -1.188 . . . . 75.340000000000003 107.794 174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 29.2 tttm -54.21 -35.89 62.9 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.646 -0.706 . . . . 71.329999999999998 110.661 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.37 -33.91 32.06 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.596 -0.274 . . . . 72.230000000000004 111.62 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.71 -24.25 62.61 Favored 'General case' 0 C--O 1.177 -2.76 0 CA-C-O 120.545 0.212 . . . . 74.109999999999999 111.1 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.9 OUTLIER -127.01 18.66 7.14 Favored 'General case' 0 CA--C 1.463 -2.401 0 O-C-N 120.778 -1.202 . . . . 71.530000000000001 111.428 177.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.19 32.44 0.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.066 1.346 . . . . 74.25 112.663 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.82 162.11 0.57 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.072 -1.455 . . . . 52.439999999999998 107.072 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.404 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.0 m-85 -80.48 155.87 73.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 111.858 0.318 . . . . 74.230000000000004 111.858 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.5 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 31.8 Cg_endo -66.03 161.87 37.92 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.048 2.499 . . . . 74.329999999999998 110.64 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -97.85 156.61 16.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.301 -1.37 . . . . 42.039999999999999 107.301 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.3 t -66.61 -13.79 61.57 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 119.138 0.881 . . . . 74.129999999999995 110.94 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 -65.14 1.01 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.448 -0.342 . . . . 62.549999999999997 111.33 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -77.41 -33.88 54.88 Favored 'General case' 0 CA--C 1.481 -1.707 0 O-C-N 121.95 -0.468 . . . . 73.099999999999994 111.197 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.583 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -76.73 -20.9 75.75 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 118.881 -1.628 . . . . 71.109999999999999 112.554 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.78 -49.53 61.91 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 106.069 -1.826 . . . . 75.040000000000006 106.069 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.0 -33.59 73.49 Favored 'General case' 0 C--O 1.169 -3.174 0 CA-C-N 114.646 -1.161 . . . . 71.439999999999998 110.272 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -80.07 -5.37 55.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.802 0.668 . . . . 64.409999999999997 112.802 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 84.6 mt -96.42 -17.8 20.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.192 0.52 . . . . 75.010000000000005 109.858 173.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.53 -33.93 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.373 0.606 . . . . 74.230000000000004 111.441 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 83.8 tttt -122.67 148.79 44.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 126.357 1.863 . . . . 64.120000000000005 106.861 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -56.51 135.56 76.98 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 118.152 0.433 . . . . 71.200000000000003 111.157 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 39.7 Cg_endo -63.47 150.75 87.71 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.825 3.017 . . . . 61.310000000000002 112.685 -174.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -98.45 146.81 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.618 -0.433 . . . . 74.310000000000002 110.557 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.71 -146.39 18.55 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.932 -1.267 . . . . 54.109999999999999 109.932 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -126.72 86.43 58.61 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-O 121.663 0.744 . . . . 71.319999999999993 111.697 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 1.6 Cg_endo -82.17 154.76 16.84 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.975 2.45 . . . . 74.409999999999997 111.126 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.2 143.5 65.23 Favored Pre-proline 0 C--O 1.211 -0.927 0 C-N-CA 123.615 0.766 . . . . 61.119999999999997 110.087 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.65 100.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.178 3.252 . . . . 74.510000000000005 115.017 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -147.31 148.02 30.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.203 -1.777 . . . . 75.219999999999999 106.203 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.33 91.58 3.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.484 -0.562 . . . . 74.5 109.484 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.644 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.7 t90 -54.58 138.83 40.07 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 123.969 0.793 . . . . 74.409999999999997 111.514 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -126.72 134.4 50.67 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 114.966 -1.016 . . . . 72.129999999999995 109.965 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 24.1 pttm -90.95 -176.43 4.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.321 -0.552 . . . . 65.120000000000005 109.883 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 72.43 15.59 5.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.137 1.375 . . . . 70.010000000000005 109.958 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 110.39 5.17 28.4 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 114.709 -1.132 . . . . 71.140000000000001 114.769 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.644 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 67.84 93.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.276 1.036 . . . . 74.019999999999996 110.644 -175.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.7 tp -132.6 158.33 42.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.899 -1.046 . . . . 74.409999999999997 108.651 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -84.85 -171.76 3.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.419 -0.956 . . . . 54.5 108.419 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -78.61 70.62 4.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.599 1.19 . . . . 74.239999999999995 110.504 176.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.9 mt -126.83 147.65 62.04 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 114.694 -1.139 . . . . 73.129999999999995 109.442 -174.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.63 158.36 53.73 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.634 1.556 . . . . 71.109999999999999 109.663 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 111' ' ' PRO . 6.0 p -79.6 175.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.43 -0.581 . . . . 75.420000000000002 109.43 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 105' ' ' VAL . 5.8 p-10 -71.38 158.19 88.48 Favored Pre-proline 0 C--O 1.249 1.062 0 N-CA-C 113.375 0.88 . . . . 74.319999999999993 113.375 -168.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 10.1 Cg_endo -53.36 169.1 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.679 2.919 . . . . 71.010000000000005 112.06 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 64.13 15.27 9.18 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.842 1.257 . . . . 64.340000000000003 109.142 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.0 68.43 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 114.266 -1.334 . . . . 42.350000000000001 115.152 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.478 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 3.8 m-80 -91.78 154.18 43.8 Favored Pre-proline 0 C--O 1.262 1.733 0 CA-C-N 119.927 1.863 . . . . 74.219999999999999 109.04 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.576 ' HA ' HG21 ' A' ' 105' ' ' VAL . 1.5 Cg_endo -85.73 152.08 10.08 Favored 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 121.801 1.667 . . . . 70.310000000000002 108.365 165.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 70.0 m-85 -69.16 143.96 53.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.907 0.384 . . . . 74.209999999999994 110.252 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 1.6 mm100 -101.47 120.86 40.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.48 -1.674 . . . . 71.519999999999996 106.48 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.38 118.93 37.95 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 72.030000000000001 112.693 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 89.2 mt -130.34 153.71 48.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.669 -0.863 . . . . 71.129999999999995 108.669 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -113.5 -177.8 0.47 Allowed Pre-proline 0 C--N 1.297 -1.71 0 CA-C-O 117.055 -1.45 . . . . 71.299999999999997 109.284 -176.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.742 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 19.0 Cg_endo . . . . . 0 C--N 1.382 2.33 0 C-N-CA 122.956 2.437 . . . . 43.240000000000002 115.882 -166.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.488 -1.628 0 CA-C-O 118.704 -1.053 . . . . 50.219999999999999 113.548 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.56 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 11.1 Cg_exo -37.85 -29.52 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.574 1 C-N-CA 126.857 5.038 . . . . 73.340000000000003 118.343 -179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -170.43 151.76 3.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.915 1.234 . . . . 62.020000000000003 113.856 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.695 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -113.65 106.66 14.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.703 1.601 . . . . 74.430000000000007 107.518 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.81 125.03 32.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.747 -0.781 . . . . 64.540000000000006 109.416 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 27.0 p90 -167.1 165.35 15.64 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 110.41 -0.218 . . . . 72.120000000000005 110.41 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.1 p -125.7 148.0 49.18 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.805 -0.813 . . . . 51.340000000000003 108.805 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.26 133.5 50.72 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.776 0.658 . . . . 71.329999999999998 112.776 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.95 173.18 31.8 Favored Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 111.202 -0.759 . . . . 55.310000000000002 111.202 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.21 -20.32 26.24 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 115.583 1.697 . . . . 51.039999999999999 115.583 -173.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.538 ' OD2' ' HE2' ' A' ' 133' ' ' LYS . 5.0 t70 -94.88 -0.99 53.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.722 0.773 . . . . 72.310000000000002 109.757 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.76 24.48 60.15 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 111.319 -0.713 . . . . 74.030000000000001 111.319 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.538 ' HE2' ' OD2' ' A' ' 131' ' ' ASP . 68.5 mttm -112.13 147.31 36.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.151 0.5 . . . . 65.200000000000003 111.771 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 2.7 tm-20 -100.71 102.33 13.41 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 102.751 -3.055 . . . . 75.25 102.751 165.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 -173.29 23.14 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.196 -1.366 . . . . 51.350000000000001 111.446 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.15 128.16 8.11 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 107.311 -2.316 . . . . 61.219999999999999 107.311 172.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.55 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 62.8 m -177.78 -179.04 0.75 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.022 1.329 . . . . 73.239999999999995 107.463 -171.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.62 -68.6 0.55 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.323 0.583 . . . . 62.43 110.156 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.48 -16.42 11.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.223 -0.899 . . . . 72.349999999999994 110.857 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -82.72 -9.92 59.14 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.244 -0.434 . . . . 63.109999999999999 110.762 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -86.96 155.13 20.31 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.211 -0.904 . . . . 74.219999999999999 110.849 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 8.8 p-10 -79.88 136.16 36.61 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.869 -1.53 . . . . 61.219999999999999 106.869 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -97.84 130.86 45.96 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.66 -1.237 . . . . 60.350000000000001 107.66 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -143.26 153.25 24.68 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 118.712 -1.709 . . . . 63.43 114.294 -173.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -120.08 129.55 54.26 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.264 -2.125 . . . . 71.530000000000001 105.264 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -142.43 144.1 32.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.806 -0.813 . . . . 74.349999999999994 108.806 -168.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -130.47 115.13 16.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.97 -1.122 . . . . 75.200000000000003 107.97 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 107.34 -1.356 . . . . 44.119999999999997 107.34 179.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.478 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.7 mpt? . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 109.378 -0.601 . . . . 64.030000000000001 109.378 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -92.4 62.02 3.91 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.906 0.706 . . . . 73.409999999999997 112.906 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -148.38 147.79 26.75 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 107.497 -1.297 . . . . 74.540000000000006 107.497 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.06 151.69 26.83 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.469 2.113 . . . . 64.400000000000006 109.835 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 76.76 -57.28 0.54 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.224 1.009 . . . . 65.120000000000005 109.389 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 49.3 mt-30 -68.79 -16.39 63.78 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.888 -0.508 . . . . 60.130000000000003 111.344 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 -25.89 67.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.872 -0.604 . . . . 61.299999999999997 109.386 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -83.49 -24.58 31.68 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 108.825 -0.806 . . . . 74.540000000000006 108.825 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 44' ' ' GLN . 69.4 t -74.37 -43.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.82 -0.627 . . . . 62.520000000000003 110.233 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -66.43 -39.59 89.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.095 -0.502 . . . . 62.409999999999997 111.901 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.02 -34.79 51.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.786 0.327 . . . . 64.019999999999996 110.289 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 143' ' ' ILE . . . -66.96 -39.36 87.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.055 -0.521 . . . . 60.009999999999998 110.671 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.554 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 66.1 mttm -65.68 -25.6 67.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.357 0.598 . . . . 64.209999999999994 111.225 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 -32.31 35.5 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.762 -1.209 . . . . 74.329999999999998 110.538 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 56' ' ' ALA 0.354 70.4 m-20 -87.33 -20.62 26.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.268 1.21 . . . . 74.540000000000006 114.268 -175.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 144' ' ' GLY . 15.4 pt -71.64 -28.43 31.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.714 -0.847 . . . . 74.530000000000001 108.714 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -73.82 -27.03 60.9 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.844 -0.616 . . . . 53.229999999999997 110.565 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -62.5 -43.27 99.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.444 -0.798 . . . . 53.100000000000001 109.958 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.463 HG12 ' HG ' ' A' ' 100' ' ' LEU . 27.3 mt -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.735 0 CA-C-N 115.232 -0.895 . . . . 73.109999999999999 109.681 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.69 -25.28 62.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.835 -0.62 . . . . 71.310000000000002 111.995 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.78 -35.12 20.92 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.196 0.522 . . . . 44.43 110.11 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 63' ' ' MET . . . -80.58 -28.3 37.19 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.779 -0.368 . . . . 64.329999999999998 111.242 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.89 -26.85 64.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.883 -1.155 . . . . 72.319999999999993 107.883 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.3 t70 -69.09 -23.97 64.08 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.287 1.041 . . . . 65.040000000000006 109.232 173.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.424 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 51.1 ttm -78.76 -37.94 39.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.534 -0.757 . . . . 73.319999999999993 109.674 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.481 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 81.9 t80 -66.01 -38.12 87.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.063 -1.088 . . . . 75.540000000000006 108.063 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.541 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 75.9 tttt -54.54 -33.14 59.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.357 -1.292 . . . . 74.150000000000006 109.945 173.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 tp -83.13 -34.93 25.94 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.683 -0.407 . . . . 75.25 110.593 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 29.7 t70 -70.98 -25.61 62.78 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 120.901 0.381 . . . . 63.310000000000002 111.909 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.564 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -125.65 19.84 7.92 Favored 'General case' 0 CA--C 1.462 -2.427 0 O-C-N 121.068 -1.02 . . . . 65.510000000000005 110.949 175.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 p90 43.85 33.65 0.77 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 124.621 1.201 . . . . 73.040000000000006 113.549 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.85 160.36 1.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.739 -0.837 . . . . 75.540000000000006 108.739 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.541 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 27.6 m-85 -82.98 152.66 66.03 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.932 -0.396 . . . . 72.230000000000004 109.932 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.502 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.9 Cg_endo -63.82 164.73 20.67 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.972 3.114 . . . . 70.340000000000003 112.96 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.1 p -97.67 156.25 16.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 106.049 -1.834 . . . . 74.340000000000003 106.049 172.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -66.15 -14.47 61.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.43 0.633 . . . . 62.119999999999997 110.566 -176.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.42 -66.19 0.94 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.385 -0.598 . . . . 71.349999999999994 109.385 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -79.66 -35.98 38.42 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 116.186 -0.461 . . . . 72.530000000000001 111.087 -173.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.588 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -76.77 -21.4 74.56 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 118.021 -2.037 . . . . 54.240000000000002 112.453 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.23 -46.85 66.37 Favored 'General case' 0 C--O 1.259 1.591 0 N-CA-C 106.491 -1.67 . . . . 73.200000000000003 106.491 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.8 mt-10 -60.37 -37.69 81.54 Favored 'General case' 0 C--O 1.171 -3.067 0 CA-C-N 114.603 -1.18 . . . . 72.109999999999999 109.401 174.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.554 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.37 -3.26 39.22 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.862 0.689 . . . . 41.219999999999999 112.862 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 76.8 mt -95.18 -22.79 17.61 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.099 0.476 . . . . 72.340000000000003 110.168 173.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -107.78 -25.88 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.547 0.689 . . . . 74.140000000000001 111.222 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 85.0 tttt -127.03 147.39 50.14 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 126.432 1.893 . . . . 63.539999999999999 107.001 -175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -54.86 128.53 63.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.606 0.762 . . . . 75.120000000000005 111.78 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 37.1 Cg_endo -66.8 131.03 24.62 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.405 2.737 . . . . 74.230000000000004 111.701 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -94.68 -179.15 4.78 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.11 -0.7 . . . . 61.340000000000003 109.11 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.88 -125.12 8.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 108.207 -1.957 . . . . 74.409999999999997 108.207 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.8 80.21 14.2 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 118.093 0.946 . . . . 72.530000000000001 112.697 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.564 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 14.4 Cg_endo -82.94 142.54 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.205 1.936 . . . . 70.319999999999993 110.479 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 50.8 mt-30 -83.06 115.98 61.79 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 107.149 -1.426 . . . . 43.509999999999998 107.149 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.521 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 51.4 Cg_exo -51.18 98.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 123.409 2.74 . . . . 65.340000000000003 117.678 -168.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HE2' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -111.19 148.93 31.71 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 101.995 -3.335 . . . . 53.149999999999999 101.995 163.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.54 99.6 0.11 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 120.108 -0.637 . . . . 71.040000000000006 109.736 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.593 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.2 t90 -62.16 141.88 57.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 124.42 1.088 . . . . 74.25 110.693 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.99 133.4 50.57 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.719 -0.673 . . . . 73.019999999999996 109.284 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -82.46 -176.92 6.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.15 0.5 . . . . 71.310000000000002 110.359 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.4 t70 71.36 15.71 6.22 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.498 1.119 . . . . 63.530000000000001 110.292 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 109.21 7.97 27.89 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.057 -0.974 . . . . 73.5 114.115 171.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.593 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 63.78 92.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.136 0.97 . . . . 71.049999999999997 109.139 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 101' ' ' LYS . 6.8 tt -138.21 168.01 20.64 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.978 -1.489 . . . . 72.209999999999994 106.978 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' N ' HD23 ' A' ' 100' ' ' LEU . 71.5 mmtt -72.44 179.8 3.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.216 -1.031 . . . . 72.140000000000001 108.216 176.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -80.41 77.21 7.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.172 0.987 . . . . 74.540000000000006 110.376 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.9 mt -131.41 149.89 74.86 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.806 -1.543 . . . . 75.049999999999997 108.394 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.49 -170.17 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.861 1.707 . . . . 73.450000000000003 111.035 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.627 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.5 p -83.93 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.705 -0.85 . . . . 62.219999999999999 108.705 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.543 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 t0 -75.38 156.79 85.24 Favored Pre-proline 0 C--O 1.251 1.175 0 N-CA-C 108.898 -0.778 . . . . 75.310000000000002 108.898 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 6.0 Cg_endo -49.15 170.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 123.689 2.926 . . . . 54.420000000000002 113.408 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.594 ' HB2' HD22 ' A' ' 110' ' ' ASN . 1.7 m-90 67.21 14.39 9.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.959 1.704 . . . . 74.239999999999995 110.467 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.87 22.8 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 115.467 -0.788 . . . . 63.009999999999998 114.25 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.594 HD22 ' HB2' ' A' ' 108' ' ' TRP . 56.7 m-80 -69.95 134.53 87.72 Favored Pre-proline 0 C--O 1.255 1.378 0 N-CA-C 113.319 0.859 . . . . 65.040000000000006 113.319 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.627 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.5 Cg_endo -71.51 154.12 60.36 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.429 2.086 . . . . 64.519999999999996 110.404 173.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -73.29 141.2 47.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.882 -1.525 . . . . 74.209999999999994 106.882 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.3 mm100 -102.89 113.83 27.6 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.417 -1.697 . . . . 54.509999999999998 106.417 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.57 120.02 40.05 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.72 -0.673 . . . . 71.209999999999994 112.518 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 97.5 mt -129.29 153.61 47.65 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.385 0.674 . . . . 74.349999999999994 109.246 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.14 -179.1 0.63 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 117.104 -1.426 . . . . 74.010000000000005 108.364 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 25.0 Cg_endo . . . . . 0 C--N 1.384 2.416 0 C-N-CA 123.042 2.495 . . . . 72.120000000000005 116.785 -162.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.669 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.479 -2.218 0 CA-C-O 118.65 -1.083 . . . . 53.350000000000001 113.248 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.542 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 11.8 Cg_exo -43.34 -24.67 0.61 Allowed 'Trans proline' 0 C--N 1.371 1.754 1 C-N-CA 126.052 4.502 . . . . 71.230000000000004 117.179 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -168.89 143.91 3.24 Favored 'General case' 0 C--O 1.254 1.308 0 CA-C-N 118.861 0.755 . . . . 45.130000000000003 112.18 173.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.48 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.3 m-20 -122.99 117.68 26.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.518 -1.29 . . . . 64.5 107.518 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 pp -145.42 140.03 27.32 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.742 -0.783 . . . . 54.509999999999998 111.671 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.473 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 45.8 p90 -166.23 167.88 15.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.295 -1.002 . . . . 74.540000000000006 108.295 -175.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.9 p -124.18 136.85 54.49 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.593 -0.891 . . . . 71.230000000000004 108.593 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.65 135.3 57.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.846 -0.742 . . . . 73.430000000000007 111.541 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.87 -172.2 9.74 Favored Glycine 0 CA--C 1.495 -1.173 0 CA-C-N 115.817 -0.629 . . . . 65.319999999999993 112.848 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.33 -7.81 10.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 114.101 1.148 . . . . 64.140000000000001 114.101 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.66 -7.05 41.91 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.091 -0.644 . . . . 70.530000000000001 110.149 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 22.16 76.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 121.124 -0.56 . . . . 73.239999999999995 111.764 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -140.53 143.51 35.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.625 -1.25 . . . . 71.129999999999995 107.625 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -81.66 108.93 15.62 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.712 0.767 . . . . 72.099999999999994 109.997 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.4 -173.94 20.41 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.265 -0.88 . . . . 70.150000000000006 111.526 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.62 128.11 8.31 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.735 -0.946 . . . . 71.030000000000001 110.735 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.54 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 19.4 m 178.17 -176.87 0.21 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 127.143 2.177 . . . . 72.439999999999998 105.962 -172.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -87.49 -58.36 2.61 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.931 -1.107 . . . . 71.409999999999997 110.827 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.71 -28.81 13.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.638 0.732 . . . . 75.140000000000001 111.408 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.95 9.17 23.11 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.761 -0.587 . . . . 73.510000000000005 111.753 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.54 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -99.29 155.75 17.35 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 115.845 -0.616 . . . . 62.340000000000003 110.782 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -80.47 125.6 30.15 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.174 -1.417 . . . . 73.150000000000006 107.174 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.454 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.6 pp -106.71 141.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.508 -0.923 . . . . 72.040000000000006 108.508 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.421 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -173.78 170.85 44.01 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 118.212 -1.946 . . . . 71.239999999999995 114.41 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -113.72 137.26 51.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.847 -1.538 . . . . 74.010000000000005 106.847 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.404 ' CZ3' ' HB3' ' A' ' 124' ' ' ASP . 8.7 t-105 -141.79 124.53 15.99 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.562 . . . . 64.329999999999998 106.781 -170.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -102.73 114.2 28.24 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.053 -1.091 . . . . 71.230000000000004 108.053 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 7.3 p30 . . . . . 0 C--N 1.294 -1.814 0 N-CA-C 107.759 -1.2 . . . . 73.530000000000001 107.759 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.595 ' N ' ' HG1' ' A' ' 48' ' ' THR . 1.2 mpt? . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.257 -0.645 . . . . 63.219999999999999 109.257 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.7 m -100.03 86.09 3.18 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.597 0.713 . . . . 63.030000000000001 112.077 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -148.14 163.6 26.06 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 106.35 -1.722 . . . . 62.409999999999997 106.35 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.88 130.14 36.18 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.681 2.254 . . . . 70.519999999999996 111.374 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.55 -34.21 0.28 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 126.004 1.721 . . . . 51.310000000000002 111.008 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -68.29 -20.49 64.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 75.099999999999994 109.37 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.53 -29.46 70.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.315 -0.857 . . . . 62.350000000000001 110.073 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -80.62 -26.55 37.68 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 108.108 -1.071 . . . . 74.409999999999997 108.108 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.419 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.3 t -75.35 -43.6 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.572 -0.74 . . . . 73.25 110.299 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.595 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.1 t -67.93 -37.05 81.18 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.584 -0.735 . . . . 54.399999999999999 111.309 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.87 -34.26 32.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 110.127 -0.323 . . . . 64.310000000000002 110.127 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.755 -0.657 . . . . 71.430000000000007 110.616 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 70.9 mmtt -65.28 -26.31 68.02 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.421 0.629 . . . . 72.409999999999997 111.05 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.29 -32.48 19.81 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.536 -1.025 . . . . 73.099999999999994 110.536 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 57' ' ' ILE . 70.1 m-20 -77.11 -33.58 56.88 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 120.917 -0.313 . . . . 72.430000000000007 111.465 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 pt -67.73 -29.74 46.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.701 -0.4 . . . . 60.520000000000003 110.313 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -73.23 -30.17 63.3 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.212 -0.662 . . . . 73.019999999999996 109.212 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.43 -40.58 96.01 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.052 -0.976 . . . . 74.010000000000005 109.991 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 53' ' ' ASP . 28.8 mt -66.28 -40.18 86.16 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.628 0 CA-C-N 115.103 -0.953 . . . . 71.430000000000007 109.71 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.03 66.8 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.29 -0.413 . . . . 62.439999999999998 111.447 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.03 -29.69 26.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.154 0.502 . . . . 62.210000000000001 110.319 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.31 -28.13 23.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.078 0.466 . . . . 72.400000000000006 110.975 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.99 -28.29 65.4 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.812 -1.551 . . . . 72.439999999999998 106.812 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.9 t70 -70.06 -24.16 63.2 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.598 -1.183 . . . . 74.219999999999999 108.75 172.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.7 mmt -79.93 -34.73 38.64 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.468 -0.787 . . . . 60.229999999999997 110.216 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.574 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 49.0 t80 -67.69 -31.7 71.84 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 107.103 -1.443 . . . . 75.140000000000001 107.103 171.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 56.9 tttp -57.92 -32.5 67.82 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.654 -0.703 . . . . 65.230000000000004 110.326 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -77.01 -36.11 56.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.148 0.499 . . . . 61.350000000000001 110.206 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -71.06 -25.44 62.63 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-N 115.7 -0.682 . . . . 74.329999999999998 110.856 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.5 18.41 5.29 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.924 -0.56 . . . . 72.230000000000004 110.27 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HD2' ' HG3' ' A' ' 90' ' ' GLN . 17.6 p90 42.89 31.35 0.31 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.014 1.326 . . . . 53.210000000000001 113.253 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.44 162.5 0.52 Allowed 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.516 -1.29 . . . . 71.120000000000005 107.516 -172.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 21.2 m-85 -78.63 151.63 77.32 Favored Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 120.305 -0.558 . . . . 73.200000000000003 111.31 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 14.1 Cg_endo -59.76 170.55 3.45 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 124.307 3.338 . . . . 73.239999999999995 112.725 177.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 76' ' ' GLN . 77.7 p -101.82 155.66 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.492 -1.67 . . . . 51.299999999999997 106.492 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -70.55 -15.07 62.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 119.796 1.18 . . . . 43.149999999999999 111.814 -173.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.48 -63.74 1.1 Allowed 'General case' 0 C--O 1.241 0.619 0 CA-C-N 116.311 -0.404 . . . . 72.310000000000002 110.886 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 48.8 mt-30 -76.08 -38.53 56.92 Favored 'General case' 0 CA--C 1.484 -1.584 0 C-N-CA 120.889 -0.325 . . . . 75.319999999999993 110.646 -174.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -71.31 -21.23 78.56 Favored Glycine 0 N--CA 1.418 -2.512 0 C-N-CA 119.101 -1.523 . . . . 72.540000000000006 112.83 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.54 -45.5 75.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.728 -1.582 . . . . 73.239999999999995 106.728 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.6 mt-10 -79.88 -2.83 45.37 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.842 -1.072 . . . . 72.310000000000002 111.077 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -99.8 -8.16 24.53 Favored 'General case' 0 C--O 1.204 -1.33 0 CA-C-O 121.677 0.751 . . . . 41.439999999999998 109.326 174.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 77' ' ' GLY . 5.4 mp -98.52 -24.25 15.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.481 -0.781 . . . . 65.409999999999997 110.026 174.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.92 -27.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.913 -0.585 . . . . 50.399999999999999 111.129 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 87.8 tttt -130.04 151.49 50.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.558 -1.645 . . . . 61.310000000000002 106.558 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -53.55 135.08 53.77 Favored Pre-proline 0 N--CA 1.485 1.308 0 CA-C-N 118.7 0.682 . . . . 75.019999999999996 110.94 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 7.2 Cg_endo -47.99 130.05 19.18 Favored 'Trans proline' 0 C--O 1.246 0.885 1 C-N-CA 125.357 4.038 . . . . 72.120000000000005 116.355 -170.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -82.19 148.97 28.16 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.183 -1.414 . . . . 44.229999999999997 107.183 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 89' ' ' PRO . . . 94.66 -157.28 22.29 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 109.634 -1.386 . . . . 35.43 109.634 -176.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.43 99.69 29.69 Favored Pre-proline 1 N--CA 1.369 -4.521 0 CA-C-N 117.68 0.74 . . . . 74.430000000000007 110.195 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 87' ' ' GLY . 96.4 Cg_endo -95.41 162.64 1.54 Allowed 'Trans proline' 0 N--CA 1.443 -1.493 0 C-N-CA 122.126 1.884 . . . . 75.030000000000001 109.756 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.408 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 25.8 mt-30 -82.8 159.18 63.92 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.432 . . . . 51.240000000000002 109.835 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.35 99.9 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.904 1.736 . . . . 75.030000000000001 111.315 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -150.51 146.07 26.38 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.485 -1.302 . . . . 52.329999999999998 107.485 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.64 89.52 1.32 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 120.733 0.301 . . . . 73.319999999999993 111.088 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.472 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 88.7 t90 -54.91 139.48 40.27 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.954 -1.021 . . . . 74.310000000000002 111.733 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.43 130.01 56.69 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.788 -1.096 . . . . 75.540000000000006 108.961 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -74.38 177.62 5.79 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.933 0.873 . . . . 65.25 110.801 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 62.24 36.11 14.98 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.345 -1.752 . . . . 44.140000000000001 109.398 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 92.55 7.73 63.03 Favored Glycine 0 CA--C 1.488 -1.611 0 CA-C-N 113.749 -1.569 . . . . 30.300000000000001 115.224 165.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 63.12 85.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.253 1.025 . . . . 72.400000000000006 108.649 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.1 tt -138.8 155.63 48.01 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.517 -1.66 . . . . 64.0 106.517 -173.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -63.53 141.5 58.74 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.799 -1.186 . . . . 64.109999999999999 107.799 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -74.0 79.09 1.69 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.039 0.923 . . . . 74.209999999999994 112.323 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -130.35 149.21 72.71 Favored Pre-proline 0 C--N 1.288 -2.094 0 CA-C-N 113.773 -1.558 . . . . 71.349999999999994 108.061 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 171.82 1.21 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.792 2.328 . . . . 73.230000000000004 111.873 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.694 HG21 ' HA ' ' A' ' 111' ' ' PRO . 2.6 p -79.21 171.78 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.547 0 CA-C-N 116.342 -0.39 . . . . 63.420000000000002 110.082 -173.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.49 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.2 t70 -82.76 153.89 67.76 Favored Pre-proline 0 C--O 1.256 1.423 0 C-N-CA 119.579 -0.848 . . . . 71.319999999999993 109.67 -169.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 10.3 Cg_exo -42.81 171.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.867 3.044 . . . . 72.430000000000007 115.051 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 70.15 14.17 7.7 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.484 2.313 . . . . 74.040000000000006 109.175 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.15 19.09 56.63 Favored Glycine 0 N--CA 1.466 0.635 0 CA-C-N 114.967 -1.015 . . . . 42.240000000000002 113.176 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.05 128.26 65.97 Favored Pre-proline 0 C--O 1.27 2.139 0 CA-C-O 121.526 0.679 . . . . 73.25 111.84 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.694 ' HA ' HG21 ' A' ' 105' ' ' VAL . 73.7 Cg_endo -80.46 154.2 21.1 Favored 'Trans proline' 0 N--CA 1.419 -2.888 0 C-N-CA 122.264 1.976 . . . . 71.019999999999996 110.302 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.463 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 46.7 m-85 -80.75 139.49 36.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.823 -1.177 . . . . 64.209999999999994 107.823 172.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.517 ' OE1' HD13 ' A' ' 128' ' ' LEU . 1.2 mm100 -103.98 118.45 36.7 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.327 -1.36 . . . . 72.549999999999997 107.327 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -103.82 117.66 34.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.893 -1.151 . . . . 65.109999999999999 107.893 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.0 mt -129.57 153.42 48.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.413 -0.958 . . . . 72.310000000000002 108.413 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.843 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.56 179.63 0.81 Allowed Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-O 117.001 -1.475 . . . . 74.209999999999994 108.351 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.843 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 9.1 Cg_endo . . . . . 0 C--N 1.38 2.2 0 C-N-CA 123.565 2.844 . . . . 71.519999999999996 114.796 -168.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.731 0 N-CA-C 117.952 1.941 . . . . 61.409999999999997 117.952 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 7.2 Cg_exo -31.25 -26.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.502 1 C-N-CA 129.208 6.605 . . . . 74.310000000000002 119.505 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.285 47.6 p90 -169.9 149.03 3.61 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 119.717 1.144 . . . . 53.210000000000001 112.912 170.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.0 OUTLIER -112.66 106.29 14.65 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.483 -1.303 . . . . 70.329999999999998 107.483 -176.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 57' ' ' ILE . 3.4 tm? -128.46 128.08 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.202 -0.936 . . . . 73.510000000000005 110.254 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -166.57 164.33 17.0 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 120.855 -0.338 . . . . 74.019999999999996 111.862 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.463 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 23.0 t -125.07 141.71 51.95 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.882 -2.266 . . . . 74.25 104.882 171.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.517 HD13 ' OE1' ' A' ' 113' ' ' GLN . 5.3 mp -59.56 155.0 16.2 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.789 1.033 . . . . 72.409999999999997 113.789 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.7 172.85 53.79 Favored Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 115.561 -0.745 . . . . 70.019999999999996 112.292 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.52 -28.47 2.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 116.79 2.144 . . . . 61.109999999999999 116.79 -173.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.33 -2.06 52.8 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.837 0.744 . . . . 71.349999999999994 111.27 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.42 24.75 27.82 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.986 -0.626 . . . . 53.229999999999997 112.082 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -140.89 146.32 37.31 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.412 -0.588 . . . . 75.209999999999994 109.412 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -81.88 117.85 22.47 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 120.825 0.345 . . . . 64.319999999999993 110.777 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -149.47 -174.23 20.71 Favored Glycine 0 C--N 1.317 -0.497 0 N-CA-C 110.441 -1.064 . . . . 34.229999999999997 110.441 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.91 128.14 8.6 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 109.791 -1.324 . . . . 73.140000000000001 109.791 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.507 ' H ' ' HB2' ' A' ' 141' ' ' ALA . 23.2 t 178.02 -176.65 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.384 -0.969 . . . . 73.239999999999995 108.384 -171.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.41 -71.11 0.36 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.116 -0.698 . . . . 74.109999999999999 109.116 172.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -98.76 -17.06 18.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.303 0.573 . . . . 71.019999999999996 111.525 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 15.1 m-20 -91.67 9.24 33.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.683 0.754 . . . . 73.109999999999999 110.763 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.507 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.54 152.87 19.4 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.591 -0.731 . . . . 63.329999999999998 110.31 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.79 119.39 21.93 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.931 -1.877 . . . . 51.399999999999999 105.931 171.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.563 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.35 128.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 115.754 -0.657 . . . . 73.109999999999999 109.936 -174.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.13 -179.8 38.56 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 118.463 -1.827 . . . . 75.5 113.31 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 7.2 t30 -123.73 147.88 47.09 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 105.725 -1.954 . . . . 73.329999999999998 105.725 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -142.88 135.92 28.15 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.75 -1.204 . . . . 75.439999999999998 107.75 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.9 106.58 13.97 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.176 -1.009 . . . . 73.150000000000006 108.484 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 2.6 t-20 . . . . . 0 N--CA 1.419 -1.988 0 N-CA-C 107.087 -1.449 . . . . 65.409999999999997 107.087 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.7 ttt . . . . . 0 C--O 1.217 -0.65 0 N-CA-C 107.724 -1.213 . . . . 73.129999999999995 107.724 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -110.22 89.41 3.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.024 0.916 . . . . 32.43 110.426 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 12.7 ptm180 -155.89 161.29 29.79 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.191 -1.781 . . . . 70.200000000000003 106.191 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.02 120.53 0.54 Allowed 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 124.057 3.171 . . . . 74.340000000000003 114.68 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t0 74.36 -35.79 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 126.81 2.044 . . . . 64.140000000000001 112.186 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.548 ' HA ' HG23 ' A' ' 47' ' ' VAL . 84.6 mm-40 -68.76 -24.39 64.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.504 0.668 . . . . 72.450000000000003 109.528 176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -62.11 -29.17 70.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.035 -0.984 . . . . 61.310000000000002 109.329 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.8 -23.73 39.05 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.118 -0.492 . . . . 74.329999999999998 110.249 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.548 HG23 ' HA ' ' A' ' 44' ' ' GLN . 40.2 t -74.59 -44.01 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.189 -1.041 . . . . 52.420000000000002 108.189 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 45' ' ' ALA . 14.6 t -67.96 -34.2 76.11 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.52 -0.763 . . . . 54.329999999999998 111.525 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 45' ' ' ALA . 19.8 m -69.22 -43.3 81.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 C-N-CA 119.434 -0.906 . . . . 74.129999999999995 109.566 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.422 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -59.6 -41.74 91.01 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.128 0.971 . . . . 51.329999999999998 110.958 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 58.7 mtpt -66.6 -21.89 66.13 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.635 -0.711 . . . . 74.310000000000002 111.925 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.27 -31.71 18.86 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 110.105 -1.198 . . . . 72.219999999999999 110.105 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.4 ' OD1' HD13 ' A' ' 103' ' ' LEU . 24.2 m-20 -70.42 -39.33 74.49 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.331 0.586 . . . . 72.310000000000002 110.622 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.627 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 17.6 pt -70.23 -25.5 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.942 -0.572 . . . . 54.310000000000002 110.673 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -68.41 -31.87 71.51 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.735 -0.839 . . . . 63.299999999999997 108.735 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -29.3 64.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.272 -0.876 . . . . 63.240000000000002 109.78 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 18.1 mm -59.88 -48.3 88.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 CA-C-N 115.03 -0.987 . . . . 61.119999999999997 108.731 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB2' HD21 ' A' ' 145' ' ' ASN . . . -58.22 -34.01 69.95 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.854 0.359 . . . . 54.340000000000003 111.314 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.53 -42.54 67.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.736 -0.665 . . . . 75.25 111.037 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.41 24.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.464 0.542 . . . . 62.100000000000001 112.464 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.31 -30.11 69.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.166 -1.42 . . . . 74.420000000000002 107.166 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.5 t70 -69.88 -27.61 64.96 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.289 1.042 . . . . 73.329999999999998 109.601 173.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 63.3 mtt -78.34 -30.21 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.707 -0.679 . . . . 72.420000000000002 110.331 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -71.3 -36.22 71.56 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.017 -1.105 . . . . 72.209999999999994 108.017 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 51.9 tttp -55.17 -31.59 61.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.316 -0.856 . . . . 73.439999999999998 109.93 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.93 -31.05 23.84 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.291 -0.868 . . . . 73.239999999999995 110.806 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.46 -27.12 56.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.925 0.393 . . . . 74.230000000000004 111.333 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.47 24.16 5.13 Favored 'General case' 0 CA--C 1.46 -2.513 0 N-CA-C 109.479 -0.563 . . . . 62.25 109.479 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.3 p90 43.26 33.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.417 1.087 . . . . 64.329999999999998 113.824 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 179.87 160.09 0.82 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.125 -0.694 . . . . 72.299999999999997 109.125 -173.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 24.4 m-85 -81.23 150.91 68.86 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 123.451 0.469 . . . . 62.43 110.131 171.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.552 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.8 Cg_endo -65.01 170.09 10.91 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.607 2.871 . . . . 74.099999999999994 113.255 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 73.3 p -110.01 153.98 23.82 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.196 -1.779 . . . . 74.450000000000003 106.196 171.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.433 ' N ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -59.59 -20.98 59.62 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.433 0.635 . . . . 72.209999999999994 111.933 -178.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -98.38 -65.95 0.93 Allowed 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 122.055 -0.403 . . . . 73.140000000000001 111.313 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -75.99 -37.32 58.64 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 116.604 -0.271 . . . . 75.219999999999999 111.287 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -78.53 -21.41 69.5 Favored Glycine 0 N--CA 1.413 -2.865 0 C-N-CA 118.372 -1.871 . . . . 75.310000000000002 112.83 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.92 -44.64 65.74 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 106.324 -1.732 . . . . 72.109999999999999 106.324 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 10.1 mm-40 -60.47 -41.34 93.97 Favored 'General case' 0 C--O 1.162 -3.526 0 CA-C-N 114.7 -1.136 . . . . 65.530000000000001 109.828 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.55 1.37 19.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.942 0.719 . . . . 54.509999999999998 112.942 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 63.5 mt -101.64 -20.97 14.8 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.229 -0.295 . . . . 70.120000000000005 111.008 172.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.3 t -111.04 -26.42 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-O 121.822 0.82 . . . . 74.409999999999997 111.026 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 38.3 ttmt -122.87 146.65 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 126.972 2.109 . . . . 72.319999999999993 105.83 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' A' ' 84' ' ' LYS . 3.8 mppt? -55.95 141.86 66.27 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 118.517 0.599 . . . . 71.540000000000006 111.501 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.77 122.35 10.87 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 123.063 2.508 . . . . 72.230000000000004 112.397 -172.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.3 p -71.26 140.66 50.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.335 -1.302 . . . . 60.119999999999997 111.132 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.12 -116.55 5.61 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.54 -1.024 . . . . 75.109999999999999 110.54 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.24 92.53 7.48 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 112.872 0.693 . . . . 73.340000000000003 112.872 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.73 162.38 14.27 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.739 1.626 . . . . 70.030000000000001 107.954 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -74.87 158.97 84.03 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-O 118.608 -0.71 . . . . 75.239999999999995 109.392 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.42 98.3 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 121.56 1.507 . . . . 70.530000000000001 110.625 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 10.1 tmtt? -152.77 144.18 23.31 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.183 -1.784 . . . . 74.329999999999998 106.183 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.513 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 33.5 m-80 -78.7 94.76 5.14 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 118.239 0.472 . . . . 71.430000000000007 111.315 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.456 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.5 t90 -57.65 144.17 38.69 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.037 1.335 . . . . 74.040000000000006 112.519 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.93 135.16 55.27 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.806 -1.088 . . . . 73.219999999999999 108.984 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -84.06 -174.3 5.2 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.435 -0.58 . . . . 75.030000000000001 109.435 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 58.91 34.64 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 114.241 1.2 . . . . 74.239999999999995 114.241 176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 89.87 6.55 69.59 Favored Glycine 0 CA--C 1.487 -1.717 0 CA-C-N 115.344 -0.844 . . . . 72.209999999999994 114.358 168.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.456 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.5 OUTLIER 66.18 91.9 0.08 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.311 1.053 . . . . 62.350000000000001 111.301 -176.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.3 tp -138.28 170.97 15.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.618 -1.173 . . . . 71.430000000000007 108.174 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.87 -165.54 1.22 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.729 -0.607 . . . . 61.520000000000003 109.617 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.525 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -70.39 39.83 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.893 0.854 . . . . 75.329999999999998 112.272 178.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.4 HD13 ' OD1' ' A' ' 53' ' ' ASP . 84.8 mt -102.13 148.59 35.59 Favored Pre-proline 0 C--N 1.294 -1.844 0 C-N-CA 124.328 1.051 . . . . 73.099999999999994 110.2 -175.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.85 -166.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.908 3.072 . . . . 72.019999999999996 112.229 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.487 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 3.6 p -85.01 172.04 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 107.353 -1.351 . . . . 71.129999999999995 107.353 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.597 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -80.21 155.98 74.3 Favored Pre-proline 0 C--O 1.256 1.415 0 C-N-CA 119.723 -0.791 . . . . 73.329999999999998 109.847 -172.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 11.2 Cg_endo -54.3 171.54 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.562 2.842 . . . . 73.219999999999999 113.298 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.584 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 65.57 15.76 10.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.909 1.684 . . . . 64.230000000000004 109.738 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.63 29.76 75.86 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.921 -1.036 . . . . 73.430000000000007 113.926 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.584 ' ND2' ' HB2' ' A' ' 108' ' ' TRP . 58.1 m-80 -93.11 119.82 67.36 Favored Pre-proline 0 C--O 1.249 1.056 0 CA-C-N 117.672 0.736 . . . . 74.209999999999994 110.802 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.487 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 46.3 Cg_exo -62.91 143.12 90.77 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 121.955 1.77 . . . . 74.420000000000002 108.824 168.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -69.18 144.4 53.79 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.149 0.5 . . . . 70.010000000000005 110.332 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.655 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -102.62 114.77 29.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.403 -1.703 . . . . 53.409999999999997 106.403 -178.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.13 117.3 34.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.395 -1.335 . . . . 73.450000000000003 107.395 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.1 mt -129.67 154.02 47.56 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.239 0.542 . . . . 72.150000000000006 109.808 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.744 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -112.78 -178.63 0.54 Allowed Pre-proline 0 N--CA 1.401 -2.884 0 CA-C-O 116.109 -1.9 . . . . 54.439999999999998 106.959 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.744 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 9.5 Cg_endo . . . . . 0 C--N 1.395 3.023 0 C-N-CA 123.146 2.564 . . . . 72.319999999999993 115.191 -164.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.486 -1.723 0 CA-C-O 118.553 -1.137 . . . . 71.230000000000004 113.058 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.52 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 34.9 Cg_exo -36.61 -29.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 1 C-N-CA 126.637 4.892 . . . . 74.319999999999993 118.352 -178.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.527 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 46.4 p90 -172.17 168.27 5.76 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.102 0.865 . . . . 73.519999999999996 111.247 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.6 106.33 5.63 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.835 0.854 . . . . 75.329999999999998 109.145 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -125.48 127.31 46.28 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.579 -0.896 . . . . 73.129999999999995 108.579 -178.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 30.0 p90 -166.61 169.42 13.65 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.252 -0.579 . . . . 71.140000000000001 112.301 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.2 t -125.02 149.27 47.93 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.681 -1.229 . . . . 55.240000000000002 107.681 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.655 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 82.1 mt -69.16 154.6 41.78 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 110.355 -0.239 . . . . 52.229999999999997 110.355 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.36 -174.76 24.8 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 121.449 -0.405 . . . . 52.340000000000003 113.87 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -55.15 -24.37 26.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.906 1.446 . . . . 72.140000000000001 114.906 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -93.85 -6.04 46.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.21 -0.596 . . . . 72.329999999999998 110.946 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 128' ' ' LEU . . . 91.17 19.18 43.39 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.608 -0.806 . . . . 64.120000000000005 113.086 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -140.79 148.62 40.92 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.326 -0.62 . . . . 71.540000000000006 109.326 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.36 122.57 23.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.111 0.481 . . . . 63.020000000000003 110.55 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.62 -175.06 22.27 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 110.369 -1.092 . . . . 72.310000000000002 110.369 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -115.19 127.34 7.59 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 108.102 -1.999 . . . . 45.200000000000003 108.102 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 69.3 m 179.66 -177.15 0.33 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.617 1.167 . . . . 72.439999999999998 108.22 -169.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.94 -67.65 0.74 Allowed 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.95 0.156 . . . . 75.25 110.692 170.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.19 -21.34 17.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.137 0.494 . . . . 75.400000000000006 111.609 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -93.21 15.07 16.26 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.153 0.501 . . . . 74.230000000000004 111.077 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -91.68 155.86 18.0 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 115.995 -0.548 . . . . 64.109999999999999 111.164 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.44 127.86 32.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.235 -1.765 . . . . 73.510000000000005 106.235 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -96.96 121.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 108.333 -0.988 . . . . 63.539999999999999 108.333 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -142.26 152.54 23.77 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.188 -1.482 . . . . 51.439999999999998 114.796 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.486 HD21 ' HB2' ' A' ' 58' ' ' ALA . 3.6 t30 -130.25 120.08 23.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.536 -1.283 . . . . 63.109999999999999 107.536 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.527 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 2.5 p90 -160.24 177.57 10.51 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.722 0.772 . . . . 75.030000000000001 111.945 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.34 117.44 26.96 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 106.377 -1.712 . . . . 74.530000000000001 106.377 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 C--N 1.298 -1.641 0 N-CA-C 106.966 -1.494 . . . . 71.230000000000004 106.966 -176.908 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 108.444 -0.947 . . . . 71.129999999999995 108.444 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 m -121.64 80.12 1.64 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.361 0.6 . . . . 71.209999999999994 111.749 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -149.82 161.17 32.18 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.937 -1.875 . . . . 71.129999999999995 105.937 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -45.71 128.78 11.17 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.032 2.488 . . . . 71.230000000000004 112.088 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.266 20.6 m-20 75.99 -41.33 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.281 1.432 . . . . 64.200000000000003 113.705 -176.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.55 -23.03 64.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.265 0.555 . . . . 73.549999999999997 110.113 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.51 65.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.084 -0.962 . . . . 65.209999999999994 110.512 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -88.35 -26.56 22.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.212 -1.033 . . . . 73.409999999999997 108.212 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.493 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 39.1 t -75.71 -40.76 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.076 -0.966 . . . . 62.109999999999999 109.948 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -63.48 -29.55 70.81 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.487 -0.779 . . . . 74.219999999999999 110.861 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -73.63 -44.85 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 108.357 -0.979 . . . . 73.209999999999994 108.357 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.47 -42.33 87.25 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.937 -1.029 . . . . 65.349999999999994 111.532 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -66.7 -25.07 66.35 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 121.331 0.586 . . . . 74.409999999999997 111.944 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.81 -22.86 34.82 Favored Glycine 0 C--N 1.31 -0.889 0 N-CA-C 110.447 -1.061 . . . . 55.240000000000002 110.447 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 15.4 t70 -82.25 -38.33 24.62 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.296 -0.631 . . . . 74.450000000000003 109.296 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.46 HG21 ' HA2' ' A' ' 144' ' ' GLY . 28.5 pt -65.53 -34.56 71.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.231 -0.655 . . . . 74.329999999999998 109.231 173.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -66.98 -28.04 67.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.783 -0.451 . . . . 73.230000000000004 109.783 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.82 -44.04 86.81 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.334 -0.617 . . . . 73.409999999999997 109.334 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.4 HG12 HD13 ' A' ' 100' ' ' LEU . 69.4 mt -64.83 -38.94 84.01 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.238 -0.892 . . . . 74.219999999999999 109.863 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . . . -59.62 -26.38 65.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.073 0.463 . . . . 62.530000000000001 111.573 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.7 -33.2 18.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.091 0.472 . . . . 73.549999999999997 110.204 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.507 ' HA ' ' SD ' ' A' ' 63' ' ' MET . . . -84.36 -26.83 28.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.033 -0.531 . . . . 74.209999999999994 111.898 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.1 -25.39 62.58 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.003 -1.48 . . . . 75.540000000000006 107.003 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 65' ' ' LYS . 28.7 t70 -75.4 -20.1 59.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.827 -1.079 . . . . 72.510000000000005 109.193 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.507 ' SD ' ' HA ' ' A' ' 60' ' ' ALA . 72.3 mtp -81.29 -29.72 34.21 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.378 -0.828 . . . . 73.040000000000006 109.538 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.18 -39.36 71.89 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 106.246 -1.761 . . . . 73.109999999999999 106.246 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 32.8 tttm -56.26 -26.55 52.05 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.178 -0.919 . . . . 62.020000000000003 110.175 173.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.22 -36.58 19.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.853 -0.612 . . . . 64.319999999999993 110.418 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.8 t70 -74.23 -25.94 59.95 Favored 'General case' 0 C--O 1.209 -1.054 0 O-C-N 122.281 -0.262 . . . . 63.32 111.318 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.604 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -127.02 20.39 6.95 Favored 'General case' 0 CA--C 1.456 -2.668 0 CA-C-O 118.75 -0.643 . . . . 74.109999999999999 111.209 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 43.07 32.15 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.733 1.271 . . . . 75.109999999999999 113.191 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.95 161.44 0.56 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.776 -1.194 . . . . 73.120000000000005 107.776 -172.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 12.6 m-85 -76.93 157.15 81.97 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 123.361 0.413 . . . . 74.329999999999998 111.923 174.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.523 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 6.9 Cg_exo -72.86 170.41 19.73 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.838 2.358 . . . . 61.310000000000002 111.334 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 p -104.28 156.27 18.05 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.05 -1.463 . . . . 62.130000000000003 107.05 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -70.64 -12.3 61.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 119.711 1.141 . . . . 62.530000000000001 110.492 -175.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -100.85 -65.09 0.99 Allowed 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.865 -0.607 . . . . 52.310000000000002 110.581 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -75.79 -39.55 56.73 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 120.548 -0.461 . . . . 74.340000000000003 110.133 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -73.83 -21.38 79.33 Favored Glycine 0 N--CA 1.415 -2.765 0 C-N-CA 119.091 -1.528 . . . . 74.030000000000001 113.785 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.65 -46.86 44.05 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 107.625 -1.25 . . . . 44.32 107.625 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.09 -29.99 70.7 Favored 'General case' 0 C--O 1.183 -2.41 0 CA-C-N 114.955 -1.021 . . . . 74.129999999999995 110.119 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -86.03 -0.27 55.12 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.488 0.493 . . . . 53.119999999999997 112.252 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 65.9 mt -97.01 -21.47 17.39 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.404 0.621 . . . . 72.219999999999999 110.058 172.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.79 -30.67 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 121.575 0.702 . . . . 70.420000000000002 110.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 99.2 mttt -125.35 151.49 46.02 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 125.942 1.697 . . . . 70.329999999999998 107.436 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -54.27 142.16 49.64 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 112.755 0.65 . . . . 32.420000000000002 112.755 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 6.7 Cg_endo -45.42 131.64 12.13 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.961 3.774 . . . . 62.030000000000001 114.96 -175.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -95.07 -1.49 52.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.939 -1.028 . . . . 74.25 110.032 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.99 11.74 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.258 -0.883 . . . . 73.109999999999999 111.586 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -126.7 86.08 59.3 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-O 121.555 0.693 . . . . 74.200000000000003 110.642 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.604 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 88.4 Cg_endo -91.35 161.82 3.68 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.585 2.19 . . . . 73.030000000000001 112.911 -176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.06 134.96 20.52 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.471 -0.937 . . . . 74.450000000000003 108.471 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -35.78 100.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 125.219 3.946 . . . . 74.140000000000001 115.014 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.526 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.85 147.3 27.08 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.018 -1.845 . . . . 74.129999999999995 106.018 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.526 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 3.7 m-20 -70.28 101.4 1.9 Allowed 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.501 0.667 . . . . 70.310000000000002 111.726 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.478 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 85.2 t90 -67.46 145.05 55.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.783 -1.099 . . . . 63.149999999999999 110.892 175.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -131.18 134.56 46.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.923 -0.769 . . . . 71.129999999999995 108.923 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 47.7 pttt -82.25 -165.84 1.11 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.486 -1.302 . . . . 75.239999999999995 107.486 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 66.15 19.05 11.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.533 1.158 . . . . 61.229999999999997 109.139 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 85.08 17.25 63.31 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.43 -1.259 . . . . 74.439999999999998 113.214 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.3 m-85 64.37 90.06 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.325 1.06 . . . . 75.400000000000006 110.602 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.4 HD13 HG12 ' A' ' 57' ' ' ILE . 66.3 tp -138.49 169.28 18.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.963 -1.125 . . . . 70.129999999999995 107.963 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -86.69 -171.94 3.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.948 -1.131 . . . . 53.030000000000001 107.948 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -75.4 70.05 2.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.661 1.22 . . . . 74.400000000000006 110.849 177.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -130.41 147.83 67.45 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.197 -1.365 . . . . 64.030000000000001 108.314 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.84 -168.98 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.835 2.357 . . . . 75.140000000000001 112.001 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.7 p -88.45 174.64 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 107.847 -1.168 . . . . 73.329999999999998 107.847 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 9.4 t70 -78.7 152.67 77.95 Favored Pre-proline 0 C--O 1.256 1.444 0 CA-C-N 119.255 0.934 . . . . 62.299999999999997 110.359 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 90.0 Cg_exo -49.76 172.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.573 2.849 . . . . 61.43 114.162 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 68.88 14.43 8.9 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.746 2.018 . . . . 74.340000000000003 109.026 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.9 33.33 78.12 Favored Glycine 0 C--N 1.32 -0.325 0 CA-C-N 114.83 -1.077 . . . . 60.5 112.628 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -93.72 131.99 30.9 Favored Pre-proline 0 C--O 1.258 1.506 0 N-CA-C 111.934 0.346 . . . . 71.450000000000003 111.934 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.533 ' HA ' HG21 ' A' ' 105' ' ' VAL . 66.6 Cg_endo -78.32 151.09 26.05 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 122.264 1.976 . . . . 73.439999999999998 110.362 174.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 8.6 m-85 -78.51 142.39 37.47 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.789 0.328 . . . . 70.340000000000003 110.309 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.578 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -104.52 113.82 27.63 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 106.45 -1.685 . . . . 75.409999999999997 106.45 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.5 118.0 35.14 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.113 -1.81 . . . . 70.409999999999997 106.113 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 91.2 mt -129.35 145.4 51.39 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.188 -0.671 . . . . 72.129999999999995 109.188 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.746 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -106.81 -178.32 0.58 Allowed Pre-proline 0 N--CA 1.402 -2.838 0 CA-C-O 115.907 -1.996 . . . . 52.25 106.641 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.746 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 2.9 Cg_endo . . . . . 0 C--N 1.394 2.927 0 C-N-CA 123.049 2.499 . . . . 43.420000000000002 114.556 -162.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 148' ' ' ASN . . . . . . . . 0 N--CA 1.424 -2.107 0 N-CA-C 117.331 1.692 . . . . 74.329999999999998 117.331 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.543 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 44.6 Cg_exo -36.93 -37.24 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 127.629 5.553 . . . . 70.430000000000007 118.209 -175.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.289 29.3 p90 -161.28 144.73 12.84 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 117.829 -1.548 . . . . 73.299999999999997 114.776 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -113.79 105.87 13.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.586 -1.635 . . . . 42.229999999999997 106.586 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.42 126.9 41.51 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.863 -1.148 . . . . 74.150000000000006 109.865 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 34.0 p90 -167.39 166.13 14.62 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.218 0.324 . . . . 72.329999999999998 111.837 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.51 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 29.8 t -125.37 149.74 47.86 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.607 -1.998 . . . . 72.409999999999997 105.607 170.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.578 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 95.0 mt -63.68 145.09 56.39 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.719 0.295 . . . . 74.420000000000002 110.851 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.17 -169.67 45.98 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.416 -0.897 . . . . 74.319999999999993 111.404 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.5 -6.29 14.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 123.818 0.847 . . . . 71.450000000000003 113.101 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -96.0 -9.07 31.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.559 0.695 . . . . 53.140000000000001 110.101 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.53 7.88 70.01 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-N 115.815 -0.629 . . . . 52.520000000000003 113.301 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -140.05 147.55 40.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.827 -1.546 . . . . 51.229999999999997 106.827 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 119.81 21.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.668 -0.813 . . . . 62.439999999999998 111.643 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.75 -173.94 21.3 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.492 -1.043 . . . . 72.439999999999998 110.492 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.07 127.55 7.84 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.164 -1.574 . . . . 63.409999999999997 109.164 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.516 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 58.1 m 178.79 -177.54 0.27 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 126.421 1.888 . . . . 45.100000000000001 106.68 -171.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.85 -76.77 0.17 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.065 -0.654 . . . . 70.120000000000005 110.738 171.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -96.44 -14.7 22.22 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.731 -0.388 . . . . 73.219999999999999 111.708 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -90.13 3.28 53.86 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.334 0.587 . . . . 74.239999999999995 110.689 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -94.68 157.74 15.83 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 115.149 -0.932 . . . . 44.439999999999998 110.297 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.19 126.85 31.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.68 -1.6 . . . . 72.530000000000001 106.68 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -96.86 119.05 44.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 111.287 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA2' HG21 ' A' ' 54' ' ' ILE . . . -174.44 162.35 32.57 Favored Glycine 0 N--CA 1.41 -3.096 0 C-N-CA 119.515 -1.326 . . . . 53.420000000000002 112.202 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -106.2 160.79 15.07 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.476 -0.935 . . . . 64.400000000000006 108.476 177.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -143.01 137.4 29.27 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.138 -1.06 . . . . 72.409999999999997 108.138 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -106.46 91.66 3.79 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.66 -1.216 . . . . 74.540000000000006 109.111 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.568 ' HB2' ' HA3' ' A' ' 121' ' ' GLY . 10.1 t30 . . . . . 0 CA--C 1.506 -0.732 0 O-C-N 126.282 2.239 . . . . 75.230000000000004 107.45 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.638 ' N ' ' HG1' ' A' ' 48' ' ' THR . 8.2 tpt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 107.042 -1.466 . . . . 65.219999999999999 107.042 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -118.44 98.21 6.15 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.809 0.67 . . . . 73.319999999999993 112.809 -173.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -155.58 165.49 18.29 Favored Pre-proline 0 C--O 1.252 1.23 0 N-CA-C 104.9 -2.259 . . . . 74.510000000000005 104.9 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.7 124.57 12.53 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.747 2.298 . . . . 74.310000000000002 111.913 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 75.08 -26.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.969 2.108 . . . . 62.350000000000001 111.777 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.411 ' HA ' HG23 ' A' ' 47' ' ' VAL . 62.5 mt-30 -68.69 -19.23 64.37 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 121.659 -0.651 . . . . 74.409999999999997 109.47 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.17 65.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.159 -0.928 . . . . 75.329999999999998 110.188 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' O ' HG22 ' A' ' 49' ' ' VAL . 66.1 mttm -90.35 -25.58 20.38 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.041 -0.726 . . . . 71.129999999999995 109.041 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.6 t -73.93 -40.92 53.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.75 0.785 . . . . 74.209999999999994 109.018 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.638 ' HG1' ' N ' ' A' ' 39' ' ' MET . 10.9 t -65.43 -25.84 67.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.795 -1.093 . . . . 74.219999999999999 111.668 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 46' ' ' LYS . 6.0 m -82.69 -34.35 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 108.746 -0.835 . . . . 73.530000000000001 108.746 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 54' ' ' ILE . . . -61.84 -32.24 72.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.112 -0.949 . . . . 65.030000000000001 110.815 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.3 mmmt -65.14 -25.2 67.65 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.954 -0.567 . . . . 54.109999999999999 110.372 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.47 -27.29 18.11 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 111.164 -0.774 . . . . 52.020000000000003 111.164 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -79.19 -36.25 40.55 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.802 -0.444 . . . . 64.239999999999995 109.802 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 50' ' ' ALA . 26.6 pt -69.17 -31.02 48.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.595 -0.52 . . . . 73.219999999999999 109.595 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.5 tptt -65.79 -33.03 74.91 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.096 -0.705 . . . . 72.329999999999998 109.096 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.54 80.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.337 -0.847 . . . . 74.0 110.038 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.485 HG12 HD13 ' A' ' 100' ' ' LEU . 53.2 mt -68.27 -36.94 77.11 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 CA-C-N 115.829 -0.623 . . . . 72.099999999999994 110.238 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.39 66.81 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.032 0.444 . . . . 62.140000000000001 110.766 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -88.63 -36.03 16.5 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 115.482 -0.781 . . . . 54.43 110.202 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.1 -28.12 60.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.004 0.43 . . . . 72.049999999999997 111.186 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -67.88 -29.45 68.56 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.598 -1.26 . . . . 75.439999999999998 107.598 177.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.4 t70 -72.84 -23.15 60.72 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.873 -1.058 . . . . 54.119999999999997 109.475 174.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 62.5 mtt -81.26 -39.65 24.97 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.943 -0.762 . . . . 75.25 108.943 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 87.7 t80 -64.39 -35.75 81.92 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.076 -1.083 . . . . 74.519999999999996 108.076 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.598 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 82.3 tttt -54.95 -31.78 60.86 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.052 -0.977 . . . . 65.430000000000007 111.215 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.9 -29.05 16.9 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.632 0.604 . . . . 71.310000000000002 112.632 172.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.521 ' HB3' ' HA ' ' A' ' 64' ' ' TYR . 19.4 t70 -72.15 -24.3 61.43 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.98 0.512 . . . . 73.030000000000001 111.311 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -128.48 18.84 6.32 Favored 'General case' 0 CA--C 1.455 -2.686 0 N-CA-C 108.071 -1.085 . . . . 73.239999999999995 108.071 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.0 p90 43.61 32.88 0.59 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.436 1.495 . . . . 72.150000000000006 114.134 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.15 161.09 1.09 Allowed 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.595 -0.891 . . . . 71.299999999999997 108.595 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.598 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 15.6 m-85 -78.12 154.02 79.88 Favored Pre-proline 0 N--CA 1.427 -1.62 0 O-C-N 123.713 0.633 . . . . 65.530000000000001 111.466 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.504 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 31.2 Cg_endo -66.87 165.76 24.87 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.108 2.539 . . . . 72.310000000000002 111.736 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.43 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 41.4 p -100.27 155.45 17.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.75 -1.944 . . . . 70.230000000000004 105.75 170.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.668 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.3 t -67.23 -12.13 59.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 119.736 1.153 . . . . 62.119999999999997 111.664 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -102.63 -64.9 1.03 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.268 -0.423 . . . . 74.040000000000006 111.062 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.33 -34.54 48.52 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 122.113 -0.367 . . . . 74.420000000000002 110.455 -174.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.657 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -78.4 -20.71 71.41 Favored Glycine 0 N--CA 1.412 -2.901 0 C-N-CA 119.112 -1.518 . . . . 63.140000000000001 112.757 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.78 -44.57 66.39 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 105.361 -2.088 . . . . 74.549999999999997 105.361 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 13.5 mm-40 -65.51 -16.69 63.92 Favored 'General case' 0 C--O 1.189 -2.09 0 CA-C-N 114.141 -1.39 . . . . 73.510000000000005 111.454 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.657 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -98.37 -3.39 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.374 0.607 . . . . 74.409999999999997 111.391 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 mp -98.56 -15.56 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 61.310000000000002 108.773 173.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.04 -39.93 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.602 -0.726 . . . . 75.150000000000006 110.859 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 5.6 ttpm? -116.35 150.29 37.96 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.047 -1.464 . . . . 74.450000000000003 107.047 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -54.37 137.02 60.48 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 118.341 0.518 . . . . 64.510000000000005 111.474 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.79 140.59 81.03 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.49 2.793 . . . . 74.340000000000003 111.994 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.7 p -83.04 178.1 8.3 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.004 -0.544 . . . . 75.340000000000003 110.346 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.12 -114.58 4.58 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.12 -0.792 . . . . 73.349999999999994 111.12 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -148.56 116.41 3.93 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 120.611 -0.435 . . . . 74.530000000000001 110.931 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -103.5 162.94 0.24 Allowed 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 123.846 3.031 . . . . 73.540000000000006 111.088 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -76.65 159.29 79.59 Favored Pre-proline 0 C--O 1.207 -1.167 0 O-C-N 121.682 -0.636 . . . . 71.340000000000003 109.557 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -70.77 99.06 0.82 Allowed 'Trans proline' 0 C--O 1.248 1.015 0 C-N-CA 121.335 1.356 . . . . 61.109999999999999 112.586 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 67.6 mttm -146.66 148.56 32.17 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.818 -1.919 . . . . 74.430000000000007 105.818 174.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -76.41 92.99 3.43 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.628 -0.829 . . . . 70.409999999999997 110.372 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.617 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 79.4 t90 -53.69 143.53 20.24 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.237 1.415 . . . . 70.310000000000002 111.578 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -124.11 136.72 54.43 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.816 -1.083 . . . . 71.109999999999999 109.806 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 64.0 pttt -88.04 -168.75 2.31 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.631 -0.878 . . . . 75.25 108.631 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.66 16.3 6.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.708 1.242 . . . . 71.219999999999999 110.212 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.56 11.67 50.29 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.246 -1.343 . . . . 73.150000000000006 113.979 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.88 91.37 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.272 1.034 . . . . 70.430000000000007 111.181 -176.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 46.2 tp -138.94 156.09 47.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.551 -1.204 . . . . 71.25 108.414 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.499 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.5 mmmt -77.53 -177.63 4.84 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.45 -0.944 . . . . 75.219999999999999 108.45 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -82.29 74.22 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.5 -0.88 . . . . 44.509999999999998 110.86 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.88 147.83 67.8 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 125.133 1.373 . . . . 63.240000000000002 107.32 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.98 166.46 12.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.834 2.356 . . . . 72.439999999999998 113.704 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' A' ' 111' ' ' PRO . 6.2 p -79.36 176.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.408 -0.815 . . . . 72.129999999999995 109.138 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.483 ' H ' HG22 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -69.29 146.09 96.4 Favored Pre-proline 0 C--O 1.257 1.466 0 N-CA-C 112.508 0.558 . . . . 75.319999999999993 112.508 -175.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.414 ' HG3' ' HB3' ' A' ' 46' ' ' LYS . 5.8 Cg_endo -50.57 171.46 0.1 Allowed 'Trans proline' 0 C--O 1.197 -1.535 0 C-N-CA 124.118 3.212 . . . . 74.219999999999999 112.916 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.496 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.1 m-90 62.27 14.96 7.18 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.971 1.308 . . . . 75.049999999999997 109.298 -177.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.47 30.05 76.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.811 1.084 . . . . 61.229999999999997 115.811 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.496 ' ND2' ' HE3' ' A' ' 108' ' ' TRP . 15.4 m-80 -93.17 130.66 35.17 Favored Pre-proline 0 C--O 1.256 1.398 0 CA-C-N 119.085 1.443 . . . . 73.150000000000006 110.981 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.542 ' HA ' HG21 ' A' ' 105' ' ' VAL . 27.0 Cg_endo -70.98 148.57 57.45 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 121.434 1.423 . . . . 72.099999999999994 109.18 168.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 32.9 m-85 -69.45 143.86 53.45 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.07 0.462 . . . . 71.310000000000002 111.963 -177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.418 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -102.61 114.22 28.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.802 -1.925 . . . . 52.439999999999998 105.802 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.25 120.09 41.18 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.258 -0.883 . . . . 70.519999999999996 111.311 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.1 mt -127.72 153.57 46.36 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.629 -0.878 . . . . 75.109999999999999 108.629 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -114.85 -178.69 0.53 Allowed Pre-proline 0 N--CA 1.406 -2.666 0 CA-C-O 117.035 -1.46 . . . . 73.200000000000003 107.73 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.7 Cg_endo . . . . . 0 CA--C 1.482 -2.083 0 C-N-CA 122.522 2.148 . . . . 71.409999999999997 115.116 -170.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.432 -1.577 0 CA-C-O 118.337 -1.257 . . . . 72.420000000000002 112.53 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.567 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 20.2 Cg_exo -41.21 -25.04 0.22 Allowed 'Trans proline' 0 N--CA 1.504 2.112 1 C-N-CA 126.954 5.103 . . . . 74.319999999999993 118.852 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.589 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.0 p90 178.19 165.95 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.997 0.817 . . . . 71.519999999999996 109.766 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 2.6 m-20 -139.32 113.17 8.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.371 0.668 . . . . 73.109999999999999 109.424 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.472 ' HG ' HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -125.29 124.58 41.93 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.786 -0.766 . . . . 73.450000000000003 110.371 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -164.43 166.43 20.58 Favored 'General case' 0 C--O 1.208 -1.109 0 O-C-N 123.087 0.242 . . . . 64.040000000000006 110.352 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.46 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 18.8 t -125.51 153.21 43.93 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.381 -1.34 . . . . 71.540000000000006 107.381 171.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.418 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 88.8 mt -66.26 128.6 36.77 Favored 'General case' 0 C--O 1.204 -1.316 0 O-C-N 123.227 0.329 . . . . 73.129999999999995 111.557 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.53 15.89 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.918 -0.658 . . . . 63.530000000000001 112.235 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.24 -16.74 9.02 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.82 1.415 . . . . 74.329999999999998 114.82 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.4 -9.38 35.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.15 0.976 . . . . 72.329999999999998 109.802 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.85 10.28 86.33 Favored Glycine 0 CA--C 1.505 -0.585 0 CA-C-N 115.334 -0.848 . . . . 72.129999999999995 112.281 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.598 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 5.2 mmpt? -124.77 147.89 48.43 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.58 0.352 . . . . 74.420000000000002 110.348 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.59 104.91 17.29 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 122.081 0.944 . . . . 74.219999999999999 108.733 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.85 -173.64 21.08 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.24 -0.891 . . . . 63.219999999999999 111.169 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.28 127.59 9.08 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.646 -1.782 . . . . 53.340000000000003 108.646 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.464 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 37.6 m 179.63 -177.91 0.36 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.207 -1.775 . . . . 44.329999999999998 106.207 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.54 -75.37 0.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 118.294 0.497 . . . . 62.409999999999997 110.32 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -99.76 -17.95 17.46 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.87 -0.604 . . . . 73.420000000000002 110.831 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.47 -8.21 59.02 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.466 0.65 . . . . 70.230000000000004 109.989 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -87.14 156.97 19.48 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 114.806 -1.088 . . . . 62.439999999999998 109.136 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -77.39 134.51 38.41 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.543 -1.28 . . . . 73.030000000000001 107.543 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.5 pp -96.82 119.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.893 -0.594 . . . . 65.040000000000006 110.719 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 54' ' ' ILE . . . -174.33 167.2 39.49 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 118.818 -1.658 . . . . 72.129999999999995 113.116 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.59 150.1 36.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.977 -0.749 . . . . 75.430000000000007 108.977 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.589 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 13.7 p90 -165.11 179.23 6.47 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.768 -0.651 . . . . 75.409999999999997 109.831 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -119.43 122.23 41.26 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.55 -1.278 . . . . 50.240000000000002 107.55 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.06 -1.089 . . . . 71.329999999999998 108.06 177.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.592 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.4 mpt? . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.426 -0.953 . . . . 71.530000000000001 108.426 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.5 t -108.88 77.77 1.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.074 -0.65 . . . . 74.25 110.724 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -155.16 155.26 29.87 Favored Pre-proline 0 C--N 1.316 -0.871 0 C-N-CA 124.814 1.246 . . . . 74.510000000000005 107.986 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.59 138.56 75.23 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.684 2.256 . . . . 41.100000000000001 110.894 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t70 76.56 -37.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.716 2.007 . . . . 74.439999999999998 110.49 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.592 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 77.8 mt-30 -68.68 -21.07 64.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.66 0.743 . . . . 73.340000000000003 109.504 173.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.22 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 55.399999999999999 109.943 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 67.3 mttm -93.23 -24.47 18.18 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.954 -0.758 . . . . 64.439999999999998 108.954 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 97.7 t -71.48 -44.66 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 108.248 -1.019 . . . . 73.430000000000007 108.248 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -65.96 -15.9 63.4 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.069 -0.969 . . . . 72.140000000000001 111.248 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -84.08 -52.66 12.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.585 -0.894 . . . . 72.120000000000005 108.585 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.97 -33.81 71.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.792 -1.094 . . . . 51.520000000000003 112.979 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 30.8 mmmt -65.36 -25.74 67.72 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.739 0.78 . . . . 65.129999999999995 109.982 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -27.97 24.92 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.836 -0.906 . . . . 75.219999999999999 110.836 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.418 ' OD1' HD13 ' A' ' 103' ' ' LEU . 77.5 m-20 -77.23 -34.67 55.95 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.137 0.494 . . . . 62.130000000000003 110.607 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.0 pt -68.1 -34.22 65.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 116.021 -0.536 . . . . 73.329999999999998 109.558 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -67.24 -29.36 68.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 71.310000000000002 109.811 178.133 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.52 75.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.337 -0.847 . . . . 64.439999999999998 109.5 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.567 HG12 ' HG ' ' A' ' 100' ' ' LEU . 66.8 mt -66.64 -34.81 72.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.568 0 CA-C-N 115.355 -0.838 . . . . 75.150000000000006 110.02 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.68 -26.61 68.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.117 0.485 . . . . 71.239999999999995 111.22 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -87.23 -34.36 18.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.119 0.485 . . . . 73.140000000000001 109.752 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.63 -28.55 33.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.632 0.604 . . . . 61.109999999999999 112.632 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.53 -29.84 68.51 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.216 -1.401 . . . . 74.409999999999997 107.216 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 32.4 t70 -71.89 -21.66 61.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.193 -1.367 . . . . 64.230000000000004 109.1 174.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.474 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.0 mtt -83.0 -30.29 28.28 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.754 -0.591 . . . . 73.219999999999999 109.607 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CD1' ' HD3' ' A' ' 72' ' ' PRO . 55.1 t80 -68.47 -35.62 77.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.955 -1.498 . . . . 73.329999999999998 106.955 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 83.9 tttt -55.02 -35.77 64.78 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.206 -0.906 . . . . 74.230000000000004 110.044 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.93 -36.43 56.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 73.120000000000005 111.813 172.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 92' ' ' LYS . 13.4 t70 -71.02 -26.69 63.22 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.81 -0.632 . . . . 62.420000000000002 111.178 -172.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -130.47 22.42 5.13 Favored 'General case' 0 CA--C 1.449 -2.929 0 CA-C-O 118.975 -0.536 . . . . 71.420000000000002 112.009 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.7 p90 42.99 31.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.063 1.477 . . . . 74.310000000000002 113.495 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.18 161.44 0.6 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.683 -1.228 . . . . 74.310000000000002 107.683 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 26.0 m-85 -80.08 154.14 74.92 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 123.289 0.368 . . . . 73.340000000000003 111.062 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 22.9 Cg_endo -64.43 167.62 14.54 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 123.471 2.781 . . . . 62.130000000000003 111.803 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.407 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 53.2 p -98.21 155.71 17.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.635 -1.617 . . . . 75.109999999999999 106.635 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.543 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -66.13 -15.45 63.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 118.967 0.803 . . . . 64.0 111.283 -175.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -102.23 -64.49 1.06 Allowed 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 122.156 -0.34 . . . . 73.120000000000005 111.465 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -75.89 -39.65 56.01 Favored 'General case' 0 CA--C 1.486 -1.519 0 O-C-N 122.171 -0.33 . . . . 73.430000000000007 110.795 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -73.61 -20.85 79.86 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 118.614 -1.755 . . . . 60.149999999999999 113.169 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.5 -48.12 73.68 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 106.94 -1.504 . . . . 73.310000000000002 106.94 177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 48.4 mt-10 -71.22 -23.09 61.95 Favored 'General case' 0 C--O 1.18 -2.597 0 CA-C-N 114.553 -1.203 . . . . 74.150000000000006 111.019 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.624 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -82.76 -2.79 55.4 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.266 0.555 . . . . 73.209999999999994 111.125 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.581 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 70.8 mt -96.23 -28.24 14.63 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.479 -0.782 . . . . 70.409999999999997 110.217 173.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.77 -32.5 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.438 0.637 . . . . 51.450000000000003 111.183 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 35.8 ttpt -120.59 150.48 40.82 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.188 -1.782 . . . . 75.409999999999997 106.188 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -54.54 141.32 54.99 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 118.489 0.586 . . . . 74.400000000000006 111.118 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.64 136.32 64.39 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.539 2.826 . . . . 63.140000000000001 111.878 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -81.47 -21.67 38.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.694 -0.685 . . . . 70.299999999999997 111.138 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.03 -146.39 9.26 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.894 -1.282 . . . . 64.420000000000002 109.894 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -117.69 95.87 48.52 Favored Pre-proline 0 C--N 1.288 -2.104 0 O-C-N 122.397 -0.472 . . . . 64.239999999999995 110.795 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.93 162.08 32.49 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.727 1.618 . . . . 75.530000000000001 108.751 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -82.69 159.21 64.16 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-O 118.205 -0.902 . . . . 73.530000000000001 108.958 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.48 97.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.707 1.605 . . . . 74.040000000000006 111.41 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 55.5 tttm -152.09 147.33 26.34 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.894 -1.891 . . . . 54.409999999999997 105.894 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.88 91.55 3.56 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.936 -0.306 . . . . 73.340000000000003 111.153 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -54.53 144.03 22.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.003 1.321 . . . . 73.319999999999993 111.498 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 3.1 t-20 -123.43 135.19 53.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.516 -0.766 . . . . 60.299999999999997 109.99 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -84.88 176.34 8.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.47 0.652 . . . . 75.219999999999999 111.398 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 71.4 20.28 4.97 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.608 1.563 . . . . 62.020000000000003 111.388 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 103.16 12.13 32.29 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.904 -1.141 . . . . 52.210000000000001 112.718 171.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 0.5 OUTLIER 62.75 85.33 0.13 Allowed 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.552 1.168 . . . . 73.109999999999999 108.89 -173.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.567 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -133.32 150.4 51.87 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.485 -2.043 . . . . 71.040000000000006 105.485 -174.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.48 ' N ' HD23 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.03 -178.14 0.96 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.908 0.322 . . . . 73.150000000000006 110.738 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -77.62 53.02 1.04 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.882 1.325 . . . . 54.219999999999999 112.718 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 ' OD1' ' A' ' 53' ' ' ASP . 70.8 mt -118.55 148.57 44.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 113.578 -1.647 . . . . 73.299999999999997 107.858 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.01 -175.46 1.46 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.604 2.202 . . . . 74.140000000000001 113.188 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.1 p -79.71 173.44 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.261 1.68 0 N-CA-C 108.271 -1.011 . . . . 44.219999999999999 108.271 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 5.8 p-10 -79.8 160.34 69.41 Favored Pre-proline 0 C--O 1.252 1.198 0 N-CA-C 113.635 0.976 . . . . 72.239999999999995 113.635 -168.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 10.8 Cg_endo -56.11 169.53 1.43 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.358 2.705 . . . . 73.140000000000001 111.681 173.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 64.81 14.58 9.27 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.853 1.261 . . . . 64.340000000000003 109.127 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.19 25.33 62.2 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 114.014 -1.448 . . . . 74.420000000000002 115.381 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.543 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 8.2 m-80 -82.73 148.74 58.56 Favored Pre-proline 0 C--O 1.271 2.215 0 CA-C-N 119.497 1.649 . . . . 63.200000000000003 108.634 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.491 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 3.6 Cg_endo -88.89 148.47 5.8 Favored 'Trans proline' 0 N--CA 1.424 -2.57 0 C-N-CA 121.988 1.792 . . . . 63.310000000000002 109.087 168.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -68.2 142.49 55.66 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 120.48 -0.488 . . . . 70.219999999999999 110.136 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.0 mm100 -101.7 119.52 38.91 Favored 'General case' 0 C--O 1.266 1.928 0 N-CA-C 105.027 -2.212 . . . . 74.5 105.027 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 118.3 33.84 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.405 -1.332 . . . . 73.329999999999998 107.405 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 75.9 mt -129.98 150.36 51.29 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.01 -0.737 . . . . 75.099999999999994 109.01 169.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.707 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -122.24 -178.47 0.63 Allowed Pre-proline 0 N--CA 1.402 -2.836 0 N-CA-C 105.124 -2.176 . . . . 33.200000000000003 105.124 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.709 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 17.9 Cg_endo . . . . . 0 CA--C 1.492 -1.589 0 CA-C-N 122.327 1.867 . . . . 73.310000000000002 114.094 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.484 -1.893 0 CA-C-O 118.023 -1.432 . . . . 72.0 112.424 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.519 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 16.6 Cg_exo -41.51 -23.88 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.914 1 C-N-CA 126.667 4.911 . . . . 74.450000000000003 118.525 -177.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.6 p90 177.59 156.51 0.35 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.656 0.662 . . . . 74.430000000000007 110.285 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 2.7 m-20 -134.29 106.83 7.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.025 0.828 . . . . 74.420000000000002 108.789 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 57' ' ' ILE . 3.1 tm? -116.8 126.55 53.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.856 -0.794 . . . . 63.420000000000002 108.856 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.547 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 23.9 p90 -168.2 168.61 11.52 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 120.571 -0.451 . . . . 65.409999999999997 111.554 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.449 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 67.6 m -125.78 152.25 45.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.524 -1.287 . . . . 52.109999999999999 107.524 166.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.435 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 96.5 mt -60.17 148.64 35.49 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.742 0.651 . . . . 72.299999999999997 111.562 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.02 -172.27 5.27 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.768 0.667 . . . . 51.229999999999997 114.768 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.434 ' H ' ' HA ' ' A' ' 140' ' ' ASP . . . -57.47 -28.15 63.12 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 114.021 1.119 . . . . 52.049999999999997 114.021 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -94.23 -5.66 46.41 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.264 -0.574 . . . . 74.230000000000004 110.493 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.82 27.43 56.7 Favored Glycine 0 C--N 1.319 -0.386 0 N-CA-C 110.531 -1.028 . . . . 52.229999999999997 110.531 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -125.89 141.48 51.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.78 -1.193 . . . . 72.329999999999998 107.78 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.652 ' HA ' ' OD1' ' A' ' 142' ' ' ASP 0.271 0.0 OUTLIER -81.15 106.72 13.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.833 0.825 . . . . 63.409999999999997 112.767 178.556 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.09 173.27 29.82 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.347 -0.842 . . . . 73.540000000000006 113.315 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.4 129.61 9.88 Favored Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.586 -1.806 . . . . 73.129999999999995 108.586 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.642 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 23.8 m -178.76 -177.24 0.5 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.223 1.409 . . . . 74.310000000000002 107.513 -171.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -97.46 -49.9 4.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.045 -1.062 . . . . 62.109999999999999 108.887 171.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.544 ' HA ' HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -88.28 -41.65 12.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.679 -0.691 . . . . 74.200000000000003 110.673 -177.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.434 ' HA ' ' H ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER -96.28 18.3 14.05 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.606 0.717 . . . . 73.109999999999999 110.8 -175.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -81.2 156.88 25.44 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.259 -0.882 . . . . 70.120000000000005 109.922 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.652 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 36.4 m-20 -76.87 129.85 36.78 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 104.508 -2.404 . . . . 74.319999999999993 104.508 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.56 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -94.98 111.97 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 C-N-CA 118.59 -1.244 . . . . 73.010000000000005 108.37 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -175.09 176.69 47.2 Favored Glycine 1 N--CA 1.396 -4.027 0 CA-C-N 114.413 -1.267 . . . . 55.539999999999999 110.852 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.29 149.23 24.09 Favored 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 107.872 -1.158 . . . . 73.049999999999997 107.872 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.614 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 2.1 p90 -156.77 177.83 11.04 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 123.707 0.629 . . . . 72.120000000000005 112.082 -173.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -125.05 115.3 20.3 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.5 -0.926 . . . . 71.040000000000006 108.5 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 117.227 -1.368 . . . . 75.200000000000003 108.376 178.509 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.577 ' N ' ' HG1' ' A' ' 48' ' ' THR . 9.9 ttt . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 106.633 -1.618 . . . . 72.430000000000007 106.633 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.3 m -104.11 87.11 2.69 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.189 0.811 . . . . 72.319999999999993 113.189 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -154.54 154.16 28.96 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 104.835 -2.283 . . . . 74.109999999999999 104.835 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.1 141.07 70.04 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 122.167 1.911 . . . . 64.219999999999999 110.45 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 75.73 -36.13 0.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.299 1.44 . . . . 75.230000000000004 110.785 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.41 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . 78.2 mt-30 -77.16 -15.16 59.63 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.689 -0.632 . . . . 73.450000000000003 109.961 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.7 75.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.134 -0.939 . . . . 65.129999999999995 110.545 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -86.94 -22.11 25.83 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.816 -0.629 . . . . 62.420000000000002 110.871 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 49.1 t -73.09 -43.21 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 121.421 0.629 . . . . 74.120000000000005 109.599 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.577 ' HG1' ' N ' ' A' ' 39' ' ' MET . 14.8 t -64.52 -38.42 90.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.09 -0.505 . . . . 74.430000000000007 111.747 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.2 t -70.35 -37.31 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 108.917 -0.772 . . . . 73.5 108.917 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -58.56 -40.67 83.7 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.908 -1.042 . . . . 34.219999999999999 111.151 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 13.8 mmmm -65.57 -25.66 67.51 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.163 -0.472 . . . . 71.25 111.182 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.22 -28.15 23.58 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.606 -0.807 . . . . 73.299999999999997 111.088 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -82.11 -30.1 31.38 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.008 0.433 . . . . 72.430000000000007 111.469 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 50' ' ' ALA . 17.2 pt -73.0 -27.21 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.305 -0.558 . . . . 71.450000000000003 109.943 172.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 28.5 tptt -72.58 -26.83 61.85 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.391 -0.596 . . . . 71.329999999999998 109.391 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.86 -44.34 81.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 71.019999999999996 109.16 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 125' ' ' LEU . 74.9 mt -63.44 -34.62 68.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.684 0 CA-C-N 115.124 -0.944 . . . . 72.140000000000001 110.178 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HB2' HD21 ' A' ' 145' ' ' ASN . . . -60.71 -34.42 74.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.898 0.38 . . . . 73.329999999999998 111.135 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -80.81 -26.85 36.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.837 -0.62 . . . . 72.239999999999995 110.051 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.13 -29.25 24.97 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 120.926 0.393 . . . . 74.140000000000001 110.733 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -27.48 62.4 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.218 -1.401 . . . . 75.420000000000002 107.218 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 10.7 t70 -66.45 -32.26 73.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.613 -1.176 . . . . 73.519999999999996 108.71 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 67.1 mtt -76.2 -31.1 58.26 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 115.18 -0.918 . . . . 73.140000000000001 109.518 177.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -69.95 -37.97 76.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.52 -0.548 . . . . 73.329999999999998 109.52 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 19.4 pttp -66.36 -19.23 65.75 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 118.867 -1.133 . . . . 75.219999999999999 109.453 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.33 -38.21 17.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.545 -0.752 . . . . 74.049999999999997 110.471 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 15.9 t70 -73.3 -26.82 61.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.12 0.415 . . . . 71.109999999999999 112.12 -174.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.36 24.48 5.87 Favored 'General case' 0 CA--C 1.455 -2.676 0 N-CA-C 108.108 -1.071 . . . . 61.130000000000003 108.108 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 44.09 32.82 0.7 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.84 1.256 . . . . 64.109999999999999 113.731 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.35 155.98 0.41 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.755 -0.831 . . . . 54.520000000000003 108.755 -174.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 10.2 m-85 -77.14 157.73 80.7 Favored Pre-proline 0 N--CA 1.423 -1.779 0 O-C-N 123.572 0.545 . . . . 74.019999999999996 110.932 171.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.475 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 60.8 Cg_endo -70.78 163.25 39.74 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.756 2.304 . . . . 63.340000000000003 113.244 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.6 p -104.93 155.14 19.21 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.464 -2.05 . . . . 61.210000000000001 105.464 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -67.44 -11.9 58.95 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.105 0.955 . . . . 63.140000000000001 111.504 -173.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -102.31 -65.58 0.98 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 121.795 -0.566 . . . . 64.540000000000006 110.377 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -77.72 -34.69 52.55 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 116.375 -0.375 . . . . 72.329999999999998 111.011 -170.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -84.26 -20.94 58.0 Favored Glycine 0 N--CA 1.417 -2.605 0 C-N-CA 118.664 -1.732 . . . . 75.150000000000006 112.658 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -73.7 -42.72 60.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.582 -1.636 . . . . 71.450000000000003 106.582 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.98 -27.4 67.42 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-N 115.435 -0.802 . . . . 73.25 110.826 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.564 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -84.79 -4.08 58.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.092 0.472 . . . . 75.129999999999995 111.515 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 114' ' ' TYR . 1.2 tp -95.79 -25.38 16.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.524 0.678 . . . . 75.519999999999996 109.297 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.05 -41.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.608 -0.724 . . . . 63.539999999999999 110.366 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -111.41 148.51 32.9 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.41 -0.959 . . . . 74.299999999999997 108.41 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.63 128.08 60.92 Favored Pre-proline 0 C--O 1.25 1.125 0 C-N-CA 124.067 0.947 . . . . 74.200000000000003 109.797 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.532 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 19.7 Cg_endo -53.62 126.39 21.67 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 124.503 3.469 . . . . 61.030000000000001 113.613 -171.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -74.44 117.91 16.79 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.667 -1.151 . . . . 60.509999999999998 110.566 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.67 -146.14 16.06 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 108.761 -1.736 . . . . 72.219999999999999 108.761 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -125.83 92.83 45.45 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 112.901 0.704 . . . . 70.140000000000001 112.901 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HG3' ' HG2' ' A' ' 85' ' ' PRO . 85.8 Cg_endo -76.0 163.12 33.63 Favored 'Trans proline' 0 C--O 1.262 1.693 0 C-N-CA 122.649 2.233 . . . . 70.430000000000007 107.562 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.35 159.57 83.35 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 108.584 -0.895 . . . . 74.329999999999998 108.584 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.69 98.01 0.18 Allowed 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 121.11 1.207 . . . . 71.150000000000006 110.332 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.1 tmtm? -151.79 148.31 27.7 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.474 -2.046 . . . . 70.530000000000001 105.474 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.546 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 90.0 m-20 -72.85 93.76 1.74 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.909 0.707 . . . . 62.340000000000003 112.909 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.544 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.4 t90 -64.18 144.37 57.17 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.851 0.86 . . . . 73.040000000000006 110.472 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -131.81 135.5 46.79 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.162 -0.681 . . . . 60.5 109.162 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 63.5 pttt -85.09 -174.88 5.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.075 0.464 . . . . 74.129999999999995 109.777 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 70.2 15.04 7.6 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.473 1.109 . . . . 63.310000000000002 110.4 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.3 14.93 21.0 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.498 -1.228 . . . . 72.109999999999999 114.078 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.544 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 61.17 89.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.449 1.118 . . . . 75.25 110.975 -176.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 57.2 tp -128.01 170.82 12.46 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 124.756 1.222 . . . . 70.150000000000006 108.092 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.2 mmmt -88.04 179.47 6.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.549 -1.278 . . . . 53.450000000000003 107.549 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.52 ' HD3' ' H ' ' A' ' 102' ' ' LYS 0.26 0.0 OUTLIER -77.33 72.37 3.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.851 1.31 . . . . 72.549999999999997 110.959 175.861 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -130.73 148.21 69.2 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 113.643 -1.617 . . . . 72.400000000000006 107.808 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.18 170.41 13.28 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.871 1.714 . . . . 74.010000000000005 110.887 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 111' ' ' PRO . 5.3 p -79.73 171.7 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.774 -0.824 . . . . 74.120000000000005 108.774 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.511 ' OD2' ' HD2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -75.55 149.03 83.51 Favored Pre-proline 0 C--O 1.253 1.269 0 C-N-CA 119.884 -0.726 . . . . 73.239999999999995 112.364 -171.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.511 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 36.0 Cg_exo -47.09 171.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.373 3.382 . . . . 72.299999999999997 113.93 172.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 70.14 14.81 7.67 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 126.677 1.991 . . . . 75.230000000000004 108.596 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.91 32.29 59.12 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 114.174 -1.375 . . . . 73.239999999999995 113.057 -175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -92.27 125.67 55.54 Favored Pre-proline 0 C--O 1.263 1.796 0 CA-C-N 116.752 0.276 . . . . 72.340000000000003 111.212 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.64 ' HA ' HG21 ' A' ' 105' ' ' VAL . 7.9 Cg_exo -71.1 154.09 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.034 1.822 . . . . 53.420000000000002 108.522 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -71.75 142.75 49.74 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.969 -1.093 . . . . 74.120000000000005 108.806 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.58 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 2.1 mm100 -102.14 113.76 27.31 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 105.066 -2.198 . . . . 62.140000000000001 105.066 -178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.409 ' HB2' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -104.62 118.46 36.64 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.823 -1.081 . . . . 74.430000000000007 111.318 -177.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.2 mt -129.31 154.02 47.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.345 -0.843 . . . . 61.009999999999998 109.343 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.721 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -108.93 -177.38 0.47 Allowed Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-O 116.971 -1.49 . . . . 75.420000000000002 108.711 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 20.1 Cg_endo . . . . . 0 C--N 1.389 2.696 0 C-N-CA 123.19 2.593 . . . . 72.329999999999998 116.359 -162.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.426 -1.981 0 CA-C-O 118.027 -1.43 . . . . 63.109999999999999 111.303 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.569 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -34.81 -27.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.033 1 C-N-CA 127.052 5.168 . . . . 73.450000000000003 118.027 -178.937 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 50.8 p90 -165.45 170.42 14.5 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 118.749 0.704 . . . . 73.329999999999998 111.156 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.7 m-20 -132.4 107.13 8.31 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.534 -1.284 . . . . 72.329999999999998 107.534 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.09 128.97 54.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.557 -0.905 . . . . 64.230000000000004 108.557 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -166.28 166.01 17.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.004 -0.369 . . . . 73.219999999999999 110.004 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.515 ' HB3' HD11 ' A' ' 143' ' ' ILE . 18.5 t -124.95 146.76 49.22 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.96 -1.867 . . . . 72.400000000000006 105.96 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.58 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 98.3 mt -64.23 155.97 30.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.788 0.328 . . . . 70.239999999999995 111.429 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -83.76 -166.19 39.89 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.577 -0.821 . . . . 60.409999999999997 112.368 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.69 -22.05 64.99 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.553 0.946 . . . . 62.0 113.553 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.86 -2.75 52.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.755 0.788 . . . . 74.349999999999994 110.527 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.433 ' O ' HD13 ' A' ' 128' ' ' LEU . . . 72.29 27.44 69.91 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.797 -0.716 . . . . 51.020000000000003 111.74 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -140.07 148.45 41.77 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 123.159 0.583 . . . . 64.340000000000003 110.553 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -84.87 109.18 17.94 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.433 0.635 . . . . 64.099999999999994 110.596 176.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -147.6 -173.22 18.48 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.851 -1.068 . . . . 61.210000000000001 110.67 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.27 128.21 8.12 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.849 -1.7 . . . . 74.439999999999998 108.849 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 141' ' ' ALA . 60.2 m 179.95 -177.48 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.879 1.672 . . . . 72.0 106.698 -170.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -78.66 -62.56 1.65 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.929 0.331 . . . . 54.149999999999999 110.229 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.52 -11.82 14.03 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.513 0.56 . . . . 72.530000000000001 112.513 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.69 11.71 28.09 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.757 0.789 . . . . 70.019999999999996 110.595 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.441 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.0 155.8 17.86 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.805 -1.089 . . . . 62.509999999999998 110.275 178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.1 p-10 -79.67 135.66 36.6 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.31 -1.737 . . . . 64.530000000000001 106.31 173.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.59 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.34 113.11 29.92 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 108.041 -1.096 . . . . 73.450000000000003 108.041 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.65 151.5 18.98 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 119.368 -1.396 . . . . 54.409999999999997 114.582 -170.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.535 HD21 ' HB2' ' A' ' 58' ' ' ALA . 5.2 t30 -153.13 127.0 8.91 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 113.555 -1.323 . . . . 74.430000000000007 107.704 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.436 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 5.7 p90 -150.73 157.67 43.23 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 120.119 -0.632 . . . . 71.349999999999994 112.398 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -94.14 108.19 20.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.525 -1.657 . . . . 73.420000000000002 106.525 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.3 t30 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 114.534 -1.212 . . . . 61.409999999999997 108.696 -176.748 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 108.387 -0.968 . . . . 34.439999999999998 108.387 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -115.62 89.03 3.01 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.832 -0.747 . . . . 52.240000000000002 110.225 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -155.65 161.56 29.2 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 125.983 1.713 . . . . 73.420000000000002 106.426 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.49 133.17 42.72 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.463 2.109 . . . . 60.020000000000003 110.908 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 74.63 -37.25 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.98 1.312 . . . . 64.25 111.624 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.1 mm100 -68.69 -24.97 64.56 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.266 0.555 . . . . 54.530000000000001 109.931 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.77 -16.92 64.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.342 -0.845 . . . . 63.219999999999999 110.242 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.51 -25.89 22.32 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 108.369 -0.975 . . . . 74.319999999999993 108.369 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 47.4 t -75.82 -43.38 39.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.631 -0.713 . . . . 71.129999999999995 110.216 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -65.23 -29.02 69.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.27 -0.877 . . . . 74.099999999999994 111.585 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.7 m -84.03 -34.49 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.158 -0.617 . . . . 73.129999999999995 109.941 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -60.2 -37.84 81.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.465 -0.789 . . . . 44.140000000000001 110.451 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 70.2 mmtt -65.3 -26.23 67.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.704 -0.68 . . . . 74.510000000000005 110.423 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.99 -28.39 18.29 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.225 -0.988 . . . . 72.209999999999994 111.324 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.45 -27.26 32.01 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.04 0.385 . . . . 60.530000000000001 112.04 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 pt -72.06 -30.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.303 -0.559 . . . . 71.319999999999993 109.617 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 73.0 mmtt -71.52 -24.27 61.93 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 116.414 -0.357 . . . . 30.300000000000001 110.704 175.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.03 75.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.621 -0.718 . . . . 74.230000000000004 109.554 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.414 HG12 ' HG ' ' A' ' 100' ' ' LEU . 71.7 mt -68.99 -34.07 62.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.385 -0.825 . . . . 75.310000000000002 109.673 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.438 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . . . -58.97 -33.98 71.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 62.049999999999997 110.783 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -82.36 -36.27 26.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.485 -0.779 . . . . 73.040000000000006 110.166 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.59 -28.92 41.06 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.042 0.386 . . . . 74.530000000000001 112.042 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.456 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -70.38 -30.14 66.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.964 -1.495 . . . . 44.109999999999999 106.964 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.7 t70 -71.08 -19.54 62.46 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.453 -1.249 . . . . 74.040000000000006 109.543 174.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.8 mtt -81.54 -41.04 22.22 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.921 -0.77 . . . . 61.030000000000001 108.921 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' HD2' ' CE1' ' A' ' 99' ' ' TYR . 46.4 t80 -64.58 -35.97 82.7 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 107.612 -1.255 . . . . 72.030000000000001 107.612 173.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.599 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.1 tttt -54.37 -40.07 67.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.908 -1.042 . . . . 72.0 110.631 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.22 -32.25 38.52 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.527 -0.469 . . . . 54.530000000000001 111.363 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.605 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 36.1 t70 -69.81 -24.03 63.41 Favored 'General case' 0 C--O 1.184 -2.37 0 C-N-CA 121.02 -0.272 . . . . 74.439999999999998 111.413 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -128.03 19.16 6.54 Favored 'General case' 0 CA--C 1.459 -2.527 0 O-C-N 121.137 -0.977 . . . . 65.109999999999999 110.909 176.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 43.58 34.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.893 1.371 . . . . 73.219999999999999 113.107 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.92 152.9 0.37 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.532 -1.213 . . . . 74.409999999999997 108.096 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.599 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.6 m-85 -76.38 148.65 80.76 Favored Pre-proline 0 N--CA 1.431 -1.401 0 O-C-N 123.496 0.498 . . . . 73.409999999999997 110.76 172.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 28.4 Cg_endo -61.41 162.27 21.13 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.811 3.007 . . . . 52.399999999999999 111.883 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -96.77 156.06 16.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.632 -1.618 . . . . 75.230000000000004 106.632 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.1 t -69.12 -11.58 60.92 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.287 0.948 . . . . 61.210000000000001 110.934 -175.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -102.45 -65.84 0.97 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.096 -0.502 . . . . 75.430000000000007 110.99 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.33 -40.42 51.39 Favored 'General case' 0 CA--C 1.486 -1.505 0 O-C-N 122.141 -0.349 . . . . 72.400000000000006 110.393 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.7 -20.54 79.48 Favored Glycine 0 N--CA 1.41 -3.066 0 C-N-CA 119.25 -1.453 . . . . 32.340000000000003 113.076 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.38 -45.64 68.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.742 -1.577 . . . . 41.539999999999999 106.742 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.45 -8.68 57.09 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.18 -0.918 . . . . 64.439999999999998 111.733 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.586 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -96.88 -6.01 36.81 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.478 0.656 . . . . 71.129999999999995 110.209 175.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 86.4 mt -95.06 -19.81 19.84 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.791 -0.818 . . . . 70.430000000000007 108.791 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 t -106.11 -44.56 7.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.633 -0.712 . . . . 54.340000000000003 110.931 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.2 mppt? -108.82 148.69 30.19 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.216 -1.031 . . . . 73.230000000000004 108.216 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.54 133.05 63.71 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 123.82 0.848 . . . . 74.239999999999995 109.833 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.458 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 18.4 Cg_endo -55.3 121.05 9.23 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.688 2.925 . . . . 72.209999999999994 113.291 -172.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 t -87.12 -2.48 58.66 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.479 -1.237 . . . . 73.409999999999997 109.175 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.29 -147.75 12.61 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.768 -0.933 . . . . 32.329999999999998 110.768 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -115.63 99.13 52.16 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 117.7 0.75 . . . . 73.030000000000001 110.462 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.49 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 85.7 Cg_endo -102.85 162.2 0.28 Allowed 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 122.904 2.403 . . . . 71.530000000000001 112.887 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.428 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 45.5 mt-30 -105.54 98.55 17.56 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 106.0 -1.852 . . . . 74.409999999999997 106.0 174.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -36.69 99.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 125.186 3.924 . . . . 64.230000000000004 119.675 -167.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.605 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 4.1 mptp? -109.53 149.17 30.01 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 102.103 -3.295 . . . . 55.219999999999999 102.103 160.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.35 92.34 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 123.268 0.355 . . . . 73.219999999999999 110.277 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.585 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -54.95 140.85 35.89 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 124.969 1.308 . . . . 73.099999999999994 112.678 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.59 137.89 54.55 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.929 -1.032 . . . . 61.299999999999997 110.14 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -93.12 -178.1 4.68 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.736 0.779 . . . . 72.329999999999998 111.023 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t0 65.73 24.29 11.5 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.649 1.58 . . . . 74.099999999999994 110.846 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.91 27.58 Favored Glycine 0 CA--C 1.496 -1.132 0 CA-C-N 114.643 -1.162 . . . . 54.210000000000001 115.051 168.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.585 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.5 90.28 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.384 1.087 . . . . 74.25 110.775 -175.114 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 101' ' ' LYS . 5.7 tt -138.18 151.04 47.33 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.356 -2.461 . . . . 74.409999999999997 104.356 -179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.509 ' N ' HD23 ' A' ' 100' ' ' LEU . 55.8 mtmt -67.39 -172.47 0.23 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.357 -0.537 . . . . 74.510000000000005 111.597 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 67.94 6.42 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.094 0.95 . . . . 74.310000000000002 111.384 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.52 148.28 69.44 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 126.263 1.825 . . . . 62.43 107.488 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.19 -171.56 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.126 2.551 . . . . 73.439999999999998 113.289 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.2 p -85.66 175.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 N-CA-C 108.611 -0.885 . . . . 74.299999999999997 108.611 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.471 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.3 t70 -77.58 158.35 78.76 Favored Pre-proline 0 C--O 1.251 1.182 0 CA-C-N 118.89 0.768 . . . . 70.0 109.692 -170.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 68.4 Cg_exo -47.55 170.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.39 2.726 . . . . 74.329999999999998 113.855 173.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.702 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 1.2 m-90 65.13 15.46 10.01 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.018 1.727 . . . . 75.209999999999994 110.565 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.15 1.67 50.35 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.135 -0.939 . . . . 21.300000000000001 114.993 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.702 ' ND2' ' HB2' ' A' ' 108' ' ' TRP . 47.5 m-80 -70.51 128.08 91.46 Favored Pre-proline 0 C--O 1.258 1.544 0 N-CA-C 113.78 1.03 . . . . 70.319999999999993 113.78 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.556 ' HA ' HG21 ' A' ' 105' ' ' VAL . 21.1 Cg_exo -67.76 146.64 73.32 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.194 1.929 . . . . 35.329999999999998 108.706 166.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -69.64 144.42 52.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.869 -0.789 . . . . 74.030000000000001 108.869 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -100.63 113.65 26.68 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.058 -2.201 . . . . 73.349999999999994 105.058 -177.269 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.07 119.03 38.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.115 -0.948 . . . . 73.129999999999995 111.983 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 88.4 mt -129.33 153.23 48.05 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.251 -1.018 . . . . 70.420000000000002 108.251 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.839 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -104.25 -178.62 0.65 Allowed Pre-proline 0 N--CA 1.419 -2.017 0 CA-C-O 116.55 -1.691 . . . . 71.030000000000001 108.486 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.839 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 6.9 Cg_endo . . . . . 0 C--N 1.384 2.437 0 C-N-CA 123.704 2.936 . . . . 63.530000000000001 115.623 -165.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.956 0 N-CA-C 116.552 1.381 . . . . 65.140000000000001 116.552 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -34.3 -19.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.576 1 C-N-CA 128.608 6.205 . . . . 73.340000000000003 120.367 -178.789 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' A' ' 147' ' ' ASP . 19.3 p90 -171.53 151.9 3.09 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.112 1.324 . . . . 63.109999999999999 113.698 171.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.1 m-20 -112.27 106.8 15.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.02 -1.474 . . . . 73.129999999999995 107.02 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.51 128.37 45.55 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.979 -0.688 . . . . 72.200000000000003 109.879 -177.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 33.9 p90 -165.94 165.34 18.17 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 111.927 0.343 . . . . 72.409999999999997 111.927 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 143' ' ' ILE . 46.7 t -125.6 138.19 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.296 -1.372 . . . . 54.210000000000001 107.296 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.26 128.13 34.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 111.642 0.238 . . . . 75.400000000000006 111.642 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.86 171.32 22.51 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.389 -0.684 . . . . 53.520000000000003 111.389 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 108' ' ' TRP . . . -63.31 -3.34 1.88 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 115.489 1.662 . . . . 75.430000000000007 115.489 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -100.33 -2.11 34.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.796 0.808 . . . . 73.349999999999994 109.739 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.95 38.86 64.4 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.037 -0.825 . . . . 62.119999999999997 111.037 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -138.84 147.87 43.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.056 -0.72 . . . . 74.200000000000003 109.056 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 7.2 pt-20 -97.99 103.33 15.26 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 105.976 -1.861 . . . . 74.209999999999994 105.976 165.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.53 -172.34 20.29 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.03 -1.441 . . . . 75.420000000000002 111.209 -171.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.57 8.76 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.472 -1.051 . . . . 74.129999999999995 110.472 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.562 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 13.4 m 177.82 -177.67 0.21 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 127.663 2.385 . . . . 70.120000000000005 105.895 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -66.49 0.92 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 119.03 0.832 . . . . 73.120000000000005 110.341 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 130' ' ' ALA . 5.1 t30 -87.23 -27.71 22.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.108 0.956 . . . . 74.209999999999994 111.707 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 9.55 42.86 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.572 0.701 . . . . 63.219999999999999 111.448 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.562 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -103.36 157.41 17.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 115.129 -0.942 . . . . 31.23 109.466 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 8.9 p-10 -78.45 127.23 31.88 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.991 -1.485 . . . . 74.450000000000003 106.991 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 133.45 37.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.811 -1.181 . . . . 73.230000000000004 107.811 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.03 169.59 34.74 Favored Glycine 0 N--CA 1.414 -2.814 0 C-N-CA 117.685 -2.198 . . . . 62.229999999999997 114.276 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 58' ' ' ALA . 8.0 t30 -131.36 148.35 52.66 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.141 -1.8 . . . . 71.230000000000004 106.141 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -143.61 135.12 26.14 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.637 -0.825 . . . . 74.409999999999997 110.346 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.487 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 16.1 t0 -104.66 105.25 15.26 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 105.675 -1.972 . . . . 74.510000000000005 105.675 174.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 C--N 1.274 -2.696 0 N-CA-C 105.94 -1.874 . . . . 63.539999999999999 105.94 178.1 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.674 ' N ' ' HG1' ' A' ' 48' ' ' THR . 19.8 ttt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 65.040000000000006 109.449 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 m -96.18 91.3 5.85 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.676 0.75 . . . . 72.439999999999998 112.66 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 12.6 ptp180 -156.79 165.0 19.72 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 106.859 -1.534 . . . . 62.350000000000001 106.859 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -42.79 120.33 1.8 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.864 3.043 . . . . 74.140000000000001 114.608 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.65 -31.86 0.23 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 127.575 2.35 . . . . 65.219999999999999 113.048 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.498 ' HA ' HG23 ' A' ' 47' ' ' VAL . 10.7 mm100 -68.92 -22.78 64.14 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.967 -1.123 . . . . 70.439999999999998 107.967 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 48' ' ' THR . . . -63.74 -26.1 68.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.659 -1.155 . . . . 70.319999999999993 109.912 173.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 63.3 mttp -80.6 -26.08 38.06 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.928 -0.768 . . . . 72.129999999999995 108.928 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.539 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 43.9 t -74.29 -44.57 48.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 122.054 0.931 . . . . 72.329999999999998 108.637 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.674 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.4 t -71.11 -30.99 67.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.474 -1.239 . . . . 75.340000000000003 112.071 -173.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.63 -40.21 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 120.321 -0.552 . . . . 73.439999999999998 110.124 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -60.53 -31.68 70.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.275 0.56 . . . . 61.409999999999997 111.122 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 29.6 mtpp -66.26 -25.43 66.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.989 0.899 . . . . 61.119999999999997 111.281 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.96 -30.49 31.55 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.737 -1.345 . . . . 63.450000000000003 109.737 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.688 ' O ' HG13 ' A' ' 57' ' ' ILE . 72.9 m-20 -73.33 -38.54 65.76 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.314 -0.443 . . . . 73.099999999999994 110.739 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.466 HD12 ' C ' ' A' ' 144' ' ' GLY . 19.0 pt -62.49 -36.2 73.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 121.209 -0.196 . . . . 64.340000000000003 111.052 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.87 -30.15 70.24 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.942 -0.703 . . . . 61.229999999999997 110.8 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -69.13 -44.35 72.54 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.677 -0.692 . . . . 72.439999999999998 111.048 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.688 HG13 ' O ' ' A' ' 53' ' ' ASP . 23.3 mt -63.52 -42.49 96.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-N 115.349 -0.841 . . . . 61.5 109.223 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.54 -27.71 67.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.863 -0.608 . . . . 72.129999999999995 111.618 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -76.91 -30.63 56.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.618 0.723 . . . . 64.109999999999999 109.416 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.88 -24.45 38.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.172 -0.467 . . . . 73.230000000000004 110.115 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.91 -31.25 71.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.37 -1.344 . . . . 74.129999999999995 107.37 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 4.5 t70 -66.08 -28.82 69.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.174 -0.921 . . . . 71.420000000000002 109.66 170.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.8 ttm -82.82 -28.24 30.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.914 -0.585 . . . . 71.150000000000006 110.166 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -72.46 -34.35 67.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.318 -1.364 . . . . 74.140000000000001 107.318 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 28.5 ttpp -57.5 -25.76 60.28 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.215 -0.902 . . . . 55.310000000000002 109.561 171.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.9 tp -87.3 -36.0 18.12 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 123.386 0.674 . . . . 75.209999999999994 111.365 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.51 -27.0 58.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.942 0.401 . . . . 75.109999999999999 110.398 -173.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -130.61 24.39 5.08 Favored 'General case' 0 CA--C 1.457 -2.621 0 N-CA-C 112.418 0.525 . . . . 71.099999999999994 112.418 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.1 p90 42.65 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 125.015 1.447 . . . . 75.349999999999994 113.948 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.24 161.74 1.13 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.747 -0.835 . . . . 63.149999999999999 108.747 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.54 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 13.4 m-85 -78.89 155.52 77.75 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 123.617 0.573 . . . . 75.420000000000002 110.501 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.542 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 51.0 Cg_endo -73.81 160.74 43.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.341 2.028 . . . . 75.519999999999996 110.917 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -92.58 155.74 17.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.096 -1.816 . . . . 73.239999999999995 106.096 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.575 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.2 t -70.1 -7.32 40.49 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.61 1.095 . . . . 74.109999999999999 111.421 -176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -103.02 -66.89 0.91 Allowed 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 121.934 -0.479 . . . . 61.340000000000003 110.877 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -84.17 -31.65 25.03 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.905 -0.589 . . . . 73.140000000000001 112.469 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -78.35 -21.32 70.25 Favored Glycine 0 N--CA 1.409 -3.126 0 C-N-CA 117.54 -2.267 . . . . 74.019999999999996 111.316 176.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.89 -46.67 70.99 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 106.602 -1.629 . . . . 64.239999999999995 106.602 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.0 -31.62 72.94 Favored 'General case' 0 N--CA 1.396 -3.174 0 CA-C-N 114.918 -1.037 . . . . 73.099999999999994 109.358 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.603 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -79.8 -2.21 42.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 73.510000000000005 111.917 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.611 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 63.3 mt -98.26 -24.56 15.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.915 -0.584 . . . . 55.310000000000002 110.28 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.42 -32.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.367 0.603 . . . . 51.229999999999997 110.687 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -117.66 146.43 43.7 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 125.266 1.426 . . . . 71.310000000000002 107.158 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -54.59 129.19 62.69 Favored Pre-proline 0 N--CA 1.433 -1.3 0 C-N-CA 123.506 0.722 . . . . 74.299999999999997 109.641 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -58.96 126.17 20.32 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 124.214 3.276 . . . . 75.120000000000005 113.163 -172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -96.62 91.49 5.77 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-O 122.051 0.929 . . . . 73.140000000000001 109.876 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.6 -126.33 1.18 Allowed Glycine 0 N--CA 1.422 -2.284 0 CA-C-N 114.365 -1.289 . . . . 72.120000000000005 110.03 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -126.56 91.93 46.29 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 117.208 0.504 . . . . 71.409999999999997 109.704 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -97.21 162.91 0.98 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.65 1.567 . . . . 71.310000000000002 110.632 172.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -90.33 159.08 42.56 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.41 -1.33 . . . . 63.420000000000002 107.41 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.05 98.18 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.441 1.427 . . . . 54.219999999999999 111.965 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -151.53 147.43 26.81 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.921 -2.251 . . . . 74.219999999999999 104.921 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.26 94.4 8.42 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.831 -0.748 . . . . 74.540000000000006 110.128 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -54.05 140.23 32.24 Favored 'General case' 0 C--O 1.251 1.156 0 C-N-CA 124.235 1.014 . . . . 70.299999999999997 112.665 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -115.6 132.25 56.69 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.052 -1.431 . . . . 72.340000000000003 109.56 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 14.8 ptmm? -79.15 -176.88 5.36 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 119.759 -0.776 . . . . 71.299999999999997 109.522 175.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 96' ' ' LYS . 7.2 t70 69.34 31.06 3.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.437 -1.256 . . . . 62.350000000000001 109.477 170.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 92.02 7.15 64.46 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-N 114.469 -1.241 . . . . 61.020000000000003 113.534 167.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 62.91 87.57 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.817 -1.179 . . . . 70.329999999999998 107.817 -169.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HG ' HG12 ' A' ' 57' ' ' ILE . 2.7 tt -129.96 149.88 51.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.902 -1.888 . . . . 73.510000000000005 105.902 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -73.8 -178.74 3.32 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.011 -0.366 . . . . 75.430000000000007 110.011 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -82.21 73.61 9.23 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.582 1.182 . . . . 72.340000000000003 109.504 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -130.64 148.59 70.65 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.859 -1.973 . . . . 72.430000000000007 107.256 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.57 177.28 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.05 1.833 . . . . 73.409999999999997 111.117 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.545 HG21 ' HA ' ' A' ' 111' ' ' PRO . 3.3 p -82.41 174.67 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.521 -0.918 . . . . 73.310000000000002 108.521 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.0 t70 -69.45 139.1 89.12 Favored Pre-proline 0 C--O 1.258 1.503 0 N-CA-C 110.579 -0.156 . . . . 42.43 110.579 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.449 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 6.3 Cg_endo -50.5 172.19 0.09 OUTLIER 'Trans proline' 0 C--O 1.193 -1.744 0 C-N-CA 124.13 3.22 . . . . 64.430000000000007 113.301 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.406 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 66.64 14.67 9.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.118 1.367 . . . . 71.209999999999994 109.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.21 32.17 81.38 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 55.210000000000001 114.671 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.482 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 90.8 m-20 -92.9 119.97 67.44 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 117.629 0.714 . . . . 73.129999999999995 110.698 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 105' ' ' VAL . 36.8 Cg_exo -68.41 139.58 45.7 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.291 1.327 . . . . 75.040000000000006 108.669 167.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.642 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 56.0 m-85 -68.36 144.74 54.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.051 0.453 . . . . 64.150000000000006 110.317 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.569 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -102.3 114.06 27.9 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.839 -1.541 . . . . 61.229999999999997 106.839 -176.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.41 118.47 36.11 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.656 -1.239 . . . . 64.150000000000006 107.656 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.77 153.64 47.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.763 0.664 . . . . 71.129999999999995 109.223 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.788 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -121.85 -179.77 0.82 Allowed Pre-proline 0 N--CA 1.393 -3.302 0 N-CA-C 107.852 -1.166 . . . . 72.420000000000002 107.852 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.788 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 26.6 Cg_endo . . . . . 0 N--CA 1.449 -1.144 0 C-N-CA 122.066 1.844 . . . . 75.140000000000001 114.272 -174.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.792 0 CA-C-O 118.481 -1.177 . . . . 63.100000000000001 112.542 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 54.4 Cg_exo -60.63 -26.43 82.89 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.109 3.206 . . . . 73.030000000000001 110.84 165.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.1 p90 -173.81 168.08 4.33 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.61 0.764 . . . . 70.150000000000006 110.019 166.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.61 112.56 8.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.904 -1.147 . . . . 62.539999999999999 107.904 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.507 HD21 ' HB ' ' A' ' 57' ' ' ILE . 52.9 tp -128.14 123.97 35.72 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.213 -0.929 . . . . 64.120000000000005 110.505 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.439 ' HB3' ' HA3' ' A' ' 144' ' ' GLY . 53.5 p90 -168.06 169.06 11.45 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 120.889 -0.324 . . . . 55.109999999999999 111.474 -174.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.642 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 22.2 t -125.14 160.69 28.53 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.844 -1.539 . . . . 75.219999999999999 106.844 170.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.569 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 89.5 mt -68.83 167.1 16.26 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.307 0.38 . . . . 73.340000000000003 110.636 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.65 -170.81 43.51 Favored Glycine 0 CA--C 1.496 -1.143 0 C-N-CA 119.419 -1.372 . . . . 73.299999999999997 111.77 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.65 -15.1 36.77 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.391 0.676 . . . . 71.340000000000003 112.731 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -94.45 -9.38 35.71 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.205 0.526 . . . . 74.150000000000006 110.714 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.8 23.73 66.29 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 121.109 -0.567 . . . . 73.409999999999997 112.167 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.01 148.62 42.12 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.47 -0.937 . . . . 62.409999999999997 108.47 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.44 105.98 18.06 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.693 0.759 . . . . 53.340000000000003 110.835 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.02 -174.32 21.16 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.148 -0.933 . . . . 52.049999999999997 111.234 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.74 129.58 9.94 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.577 -1.409 . . . . 61.25 109.577 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.3 m -177.74 -178.49 0.72 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 124.604 1.162 . . . . 63.409999999999997 108.275 -171.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -99.67 -25.99 14.21 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.754 -0.378 . . . . 72.209999999999994 111.933 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.88 -33.45 2.93 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.608 0.718 . . . . 43.329999999999998 110.038 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -95.38 15.21 20.1 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.909 -0.587 . . . . 63.119999999999997 110.897 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -87.27 155.32 20.12 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-N 115.994 -0.548 . . . . 63.409999999999997 110.043 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.73 129.11 34.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.901 -1.518 . . . . 74.010000000000005 106.901 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.571 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -96.48 115.92 37.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-O 121.472 0.653 . . . . 75.200000000000003 109.301 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.466 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -163.97 177.81 39.61 Favored Glycine 0 N--CA 1.417 -2.57 0 C-N-CA 118.756 -1.688 . . . . 72.299999999999997 113.719 -176.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.48 146.05 16.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.26 -1.385 . . . . 72.219999999999999 107.26 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 16.2 p90 -157.41 168.76 26.4 Favored 'General case' 0 C--N 1.267 -2.999 0 CA-C-O 120.972 0.415 . . . . 74.230000000000004 110.798 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 17.3 t70 -105.87 125.19 50.7 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.069 -1.456 . . . . 43.5 107.069 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.524 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 4.0 p-10 . . . . . 0 N--CA 1.421 -1.882 0 O-C-N 125.01 1.444 . . . . 61.409999999999997 108.553 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.643 ' N ' ' HG1' ' A' ' 48' ' ' THR . 46.5 tpp . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.692 0.282 . . . . 64.310000000000002 110.764 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -105.87 91.79 3.89 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.91 -0.494 . . . . 65.540000000000006 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -148.69 164.95 19.28 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 106.547 -1.649 . . . . 72.329999999999998 106.547 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 44' ' ' GLN . 51.7 Cg_exo -46.98 120.5 4.22 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.204 2.602 . . . . 70.430000000000007 112.939 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t70 73.34 -30.07 0.21 Allowed 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 127.135 2.174 . . . . 64.409999999999997 110.928 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.481 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 14.0 mm100 -68.02 -25.17 65.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.224 -0.898 . . . . 74.299999999999997 109.516 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.48 65.37 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.314 -0.857 . . . . 71.120000000000005 110.328 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -87.65 -26.69 22.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.457 -0.942 . . . . 64.319999999999993 108.457 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 37.6 t -74.71 -44.6 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.71 0.767 . . . . 41.200000000000003 109.261 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.643 ' HG1' ' N ' ' A' ' 39' ' ' MET . 14.2 t -59.85 -38.18 81.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.326 -1.306 . . . . 73.329999999999998 112.889 -172.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -84.37 -34.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 119.88 -0.728 . . . . 44.299999999999997 110.442 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -60.2 -32.99 71.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.136 -0.484 . . . . 75.129999999999995 111.813 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 12.2 mmmm -65.73 -25.33 67.24 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.993 0.902 . . . . 75.430000000000007 110.048 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.6 -22.54 39.58 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.632 -0.987 . . . . 60.439999999999998 110.632 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 57' ' ' ILE . 75.5 m-20 -82.76 -38.48 23.15 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.671 0.272 . . . . 75.540000000000006 110.27 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.7 pt -64.02 -32.53 57.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.432 -0.581 . . . . 75.129999999999995 109.432 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -33.03 73.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.907 -0.588 . . . . 65.329999999999998 110.621 176.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.64 74.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.023 -0.535 . . . . 63.219999999999999 110.334 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 53' ' ' ASP . 55.3 mt -65.09 -37.83 81.21 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 CA-C-N 115.755 -0.657 . . . . 72.319999999999993 110.268 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.57 67.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.219 0.533 . . . . 74.040000000000006 111.06 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.27 -19.99 24.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.194 0.521 . . . . 34.219999999999999 110.251 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -29.02 21.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.226 0.536 . . . . 73.200000000000003 110.115 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.92 -30.27 67.64 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.688 -1.597 . . . . 73.239999999999995 106.688 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 31.8 t70 -73.15 -20.51 60.89 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.351 -1.295 . . . . 72.099999999999994 109.428 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.2 ttt -79.18 -34.32 43.14 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 115.747 -0.661 . . . . 75.420000000000002 109.367 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.438 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 1.3 t80 -64.05 -39.66 94.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.695 -1.595 . . . . 74.230000000000004 106.695 172.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 76.7 tttt -54.61 -33.02 59.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.813 -1.085 . . . . 64.409999999999997 110.304 175.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 99.3 mt -82.83 -36.2 25.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.137 -0.483 . . . . 74.439999999999998 111.522 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.16 -25.26 63.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.255 0.465 . . . . 62.140000000000001 112.255 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 12.0 m-80 -128.67 18.94 6.21 Favored 'General case' 0 CA--C 1.442 -3.209 0 O-C-N 121.962 -0.461 . . . . 64.319999999999993 111.062 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 p90 43.37 33.51 0.62 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 125.13 1.519 . . . . 74.109999999999999 112.558 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -177.52 156.3 1.16 Allowed 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.709 -1.219 . . . . 64.109999999999999 107.709 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.3 m-85 -78.83 148.6 72.72 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 123.254 0.347 . . . . 64.010000000000005 111.257 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.587 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 33.6 Cg_endo -66.4 158.41 55.4 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.892 2.394 . . . . 43.240000000000002 109.752 174.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.464 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 47.4 p -94.01 156.71 16.46 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.841 -1.17 . . . . 74.430000000000007 107.841 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.5 t -66.38 -13.09 60.14 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 119.9 1.227 . . . . 72.430000000000007 111.165 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -102.21 -64.75 1.04 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 121.982 -0.449 . . . . 61.039999999999999 111.162 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -40.26 60.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 109.096 -0.705 . . . . 61.530000000000001 109.096 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -72.52 -20.75 79.61 Favored Glycine 0 N--CA 1.407 -3.27 0 C-N-CA 119.717 -1.23 . . . . 14.34 113.665 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.06 -47.31 62.49 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.349 -1.352 . . . . 74.239999999999995 107.349 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.56 -32.11 70.05 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 115.571 -0.74 . . . . 65.540000000000006 110.177 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.611 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -83.64 -5.54 59.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.786 0.661 . . . . 51.310000000000002 112.786 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 42.1 mt -93.14 -24.21 18.33 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.506 0.669 . . . . 65.310000000000002 109.822 174.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 t -102.72 -35.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.403 -0.817 . . . . 75.299999999999997 110.533 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 95.4 mttt -126.51 150.9 48.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.732 -1.581 . . . . 54.439999999999998 106.732 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -54.22 141.15 52.25 Favored Pre-proline 0 N--CA 1.48 1.063 0 N-CA-C 113.244 0.831 . . . . 74.140000000000001 113.244 -172.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 30.2 Cg_endo -61.15 152.66 70.23 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.974 3.116 . . . . 45.439999999999998 114.551 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -110.78 111.19 22.19 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 114.14 -1.391 . . . . 65.019999999999996 110.219 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.53 -121.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.769 -0.729 . . . . 70.439999999999998 111.583 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -136.96 91.91 14.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 C-N-CA 121.136 -0.226 . . . . 73.319999999999993 110.527 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 18.3 Cg_endo -95.27 161.54 1.6 Allowed 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 121.925 1.75 . . . . 74.209999999999994 110.596 172.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -87.63 159.26 49.92 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 106.76 -1.57 . . . . 71.230000000000004 106.76 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.55 99.31 0.31 Allowed 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 120.906 1.07 . . . . 73.540000000000006 110.684 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -150.84 149.33 29.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.571 -1.64 . . . . 74.109999999999999 106.571 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -66.01 97.58 0.38 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.007 0.743 . . . . 74.319999999999993 113.007 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.558 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.1 t90 -71.94 143.5 49.26 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.752 -0.658 . . . . 74.450000000000003 109.573 171.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -134.95 137.4 43.06 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.604 -0.517 . . . . 73.430000000000007 109.604 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' HG3' ' OD2' ' A' ' 97' ' ' ASP . 22.4 pttp -76.46 -166.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.142 -0.688 . . . . 74.349999999999994 109.142 175.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' A' ' 96' ' ' LYS . 41.0 m-20 66.32 8.65 5.8 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.437 1.095 . . . . 73.299999999999997 112.509 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 96.0 21.02 24.31 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 115.212 -0.904 . . . . 33.049999999999997 111.771 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.6 93.51 0.08 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.322 1.058 . . . . 63.219999999999999 111.101 -177.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.43 152.67 48.73 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.122 -0.944 . . . . 63.039999999999999 108.98 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.83 -169.05 2.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.976 -1.12 . . . . 74.230000000000004 107.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -72.75 70.69 0.98 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 122.747 1.261 . . . . 65.219999999999999 110.492 174.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.43 148.54 70.52 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 125.765 1.626 . . . . 62.130000000000003 108.331 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.63 -168.76 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.425 2.083 . . . . 73.140000000000001 110.754 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.649 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.7 p -86.41 174.25 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 106.576 -1.638 . . . . 61.340000000000003 106.576 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.424 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 4.3 t70 -97.37 151.59 37.75 Favored Pre-proline 0 C--O 1.252 1.193 0 C-N-CA 117.255 -1.778 . . . . 71.150000000000006 110.818 -173.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -38.79 171.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.824 3.683 . . . . 54.219999999999999 115.383 166.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.585 ' HB2' HD22 ' A' ' 110' ' ' ASN . 3.5 m-90 67.9 14.5 9.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.386 -1.733 . . . . 71.329999999999998 107.064 -171.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.31 29.22 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 114.052 -1.431 . . . . 72.439999999999998 114.497 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.585 HD22 ' HB2' ' A' ' 108' ' ' TRP . 54.1 m-80 -92.14 131.57 34.6 Favored Pre-proline 0 C--O 1.261 1.661 0 CA-C-N 117.941 0.871 . . . . 73.340000000000003 112.162 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.649 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 16.1 Cg_exo -70.15 148.88 63.52 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.356 2.037 . . . . 75.019999999999996 109.516 170.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.519 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 27.7 m-85 -69.59 140.31 53.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.199 -1.0 . . . . 70.010000000000005 108.588 175.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -101.57 115.04 29.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.74 -1.578 . . . . 74.329999999999998 106.74 -173.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.92 119.81 39.51 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.88 -1.054 . . . . 72.5 112.319 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 83.0 mt -128.57 143.9 51.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.242 -1.021 . . . . 75.400000000000006 108.242 172.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.758 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -111.17 -178.21 0.52 Allowed Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 107.525 -1.287 . . . . 50.25 107.525 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.758 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 37.3 Cg_endo . . . . . 0 CA--C 1.486 -1.922 0 CA-C-N 121.734 1.655 . . . . 61.399999999999999 114.678 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . . . . . . 0 CA--C 1.477 -2.343 0 CA-C-O 118.128 -1.373 . . . . 72.319999999999993 113.751 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 34.8 Cg_exo -46.02 -22.76 1.51 Allowed 'Trans proline' 0 C--N 1.376 1.974 1 C-N-CA 126.511 4.807 . . . . 70.040000000000006 116.264 177.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.2 p90 179.91 166.76 1.24 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.97 0.508 . . . . 64.430000000000007 110.571 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 7.5 m-20 -139.53 108.97 6.15 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.069 0.856 . . . . 73.010000000000005 109.251 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -123.46 130.27 52.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.332 -0.547 . . . . 72.239999999999995 110.085 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -166.88 161.91 15.52 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 116.544 -0.298 . . . . 74.299999999999997 110.714 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.519 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 25.1 t -126.01 135.99 52.45 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.573 -1.269 . . . . 73.319999999999993 107.573 171.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.23 133.53 55.3 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.089 0.403 . . . . 62.43 112.089 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -86.14 -159.19 32.2 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.889 -0.596 . . . . 55.409999999999997 113.384 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -13.05 47.74 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.763 1.394 . . . . 71.540000000000006 114.763 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 140' ' ' ASP . 36.7 t70 -94.95 -10.09 32.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 119.812 -0.755 . . . . 70.519999999999996 110.181 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.18 70.95 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.736 -0.665 . . . . 73.200000000000003 112.538 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -140.7 137.75 33.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.469 -0.938 . . . . 73.140000000000001 108.469 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.34 112.88 12.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.245 0.545 . . . . 61.149999999999999 109.62 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.44 -173.61 20.79 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 108.857 -1.697 . . . . 32.520000000000003 108.857 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.51 126.3 8.3 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 118.706 -1.711 . . . . 71.219999999999999 109.861 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 141' ' ' ALA . 28.6 m 178.08 -178.67 0.26 Allowed 'General case' 0 C--O 1.251 1.146 0 C-N-CA 127.094 2.158 . . . . 73.420000000000002 106.713 -174.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.01 -56.72 2.76 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.293 -0.563 . . . . 63.409999999999997 112.501 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -107.74 -23.64 12.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.239 -0.584 . . . . 74.420000000000002 111.391 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 10.4 m-20 -76.11 -28.82 57.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 121.964 0.888 . . . . 62.409999999999997 109.242 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 137' ' ' SER . . . -80.8 159.41 25.14 Favored 'General case' 0 CA--C 1.47 -2.131 0 CA-C-N 113.572 -1.649 . . . . 44.329999999999998 111.033 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -76.65 135.5 39.13 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 107.027 -1.471 . . . . 54.020000000000003 107.027 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.506 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -97.71 128.85 48.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.394 -0.821 . . . . 65.209999999999994 110.295 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -172.55 -179.74 43.55 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 119.325 -1.417 . . . . 73.420000000000002 112.269 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.52 155.13 17.07 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.068 -1.456 . . . . 64.540000000000006 107.068 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.456 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 3.2 p90 -165.69 177.51 7.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.191 0.519 . . . . 73.140000000000001 111.435 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -116.1 125.59 52.59 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.398 -1.704 . . . . 61.140000000000001 106.398 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.537 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 41.0 t30 . . . . . 0 C--N 1.304 -1.388 0 N-CA-C 108.211 -1.033 . . . . 73.450000000000003 108.211 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.426 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.4 mpt? . . . . . 0 C--O 1.234 0.274 0 N-CA-C 108.549 -0.908 . . . . 71.040000000000006 108.549 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -107.14 82.3 1.66 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.297 0.57 . . . . 63.240000000000002 111.669 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -154.55 159.06 32.28 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.177 -1.786 . . . . 75.519999999999996 106.177 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.99 138.48 52.53 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.673 2.249 . . . . 72.099999999999994 111.305 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 72.99 -35.94 0.34 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.073 1.349 . . . . 72.150000000000006 113.669 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 66.0 mt-30 -74.19 -25.54 59.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.048 -1.093 . . . . 72.510000000000005 108.048 175.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.5 64.64 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.878 -1.055 . . . . 52.109999999999999 109.847 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HD2' ' HB3' ' A' ' 107' ' ' PRO . 44.0 mmtm -85.32 -25.62 27.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.093 -1.077 . . . . 71.129999999999995 108.093 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 86.4 t -74.63 -44.36 46.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.239 -0.891 . . . . 63.130000000000003 109.545 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -65.7 -25.45 67.32 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 115.145 -0.934 . . . . 71.120000000000005 111.659 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.5 -49.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 N-CA-C 108.747 -0.835 . . . . 74.329999999999998 108.747 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' HB3' HD12 ' A' ' 143' ' ' ILE . . . -64.44 -24.74 67.73 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.987 -1.006 . . . . 72.040000000000006 112.064 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.1 mmmt -65.74 -26.41 67.72 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.604 0.716 . . . . 73.030000000000001 110.762 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.2 -26.94 29.48 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 110.005 -1.238 . . . . 72.219999999999999 110.005 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.623 ' O ' HG13 ' A' ' 57' ' ' ILE . 65.7 m-20 -78.26 -38.13 43.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.432 -0.384 . . . . 75.019999999999996 110.687 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.459 HG21 ' HA2' ' A' ' 144' ' ' GLY . 19.8 pt -66.61 -38.19 81.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.355 -0.216 . . . . 70.120000000000005 111.082 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.5 tptt -69.0 -26.72 65.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.002 0.43 . . . . 70.310000000000002 110.121 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -66.93 -45.16 78.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 63.43 110.242 174.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 53' ' ' ASP . 34.1 mt -64.73 -42.27 94.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.729 -0.669 . . . . 63.0 109.507 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.15 -28.4 66.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.865 -0.607 . . . . 53.329999999999998 111.235 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.62 -30.1 29.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 64.540000000000006 110.02 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.67 -28.1 30.87 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.712 -0.677 . . . . 73.140000000000001 110.366 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.48 -30.7 71.09 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.822 -1.177 . . . . 75.120000000000005 107.822 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.62 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.8 t70 -71.22 -23.25 61.98 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 122.183 0.992 . . . . 71.109999999999999 109.273 173.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 mtt -83.59 -28.43 28.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.726 -0.67 . . . . 64.430000000000007 110.724 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.545 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 70.8 t80 -71.55 -36.06 70.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.553 -1.277 . . . . 74.400000000000006 107.553 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.641 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 74.8 tttt -53.95 -36.09 62.46 Favored 'General case' 0 C--O 1.208 -1.114 0 CA-C-N 114.917 -1.038 . . . . 70.109999999999999 109.108 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.8 tp -76.48 -36.73 57.69 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.011 -0.541 . . . . 74.340000000000003 111.333 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.547 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 19.0 t70 -71.95 -23.77 61.5 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 112.035 0.383 . . . . 75.099999999999994 112.035 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.2 20.03 5.84 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 109.13 -0.693 . . . . 63.109999999999999 109.13 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.9 p90 42.95 32.96 0.46 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.999 1.437 . . . . 72.439999999999998 113.602 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 159.1 0.99 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.762 -0.829 . . . . 43.409999999999997 108.762 -172.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 23.7 m-85 -78.55 151.48 77.41 Favored Pre-proline 0 N--CA 1.425 -1.717 0 O-C-N 123.486 0.491 . . . . 63.539999999999999 111.23 173.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.5 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 30.8 Cg_endo -66.28 162.26 36.89 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.349 2.7 . . . . 73.340000000000003 111.055 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 76' ' ' GLN . 69.5 p -98.62 156.33 16.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.27 -1.752 . . . . 65.239999999999995 106.27 174.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -67.81 -12.58 60.9 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 119.656 1.116 . . . . 72.230000000000004 111.765 -175.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -102.09 -64.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.979 -0.45 . . . . 75.219999999999999 110.742 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.408 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 14.9 mm100 -74.12 -40.87 62.37 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 110.253 -0.277 . . . . 70.109999999999999 110.253 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.639 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.49 -20.94 79.43 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 119.088 -1.529 . . . . 64.219999999999999 113.458 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.0 -47.37 62.47 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.567 -1.642 . . . . 72.329999999999998 106.567 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 30.4 mt-10 -60.98 -33.48 73.29 Favored 'General case' 0 C--O 1.169 -3.175 0 CA-C-N 114.994 -1.003 . . . . 75.019999999999996 110.347 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.639 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.35 -7.05 55.44 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.629 . . . . 43.340000000000003 111.811 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -95.92 -18.5 20.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.932 -0.576 . . . . 73.450000000000003 110.322 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.86 -34.32 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 116.2 -0.454 . . . . 74.439999999999998 111.863 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 42.7 pttt -125.97 152.29 45.89 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.564 -2.013 . . . . 74.140000000000001 105.564 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 84' ' ' LYS . 3.9 mppt? -54.74 135.08 64.97 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 118.956 0.798 . . . . 73.129999999999995 111.813 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.545 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 18.3 Cg_endo -60.87 125.05 16.19 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.944 3.096 . . . . 74.409999999999997 113.352 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.0 t -84.1 139.92 32.14 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.429 -1.323 . . . . 73.420000000000002 107.429 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.13 -131.84 8.35 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.682 -1.767 . . . . 75.299999999999997 108.682 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.15 97.4 32.0 Favored Pre-proline 0 C--N 1.299 -1.591 0 CA-C-N 118.088 0.944 . . . . 71.239999999999995 111.966 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -92.46 150.25 2.94 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.335 1.356 . . . . 73.540000000000006 109.568 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -79.66 160.33 69.8 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.044 -1.095 . . . . 72.030000000000001 108.044 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.6 97.63 0.27 Allowed 'Trans proline' 0 C--O 1.249 1.056 0 CA-C-N 120.602 1.251 . . . . 65.200000000000003 109.64 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.547 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . 8.2 tmtm? -152.74 147.29 25.91 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.924 -2.25 . . . . 73.540000000000006 104.924 -175.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -81.76 92.7 6.68 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.278 -0.969 . . . . 73.439999999999998 111.051 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.492 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.9 t90 -54.9 143.69 25.25 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.288 1.035 . . . . 71.329999999999998 111.584 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.37 137.2 53.43 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.855 0.862 . . . . 74.409999999999997 109.003 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -84.71 -169.06 2.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.011 -0.737 . . . . 71.040000000000006 109.011 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t0 71.1 12.47 6.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.304 1.442 . . . . 71.0 110.535 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.52 14.98 30.93 Favored Glycine 0 N--CA 1.425 -2.061 0 CA-C-N 114.341 -1.3 . . . . 74.340000000000003 112.946 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.43 91.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 122.633 1.206 . . . . 71.239999999999995 109.533 -174.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -123.92 171.26 9.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 113.91 -1.495 . . . . 71.219999999999999 109.282 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HG3' ' HB1' ' A' ' 56' ' ' ALA . 73.9 mmtt -94.12 -168.57 1.89 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.396 -1.335 . . . . 72.439999999999998 107.396 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.73 70.85 3.26 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.716 1.246 . . . . 73.409999999999997 110.535 175.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.1 mt -130.34 147.63 66.59 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 115.064 -0.971 . . . . 54.009999999999998 110.715 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.7 -168.52 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.395 2.063 . . . . 75.129999999999995 110.526 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.612 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -86.13 173.8 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.556 -0.905 . . . . 75.420000000000002 108.556 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.482 ' HB2' ' HD2' ' A' ' 107' ' ' PRO . 4.1 p-10 -72.77 157.58 88.59 Favored Pre-proline 0 C--O 1.249 1.068 0 CA-C-N 118.654 0.661 . . . . 55.32 111.786 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 24.3 Cg_endo -59.8 171.47 2.79 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.615 2.21 . . . . 53.020000000000003 113.197 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 68.45 15.09 9.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.503 1.521 . . . . 73.140000000000001 110.482 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.2 69.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.135 -0.939 . . . . 64.109999999999999 114.132 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.18 142.29 40.96 Favored Pre-proline 0 C--O 1.253 1.249 0 CA-C-N 117.76 0.78 . . . . 74.439999999999998 111.26 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.612 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 84.0 Cg_endo -85.04 147.74 10.45 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.491 2.127 . . . . 44.32 111.681 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.33 141.94 56.97 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.564 0.697 . . . . 60.140000000000001 110.627 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -104.63 112.84 26.07 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.772 -1.195 . . . . 74.319999999999993 107.772 176.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -117.4 118.9 33.48 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.955 -1.02 . . . . 75.299999999999997 109.585 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 70.2 mt -127.55 154.56 45.03 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.347 -1.353 . . . . 71.409999999999997 107.347 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.734 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -104.13 -178.39 0.62 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 116.592 -1.671 . . . . 64.049999999999997 108.669 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.734 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 16.8 Cg_endo -47.43 113.15 0.66 Allowed 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 123.269 2.646 . . . . 71.230000000000004 115.113 -165.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -89.29 -94.33 1.11 Allowed Glycine 0 N--CA 1.397 -3.901 0 CA-C-N 113.663 -1.608 . . . . 64.510000000000005 111.266 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.6 m -111.78 105.33 13.79 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 108.168 -1.049 . . . . 74.319999999999993 108.168 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 77.26 -33.07 0.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.483 1.513 . . . . 54.310000000000002 113.718 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -101.62 127.14 9.14 Favored Glycine 0 CA--C 1.474 -2.528 0 C-N-CA 118.933 -1.603 . . . . 72.120000000000005 114.334 -169.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.592 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 2.7 Cg_exo -39.78 -20.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.217 1 C-N-CA 126.941 5.094 . . . . 53.119999999999997 116.967 176.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.506 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 48.6 p90 -164.85 168.41 17.74 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.739 0.7 . . . . 73.140000000000001 112.134 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.5 m-20 -139.93 107.02 5.45 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.642 1.177 . . . . 74.109999999999999 109.662 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.85 140.95 44.56 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 117.363 -1.735 . . . . 63.350000000000001 111.998 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.564 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 24.4 p90 -166.52 170.08 13.15 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 71.409999999999997 111.727 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 m -124.33 151.22 44.57 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 107.596 -1.261 . . . . 75.439999999999998 107.596 174.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.0 mt -74.96 157.89 34.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.854 0.359 . . . . 73.450000000000003 110.989 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.85 179.21 49.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.506 -0.854 . . . . 62.219999999999999 112.209 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.79 -25.44 63.11 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.812 0.845 . . . . 73.140000000000001 112.882 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -94.79 3.38 55.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.397 0.617 . . . . 73.319999999999993 110.844 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.81 34.74 55.77 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 116.246 -0.434 . . . . 50.43 112.585 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -139.96 147.92 41.18 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.827 -0.186 . . . . 74.329999999999998 110.526 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -93.47 105.8 17.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.189 0.995 . . . . 75.420000000000002 110.649 173.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.11 -173.25 20.24 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 115.162 -0.926 . . . . 75.409999999999997 111.075 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.38 127.02 8.14 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 108.479 -1.848 . . . . 71.540000000000006 108.479 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 57.9 m 179.18 -176.76 0.27 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.264 -1.754 . . . . 72.549999999999997 106.264 -171.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.19 -71.86 0.45 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.763 0.711 . . . . 71.200000000000003 110.186 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -99.04 -6.12 29.09 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.134 0.492 . . . . 74.430000000000007 111.231 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 10.3 m-20 -100.58 7.85 43.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.384 0.611 . . . . 75.120000000000005 110.197 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -89.48 156.62 18.53 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.482 -0.781 . . . . 60.520000000000003 110.874 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 1.3 p-10 -79.17 129.05 34.05 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.706 -2.331 . . . . 73.519999999999996 104.706 172.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.502 HG21 HG13 ' A' ' 47' ' ' VAL . 22.8 pt -114.19 113.79 44.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 CA-C-O 121.663 0.744 . . . . 74.109999999999999 110.88 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 126' ' ' TYR . . . -168.05 -179.68 40.72 Favored Glycine 0 N--CA 1.408 -3.184 0 N-CA-C 110.949 -0.86 . . . . 51.009999999999998 110.949 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.416 ' C ' HD22 ' A' ' 145' ' ' ASN . 0.2 OUTLIER -151.51 156.19 40.04 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 109.888 -0.412 . . . . 65.439999999999998 109.888 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.506 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 7.1 p90 -155.69 177.25 11.6 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 115.3 -0.864 . . . . 74.230000000000004 109.226 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -129.93 136.39 49.42 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 123.894 0.746 . . . . 75.209999999999994 110.079 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.592 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 30.6 t30 . . . . . 0 C--O 1.255 1.347 0 O-C-N 125.833 1.958 . . . . 75.430000000000007 107.299 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.599 ' N ' ' HG1' ' A' ' 48' ' ' THR . 20.1 mmt . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 112.224 0.453 . . . . 71.430000000000007 112.224 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -100.36 80.63 2.26 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.901 -1.148 . . . . 52.219999999999999 107.901 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -145.53 158.08 51.01 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.311 -1.366 . . . . 40.329999999999998 107.311 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.53 123.24 10.98 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.113 2.542 . . . . 74.120000000000005 111.873 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t70 75.62 -32.47 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 126.824 2.05 . . . . 40.229999999999997 111.772 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.411 ' HA ' HG23 ' A' ' 47' ' ' VAL . 55.8 mt-30 -69.87 -13.9 62.48 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.833 -0.542 . . . . 75.219999999999999 110.804 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.42 -27.83 69.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.451 -0.795 . . . . 74.209999999999994 109.254 171.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -82.08 -25.72 34.28 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 108.183 -1.043 . . . . 74.129999999999995 108.183 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 139' ' ' ASN . 86.9 t -75.11 -43.99 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.656 0.741 . . . . 41.420000000000002 110.015 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.599 ' HG1' ' N ' ' A' ' 39' ' ' MET . 6.0 t -66.63 -38.26 86.55 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.91 -1.041 . . . . 65.239999999999995 110.993 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.09 -30.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 119.819 -0.752 . . . . 61.439999999999998 110.064 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.9 -39.41 81.39 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 115.789 -0.641 . . . . 24.210000000000001 111.51 -178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.66 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 67.8 mttm -66.05 -25.43 67.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.211 0.529 . . . . 64.430000000000007 111.435 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.73 -34.36 25.08 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.037 -1.225 . . . . 72.120000000000005 110.037 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.554 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 m-20 -77.1 -32.95 56.98 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.083 0.771 . . . . 73.019999999999996 113.083 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.77 -34.79 62.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 122.162 -0.336 . . . . 61.409999999999997 111.414 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.2 mptp? -69.92 -30.19 67.54 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.531 0.682 . . . . 75.430000000000007 109.782 176.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.19 -44.5 91.81 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.175 -0.921 . . . . 64.430000000000007 110.21 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 53' ' ' ASP . 76.1 mt -60.9 -39.22 81.29 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.074 -0.967 . . . . 74.519999999999996 110.152 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.527 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . . . -57.73 -35.47 70.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.249 0.343 . . . . 73.439999999999998 111.529 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.14 -34.28 70.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.999 0.428 . . . . 73.439999999999998 110.112 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.26 -29.35 48.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.476 . . . . 44.140000000000001 110.26 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.19 -29.73 67.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.349 -1.352 . . . . 64.430000000000007 107.349 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 38.9 m-20 -69.79 -24.46 63.5 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.509 -0.769 . . . . 72.409999999999997 110.961 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.7 mtm -79.25 -34.35 42.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.426 -0.91 . . . . 54.530000000000001 109.954 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 90.5 t80 -65.43 -36.79 84.98 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 107.648 -1.242 . . . . 74.140000000000001 107.648 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 37.8 ttpt -54.32 -37.74 65.2 Favored 'General case' 0 C--O 1.203 -1.381 0 CA-C-N 115.419 -0.81 . . . . 64.200000000000003 110.103 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.04 -27.68 23.04 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.819 -0.752 . . . . 52.229999999999997 112.576 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 90' ' ' GLN . 12.7 t70 -76.41 -25.48 54.55 Favored 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 120.034 -0.666 . . . . 71.219999999999999 111.289 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.402 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -121.2 22.37 10.91 Favored 'General case' 0 CA--C 1.458 -2.573 0 O-C-N 120.92 -1.112 . . . . 72.420000000000002 110.257 174.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.3 p90 43.29 32.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 125.111 1.507 . . . . 74.120000000000005 113.366 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.5 157.35 0.47 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.797 -1.186 . . . . 65.030000000000001 107.797 -173.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.53 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 17.0 m-85 -76.07 156.03 84.23 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 109.067 -0.716 . . . . 73.099999999999994 109.067 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.517 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 36.3 Cg_endo -64.05 156.78 56.85 Favored 'Trans proline' 0 C--O 1.217 -0.557 0 C-N-CA 122.606 2.204 . . . . 73.430000000000007 112.2 -177.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.422 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 62.8 p -93.49 155.38 17.37 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.992 -2.225 . . . . 65.25 104.992 171.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -72.38 -8.48 55.19 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 119.716 1.144 . . . . 64.340000000000003 111.097 -174.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -102.58 -66.01 0.96 Allowed 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.903 -0.589 . . . . 75.430000000000007 110.741 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -81.13 -35.53 31.44 Favored 'General case' 0 CA--C 1.467 -2.227 0 O-C-N 121.287 -0.883 . . . . 51.350000000000001 112.589 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.615 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -72.56 -21.58 79.45 Favored Glycine 0 N--CA 1.417 -2.631 0 C-N-CA 118.014 -2.041 . . . . 73.030000000000001 111.562 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.78 -43.62 62.58 Favored 'General case' 0 C--O 1.246 0.912 0 N-CA-C 105.995 -1.854 . . . . 73.109999999999999 105.995 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -61.44 -36.53 80.63 Favored 'General case' 0 C--O 1.192 -1.94 0 CA-C-N 114.473 -1.24 . . . . 62.219999999999999 110.349 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.457 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -84.54 -3.01 58.2 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.697 0.799 . . . . 55.140000000000001 112.598 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 58.0 mt -93.99 -27.31 16.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.498 -0.556 . . . . 73.239999999999995 109.498 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.07 -37.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.762 -0.654 . . . . 74.120000000000005 111.382 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.9 ttmp? -118.65 149.22 41.77 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.48 -1.674 . . . . 72.409999999999997 106.48 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -54.69 132.98 65.05 Favored Pre-proline 0 C--O 1.245 0.83 0 CA-C-O 120.767 0.318 . . . . 71.549999999999997 111.246 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -58.41 153.26 48.74 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 124.792 3.661 . . . . 54.450000000000003 113.9 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.7 p -90.94 137.82 32.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.38 -0.827 . . . . 72.099999999999994 110.174 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.39 -161.33 18.99 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.997 -1.241 . . . . 72.519999999999996 109.997 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -111.75 105.08 56.59 Favored Pre-proline 0 N--CA 1.391 -3.378 0 N-CA-C 108.864 -0.791 . . . . 71.140000000000001 108.864 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 3.0 Cg_endo -86.31 162.56 9.82 Favored 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 122.954 2.436 . . . . 74.129999999999995 110.242 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' A' ' 67' ' ' ASP . 81.2 mm-40 -91.3 111.41 48.66 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 109.608 -0.515 . . . . 74.329999999999998 109.608 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -51.1 101.51 0.05 OUTLIER 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 124.336 3.357 . . . . 74.409999999999997 117.936 -166.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -135.84 83.52 2.02 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.254 -1.017 . . . . 61.25 108.254 165.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 16.01 84.16 0.01 OUTLIER 'General case' 0 C--O 1.247 0.929 0 C-N-CA 127.676 2.391 . . . . 61.039999999999999 114.058 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.682 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -55.68 137.56 49.13 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.085 0.469 . . . . 65.299999999999997 110.917 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -134.08 129.21 35.67 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.258 -0.883 . . . . 74.409999999999997 109.719 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.38 174.27 8.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.876 0.846 . . . . 73.519999999999996 110.929 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 66.02 28.55 10.41 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.924 -1.489 . . . . 72.099999999999994 110.407 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 99.41 16.38 29.71 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.054 -1.43 . . . . 62.539999999999999 115.313 165.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.682 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 2.5 m-85 63.04 90.15 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 122.492 1.139 . . . . 74.129999999999995 111.608 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 mt -117.64 171.8 7.78 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.82 -1.082 . . . . 70.239999999999995 112.224 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.411 ' HB2' HD22 ' A' ' 103' ' ' LEU . 69.8 mmtt -93.47 -163.4 1.04 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 112.955 -1.93 . . . . 63.100000000000001 107.454 174.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.47 28.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.717 1.207 . . . . 73.150000000000006 112.944 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 103' ' ' LEU . 2.4 pt? -107.36 148.14 36.57 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.766 -0.584 . . . . 73.109999999999999 111.342 -174.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.15 -167.74 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.111 2.54 . . . . 71.25 110.041 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.66 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.97 167.89 2.12 Favored 'Isoleucine or valine' 0 C--O 1.258 1.527 0 N-CA-C 108.287 -1.005 . . . . 74.299999999999997 108.287 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 t70 -79.87 151.81 73.95 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 119.761 -0.776 . . . . 50.409999999999997 109.554 -171.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 59.7 Cg_exo -44.85 171.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 124.082 3.188 . . . . 54.43 113.953 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.451 ' CD1' ' HA ' ' A' ' 130' ' ' ALA . 2.3 m-90 69.91 14.28 7.93 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 126.127 1.771 . . . . 74.349999999999994 109.287 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.78 21.19 58.03 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 114.765 -1.107 . . . . 54.100000000000001 112.773 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -92.96 120.86 66.81 Favored Pre-proline 0 C--O 1.254 1.341 0 N-CA-C 112.881 0.697 . . . . 71.510000000000005 112.881 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.66 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.1 Cg_exo -59.6 143.91 99.55 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.592 2.195 . . . . 53.549999999999997 111.138 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 43.2 m-85 -69.39 143.1 53.76 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.605 -1.258 . . . . 73.230000000000004 107.605 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.519 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -103.07 119.65 39.25 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.196 -1.409 . . . . 75.239999999999995 107.196 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.26 117.93 34.97 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.289 0.566 . . . . 63.119999999999997 111.118 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 88.9 mt -128.8 153.7 47.15 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.525 -0.761 . . . . 65.349999999999994 109.044 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.779 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -113.91 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.408 -2.571 0 CA-C-O 117.89 -1.052 . . . . 63.119999999999997 109.597 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.779 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 32.2 Cg_endo -60.05 125.57 17.96 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.493 2.129 . . . . 75.099999999999994 114.699 -171.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.81 -76.54 0.11 Allowed Glycine 0 N--CA 1.415 -2.746 0 CA-C-N 114.169 -1.378 . . . . 71.299999999999997 112.002 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.3 m -95.11 95.29 8.47 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.684 -0.858 . . . . 74.5 108.684 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.527 ' HE2' ' OD1' ' A' ' 148' ' ' ASN . 0.1 OUTLIER 45.33 24.28 0.15 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.513 1.925 . . . . 61.020000000000003 115.634 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -137.47 121.8 2.37 Favored Glycine 0 CA--C 1.483 -1.937 0 CA-C-O 118.136 -1.369 . . . . 62.140000000000001 113.431 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 23.2 Cg_exo -41.37 -23.66 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.473 1 C-N-CA 126.905 5.07 . . . . 74.099999999999994 117.467 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 146' ' ' TRP . 54.8 p90 -179.51 170.14 1.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.364 0.529 . . . . 65.400000000000006 110.114 173.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 16.8 m-20 -137.41 109.0 6.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.997 -0.742 . . . . 73.439999999999998 108.997 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.24 126.29 51.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.54 -0.911 . . . . 60.43 108.54 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 113' ' ' GLN . 29.8 p90 -166.92 162.77 15.96 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 122.851 0.094 . . . . 71.040000000000006 110.771 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.496 ' HB3' HD11 ' A' ' 143' ' ' ILE . 23.0 t -126.07 143.13 51.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.9 -1.518 . . . . 73.230000000000004 106.9 171.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.519 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 87.8 mt -60.07 136.27 57.97 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.351 0.407 . . . . 73.510000000000005 110.067 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 141' ' ' ALA . . . -75.32 -164.49 13.84 Favored Glycine 0 C--O 1.229 -0.195 0 C-N-CA 121.111 -0.566 . . . . 35.520000000000003 114.058 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.451 ' HA ' ' CD1' ' A' ' 108' ' ' TRP . . . -55.37 -34.47 64.34 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.5 0.926 . . . . 73.040000000000006 113.5 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.13 -2.23 53.04 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.707 0.765 . . . . 70.030000000000001 109.348 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.73 17.22 80.08 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.8 -0.92 . . . . 43.210000000000001 110.8 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -100.46 144.85 28.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 112.072 0.397 . . . . 60.229999999999997 112.072 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.11 101.14 11.45 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 103.005 -2.961 . . . . 72.430000000000007 103.005 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.24 -173.02 22.76 Favored Glycine 0 CA--C 1.497 -1.093 0 CA-C-N 114.387 -1.278 . . . . 63.420000000000002 110.984 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.63 126.54 8.22 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 108.377 -1.889 . . . . 53.439999999999998 108.377 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.482 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.6 m 178.07 -178.7 0.26 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 126.746 2.019 . . . . 70.540000000000006 106.224 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.76 -58.29 2.14 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.683 -0.858 . . . . 63.020000000000003 108.683 171.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.51 ' HA ' HG21 ' A' ' 47' ' ' VAL . 3.0 t-20 -89.09 -38.58 14.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.272 -0.876 . . . . 75.340000000000003 111.846 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -90.45 8.68 32.55 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.177 0.513 . . . . 73.519999999999996 111.313 -174.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.482 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -104.87 157.54 17.14 Favored 'General case' 0 CA--C 1.477 -1.835 0 CA-C-N 115.585 -0.734 . . . . 71.420000000000002 109.828 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.73 136.47 38.17 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 107.149 -1.426 . . . . 72.299999999999997 107.149 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -94.73 118.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 121.622 0.725 . . . . 62.420000000000002 109.274 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.19 157.0 25.9 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.595 -1.288 . . . . 74.120000000000005 114.421 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 58' ' ' ALA . 4.4 t30 -148.92 129.53 14.03 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 125.208 1.403 . . . . 65.439999999999998 107.571 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.472 ' HA ' ' CE1' ' A' ' 123' ' ' PHE . 5.1 p90 -160.63 177.18 10.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.212 0.529 . . . . 72.140000000000001 111.439 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -115.63 134.27 55.21 Favored 'General case' 0 CA--C 1.472 -2.031 0 N-CA-C 107.725 -1.213 . . . . 53.240000000000002 107.725 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.527 ' OD1' ' HE2' ' A' ' 120' ' ' LYS . 24.9 t-20 . . . . . 0 C--N 1.292 -1.927 0 N-CA-C 107.713 -1.217 . . . . 72.450000000000003 107.713 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.653 ' N ' ' HG1' ' A' ' 48' ' ' THR . 1.4 mpt? . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.226 -0.657 . . . . 74.400000000000006 109.226 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 m -97.58 74.11 2.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.401 0.619 . . . . 53.25 110.339 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -148.49 158.5 40.42 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.054 -0.975 . . . . 75.109999999999999 108.472 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 44' ' ' GLN . 76.1 Cg_exo -50.63 121.25 7.63 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.633 2.889 . . . . 55.43 112.771 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t0 76.88 -26.4 0.19 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.023 1.729 . . . . 72.430000000000007 110.778 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 42' ' ' PRO . 73.2 mm-40 -70.96 -17.0 62.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.204 -0.907 . . . . 65.239999999999995 108.702 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.37 68.91 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.231 -0.895 . . . . 74.319999999999993 109.75 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 55.3 mttp -83.75 -25.68 30.31 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 108.549 -0.908 . . . . 71.540000000000006 108.549 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 52.0 t -74.79 -43.03 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.615 0.722 . . . . 74.010000000000005 109.494 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.653 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.4 t -63.99 -31.85 73.18 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.034 -0.984 . . . . 72.25 111.718 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -79.8 -39.63 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 119.533 -0.867 . . . . 71.329999999999998 109.565 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.81 -39.22 80.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.254 1.022 . . . . 71.230000000000004 112.356 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -65.72 -24.92 67.08 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.256 0.551 . . . . 63.219999999999999 111.141 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.21 -27.88 21.86 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.093 -0.803 . . . . 64.530000000000001 111.093 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.75 -38.98 57.94 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.168 0.509 . . . . 73.099999999999994 110.624 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 pt -66.31 -35.12 74.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.011 -0.541 . . . . 75.519999999999996 109.897 174.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 9.6 tptp -68.89 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 73.120000000000005 109.74 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.54 -40.73 97.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.31 -0.859 . . . . 61.140000000000001 109.614 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 125' ' ' LEU . 74.3 mt -66.14 -35.12 74.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 CA-C-N 115.014 -0.994 . . . . 72.319999999999993 110.665 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -27.49 69.29 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.279 0.562 . . . . 75.540000000000006 111.018 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.19 -33.44 29.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.695 0.759 . . . . 63.340000000000003 109.413 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.12 53.71 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.562 -0.745 . . . . 51.219999999999999 110.886 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.456 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -68.27 -30.18 69.14 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 72.439999999999998 108.571 178.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.528 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 3.2 t70 -66.49 -30.43 70.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 71.430000000000007 109.64 173.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 88.8 mtp -74.66 -33.92 62.61 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.962 -0.563 . . . . 73.200000000000003 110.212 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -71.55 -36.18 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.219 -0.66 . . . . 74.040000000000006 109.219 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 15.5 pttp -67.74 -16.39 64.11 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 119.123 -1.031 . . . . 71.430000000000007 109.269 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.1 tp -88.65 -36.12 16.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.838 -1.074 . . . . 75.530000000000001 109.808 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 23.9 t70 -75.17 -24.55 57.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.026 0.38 . . . . 63.119999999999997 112.026 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.77 24.48 5.71 Favored 'General case' 0 CA--C 1.464 -2.361 0 C-N-CA 119.747 -0.781 . . . . 75.5 109.637 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.34 32.48 0.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.418 1.487 . . . . 71.239999999999995 113.925 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.03 161.23 0.57 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.701 -1.222 . . . . 73.329999999999998 107.701 -174.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.615 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 16.4 m-85 -77.14 155.07 82.5 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 123.475 0.485 . . . . 73.239999999999995 110.816 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.46 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.0 Cg_endo -63.59 162.12 29.11 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.142 2.561 . . . . 73.140000000000001 112.457 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.0 p -98.32 155.24 17.3 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 105.507 -2.034 . . . . 73.349999999999994 105.507 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.71 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.79 -11.55 60.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 119.56 1.073 . . . . 72.340000000000003 111.549 -173.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -102.02 -65.42 0.99 Allowed 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.855 -0.612 . . . . 72.310000000000002 110.295 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -77.14 -39.52 48.95 Favored 'General case' 0 CA--C 1.493 -1.222 0 O-C-N 122.079 -0.388 . . . . 74.319999999999993 111.044 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.601 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -77.18 -21.17 74.09 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 118.529 -1.796 . . . . 62.450000000000003 112.961 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 82' ' ' VAL . 6.3 tt -70.27 -49.99 44.16 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.644 -1.243 . . . . 65.310000000000002 107.644 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.3 -23.92 64.8 Favored 'General case' 0 C--O 1.188 -2.139 0 CA-C-N 115.289 -0.868 . . . . 75.5 110.104 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.502 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -80.21 -7.11 58.82 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 111.945 176.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 96.4 mt -91.56 -24.82 19.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.646 -0.872 . . . . 71.109999999999999 108.646 171.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 78' ' ' LEU . 21.8 t -90.84 -47.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.964 -1.016 . . . . 72.25 110.942 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -117.75 151.25 37.66 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 125.904 1.681 . . . . 73.129999999999995 108.411 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -53.34 129.49 51.66 Favored Pre-proline 0 C--O 1.249 1.059 0 N-CA-C 108.955 -0.757 . . . . 62.509999999999998 108.955 -178.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 29.8 Cg_endo -58.5 127.36 24.37 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 124.067 3.178 . . . . 62.32 113.05 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -93.16 107.94 19.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.503 -0.771 . . . . 74.420000000000002 110.155 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.49 -133.06 3.94 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 109.065 -1.614 . . . . 43.420000000000002 109.065 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -125.02 87.79 54.97 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 117.781 0.791 . . . . 63.439999999999998 112.733 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.85 163.0 6.13 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 122.818 2.345 . . . . 53.420000000000002 108.455 171.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -108.37 148.03 36.82 Favored Pre-proline 0 C--N 1.288 -2.065 0 N-CA-C 108.952 -0.759 . . . . 73.209999999999994 108.952 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.462 ' C ' ' HD2' ' A' ' 92' ' ' LYS . 74.5 Cg_exo -50.82 98.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.63 2.886 . . . . 62.450000000000003 116.089 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 2.6 mptp? -147.27 148.75 31.76 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 127.641 2.377 . . . . 61.539999999999999 106.618 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -73.69 89.27 1.76 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 111.632 0.234 . . . . 73.030000000000001 111.632 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.628 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.2 t90 -54.96 143.76 25.29 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 124.59 1.156 . . . . 73.430000000000007 112.224 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 15.5 t-20 -126.39 137.02 53.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.158 -0.928 . . . . 73.030000000000001 111.137 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -86.23 173.79 9.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.659 0.742 . . . . 74.140000000000001 111.502 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.9 t70 69.08 15.32 8.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.497 -1.229 . . . . 64.049999999999997 112.435 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 119.6 8.81 8.84 Favored Glycine 0 CA--C 1.494 -1.276 0 C-N-CA 119.529 -1.319 . . . . 63.100000000000001 114.437 168.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.628 ' OH ' ' HA ' ' A' ' 94' ' ' TRP 0.268 0.3 OUTLIER 65.67 78.56 0.27 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 123.231 1.491 . . . . 75.120000000000005 110.787 -174.458 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.3 tp -121.42 169.09 10.97 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 112.715 -2.038 . . . . 73.109999999999999 107.769 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.01 -164.5 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.26 -1.015 . . . . 72.140000000000001 108.26 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -76.45 68.34 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 122.655 1.217 . . . . 74.219999999999999 109.275 173.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 148.63 70.84 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 114.564 -1.198 . . . . 73.519999999999996 111.0 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -168.2 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.058 2.505 . . . . 72.109999999999999 110.795 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.661 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 9.6 p -79.59 166.47 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 108.95 -0.759 . . . . 53.219999999999999 108.95 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.37 153.88 76.63 Favored Pre-proline 0 C--O 1.252 1.194 0 N-CA-C 108.805 -0.813 . . . . 65.030000000000001 108.805 -172.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.474 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 77.2 Cg_exo -50.0 172.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.432 2.755 . . . . 74.219999999999999 114.549 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.486 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 2.2 m-90 69.92 15.16 7.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.64 1.976 . . . . 64.219999999999999 109.66 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 13.67 52.77 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 114.83 -1.077 . . . . 60.240000000000002 114.152 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.15 132.96 43.81 Favored Pre-proline 0 N--CA 1.424 -1.769 0 CA-C-O 121.832 0.825 . . . . 74.409999999999997 111.595 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.661 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 71.8 Cg_endo -75.13 154.94 42.23 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 122.716 2.278 . . . . 70.530000000000001 111.142 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.68 136.37 48.99 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 106.898 -1.519 . . . . 74.439999999999998 106.898 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -102.66 114.06 27.97 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 105.225 -2.139 . . . . 73.420000000000002 105.225 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.443 ' CZ ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -104.4 118.35 36.4 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.303 -0.862 . . . . 65.019999999999996 109.996 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 93.5 mt -129.35 153.18 48.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.758 -0.83 . . . . 52.329999999999998 108.758 176.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.715 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -108.78 -177.31 0.46 Allowed Pre-proline 0 N--CA 1.412 -2.35 0 CA-C-O 116.588 -1.672 . . . . 63.25 107.633 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.715 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.2 Cg_endo -47.68 111.77 0.47 Allowed 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 122.653 2.235 . . . . 74.040000000000006 115.35 -165.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.74 -86.74 1.93 Allowed Glycine 0 N--CA 1.421 -2.362 0 CA-C-N 113.726 -1.579 . . . . 73.530000000000001 111.562 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 m -105.88 96.4 6.46 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 109.274 -0.639 . . . . 64.120000000000005 109.274 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 67.01 11.15 8.22 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.667 1.187 . . . . 64.409999999999997 114.195 172.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -140.98 132.08 5.21 Favored Glycine 0 CA--C 1.489 -1.561 0 C-N-CA 117.957 -2.068 . . . . 72.049999999999997 114.597 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.587 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -39.2 -20.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.062 1 C-N-CA 127.201 5.267 . . . . 53.299999999999997 118.025 177.415 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.3 p90 -170.98 165.65 7.57 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.605 0.639 . . . . 73.140000000000001 110.059 173.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 19.6 m-20 -135.08 110.37 8.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.487 -0.931 . . . . 74.019999999999996 108.487 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.522 HD11 HD12 ' A' ' 57' ' ' ILE . 3.4 tm? -118.81 129.54 55.28 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.116 -0.698 . . . . 74.530000000000001 109.116 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -166.97 168.72 13.65 Favored 'General case' 0 C--O 1.204 -1.322 0 O-C-N 123.492 0.495 . . . . 72.439999999999998 109.9 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 15.6 m -124.13 142.28 51.35 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.354 -2.091 . . . . 74.030000000000001 105.354 171.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.44 143.09 50.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.932 -0.707 . . . . 53.329999999999998 111.748 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.68 174.48 11.09 Favored Glycine 0 C--O 1.243 0.694 0 CA-C-N 116.026 -0.534 . . . . 75.120000000000005 113.826 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.414 ' HB3' HD22 ' A' ' 139' ' ' ASN . . . -63.96 5.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.593 1.331 . . . . 65.329999999999998 114.593 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.12 -10.18 34.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.365 -0.976 . . . . 71.030000000000001 108.365 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.74 88.16 Favored Glycine 0 CA--C 1.507 -0.434 0 CA-C-N 115.502 -0.772 . . . . 33.130000000000003 111.534 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -140.62 151.31 44.53 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 106.486 -1.672 . . . . 62.420000000000002 106.486 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.645 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -66.75 113.02 4.54 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.86 -0.422 . . . . 70.329999999999998 109.86 -173.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -140.52 -173.34 13.36 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 116.29 -0.414 . . . . 73.030000000000001 112.696 -174.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -139.8 127.84 3.72 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.333 -0.937 . . . . 42.109999999999999 111.782 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 74.2 m 178.81 -177.98 0.29 Allowed 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 128.38 2.672 . . . . 60.219999999999999 105.07 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.14 -54.0 47.31 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.862 1.21 . . . . 71.019999999999996 111.454 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.414 HD22 ' HB3' ' A' ' 130' ' ' ALA . 3.1 p-10 -105.12 -14.63 15.33 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.629 -0.829 . . . . 74.329999999999998 112.468 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 16.7 m-20 -95.31 9.37 40.08 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.774 -0.77 . . . . 73.329999999999998 111.21 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -87.41 155.08 20.18 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 109.059 -0.719 . . . . 61.229999999999997 109.059 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 42.1 m-20 -79.26 124.09 28.05 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.09 -1.818 . . . . 74.230000000000004 106.09 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.19 120.82 46.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 CA-C-N 115.956 -0.565 . . . . 73.239999999999995 109.95 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.28 177.54 40.61 Favored Glycine 0 N--CA 1.412 -2.964 0 C-N-CA 119.348 -1.406 . . . . 63.43 112.878 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -162.02 158.67 25.35 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.112 -1.81 . . . . 73.129999999999995 106.112 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 5.4 p90 -168.94 177.57 4.9 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.429 0.633 . . . . 65.400000000000006 112.623 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -109.88 121.61 45.62 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.611 -1.626 . . . . 74.040000000000006 106.611 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.305 -1.342 0 O-C-N 124.24 0.962 . . . . 71.400000000000006 110.557 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 N-CA-C 106.135 -1.802 . . . . 74.230000000000004 106.135 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -113.47 83.38 1.83 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.828 0.677 . . . . 73.310000000000002 112.828 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -153.22 165.83 16.82 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.088 -1.449 . . . . 75.049999999999997 107.088 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -49.24 139.35 27.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.55 2.167 . . . . 73.120000000000005 111.043 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.15 -49.0 0.53 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.258 1.423 . . . . 61.210000000000001 110.0 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' OE1' ' HB3' ' A' ' 138' ' ' ASP . 74.8 mm-40 -68.52 -23.36 64.53 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.419 -1.264 . . . . 75.209999999999994 110.166 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.09 -26.37 68.19 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.504 0.722 . . . . 71.230000000000004 110.579 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -85.46 -24.19 27.51 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.39 -0.596 . . . . 72.030000000000001 109.39 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.18 -42.18 51.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.955 -0.757 . . . . 53.009999999999998 108.955 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.7 t -67.84 -25.88 65.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.471 -0.786 . . . . 73.430000000000007 112.387 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.8 -37.79 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 119.609 -0.836 . . . . 74.409999999999997 109.462 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -58.73 -33.93 70.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.252 1.021 . . . . 63.240000000000002 111.505 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 73.7 mmtt -65.44 -26.15 67.83 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.801 0.81 . . . . 73.040000000000006 110.217 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.56 -33.31 10.34 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.378 -1.089 . . . . 71.200000000000003 110.378 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 33.1 m-20 -71.95 -33.7 68.4 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.999 0.428 . . . . 61.210000000000001 111.718 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.466 HD12 ' C ' ' A' ' 144' ' ' GLY . 11.5 pt -68.04 -34.09 64.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.8 -0.36 . . . . 54.340000000000003 110.28 172.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 14.0 mptt -65.76 -29.79 70.34 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.997 0.427 . . . . 52.0 110.787 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.48 -40.42 93.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 44.439999999999998 110.011 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.405 HG12 ' HG ' ' A' ' 100' ' ' LEU . 70.3 mt -67.15 -34.31 68.67 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-N 115.191 -0.913 . . . . 73.409999999999997 110.627 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . . . -59.68 -35.63 74.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.944 0.402 . . . . 63.450000000000003 110.448 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.86 -31.9 63.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.298 0.571 . . . . 51.200000000000003 109.903 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.02 -28.3 43.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.801 -0.636 . . . . 64.230000000000004 110.601 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.79 -31.15 69.95 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.361 -1.348 . . . . 75.430000000000007 107.361 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.7 m-20 -72.79 -18.26 61.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.72 -0.673 . . . . 70.109999999999999 110.353 171.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.7 mtm -84.26 -31.16 25.1 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 121.995 -0.441 . . . . 74.109999999999999 111.632 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.64 -37.11 70.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.07 -1.456 . . . . 72.420000000000002 107.07 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.582 ' HD2' ' CE1' ' A' ' 71' ' ' TYR . 86.0 tttt -54.94 -31.28 60.29 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.733 -1.121 . . . . 75.25 109.605 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.5 tp -83.5 -35.41 24.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.479 -0.782 . . . . 73.450000000000003 110.531 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 23.6 t70 -78.49 -25.55 45.74 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.209 0.448 . . . . 65.400000000000006 112.209 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.569 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.9 OUTLIER -125.94 22.35 7.39 Favored 'General case' 0 CA--C 1.461 -2.457 0 O-C-N 121.398 -0.814 . . . . 55.340000000000003 110.881 175.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 p90 43.18 34.16 0.65 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.858 1.263 . . . . 63.310000000000002 113.703 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.7 161.3 0.67 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.664 -1.236 . . . . 71.540000000000006 107.664 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.582 ' CE1' ' HD2' ' A' ' 65' ' ' LYS . 12.3 m-85 -75.9 161.47 75.58 Favored Pre-proline 0 C--N 1.309 -1.172 0 O-C-N 123.367 0.417 . . . . 73.540000000000006 111.717 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.532 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 1.7 Cg_endo -78.44 164.11 26.58 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.226 1.951 . . . . 73.439999999999998 109.363 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 p -97.78 156.43 16.57 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.931 -1.877 . . . . 51.009999999999998 105.931 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -4.12 31.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.13 -1.428 . . . . 53.5 111.051 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -102.8 -67.65 0.87 Allowed 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.772 -0.649 . . . . 75.109999999999999 109.648 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -80.58 -34.99 34.88 Favored 'General case' 0 CA--C 1.487 -1.481 0 CA-C-N 115.973 -0.558 . . . . 71.239999999999995 111.468 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.568 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.34 -20.51 78.78 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 118.225 -1.941 . . . . 71.349999999999994 112.696 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.97 -50.86 37.63 Favored 'General case' 0 C--O 1.26 1.606 0 N-CA-C 107.53 -1.285 . . . . 62.450000000000003 107.53 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 8.5 pt-20 -65.19 -28.25 69.26 Favored 'General case' 0 C--O 1.17 -3.09 0 CA-C-N 114.866 -1.061 . . . . 73.409999999999997 109.824 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.526 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.44 -6.16 52.44 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.629 0.603 . . . . 60.130000000000003 112.629 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 95.5 mt -95.38 -19.43 19.93 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.161 0.505 . . . . 54.450000000000003 110.014 172.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.5 t -98.53 -39.43 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.565 1.174 . . . . 64.219999999999999 110.715 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 25.1 tttm -121.29 148.3 44.49 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 127.521 2.328 . . . . 70.430000000000007 107.659 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -56.76 132.84 78.66 Favored Pre-proline 0 N--CA 1.475 0.775 0 O-C-N 123.141 0.275 . . . . 72.239999999999995 111.542 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.426 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 37.6 Cg_endo -63.44 128.74 23.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 123.327 2.684 . . . . 74.310000000000002 112.096 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -90.99 105.5 17.87 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.5 -0.773 . . . . 75.329999999999998 110.238 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.27 7.69 Favored Glycine 0 N--CA 1.418 -2.528 0 N-CA-C 109.906 -1.278 . . . . 73.120000000000005 109.906 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -118.62 88.2 33.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.936 0.368 . . . . 74.150000000000006 110.902 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.569 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 13.8 Cg_endo -92.69 159.4 2.86 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.707 1.605 . . . . 63.119999999999997 109.438 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -88.21 159.12 48.47 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.047 -0.723 . . . . 74.420000000000002 109.047 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.39 99.21 0.2 Allowed 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 121.692 1.595 . . . . 74.540000000000006 111.427 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.594 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.55 148.25 28.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.899 -1.889 . . . . 72.049999999999997 105.899 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.594 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 51.3 m-80 -65.48 91.36 0.12 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 122.373 -0.204 . . . . 74.439999999999998 111.503 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.507 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 84.2 t90 -66.6 140.27 57.93 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.483 -0.562 . . . . 72.340000000000003 109.483 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -127.95 134.47 49.31 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.811 -0.811 . . . . 55.409999999999997 108.811 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 65.3 pttt -75.58 -169.36 1.02 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.319 -0.993 . . . . 52.539999999999999 108.319 174.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.426 ' HB2' ' HG3' ' A' ' 96' ' ' LYS . 27.7 t70 67.64 15.3 9.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.973 0.892 . . . . 71.319999999999993 110.819 169.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 102.95 9.79 38.86 Favored Glycine 0 CA--C 1.495 -1.214 0 CA-C-N 114.995 -1.002 . . . . 72.430000000000007 113.855 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.2 OUTLIER 61.88 92.37 0.06 Allowed 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 122.085 0.945 . . . . 74.340000000000003 109.601 -173.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 101' ' ' LYS . 2.7 tt -128.91 155.63 44.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.014 -1.847 . . . . 72.540000000000006 106.014 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' H ' HD23 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.97 -171.93 0.35 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.053 -0.351 . . . . 64.25 110.053 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 28.81 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.797 1.036 . . . . 63.130000000000003 113.797 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.41 147.99 35.55 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 109.296 -0.631 . . . . 74.230000000000004 109.296 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.98 -167.96 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.975 2.45 . . . . 71.129999999999995 111.897 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.608 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.0 175.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.417 -0.957 . . . . 64.239999999999995 108.417 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.571 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.7 t70 -78.73 159.92 73.04 Favored Pre-proline 0 C--O 1.256 1.44 0 CA-C-N 119.081 0.855 . . . . 72.120000000000005 109.173 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.571 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 4.0 Cg_endo -49.05 170.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 123.551 2.834 . . . . 53.420000000000002 113.242 173.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 66.71 14.56 9.83 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.437 1.895 . . . . 72.209999999999994 110.931 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 -0.65 34.86 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.804 -0.635 . . . . 50.210000000000001 114.002 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.9 135.45 87.6 Favored Pre-proline 0 C--O 1.263 1.791 0 CA-C-O 121.451 0.643 . . . . 74.340000000000003 112.077 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.608 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 92.2 Cg_endo -80.22 154.12 21.82 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 C-N-CA 122.118 1.879 . . . . 73.430000000000007 110.035 174.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -74.4 143.17 44.9 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.651 -1.24 . . . . 73.310000000000002 107.651 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -102.18 113.89 27.56 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 104.656 -2.35 . . . . 74.340000000000003 104.656 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.56 118.21 36.49 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.988 -1.006 . . . . 70.319999999999993 111.882 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 87.8 mt -129.11 144.19 51.12 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.107 -0.951 . . . . 62.030000000000001 109.242 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -101.59 -177.0 0.5 Allowed Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 104.404 -2.443 . . . . 75.209999999999994 104.404 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 Cg_endo -47.78 108.51 0.17 Allowed 'Trans proline' 0 C--N 1.385 2.491 0 CA-C-N 123.179 2.171 . . . . 53.32 113.015 -168.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -106.82 -86.12 1.84 Allowed Glycine 0 N--CA 1.405 -3.394 0 CA-C-N 114.46 -1.246 . . . . 53.350000000000001 112.051 -175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 m -96.26 95.53 8.16 Favored 'General case' 0 N--CA 1.406 -2.655 0 C-N-CA 118.448 -1.301 . . . . 63.009999999999998 109.836 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 66.25 4.45 3.17 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 125.418 1.487 . . . . 73.230000000000004 114.579 171.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -139.88 144.94 15.71 Favored Glycine 0 CA--C 1.491 -1.415 0 C-N-CA 118.73 -1.7 . . . . 70.420000000000002 114.112 -174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.5 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 33.5 Cg_exo -38.61 -27.08 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.131 1 C-N-CA 127.163 5.242 . . . . 54.420000000000002 117.992 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -173.2 146.71 1.47 Allowed 'General case' 0 C--O 1.249 1.039 0 CA-C-N 119.071 0.85 . . . . 74.299999999999997 111.859 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.2 m-20 -118.48 106.61 12.86 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.142 -1.429 . . . . 62.549999999999997 107.142 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.3 129.52 46.45 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 120.886 -1.134 . . . . 72.0 110.76 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -165.21 166.46 18.88 Favored 'General case' 0 C--O 1.194 -1.832 0 CA-C-N 116.845 -0.161 . . . . 73.239999999999995 111.251 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.0 t -125.28 139.94 53.27 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 63.109999999999999 105.649 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.13 155.29 20.91 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.914 1.079 . . . . 74.120000000000005 113.914 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.75 165.15 37.76 Favored Glycine 0 CA--C 1.49 -1.473 0 N-CA-C 110.774 -0.931 . . . . 71.409999999999997 110.774 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.46 -24.01 4.56 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 115.924 1.824 . . . . 65.099999999999994 115.924 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.27 -1.72 28.34 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.575 -0.703 . . . . 74.019999999999996 111.603 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.49 38.49 5.0 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.466 -0.873 . . . . 72.219999999999999 113.813 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -130.34 147.84 52.1 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.305 -0.628 . . . . 72.109999999999999 109.305 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 9.4 pt-20 -101.89 105.46 16.28 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.077 -1.453 . . . . 74.010000000000005 107.077 167.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.18 -173.73 21.39 Favored Glycine 0 C--N 1.29 -1.991 0 N-CA-C 110.395 -1.082 . . . . 54.329999999999998 110.395 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.91 129.78 10.01 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.687 -1.365 . . . . 45.329999999999998 109.687 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.56 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.9 t 179.59 -178.39 0.38 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.735 -1.58 . . . . 70.219999999999999 106.735 -172.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.447 ' HB3' ' OE1' ' A' ' 44' ' ' GLN . 4.3 m-20 -87.26 -66.8 0.87 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.345 -0.613 . . . . 74.349999999999994 109.345 173.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.83 -30.73 14.67 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.928 -1.033 . . . . 74.430000000000007 111.908 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.76 17.88 16.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.649 0.738 . . . . 70.040000000000006 110.907 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.56 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -100.67 155.75 17.71 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-N 114.943 -1.026 . . . . 71.109999999999999 109.554 176.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.516 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.8 p-10 -79.13 135.06 36.72 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.397 -1.334 . . . . 65.230000000000004 107.397 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.59 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -104.18 123.64 58.11 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-N 115.728 -0.669 . . . . 75.239999999999995 109.623 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.466 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -159.29 179.81 34.63 Favored Glycine 0 N--CA 1.412 -2.911 0 C-N-CA 118.878 -1.63 . . . . 24.440000000000001 112.702 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.521 ' OD1' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -137.5 150.4 47.52 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 105.774 -1.935 . . . . 61.439999999999998 105.774 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -143.87 144.54 31.79 Favored 'General case' 0 C--N 1.267 -3.013 0 C-N-CA 119.269 -0.972 . . . . 72.120000000000005 110.003 -165.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -127.38 95.68 4.34 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.87 -1.53 . . . . 65.450000000000003 106.87 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.6 t30 . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 113.816 -1.538 . . . . 72.219999999999999 107.676 -176.725 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.571 ' N ' ' HG1' ' A' ' 48' ' ' THR . 11.8 ttt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.55 -1.278 . . . . 71.140000000000001 107.55 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.9 m -104.94 86.66 2.49 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.902 0.704 . . . . 71.430000000000007 112.902 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -153.77 159.75 31.72 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.184 -1.413 . . . . 73.420000000000002 107.184 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.09 125.55 16.55 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.681 2.254 . . . . 74.340000000000003 111.787 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 75.95 -33.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.779 2.032 . . . . 44.020000000000003 111.55 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HA ' HG23 ' A' ' 47' ' ' VAL . 63.7 mt-30 -70.0 -20.7 63.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.784 0.802 . . . . 55.420000000000002 109.217 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.85 64.29 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.715 -1.13 . . . . 72.019999999999996 110.13 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 91.6 mttt -89.25 -25.08 21.9 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.766 -0.827 . . . . 71.549999999999997 108.766 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' A' ' 44' ' ' GLN . 44.9 t -74.39 -43.89 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 108.34 -0.985 . . . . 73.230000000000004 108.34 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.571 ' HG1' ' N ' ' A' ' 39' ' ' MET . 12.0 t -66.26 -29.59 69.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.403 -1.271 . . . . 73.25 111.831 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -83.87 -33.75 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.039 -0.665 . . . . 71.099999999999994 110.248 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' A' ' 143' ' ' ILE . . . -71.95 -34.27 68.86 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.752 -0.658 . . . . 73.140000000000001 111.587 -176.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.624 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 57.2 mtpt -70.39 -25.45 63.25 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.769 -0.772 . . . . 73.120000000000005 111.97 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.06 -26.21 45.6 Favored Glycine 0 C--O 1.246 0.88 0 N-CA-C 109.495 -1.442 . . . . 53.340000000000003 109.495 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.593 ' O ' HG13 ' A' ' 57' ' ' ILE . 20.7 t70 -77.32 -38.38 50.57 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.265 -0.967 . . . . 61.340000000000003 109.391 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 51' ' ' LYS . 20.3 pt -65.92 -30.39 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 122.202 -0.311 . . . . 73.519999999999996 110.823 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.624 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.2 mptm? -71.08 -27.3 63.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.571 -0.452 . . . . 72.129999999999995 110.277 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -69.92 -48.87 56.82 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.568 -0.742 . . . . 60.420000000000002 110.243 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.65 ' HB ' HD21 ' A' ' 125' ' ' LEU . 30.6 mt -61.06 -42.6 93.77 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 115.192 -0.913 . . . . 73.010000000000005 108.985 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -28.91 68.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.502 . . . . 61.119999999999997 111.876 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.04 -24.21 35.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.512 0.672 . . . . 73.140000000000001 109.606 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 -27.05 29.76 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.754 -0.832 . . . . 51.549999999999997 108.754 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -68.77 -31.14 69.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.211 -1.403 . . . . 73.530000000000001 107.211 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.3 m-20 -68.92 -24.25 64.27 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.911 -0.586 . . . . 72.299999999999997 110.007 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 mmt -78.35 -34.98 48.06 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 120.889 -0.324 . . . . 71.120000000000005 111.305 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.551 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 58.7 t80 -69.8 -36.66 75.87 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.55 -1.278 . . . . 72.010000000000005 107.55 174.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.56 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 80.9 tttt -54.34 -35.36 62.64 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 114.876 -1.056 . . . . 72.409999999999997 110.485 173.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 95.6 mt -87.0 -29.09 22.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 111.317 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t70 -78.2 -24.37 47.16 Favored 'General case' 0 C--O 1.201 -1.451 0 CA-C-O 120.632 0.253 . . . . 72.25 111.383 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -128.99 24.38 5.64 Favored 'General case' 0 CA--C 1.469 -2.14 0 N-CA-C 109.175 -0.676 . . . . 74.400000000000006 109.175 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.6 p90 42.97 31.44 0.33 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 126.131 1.772 . . . . 70.420000000000002 114.736 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.41 162.33 0.51 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.66 -1.237 . . . . 73.530000000000001 107.66 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.4 m-85 -76.6 153.57 83.54 Favored Pre-proline 0 C--N 1.296 -1.739 0 C-N-CA 120.252 -0.579 . . . . 63.119999999999997 110.274 173.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 20.8 Cg_endo -61.98 164.37 16.94 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 123.28 2.653 . . . . 42.530000000000001 110.904 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.428 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 37.8 p -95.05 155.36 16.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.354 -1.721 . . . . 64.5 106.354 173.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.608 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -69.05 -12.8 62.01 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 119.837 1.199 . . . . 61.310000000000002 110.503 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -102.48 -65.24 1.0 Allowed 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.938 -1.028 . . . . 75.150000000000006 110.746 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -84.79 -29.23 25.58 Favored 'General case' 0 CA--C 1.478 -1.797 0 O-C-N 121.885 -0.509 . . . . 74.450000000000003 111.387 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.53 -20.79 79.46 Favored Glycine 0 N--CA 1.411 -3.022 0 C-N-CA 119.202 -1.475 . . . . 64.140000000000001 111.818 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.46 -46.14 70.58 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.226 -1.768 . . . . 72.420000000000002 106.226 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.96 -21.66 66.43 Favored 'General case' 0 C--O 1.17 -3.103 0 CA-C-N 114.762 -1.108 . . . . 74.140000000000001 110.814 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.693 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -89.89 -4.22 57.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.656 0.741 . . . . 71.349999999999994 111.351 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.455 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 4.7 mp -99.51 -21.21 16.03 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.521 -0.763 . . . . 61.130000000000003 110.086 174.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 35.9 t -108.01 -30.97 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 115.985 -0.552 . . . . 73.450000000000003 110.737 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.7 mptp? -122.57 150.5 42.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.018 1.327 . . . . 71.049999999999997 107.978 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -54.9 135.71 66.23 Favored Pre-proline 0 N--CA 1.48 1.05 0 CA-C-N 118.405 0.548 . . . . 72.409999999999997 111.351 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.551 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 13.5 Cg_endo -53.04 153.09 16.51 Favored 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 124.633 3.556 . . . . 75.439999999999998 114.1 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 p -98.96 132.49 44.24 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.788 -0.642 . . . . 62.520000000000003 109.844 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.79 -137.38 14.26 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.903 -1.279 . . . . 71.430000000000007 109.903 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -129.7 105.85 17.09 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 117.362 0.581 . . . . 73.019999999999996 110.364 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -85.54 162.94 10.94 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.072 1.848 . . . . 74.349999999999994 108.979 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.14 156.69 46.22 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.446 -0.946 . . . . 71.340000000000003 108.446 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -58.45 98.76 0.1 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.583 2.189 . . . . 73.099999999999994 116.08 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 66' ' ' LEU . 67.5 mttm -151.32 148.52 28.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.545 1.938 . . . . 70.239999999999995 107.757 172.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -82.13 97.35 8.15 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.815 -0.354 . . . . 64.439999999999998 110.304 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.543 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.2 t90 -54.68 142.74 27.32 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.554 1.142 . . . . 65.540000000000006 112.696 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -123.85 136.96 54.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.956 -1.02 . . . . 72.230000000000004 109.212 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -81.09 -163.9 0.67 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 75.319999999999993 108.208 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 61.96 23.61 13.93 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.297 0.639 . . . . 74.409999999999997 110.915 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 78.54 24.41 62.94 Favored Glycine 0 CA--C 1.48 -2.12 0 CA-C-N 114.981 -1.009 . . . . 54.43 112.819 171.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 63.39 78.1 0.3 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 123.136 1.446 . . . . 70.0 109.138 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.438 HD12 HG12 ' A' ' 57' ' ' ILE . 63.0 tp -117.67 166.9 11.86 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.041 -1.89 . . . . 71.319999999999993 107.861 -172.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.64 -174.72 5.43 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 75.129999999999995 109.299 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 35.35 1.03 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.516 1.151 . . . . 63.240000000000002 110.395 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.04 149.07 40.34 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 113.804 -1.543 . . . . 54.100000000000001 108.842 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.29 177.08 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.483 2.789 . . . . 74.540000000000006 113.835 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.571 HG21 ' HA ' ' A' ' 111' ' ' PRO . 5.1 p -79.39 175.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.41 -0.814 . . . . 75.510000000000005 109.066 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.3 p-10 -69.89 158.68 86.64 Favored Pre-proline 0 C--O 1.258 1.527 0 N-CA-C 113.496 0.924 . . . . 64.040000000000006 113.496 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.438 ' CB ' ' HB3' ' A' ' 46' ' ' LYS . 50.5 Cg_exo -58.0 171.73 1.51 Allowed 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.815 2.343 . . . . 74.510000000000005 111.47 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.515 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 3.2 m-90 65.94 14.49 9.62 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 125.033 1.333 . . . . 65.510000000000005 108.845 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.66 57.98 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.189 -1.369 . . . . 64.25 115.033 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.547 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 7.5 m-80 -92.91 152.62 41.69 Favored Pre-proline 0 C--O 1.264 1.824 0 CA-C-N 118.947 1.374 . . . . 75.450000000000003 108.573 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.571 ' HA ' HG21 ' A' ' 105' ' ' VAL . 58.8 Cg_endo -82.33 141.06 11.22 Favored 'Trans proline' 0 N--CA 1.425 -2.522 0 C-N-CA 121.32 1.347 . . . . 75.049999999999997 110.579 165.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 31.7 m-85 -68.07 144.76 54.94 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 109.743 -0.466 . . . . 74.409999999999997 109.743 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -102.36 119.3 38.58 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.212 -1.403 . . . . 74.140000000000001 107.212 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -107.77 118.1 35.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.249 -1.389 . . . . 74.329999999999998 107.249 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 95.7 mt -129.23 153.17 48.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.254 -0.647 . . . . 64.200000000000003 109.254 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -117.81 -178.37 0.53 Allowed Pre-proline 0 N--CA 1.414 -2.26 0 CA-C-O 117.319 -1.324 . . . . 72.239999999999995 108.273 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 36.5 Cg_endo -58.36 121.7 10.43 Favored 'Trans proline' 0 CA--C 1.492 -1.601 0 CA-C-N 122.041 1.765 . . . . 73.239999999999995 114.651 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -118.55 -84.03 0.92 Allowed Glycine 0 N--CA 1.418 -2.526 0 CA-C-N 114.266 -1.334 . . . . 40.32 111.021 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.5 m -110.04 107.17 16.94 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 107.906 -1.146 . . . . 73.310000000000002 107.906 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 70.96 -7.7 1.07 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.356 1.613 . . . . 73.310000000000002 115.356 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -132.3 126.6 4.61 Favored Glycine 0 CA--C 1.465 -3.045 0 C-N-CA 116.864 -2.589 . . . . 41.229999999999997 115.587 -171.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.52 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 39.8 Cg_exo -43.93 -23.71 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.168 1 C-N-CA 126.455 4.77 . . . . 64.129999999999995 115.711 176.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.494 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.0 p90 -176.12 169.35 2.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 118.023 0.374 . . . . 73.230000000000004 110.095 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 24.3 m-20 -136.79 112.24 9.27 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.4 -1.333 . . . . 74.019999999999996 107.4 174.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 57' ' ' ILE . 47.5 tp -124.53 126.29 45.59 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.465 -0.494 . . . . 54.409999999999997 109.952 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 31.2 p90 -167.38 168.49 13.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.738 -0.385 . . . . 74.109999999999999 111.261 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.551 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 50.9 p -125.63 146.55 49.66 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.088 -1.078 . . . . 74.219999999999999 108.088 171.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 90.3 mt -66.69 145.38 55.62 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 110.341 -0.244 . . . . 54.340000000000003 110.341 175.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -81.1 -171.03 44.33 Favored Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.163 -1.017 . . . . 73.340000000000003 112.412 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.22 -8.21 5.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.896 1.073 . . . . 43.439999999999998 113.896 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -94.74 -9.71 33.85 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.133 0.492 . . . . 50.140000000000001 109.941 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.9 12.09 84.2 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 111.772 -0.531 . . . . 63.32 111.772 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -140.12 147.74 40.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.446 0.699 . . . . 73.129999999999995 109.17 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -81.72 114.3 20.28 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.29 0.567 . . . . 74.219999999999999 111.021 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.04 -174.23 21.1 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.216 -1.154 . . . . 55.399999999999999 110.216 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.18 126.63 8.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.639 -1.267 . . . . 73.519999999999996 110.078 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.487 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 39.3 m 177.92 -177.27 0.21 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.808 2.043 . . . . 70.420000000000002 106.134 -172.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.45 -69.55 0.68 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 118.771 -1.172 . . . . 75.239999999999995 112.388 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -91.17 -21.99 20.88 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.126 0.489 . . . . 74.109999999999999 111.504 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.81 -6.72 59.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.125 0.488 . . . . 73.540000000000006 110.673 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -92.92 156.68 16.78 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.376 -0.829 . . . . 63.109999999999999 111.505 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -78.85 118.4 20.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.635 -1.246 . . . . 73.540000000000006 107.635 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.6 pp -96.7 132.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.583 0 N-CA-C 108.525 -0.917 . . . . 72.230000000000004 108.525 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.0 176.79 42.47 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.248 -1.453 . . . . 73.340000000000003 112.072 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.66 145.98 24.78 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.477 -1.305 . . . . 71.200000000000003 107.477 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 7.4 p90 -161.35 175.47 12.2 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 116.072 -0.513 . . . . 75.420000000000002 110.477 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -113.61 122.62 47.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.921 -1.881 . . . . 63.409999999999997 105.921 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.305 -1.335 0 C-N-CA 124.587 1.155 . . . . 73.019999999999996 108.346 -178.501 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.633 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 20.1 mmt . . . . . 0 CA--C 1.505 -0.782 0 N-CA-C 110.467 -0.198 . . . . 70.310000000000002 110.467 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 m -107.29 73.79 0.94 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.054 0.454 . . . . 70.200000000000003 109.892 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -155.16 151.77 23.58 Favored Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 124.018 0.927 . . . . 74.230000000000004 109.42 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.87 131.42 38.2 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.534 2.823 . . . . 74.409999999999997 112.632 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 77.02 -36.14 0.24 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.321 2.249 . . . . 74.109999999999999 110.898 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.633 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.5 mm100 -68.92 -24.11 64.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.47 0.652 . . . . 71.010000000000005 109.569 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -66.77 -27.1 67.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.472 -0.786 . . . . 74.109999999999999 109.543 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 98.1 mttt -79.19 -26.13 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.228 -0.656 . . . . 74.299999999999997 109.228 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.8 -43.15 46.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.292 -0.867 . . . . 73.219999999999999 109.139 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -69.87 -33.03 71.7 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.1 -0.954 . . . . 52.119999999999997 111.592 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 45' ' ' ALA . 11.2 m -73.92 -31.93 32.22 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 C-N-CA 119.361 -0.936 . . . . 45.200000000000003 109.694 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -68.25 -40.28 82.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.793 -0.639 . . . . 42.43 110.408 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 96.2 mttt -69.95 -25.29 63.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.408 0.623 . . . . 74.329999999999998 111.561 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.6 -27.74 46.0 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 109.944 -1.262 . . . . 63.109999999999999 109.944 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.596 ' O ' HG13 ' A' ' 57' ' ' ILE . 5.2 t70 -73.99 -42.63 60.13 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.397 -0.902 . . . . 74.319999999999993 109.014 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.2 pt -63.93 -28.86 45.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 63.520000000000003 110.782 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 5.5 mptp? -70.74 -30.6 67.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.027 0.441 . . . . 72.019999999999996 110.346 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.73 -44.13 70.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 54.310000000000002 109.741 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 53' ' ' ASP . 36.8 mt -65.17 -39.77 86.6 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 CA-C-N 115.126 -0.943 . . . . 74.439999999999998 109.983 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.76 -31.56 66.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.345 -0.389 . . . . 73.239999999999995 111.007 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.24 46.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.222 0.534 . . . . 52.240000000000002 109.798 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.45 -26.64 38.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.019 -0.537 . . . . 70.430000000000007 109.917 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -30.44 69.98 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.132 -1.433 . . . . 70.349999999999994 107.132 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 68.9 m-20 -72.66 -18.54 61.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.484 -0.78 . . . . 75.430000000000007 109.817 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 mmt -82.11 -35.23 28.76 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.772 -0.649 . . . . 73.030000000000001 109.559 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.4 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 82.7 t80 -68.58 -34.71 76.27 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.386 -1.338 . . . . 71.040000000000006 107.386 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.628 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 85.9 tttt -55.87 -30.39 61.43 Favored 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 114.597 -1.183 . . . . 71.019999999999996 110.026 173.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.18 -34.41 20.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.804 0.298 . . . . 70.430000000000007 111.804 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.14 -23.74 61.35 Favored 'General case' 0 C--O 1.196 -1.763 0 CA-C-O 120.677 0.275 . . . . 61.350000000000001 111.273 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -129.51 20.56 5.64 Favored 'General case' 0 CA--C 1.452 -2.794 0 O-C-N 121.927 -0.483 . . . . 52.100000000000001 111.839 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 p90 42.69 32.68 0.4 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.87 1.356 . . . . 72.340000000000003 113.693 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.93 161.41 1.18 Allowed 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.898 -1.149 . . . . 72.439999999999998 107.898 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.628 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 25.3 m-85 -79.33 159.48 72.45 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 123.287 0.367 . . . . 61.109999999999999 111.557 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 58.3 Cg_endo -71.56 160.41 48.42 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.531 2.154 . . . . 75.299999999999997 112.377 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 52.6 p -96.28 155.33 16.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.232 -2.136 . . . . 74.430000000000007 105.232 171.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.48 -9.54 54.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 119.156 0.889 . . . . 64.510000000000005 110.777 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -102.7 -67.04 0.89 Allowed 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.737 -0.665 . . . . 71.409999999999997 110.629 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -81.56 -38.37 26.25 Favored 'General case' 0 CA--C 1.477 -1.837 0 C-N-CA 120.32 -0.552 . . . . 63.240000000000002 111.298 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 81' ' ' LEU . . . -71.95 -20.6 78.96 Favored Glycine 0 N--CA 1.412 -2.919 0 C-N-CA 118.395 -1.86 . . . . 72.409999999999997 112.141 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.33 -47.0 53.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.539 -1.282 . . . . 63.509999999999998 107.539 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -65.02 -31.06 72.11 Favored 'General case' 0 C--O 1.189 -2.107 0 CA-C-N 115.643 -0.708 . . . . 72.340000000000003 110.606 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -82.63 -5.12 58.64 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.186 0.517 . . . . 62.310000000000002 111.992 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.57 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 13.7 tp -96.33 -24.56 16.12 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.203 -1.036 . . . . 73.329999999999998 108.203 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.95 -38.14 5.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.135 -0.939 . . . . 73.409999999999997 110.751 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 61.9 mtpt -124.2 151.98 43.44 Favored 'General case' 0 C--O 1.204 -1.342 0 C-N-CA 125.552 1.541 . . . . 74.299999999999997 108.126 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -54.57 127.67 59.55 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 113.324 0.861 . . . . 74.109999999999999 113.324 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.7 123.07 12.91 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.97 3.78 . . . . 61.109999999999999 115.797 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -99.57 115.12 28.66 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.13 -1.395 . . . . 71.120000000000005 108.35 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 150.8 -116.76 0.79 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.091 -1.604 . . . . 41.299999999999997 109.091 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -137.65 90.97 14.19 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 117.558 0.679 . . . . 72.030000000000001 110.64 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.53 162.88 0.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.637 2.225 . . . . 73.420000000000002 112.448 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.251 0.6 OUTLIER -110.16 132.22 21.58 Favored Pre-proline 0 C--N 1.261 -3.261 0 CA-C-N 112.89 -1.959 . . . . 71.25 106.502 -171.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.91 99.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.688 2.925 . . . . 55.299999999999997 114.271 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -152.15 149.36 28.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.41 -1.7 . . . . 73.129999999999995 106.41 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.83 99.28 2.61 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 118.697 0.68 . . . . 72.319999999999993 111.201 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.512 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.5 t90 -61.97 144.11 55.55 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 125.028 1.331 . . . . 64.310000000000002 111.652 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.29 134.06 54.1 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.722 -0.672 . . . . 72.329999999999998 109.291 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.85 176.06 8.17 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.935 0.874 . . . . 61.450000000000003 111.354 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 57.78 28.97 16.71 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.436 -1.711 . . . . 74.340000000000003 112.858 168.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.57 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 120.65 -4.81 11.8 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.277 -1.439 . . . . 63.439999999999998 115.36 168.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.93 93.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.368 1.08 . . . . 74.400000000000006 109.411 -169.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -131.76 170.1 15.29 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.224 -2.139 . . . . 64.439999999999998 105.224 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.526 ' H ' HD23 ' A' ' 100' ' ' LEU . 96.4 mttt -88.93 -165.02 1.23 Allowed 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.725 -1.213 . . . . 63.509999999999998 107.725 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.23 32.54 0.45 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.893 0.854 . . . . 73.209999999999994 112.231 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 101' ' ' LYS . 11.3 mp -94.77 149.61 36.67 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 125.028 1.331 . . . . 71.329999999999998 109.463 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.84 -167.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 123.643 2.895 . . . . 64.409999999999997 113.735 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.5 p -101.28 176.12 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.813 -1.18 . . . . 70.420000000000002 107.813 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.43 144.87 95.0 Favored Pre-proline 0 C--O 1.255 1.384 0 CA-C-N 118.705 0.684 . . . . 73.340000000000003 111.29 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 8.7 Cg_endo -51.39 171.78 0.13 Allowed 'Trans proline' 0 C--O 1.195 -1.633 0 C-N-CA 123.79 2.993 . . . . 73.019999999999996 112.597 174.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.435 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.2 m-90 62.54 14.97 7.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.921 1.289 . . . . 75.340000000000003 109.471 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.37 12.97 77.13 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 116.401 1.32 . . . . 44.009999999999998 116.401 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.435 ' ND2' ' HE3' ' A' ' 108' ' ' TRP . 14.9 m-80 -78.64 125.03 85.04 Favored Pre-proline 0 C--O 1.256 1.433 0 CA-C-N 120.15 1.975 . . . . 54.509999999999998 111.482 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.541 ' HA ' HG21 ' A' ' 105' ' ' VAL . 39.4 Cg_exo -67.53 146.71 74.97 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.093 1.862 . . . . 75.420000000000002 108.734 167.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.59 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 54.2 m-85 -68.93 145.33 53.74 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.381 0.61 . . . . 74.140000000000001 112.122 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.4 ' CD ' HD13 ' A' ' 128' ' ' LEU . 2.5 mm100 -101.85 118.23 36.48 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.555 -2.017 . . . . 71.329999999999998 105.555 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.53 118.64 35.67 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.708 -0.678 . . . . 75.209999999999994 111.958 -177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -129.81 154.0 47.69 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.294 -0.866 . . . . 62.109999999999999 109.838 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.809 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -101.76 -177.26 0.53 Allowed Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-O 116.572 -1.68 . . . . 64.409999999999997 107.817 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.809 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 10.1 Cg_endo -40.56 112.3 0.17 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.585 2.857 . . . . 63.030000000000001 115.48 -164.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.89 -88.51 1.12 Allowed Glycine 0 N--CA 1.421 -2.344 0 CA-C-N 114.338 -1.301 . . . . 72.140000000000001 111.725 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.9 m -108.07 95.76 5.9 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 108.456 -0.942 . . . . 62.409999999999997 108.456 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 65.6 -6.16 0.43 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.159 1.384 . . . . 71.0 113.329 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -111.41 127.0 7.97 Favored Glycine 0 N--CA 1.423 -2.23 0 CA-C-O 118.749 -1.028 . . . . 34.009999999999998 113.336 -174.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.598 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -35.07 -23.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.48 1 C-N-CA 127.339 5.36 . . . . 62.210000000000001 118.778 179.97 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 54.4 p90 -166.21 171.59 12.09 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 119.593 1.088 . . . . 72.129999999999995 112.042 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.86 106.57 6.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.009 0.924 . . . . 71.329999999999998 108.889 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.39 128.3 52.07 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.686 -0.857 . . . . 33.340000000000003 108.686 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.417 ' HB3' ' HA3' ' A' ' 144' ' ' GLY . 42.0 p90 -166.91 168.1 14.26 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 110.298 -0.26 . . . . 73.120000000000005 110.298 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.59 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 13.1 t -125.64 154.35 42.45 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.893 -1.521 . . . . 63.100000000000001 106.893 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.4 HD13 ' CD ' ' A' ' 113' ' ' GLN . 7.5 mp -72.17 157.45 37.72 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.839 -0.344 . . . . 74.340000000000003 111.534 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.17 -169.94 29.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.235 -0.983 . . . . 42.329999999999998 112.999 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.03 -21.84 66.44 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.134 0.79 . . . . 73.040000000000006 113.134 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -94.43 -2.47 51.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.65 0.738 . . . . 71.030000000000001 110.216 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.72 45.68 73.92 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.042 -1.623 . . . . 75.439999999999998 109.042 -174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -135.28 144.34 46.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.849 -1.167 . . . . 73.450000000000003 107.849 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 142' ' ' ASP 0.253 0.5 OUTLIER -102.86 106.7 17.33 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 121.982 0.896 . . . . 72.200000000000003 111.014 173.971 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.01 -173.34 20.26 Favored Glycine 0 C--N 1.294 -1.793 0 N-CA-C 111.066 -0.813 . . . . 64.030000000000001 111.066 -177.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -111.77 125.61 7.31 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 107.727 -2.149 . . . . 25.199999999999999 107.727 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.536 ' CB ' ' HB3' ' A' ' 140' ' ' ASP . 74.6 m 179.24 -176.34 0.26 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.897 1.279 . . . . 72.140000000000001 107.898 -167.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.21 -73.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.943 0.401 . . . . 72.450000000000003 110.412 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -107.22 -8.98 16.23 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.554 0.692 . . . . 53.409999999999997 110.12 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 137' ' ' SER . 22.2 t70 -89.65 2.32 54.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 123.073 1.416 . . . . 64.340000000000003 108.871 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.36 155.8 17.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.73 -1.577 . . . . 73.310000000000002 110.595 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.6 p-10 -84.73 122.46 29.13 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.775 -1.935 . . . . 61.210000000000001 105.775 171.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.29 113.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-O 121.982 0.896 . . . . 70.329999999999998 111.142 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 126' ' ' TYR . . . -163.56 -179.8 38.16 Favored Glycine 0 N--CA 1.41 -3.087 0 C-N-CA 119.271 -1.442 . . . . 60.539999999999999 112.917 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.11 158.83 19.73 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.437 -1.32 . . . . 64.340000000000003 107.437 -177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.493 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 9.8 p90 -163.2 177.58 8.93 Favored 'General case' 0 C--N 1.279 -2.467 0 O-C-N 123.657 0.598 . . . . 75.099999999999994 110.629 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -105.33 120.58 41.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.229 -1.396 . . . . 73.209999999999994 107.229 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.298 -1.647 0 O-C-N 125.167 1.542 . . . . 63.030000000000001 106.87 178.842 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 25.7 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.134 0.492 . . . . 65.530000000000001 111.04 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -113.86 62.55 0.65 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.104 -0.702 . . . . 73.209999999999994 109.104 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 25.0 ptt180 -155.58 160.25 30.99 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.347 -0.983 . . . . 75.329999999999998 108.347 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' ARG . 11.9 Cg_exo -28.63 119.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 126.053 4.502 . . . . 70.129999999999995 116.341 -176.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t70 65.33 -37.24 0.23 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 127.605 2.362 . . . . 74.230000000000004 113.912 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 47' ' ' VAL . 92.4 mt-30 -68.76 -19.96 64.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.305 0.574 . . . . 71.219999999999999 110.123 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 39' ' ' MET . . . -64.1 -24.48 67.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.303 -0.862 . . . . 53.100000000000001 109.988 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HB3' ' HG3' ' A' ' 107' ' ' PRO . 89.2 mttt -86.1 -25.0 26.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.019 -0.734 . . . . 63.210000000000001 109.019 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 44' ' ' GLN . 58.0 t -74.25 -44.26 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-N 115.493 -0.776 . . . . 74.450000000000003 109.814 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.3 t -65.7 -36.04 82.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.063 -0.971 . . . . 63.130000000000003 111.512 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 m -74.21 -35.79 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 C-N-CA 119.917 -0.713 . . . . 73.099999999999994 109.74 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -65.24 -32.9 74.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.932 -0.576 . . . . 64.099999999999994 110.378 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 73.7 mmtt -65.63 -25.9 67.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.431 0.634 . . . . 73.340000000000003 110.293 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.59 -31.52 18.44 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 110.595 -1.002 . . . . 55.439999999999998 110.595 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 57' ' ' ILE . 77.2 m-20 -76.53 -33.8 58.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.915 0.388 . . . . 55.240000000000002 110.323 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -67.11 -35.81 75.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.954 -0.387 . . . . 64.019999999999996 109.954 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -66.78 -30.7 70.97 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 120.878 0.371 . . . . 75.299999999999997 110.665 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.35 -45.39 88.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.338 -0.846 . . . . 72.549999999999997 110.046 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 125' ' ' LEU . 64.2 mt -64.81 -38.66 83.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 CA-C-N 115.267 -0.879 . . . . 73.340000000000003 110.161 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.48 68.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.999 0.428 . . . . 62.520000000000003 111.498 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.83 -33.21 27.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.566 0.698 . . . . 73.329999999999998 109.727 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.07 35.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.668 -0.697 . . . . 73.430000000000007 111.108 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -65.12 -30.35 71.28 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.778 -1.193 . . . . 75.140000000000001 107.778 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 18.9 t70 -73.71 -24.62 59.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.527 -0.76 . . . . 64.519999999999996 110.084 174.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.9 mtm -78.56 -25.77 45.45 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.789 -0.569 . . . . 74.150000000000006 110.465 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.465 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 31.1 t80 -72.04 -40.31 68.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.545 -1.65 . . . . 72.239999999999995 106.545 170.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 31.7 tttm -54.25 -37.29 64.5 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.307 -0.86 . . . . 65.109999999999999 110.354 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -73.01 -36.49 67.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.612 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.1 t70 -71.65 -23.46 61.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.327 0.651 . . . . 71.209999999999994 112.192 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.418 HD22 ' C ' ' A' ' 67' ' ' ASP . 0.7 OUTLIER -128.48 20.29 6.18 Favored 'General case' 0 CA--C 1.457 -2.625 0 O-C-N 121.941 -0.474 . . . . 75.129999999999995 110.089 178.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.3 p90 42.9 31.65 0.34 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.118 1.511 . . . . 73.409999999999997 112.63 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.12 161.99 0.46 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.378 -1.341 . . . . 70.019999999999996 107.378 -171.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -74.67 158.96 84.31 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 112.746 0.647 . . . . 75.430000000000007 112.746 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.568 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 49.1 Cg_endo -72.69 159.27 49.01 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 123.164 2.576 . . . . 63.420000000000002 109.776 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.482 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 70.5 p -90.43 156.26 18.34 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.442 -1.318 . . . . 73.120000000000005 107.442 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.646 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 3.2 t -65.86 -17.78 64.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 119.767 1.167 . . . . 75.430000000000007 111.232 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.65 -65.9 0.94 Allowed 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.082 -0.387 . . . . 72.400000000000006 111.706 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.445 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.3 mm-40 -81.3 -32.63 33.04 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 120.959 -0.296 . . . . 74.230000000000004 111.573 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.68 -20.85 79.37 Favored Glycine 0 N--CA 1.408 -3.188 0 C-N-CA 118.958 -1.591 . . . . 71.439999999999998 112.712 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.81 -46.41 68.71 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.484 -1.672 . . . . 73.409999999999997 106.484 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.16 -14.74 62.37 Favored 'General case' 0 C--O 1.196 -1.739 0 CA-C-N 114.718 -1.128 . . . . 74.049999999999997 111.044 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.632 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -89.84 -8.68 51.44 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.332 0.587 . . . . 61.310000000000002 110.16 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.539 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 88.9 mt -93.08 -22.68 18.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.841 -0.618 . . . . 65.030000000000001 109.634 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.31 -34.96 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 115.885 -0.598 . . . . 63.310000000000002 111.545 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 1.8 tpmt? -122.84 151.23 41.89 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.314 -1.736 . . . . 75.219999999999999 106.314 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -53.67 137.04 53.65 Favored Pre-proline 0 N--CA 1.49 1.542 0 CA-C-N 119.058 0.844 . . . . 73.340000000000003 111.636 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.564 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 17.9 Cg_endo -55.41 137.67 78.06 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 124.558 3.505 . . . . 73.109999999999999 117.071 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 p -89.74 -179.66 5.81 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 112.927 -1.942 . . . . 70.450000000000003 107.558 173.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 -131.15 13.22 Favored Glycine 0 C--O 1.249 1.042 0 C-N-CA 119.72 -1.229 . . . . 62.229999999999997 110.423 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -135.93 89.98 19.81 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 112.372 0.508 . . . . 65.310000000000002 112.372 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 96.7 Cg_endo -91.95 163.25 3.28 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.784 2.323 . . . . 70.109999999999999 109.523 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -99.86 158.63 31.75 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 108.477 -0.934 . . . . 75.239999999999995 108.477 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.83 99.28 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.038 1.826 . . . . 72.030000000000001 110.622 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . 12.7 tmtt? -151.49 147.39 26.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.025 -1.472 . . . . 75.040000000000006 107.025 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.554 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 38.1 m-80 -63.34 89.52 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.025 0.75 . . . . 74.109999999999999 113.025 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.564 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 84.1 t90 -66.08 144.6 56.6 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.763 1.625 . . . . 73.329999999999998 111.326 175.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.53 130.39 52.36 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.359 -0.608 . . . . 63.100000000000001 109.359 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.448 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 62.5 pttt -83.3 -171.55 3.64 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 119.465 -0.894 . . . . 65.450000000000003 108.723 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.1 t0 66.27 28.72 9.86 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.243 1.021 . . . . 75.409999999999997 108.829 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 91.57 9.13 63.28 Favored Glycine 0 CA--C 1.473 -2.535 0 CA-C-N 114.021 -1.445 . . . . 62.329999999999998 114.114 167.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.7 OUTLIER 61.61 79.46 0.25 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.667 -1.234 . . . . 64.219999999999999 107.667 -172.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.5 tt -124.55 152.3 43.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.678 -1.601 . . . . 71.140000000000001 106.678 -171.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.72 179.71 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.675 -0.861 . . . . 62.240000000000002 108.675 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -80.66 67.08 6.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.386 1.088 . . . . 74.140000000000001 113.738 -179.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.66 147.6 61.41 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 105.548 -2.019 . . . . 54.439999999999998 105.548 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.81 -168.84 0.25 Allowed 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.24 1.96 . . . . 75.120000000000005 112.139 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.555 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.0 p -79.37 173.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.687 -1.597 . . . . 74.109999999999999 106.687 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.9 p-10 -79.59 157.45 74.7 Favored Pre-proline 0 C--O 1.252 1.228 0 CA-C-N 119.155 0.889 . . . . 62.240000000000002 112.723 -170.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HG3' ' HB3' ' A' ' 46' ' ' LYS . 10.3 Cg_endo -54.12 171.2 0.39 Allowed 'Trans proline' 0 C--O 1.201 -1.352 0 C-N-CA 123.571 2.848 . . . . 63.340000000000003 111.939 173.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 65.09 15.02 9.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.997 1.319 . . . . 65.230000000000004 109.559 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.73 27.87 64.7 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.234 -1.348 . . . . 74.200000000000003 114.804 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.49 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 4.5 m-80 -89.64 151.16 45.47 Favored Pre-proline 0 C--O 1.257 1.455 0 CA-C-N 119.24 1.52 . . . . 73.030000000000001 108.459 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.555 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 62.9 Cg_endo -82.14 144.91 13.54 Favored 'Trans proline' 0 N--CA 1.411 -3.379 0 N-CA-C 108.28 -1.469 . . . . 72.439999999999998 108.28 165.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 68.9 m-85 -67.28 143.01 56.68 Favored 'General case' 0 C--O 1.253 1.286 0 N-CA-C 106.535 -1.654 . . . . 73.230000000000004 106.535 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -101.2 114.47 28.46 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.167 -1.79 . . . . 72.209999999999994 106.167 -175.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -98.69 119.04 36.75 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.972 -1.122 . . . . 75.430000000000007 107.972 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.0 mt -128.46 153.14 47.44 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.463 -1.31 . . . . 71.010000000000005 107.463 175.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.791 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -124.89 -179.05 0.77 Allowed Pre-proline 0 N--CA 1.395 -3.178 0 N-CA-C 107.605 -1.257 . . . . 73.319999999999993 107.605 -175.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.791 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 43.6 Cg_endo -64.23 132.06 32.55 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 121.512 1.474 . . . . 73.109999999999999 114.092 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.95 -67.47 0.02 OUTLIER Glycine 0 N--CA 1.425 -2.054 0 CA-C-N 114.471 -1.24 . . . . 74.049999999999997 111.484 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.3 p -95.6 95.89 8.67 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 122.653 -0.322 . . . . 75.25 110.179 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.41 21.69 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.366 1.617 . . . . 75.209999999999994 115.366 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.36 138.06 9.94 Favored Glycine 0 CA--C 1.466 -3.005 0 CA-C-O 118.871 -0.961 . . . . 61.520000000000003 113.528 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 147' ' ' ASP . 44.0 Cg_exo -64.26 -28.14 63.99 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.522 3.481 . . . . 74.140000000000001 111.99 165.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 52.5 p90 176.0 164.9 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.409 0.684 . . . . 44.219999999999999 110.024 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 32.6 m-20 -139.64 123.07 17.17 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.537 -0.542 . . . . 72.209999999999994 109.537 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.569 HD11 HD12 ' A' ' 57' ' ' ILE . 3.4 tm? -130.66 124.66 32.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.423 -0.954 . . . . 42.329999999999998 108.423 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 44.3 p90 -167.4 168.11 13.34 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-O 119.505 -0.284 . . . . 72.239999999999995 110.914 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -126.25 156.57 40.09 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 123.77 0.828 . . . . 74.439999999999998 109.636 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.16 151.59 46.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.418 -0.355 . . . . 64.140000000000001 111.363 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.28 -178.86 45.79 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.443 -0.884 . . . . 72.239999999999995 112.21 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.96 25.96 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.2 1.185 . . . . 61.109999999999999 114.2 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -94.48 -9.99 33.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.986 -0.685 . . . . 74.25 111.241 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.47 4.87 72.96 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.827 -0.909 . . . . 63.509999999999998 110.827 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -99.69 144.03 29.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.654 -0.869 . . . . 64.5 108.654 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -100.7 105.07 16.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.949 -1.13 . . . . 75.400000000000006 107.949 172.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.27 -173.55 20.63 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.079 -0.808 . . . . 54.25 111.079 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.77 127.63 9.27 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 108.312 -1.915 . . . . 62.109999999999999 108.312 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.414 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 30.4 m 179.53 -177.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 125.904 1.682 . . . . 73.340000000000003 107.53 -170.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.43 -72.96 0.45 Allowed 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.644 -0.822 . . . . 73.510000000000005 111.043 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -95.84 -14.65 23.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.01 0.433 . . . . 72.519999999999996 111.543 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -97.49 5.47 49.59 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.383 0.611 . . . . 71.329999999999998 110.353 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -88.23 156.96 18.93 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.329 -0.85 . . . . 74.010000000000005 112.597 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 11.3 p-10 -78.76 112.94 16.41 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.45 -1.685 . . . . 74.129999999999995 106.45 172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 119.06 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.083 0 CA-C-N 114.939 -1.028 . . . . 63.219999999999999 111.451 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -169.96 -179.2 41.45 Favored Glycine 0 N--CA 1.41 -3.043 0 C-N-CA 119.612 -1.28 . . . . 62.109999999999999 112.859 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.0 149.46 28.9 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.9 -1.518 . . . . 70.530000000000001 106.9 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.464 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 4.1 p90 -170.19 178.38 3.86 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.334 0.588 . . . . 73.310000000000002 110.19 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 36.1 t70 -118.3 137.02 53.35 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 106.511 -1.663 . . . . 63.520000000000003 106.511 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.484 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 3.7 p-10 . . . . . 0 C--O 1.253 1.24 0 O-C-N 124.586 1.179 . . . . 65.219999999999999 109.013 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 107.566 -1.272 . . . . 72.230000000000004 107.566 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.3 m -119.78 88.97 3.04 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.026 0.75 . . . . 64.310000000000002 113.026 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 16.3 ptp180 -156.29 170.73 8.36 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.191 -1.781 . . . . 73.319999999999993 106.191 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 41' ' ' ARG . 54.4 Cg_exo -43.1 125.57 4.28 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 123.434 2.756 . . . . 62.200000000000003 113.838 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.1 -33.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.61 1.564 . . . . 42.109999999999999 113.346 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -73.23 -28.93 62.44 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.709 -0.478 . . . . 75.219999999999999 109.709 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.01 72.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.008 -0.738 . . . . 75.230000000000004 109.008 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 107' ' ' PRO . 65.3 mttm -74.7 -25.28 59.04 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.161 -0.927 . . . . 53.130000000000003 109.889 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 56.5 t -75.29 -44.57 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 71.0 109.09 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -73.62 -31.94 63.81 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.446 -0.797 . . . . 62.130000000000003 112.102 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -71.74 -36.17 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 119.404 -0.918 . . . . 51.439999999999998 109.034 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -65.16 -31.67 72.97 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.344 -0.844 . . . . 71.310000000000002 111.251 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 31.5 mmmt -64.86 -25.75 68.03 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.239 0.542 . . . . 73.439999999999998 110.549 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.79 -33.5 15.58 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.953 -0.859 . . . . 44.210000000000001 110.953 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 56' ' ' ALA 0.263 19.8 m-20 -81.13 -26.35 36.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.377 0.88 . . . . 74.049999999999997 113.377 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.96 -31.53 30.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.867 -0.79 . . . . 72.140000000000001 108.867 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -70.41 -25.91 63.44 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.212 -0.662 . . . . 73.010000000000005 109.212 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -67.05 -47.3 71.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.087 -0.961 . . . . 63.0 109.868 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.444 HG12 HD13 ' A' ' 100' ' ' LEU . 70.2 mt -60.84 -45.75 97.49 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.085 -0.961 . . . . 70.239999999999995 109.621 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.81 57.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.009 -0.541 . . . . 72.010000000000005 112.379 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.36 -39.6 16.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.879 0.371 . . . . 33.43 110.609 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.42 -28.31 52.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.477 -0.489 . . . . 74.230000000000004 110.907 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.86 -26.66 66.14 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.6 -1.259 . . . . 75.120000000000005 107.6 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.606 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 10.0 t70 -76.12 -21.09 57.03 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.149 -0.932 . . . . 72.349999999999994 108.698 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.9 mtt -77.37 -37.44 52.19 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.616 -0.678 . . . . 75.510000000000005 109.465 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 73.4 t80 -61.98 -37.34 84.42 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.994 -1.113 . . . . 71.150000000000006 107.994 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.6 tttt -54.47 -39.47 67.52 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 114.638 -1.165 . . . . 65.349999999999994 109.796 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.449 ' HB3' ' HE3' ' A' ' 92' ' ' LYS . 4.5 mm? -80.64 -30.45 36.67 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.358 0.873 . . . . 53.32 113.358 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -71.14 -24.95 62.37 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.388 0.614 . . . . 73.409999999999997 110.873 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.4 23.15 5.96 Favored 'General case' 0 CA--C 1.454 -2.736 0 O-C-N 121.372 -0.83 . . . . 74.140000000000001 111.669 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 42.58 32.82 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.448 1.499 . . . . 64.340000000000003 113.67 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.34 151.41 0.27 Allowed 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.608 -0.886 . . . . 62.119999999999997 108.608 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.645 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 21.2 m-85 -74.79 152.55 87.0 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 123.266 0.354 . . . . 72.409999999999997 110.271 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 32.7 Cg_endo -62.01 164.9 15.56 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.562 2.841 . . . . 65.209999999999994 112.557 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.404 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 58.2 p -102.46 154.98 18.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.614 -1.995 . . . . 64.439999999999998 105.614 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.464 ' N ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -69.07 -8.21 43.1 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 119.312 0.96 . . . . 74.430000000000007 110.614 -175.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.37 -67.02 0.89 Allowed 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 116.046 -0.524 . . . . 72.329999999999998 109.996 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -77.95 -39.56 42.24 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 121.958 -0.464 . . . . 75.239999999999995 110.652 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.617 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -75.73 -21.03 77.59 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 118.675 -1.726 . . . . 65.329999999999998 113.157 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 tt -68.0 -49.06 63.83 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.257 -1.386 . . . . 73.510000000000005 107.257 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 17.9 mt-10 -68.03 -26.69 66.01 Favored 'General case' 0 C--O 1.166 -3.302 0 CA-C-N 114.767 -1.106 . . . . 70.230000000000004 111.386 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.539 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -79.18 -7.69 58.41 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.31 0.576 . . . . 55.119999999999997 111.35 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 81.7 mt -93.28 -22.72 18.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.788 -0.642 . . . . 60.539999999999999 109.604 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.45 -38.3 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 116.134 -0.485 . . . . 74.510000000000005 112.056 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 57.0 pttt -119.01 151.25 38.54 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.673 -1.603 . . . . 72.349999999999994 106.673 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -55.19 130.82 68.79 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 122.754 0.422 . . . . 60.32 110.373 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 30.6 Cg_endo -58.88 124.22 15.23 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.554 2.836 . . . . 65.310000000000002 112.493 -173.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.2 p -83.27 116.08 22.26 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.652 -0.704 . . . . 73.010000000000005 110.487 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.43 -136.46 6.73 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.889 -1.684 . . . . 74.040000000000006 108.889 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -133.91 94.12 19.2 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 117.296 0.548 . . . . 63.109999999999999 111.481 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.27 162.65 17.5 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 123.007 2.471 . . . . 53.350000000000001 108.868 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.4 108.59 34.66 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 108.823 -0.806 . . . . 62.329999999999998 108.823 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -29.08 98.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.254 1 C-N-CA 125.857 4.372 . . . . 64.409999999999997 117.643 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 66' ' ' LEU . 54.9 mttm -138.77 149.48 45.05 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 125.971 1.708 . . . . 72.329999999999998 107.562 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.59 92.12 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.336 -0.393 . . . . 71.200000000000003 110.628 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.589 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 86.2 t90 -65.65 143.02 57.84 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 115.608 -0.724 . . . . 74.209999999999994 110.102 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -135.38 133.14 38.39 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.534 -0.757 . . . . 70.120000000000005 109.038 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -78.28 -171.53 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.327 -0.99 . . . . 74.530000000000001 108.327 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t0 66.89 25.25 9.52 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 122.189 0.995 . . . . 63.450000000000003 109.266 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 90.56 12.85 60.52 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 114.311 -1.313 . . . . 55.210000000000001 113.643 170.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.589 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.1 m-85 62.26 81.26 0.2 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.701 1.238 . . . . 73.049999999999997 107.811 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 57' ' ' ILE . 64.0 tp -128.72 172.24 11.44 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.807 -1.542 . . . . 64.099999999999994 108.926 -171.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 35.1 mmtp -77.29 -172.67 2.54 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.743 -1.206 . . . . 70.129999999999995 107.743 172.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -87.1 63.94 8.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.877 1.322 . . . . 72.219999999999999 108.966 177.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.405 HD12 ' HD2' ' A' ' 104' ' ' PRO . 28.9 tp -115.6 142.45 28.91 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.159 -1.837 . . . . 73.109999999999999 110.711 -172.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.405 ' HD2' HD12 ' A' ' 103' ' ' LEU . 26.4 Cg_exo -68.37 -167.17 0.17 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.393 2.728 . . . . 75.019999999999996 110.826 170.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.722 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.6 p -78.83 173.17 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 109.114 -0.698 . . . . 71.209999999999994 109.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.538 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.6 t70 -80.73 161.57 63.38 Favored Pre-proline 0 C--O 1.255 1.35 0 N-CA-C 108.553 -0.906 . . . . 72.109999999999999 108.553 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 72.1 Cg_exo -47.24 170.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.067 2.511 . . . . 74.299999999999997 114.258 172.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.453 ' CG ' ' HA ' ' A' ' 130' ' ' ALA . 1.7 m-90 65.79 14.27 9.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.928 2.091 . . . . 74.510000000000005 111.034 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.52 -6.71 15.54 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.86 -0.609 . . . . 63.32 114.043 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.89 133.94 88.04 Favored Pre-proline 0 C--O 1.258 1.534 0 N-CA-C 113.019 0.748 . . . . 54.509999999999998 113.019 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.722 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 72.0 Cg_endo -75.58 145.86 29.99 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.659 2.239 . . . . 71.0 112.098 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -69.7 134.01 48.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.258 -1.386 . . . . 63.219999999999999 107.258 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -104.2 113.98 27.9 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.328 -0.851 . . . . 72.010000000000005 109.315 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.92 118.24 36.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.663 -1.606 . . . . 74.209999999999994 106.663 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.1 mt -128.82 153.59 47.28 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.687 -1.227 . . . . 72.239999999999995 107.687 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.676 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.77 -178.58 0.57 Allowed Pre-proline 0 N--CA 1.404 -2.745 0 CA-C-O 116.589 -1.672 . . . . 54.240000000000002 107.672 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.676 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 12.4 Cg_endo -47.12 108.86 0.18 Allowed 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 123.005 2.47 . . . . 71.200000000000003 115.488 -162.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.55 -89.65 0.6 Allowed Glycine 0 N--CA 1.414 -2.788 0 CA-C-N 113.862 -1.517 . . . . 64.030000000000001 112.03 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 m -112.73 96.87 6.21 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 110.231 -0.285 . . . . 73.299999999999997 110.231 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 69.59 -1.5 2.24 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.999 1.319 . . . . 71.430000000000007 113.13 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -121.22 125.21 6.09 Favored Glycine 0 N--CA 1.428 -1.898 0 CA-C-O 118.374 -1.237 . . . . 72.099999999999994 113.0 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.544 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 13.4 Cg_exo -37.85 -26.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 127.299 5.332 . . . . 62.340000000000003 118.559 -178.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.261 40.3 p90 -169.32 147.08 3.63 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 119.353 0.979 . . . . 75.109999999999999 113.12 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.6 m-20 -112.47 109.83 19.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.281 -1.327 . . . . 74.420000000000002 107.441 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.489 ' O ' ' HA3' ' A' ' 144' ' ' GLY . 3.2 tm? -124.7 129.93 51.44 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.957 -0.697 . . . . 71.129999999999995 109.655 -176.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.409 ' HA ' ' HA3' ' A' ' 144' ' ' GLY . 55.7 p90 -167.81 164.59 14.17 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 112.442 0.534 . . . . 72.340000000000003 112.442 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -125.8 136.67 53.38 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.386 -2.449 . . . . 51.329999999999998 104.386 166.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mp -57.88 154.27 12.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.483 0.659 . . . . 65.310000000000002 112.392 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.43 173.31 40.38 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.894 -1.048 . . . . 75.519999999999996 113.902 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.453 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -48.36 -28.81 3.41 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 116.732 2.123 . . . . 75.209999999999994 116.732 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.26 -7.37 42.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.447 0.567 . . . . 72.420000000000002 111.397 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.43 28.31 25.09 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.495 -0.86 . . . . 71.340000000000003 112.439 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -127.65 138.63 52.88 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.634 -0.876 . . . . 73.540000000000006 108.634 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.39 105.38 7.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.617 0.722 . . . . 72.129999999999995 109.741 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.41 -174.4 22.2 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.812 -0.709 . . . . 71.540000000000006 113.873 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -116.79 128.66 8.01 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.363 -1.495 . . . . 34.229999999999997 109.363 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 38.8 m -178.26 -177.36 0.58 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 125.758 1.623 . . . . 75.549999999999997 108.196 -170.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.38 -73.25 0.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.877 -0.515 . . . . 70.340000000000003 110.53 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.44 -6.96 29.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.188 0.518 . . . . 72.450000000000003 111.718 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -100.54 9.34 42.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.335 0.588 . . . . 71.5 110.917 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -86.11 157.78 19.95 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.813 -0.631 . . . . 60.399999999999999 111.162 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.73 112.33 13.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.931 -1.877 . . . . 63.020000000000003 105.931 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.597 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.6 pp -96.32 123.45 48.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.472 0.653 . . . . 72.409999999999997 111.067 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -175.11 177.24 47.17 Favored Glycine 0 N--CA 1.413 -2.869 0 N-CA-C 110.155 -1.178 . . . . 72.340000000000003 110.155 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -103.36 162.92 12.6 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.136 -1.802 . . . . 70.349999999999994 106.136 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -143.64 124.7 14.43 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.119 -1.067 . . . . 75.239999999999995 108.119 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -111.58 112.38 24.05 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.899 -1.519 . . . . 75.430000000000007 106.899 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.416 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 4.7 p-10 . . . . . 0 C--N 1.293 -1.88 0 N-CA-C 109.413 -0.588 . . . . 71.140000000000001 109.413 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.491 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.8 mpt? . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.358 -0.608 . . . . 73.129999999999995 109.358 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -118.12 84.62 2.2 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.82 0.819 . . . . 74.519999999999996 110.501 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 99.1 mtt180 -153.07 165.78 16.88 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 106.292 -1.744 . . . . 65.439999999999998 106.292 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.94 130.25 38.32 Favored 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 122.515 2.143 . . . . 63.310000000000002 111.422 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' VAL . 33.5 m-20 72.85 -31.67 0.23 Allowed 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 125.393 1.477 . . . . 70.209999999999994 113.597 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 13.9 mm100 -68.93 -32.59 72.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.955 -0.757 . . . . 73.5 108.955 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.63 -17.89 64.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 74.439999999999998 110.747 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 57.0 mttp -89.44 -24.66 21.82 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.156 -0.683 . . . . 73.409999999999997 109.156 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 43' ' ' ASP . 59.5 t -75.0 -43.93 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.913 0.863 . . . . 73.540000000000006 108.698 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.4 t -64.65 -28.11 69.39 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.227 -1.351 . . . . 72.140000000000001 111.762 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.16 -37.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 119.597 -0.841 . . . . 73.530000000000001 110.146 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.677 -0.692 . . . . 62.409999999999997 110.667 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.505 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 55.0 mtpt -68.53 -22.47 64.51 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 121.379 0.609 . . . . 65.420000000000002 111.749 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.56 -31.1 46.63 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.618 -1.393 . . . . 73.109999999999999 109.618 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.6 m-20 -76.08 -31.15 58.6 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.223 -0.489 . . . . 72.409999999999997 111.359 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.417 HG21 ' HA2' ' A' ' 144' ' ' GLY . 14.3 pt -66.89 -30.82 50.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 C-N-CA 120.373 -0.531 . . . . 71.439999999999998 109.879 173.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HD2' ' OD1' ' A' ' 145' ' ' ASN . 14.2 mptt -67.17 -31.83 72.51 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 120.075 -0.65 . . . . 74.510000000000005 109.984 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.4 71.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 44.530000000000001 110.83 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.561 HG12 HD13 ' A' ' 100' ' ' LEU . 44.1 mt -62.75 -43.15 98.49 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 116.013 -0.539 . . . . 74.239999999999995 109.715 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -22.72 66.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.02 0.438 . . . . 72.439999999999998 111.681 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 -33.96 20.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.397 0.618 . . . . 65.129999999999995 109.951 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' TYR . . . -81.9 -27.48 33.38 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 110.552 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.28 -30.33 71.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 106.927 -1.508 . . . . 71.420000000000002 106.927 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 20.0 t70 -73.92 -17.21 61.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.705 -1.134 . . . . 65.120000000000005 109.21 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.8 mtm -84.01 -32.17 25.08 Favored 'General case' 0 C--O 1.204 -1.307 0 O-C-N 121.638 -0.664 . . . . 71.239999999999995 109.428 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -63.61 -35.47 80.61 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.17 -1.789 . . . . 64.540000000000006 106.17 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 60.5 tttp -58.12 -38.01 75.69 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 115.594 -0.73 . . . . 70.409999999999997 110.569 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 tp -74.73 -36.22 62.66 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.492 0.663 . . . . 73.230000000000004 109.667 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 13.8 t70 -74.37 -24.55 59.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.188 -0.914 . . . . 74.140000000000001 111.772 -174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -128.54 22.84 5.92 Favored 'General case' 0 CA--C 1.455 -2.699 0 O-C-N 121.549 -0.719 . . . . 73.129999999999995 110.62 177.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 42.44 31.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.501 1.52 . . . . 65.420000000000002 112.822 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.64 161.43 0.52 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.873 -1.158 . . . . 71.219999999999999 107.873 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.653 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 19.7 m-85 -75.74 155.07 85.27 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 123.301 0.376 . . . . 73.140000000000001 111.872 174.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 37.0 Cg_endo -66.7 157.8 59.22 Favored 'Trans proline' 0 C--O 1.211 -0.849 0 C-N-CA 122.693 2.262 . . . . 72.299999999999997 110.391 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 p -94.37 155.55 16.93 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 107.119 -1.437 . . . . 74.439999999999998 107.119 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.659 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -72.79 -4.54 32.2 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.013 1.279 . . . . 72.530000000000001 111.257 -176.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -102.75 -66.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 120.113 -0.635 . . . . 51.450000000000003 110.241 169.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -74.94 -45.99 38.68 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.531 -0.544 . . . . 71.310000000000002 109.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -72.16 -19.97 78.83 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 120.322 -0.942 . . . . 73.519999999999996 113.775 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tt -73.17 -48.66 33.4 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 107.841 -1.17 . . . . 72.430000000000007 107.841 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.53 -37.13 82.61 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 108.323 -0.991 . . . . 72.219999999999999 108.323 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -77.89 -5.61 51.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.041 0.756 . . . . 63.310000000000002 113.041 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.53 ' HG ' ' HA2' ' A' ' 98' ' ' GLY . 15.3 tp -94.43 -23.47 17.73 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.38 -0.97 . . . . 53.420000000000002 108.38 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.28 -38.78 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.924 -1.034 . . . . 63.520000000000003 110.562 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 43.8 tttm -124.06 150.69 44.68 Favored 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 126.598 1.959 . . . . 72.439999999999998 107.17 -174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -54.11 141.66 49.5 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 113.242 0.83 . . . . 74.230000000000004 113.242 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 7.7 Cg_endo -45.15 136.47 10.67 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 125.104 3.87 . . . . 54.340000000000003 115.992 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -101.41 -11.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.63 -1.168 . . . . 51.450000000000003 108.989 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.84 -148.62 24.07 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.949 -0.861 . . . . 52.43 110.949 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -117.12 101.16 53.34 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-O 121.555 0.693 . . . . 75.129999999999995 111.345 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.581 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 95.6 Cg_endo -99.71 162.82 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.772 2.981 . . . . 74.409999999999997 112.447 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -87.54 159.04 50.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.822 -1.177 . . . . 74.209999999999994 107.822 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.75 98.42 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.612 1.541 . . . . 74.219999999999999 112.904 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 2.3 mptp? -150.05 148.12 28.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.008 1.723 . . . . 35.329999999999998 106.46 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.57 98.01 5.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.004 0.431 . . . . 61.32 111.034 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.635 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 85.5 t90 -54.73 144.18 23.01 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.349 1.86 . . . . 73.140000000000001 113.042 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -116.65 135.33 53.88 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.526 1.13 . . . . 75.140000000000001 109.221 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -82.39 178.7 8.1 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 122.09 0.947 . . . . 74.400000000000006 110.909 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 55.63 45.92 23.76 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.894 -1.957 . . . . 65.120000000000005 111.905 168.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.53 ' HA2' ' HG ' ' A' ' 81' ' ' LEU . . . 105.7 -10.19 45.09 Favored Glycine 0 CA--C 1.477 -2.336 0 CA-C-N 114.427 -1.26 . . . . 62.049999999999997 114.856 163.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.635 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 64.55 96.15 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 122.182 0.991 . . . . 71.450000000000003 109.63 -171.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.561 HD13 HG12 ' A' ' 57' ' ' ILE . 59.3 tp -138.79 170.04 16.71 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.697 -1.138 . . . . 73.25 107.937 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.82 -170.32 2.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.747 -1.575 . . . . 64.349999999999994 106.747 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.71 75.91 10.27 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.606 -0.837 . . . . 71.129999999999995 109.996 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -130.85 147.85 67.86 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.379 -1.282 . . . . 74.040000000000006 108.753 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.59 178.01 7.26 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.538 2.159 . . . . 72.409999999999997 112.806 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 111' ' ' PRO . 3.9 p -85.5 175.75 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.716 -0.846 . . . . 73.409999999999997 108.716 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 112' ' ' TYR . 5.8 p-10 -78.65 158.2 76.1 Favored Pre-proline 0 C--O 1.251 1.184 0 CA-C-N 119.381 0.991 . . . . 74.340000000000003 113.132 -170.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 7.8 Cg_endo -54.52 171.07 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.266 2.644 . . . . 73.409999999999997 112.654 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.52 ' NE1' ' HD2' ' A' ' 46' ' ' LYS . 3.1 m-90 64.01 14.69 8.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.559 1.544 . . . . 74.340000000000003 108.856 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.46 38.33 79.5 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 114.026 -1.443 . . . . 73.019999999999996 115.167 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.521 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 13.2 m-80 -91.68 146.32 32.88 Favored Pre-proline 0 C--O 1.266 1.924 0 CA-C-N 119.954 1.877 . . . . 73.349999999999994 108.898 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.528 ' HA ' HG21 ' A' ' 105' ' ' VAL . 36.6 Cg_endo -89.35 137.83 3.12 Favored 'Trans proline' 0 N--CA 1.428 -2.377 0 C-N-CA 122.053 1.835 . . . . 63.329999999999998 109.565 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 59.2 m-85 -68.04 143.41 55.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.883 0.373 . . . . 74.349999999999994 110.601 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.524 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -102.67 117.34 34.46 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.112 -1.44 . . . . 73.140000000000001 107.112 -176.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -104.14 120.65 41.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.876 -0.416 . . . . 73.129999999999995 109.876 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 92.6 mt -127.98 153.56 46.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.452 -0.573 . . . . 73.430000000000007 109.452 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.756 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.63 -176.61 0.41 Allowed Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 116.567 -1.683 . . . . 44.109999999999999 107.306 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.5 Cg_endo -49.89 115.96 2.13 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.383 2.055 . . . . 71.120000000000005 114.707 -169.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -107.0 -84.53 1.7 Allowed Glycine 0 N--CA 1.424 -2.163 0 CA-C-N 114.205 -1.361 . . . . 51.420000000000002 111.664 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.1 m -103.55 96.47 6.75 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.404 -0.961 . . . . 71.299999999999997 108.404 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.43 12.05 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.606 1.962 . . . . 74.349999999999994 116.12 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -126.7 131.28 7.27 Favored Glycine 0 C--O 1.202 -1.894 0 C-N-CA 119.38 -1.39 . . . . 61.030000000000001 113.632 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.577 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 32.4 Cg_exo -40.3 -23.98 0.13 Allowed 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 126.782 4.988 . . . . 64.299999999999997 117.731 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.516 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 51.3 p90 -176.64 163.8 2.4 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 118.351 0.523 . . . . 73.319999999999993 109.682 176.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 146' ' ' TRP . 23.9 m-20 -139.86 118.45 12.28 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 124.279 0.987 . . . . 53.130000000000003 108.792 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . 0.26 4.4 pp -143.27 138.24 29.45 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.283 -1.367 . . . . 62.409999999999997 112.649 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 39.5 p90 -165.46 167.06 17.93 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.871 -1.059 . . . . 75.409999999999997 108.332 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.657 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 8.7 t -125.79 157.35 37.73 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.849 -1.167 . . . . 74.450000000000003 107.849 172.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.524 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 91.3 mt -67.33 154.13 42.05 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.835 0.709 . . . . 73.120000000000005 111.185 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.22 -164.58 21.89 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.342 -0.932 . . . . 71.219999999999999 114.16 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.9 -16.85 32.72 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.758 1.022 . . . . 75.200000000000003 113.758 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -106.29 1.55 26.01 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.625 0.726 . . . . 74.219999999999999 110.026 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 43.16 99.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.1 -0.8 . . . . 43.439999999999998 111.1 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 134' ' ' GLU . 8.8 tmtt? -141.15 147.16 37.99 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.231 -1.396 . . . . 72.310000000000002 107.231 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.72 106.55 18.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.795 0.807 . . . . 62.119999999999997 111.426 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.64 -178.85 24.97 Favored Glycine 0 C--N 1.291 -1.963 0 N-CA-C 110.722 -0.951 . . . . 15.51 110.722 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.89 127.09 8.81 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.468 -1.853 . . . . 45.32 108.468 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.491 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 53.3 m 179.28 -177.48 0.31 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.775 1.63 . . . . 64.109999999999999 107.507 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.96 -74.68 0.35 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.874 0.368 . . . . 63.340000000000003 110.638 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -94.0 -16.67 23.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.024 0.44 . . . . 65.25 111.086 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.99 3.95 53.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.56 0.695 . . . . 71.239999999999995 109.9 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.491 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -97.98 157.05 16.34 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 115.211 -0.904 . . . . 71.540000000000006 111.175 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -78.34 134.74 37.43 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.735 -1.209 . . . . 72.150000000000006 107.735 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.541 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -107.21 121.33 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 115.335 -0.848 . . . . 44.32 111.633 -175.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 126' ' ' TYR . . . -167.05 177.32 41.75 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 118.727 -1.702 . . . . 35.210000000000001 114.279 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.511 ' OD1' ' HD2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -156.56 157.08 34.71 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.627 -0.786 . . . . 72.019999999999996 109.357 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.516 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 4.9 p90 -163.08 177.1 9.41 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.529 0.518 . . . . 75.200000000000003 111.204 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 122' ' ' PRO . 35.3 t70 -120.02 130.79 54.89 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.186 -1.783 . . . . 74.230000000000004 106.186 175.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.41 ' HA ' ' CA ' ' A' ' 121' ' ' GLY . 4.1 p-10 . . . . . 0 C--N 1.296 -1.728 0 O-C-N 124.387 1.054 . . . . 71.25 110.316 -174.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.646 ' N ' ' HG1' ' A' ' 48' ' ' THR . 2.0 mpt? . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 110.611 -0.144 . . . . 74.510000000000005 110.611 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -103.07 77.91 1.6 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.293 0.568 . . . . 74.25 112.342 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -155.43 158.93 32.03 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 107.203 -1.406 . . . . 72.120000000000005 107.203 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.92 143.93 69.8 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.277 1.985 . . . . 74.019999999999996 110.716 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 75.06 -52.25 0.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.85 1.26 . . . . 64.430000000000007 110.96 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 86.6 mt-30 -68.48 -17.96 64.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 70.319999999999993 110.601 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.42 -27.11 68.86 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.529 -0.759 . . . . 74.099999999999994 110.018 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.74 -25.04 24.9 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.523 -0.547 . . . . 63.509999999999998 109.523 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 92.3 t -74.09 -43.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.587 -0.733 . . . . 63.100000000000001 109.112 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.646 ' HG1' ' N ' ' A' ' 39' ' ' MET . 5.8 t -68.18 -29.84 68.81 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.056 -0.975 . . . . 71.319999999999993 111.504 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.0 t -76.36 -47.69 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.935 -0.395 . . . . 74.420000000000002 109.935 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.22 80.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.398 -0.819 . . . . 64.25 111.498 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 47.6 mtpt -67.4 -23.57 65.57 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.239 -0.584 . . . . 63.210000000000001 112.316 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.78 -37.68 38.74 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.896 -1.145 . . . . 71.319999999999993 110.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 m-20 -77.34 -24.16 50.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.426 -0.51 . . . . 75.450000000000003 111.813 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 51' ' ' LYS . 15.5 pt -72.69 -27.26 25.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.084 -0.646 . . . . 63.240000000000002 110.842 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 2.0 mptm? -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.49 -0.884 . . . . 73.450000000000003 109.58 173.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.53 -42.38 92.03 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.327 -0.851 . . . . 63.310000000000002 109.86 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 53' ' ' ASP . 73.7 mt -62.99 -34.29 65.57 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.18 0 CA-C-N 115.655 -0.702 . . . . 64.230000000000004 110.111 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.03 -31.3 70.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.846 0.355 . . . . 75.109999999999999 110.766 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.51 42.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.261 0.553 . . . . 63.039999999999999 109.849 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -28.99 35.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.009 -0.541 . . . . 74.340000000000003 110.155 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -30.01 68.67 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.982 -1.488 . . . . 73.439999999999998 106.982 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 65' ' ' LYS . 17.3 t70 -68.67 -29.01 67.38 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.111 -0.949 . . . . 64.439999999999998 109.963 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -71.99 -36.21 69.71 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.46 -0.496 . . . . 72.230000000000004 109.668 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -70.28 -38.03 74.96 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 107.794 -1.188 . . . . 75.340000000000003 107.794 174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 62' ' ' ASP . 29.2 tttm -54.21 -35.89 62.9 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.646 -0.706 . . . . 71.329999999999998 110.661 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.37 -33.91 32.06 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.596 -0.274 . . . . 72.230000000000004 111.62 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.71 -24.25 62.61 Favored 'General case' 0 C--O 1.177 -2.76 0 CA-C-O 120.545 0.212 . . . . 74.109999999999999 111.1 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.9 OUTLIER -127.01 18.66 7.14 Favored 'General case' 0 CA--C 1.463 -2.401 0 O-C-N 120.778 -1.202 . . . . 71.530000000000001 111.428 177.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.6 p90 43.19 32.44 0.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.066 1.346 . . . . 74.25 112.663 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.82 162.11 0.57 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.072 -1.455 . . . . 52.439999999999998 107.072 -171.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.404 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.0 m-85 -80.48 155.87 73.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 111.858 0.318 . . . . 74.230000000000004 111.858 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.5 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 31.8 Cg_endo -66.03 161.87 37.92 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.048 2.499 . . . . 74.329999999999998 110.64 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -97.85 156.61 16.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.301 -1.37 . . . . 42.039999999999999 107.301 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.3 t -66.61 -13.79 61.57 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 119.138 0.881 . . . . 74.129999999999995 110.94 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 -65.14 1.01 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.448 -0.342 . . . . 62.549999999999997 111.33 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -77.41 -33.88 54.88 Favored 'General case' 0 CA--C 1.481 -1.707 0 O-C-N 121.95 -0.468 . . . . 73.099999999999994 111.197 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.583 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -76.73 -20.9 75.75 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 118.881 -1.628 . . . . 71.109999999999999 112.554 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.78 -49.53 61.91 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 106.069 -1.826 . . . . 75.040000000000006 106.069 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.0 -33.59 73.49 Favored 'General case' 0 C--O 1.169 -3.174 0 CA-C-N 114.646 -1.161 . . . . 71.439999999999998 110.272 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -80.07 -5.37 55.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.802 0.668 . . . . 64.409999999999997 112.802 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 84.6 mt -96.42 -17.8 20.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.192 0.52 . . . . 75.010000000000005 109.858 173.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.53 -33.93 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.373 0.606 . . . . 74.230000000000004 111.441 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 83.8 tttt -122.67 148.79 44.87 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 126.357 1.863 . . . . 64.120000000000005 106.861 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -56.51 135.56 76.98 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 118.152 0.433 . . . . 71.200000000000003 111.157 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 39.7 Cg_endo -63.47 150.75 87.71 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.825 3.017 . . . . 61.310000000000002 112.685 -174.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -98.45 146.81 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.618 -0.433 . . . . 74.310000000000002 110.557 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.71 -146.39 18.55 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.932 -1.267 . . . . 54.109999999999999 109.932 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -126.72 86.43 58.61 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-O 121.663 0.744 . . . . 71.319999999999993 111.697 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 1.6 Cg_endo -82.17 154.76 16.84 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.975 2.45 . . . . 74.409999999999997 111.126 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.2 143.5 65.23 Favored Pre-proline 0 C--O 1.211 -0.927 0 C-N-CA 123.615 0.766 . . . . 61.119999999999997 110.087 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.65 100.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.178 3.252 . . . . 74.510000000000005 115.017 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -147.31 148.02 30.97 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.203 -1.777 . . . . 75.219999999999999 106.203 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.33 91.58 3.84 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.484 -0.562 . . . . 74.5 109.484 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.644 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.7 t90 -54.58 138.83 40.07 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 123.969 0.793 . . . . 74.409999999999997 111.514 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -126.72 134.4 50.67 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 114.966 -1.016 . . . . 72.129999999999995 109.965 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 24.1 pttm -90.95 -176.43 4.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.321 -0.552 . . . . 65.120000000000005 109.883 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 72.43 15.59 5.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.137 1.375 . . . . 70.010000000000005 109.958 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 110.39 5.17 28.4 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 114.709 -1.132 . . . . 71.140000000000001 114.769 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.644 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 67.84 93.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.276 1.036 . . . . 74.019999999999996 110.644 -175.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.7 tp -132.6 158.33 42.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.899 -1.046 . . . . 74.409999999999997 108.651 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -84.85 -171.76 3.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.419 -0.956 . . . . 54.5 108.419 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -78.61 70.62 4.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.599 1.19 . . . . 74.239999999999995 110.504 176.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.9 mt -126.83 147.65 62.04 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 114.694 -1.139 . . . . 73.129999999999995 109.442 -174.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.63 158.36 53.73 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.634 1.556 . . . . 71.109999999999999 109.663 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 111' ' ' PRO . 6.0 p -79.6 175.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.43 -0.581 . . . . 75.420000000000002 109.43 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 105' ' ' VAL . 5.8 p-10 -71.38 158.19 88.48 Favored Pre-proline 0 C--O 1.249 1.062 0 N-CA-C 113.375 0.88 . . . . 74.319999999999993 113.375 -168.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 10.1 Cg_endo -53.36 169.1 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.679 2.919 . . . . 71.010000000000005 112.06 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 64.13 15.27 9.18 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.842 1.257 . . . . 64.340000000000003 109.142 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.0 68.43 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 114.266 -1.334 . . . . 42.350000000000001 115.152 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.478 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 3.8 m-80 -91.78 154.18 43.8 Favored Pre-proline 0 C--O 1.262 1.733 0 CA-C-N 119.927 1.863 . . . . 74.219999999999999 109.04 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.576 ' HA ' HG21 ' A' ' 105' ' ' VAL . 1.5 Cg_endo -85.73 152.08 10.08 Favored 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 121.801 1.667 . . . . 70.310000000000002 108.365 165.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 106' ' ' ASP . 70.0 m-85 -69.16 143.96 53.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.907 0.384 . . . . 74.209999999999994 110.252 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 1.6 mm100 -101.47 120.86 40.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.48 -1.674 . . . . 71.519999999999996 106.48 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.38 118.93 37.95 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 72.030000000000001 112.693 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 89.2 mt -130.34 153.71 48.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.669 -0.863 . . . . 71.129999999999995 108.669 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -113.5 -177.8 0.47 Allowed Pre-proline 0 C--N 1.297 -1.71 0 CA-C-O 117.055 -1.45 . . . . 71.299999999999997 109.284 -176.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.742 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 19.0 Cg_endo -50.08 112.29 0.69 Allowed 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.956 2.437 . . . . 43.240000000000002 115.882 -166.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.59 -91.48 1.02 Allowed Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 113.731 -1.577 . . . . 70.430000000000007 110.81 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.3 m -106.93 96.81 6.7 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.207 -1.034 . . . . 71.140000000000001 108.207 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 68.47 -13.61 0.3 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.507 1.123 . . . . 72.25 113.734 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -102.95 116.64 5.53 Favored Glycine 0 CA--C 1.488 -1.628 0 CA-C-O 118.704 -1.053 . . . . 50.219999999999999 113.548 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.56 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 11.1 Cg_exo -37.85 -29.52 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.574 1 C-N-CA 126.857 5.038 . . . . 73.340000000000003 118.343 -179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -170.43 151.76 3.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.915 1.234 . . . . 62.020000000000003 113.856 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.695 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -113.65 106.66 14.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.703 1.601 . . . . 74.430000000000007 107.518 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.81 125.03 32.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.747 -0.781 . . . . 64.540000000000006 109.416 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 27.0 p90 -167.1 165.35 15.64 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 110.41 -0.218 . . . . 72.120000000000005 110.41 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.1 p -125.7 148.0 49.18 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.805 -0.813 . . . . 51.340000000000003 108.805 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.26 133.5 50.72 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.776 0.658 . . . . 71.329999999999998 112.776 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.95 173.18 31.8 Favored Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 111.202 -0.759 . . . . 55.310000000000002 111.202 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.21 -20.32 26.24 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 115.583 1.697 . . . . 51.039999999999999 115.583 -173.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.538 ' OD2' ' HE2' ' A' ' 133' ' ' LYS . 5.0 t70 -94.88 -0.99 53.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.722 0.773 . . . . 72.310000000000002 109.757 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.76 24.48 60.15 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 111.319 -0.713 . . . . 74.030000000000001 111.319 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.538 ' HE2' ' OD2' ' A' ' 131' ' ' ASP . 68.5 mttm -112.13 147.31 36.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.151 0.5 . . . . 65.200000000000003 111.771 -176.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 2.7 tm-20 -100.71 102.33 13.41 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 102.751 -3.055 . . . . 75.25 102.751 165.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.35 -173.29 23.14 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.196 -1.366 . . . . 51.350000000000001 111.446 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.15 128.16 8.11 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 107.311 -2.316 . . . . 61.219999999999999 107.311 172.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.55 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 62.8 m -177.78 -179.04 0.75 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 125.022 1.329 . . . . 73.239999999999995 107.463 -171.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -75.62 -68.6 0.55 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.323 0.583 . . . . 62.43 110.156 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.48 -16.42 11.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.223 -0.899 . . . . 72.349999999999994 110.857 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -82.72 -9.92 59.14 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.244 -0.434 . . . . 63.109999999999999 110.762 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -86.96 155.13 20.31 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.211 -0.904 . . . . 74.219999999999999 110.849 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 8.8 p-10 -79.88 136.16 36.61 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.869 -1.53 . . . . 61.219999999999999 106.869 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -97.84 130.86 45.96 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.66 -1.237 . . . . 60.350000000000001 107.66 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -143.26 153.25 24.68 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 118.712 -1.709 . . . . 63.43 114.294 -173.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -120.08 129.55 54.26 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.264 -2.125 . . . . 71.530000000000001 105.264 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -142.43 144.1 32.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.806 -0.813 . . . . 74.349999999999994 108.806 -168.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -130.47 115.13 16.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.97 -1.122 . . . . 75.200000000000003 107.97 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 107.34 -1.356 . . . . 44.119999999999997 107.34 179.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.478 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.7 mpt? . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 109.378 -0.601 . . . . 64.030000000000001 109.378 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -92.4 62.02 3.91 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.906 0.706 . . . . 73.409999999999997 112.906 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -148.38 147.79 26.75 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 107.497 -1.297 . . . . 74.540000000000006 107.497 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.06 151.69 26.83 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.469 2.113 . . . . 64.400000000000006 109.835 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 76.76 -57.28 0.54 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.224 1.009 . . . . 65.120000000000005 109.389 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 49.3 mt-30 -68.79 -16.39 63.78 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.888 -0.508 . . . . 60.130000000000003 111.344 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 -25.89 67.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.872 -0.604 . . . . 61.299999999999997 109.386 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -83.49 -24.58 31.68 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 108.825 -0.806 . . . . 74.540000000000006 108.825 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 44' ' ' GLN . 69.4 t -74.37 -43.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.82 -0.627 . . . . 62.520000000000003 110.233 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -66.43 -39.59 89.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.095 -0.502 . . . . 62.409999999999997 111.901 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.02 -34.79 51.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.786 0.327 . . . . 64.019999999999996 110.289 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 143' ' ' ILE . . . -66.96 -39.36 87.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.055 -0.521 . . . . 60.009999999999998 110.671 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.554 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 66.1 mttm -65.68 -25.6 67.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.357 0.598 . . . . 64.209999999999994 111.225 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.26 -32.31 35.5 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.762 -1.209 . . . . 74.329999999999998 110.538 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 56' ' ' ALA 0.354 70.4 m-20 -87.33 -20.62 26.52 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.268 1.21 . . . . 74.540000000000006 114.268 -175.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 144' ' ' GLY . 15.4 pt -71.64 -28.43 31.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.714 -0.847 . . . . 74.530000000000001 108.714 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 1.4 mptm? -73.82 -27.03 60.9 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.844 -0.616 . . . . 53.229999999999997 110.565 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -62.5 -43.27 99.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.444 -0.798 . . . . 53.100000000000001 109.958 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.463 HG12 ' HG ' ' A' ' 100' ' ' LEU . 27.3 mt -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.735 0 CA-C-N 115.232 -0.895 . . . . 73.109999999999999 109.681 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.69 -25.28 62.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.835 -0.62 . . . . 71.310000000000002 111.995 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.78 -35.12 20.92 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.196 0.522 . . . . 44.43 110.11 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 63' ' ' MET . . . -80.58 -28.3 37.19 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.779 -0.368 . . . . 64.329999999999998 111.242 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.89 -26.85 64.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.883 -1.155 . . . . 72.319999999999993 107.883 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.3 t70 -69.09 -23.97 64.08 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.287 1.041 . . . . 65.040000000000006 109.232 173.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.424 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 51.1 ttm -78.76 -37.94 39.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.534 -0.757 . . . . 73.319999999999993 109.674 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.481 ' HD1' ' CE1' ' A' ' 99' ' ' TYR . 81.9 t80 -66.01 -38.12 87.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.063 -1.088 . . . . 75.540000000000006 108.063 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.541 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 75.9 tttt -54.54 -33.14 59.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.357 -1.292 . . . . 74.150000000000006 109.945 173.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 tp -83.13 -34.93 25.94 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.683 -0.407 . . . . 75.25 110.593 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 29.7 t70 -70.98 -25.61 62.78 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 120.901 0.381 . . . . 63.310000000000002 111.909 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.564 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -125.65 19.84 7.92 Favored 'General case' 0 CA--C 1.462 -2.427 0 O-C-N 121.068 -1.02 . . . . 65.510000000000005 110.949 175.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.5 p90 43.85 33.65 0.77 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 124.621 1.201 . . . . 73.040000000000006 113.549 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.85 160.36 1.12 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.739 -0.837 . . . . 75.540000000000006 108.739 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.541 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 27.6 m-85 -82.98 152.66 66.03 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.932 -0.396 . . . . 72.230000000000004 109.932 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.502 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.9 Cg_endo -63.82 164.73 20.67 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.972 3.114 . . . . 70.340000000000003 112.96 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.1 p -97.67 156.25 16.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 106.049 -1.834 . . . . 74.340000000000003 106.049 172.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -66.15 -14.47 61.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.43 0.633 . . . . 62.119999999999997 110.566 -176.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.42 -66.19 0.94 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.385 -0.598 . . . . 71.349999999999994 109.385 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -79.66 -35.98 38.42 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 116.186 -0.461 . . . . 72.530000000000001 111.087 -173.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.588 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -76.77 -21.4 74.56 Favored Glycine 0 N--CA 1.409 -3.161 0 C-N-CA 118.021 -2.037 . . . . 54.240000000000002 112.453 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.23 -46.85 66.37 Favored 'General case' 0 C--O 1.259 1.591 0 N-CA-C 106.491 -1.67 . . . . 73.200000000000003 106.491 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.8 mt-10 -60.37 -37.69 81.54 Favored 'General case' 0 C--O 1.171 -3.067 0 CA-C-N 114.603 -1.18 . . . . 72.109999999999999 109.401 174.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.554 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.37 -3.26 39.22 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.862 0.689 . . . . 41.219999999999999 112.862 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 76.8 mt -95.18 -22.79 17.61 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.099 0.476 . . . . 72.340000000000003 110.168 173.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -107.78 -25.88 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.547 0.689 . . . . 74.140000000000001 111.222 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 85.0 tttt -127.03 147.39 50.14 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 126.432 1.893 . . . . 63.539999999999999 107.001 -175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -54.86 128.53 63.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.606 0.762 . . . . 75.120000000000005 111.78 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 37.1 Cg_endo -66.8 131.03 24.62 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.405 2.737 . . . . 74.230000000000004 111.701 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -94.68 -179.15 4.78 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.11 -0.7 . . . . 61.340000000000003 109.11 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.88 -125.12 8.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 108.207 -1.957 . . . . 74.409999999999997 108.207 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.8 80.21 14.2 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 118.093 0.946 . . . . 72.530000000000001 112.697 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.564 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 14.4 Cg_endo -82.94 142.54 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.205 1.936 . . . . 70.319999999999993 110.479 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 50.8 mt-30 -83.06 115.98 61.79 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 107.149 -1.426 . . . . 43.509999999999998 107.149 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 51.4 Cg_exo -51.18 98.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 123.409 2.74 . . . . 65.340000000000003 117.678 -168.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HE2' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -111.19 148.93 31.71 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 101.995 -3.335 . . . . 53.149999999999999 101.995 163.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.54 99.6 0.11 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 120.108 -0.637 . . . . 71.040000000000006 109.736 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.593 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 87.2 t90 -62.16 141.88 57.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 124.42 1.088 . . . . 74.25 110.693 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.99 133.4 50.57 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.719 -0.673 . . . . 73.019999999999996 109.284 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -82.46 -176.92 6.47 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.15 0.5 . . . . 71.310000000000002 110.359 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.4 t70 71.36 15.71 6.22 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.498 1.119 . . . . 63.530000000000001 110.292 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 109.21 7.97 27.89 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.057 -0.974 . . . . 73.5 114.115 171.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.593 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 63.78 92.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.136 0.97 . . . . 71.049999999999997 109.139 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 101' ' ' LYS . 6.8 tt -138.21 168.01 20.64 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.978 -1.489 . . . . 72.209999999999994 106.978 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' N ' HD23 ' A' ' 100' ' ' LEU . 71.5 mmtt -72.44 179.8 3.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.216 -1.031 . . . . 72.140000000000001 108.216 176.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -80.41 77.21 7.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.172 0.987 . . . . 74.540000000000006 110.376 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.9 mt -131.41 149.89 74.86 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.806 -1.543 . . . . 75.049999999999997 108.394 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.49 -170.17 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.861 1.707 . . . . 73.450000000000003 111.035 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.627 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.5 p -83.93 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.705 -0.85 . . . . 62.219999999999999 108.705 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.543 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 t0 -75.38 156.79 85.24 Favored Pre-proline 0 C--O 1.251 1.175 0 N-CA-C 108.898 -0.778 . . . . 75.310000000000002 108.898 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 6.0 Cg_endo -49.15 170.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 123.689 2.926 . . . . 54.420000000000002 113.408 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.594 ' HB2' HD22 ' A' ' 110' ' ' ASN . 1.7 m-90 67.21 14.39 9.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.959 1.704 . . . . 74.239999999999995 110.467 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.87 22.8 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 115.467 -0.788 . . . . 63.009999999999998 114.25 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.594 HD22 ' HB2' ' A' ' 108' ' ' TRP . 56.7 m-80 -69.95 134.53 87.72 Favored Pre-proline 0 C--O 1.255 1.378 0 N-CA-C 113.319 0.859 . . . . 65.040000000000006 113.319 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.627 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 54.5 Cg_endo -71.51 154.12 60.36 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.429 2.086 . . . . 64.519999999999996 110.404 173.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -73.29 141.2 47.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.882 -1.525 . . . . 74.209999999999994 106.882 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.3 mm100 -102.89 113.83 27.6 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.417 -1.697 . . . . 54.509999999999998 106.417 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.57 120.02 40.05 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.72 -0.673 . . . . 71.209999999999994 112.518 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 97.5 mt -129.29 153.61 47.65 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.385 0.674 . . . . 74.349999999999994 109.246 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.14 -179.1 0.63 Allowed Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-O 117.104 -1.426 . . . . 74.010000000000005 108.364 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 25.0 Cg_endo -50.37 115.31 1.85 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.042 2.495 . . . . 72.120000000000005 116.785 -162.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.65 -90.17 2.14 Favored Glycine 0 N--CA 1.42 -2.407 0 CA-C-N 113.955 -1.475 . . . . 35.229999999999997 110.976 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.44 95.76 6.29 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.417 0.627 . . . . 73.120000000000005 111.836 -177.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 59.24 20.08 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.371 1.468 . . . . 62.43 112.763 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.669 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -134.88 115.52 1.42 Allowed Glycine 0 CA--C 1.479 -2.218 0 C-N-CA 119.154 -1.498 . . . . 53.350000000000001 113.248 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.542 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 11.8 Cg_exo -43.34 -24.67 0.61 Allowed 'Trans proline' 0 C--N 1.371 1.754 1 C-N-CA 126.052 4.502 . . . . 71.230000000000004 117.179 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -168.89 143.91 3.24 Favored 'General case' 0 C--O 1.254 1.308 0 CA-C-N 118.861 0.755 . . . . 45.130000000000003 112.18 173.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.48 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 3.3 m-20 -122.99 117.68 26.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.518 -1.29 . . . . 64.5 107.518 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 pp -145.42 140.03 27.32 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.742 -0.783 . . . . 54.509999999999998 111.671 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.473 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 45.8 p90 -166.23 167.88 15.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.295 -1.002 . . . . 74.540000000000006 108.295 -175.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.9 p -124.18 136.85 54.49 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.593 -0.891 . . . . 71.230000000000004 108.593 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.65 135.3 57.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.846 -0.742 . . . . 73.430000000000007 111.541 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.87 -172.2 9.74 Favored Glycine 0 CA--C 1.495 -1.173 0 CA-C-N 115.817 -0.629 . . . . 65.319999999999993 112.848 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.33 -7.81 10.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 114.101 1.148 . . . . 64.140000000000001 114.101 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.66 -7.05 41.91 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.091 -0.644 . . . . 70.530000000000001 110.149 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 22.16 76.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 121.124 -0.56 . . . . 73.239999999999995 111.764 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -140.53 143.51 35.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.625 -1.25 . . . . 71.129999999999995 107.625 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -81.66 108.93 15.62 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.712 0.767 . . . . 72.099999999999994 109.997 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.4 -173.94 20.41 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.265 -0.88 . . . . 70.150000000000006 111.526 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -112.62 128.11 8.31 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.735 -0.946 . . . . 71.030000000000001 110.735 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.54 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 19.4 m 178.17 -176.87 0.21 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 127.143 2.177 . . . . 72.439999999999998 105.962 -172.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -87.49 -58.36 2.61 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.931 -1.107 . . . . 71.409999999999997 110.827 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.71 -28.81 13.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.638 0.732 . . . . 75.140000000000001 111.408 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.95 9.17 23.11 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.761 -0.587 . . . . 73.510000000000005 111.753 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.54 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -99.29 155.75 17.35 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 115.845 -0.616 . . . . 62.340000000000003 110.782 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -80.47 125.6 30.15 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.174 -1.417 . . . . 73.150000000000006 107.174 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.454 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.6 pp -106.71 141.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.508 -0.923 . . . . 72.040000000000006 108.508 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.421 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -173.78 170.85 44.01 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 118.212 -1.946 . . . . 71.239999999999995 114.41 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -113.72 137.26 51.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.847 -1.538 . . . . 74.010000000000005 106.847 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.404 ' CZ3' ' HB3' ' A' ' 124' ' ' ASP . 8.7 t-105 -141.79 124.53 15.99 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.562 . . . . 64.329999999999998 106.781 -170.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -102.73 114.2 28.24 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.053 -1.091 . . . . 71.230000000000004 108.053 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 7.3 p30 . . . . . 0 C--N 1.294 -1.814 0 N-CA-C 107.759 -1.2 . . . . 73.530000000000001 107.759 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.595 ' N ' ' HG1' ' A' ' 48' ' ' THR . 1.2 mpt? . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.257 -0.645 . . . . 63.219999999999999 109.257 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.7 m -100.03 86.09 3.18 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.597 0.713 . . . . 63.030000000000001 112.077 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -148.14 163.6 26.06 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 106.35 -1.722 . . . . 62.409999999999997 106.35 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.88 130.14 36.18 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.681 2.254 . . . . 70.519999999999996 111.374 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.55 -34.21 0.28 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 126.004 1.721 . . . . 51.310000000000002 111.008 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -68.29 -20.49 64.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 75.099999999999994 109.37 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.53 -29.46 70.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.315 -0.857 . . . . 62.350000000000001 110.073 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -80.62 -26.55 37.68 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 108.108 -1.071 . . . . 74.409999999999997 108.108 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.419 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.3 t -75.35 -43.6 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.572 -0.74 . . . . 73.25 110.299 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.595 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.1 t -67.93 -37.05 81.18 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.584 -0.735 . . . . 54.399999999999999 111.309 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.87 -34.26 32.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 110.127 -0.323 . . . . 64.310000000000002 110.127 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.755 -0.657 . . . . 71.430000000000007 110.616 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 70.9 mmtt -65.28 -26.31 68.02 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.421 0.629 . . . . 72.409999999999997 111.05 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.29 -32.48 19.81 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.536 -1.025 . . . . 73.099999999999994 110.536 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 57' ' ' ILE . 70.1 m-20 -77.11 -33.58 56.88 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 120.917 -0.313 . . . . 72.430000000000007 111.465 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.5 pt -67.73 -29.74 46.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.701 -0.4 . . . . 60.520000000000003 110.313 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -73.23 -30.17 63.3 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.212 -0.662 . . . . 73.019999999999996 109.212 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.43 -40.58 96.01 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.052 -0.976 . . . . 74.010000000000005 109.991 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 53' ' ' ASP . 28.8 mt -66.28 -40.18 86.16 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.628 0 CA-C-N 115.103 -0.953 . . . . 71.430000000000007 109.71 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.03 66.8 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.29 -0.413 . . . . 62.439999999999998 111.447 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.03 -29.69 26.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.154 0.502 . . . . 62.210000000000001 110.319 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.31 -28.13 23.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.078 0.466 . . . . 72.400000000000006 110.975 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.99 -28.29 65.4 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.812 -1.551 . . . . 72.439999999999998 106.812 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.9 t70 -70.06 -24.16 63.2 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.598 -1.183 . . . . 74.219999999999999 108.75 172.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.7 mmt -79.93 -34.73 38.64 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.468 -0.787 . . . . 60.229999999999997 110.216 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.574 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 49.0 t80 -67.69 -31.7 71.84 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 107.103 -1.443 . . . . 75.140000000000001 107.103 171.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 56.9 tttp -57.92 -32.5 67.82 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.654 -0.703 . . . . 65.230000000000004 110.326 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -77.01 -36.11 56.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.148 0.499 . . . . 61.350000000000001 110.206 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -71.06 -25.44 62.63 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-N 115.7 -0.682 . . . . 74.329999999999998 110.856 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.5 18.41 5.29 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.924 -0.56 . . . . 72.230000000000004 110.27 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HD2' ' HG3' ' A' ' 90' ' ' GLN . 17.6 p90 42.89 31.35 0.31 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.014 1.326 . . . . 53.210000000000001 113.253 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.44 162.5 0.52 Allowed 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.516 -1.29 . . . . 71.120000000000005 107.516 -172.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 21.2 m-85 -78.63 151.63 77.32 Favored Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 120.305 -0.558 . . . . 73.200000000000003 111.31 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 14.1 Cg_endo -59.76 170.55 3.45 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 124.307 3.338 . . . . 73.239999999999995 112.725 177.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 76' ' ' GLN . 77.7 p -101.82 155.66 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.492 -1.67 . . . . 51.299999999999997 106.492 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -70.55 -15.07 62.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 119.796 1.18 . . . . 43.149999999999999 111.814 -173.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.48 -63.74 1.1 Allowed 'General case' 0 C--O 1.241 0.619 0 CA-C-N 116.311 -0.404 . . . . 72.310000000000002 110.886 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 48.8 mt-30 -76.08 -38.53 56.92 Favored 'General case' 0 CA--C 1.484 -1.584 0 C-N-CA 120.889 -0.325 . . . . 75.319999999999993 110.646 -174.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -71.31 -21.23 78.56 Favored Glycine 0 N--CA 1.418 -2.512 0 C-N-CA 119.101 -1.523 . . . . 72.540000000000006 112.83 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.54 -45.5 75.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.728 -1.582 . . . . 73.239999999999995 106.728 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 42.6 mt-10 -79.88 -2.83 45.37 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.842 -1.072 . . . . 72.310000000000002 111.077 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -99.8 -8.16 24.53 Favored 'General case' 0 C--O 1.204 -1.33 0 CA-C-O 121.677 0.751 . . . . 41.439999999999998 109.326 174.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 77' ' ' GLY . 5.4 mp -98.52 -24.25 15.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.481 -0.781 . . . . 65.409999999999997 110.026 174.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.92 -27.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.913 -0.585 . . . . 50.399999999999999 111.129 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 87.8 tttt -130.04 151.49 50.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.558 -1.645 . . . . 61.310000000000002 106.558 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -53.55 135.08 53.77 Favored Pre-proline 0 N--CA 1.485 1.308 0 CA-C-N 118.7 0.682 . . . . 75.019999999999996 110.94 -176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 7.2 Cg_endo -47.99 130.05 19.18 Favored 'Trans proline' 0 C--O 1.246 0.885 1 C-N-CA 125.357 4.038 . . . . 72.120000000000005 116.355 -170.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 t -82.19 148.97 28.16 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.183 -1.414 . . . . 44.229999999999997 107.183 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 89' ' ' PRO . . . 94.66 -157.28 22.29 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 109.634 -1.386 . . . . 35.43 109.634 -176.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.43 99.69 29.69 Favored Pre-proline 1 N--CA 1.369 -4.521 0 CA-C-N 117.68 0.74 . . . . 74.430000000000007 110.195 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 87' ' ' GLY . 96.4 Cg_endo -95.41 162.64 1.54 Allowed 'Trans proline' 0 N--CA 1.443 -1.493 0 C-N-CA 122.126 1.884 . . . . 75.030000000000001 109.756 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.408 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 25.8 mt-30 -82.8 159.18 63.92 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.432 . . . . 51.240000000000002 109.835 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.35 99.9 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.904 1.736 . . . . 75.030000000000001 111.315 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -150.51 146.07 26.38 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.485 -1.302 . . . . 52.329999999999998 107.485 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -72.64 89.52 1.32 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 120.733 0.301 . . . . 73.319999999999993 111.088 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.472 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 88.7 t90 -54.91 139.48 40.27 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.954 -1.021 . . . . 74.310000000000002 111.733 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.43 130.01 56.69 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.788 -1.096 . . . . 75.540000000000006 108.961 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -74.38 177.62 5.79 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.933 0.873 . . . . 65.25 110.801 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 t70 62.24 36.11 14.98 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.345 -1.752 . . . . 44.140000000000001 109.398 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 92.55 7.73 63.03 Favored Glycine 0 CA--C 1.488 -1.611 0 CA-C-N 113.749 -1.569 . . . . 30.300000000000001 115.224 165.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 63.12 85.83 0.13 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.253 1.025 . . . . 72.400000000000006 108.649 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 57' ' ' ILE . 1.1 tt -138.8 155.63 48.01 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.517 -1.66 . . . . 64.0 106.517 -173.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -63.53 141.5 58.74 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.799 -1.186 . . . . 64.109999999999999 107.799 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -74.0 79.09 1.69 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.039 0.923 . . . . 74.209999999999994 112.323 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.7 mp -130.35 149.21 72.71 Favored Pre-proline 0 C--N 1.288 -2.094 0 CA-C-N 113.773 -1.558 . . . . 71.349999999999994 108.061 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 171.82 1.21 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.792 2.328 . . . . 73.230000000000004 111.873 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.694 HG21 ' HA ' ' A' ' 111' ' ' PRO . 2.6 p -79.21 171.78 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.258 1.547 0 CA-C-N 116.342 -0.39 . . . . 63.420000000000002 110.082 -173.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.49 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 6.2 t70 -82.76 153.89 67.76 Favored Pre-proline 0 C--O 1.256 1.423 0 C-N-CA 119.579 -0.848 . . . . 71.319999999999993 109.67 -169.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 10.3 Cg_exo -42.81 171.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.867 3.044 . . . . 72.430000000000007 115.051 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 70.15 14.17 7.7 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 127.484 2.313 . . . . 74.040000000000006 109.175 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.15 19.09 56.63 Favored Glycine 0 N--CA 1.466 0.635 0 CA-C-N 114.967 -1.015 . . . . 42.240000000000002 113.176 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.05 128.26 65.97 Favored Pre-proline 0 C--O 1.27 2.139 0 CA-C-O 121.526 0.679 . . . . 73.25 111.84 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.694 ' HA ' HG21 ' A' ' 105' ' ' VAL . 73.7 Cg_endo -80.46 154.2 21.1 Favored 'Trans proline' 0 N--CA 1.419 -2.888 0 C-N-CA 122.264 1.976 . . . . 71.019999999999996 110.302 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.463 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 46.7 m-85 -80.75 139.49 36.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.823 -1.177 . . . . 64.209999999999994 107.823 172.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.517 ' OE1' HD13 ' A' ' 128' ' ' LEU . 1.2 mm100 -103.98 118.45 36.7 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.327 -1.36 . . . . 72.549999999999997 107.327 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -103.82 117.66 34.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.893 -1.151 . . . . 65.109999999999999 107.893 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.0 mt -129.57 153.42 48.06 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.413 -0.958 . . . . 72.310000000000002 108.413 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.843 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -109.56 179.63 0.81 Allowed Pre-proline 0 N--CA 1.401 -2.902 0 CA-C-O 117.001 -1.475 . . . . 74.209999999999994 108.351 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.843 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 9.1 Cg_endo -48.46 109.67 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.565 2.844 . . . . 71.519999999999996 114.796 -168.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -145.65 -63.99 0.01 OUTLIER Glycine 0 N--CA 1.405 -3.373 0 C-N-CA 119.563 -1.303 . . . . 65.340000000000003 112.449 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.555 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 11.4 m -83.85 104.98 14.38 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 108.399 -0.963 . . . . 72.310000000000002 108.399 -177.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 119' ' ' THR . 55.2 pttt 66.42 -26.26 0.11 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 127.51 2.324 . . . . 72.310000000000002 115.93 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -161.13 176.73 37.68 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 117.564 -2.255 . . . . 61.409999999999997 117.952 -173.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 7.2 Cg_exo -31.25 -26.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.502 1 C-N-CA 129.208 6.605 . . . . 74.310000000000002 119.505 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.285 47.6 p90 -169.9 149.03 3.61 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 119.717 1.144 . . . . 53.210000000000001 112.912 170.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.0 OUTLIER -112.66 106.29 14.65 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.483 -1.303 . . . . 70.329999999999998 107.483 -176.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 57' ' ' ILE . 3.4 tm? -128.46 128.08 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.202 -0.936 . . . . 73.510000000000005 110.254 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -166.57 164.33 17.0 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 120.855 -0.338 . . . . 74.019999999999996 111.862 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.463 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 23.0 t -125.07 141.71 51.95 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.882 -2.266 . . . . 74.25 104.882 171.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.517 HD13 ' OE1' ' A' ' 113' ' ' GLN . 5.3 mp -59.56 155.0 16.2 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.789 1.033 . . . . 72.409999999999997 113.789 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.7 172.85 53.79 Favored Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 115.561 -0.745 . . . . 70.019999999999996 112.292 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.52 -28.47 2.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 116.79 2.144 . . . . 61.109999999999999 116.79 -173.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.33 -2.06 52.8 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.837 0.744 . . . . 71.349999999999994 111.27 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.42 24.75 27.82 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.986 -0.626 . . . . 53.229999999999997 112.082 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -140.89 146.32 37.31 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.412 -0.588 . . . . 75.209999999999994 109.412 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -81.88 117.85 22.47 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 120.825 0.345 . . . . 64.319999999999993 110.777 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -149.47 -174.23 20.71 Favored Glycine 0 C--N 1.317 -0.497 0 N-CA-C 110.441 -1.064 . . . . 34.229999999999997 110.441 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.91 128.14 8.6 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 109.791 -1.324 . . . . 73.140000000000001 109.791 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.507 ' H ' ' HB2' ' A' ' 141' ' ' ALA . 23.2 t 178.02 -176.65 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.384 -0.969 . . . . 73.239999999999995 108.384 -171.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.41 -71.11 0.36 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.116 -0.698 . . . . 74.109999999999999 109.116 172.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -98.76 -17.06 18.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.303 0.573 . . . . 71.019999999999996 111.525 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 15.1 m-20 -91.67 9.24 33.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.683 0.754 . . . . 73.109999999999999 110.763 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.507 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.54 152.87 19.4 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.591 -0.731 . . . . 63.329999999999998 110.31 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.79 119.39 21.93 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.931 -1.877 . . . . 51.399999999999999 105.931 171.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.563 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.7 pp -96.35 128.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 115.754 -0.657 . . . . 73.109999999999999 109.936 -174.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.13 -179.8 38.56 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 118.463 -1.827 . . . . 75.5 113.31 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 7.2 t30 -123.73 147.88 47.09 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 105.725 -1.954 . . . . 73.329999999999998 105.725 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -142.88 135.92 28.15 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.75 -1.204 . . . . 75.439999999999998 107.75 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.9 106.58 13.97 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.176 -1.009 . . . . 73.150000000000006 108.484 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 2.6 t-20 . . . . . 0 N--CA 1.419 -1.988 0 N-CA-C 107.087 -1.449 . . . . 65.409999999999997 107.087 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.7 ttt . . . . . 0 C--O 1.217 -0.65 0 N-CA-C 107.724 -1.213 . . . . 73.129999999999995 107.724 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -110.22 89.41 3.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.024 0.916 . . . . 32.43 110.426 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 12.7 ptm180 -155.89 161.29 29.79 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.191 -1.781 . . . . 70.200000000000003 106.191 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.02 120.53 0.54 Allowed 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 124.057 3.171 . . . . 74.340000000000003 114.68 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t0 74.36 -35.79 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 126.81 2.044 . . . . 64.140000000000001 112.186 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.548 ' HA ' HG23 ' A' ' 47' ' ' VAL . 84.6 mm-40 -68.76 -24.39 64.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.504 0.668 . . . . 72.450000000000003 109.528 176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -62.11 -29.17 70.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.035 -0.984 . . . . 61.310000000000002 109.329 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.8 -23.73 39.05 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.118 -0.492 . . . . 74.329999999999998 110.249 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.548 HG23 ' HA ' ' A' ' 44' ' ' GLN . 40.2 t -74.59 -44.01 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.189 -1.041 . . . . 52.420000000000002 108.189 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 45' ' ' ALA . 14.6 t -67.96 -34.2 76.11 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.52 -0.763 . . . . 54.329999999999998 111.525 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 45' ' ' ALA . 19.8 m -69.22 -43.3 81.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 C-N-CA 119.434 -0.906 . . . . 74.129999999999995 109.566 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.422 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -59.6 -41.74 91.01 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.128 0.971 . . . . 51.329999999999998 110.958 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 58.7 mtpt -66.6 -21.89 66.13 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.635 -0.711 . . . . 74.310000000000002 111.925 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.27 -31.71 18.86 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 110.105 -1.198 . . . . 72.219999999999999 110.105 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.4 ' OD1' HD13 ' A' ' 103' ' ' LEU . 24.2 m-20 -70.42 -39.33 74.49 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.331 0.586 . . . . 72.310000000000002 110.622 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.627 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 17.6 pt -70.23 -25.5 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.942 -0.572 . . . . 54.310000000000002 110.673 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -68.41 -31.87 71.51 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.735 -0.839 . . . . 63.299999999999997 108.735 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -29.3 64.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.272 -0.876 . . . . 63.240000000000002 109.78 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 18.1 mm -59.88 -48.3 88.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 CA-C-N 115.03 -0.987 . . . . 61.119999999999997 108.731 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB2' HD21 ' A' ' 145' ' ' ASN . . . -58.22 -34.01 69.95 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.854 0.359 . . . . 54.340000000000003 111.314 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.53 -42.54 67.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.736 -0.665 . . . . 75.25 111.037 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.41 24.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.464 0.542 . . . . 62.100000000000001 112.464 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.31 -30.11 69.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.166 -1.42 . . . . 74.420000000000002 107.166 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 26.5 t70 -69.88 -27.61 64.96 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.289 1.042 . . . . 73.329999999999998 109.601 173.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 63.3 mtt -78.34 -30.21 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.707 -0.679 . . . . 72.420000000000002 110.331 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -71.3 -36.22 71.56 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.017 -1.105 . . . . 72.209999999999994 108.017 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 51.9 tttp -55.17 -31.59 61.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.316 -0.856 . . . . 73.439999999999998 109.93 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.93 -31.05 23.84 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.291 -0.868 . . . . 73.239999999999995 110.806 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.46 -27.12 56.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.925 0.393 . . . . 74.230000000000004 111.333 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.47 24.16 5.13 Favored 'General case' 0 CA--C 1.46 -2.513 0 N-CA-C 109.479 -0.563 . . . . 62.25 109.479 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.3 p90 43.26 33.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.417 1.087 . . . . 64.329999999999998 113.824 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 179.87 160.09 0.82 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.125 -0.694 . . . . 72.299999999999997 109.125 -173.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 24.4 m-85 -81.23 150.91 68.86 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 123.451 0.469 . . . . 62.43 110.131 171.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.552 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 36.8 Cg_endo -65.01 170.09 10.91 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.607 2.871 . . . . 74.099999999999994 113.255 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.402 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 73.3 p -110.01 153.98 23.82 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.196 -1.779 . . . . 74.450000000000003 106.196 171.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.433 ' N ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -59.59 -20.98 59.62 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.433 0.635 . . . . 72.209999999999994 111.933 -178.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -98.38 -65.95 0.93 Allowed 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 122.055 -0.403 . . . . 73.140000000000001 111.313 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -75.99 -37.32 58.64 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 116.604 -0.271 . . . . 75.219999999999999 111.287 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 72' ' ' PRO . . . -78.53 -21.41 69.5 Favored Glycine 0 N--CA 1.413 -2.865 0 C-N-CA 118.372 -1.871 . . . . 75.310000000000002 112.83 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.92 -44.64 65.74 Favored 'General case' 0 C--O 1.254 1.3 0 N-CA-C 106.324 -1.732 . . . . 72.109999999999999 106.324 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 10.1 mm-40 -60.47 -41.34 93.97 Favored 'General case' 0 C--O 1.162 -3.526 0 CA-C-N 114.7 -1.136 . . . . 65.530000000000001 109.828 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -77.55 1.37 19.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.942 0.719 . . . . 54.509999999999998 112.942 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 63.5 mt -101.64 -20.97 14.8 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.229 -0.295 . . . . 70.120000000000005 111.008 172.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.3 t -111.04 -26.42 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-O 121.822 0.82 . . . . 74.409999999999997 111.026 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 38.3 ttmt -122.87 146.65 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 126.972 2.109 . . . . 72.319999999999993 105.83 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' A' ' 84' ' ' LYS . 3.8 mppt? -55.95 141.86 66.27 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 118.517 0.599 . . . . 71.540000000000006 111.501 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.77 122.35 10.87 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 123.063 2.508 . . . . 72.230000000000004 112.397 -172.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.3 p -71.26 140.66 50.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.335 -1.302 . . . . 60.119999999999997 111.132 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.12 -116.55 5.61 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.54 -1.024 . . . . 75.109999999999999 110.54 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.24 92.53 7.48 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 112.872 0.693 . . . . 73.340000000000003 112.872 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.73 162.38 14.27 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.739 1.626 . . . . 70.030000000000001 107.954 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -74.87 158.97 84.03 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-O 118.608 -0.71 . . . . 75.239999999999995 109.392 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.42 98.3 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 121.56 1.507 . . . . 70.530000000000001 110.625 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 10.1 tmtt? -152.77 144.18 23.31 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.183 -1.784 . . . . 74.329999999999998 106.183 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.513 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 33.5 m-80 -78.7 94.76 5.14 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 118.239 0.472 . . . . 71.430000000000007 111.315 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.456 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.5 t90 -57.65 144.17 38.69 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 125.037 1.335 . . . . 74.040000000000006 112.519 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.93 135.16 55.27 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.806 -1.088 . . . . 73.219999999999999 108.984 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -84.06 -174.3 5.2 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.435 -0.58 . . . . 75.030000000000001 109.435 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 58.91 34.64 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 114.241 1.2 . . . . 74.239999999999995 114.241 176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 89.87 6.55 69.59 Favored Glycine 0 CA--C 1.487 -1.717 0 CA-C-N 115.344 -0.844 . . . . 72.209999999999994 114.358 168.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.456 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.5 OUTLIER 66.18 91.9 0.08 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.311 1.053 . . . . 62.350000000000001 111.301 -176.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.3 tp -138.28 170.97 15.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.618 -1.173 . . . . 71.430000000000007 108.174 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.87 -165.54 1.22 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.729 -0.607 . . . . 61.520000000000003 109.617 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.525 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -70.39 39.83 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.893 0.854 . . . . 75.329999999999998 112.272 178.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.4 HD13 ' OD1' ' A' ' 53' ' ' ASP . 84.8 mt -102.13 148.59 35.59 Favored Pre-proline 0 C--N 1.294 -1.844 0 C-N-CA 124.328 1.051 . . . . 73.099999999999994 110.2 -175.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.85 -166.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.908 3.072 . . . . 72.019999999999996 112.229 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.487 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 3.6 p -85.01 172.04 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 107.353 -1.351 . . . . 71.129999999999995 107.353 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.597 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -80.21 155.98 74.3 Favored Pre-proline 0 C--O 1.256 1.415 0 C-N-CA 119.723 -0.791 . . . . 73.329999999999998 109.847 -172.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 11.2 Cg_endo -54.3 171.54 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.562 2.842 . . . . 73.219999999999999 113.298 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.584 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 65.57 15.76 10.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.909 1.684 . . . . 64.230000000000004 109.738 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.63 29.76 75.86 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.921 -1.036 . . . . 73.430000000000007 113.926 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.584 ' ND2' ' HB2' ' A' ' 108' ' ' TRP . 58.1 m-80 -93.11 119.82 67.36 Favored Pre-proline 0 C--O 1.249 1.056 0 CA-C-N 117.672 0.736 . . . . 74.209999999999994 110.802 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.487 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 46.3 Cg_exo -62.91 143.12 90.77 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 121.955 1.77 . . . . 74.420000000000002 108.824 168.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -69.18 144.4 53.79 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.149 0.5 . . . . 70.010000000000005 110.332 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.655 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -102.62 114.77 29.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.403 -1.703 . . . . 53.409999999999997 106.403 -178.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.13 117.3 34.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.395 -1.335 . . . . 73.450000000000003 107.395 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.1 mt -129.67 154.02 47.56 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.239 0.542 . . . . 72.150000000000006 109.808 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.744 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -112.78 -178.63 0.54 Allowed Pre-proline 0 N--CA 1.401 -2.884 0 CA-C-O 116.109 -1.9 . . . . 54.439999999999998 106.959 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.744 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 9.5 Cg_endo -40.26 109.67 0.1 Allowed 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 123.146 2.564 . . . . 72.319999999999993 115.191 -164.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.73 -89.55 0.69 Allowed Glycine 0 N--CA 1.42 -2.42 0 CA-C-N 114.025 -1.443 . . . . 65.329999999999998 111.342 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 m -112.68 96.06 5.77 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.008 -0.738 . . . . 44.43 109.008 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 66.67 9.69 6.86 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.146 0.795 . . . . 71.530000000000001 113.146 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -126.59 132.15 7.61 Favored Glycine 0 CA--C 1.486 -1.723 0 CA-C-O 118.553 -1.137 . . . . 71.230000000000004 113.058 -176.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.52 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 34.9 Cg_exo -36.61 -29.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.801 1 C-N-CA 126.637 4.892 . . . . 74.319999999999993 118.352 -178.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.527 ' CE2' ' HA ' ' A' ' 146' ' ' TRP . 46.4 p90 -172.17 168.27 5.76 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.102 0.865 . . . . 73.519999999999996 111.247 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.6 106.33 5.63 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.835 0.854 . . . . 75.329999999999998 109.145 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -125.48 127.31 46.28 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.579 -0.896 . . . . 73.129999999999995 108.579 -178.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 30.0 p90 -166.61 169.42 13.65 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.252 -0.579 . . . . 71.140000000000001 112.301 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.2 t -125.02 149.27 47.93 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.681 -1.229 . . . . 55.240000000000002 107.681 172.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.655 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 82.1 mt -69.16 154.6 41.78 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 110.355 -0.239 . . . . 52.229999999999997 110.355 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.36 -174.76 24.8 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 121.449 -0.405 . . . . 52.340000000000003 113.87 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HA ' ' CG ' ' A' ' 108' ' ' TRP . . . -55.15 -24.37 26.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.906 1.446 . . . . 72.140000000000001 114.906 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -93.85 -6.04 46.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.21 -0.596 . . . . 72.329999999999998 110.946 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 128' ' ' LEU . . . 91.17 19.18 43.39 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.608 -0.806 . . . . 64.120000000000005 113.086 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -140.79 148.62 40.92 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.326 -0.62 . . . . 71.540000000000006 109.326 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.36 122.57 23.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.111 0.481 . . . . 63.020000000000003 110.55 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.62 -175.06 22.27 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 110.369 -1.092 . . . . 72.310000000000002 110.369 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -115.19 127.34 7.59 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 108.102 -1.999 . . . . 45.200000000000003 108.102 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 69.3 m 179.66 -177.15 0.33 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.617 1.167 . . . . 72.439999999999998 108.22 -169.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.94 -67.65 0.74 Allowed 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.95 0.156 . . . . 75.25 110.692 170.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.19 -21.34 17.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.137 0.494 . . . . 75.400000000000006 111.609 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -93.21 15.07 16.26 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.153 0.501 . . . . 74.230000000000004 111.077 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -91.68 155.86 18.0 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 115.995 -0.548 . . . . 64.109999999999999 111.164 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.44 127.86 32.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.235 -1.765 . . . . 73.510000000000005 106.235 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -96.96 121.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 108.333 -0.988 . . . . 63.539999999999999 108.333 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -142.26 152.54 23.77 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.188 -1.482 . . . . 51.439999999999998 114.796 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.486 HD21 ' HB2' ' A' ' 58' ' ' ALA . 3.6 t30 -130.25 120.08 23.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.536 -1.283 . . . . 63.109999999999999 107.536 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.527 ' HA ' ' CE2' ' A' ' 123' ' ' PHE . 2.5 p90 -160.24 177.57 10.51 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.722 0.772 . . . . 75.030000000000001 111.945 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.34 117.44 26.96 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 106.377 -1.712 . . . . 74.530000000000001 106.377 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 C--N 1.298 -1.641 0 N-CA-C 106.966 -1.494 . . . . 71.230000000000004 106.966 -176.908 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 108.444 -0.947 . . . . 71.129999999999995 108.444 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 m -121.64 80.12 1.64 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.361 0.6 . . . . 71.209999999999994 111.749 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -149.82 161.17 32.18 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.937 -1.875 . . . . 71.129999999999995 105.937 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -45.71 128.78 11.17 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.032 2.488 . . . . 71.230000000000004 112.088 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.266 20.6 m-20 75.99 -41.33 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.281 1.432 . . . . 64.200000000000003 113.705 -176.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.55 -23.03 64.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.265 0.555 . . . . 73.549999999999997 110.113 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.51 65.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.084 -0.962 . . . . 65.209999999999994 110.512 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -88.35 -26.56 22.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.212 -1.033 . . . . 73.409999999999997 108.212 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.493 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 39.1 t -75.71 -40.76 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.076 -0.966 . . . . 62.109999999999999 109.948 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -63.48 -29.55 70.81 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.487 -0.779 . . . . 74.219999999999999 110.861 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -73.63 -44.85 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 108.357 -0.979 . . . . 73.209999999999994 108.357 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.47 -42.33 87.25 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.937 -1.029 . . . . 65.349999999999994 111.532 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 14.5 mmmm -66.7 -25.07 66.35 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 121.331 0.586 . . . . 74.409999999999997 111.944 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.81 -22.86 34.82 Favored Glycine 0 C--N 1.31 -0.889 0 N-CA-C 110.447 -1.061 . . . . 55.240000000000002 110.447 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 15.4 t70 -82.25 -38.33 24.62 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.296 -0.631 . . . . 74.450000000000003 109.296 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.46 HG21 ' HA2' ' A' ' 144' ' ' GLY . 28.5 pt -65.53 -34.56 71.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.231 -0.655 . . . . 74.329999999999998 109.231 173.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -66.98 -28.04 67.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.783 -0.451 . . . . 73.230000000000004 109.783 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.82 -44.04 86.81 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.334 -0.617 . . . . 73.409999999999997 109.334 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.4 HG12 HD13 ' A' ' 100' ' ' LEU . 69.4 mt -64.83 -38.94 84.01 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.238 -0.892 . . . . 74.219999999999999 109.863 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . . . -59.62 -26.38 65.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.073 0.463 . . . . 62.530000000000001 111.573 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.7 -33.2 18.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.091 0.472 . . . . 73.549999999999997 110.204 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.507 ' HA ' ' SD ' ' A' ' 63' ' ' MET . . . -84.36 -26.83 28.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.033 -0.531 . . . . 74.209999999999994 111.898 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.1 -25.39 62.58 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.003 -1.48 . . . . 75.540000000000006 107.003 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 65' ' ' LYS . 28.7 t70 -75.4 -20.1 59.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.827 -1.079 . . . . 72.510000000000005 109.193 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.507 ' SD ' ' HA ' ' A' ' 60' ' ' ALA . 72.3 mtp -81.29 -29.72 34.21 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.378 -0.828 . . . . 73.040000000000006 109.538 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.18 -39.36 71.89 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 106.246 -1.761 . . . . 73.109999999999999 106.246 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 32.8 tttm -56.26 -26.55 52.05 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.178 -0.919 . . . . 62.020000000000003 110.175 173.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.1 tp -86.22 -36.58 19.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.853 -0.612 . . . . 64.319999999999993 110.418 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 29.8 t70 -74.23 -25.94 59.95 Favored 'General case' 0 C--O 1.209 -1.054 0 O-C-N 122.281 -0.262 . . . . 63.32 111.318 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.604 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -127.02 20.39 6.95 Favored 'General case' 0 CA--C 1.456 -2.668 0 CA-C-O 118.75 -0.643 . . . . 74.109999999999999 111.209 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.0 p90 43.07 32.15 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.733 1.271 . . . . 75.109999999999999 113.191 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 177.95 161.44 0.56 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.776 -1.194 . . . . 73.120000000000005 107.776 -172.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 65' ' ' LYS . 12.6 m-85 -76.93 157.15 81.97 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 123.361 0.413 . . . . 74.329999999999998 111.923 174.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.523 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 6.9 Cg_exo -72.86 170.41 19.73 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.838 2.358 . . . . 61.310000000000002 111.334 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.6 p -104.28 156.27 18.05 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.05 -1.463 . . . . 62.130000000000003 107.05 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.8 OUTLIER -70.64 -12.3 61.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 119.711 1.141 . . . . 62.530000000000001 110.492 -175.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -100.85 -65.09 0.99 Allowed 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.865 -0.607 . . . . 52.310000000000002 110.581 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -75.79 -39.55 56.73 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 120.548 -0.461 . . . . 74.340000000000003 110.133 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -73.83 -21.38 79.33 Favored Glycine 0 N--CA 1.415 -2.765 0 C-N-CA 119.091 -1.528 . . . . 74.030000000000001 113.785 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.65 -46.86 44.05 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 107.625 -1.25 . . . . 44.32 107.625 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.09 -29.99 70.7 Favored 'General case' 0 C--O 1.183 -2.41 0 CA-C-N 114.955 -1.021 . . . . 74.129999999999995 110.119 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 83' ' ' LYS . . . -86.03 -0.27 55.12 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.488 0.493 . . . . 53.119999999999997 112.252 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 65.9 mt -97.01 -21.47 17.39 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.404 0.621 . . . . 72.219999999999999 110.058 172.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.79 -30.67 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 121.575 0.702 . . . . 70.420000000000002 110.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 99.2 mttt -125.35 151.49 46.02 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 125.942 1.697 . . . . 70.329999999999998 107.436 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -54.27 142.16 49.64 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 112.755 0.65 . . . . 32.420000000000002 112.755 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HD3' ' CD1' ' A' ' 94' ' ' TRP . 6.7 Cg_endo -45.42 131.64 12.13 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.961 3.774 . . . . 62.030000000000001 114.96 -175.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -95.07 -1.49 52.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.939 -1.028 . . . . 74.25 110.032 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.99 11.74 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.258 -0.883 . . . . 73.109999999999999 111.586 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -126.7 86.08 59.3 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-O 121.555 0.693 . . . . 74.200000000000003 110.642 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.604 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 88.4 Cg_endo -91.35 161.82 3.68 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.585 2.19 . . . . 73.030000000000001 112.911 -176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -100.06 134.96 20.52 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.471 -0.937 . . . . 74.450000000000003 108.471 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -35.78 100.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 125.219 3.946 . . . . 74.140000000000001 115.014 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.526 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.4 tmtm? -150.85 147.3 27.08 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.018 -1.845 . . . . 74.129999999999995 106.018 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.526 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 3.7 m-20 -70.28 101.4 1.9 Allowed 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.501 0.667 . . . . 70.310000000000002 111.726 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.478 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 85.2 t90 -67.46 145.05 55.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.783 -1.099 . . . . 63.149999999999999 110.892 175.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -131.18 134.56 46.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.923 -0.769 . . . . 71.129999999999995 108.923 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 47.7 pttt -82.25 -165.84 1.11 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.486 -1.302 . . . . 75.239999999999995 107.486 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 66.15 19.05 11.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.533 1.158 . . . . 61.229999999999997 109.139 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 85.08 17.25 63.31 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.43 -1.259 . . . . 74.439999999999998 113.214 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 1.3 m-85 64.37 90.06 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.325 1.06 . . . . 75.400000000000006 110.602 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.4 HD13 HG12 ' A' ' 57' ' ' ILE . 66.3 tp -138.49 169.28 18.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.963 -1.125 . . . . 70.129999999999995 107.963 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -86.69 -171.94 3.77 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.948 -1.131 . . . . 53.030000000000001 107.948 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -75.4 70.05 2.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.661 1.22 . . . . 74.400000000000006 110.849 177.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -130.41 147.83 67.45 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.197 -1.365 . . . . 64.030000000000001 108.314 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.84 -168.98 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.835 2.357 . . . . 75.140000000000001 112.001 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.7 p -88.45 174.64 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 107.847 -1.168 . . . . 73.329999999999998 107.847 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 9.4 t70 -78.7 152.67 77.95 Favored Pre-proline 0 C--O 1.256 1.444 0 CA-C-N 119.255 0.934 . . . . 62.299999999999997 110.359 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 90.0 Cg_exo -49.76 172.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.573 2.849 . . . . 61.43 114.162 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 68.88 14.43 8.9 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.746 2.018 . . . . 74.340000000000003 109.026 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.9 33.33 78.12 Favored Glycine 0 C--N 1.32 -0.325 0 CA-C-N 114.83 -1.077 . . . . 60.5 112.628 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -93.72 131.99 30.9 Favored Pre-proline 0 C--O 1.258 1.506 0 N-CA-C 111.934 0.346 . . . . 71.450000000000003 111.934 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.533 ' HA ' HG21 ' A' ' 105' ' ' VAL . 66.6 Cg_endo -78.32 151.09 26.05 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 122.264 1.976 . . . . 73.439999999999998 110.362 174.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 8.6 m-85 -78.51 142.39 37.47 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.789 0.328 . . . . 70.340000000000003 110.309 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.578 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -104.52 113.82 27.63 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 106.45 -1.685 . . . . 75.409999999999997 106.45 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.5 118.0 35.14 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.113 -1.81 . . . . 70.409999999999997 106.113 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 91.2 mt -129.35 145.4 51.39 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.188 -0.671 . . . . 72.129999999999995 109.188 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.746 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -106.81 -178.32 0.58 Allowed Pre-proline 0 N--CA 1.402 -2.838 0 CA-C-O 115.907 -1.996 . . . . 52.25 106.641 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.746 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 2.9 Cg_endo -40.36 107.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 123.049 2.499 . . . . 43.420000000000002 114.556 -162.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.6 -74.89 0.1 Allowed Glycine 0 N--CA 1.411 -2.991 0 C-N-CA 120.54 -0.838 . . . . 71.230000000000004 112.577 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.429 HG22 ' HG2' ' A' ' 120' ' ' LYS . 9.2 m -83.18 95.84 8.24 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 109.139 -0.689 . . . . 70.409999999999997 109.139 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 119' ' ' THR . 1.0 OUTLIER 69.82 -16.8 0.26 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 126.037 1.735 . . . . 64.230000000000004 115.257 172.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 148' ' ' ASN . . . -161.21 178.04 37.31 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 117.064 -2.493 . . . . 74.329999999999998 117.331 -170.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.543 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 44.6 Cg_exo -36.93 -37.24 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 127.629 5.553 . . . . 70.430000000000007 118.209 -175.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . 0.289 29.3 p90 -161.28 144.73 12.84 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 117.829 -1.548 . . . . 73.299999999999997 114.776 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -113.79 105.87 13.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.586 -1.635 . . . . 42.229999999999997 106.586 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.42 126.9 41.51 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.863 -1.148 . . . . 74.150000000000006 109.865 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 34.0 p90 -167.39 166.13 14.62 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.218 0.324 . . . . 72.329999999999998 111.837 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.51 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 29.8 t -125.37 149.74 47.86 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.607 -1.998 . . . . 72.409999999999997 105.607 170.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.578 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 95.0 mt -63.68 145.09 56.39 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.719 0.295 . . . . 74.420000000000002 110.851 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.17 -169.67 45.98 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.416 -0.897 . . . . 74.319999999999993 111.404 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.5 -6.29 14.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 123.818 0.847 . . . . 71.450000000000003 113.101 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -96.0 -9.07 31.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.559 0.695 . . . . 53.140000000000001 110.101 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.53 7.88 70.01 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-N 115.815 -0.629 . . . . 52.520000000000003 113.301 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -140.05 147.55 40.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.827 -1.546 . . . . 51.229999999999997 106.827 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 119.81 21.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.668 -0.813 . . . . 62.439999999999998 111.643 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.75 -173.94 21.3 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.492 -1.043 . . . . 72.439999999999998 110.492 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.07 127.55 7.84 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.164 -1.574 . . . . 63.409999999999997 109.164 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.516 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 58.1 m 178.79 -177.54 0.27 Allowed 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 126.421 1.888 . . . . 45.100000000000001 106.68 -171.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.85 -76.77 0.17 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.065 -0.654 . . . . 70.120000000000005 110.738 171.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -96.44 -14.7 22.22 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.731 -0.388 . . . . 73.219999999999999 111.708 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -90.13 3.28 53.86 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.334 0.587 . . . . 74.239999999999995 110.689 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -94.68 157.74 15.83 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 115.149 -0.932 . . . . 44.439999999999998 110.297 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.19 126.85 31.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.68 -1.6 . . . . 72.530000000000001 106.68 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -96.86 119.05 44.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 111.287 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA2' HG21 ' A' ' 54' ' ' ILE . . . -174.44 162.35 32.57 Favored Glycine 0 N--CA 1.41 -3.096 0 C-N-CA 119.515 -1.326 . . . . 53.420000000000002 112.202 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -106.2 160.79 15.07 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.476 -0.935 . . . . 64.400000000000006 108.476 177.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -143.01 137.4 29.27 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.138 -1.06 . . . . 72.409999999999997 108.138 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -106.46 91.66 3.79 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.66 -1.216 . . . . 74.540000000000006 109.111 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.568 ' HB2' ' HA3' ' A' ' 121' ' ' GLY . 10.1 t30 . . . . . 0 CA--C 1.506 -0.732 0 O-C-N 126.282 2.239 . . . . 75.230000000000004 107.45 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.638 ' N ' ' HG1' ' A' ' 48' ' ' THR . 8.2 tpt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 107.042 -1.466 . . . . 65.219999999999999 107.042 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -118.44 98.21 6.15 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.809 0.67 . . . . 73.319999999999993 112.809 -173.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -155.58 165.49 18.29 Favored Pre-proline 0 C--O 1.252 1.23 0 N-CA-C 104.9 -2.259 . . . . 74.510000000000005 104.9 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.7 124.57 12.53 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.747 2.298 . . . . 74.310000000000002 111.913 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 75.08 -26.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.969 2.108 . . . . 62.350000000000001 111.777 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.411 ' HA ' HG23 ' A' ' 47' ' ' VAL . 62.5 mt-30 -68.69 -19.23 64.37 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 121.659 -0.651 . . . . 74.409999999999997 109.47 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.87 -21.17 65.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.159 -0.928 . . . . 75.329999999999998 110.188 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' O ' HG22 ' A' ' 49' ' ' VAL . 66.1 mttm -90.35 -25.58 20.38 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.041 -0.726 . . . . 71.129999999999995 109.041 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 57.6 t -73.93 -40.92 53.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.75 0.785 . . . . 74.209999999999994 109.018 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.638 ' HG1' ' N ' ' A' ' 39' ' ' MET . 10.9 t -65.43 -25.84 67.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.795 -1.093 . . . . 74.219999999999999 111.668 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 46' ' ' LYS . 6.0 m -82.69 -34.35 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 108.746 -0.835 . . . . 73.530000000000001 108.746 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 54' ' ' ILE . . . -61.84 -32.24 72.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.112 -0.949 . . . . 65.030000000000001 110.815 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 32.3 mmmt -65.14 -25.2 67.65 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.954 -0.567 . . . . 54.109999999999999 110.372 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.47 -27.29 18.11 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 111.164 -0.774 . . . . 52.020000000000003 111.164 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -79.19 -36.25 40.55 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.802 -0.444 . . . . 64.239999999999995 109.802 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 50' ' ' ALA . 26.6 pt -69.17 -31.02 48.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.595 -0.52 . . . . 73.219999999999999 109.595 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.5 tptt -65.79 -33.03 74.91 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.096 -0.705 . . . . 72.329999999999998 109.096 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.5 -43.54 80.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.337 -0.847 . . . . 74.0 110.038 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.485 HG12 HD13 ' A' ' 100' ' ' LEU . 53.2 mt -68.27 -36.94 77.11 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 CA-C-N 115.829 -0.623 . . . . 72.099999999999994 110.238 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.39 66.81 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.032 0.444 . . . . 62.140000000000001 110.766 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -88.63 -36.03 16.5 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 115.482 -0.781 . . . . 54.43 110.202 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.1 -28.12 60.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.004 0.43 . . . . 72.049999999999997 111.186 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -67.88 -29.45 68.56 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.598 -1.26 . . . . 75.439999999999998 107.598 177.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 12.4 t70 -72.84 -23.15 60.72 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.873 -1.058 . . . . 54.119999999999997 109.475 174.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 62.5 mtt -81.26 -39.65 24.97 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.943 -0.762 . . . . 75.25 108.943 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 87.7 t80 -64.39 -35.75 81.92 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.076 -1.083 . . . . 74.519999999999996 108.076 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.598 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 82.3 tttt -54.95 -31.78 60.86 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.052 -0.977 . . . . 65.430000000000007 111.215 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.9 -29.05 16.9 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.632 0.604 . . . . 71.310000000000002 112.632 172.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.521 ' HB3' ' HA ' ' A' ' 64' ' ' TYR . 19.4 t70 -72.15 -24.3 61.43 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.98 0.512 . . . . 73.030000000000001 111.311 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -128.48 18.84 6.32 Favored 'General case' 0 CA--C 1.455 -2.686 0 N-CA-C 108.071 -1.085 . . . . 73.239999999999995 108.071 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.0 p90 43.61 32.88 0.59 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.436 1.495 . . . . 72.150000000000006 114.134 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.15 161.09 1.09 Allowed 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.595 -0.891 . . . . 71.299999999999997 108.595 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.598 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 15.6 m-85 -78.12 154.02 79.88 Favored Pre-proline 0 N--CA 1.427 -1.62 0 O-C-N 123.713 0.633 . . . . 65.530000000000001 111.466 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.504 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 31.2 Cg_endo -66.87 165.76 24.87 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.108 2.539 . . . . 72.310000000000002 111.736 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.43 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 41.4 p -100.27 155.45 17.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.75 -1.944 . . . . 70.230000000000004 105.75 170.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.668 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.3 t -67.23 -12.13 59.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 119.736 1.153 . . . . 62.119999999999997 111.664 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -102.63 -64.9 1.03 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.268 -0.423 . . . . 74.040000000000006 111.062 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.33 -34.54 48.52 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 122.113 -0.367 . . . . 74.420000000000002 110.455 -174.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.657 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -78.4 -20.71 71.41 Favored Glycine 0 N--CA 1.412 -2.901 0 C-N-CA 119.112 -1.518 . . . . 63.140000000000001 112.757 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.78 -44.57 66.39 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 105.361 -2.088 . . . . 74.549999999999997 105.361 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 13.5 mm-40 -65.51 -16.69 63.92 Favored 'General case' 0 C--O 1.189 -2.09 0 CA-C-N 114.141 -1.39 . . . . 73.510000000000005 111.454 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.657 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -98.37 -3.39 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.374 0.607 . . . . 74.409999999999997 111.391 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 mp -98.56 -15.56 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 61.310000000000002 108.773 173.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.04 -39.93 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.602 -0.726 . . . . 75.150000000000006 110.859 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 5.6 ttpm? -116.35 150.29 37.96 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.047 -1.464 . . . . 74.450000000000003 107.047 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -54.37 137.02 60.48 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-N 118.341 0.518 . . . . 64.510000000000005 111.474 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -62.79 140.59 81.03 Favored 'Trans proline' 0 C--O 1.242 0.707 0 C-N-CA 123.49 2.793 . . . . 74.340000000000003 111.994 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.7 p -83.04 178.1 8.3 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 116.004 -0.544 . . . . 75.340000000000003 110.346 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.12 -114.58 4.58 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 111.12 -0.792 . . . . 73.349999999999994 111.12 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -148.56 116.41 3.93 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 120.611 -0.435 . . . . 74.530000000000001 110.931 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -103.5 162.94 0.24 Allowed 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 123.846 3.031 . . . . 73.540000000000006 111.088 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -76.65 159.29 79.59 Favored Pre-proline 0 C--O 1.207 -1.167 0 O-C-N 121.682 -0.636 . . . . 71.340000000000003 109.557 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -70.77 99.06 0.82 Allowed 'Trans proline' 0 C--O 1.248 1.015 0 C-N-CA 121.335 1.356 . . . . 61.109999999999999 112.586 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 67.6 mttm -146.66 148.56 32.17 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.818 -1.919 . . . . 74.430000000000007 105.818 174.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -76.41 92.99 3.43 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.628 -0.829 . . . . 70.409999999999997 110.372 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.617 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 79.4 t90 -53.69 143.53 20.24 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.237 1.415 . . . . 70.310000000000002 111.578 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -124.11 136.72 54.43 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.816 -1.083 . . . . 71.109999999999999 109.806 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 64.0 pttt -88.04 -168.75 2.31 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.631 -0.878 . . . . 75.25 108.631 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.66 16.3 6.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.708 1.242 . . . . 71.219999999999999 110.212 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.56 11.67 50.29 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.246 -1.343 . . . . 73.150000000000006 113.979 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 66.88 91.37 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.272 1.034 . . . . 70.430000000000007 111.181 -176.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 46.2 tp -138.94 156.09 47.53 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.551 -1.204 . . . . 71.25 108.414 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.499 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.5 mmmt -77.53 -177.63 4.84 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.45 -0.944 . . . . 75.219999999999999 108.45 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -82.29 74.22 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.5 -0.88 . . . . 44.509999999999998 110.86 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.88 147.83 67.8 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 125.133 1.373 . . . . 63.240000000000002 107.32 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.98 166.46 12.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.834 2.356 . . . . 72.439999999999998 113.704 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' A' ' 111' ' ' PRO . 6.2 p -79.36 176.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.408 -0.815 . . . . 72.129999999999995 109.138 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.483 ' H ' HG22 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -69.29 146.09 96.4 Favored Pre-proline 0 C--O 1.257 1.466 0 N-CA-C 112.508 0.558 . . . . 75.319999999999993 112.508 -175.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.414 ' HG3' ' HB3' ' A' ' 46' ' ' LYS . 5.8 Cg_endo -50.57 171.46 0.1 Allowed 'Trans proline' 0 C--O 1.197 -1.535 0 C-N-CA 124.118 3.212 . . . . 74.219999999999999 112.916 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.496 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.1 m-90 62.27 14.96 7.18 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.971 1.308 . . . . 75.049999999999997 109.298 -177.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.47 30.05 76.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.811 1.084 . . . . 61.229999999999997 115.811 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.496 ' ND2' ' HE3' ' A' ' 108' ' ' TRP . 15.4 m-80 -93.17 130.66 35.17 Favored Pre-proline 0 C--O 1.256 1.398 0 CA-C-N 119.085 1.443 . . . . 73.150000000000006 110.981 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.542 ' HA ' HG21 ' A' ' 105' ' ' VAL . 27.0 Cg_endo -70.98 148.57 57.45 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 121.434 1.423 . . . . 72.099999999999994 109.18 168.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 32.9 m-85 -69.45 143.86 53.45 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.07 0.462 . . . . 71.310000000000002 111.963 -177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.418 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.8 OUTLIER -102.61 114.22 28.26 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.802 -1.925 . . . . 52.439999999999998 105.802 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.25 120.09 41.18 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.258 -0.883 . . . . 70.519999999999996 111.311 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 94.1 mt -127.72 153.57 46.36 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.629 -0.878 . . . . 75.109999999999999 108.629 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -114.85 -178.69 0.53 Allowed Pre-proline 0 N--CA 1.406 -2.666 0 CA-C-O 117.035 -1.46 . . . . 73.200000000000003 107.73 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 18.7 Cg_endo -51.75 118.92 4.91 Favored 'Trans proline' 0 CA--C 1.482 -2.083 0 C-N-CA 122.522 2.148 . . . . 71.409999999999997 115.116 -170.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -93.85 -93.76 1.57 Allowed Glycine 0 N--CA 1.408 -3.233 0 CA-C-N 113.633 -1.621 . . . . 64.200000000000003 109.549 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.63 100.75 8.96 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 109.07 -0.715 . . . . 70.030000000000001 109.07 -177.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 66.19 10.11 6.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.539 1.136 . . . . 63.420000000000002 113.29 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -124.87 112.89 1.83 Allowed Glycine 0 N--CA 1.432 -1.577 0 CA-C-O 118.337 -1.257 . . . . 72.420000000000002 112.53 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.567 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 20.2 Cg_exo -41.21 -25.04 0.22 Allowed 'Trans proline' 0 N--CA 1.504 2.112 1 C-N-CA 126.954 5.103 . . . . 74.319999999999993 118.852 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.589 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.0 p90 178.19 165.95 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.997 0.817 . . . . 71.519999999999996 109.766 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 2.6 m-20 -139.32 113.17 8.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.371 0.668 . . . . 73.109999999999999 109.424 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.472 ' HG ' HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -125.29 124.58 41.93 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.786 -0.766 . . . . 73.450000000000003 110.371 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -164.43 166.43 20.58 Favored 'General case' 0 C--O 1.208 -1.109 0 O-C-N 123.087 0.242 . . . . 64.040000000000006 110.352 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.46 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 18.8 t -125.51 153.21 43.93 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.381 -1.34 . . . . 71.540000000000006 107.381 171.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.418 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 88.8 mt -66.26 128.6 36.77 Favored 'General case' 0 C--O 1.204 -1.316 0 O-C-N 123.227 0.329 . . . . 73.129999999999995 111.557 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.53 15.89 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.918 -0.658 . . . . 63.530000000000001 112.235 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.24 -16.74 9.02 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.82 1.415 . . . . 74.329999999999998 114.82 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.4 -9.38 35.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.15 0.976 . . . . 72.329999999999998 109.802 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.85 10.28 86.33 Favored Glycine 0 CA--C 1.505 -0.585 0 CA-C-N 115.334 -0.848 . . . . 72.129999999999995 112.281 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.598 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 5.2 mmpt? -124.77 147.89 48.43 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.58 0.352 . . . . 74.420000000000002 110.348 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.59 104.91 17.29 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 122.081 0.944 . . . . 74.219999999999999 108.733 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.85 -173.64 21.08 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.24 -0.891 . . . . 63.219999999999999 111.169 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.28 127.59 9.08 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.646 -1.782 . . . . 53.340000000000003 108.646 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.464 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 37.6 m 179.63 -177.91 0.36 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.207 -1.775 . . . . 44.329999999999998 106.207 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.54 -75.37 0.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 118.294 0.497 . . . . 62.409999999999997 110.32 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -99.76 -17.95 17.46 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.87 -0.604 . . . . 73.420000000000002 110.831 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.47 -8.21 59.02 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.466 0.65 . . . . 70.230000000000004 109.989 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -87.14 156.97 19.48 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 114.806 -1.088 . . . . 62.439999999999998 109.136 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -77.39 134.51 38.41 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.543 -1.28 . . . . 73.030000000000001 107.543 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.5 pp -96.82 119.58 45.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.893 -0.594 . . . . 65.040000000000006 110.719 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 54' ' ' ILE . . . -174.33 167.2 39.49 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 118.818 -1.658 . . . . 72.129999999999995 113.116 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.59 150.1 36.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.977 -0.749 . . . . 75.430000000000007 108.977 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.589 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 13.7 p90 -165.11 179.23 6.47 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.768 -0.651 . . . . 75.409999999999997 109.831 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -119.43 122.23 41.26 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.55 -1.278 . . . . 50.240000000000002 107.55 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.06 -1.089 . . . . 71.329999999999998 108.06 177.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.592 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.4 mpt? . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.426 -0.953 . . . . 71.530000000000001 108.426 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.5 t -108.88 77.77 1.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.074 -0.65 . . . . 74.25 110.724 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -155.16 155.26 29.87 Favored Pre-proline 0 C--N 1.316 -0.871 0 C-N-CA 124.814 1.246 . . . . 74.510000000000005 107.986 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.59 138.56 75.23 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.684 2.256 . . . . 41.100000000000001 110.894 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t70 76.56 -37.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.716 2.007 . . . . 74.439999999999998 110.49 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.592 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 77.8 mt-30 -68.68 -21.07 64.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.66 0.743 . . . . 73.340000000000003 109.504 173.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.22 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 55.399999999999999 109.943 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB3' ' CB ' ' A' ' 107' ' ' PRO . 67.3 mttm -93.23 -24.47 18.18 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.954 -0.758 . . . . 64.439999999999998 108.954 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 97.7 t -71.48 -44.66 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 108.248 -1.019 . . . . 73.430000000000007 108.248 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -65.96 -15.9 63.4 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.069 -0.969 . . . . 72.140000000000001 111.248 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -84.08 -52.66 12.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.585 -0.894 . . . . 72.120000000000005 108.585 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -58.97 -33.81 71.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.792 -1.094 . . . . 51.520000000000003 112.979 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 30.8 mmmt -65.36 -25.74 67.72 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.739 0.78 . . . . 65.129999999999995 109.982 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -27.97 24.92 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.836 -0.906 . . . . 75.219999999999999 110.836 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.418 ' OD1' HD13 ' A' ' 103' ' ' LEU . 77.5 m-20 -77.23 -34.67 55.95 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.137 0.494 . . . . 62.130000000000003 110.607 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.0 pt -68.1 -34.22 65.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 116.021 -0.536 . . . . 73.329999999999998 109.558 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -67.24 -29.36 68.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 71.310000000000002 109.811 178.133 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.52 75.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.337 -0.847 . . . . 64.439999999999998 109.5 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.567 HG12 ' HG ' ' A' ' 100' ' ' LEU . 66.8 mt -66.64 -34.81 72.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.568 0 CA-C-N 115.355 -0.838 . . . . 75.150000000000006 110.02 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.68 -26.61 68.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.117 0.485 . . . . 71.239999999999995 111.22 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -87.23 -34.36 18.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.119 0.485 . . . . 73.140000000000001 109.752 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.63 -28.55 33.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.632 0.604 . . . . 61.109999999999999 112.632 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.53 -29.84 68.51 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.216 -1.401 . . . . 74.409999999999997 107.216 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 32.4 t70 -71.89 -21.66 61.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.193 -1.367 . . . . 64.230000000000004 109.1 174.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.474 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.0 mtt -83.0 -30.29 28.28 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.754 -0.591 . . . . 73.219999999999999 109.607 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CD1' ' HD3' ' A' ' 72' ' ' PRO . 55.1 t80 -68.47 -35.62 77.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 106.955 -1.498 . . . . 73.329999999999998 106.955 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 83.9 tttt -55.02 -35.77 64.78 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.206 -0.906 . . . . 74.230000000000004 110.044 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.93 -36.43 56.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 73.120000000000005 111.813 172.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 92' ' ' LYS . 13.4 t70 -71.02 -26.69 63.22 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.81 -0.632 . . . . 62.420000000000002 111.178 -172.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -130.47 22.42 5.13 Favored 'General case' 0 CA--C 1.449 -2.929 0 CA-C-O 118.975 -0.536 . . . . 71.420000000000002 112.009 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.7 p90 42.99 31.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.063 1.477 . . . . 74.310000000000002 113.495 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.18 161.44 0.6 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.683 -1.228 . . . . 74.310000000000002 107.683 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 26.0 m-85 -80.08 154.14 74.92 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 123.289 0.368 . . . . 73.340000000000003 111.062 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 22.9 Cg_endo -64.43 167.62 14.54 Favored 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 123.471 2.781 . . . . 62.130000000000003 111.803 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.407 ' H ' ' HA3' ' A' ' 77' ' ' GLY . 53.2 p -98.21 155.71 17.04 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.635 -1.617 . . . . 75.109999999999999 106.635 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.543 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.6 OUTLIER -66.13 -15.45 63.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 118.967 0.803 . . . . 64.0 111.283 -175.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -102.23 -64.49 1.06 Allowed 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 122.156 -0.34 . . . . 73.120000000000005 111.465 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -75.89 -39.65 56.01 Favored 'General case' 0 CA--C 1.486 -1.519 0 O-C-N 122.171 -0.33 . . . . 73.430000000000007 110.795 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -73.61 -20.85 79.86 Favored Glycine 0 N--CA 1.414 -2.788 0 C-N-CA 118.614 -1.755 . . . . 60.149999999999999 113.169 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.5 -48.12 73.68 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 106.94 -1.504 . . . . 73.310000000000002 106.94 177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 48.4 mt-10 -71.22 -23.09 61.95 Favored 'General case' 0 C--O 1.18 -2.597 0 CA-C-N 114.553 -1.203 . . . . 74.150000000000006 111.019 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.624 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -82.76 -2.79 55.4 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.266 0.555 . . . . 73.209999999999994 111.125 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.581 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 70.8 mt -96.23 -28.24 14.63 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.479 -0.782 . . . . 70.409999999999997 110.217 173.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.77 -32.5 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.438 0.637 . . . . 51.450000000000003 111.183 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 79' ' ' GLU . 35.8 ttpt -120.59 150.48 40.82 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.188 -1.782 . . . . 75.409999999999997 106.188 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -54.54 141.32 54.99 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 118.489 0.586 . . . . 74.400000000000006 111.118 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.64 136.32 64.39 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.539 2.826 . . . . 63.140000000000001 111.878 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -81.47 -21.67 38.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.694 -0.685 . . . . 70.299999999999997 111.138 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.03 -146.39 9.26 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.894 -1.282 . . . . 64.420000000000002 109.894 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -117.69 95.87 48.52 Favored Pre-proline 0 C--N 1.288 -2.104 0 O-C-N 122.397 -0.472 . . . . 64.239999999999995 110.795 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.93 162.08 32.49 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.727 1.618 . . . . 75.530000000000001 108.751 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -82.69 159.21 64.16 Favored Pre-proline 0 C--N 1.292 -1.926 0 CA-C-O 118.205 -0.902 . . . . 73.530000000000001 108.958 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.48 97.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.707 1.605 . . . . 74.040000000000006 111.41 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 55.5 tttm -152.09 147.33 26.34 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.894 -1.891 . . . . 54.409999999999997 105.894 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.88 91.55 3.56 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.936 -0.306 . . . . 73.340000000000003 111.153 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -54.53 144.03 22.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.003 1.321 . . . . 73.319999999999993 111.498 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 99' ' ' TYR . 3.1 t-20 -123.43 135.19 53.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.516 -0.766 . . . . 60.299999999999997 109.99 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -84.88 176.34 8.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.47 0.652 . . . . 75.219999999999999 111.398 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 71.4 20.28 4.97 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.608 1.563 . . . . 62.020000000000003 111.388 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 103.16 12.13 32.29 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.904 -1.141 . . . . 52.210000000000001 112.718 171.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 0.5 OUTLIER 62.75 85.33 0.13 Allowed 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.552 1.168 . . . . 73.109999999999999 108.89 -173.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.567 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -133.32 150.4 51.87 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.485 -2.043 . . . . 71.040000000000006 105.485 -174.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' N ' HD23 ' A' ' 100' ' ' LEU . 13.1 mmmm -68.03 -178.14 0.96 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.908 0.322 . . . . 73.150000000000006 110.738 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -77.62 53.02 1.04 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.882 1.325 . . . . 54.219999999999999 112.718 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 ' OD1' ' A' ' 53' ' ' ASP . 70.8 mt -118.55 148.57 44.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 113.578 -1.647 . . . . 73.299999999999997 107.858 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.01 -175.46 1.46 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.604 2.202 . . . . 74.140000000000001 113.188 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 4.1 p -79.71 173.44 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.261 1.68 0 N-CA-C 108.271 -1.011 . . . . 44.219999999999999 108.271 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 5.8 p-10 -79.8 160.34 69.41 Favored Pre-proline 0 C--O 1.252 1.198 0 N-CA-C 113.635 0.976 . . . . 72.239999999999995 113.635 -168.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 106' ' ' ASP . 10.8 Cg_endo -56.11 169.53 1.43 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.358 2.705 . . . . 73.140000000000001 111.681 173.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 64.81 14.58 9.27 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.853 1.261 . . . . 64.340000000000003 109.127 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.19 25.33 62.2 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 114.014 -1.448 . . . . 74.420000000000002 115.381 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.543 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 8.2 m-80 -82.73 148.74 58.56 Favored Pre-proline 0 C--O 1.271 2.215 0 CA-C-N 119.497 1.649 . . . . 63.200000000000003 108.634 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.491 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 3.6 Cg_endo -88.89 148.47 5.8 Favored 'Trans proline' 0 N--CA 1.424 -2.57 0 C-N-CA 121.988 1.792 . . . . 63.310000000000002 109.087 168.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -68.2 142.49 55.66 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 120.48 -0.488 . . . . 70.219999999999999 110.136 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 2.0 mm100 -101.7 119.52 38.91 Favored 'General case' 0 C--O 1.266 1.928 0 N-CA-C 105.027 -2.212 . . . . 74.5 105.027 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 118.3 33.84 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.405 -1.332 . . . . 73.329999999999998 107.405 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 75.9 mt -129.98 150.36 51.29 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.01 -0.737 . . . . 75.099999999999994 109.01 169.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.707 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -122.24 -178.47 0.63 Allowed Pre-proline 0 N--CA 1.402 -2.836 0 N-CA-C 105.124 -2.176 . . . . 33.200000000000003 105.124 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.709 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 17.9 Cg_endo -54.12 116.72 3.23 Favored 'Trans proline' 0 CA--C 1.492 -1.589 0 CA-C-N 122.327 1.867 . . . . 73.310000000000002 114.094 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -104.23 -84.13 1.75 Allowed Glycine 0 N--CA 1.416 -2.638 0 CA-C-N 114.364 -1.289 . . . . 75.530000000000001 111.152 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.0 m -112.72 96.13 5.8 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 109.223 -0.658 . . . . 60.240000000000002 109.223 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt 63.13 19.54 11.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.928 1.291 . . . . 63.210000000000001 112.419 174.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -133.29 114.43 1.37 Allowed Glycine 0 CA--C 1.484 -1.893 0 CA-C-O 118.023 -1.432 . . . . 72.0 112.424 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.519 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 16.6 Cg_exo -41.51 -23.88 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.914 1 C-N-CA 126.667 4.911 . . . . 74.450000000000003 118.525 -177.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 54.6 p90 177.59 156.51 0.35 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.656 0.662 . . . . 74.430000000000007 110.285 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 2.7 m-20 -134.29 106.83 7.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.025 0.828 . . . . 74.420000000000002 108.789 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 57' ' ' ILE . 3.1 tm? -116.8 126.55 53.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.856 -0.794 . . . . 63.420000000000002 108.856 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.547 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 23.9 p90 -168.2 168.61 11.52 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 120.571 -0.451 . . . . 65.409999999999997 111.554 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.449 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 67.6 m -125.78 152.25 45.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.524 -1.287 . . . . 52.109999999999999 107.524 166.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.435 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 96.5 mt -60.17 148.64 35.49 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.742 0.651 . . . . 72.299999999999997 111.562 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.02 -172.27 5.27 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.768 0.667 . . . . 51.229999999999997 114.768 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.434 ' H ' ' HA ' ' A' ' 140' ' ' ASP . . . -57.47 -28.15 63.12 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 114.021 1.119 . . . . 52.049999999999997 114.021 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -94.23 -5.66 46.41 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.264 -0.574 . . . . 74.230000000000004 110.493 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.82 27.43 56.7 Favored Glycine 0 C--N 1.319 -0.386 0 N-CA-C 110.531 -1.028 . . . . 52.229999999999997 110.531 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -125.89 141.48 51.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.78 -1.193 . . . . 72.329999999999998 107.78 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.652 ' HA ' ' OD1' ' A' ' 142' ' ' ASP 0.271 0.0 OUTLIER -81.15 106.72 13.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.833 0.825 . . . . 63.409999999999997 112.767 178.556 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.09 173.27 29.82 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.347 -0.842 . . . . 73.540000000000006 113.315 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -105.4 129.61 9.88 Favored Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.586 -1.806 . . . . 73.129999999999995 108.586 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.642 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 23.8 m -178.76 -177.24 0.5 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 125.223 1.409 . . . . 74.310000000000002 107.513 -171.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -97.46 -49.9 4.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.045 -1.062 . . . . 62.109999999999999 108.887 171.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.544 ' HA ' HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -88.28 -41.65 12.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.679 -0.691 . . . . 74.200000000000003 110.673 -177.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.434 ' HA ' ' H ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER -96.28 18.3 14.05 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.606 0.717 . . . . 73.109999999999999 110.8 -175.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 137' ' ' SER . . . -81.2 156.88 25.44 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.259 -0.882 . . . . 70.120000000000005 109.922 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.652 ' OD1' ' HA ' ' A' ' 134' ' ' GLU . 36.4 m-20 -76.87 129.85 36.78 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 104.508 -2.404 . . . . 74.319999999999993 104.508 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.56 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -94.98 111.97 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 C-N-CA 118.59 -1.244 . . . . 73.010000000000005 108.37 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -175.09 176.69 47.2 Favored Glycine 1 N--CA 1.396 -4.027 0 CA-C-N 114.413 -1.267 . . . . 55.539999999999999 110.852 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.29 149.23 24.09 Favored 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 107.872 -1.158 . . . . 73.049999999999997 107.872 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.614 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 2.1 p90 -156.77 177.83 11.04 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 123.707 0.629 . . . . 72.120000000000005 112.082 -173.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -125.05 115.3 20.3 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.5 -0.926 . . . . 71.040000000000006 108.5 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 117.227 -1.368 . . . . 75.200000000000003 108.376 178.509 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.577 ' N ' ' HG1' ' A' ' 48' ' ' THR . 9.9 ttt . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 106.633 -1.618 . . . . 72.430000000000007 106.633 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.3 m -104.11 87.11 2.69 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.189 0.811 . . . . 72.319999999999993 113.189 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -154.54 154.16 28.96 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 104.835 -2.283 . . . . 74.109999999999999 104.835 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.1 141.07 70.04 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 122.167 1.911 . . . . 64.219999999999999 110.45 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 75.73 -36.13 0.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.299 1.44 . . . . 75.230000000000004 110.785 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.41 ' HA ' ' CG2' ' A' ' 47' ' ' VAL . 78.2 mt-30 -77.16 -15.16 59.63 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.689 -0.632 . . . . 73.450000000000003 109.961 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.7 75.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.134 -0.939 . . . . 65.129999999999995 110.545 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -86.94 -22.11 25.83 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.816 -0.629 . . . . 62.420000000000002 110.871 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 49.1 t -73.09 -43.21 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 121.421 0.629 . . . . 74.120000000000005 109.599 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.577 ' HG1' ' N ' ' A' ' 39' ' ' MET . 14.8 t -64.52 -38.42 90.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.09 -0.505 . . . . 74.430000000000007 111.747 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.2 t -70.35 -37.31 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 108.917 -0.772 . . . . 73.5 108.917 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -58.56 -40.67 83.7 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.908 -1.042 . . . . 34.219999999999999 111.151 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 13.8 mmmm -65.57 -25.66 67.51 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.163 -0.472 . . . . 71.25 111.182 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.22 -28.15 23.58 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.606 -0.807 . . . . 73.299999999999997 111.088 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -82.11 -30.1 31.38 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.008 0.433 . . . . 72.430000000000007 111.469 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 50' ' ' ALA . 17.2 pt -73.0 -27.21 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.305 -0.558 . . . . 71.450000000000003 109.943 172.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 28.5 tptt -72.58 -26.83 61.85 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.391 -0.596 . . . . 71.329999999999998 109.391 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.86 -44.34 81.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 71.019999999999996 109.16 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 125' ' ' LEU . 74.9 mt -63.44 -34.62 68.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.684 0 CA-C-N 115.124 -0.944 . . . . 72.140000000000001 110.178 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HB2' HD21 ' A' ' 145' ' ' ASN . . . -60.71 -34.42 74.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.898 0.38 . . . . 73.329999999999998 111.135 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -80.81 -26.85 36.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.837 -0.62 . . . . 72.239999999999995 110.051 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.13 -29.25 24.97 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 120.926 0.393 . . . . 74.140000000000001 110.733 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -27.48 62.4 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.218 -1.401 . . . . 75.420000000000002 107.218 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' OD1' ' HE3' ' A' ' 65' ' ' LYS . 10.7 t70 -66.45 -32.26 73.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.613 -1.176 . . . . 73.519999999999996 108.71 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 67.1 mtt -76.2 -31.1 58.26 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 115.18 -0.918 . . . . 73.140000000000001 109.518 177.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -69.95 -37.97 76.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.52 -0.548 . . . . 73.329999999999998 109.52 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 19.4 pttp -66.36 -19.23 65.75 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 118.867 -1.133 . . . . 75.219999999999999 109.453 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.33 -38.21 17.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.545 -0.752 . . . . 74.049999999999997 110.471 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 92' ' ' LYS . 15.9 t70 -73.3 -26.82 61.22 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.12 0.415 . . . . 71.109999999999999 112.12 -174.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.36 24.48 5.87 Favored 'General case' 0 CA--C 1.455 -2.676 0 N-CA-C 108.108 -1.071 . . . . 61.130000000000003 108.108 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 44.09 32.82 0.7 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.84 1.256 . . . . 64.109999999999999 113.731 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 65' ' ' LYS . . . 178.35 155.98 0.41 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.755 -0.831 . . . . 54.520000000000003 108.755 -174.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 10.2 m-85 -77.14 157.73 80.7 Favored Pre-proline 0 N--CA 1.423 -1.779 0 O-C-N 123.572 0.545 . . . . 74.019999999999996 110.932 171.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.475 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 60.8 Cg_endo -70.78 163.25 39.74 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.756 2.304 . . . . 63.340000000000003 113.244 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.6 p -104.93 155.14 19.21 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.464 -2.05 . . . . 61.210000000000001 105.464 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -67.44 -11.9 58.95 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.105 0.955 . . . . 63.140000000000001 111.504 -173.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -102.31 -65.58 0.98 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 121.795 -0.566 . . . . 64.540000000000006 110.377 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -77.72 -34.69 52.55 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 116.375 -0.375 . . . . 72.329999999999998 111.011 -170.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -84.26 -20.94 58.0 Favored Glycine 0 N--CA 1.417 -2.605 0 C-N-CA 118.664 -1.732 . . . . 75.150000000000006 112.658 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tt -73.7 -42.72 60.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.582 -1.636 . . . . 71.450000000000003 106.582 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.98 -27.4 67.42 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-N 115.435 -0.802 . . . . 73.25 110.826 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.564 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -84.79 -4.08 58.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.092 0.472 . . . . 75.129999999999995 111.515 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 114' ' ' TYR . 1.2 tp -95.79 -25.38 16.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.524 0.678 . . . . 75.519999999999996 109.297 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.05 -41.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.608 -0.724 . . . . 63.539999999999999 110.366 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -111.41 148.51 32.9 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.41 -0.959 . . . . 74.299999999999997 108.41 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.63 128.08 60.92 Favored Pre-proline 0 C--O 1.25 1.125 0 C-N-CA 124.067 0.947 . . . . 74.200000000000003 109.797 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.532 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 19.7 Cg_endo -53.62 126.39 21.67 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 124.503 3.469 . . . . 61.030000000000001 113.613 -171.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 p -74.44 117.91 16.79 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.667 -1.151 . . . . 60.509999999999998 110.566 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.67 -146.14 16.06 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 108.761 -1.736 . . . . 72.219999999999999 108.761 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -125.83 92.83 45.45 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 112.901 0.704 . . . . 70.140000000000001 112.901 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HG3' ' HG2' ' A' ' 85' ' ' PRO . 85.8 Cg_endo -76.0 163.12 33.63 Favored 'Trans proline' 0 C--O 1.262 1.693 0 C-N-CA 122.649 2.233 . . . . 70.430000000000007 107.562 171.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.35 159.57 83.35 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 108.584 -0.895 . . . . 74.329999999999998 108.584 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.69 98.01 0.18 Allowed 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 121.11 1.207 . . . . 71.150000000000006 110.332 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 93' ' ' ASN . 8.1 tmtm? -151.79 148.31 27.7 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.474 -2.046 . . . . 70.530000000000001 105.474 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.546 ' N ' ' HD3' ' A' ' 92' ' ' LYS . 90.0 m-20 -72.85 93.76 1.74 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.909 0.707 . . . . 62.340000000000003 112.909 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.544 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 88.4 t90 -64.18 144.37 57.17 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.851 0.86 . . . . 73.040000000000006 110.472 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -131.81 135.5 46.79 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.162 -0.681 . . . . 60.5 109.162 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HB3' ' CH2' ' A' ' 94' ' ' TRP . 63.5 pttt -85.09 -174.88 5.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.075 0.464 . . . . 74.129999999999995 109.777 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 70.2 15.04 7.6 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.473 1.109 . . . . 63.310000000000002 110.4 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.3 14.93 21.0 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.498 -1.228 . . . . 72.109999999999999 114.078 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.544 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 61.17 89.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.449 1.118 . . . . 75.25 110.975 -176.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 101' ' ' LYS . 57.2 tp -128.01 170.82 12.46 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 124.756 1.222 . . . . 70.150000000000006 108.092 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 32.2 mmmt -88.04 179.47 6.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.549 -1.278 . . . . 53.450000000000003 107.549 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.52 ' HD3' ' H ' ' A' ' 102' ' ' LYS 0.26 0.0 OUTLIER -77.33 72.37 3.88 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.851 1.31 . . . . 72.549999999999997 110.959 175.861 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -130.73 148.21 69.2 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 113.643 -1.617 . . . . 72.400000000000006 107.808 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.18 170.41 13.28 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.871 1.714 . . . . 74.010000000000005 110.887 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 111' ' ' PRO . 5.3 p -79.73 171.7 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.774 -0.824 . . . . 74.120000000000005 108.774 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.511 ' OD2' ' HD2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -75.55 149.03 83.51 Favored Pre-proline 0 C--O 1.253 1.269 0 C-N-CA 119.884 -0.726 . . . . 73.239999999999995 112.364 -171.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.511 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 36.0 Cg_exo -47.09 171.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.373 3.382 . . . . 72.299999999999997 113.93 172.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 70.14 14.81 7.67 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 126.677 1.991 . . . . 75.230000000000004 108.596 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.91 32.29 59.12 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 114.174 -1.375 . . . . 73.239999999999995 113.057 -175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -92.27 125.67 55.54 Favored Pre-proline 0 C--O 1.263 1.796 0 CA-C-N 116.752 0.276 . . . . 72.340000000000003 111.212 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.64 ' HA ' HG21 ' A' ' 105' ' ' VAL . 7.9 Cg_exo -71.1 154.09 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.034 1.822 . . . . 53.420000000000002 108.522 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -71.75 142.75 49.74 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.969 -1.093 . . . . 74.120000000000005 108.806 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.58 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 2.1 mm100 -102.14 113.76 27.31 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 105.066 -2.198 . . . . 62.140000000000001 105.066 -178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.409 ' HB2' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -104.62 118.46 36.64 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.823 -1.081 . . . . 74.430000000000007 111.318 -177.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 96.2 mt -129.31 154.02 47.27 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.345 -0.843 . . . . 61.009999999999998 109.343 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.721 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -108.93 -177.38 0.47 Allowed Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-O 116.971 -1.49 . . . . 75.420000000000002 108.711 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 20.1 Cg_endo -46.45 115.99 1.4 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 123.19 2.593 . . . . 72.329999999999998 116.359 -162.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.98 -90.93 0.9 Allowed Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 113.817 -1.538 . . . . 52.509999999999998 109.948 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.6 m -108.32 96.59 6.46 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.234 -1.024 . . . . 54.329999999999998 108.234 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.294 0.0 OUTLIER 54.73 4.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 126.604 1.962 . . . . 64.200000000000003 116.26 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -106.62 115.82 4.84 Favored Glycine 0 N--CA 1.426 -1.981 0 CA-C-O 118.027 -1.43 . . . . 63.109999999999999 111.303 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.569 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -34.81 -27.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.033 1 C-N-CA 127.052 5.168 . . . . 73.450000000000003 118.027 -178.937 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 50.8 p90 -165.45 170.42 14.5 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 118.749 0.704 . . . . 73.329999999999998 111.156 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.7 m-20 -132.4 107.13 8.31 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.534 -1.284 . . . . 72.329999999999998 107.534 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 145' ' ' ASN . 3.3 tm? -119.09 128.97 54.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.557 -0.905 . . . . 64.230000000000004 108.557 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -166.28 166.01 17.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.004 -0.369 . . . . 73.219999999999999 110.004 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.515 ' HB3' HD11 ' A' ' 143' ' ' ILE . 18.5 t -124.95 146.76 49.22 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.96 -1.867 . . . . 72.400000000000006 105.96 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.58 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 98.3 mt -64.23 155.97 30.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.788 0.328 . . . . 70.239999999999995 111.429 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -83.76 -166.19 39.89 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.577 -0.821 . . . . 60.409999999999997 112.368 177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.69 -22.05 64.99 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.553 0.946 . . . . 62.0 113.553 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.86 -2.75 52.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.755 0.788 . . . . 74.349999999999994 110.527 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.433 ' O ' HD13 ' A' ' 128' ' ' LEU . . . 72.29 27.44 69.91 Favored Glycine 0 C--N 1.317 -0.511 0 C-N-CA 120.797 -0.716 . . . . 51.020000000000003 111.74 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -140.07 148.45 41.77 Favored 'General case' 0 CA--C 1.493 -1.242 0 C-N-CA 123.159 0.583 . . . . 64.340000000000003 110.553 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -84.87 109.18 17.94 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.433 0.635 . . . . 64.099999999999994 110.596 176.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -147.6 -173.22 18.48 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.851 -1.068 . . . . 61.210000000000001 110.67 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.27 128.21 8.12 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.849 -1.7 . . . . 74.439999999999998 108.849 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 141' ' ' ALA . 60.2 m 179.95 -177.48 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.879 1.672 . . . . 72.0 106.698 -170.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -78.66 -62.56 1.65 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.929 0.331 . . . . 54.149999999999999 110.229 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.52 -11.82 14.03 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.513 0.56 . . . . 72.530000000000001 112.513 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.69 11.71 28.09 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.757 0.789 . . . . 70.019999999999996 110.595 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.441 ' HB2' ' H ' ' A' ' 137' ' ' SER . . . -92.0 155.8 17.86 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.805 -1.089 . . . . 62.509999999999998 110.275 178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 5.1 p-10 -79.67 135.66 36.6 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.31 -1.737 . . . . 64.530000000000001 106.31 173.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.59 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.34 113.11 29.92 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 108.041 -1.096 . . . . 73.450000000000003 108.041 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.65 151.5 18.98 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 119.368 -1.396 . . . . 54.409999999999997 114.582 -170.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.535 HD21 ' HB2' ' A' ' 58' ' ' ALA . 5.2 t30 -153.13 127.0 8.91 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 113.555 -1.323 . . . . 74.430000000000007 107.704 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.436 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 5.7 p90 -150.73 157.67 43.23 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 120.119 -0.632 . . . . 71.349999999999994 112.398 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -94.14 108.19 20.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.525 -1.657 . . . . 73.420000000000002 106.525 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.3 t30 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 114.534 -1.212 . . . . 61.409999999999997 108.696 -176.748 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' A' ' 44' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 108.387 -0.968 . . . . 34.439999999999998 108.387 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -115.62 89.03 3.01 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.832 -0.747 . . . . 52.240000000000002 110.225 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -155.65 161.56 29.2 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 125.983 1.713 . . . . 73.420000000000002 106.426 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.49 133.17 42.72 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.463 2.109 . . . . 60.020000000000003 110.908 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 74.63 -37.25 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.98 1.312 . . . . 64.25 111.624 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 39' ' ' MET . 15.1 mm100 -68.69 -24.97 64.56 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.266 0.555 . . . . 54.530000000000001 109.931 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.77 -16.92 64.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.342 -0.845 . . . . 63.219999999999999 110.242 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.51 -25.89 22.32 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 108.369 -0.975 . . . . 74.319999999999993 108.369 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 47.4 t -75.82 -43.38 39.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.631 -0.713 . . . . 71.129999999999995 110.216 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -65.23 -29.02 69.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.27 -0.877 . . . . 74.099999999999994 111.585 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.7 m -84.03 -34.49 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.158 -0.617 . . . . 73.129999999999995 109.941 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 143' ' ' ILE . . . -60.2 -37.84 81.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.465 -0.789 . . . . 44.140000000000001 110.451 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 70.2 mmtt -65.3 -26.23 67.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.704 -0.68 . . . . 74.510000000000005 110.423 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.99 -28.39 18.29 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.225 -0.988 . . . . 72.209999999999994 111.324 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.45 -27.26 32.01 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 112.04 0.385 . . . . 60.530000000000001 112.04 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 pt -72.06 -30.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.303 -0.559 . . . . 71.319999999999993 109.617 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 73.0 mmtt -71.52 -24.27 61.93 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 116.414 -0.357 . . . . 30.300000000000001 110.704 175.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.03 75.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.621 -0.718 . . . . 74.230000000000004 109.554 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.414 HG12 ' HG ' ' A' ' 100' ' ' LEU . 71.7 mt -68.99 -34.07 62.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.385 -0.825 . . . . 75.310000000000002 109.673 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.438 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . . . -58.97 -33.98 71.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 62.049999999999997 110.783 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 63' ' ' MET . . . -82.36 -36.27 26.98 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.485 -0.779 . . . . 73.040000000000006 110.166 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.59 -28.92 41.06 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.042 0.386 . . . . 74.530000000000001 112.042 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.456 HD12 ' CE1' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -70.38 -30.14 66.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.964 -1.495 . . . . 44.109999999999999 106.964 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.7 t70 -71.08 -19.54 62.46 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.453 -1.249 . . . . 74.040000000000006 109.543 174.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 63.8 mtt -81.54 -41.04 22.22 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.921 -0.77 . . . . 61.030000000000001 108.921 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' HD2' ' CE1' ' A' ' 99' ' ' TYR . 46.4 t80 -64.58 -35.97 82.7 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 107.612 -1.255 . . . . 72.030000000000001 107.612 173.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.599 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 78.1 tttt -54.37 -40.07 67.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.908 -1.042 . . . . 72.0 110.631 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.22 -32.25 38.52 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.527 -0.469 . . . . 54.530000000000001 111.363 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.605 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 36.1 t70 -69.81 -24.03 63.41 Favored 'General case' 0 C--O 1.184 -2.37 0 C-N-CA 121.02 -0.272 . . . . 74.439999999999998 111.413 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 0.8 OUTLIER -128.03 19.16 6.54 Favored 'General case' 0 CA--C 1.459 -2.527 0 O-C-N 121.137 -0.977 . . . . 65.109999999999999 110.909 176.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 p90 43.58 34.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.893 1.371 . . . . 73.219999999999999 113.107 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.92 152.9 0.37 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.532 -1.213 . . . . 74.409999999999997 108.096 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.599 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.6 m-85 -76.38 148.65 80.76 Favored Pre-proline 0 N--CA 1.431 -1.401 0 O-C-N 123.496 0.498 . . . . 73.409999999999997 110.76 172.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 28.4 Cg_endo -61.41 162.27 21.13 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.811 3.007 . . . . 52.399999999999999 111.883 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -96.77 156.06 16.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.632 -1.618 . . . . 75.230000000000004 106.632 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.1 t -69.12 -11.58 60.92 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 119.287 0.948 . . . . 61.210000000000001 110.934 -175.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -102.45 -65.84 0.97 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.096 -0.502 . . . . 75.430000000000007 110.99 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.33 -40.42 51.39 Favored 'General case' 0 CA--C 1.486 -1.505 0 O-C-N 122.141 -0.349 . . . . 72.400000000000006 110.393 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -74.7 -20.54 79.48 Favored Glycine 0 N--CA 1.41 -3.066 0 C-N-CA 119.25 -1.453 . . . . 32.340000000000003 113.076 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.38 -45.64 68.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.742 -1.577 . . . . 41.539999999999999 106.742 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.45 -8.68 57.09 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.18 -0.918 . . . . 64.439999999999998 111.733 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.586 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -96.88 -6.01 36.81 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.478 0.656 . . . . 71.129999999999995 110.209 175.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 86.4 mt -95.06 -19.81 19.84 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.791 -0.818 . . . . 70.430000000000007 108.791 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 t -106.11 -44.56 7.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.633 -0.712 . . . . 54.340000000000003 110.931 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.2 mppt? -108.82 148.69 30.19 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.216 -1.031 . . . . 73.230000000000004 108.216 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.54 133.05 63.71 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 123.82 0.848 . . . . 74.239999999999995 109.833 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.458 ' HD3' ' NE1' ' A' ' 94' ' ' TRP . 18.4 Cg_endo -55.3 121.05 9.23 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.688 2.925 . . . . 72.209999999999994 113.291 -172.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 t -87.12 -2.48 58.66 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.479 -1.237 . . . . 73.409999999999997 109.175 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.29 -147.75 12.61 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.768 -0.933 . . . . 32.329999999999998 110.768 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -115.63 99.13 52.16 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 117.7 0.75 . . . . 73.030000000000001 110.462 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.49 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 85.7 Cg_endo -102.85 162.2 0.28 Allowed 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 122.904 2.403 . . . . 71.530000000000001 112.887 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.428 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 45.5 mt-30 -105.54 98.55 17.56 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 106.0 -1.852 . . . . 74.409999999999997 106.0 174.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -36.69 99.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 125.186 3.924 . . . . 64.230000000000004 119.675 -167.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.605 ' HD3' ' HA ' ' A' ' 67' ' ' ASP . 4.1 mptp? -109.53 149.17 30.01 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 102.103 -3.295 . . . . 55.219999999999999 102.103 160.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.35 92.34 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 123.268 0.355 . . . . 73.219999999999999 110.277 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.585 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 91.0 t90 -54.95 140.85 35.89 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 124.969 1.308 . . . . 73.099999999999994 112.678 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.59 137.89 54.55 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.929 -1.032 . . . . 61.299999999999997 110.14 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -93.12 -178.1 4.68 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.736 0.779 . . . . 72.329999999999998 111.023 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 t0 65.73 24.29 11.5 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.649 1.58 . . . . 74.099999999999994 110.846 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.91 27.58 Favored Glycine 0 CA--C 1.496 -1.132 0 CA-C-N 114.643 -1.162 . . . . 54.210000000000001 115.051 168.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.585 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 60.5 90.28 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.384 1.087 . . . . 74.25 110.775 -175.114 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 101' ' ' LYS . 5.7 tt -138.18 151.04 47.33 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.356 -2.461 . . . . 74.409999999999997 104.356 -179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.509 ' N ' HD23 ' A' ' 100' ' ' LEU . 55.8 mtmt -67.39 -172.47 0.23 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.357 -0.537 . . . . 74.510000000000005 111.597 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 67.94 6.42 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.094 0.95 . . . . 74.310000000000002 111.384 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.52 148.28 69.44 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 126.263 1.825 . . . . 62.43 107.488 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.19 -171.56 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.126 2.551 . . . . 73.439999999999998 113.289 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 111' ' ' PRO . 4.2 p -85.66 175.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 N-CA-C 108.611 -0.885 . . . . 74.299999999999997 108.611 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.471 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 2.3 t70 -77.58 158.35 78.76 Favored Pre-proline 0 C--O 1.251 1.182 0 CA-C-N 118.89 0.768 . . . . 70.0 109.692 -170.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 68.4 Cg_exo -47.55 170.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.39 2.726 . . . . 74.329999999999998 113.855 173.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.702 ' HB2' ' ND2' ' A' ' 110' ' ' ASN . 1.2 m-90 65.13 15.46 10.01 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.018 1.727 . . . . 75.209999999999994 110.565 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.15 1.67 50.35 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.135 -0.939 . . . . 21.300000000000001 114.993 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.702 ' ND2' ' HB2' ' A' ' 108' ' ' TRP . 47.5 m-80 -70.51 128.08 91.46 Favored Pre-proline 0 C--O 1.258 1.544 0 N-CA-C 113.78 1.03 . . . . 70.319999999999993 113.78 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.556 ' HA ' HG21 ' A' ' 105' ' ' VAL . 21.1 Cg_exo -67.76 146.64 73.32 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.194 1.929 . . . . 35.329999999999998 108.706 166.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -69.64 144.42 52.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.869 -0.789 . . . . 74.030000000000001 108.869 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -100.63 113.65 26.68 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.058 -2.201 . . . . 73.349999999999994 105.058 -177.269 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.07 119.03 38.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.115 -0.948 . . . . 73.129999999999995 111.983 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 88.4 mt -129.33 153.23 48.05 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.251 -1.018 . . . . 70.420000000000002 108.251 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.839 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -104.25 -178.62 0.65 Allowed Pre-proline 0 N--CA 1.419 -2.017 0 CA-C-O 116.55 -1.691 . . . . 71.030000000000001 108.486 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.839 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 6.9 Cg_endo -42.33 109.83 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.704 2.936 . . . . 63.530000000000001 115.623 -165.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -145.26 -63.04 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.05 -1.072 . . . . 64.530000000000001 113.807 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 m -84.65 96.91 9.35 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.509 -1.276 . . . . 71.200000000000003 109.105 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.6 mttt 74.7 -27.43 0.19 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.215 1.406 . . . . 74.510000000000005 114.254 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -161.22 177.23 37.64 Favored Glycine 0 N--CA 1.427 -1.956 0 C-N-CA 117.637 -2.221 . . . . 65.140000000000001 116.552 -170.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -34.3 -19.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.576 1 C-N-CA 128.608 6.205 . . . . 73.340000000000003 120.367 -178.789 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' A' ' 147' ' ' ASP . 19.3 p90 -171.53 151.9 3.09 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.112 1.324 . . . . 63.109999999999999 113.698 171.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 1.1 m-20 -112.27 106.8 15.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.02 -1.474 . . . . 73.129999999999995 107.02 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.51 128.37 45.55 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.979 -0.688 . . . . 72.200000000000003 109.879 -177.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 33.9 p90 -165.94 165.34 18.17 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 111.927 0.343 . . . . 72.409999999999997 111.927 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 143' ' ' ILE . 46.7 t -125.6 138.19 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.296 -1.372 . . . . 54.210000000000001 107.296 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.26 128.13 34.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 111.642 0.238 . . . . 75.400000000000006 111.642 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.86 171.32 22.51 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.389 -0.684 . . . . 53.520000000000003 111.389 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 108' ' ' TRP . . . -63.31 -3.34 1.88 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 115.489 1.662 . . . . 75.430000000000007 115.489 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -100.33 -2.11 34.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.796 0.808 . . . . 73.349999999999994 109.739 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.95 38.86 64.4 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.037 -0.825 . . . . 62.119999999999997 111.037 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -138.84 147.87 43.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.056 -0.72 . . . . 74.200000000000003 109.056 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 7.2 pt-20 -97.99 103.33 15.26 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 105.976 -1.861 . . . . 74.209999999999994 105.976 165.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -151.53 -172.34 20.29 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.03 -1.441 . . . . 75.420000000000002 111.209 -171.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.57 8.76 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.472 -1.051 . . . . 74.129999999999995 110.472 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.562 ' N ' ' HB2' ' A' ' 141' ' ' ALA . 13.4 m 177.82 -177.67 0.21 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 127.663 2.385 . . . . 70.120000000000005 105.895 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -66.49 0.92 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 119.03 0.832 . . . . 73.120000000000005 110.341 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 130' ' ' ALA . 5.1 t30 -87.23 -27.71 22.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.108 0.956 . . . . 74.209999999999994 111.707 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 9.55 42.86 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.572 0.701 . . . . 63.219999999999999 111.448 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.562 ' HB2' ' N ' ' A' ' 137' ' ' SER . . . -103.36 157.41 17.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 115.129 -0.942 . . . . 31.23 109.466 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 134' ' ' GLU . 8.9 p-10 -78.45 127.23 31.88 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.991 -1.485 . . . . 74.450000000000003 106.991 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.8 pp -96.26 133.45 37.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.811 -1.181 . . . . 73.230000000000004 107.811 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.03 169.59 34.74 Favored Glycine 0 N--CA 1.414 -2.814 0 C-N-CA 117.685 -2.198 . . . . 62.229999999999997 114.276 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 58' ' ' ALA . 8.0 t30 -131.36 148.35 52.66 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.141 -1.8 . . . . 71.230000000000004 106.141 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -143.61 135.12 26.14 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.637 -0.825 . . . . 74.409999999999997 110.346 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.487 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 16.1 t0 -104.66 105.25 15.26 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 105.675 -1.972 . . . . 74.510000000000005 105.675 174.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 C--N 1.274 -2.696 0 N-CA-C 105.94 -1.874 . . . . 63.539999999999999 105.94 178.1 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.674 ' N ' ' HG1' ' A' ' 48' ' ' THR . 19.8 ttt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 65.040000000000006 109.449 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 m -96.18 91.3 5.85 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.676 0.75 . . . . 72.439999999999998 112.66 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 12.6 ptp180 -156.79 165.0 19.72 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 106.859 -1.534 . . . . 62.350000000000001 106.859 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -42.79 120.33 1.8 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 123.864 3.043 . . . . 74.140000000000001 114.608 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.65 -31.86 0.23 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 127.575 2.35 . . . . 65.219999999999999 113.048 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.498 ' HA ' HG23 ' A' ' 47' ' ' VAL . 10.7 mm100 -68.92 -22.78 64.14 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.967 -1.123 . . . . 70.439999999999998 107.967 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 48' ' ' THR . . . -63.74 -26.1 68.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.659 -1.155 . . . . 70.319999999999993 109.912 173.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HB3' ' CG ' ' A' ' 107' ' ' PRO . 63.3 mttp -80.6 -26.08 38.06 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.928 -0.768 . . . . 72.129999999999995 108.928 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.539 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 43.9 t -74.29 -44.57 48.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 122.054 0.931 . . . . 72.329999999999998 108.637 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.674 ' HG1' ' N ' ' A' ' 39' ' ' MET . 7.4 t -71.11 -30.99 67.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.474 -1.239 . . . . 75.340000000000003 112.071 -173.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.63 -40.21 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 120.321 -0.552 . . . . 73.439999999999998 110.124 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -60.53 -31.68 70.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.275 0.56 . . . . 61.409999999999997 111.122 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 29.6 mtpp -66.26 -25.43 66.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.989 0.899 . . . . 61.119999999999997 111.281 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.96 -30.49 31.55 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.737 -1.345 . . . . 63.450000000000003 109.737 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.688 ' O ' HG13 ' A' ' 57' ' ' ILE . 72.9 m-20 -73.33 -38.54 65.76 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.314 -0.443 . . . . 73.099999999999994 110.739 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.466 HD12 ' C ' ' A' ' 144' ' ' GLY . 19.0 pt -62.49 -36.2 73.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 121.209 -0.196 . . . . 64.340000000000003 111.052 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -66.87 -30.15 70.24 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.942 -0.703 . . . . 61.229999999999997 110.8 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -69.13 -44.35 72.54 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.677 -0.692 . . . . 72.439999999999998 111.048 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.688 HG13 ' O ' ' A' ' 53' ' ' ASP . 23.3 mt -63.52 -42.49 96.34 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-N 115.349 -0.841 . . . . 61.5 109.223 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.54 -27.71 67.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.863 -0.608 . . . . 72.129999999999995 111.618 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 62' ' ' ASP . . . -76.91 -30.63 56.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.618 0.723 . . . . 64.109999999999999 109.416 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.88 -24.45 38.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.172 -0.467 . . . . 73.230000000000004 110.115 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.91 -31.25 71.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.37 -1.344 . . . . 74.129999999999995 107.37 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 4.5 t70 -66.08 -28.82 69.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.174 -0.921 . . . . 71.420000000000002 109.66 170.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.8 ttm -82.82 -28.24 30.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.914 -0.585 . . . . 71.150000000000006 110.166 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -72.46 -34.35 67.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.318 -1.364 . . . . 74.140000000000001 107.318 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 62' ' ' ASP . 28.5 ttpp -57.5 -25.76 60.28 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.215 -0.902 . . . . 55.310000000000002 109.561 171.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.9 tp -87.3 -36.0 18.12 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 123.386 0.674 . . . . 75.209999999999994 111.365 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.51 -27.0 58.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.942 0.401 . . . . 75.109999999999999 110.398 -173.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -130.61 24.39 5.08 Favored 'General case' 0 CA--C 1.457 -2.621 0 N-CA-C 112.418 0.525 . . . . 71.099999999999994 112.418 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.1 p90 42.65 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 125.015 1.447 . . . . 75.349999999999994 113.948 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -179.24 161.74 1.13 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.747 -0.835 . . . . 63.149999999999999 108.747 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.54 ' CZ ' ' HD3' ' A' ' 65' ' ' LYS . 13.4 m-85 -78.89 155.52 77.75 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 123.617 0.573 . . . . 75.420000000000002 110.501 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.542 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 51.0 Cg_endo -73.81 160.74 43.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.341 2.028 . . . . 75.519999999999996 110.917 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -92.58 155.74 17.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.096 -1.816 . . . . 73.239999999999995 106.096 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.575 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.2 t -70.1 -7.32 40.49 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.61 1.095 . . . . 74.109999999999999 111.421 -176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -103.02 -66.89 0.91 Allowed 'General case' 0 N--CA 1.426 -1.652 0 O-C-N 121.934 -0.479 . . . . 61.340000000000003 110.877 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -84.17 -31.65 25.03 Favored 'General case' 0 CA--C 1.473 -2.014 0 CA-C-N 115.905 -0.589 . . . . 73.140000000000001 112.469 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -78.35 -21.32 70.25 Favored Glycine 0 N--CA 1.409 -3.126 0 C-N-CA 117.54 -2.267 . . . . 74.019999999999996 111.316 176.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.89 -46.67 70.99 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 106.602 -1.629 . . . . 64.239999999999995 106.602 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.0 -31.62 72.94 Favored 'General case' 0 N--CA 1.396 -3.174 0 CA-C-N 114.918 -1.037 . . . . 73.099999999999994 109.358 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.603 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -79.8 -2.21 42.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 73.510000000000005 111.917 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.611 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 63.3 mt -98.26 -24.56 15.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.915 -0.584 . . . . 55.310000000000002 110.28 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.42 -32.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.367 0.603 . . . . 51.229999999999997 110.687 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -117.66 146.43 43.7 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 125.266 1.426 . . . . 71.310000000000002 107.158 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -54.59 129.19 62.69 Favored Pre-proline 0 N--CA 1.433 -1.3 0 C-N-CA 123.506 0.722 . . . . 74.299999999999997 109.641 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -58.96 126.17 20.32 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 124.214 3.276 . . . . 75.120000000000005 113.163 -172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -96.62 91.49 5.77 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-O 122.051 0.929 . . . . 73.140000000000001 109.876 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.6 -126.33 1.18 Allowed Glycine 0 N--CA 1.422 -2.284 0 CA-C-N 114.365 -1.289 . . . . 72.120000000000005 110.03 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -126.56 91.93 46.29 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 117.208 0.504 . . . . 71.409999999999997 109.704 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -97.21 162.91 0.98 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.65 1.567 . . . . 71.310000000000002 110.632 172.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -90.33 159.08 42.56 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.41 -1.33 . . . . 63.420000000000002 107.41 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.05 98.18 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.441 1.427 . . . . 54.219999999999999 111.965 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -151.53 147.43 26.81 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.921 -2.251 . . . . 74.219999999999999 104.921 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.26 94.4 8.42 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.831 -0.748 . . . . 74.540000000000006 110.128 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 77.5 t90 -54.05 140.23 32.24 Favored 'General case' 0 C--O 1.251 1.156 0 C-N-CA 124.235 1.014 . . . . 70.299999999999997 112.665 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -115.6 132.25 56.69 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.052 -1.431 . . . . 72.340000000000003 109.56 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 14.8 ptmm? -79.15 -176.88 5.36 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 119.759 -0.776 . . . . 71.299999999999997 109.522 175.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 96' ' ' LYS . 7.2 t70 69.34 31.06 3.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.437 -1.256 . . . . 62.350000000000001 109.477 170.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 92.02 7.15 64.46 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-N 114.469 -1.241 . . . . 61.020000000000003 113.534 167.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 62.91 87.57 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.817 -1.179 . . . . 70.329999999999998 107.817 -169.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HG ' HG12 ' A' ' 57' ' ' ILE . 2.7 tt -129.96 149.88 51.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.902 -1.888 . . . . 73.510000000000005 105.902 -173.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -73.8 -178.74 3.32 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.011 -0.366 . . . . 75.430000000000007 110.011 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -82.21 73.61 9.23 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.582 1.182 . . . . 72.340000000000003 109.504 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -130.64 148.59 70.65 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.859 -1.973 . . . . 72.430000000000007 107.256 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.57 177.28 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.05 1.833 . . . . 73.409999999999997 111.117 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.545 HG21 ' HA ' ' A' ' 111' ' ' PRO . 3.3 p -82.41 174.67 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.521 -0.918 . . . . 73.310000000000002 108.521 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 110' ' ' ASN . 4.0 t70 -69.45 139.1 89.12 Favored Pre-proline 0 C--O 1.258 1.503 0 N-CA-C 110.579 -0.156 . . . . 42.43 110.579 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.449 ' CG ' ' HB3' ' A' ' 46' ' ' LYS . 6.3 Cg_endo -50.5 172.19 0.09 OUTLIER 'Trans proline' 0 C--O 1.193 -1.744 0 C-N-CA 124.13 3.22 . . . . 64.430000000000007 113.301 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.406 ' HE3' ' ND2' ' A' ' 110' ' ' ASN . 1.4 m-90 66.64 14.67 9.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.118 1.367 . . . . 71.209999999999994 109.057 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.21 32.17 81.38 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 55.210000000000001 114.671 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.482 ' HB2' ' OD2' ' A' ' 106' ' ' ASP . 90.8 m-20 -92.9 119.97 67.44 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 117.629 0.714 . . . . 73.129999999999995 110.698 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 105' ' ' VAL . 36.8 Cg_exo -68.41 139.58 45.7 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.291 1.327 . . . . 75.040000000000006 108.669 167.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.642 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 56.0 m-85 -68.36 144.74 54.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.051 0.453 . . . . 64.150000000000006 110.317 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.569 ' OE1' ' HG ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -102.3 114.06 27.9 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.839 -1.541 . . . . 61.229999999999997 106.839 -176.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.41 118.47 36.11 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.656 -1.239 . . . . 64.150000000000006 107.656 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.77 153.64 47.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.763 0.664 . . . . 71.129999999999995 109.223 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.788 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -121.85 -179.77 0.82 Allowed Pre-proline 0 N--CA 1.393 -3.302 0 N-CA-C 107.852 -1.166 . . . . 72.420000000000002 107.852 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.788 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 26.6 Cg_endo -57.82 128.43 29.04 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.066 1.844 . . . . 75.140000000000001 114.272 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.17 -89.3 0.44 Allowed Glycine 0 N--CA 1.411 -2.99 0 CA-C-N 114.131 -1.395 . . . . 61.219999999999999 111.051 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 p -108.85 101.75 10.83 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 123.028 0.531 . . . . 75.420000000000002 110.614 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp 72.63 -3.7 2.29 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.869 1.268 . . . . 63.439999999999998 112.444 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.3 123.55 7.29 Favored Glycine 0 N--CA 1.414 -2.792 0 CA-C-O 118.481 -1.177 . . . . 63.100000000000001 112.542 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 54.4 Cg_exo -60.63 -26.43 82.89 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.109 3.206 . . . . 73.030000000000001 110.84 165.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.1 p90 -173.81 168.08 4.33 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.61 0.764 . . . . 70.150000000000006 110.019 166.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.61 112.56 8.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.904 -1.147 . . . . 62.539999999999999 107.904 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.507 HD21 ' HB ' ' A' ' 57' ' ' ILE . 52.9 tp -128.14 123.97 35.72 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.213 -0.929 . . . . 64.120000000000005 110.505 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.439 ' HB3' ' HA3' ' A' ' 144' ' ' GLY . 53.5 p90 -168.06 169.06 11.45 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 120.889 -0.324 . . . . 55.109999999999999 111.474 -174.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.642 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 22.2 t -125.14 160.69 28.53 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.844 -1.539 . . . . 75.219999999999999 106.844 170.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.569 ' HG ' ' OE1' ' A' ' 113' ' ' GLN . 89.5 mt -68.83 167.1 16.26 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 123.307 0.38 . . . . 73.340000000000003 110.636 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -90.65 -170.81 43.51 Favored Glycine 0 CA--C 1.496 -1.143 0 C-N-CA 119.419 -1.372 . . . . 73.299999999999997 111.77 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.65 -15.1 36.77 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.391 0.676 . . . . 71.340000000000003 112.731 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -94.45 -9.38 35.71 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.205 0.526 . . . . 74.150000000000006 110.714 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.8 23.73 66.29 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 121.109 -0.567 . . . . 73.409999999999997 112.167 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.01 148.62 42.12 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.47 -0.937 . . . . 62.409999999999997 108.47 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.44 105.98 18.06 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.693 0.759 . . . . 53.340000000000003 110.835 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 141' ' ' ALA . . . -150.02 -174.32 21.16 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.148 -0.933 . . . . 52.049999999999997 111.234 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.74 129.58 9.94 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.577 -1.409 . . . . 61.25 109.577 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.3 m -177.74 -178.49 0.72 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 124.604 1.162 . . . . 63.409999999999997 108.275 -171.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -99.67 -25.99 14.21 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.754 -0.378 . . . . 72.209999999999994 111.933 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.88 -33.45 2.93 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.608 0.718 . . . . 43.329999999999998 110.038 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -95.38 15.21 20.1 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.909 -0.587 . . . . 63.119999999999997 110.897 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 135' ' ' GLY . . . -87.27 155.32 20.12 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-N 115.994 -0.548 . . . . 63.409999999999997 110.043 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.73 129.11 34.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.901 -1.518 . . . . 74.010000000000005 106.901 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.571 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.9 pp -96.48 115.92 37.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-O 121.472 0.653 . . . . 75.200000000000003 109.301 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.466 ' C ' HD12 ' A' ' 54' ' ' ILE . . . -163.97 177.81 39.61 Favored Glycine 0 N--CA 1.417 -2.57 0 C-N-CA 118.756 -1.688 . . . . 72.299999999999997 113.719 -176.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.48 146.05 16.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.26 -1.385 . . . . 72.219999999999999 107.26 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 16.2 p90 -157.41 168.76 26.4 Favored 'General case' 0 C--N 1.267 -2.999 0 CA-C-O 120.972 0.415 . . . . 74.230000000000004 110.798 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 122' ' ' PRO . 17.3 t70 -105.87 125.19 50.7 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.069 -1.456 . . . . 43.5 107.069 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.524 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 4.0 p-10 . . . . . 0 N--CA 1.421 -1.882 0 O-C-N 125.01 1.444 . . . . 61.409999999999997 108.553 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.643 ' N ' ' HG1' ' A' ' 48' ' ' THR . 46.5 tpp . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.692 0.282 . . . . 64.310000000000002 110.764 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.3 t -105.87 91.79 3.89 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.91 -0.494 . . . . 65.540000000000006 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -148.69 164.95 19.28 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 106.547 -1.649 . . . . 72.329999999999998 106.547 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 44' ' ' GLN . 51.7 Cg_exo -46.98 120.5 4.22 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.204 2.602 . . . . 70.430000000000007 112.939 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t70 73.34 -30.07 0.21 Allowed 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 127.135 2.174 . . . . 64.409999999999997 110.928 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.481 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 14.0 mm100 -68.02 -25.17 65.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.224 -0.898 . . . . 74.299999999999997 109.516 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.48 65.37 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.314 -0.857 . . . . 71.120000000000005 110.328 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -87.65 -26.69 22.9 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.457 -0.942 . . . . 64.319999999999993 108.457 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 37.6 t -74.71 -44.6 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.71 0.767 . . . . 41.200000000000003 109.261 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.643 ' HG1' ' N ' ' A' ' 39' ' ' MET . 14.2 t -59.85 -38.18 81.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.326 -1.306 . . . . 73.329999999999998 112.889 -172.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -84.37 -34.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 119.88 -0.728 . . . . 44.299999999999997 110.442 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' A' ' 143' ' ' ILE . . . -60.2 -32.99 71.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.136 -0.484 . . . . 75.129999999999995 111.813 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 12.2 mmmm -65.73 -25.33 67.24 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.993 0.902 . . . . 75.430000000000007 110.048 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.6 -22.54 39.58 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.632 -0.987 . . . . 60.439999999999998 110.632 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 57' ' ' ILE . 75.5 m-20 -82.76 -38.48 23.15 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 120.671 0.272 . . . . 75.540000000000006 110.27 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.7 pt -64.02 -32.53 57.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.432 -0.581 . . . . 75.129999999999995 109.432 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -33.03 73.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.907 -0.588 . . . . 65.329999999999998 110.621 176.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.64 74.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.023 -0.535 . . . . 63.219999999999999 110.334 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 53' ' ' ASP . 55.3 mt -65.09 -37.83 81.21 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 CA-C-N 115.755 -0.657 . . . . 72.319999999999993 110.268 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.57 67.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.219 0.533 . . . . 74.040000000000006 111.06 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.27 -19.99 24.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.194 0.521 . . . . 34.219999999999999 110.251 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -29.02 21.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.226 0.536 . . . . 73.200000000000003 110.115 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.92 -30.27 67.64 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.688 -1.597 . . . . 73.239999999999995 106.688 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 31.8 t70 -73.15 -20.51 60.89 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.351 -1.295 . . . . 72.099999999999994 109.428 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.2 ttt -79.18 -34.32 43.14 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 115.747 -0.661 . . . . 75.420000000000002 109.367 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.438 ' OH ' ' HB3' ' A' ' 85' ' ' PRO . 1.3 t80 -64.05 -39.66 94.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.695 -1.595 . . . . 74.230000000000004 106.695 172.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 71' ' ' TYR . 76.7 tttt -54.61 -33.02 59.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.813 -1.085 . . . . 64.409999999999997 110.304 175.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 99.3 mt -82.83 -36.2 25.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.137 -0.483 . . . . 74.439999999999998 111.522 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.16 -25.26 63.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.255 0.465 . . . . 62.140000000000001 112.255 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 12.0 m-80 -128.67 18.94 6.21 Favored 'General case' 0 CA--C 1.442 -3.209 0 O-C-N 121.962 -0.461 . . . . 64.319999999999993 111.062 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 p90 43.37 33.51 0.62 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 125.13 1.519 . . . . 74.109999999999999 112.558 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -177.52 156.3 1.16 Allowed 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.709 -1.219 . . . . 64.109999999999999 107.709 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 65' ' ' LYS . 28.3 m-85 -78.83 148.6 72.72 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 123.254 0.347 . . . . 64.010000000000005 111.257 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.587 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 33.6 Cg_endo -66.4 158.41 55.4 Favored 'Trans proline' 0 C--O 1.207 -1.056 0 C-N-CA 122.892 2.394 . . . . 43.240000000000002 109.752 174.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.464 ' N ' ' HA3' ' A' ' 77' ' ' GLY . 47.4 p -94.01 156.71 16.46 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.841 -1.17 . . . . 74.430000000000007 107.841 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 1.5 t -66.38 -13.09 60.14 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 119.9 1.227 . . . . 72.430000000000007 111.165 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -102.21 -64.75 1.04 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 121.982 -0.449 . . . . 61.039999999999999 111.162 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -40.26 60.52 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 109.096 -0.705 . . . . 61.530000000000001 109.096 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' A' ' 80' ' ' ALA . . . -72.52 -20.75 79.61 Favored Glycine 0 N--CA 1.407 -3.27 0 C-N-CA 119.717 -1.23 . . . . 14.34 113.665 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.06 -47.31 62.49 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.349 -1.352 . . . . 74.239999999999995 107.349 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.56 -32.11 70.05 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 115.571 -0.74 . . . . 65.540000000000006 110.177 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.611 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . -83.64 -5.54 59.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.786 0.661 . . . . 51.310000000000002 112.786 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 42.1 mt -93.14 -24.21 18.33 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.506 0.669 . . . . 65.310000000000002 109.822 174.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 t -102.72 -35.63 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.403 -0.817 . . . . 75.299999999999997 110.533 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 95.4 mttt -126.51 150.9 48.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.732 -1.581 . . . . 54.439999999999998 106.732 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -54.22 141.15 52.25 Favored Pre-proline 0 N--CA 1.48 1.063 0 N-CA-C 113.244 0.831 . . . . 74.140000000000001 113.244 -172.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HB3' ' OH ' ' A' ' 64' ' ' TYR . 30.2 Cg_endo -61.15 152.66 70.23 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.974 3.116 . . . . 45.439999999999998 114.551 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -110.78 111.19 22.19 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 114.14 -1.391 . . . . 65.019999999999996 110.219 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.53 -121.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.769 -0.729 . . . . 70.439999999999998 111.583 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -136.96 91.91 14.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 C-N-CA 121.136 -0.226 . . . . 73.319999999999993 110.527 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 18.3 Cg_endo -95.27 161.54 1.6 Allowed 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 121.925 1.75 . . . . 74.209999999999994 110.596 172.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -87.63 159.26 49.92 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 106.76 -1.57 . . . . 71.230000000000004 106.76 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.55 99.31 0.31 Allowed 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 120.906 1.07 . . . . 73.540000000000006 110.684 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -150.84 149.33 29.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.571 -1.64 . . . . 74.109999999999999 106.571 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -66.01 97.58 0.38 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.007 0.743 . . . . 74.319999999999993 113.007 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.558 ' HA ' ' OH ' ' A' ' 99' ' ' TYR . 90.1 t90 -71.94 143.5 49.26 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.752 -0.658 . . . . 74.450000000000003 109.573 171.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -134.95 137.4 43.06 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.604 -0.517 . . . . 73.430000000000007 109.604 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' HG3' ' OD2' ' A' ' 97' ' ' ASP . 22.4 pttp -76.46 -166.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.142 -0.688 . . . . 74.349999999999994 109.142 175.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' A' ' 96' ' ' LYS . 41.0 m-20 66.32 8.65 5.8 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 124.437 1.095 . . . . 73.299999999999997 112.509 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 81' ' ' LEU . . . 96.0 21.02 24.31 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 115.212 -0.904 . . . . 33.049999999999997 111.771 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.6 93.51 0.08 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.322 1.058 . . . . 63.219999999999999 111.101 -177.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.43 152.67 48.73 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.122 -0.944 . . . . 63.039999999999999 108.98 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.83 -169.05 2.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.976 -1.12 . . . . 74.230000000000004 107.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -72.75 70.69 0.98 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 122.747 1.261 . . . . 65.219999999999999 110.492 174.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.43 148.54 70.52 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 125.765 1.626 . . . . 62.130000000000003 108.331 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.63 -168.76 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.425 2.083 . . . . 73.140000000000001 110.754 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.649 ' CG2' ' HA ' ' A' ' 111' ' ' PRO . 2.7 p -86.41 174.25 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 106.576 -1.638 . . . . 61.340000000000003 106.576 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.424 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 4.3 t70 -97.37 151.59 37.75 Favored Pre-proline 0 C--O 1.252 1.193 0 C-N-CA 117.255 -1.778 . . . . 71.150000000000006 110.818 -173.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -38.79 171.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.824 3.683 . . . . 54.219999999999999 115.383 166.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.585 ' HB2' HD22 ' A' ' 110' ' ' ASN . 3.5 m-90 67.9 14.5 9.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.386 -1.733 . . . . 71.329999999999998 107.064 -171.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.31 29.22 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 114.052 -1.431 . . . . 72.439999999999998 114.497 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.585 HD22 ' HB2' ' A' ' 108' ' ' TRP . 54.1 m-80 -92.14 131.57 34.6 Favored Pre-proline 0 C--O 1.261 1.661 0 CA-C-N 117.941 0.871 . . . . 73.340000000000003 112.162 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.649 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 16.1 Cg_exo -70.15 148.88 63.52 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.356 2.037 . . . . 75.019999999999996 109.516 170.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.519 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 27.7 m-85 -69.59 140.31 53.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.199 -1.0 . . . . 70.010000000000005 108.588 175.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -101.57 115.04 29.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.74 -1.578 . . . . 74.329999999999998 106.74 -173.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.92 119.81 39.51 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.88 -1.054 . . . . 72.5 112.319 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 83.0 mt -128.57 143.9 51.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.242 -1.021 . . . . 75.400000000000006 108.242 172.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.758 ' HB1' ' HD2' ' A' ' 117' ' ' PRO . . . -111.17 -178.21 0.52 Allowed Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 107.525 -1.287 . . . . 50.25 107.525 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.758 ' HD2' ' HB1' ' A' ' 116' ' ' ALA . 37.3 Cg_endo -60.88 130.62 33.6 Favored 'Trans proline' 0 CA--C 1.486 -1.922 0 CA-C-N 121.734 1.655 . . . . 61.399999999999999 114.678 -175.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -121.15 -89.83 1.08 Allowed Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 113.028 -1.896 . . . . 42.340000000000003 110.889 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.3 m -105.06 106.25 16.65 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 107.675 -1.231 . . . . 71.209999999999994 107.675 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt 62.39 -16.22 0.05 Allowed 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 127.962 2.505 . . . . 65.099999999999994 115.348 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -102.22 113.15 4.52 Favored Glycine 0 CA--C 1.477 -2.343 0 CA-C-O 118.128 -1.373 . . . . 72.319999999999993 113.751 -174.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 117' ' ' PRO . 34.8 Cg_exo -46.02 -22.76 1.51 Allowed 'Trans proline' 0 C--N 1.376 1.974 1 C-N-CA 126.511 4.807 . . . . 70.040000000000006 116.264 177.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 146' ' ' TRP . 53.2 p90 179.91 166.76 1.24 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.97 0.508 . . . . 64.430000000000007 110.571 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . 7.5 m-20 -139.53 108.97 6.15 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 124.069 0.856 . . . . 73.010000000000005 109.251 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -123.46 130.27 52.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.332 -0.547 . . . . 72.239999999999995 110.085 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -166.88 161.91 15.52 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 116.544 -0.298 . . . . 74.299999999999997 110.714 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.519 ' HB2' ' CD1' ' A' ' 112' ' ' TYR . 25.1 t -126.01 135.99 52.45 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.573 -1.269 . . . . 73.319999999999993 107.573 171.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.23 133.53 55.3 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.089 0.403 . . . . 62.43 112.089 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -86.14 -159.19 32.2 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.889 -0.596 . . . . 55.409999999999997 113.384 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -13.05 47.74 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.763 1.394 . . . . 71.540000000000006 114.763 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 140' ' ' ASP . 36.7 t70 -94.95 -10.09 32.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 119.812 -0.755 . . . . 70.519999999999996 110.181 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.18 70.95 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.736 -0.665 . . . . 73.200000000000003 112.538 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -140.7 137.75 33.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.469 -0.938 . . . . 73.140000000000001 108.469 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.34 112.88 12.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.245 0.545 . . . . 61.149999999999999 109.62 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.44 -173.61 20.79 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 108.857 -1.697 . . . . 32.520000000000003 108.857 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.51 126.3 8.3 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 118.706 -1.711 . . . . 71.219999999999999 109.861 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 141' ' ' ALA . 28.6 m 178.08 -178.67 0.26 Allowed 'General case' 0 C--O 1.251 1.146 0 C-N-CA 127.094 2.158 . . . . 73.420000000000002 106.713 -174.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.01 -56.72 2.76 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.293 -0.563 . . . . 63.409999999999997 112.501 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -107.74 -23.64 12.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 120.239 -0.584 . . . . 74.420000000000002 111.391 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 10.4 m-20 -76.11 -28.82 57.64 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 121.964 0.888 . . . . 62.409999999999997 109.242 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 137' ' ' SER . . . -80.8 159.41 25.14 Favored 'General case' 0 CA--C 1.47 -2.131 0 CA-C-N 113.572 -1.649 . . . . 44.329999999999998 111.033 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -76.65 135.5 39.13 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 107.027 -1.471 . . . . 54.020000000000003 107.027 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.506 ' O ' HD12 ' A' ' 143' ' ' ILE . 2.3 pp -97.71 128.85 48.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.394 -0.821 . . . . 65.209999999999994 110.295 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -172.55 -179.74 43.55 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 119.325 -1.417 . . . . 73.420000000000002 112.269 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.52 155.13 17.07 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.068 -1.456 . . . . 64.540000000000006 107.068 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.456 ' HB2' ' O ' ' A' ' 123' ' ' PHE . 3.2 p90 -165.69 177.51 7.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.191 0.519 . . . . 73.140000000000001 111.435 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -116.1 125.59 52.59 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.398 -1.704 . . . . 61.140000000000001 106.398 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.537 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 41.0 t30 . . . . . 0 C--N 1.304 -1.388 0 N-CA-C 108.211 -1.033 . . . . 73.450000000000003 108.211 -177.4 . . . . . . . . 1 1 . 1 stop_ save_